Citrus Sinensis ID: 009186

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-
Protein Sequence
MNMQVIFVFVTGLSLQISLTRAYDKPTYIYHNCPRTNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGHEPNKVYGLFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFFSVLDTSFRLSLWNVENSPSRSFDQFVWNSMNEAVNQALSTTKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFYNDTSNGTLPPVFFSPPSPGSVTSSKGGKGKKATWIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHHHHccccccccccEEEEcccccccccEEEEEEccccccHHHHHHHHHHHHHHHHHHccccccEEEEEccEEEEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccEEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHccccccccccccccEEEcccccEEEcccccccccccccccccccccccccccccccccccccccEEEEEEEEEHHHHHHHHccEEcccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccccccccccccEEccccccccccccEEEEccccccHHHHcccccccccccccccEEEEEEEccccccccccccccccHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccEEEccccccccccccccccccccccEEEEEcccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHcHHHcccccccccccccEcccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHccccccEEEEEccEEEEEccccHccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccEEEEEEEccccccEEEEEEEEcccccHHHHHHHHHHHHHHccHHccccccEEEEccEEEEEEcccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccEEEEccHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEcccccccccccEEEEEccHccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccccEEEEcHcHcccccHHHHHHHHHHHHHEEcccHcccccHHEEEEEEcccccccccccccEEEEEcccccccccccccccccccccEEEEEEccc
Coil and Loop (DISEMBL)
MNMQVIFVFVTGLSLQisltraydkptyiyhncprtnftpnsaYQSNLNLLLSTLrsnatrgssdkfskgfyntttghepnkvyglflcrgdfgtetcqnCVSVATSytaqlcpfgkentiEYEECLLrysnisffsvLDTSFRLslwnvenspsrsfDQFVWNSMNEAVNQALSTTKMFATVKKNYTASQTLYSLVqctpdlsrddcSRCLRlaispldgccsikiggrvmypscnfRYELYQFyndtsngtlppvffsppspgsvtsskggkgkkatWIAIGTIITTITLFILLGSFVwcrrrinkdstkgaqlDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTsnvlldhemnpkisdfgmarifsgnqneantnrvagtygymapeyamEGVFSVKSDVFSFGVLLLEIISgkrnsgfylseHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLlcvqedpahrpnmSSVVVMLAsdtatlppptqpafsvdriaaksgqssssgskfcsvneitlsnvypr
Flexible Loop (DISEMBL)
MNMQVIFVFVTGLSLQISLTRAYDKPTYIYHNCPRTNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGHEPNKVYGLFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFFSVLDTSFRLSLWNVENSPSRSFDQFVWNSMNEAVNQALSTTKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAispldgccsikIGGRVMYPSCNFRYELYQFYNDTSNGTLPPVFFSPPSPGSvtsskggkgkkATWIAIGTIITTITLFILLGSFVWCRRRinkdstkgaqldwkrrISIINGIARGLLYLHEDSRLRVIHRDLKtsnvlldheMNPKISDFGMARIFsgnqneantnRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSVDRIAAKsgqssssgskfcsvneitlsnvypr
Low Complexity Region (SEG)
MNMQVIFVFVTGLSLQISLTRAYDKPTYIYHNCPRTNFTPNSAYQsnlnlllstlrsnATRGSSDKFSKGFYNTTTGHEPNKVYGLFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFFSVLDTSFRLSLWNVENSPSRSFDQFVWNSMNEAVNQALSTTKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFYNDTSNGTLppvffsppspgsvtsskggkgkkAtwiaigtiittitlfillGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSVDRIAAKsgqssssgsKFCSVNEITLSNVYPR
Disordered region (IsUnstruct)
***QVIFVFVTGLSLQISLTRAYDKPTYIYHNCPRTNFTPNSAYQSNLNLLLSTL*************KGFYNTTTGHEPNKVYGLFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFFSVLDTSFRLSLWNVENSPSRSFDQFVWNSMNEAVNQALSTTKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFYNDTSNGTLPPVF********************TWIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQE**********VVVM*************************************************
Disordered Region (DISOPRED)
**MQVIFVFVTGLSLQISLTRAYDKPTYIYHNCPRTNFTPNSAYQSNLNLLLSTLRSNA*******FSKGFYNTTTGHEPNKVYGLFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFFSVL*************************SMNEAVNQALSTTKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFY**********************************IAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFS***********************ITLSNVYPR
Disordered Region (DISEMBL)
MNMQVIFVFVTGLSLQISLTRAYDKPTYIYHNCPRTNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGHEPNKVYGLFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFFSVLDTSFRLSLWNVENSPSRSFDQFVWNSMNEAVNQALSTTKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFYNDTSNGTLPPVFFSP***************KATWIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSVDRI*************FCSVNEITLSNVYPR
Disordered Region (DISPRO)
*NMQVIFVFVTGLSLQISLTRAYDKPTYIYHNCPRTNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGHEPNKVYGLFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFFSVLDTSFRLSLWNVENSPSRSFDQFVWNSMNEAVNQALSTTKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFYNDTSNGTLPPVFFSPPSPGSV**SKGGKGKKATWIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSVDRI**************CSVNEITLSNVYPR
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNMQVIFVFVTGLSLQISLTRAYDKPTYIYHNCPRTNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGHEPNKVYGLFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFFSVLDTSFRLSLWNVENSPSRSFDQFVWNSMNEAVNQALSTTKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFYNDTSNGTLPPVFFSPPSPGSVTSSKGGKGKKATWIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	541	2.2.26 [Sep-21-2011]
Q9C5S9	674	Cysteine-rich receptor-li	yes	no	0.504	0.405	0.512	6e-81
O81906	849	G-type lectin S-receptor-	no	no	0.428	0.273	0.646	2e-80
O65468	676	Cysteine-rich receptor-li	no	no	0.504	0.403	0.505	8e-80
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.430	0.348	0.570	3e-79
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.410	0.260	0.627	1e-76
Q39086	843	Receptor-like serine/thre	no	no	0.430	0.276	0.588	3e-76
Q8L7G3	659	Cysteine-rich receptor-li	no	no	0.426	0.350	0.552	3e-76
Q9SY89	842	Putative G-type lectin S-	no	no	0.426	0.274	0.566	2e-75
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.212	0.183	0.608	4e-75
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.428	0.275	0.579	7e-75

>sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  301 bits (772), Expect = 6e-81,   Method: Compositional matrix adjust.
 Identities = 149/291 (51%), Positives = 205/291 (70%), Gaps = 18/291 (6%)

Query: 269 SSKGGKGKKATWIAIGTIITTITLFILLGSFVWCRRRI-------NK-------DSTKGA 314
           +S+ G+ +  T + +   +    L  LLG  +    RI       NK       D TK  
Sbjct: 384 NSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQI 443

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QLDW +R +II GIARG+LYLH+DSRL +IHRDLK SN+LLD ++NPKI+DFGMARIF  
Sbjct: 444 QLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGL 503

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
           +Q + NT+R+ GTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISG++NS F  S+  Q 
Sbjct: 504 DQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGESDGAQD 563

Query: 435 LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA 494
           LLT+AW+LW   +AL+L+DP++ + C ++E+++CIHIGLLCVQEDPA RP +S+V +ML 
Sbjct: 564 LLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAISTVFMMLT 623

Query: 495 SDTATLPPPTQPAFSVDRIAAK----SGQSSSSGSKFCSVNEITLSNVYPR 541
           S+T TLP P QP F +   A K    S QS+++ S   S+++ +++++YPR
Sbjct: 624 SNTVTLPVPRQPGFFIQCRAVKDPLDSDQSTTTKSFPASIDDESITDLYPR 674

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  300 bits (768), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 152/235 (64%), Positives = 176/235 (74%), Gaps = 3/235 (1%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D TK A +DWK R SII GIARGLLYLH DSRLR+IHRDLK SNVLLD EMNPKISDFGM
Sbjct: 616 DETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGM 675

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           ARIF GNQNEANT RV GTYGYM+PEYAMEG+FSVKSDV+SFGVLLLEI+SGKRN+    
Sbjct: 676 ARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRS 735

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           SEHG SL+ YAW L+  G + EL+DP ++ TC   E L+CIH+ +LCVQ+  A RPNM+S
Sbjct: 736 SEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMAS 794

Query: 489 VVVMLASDTATLPPPTQPAFSVDRIAAKSGQSS--SSGSKFCSVNEITLSNVYPR 541
           V++ML SDTATL  P QP F+  R  +     +  SS     S NEIT + V  R
Sbjct: 795 VLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  298 bits (763), Expect = 8e-80,   Method: Compositional matrix adjust.
 Identities = 147/291 (50%), Positives = 200/291 (68%), Gaps = 18/291 (6%)

Query: 269 SSKGGKGKKATWIAIGTIITTITLFILLGSFVWCRRRI-------NK-------DSTKGA 314
           +S+ G+ +  T + +   +    L  LLG  +    RI       NK       D TK  
Sbjct: 386 NSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQT 445

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QLDW +R +II GIARG+LYLH+DSRL +IHRDLK SN+LLD ++NPKI+DFGMARIF  
Sbjct: 446 QLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGL 505

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
           +Q + NT+R+ GTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISG++NS F  S+  Q 
Sbjct: 506 DQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQD 565

Query: 435 LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA 494
           LLT+ W+LW    AL+L+DP++   C ++E+++CIHIGLLCVQEDPA RP +S+V +ML 
Sbjct: 566 LLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLT 625

Query: 495 SDTATLPPPTQPAFSVDRIAAK----SGQSSSSGSKFCSVNEITLSNVYPR 541
           S+T TLP P QP F +     K    S QS+++ S   S+++  ++++YPR
Sbjct: 626 SNTVTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  296 bits (758), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 134/235 (57%), Positives = 176/235 (74%), Gaps = 2/235 (0%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  K  QLDW RR  II G+ARG+LYLH+DSRL +IHRDLK SN+LLD +MNPKI+DFGM
Sbjct: 435 DPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGM 494

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           ARIF  +Q E NT+R+ GTYGYM+PEYAM G +S+KSDV+SFGVL+LEIISGK+NS FY 
Sbjct: 495 ARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQ 554

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           ++    L++YAW LW  G  LEL+DP + + C   E+++C+HIGLLCVQEDPA RP +S+
Sbjct: 555 TDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLST 614

Query: 489 VVVMLASDTATLPPPTQPA-FSVDRIAAKS-GQSSSSGSKFCSVNEITLSNVYPR 541
           +V+ML S+T TLP P QP  F   RI        ++S S   SV++ ++++++PR
Sbjct: 615 IVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  287 bits (735), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 140/223 (62%), Positives = 175/223 (78%), Gaps = 1/223 (0%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LDWK R +II GIARGLLYLH+DSRLR+IHRDLKTSN+LLD EMNPKISDFG+ARIF G
Sbjct: 625 RLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGG 684

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
           ++  ANTNRV GTYGYM+PEYA+EG+FS KSDVFSFGV+++E ISGKRN+GF+  E   S
Sbjct: 685 SETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLS 744

Query: 435 LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML- 493
           LL +AW LW     +EL+D  L+++C     LKC+++GLLCVQEDP  RP MS+VV ML 
Sbjct: 745 LLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLG 804

Query: 494 ASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLS 536
           +S+ ATLP P QPAF + R  + S  SSS+  + CS NE+T++
Sbjct: 805 SSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTIT 847

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  286 bits (732), Expect = 3e-76,   Method: Compositional matrix adjust.
 Identities = 140/238 (58%), Positives = 172/238 (72%), Gaps = 5/238 (2%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D T+ + L+W++R  IINGIARGLLYLH+DSR R+IHRDLK SNVLLD  M PKISDFGM
Sbjct: 606 DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGM 665

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           ARIF   + EANT RV GTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEIISGKRN GFY 
Sbjct: 666 ARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYN 725

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPV----LKQTCVDAELLKCIHIGLLCVQEDPAHRP 484
           S    +LL + W+ W +G  LE++DP+    L       E+L+CI IGLLCVQE    RP
Sbjct: 726 SNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRP 785

Query: 485 NMSSVVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSG-SKFCSVNEITLSNVYPR 541
            MSSV+VML S+T  +P P +P F + R   ++  SSS+     C+VN+ITLS +  R
Sbjct: 786 VMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1

 Score =  286 bits (732), Expect = 3e-76,   Method: Compositional matrix adjust.
 Identities = 132/239 (55%), Positives = 178/239 (74%), Gaps = 8/239 (3%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  K  QL W +R  II GIARG+LYLH+DSRL +IHRDLK SN+LLD +MNPKI+DFGM
Sbjct: 423 DPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGM 482

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           ARIF  +Q + NT+R+ GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISG++N+ F  
Sbjct: 483 ARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIE 542

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           ++  Q L+T+AW+LW  G AL+L+DP +  +C  +E+++C HIGLLCVQEDP  RP MS+
Sbjct: 543 TDDAQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMST 602

Query: 489 VVVMLASDTATLPPPTQPAFSV------DRIAAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           + VML S+T  LP P QP F V      +R+   S QS+++ S   S+++ ++S++ PR
Sbjct: 603 ISVMLTSNTMALPAPQQPGFFVRSRPGTNRL--DSDQSTTNKSVTVSIDDKSMSDLDPR 659

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  283 bits (725), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 132/233 (56%), Positives = 172/233 (73%), Gaps = 2/233 (0%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D +K   LDW++R  +I GIARGLLYLH DSRL++IHRDLK SN+LLD EMNPKISDFGM
Sbjct: 612 DESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGM 671

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           ARIF+  Q+ ANT RV GTYGYMAPEYAMEG+FS KSDV+SFGVL+LEI+SG++N  F  
Sbjct: 672 ARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRG 731

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           ++HG SL+ YAW LW +G+  E++DP++K T    E ++CIH+G+LC Q+   HRPNM S
Sbjct: 732 TDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGS 790

Query: 489 VVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           V++ML S T+ LPPP QP F    + +   + +  G    SVN++T + +  R
Sbjct: 791 VLLMLESQTSQLPPPRQPTFH-SFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  282 bits (722), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 123/202 (60%), Positives = 160/202 (79%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  K  QLDW RR  +I GIARG+LYLH+DSRL +IHRDLK SN+LLD +MNPK++DFG+
Sbjct: 424 DPAKQNQLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGL 483

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           ARIF  +Q + NT+R+ GT+GYMAPEYA+ G FSVKSDV+SFGVL+LEIISGK+N+ FY 
Sbjct: 484 ARIFGMDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYE 543

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           ++    L+T+AW+LW  G AL+L+DP++   C  +E+++CIHI LLCVQEDPA RP +S+
Sbjct: 544 TDGAHDLVTHAWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILST 603

Query: 489 VVVMLASDTATLPPPTQPAFSV 510
           + +ML S+T TLP P QP F V
Sbjct: 604 IFMMLTSNTVTLPVPLQPGFPV 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  281 bits (720), Expect = 7e-75,   Method: Compositional matrix adjust.
 Identities = 135/233 (57%), Positives = 167/233 (71%), Gaps = 1/233 (0%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  K   LDWK R +I+ GI RGLLYLH DSRL++IHRDLK SN+LLD  +NPKISDFG+
Sbjct: 611 DPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGL 670

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           ARIF  N++EANT RV GTYGYM+PEYAMEG FS KSDVFS GV+ LEIISG+RNS  + 
Sbjct: 671 ARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHK 730

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
            E+  +LL YAWKLW  GEA  L DP +   C + E+ KC+HIGLLCVQE    RPN+S+
Sbjct: 731 EENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSN 790

Query: 489 VVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           V+ ML ++  +L  P QPAF V R  A   +SS   S+  S+N+++L+ V  R
Sbjct: 791 VIWMLTTENMSLADPKQPAFIVRR-GASEAESSDQSSQKVSINDVSLTAVTGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	541
224113919	532	predicted protein [Populus trichocarpa]	0.855	0.870	0.464	1e-118
296088918	519	unnamed protein product [Vitis vinifera]	0.879	0.917	0.432	1e-115
224113927	381	predicted protein [Populus trichocarpa]	0.425	0.603	0.745	4e-99
356554939	662	PREDICTED: cysteine-rich receptor-like p	0.428	0.350	0.733	1e-98
356546303	662	PREDICTED: cysteine-rich receptor-like p	0.428	0.350	0.708	3e-96
224076400	666	predicted protein [Populus trichocarpa]	0.426	0.346	0.725	3e-96
356554943	670	PREDICTED: cysteine-rich receptor-like p	0.428	0.346	0.703	5e-94
356574376	585	PREDICTED: LOW QUALITY PROTEIN: cysteine	0.878	0.811	0.404	9e-94
356510387	647	PREDICTED: cysteine-rich receptor-like p	0.428	0.358	0.721	2e-93
255555021	686	ATP binding protein, putative [Ricinus c	0.426	0.336	0.699	6e-93

>gi|224113919|ref|XP_002316614.1| predicted protein [Populus trichocarpa] gi|222859679|gb|EEE97226.1| predicted protein [Populus trichocarpa]

 Score =  431 bits (1109), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 253/545 (46%), Positives = 322/545 (59%), Gaps = 82/545 (15%)

Query: 28  YIYHNCPRTN-FTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGHEPNKVYGL 86
           Y YH C  T  F  NS YQ+NLN+LLS+L SNATR   +    GFYN +TGH+  +VYGL
Sbjct: 6   YRYHFCQNTTTFVRNSTYQANLNILLSSLASNATRNDIN----GFYNASTGHDLYEVYGL 61

Query: 87  FLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFFSVLDTSFRLS 146
           FLCR D   E CQN    ++    QLCP  +  T+  E C LR+SN +F   LD S  + 
Sbjct: 62  FLCRSDVSVEVCQN----SSQDIMQLCPNNRNATVWEELCQLRFSNKNFIGQLDISGNIL 117

Query: 147 LWN---VENSPSRSFDQFVWNSMNEAVNQALS----------TTKMFATVKKNYTASQTL 193
           L N   +ENS      Q++       VN+  S          T  M+AT K   +   TL
Sbjct: 118 LANKETIENS-----GQYI-----SVVNEKFSNLTKKAAFDPTQNMYATGKLALSDIDTL 167

Query: 194 YSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFYNDTSN-- 251
           Y+L QCT DLS  DC+ CL++AI  +  CC I  G R++  SC FR+ELY FY  T++  
Sbjct: 168 YTLGQCTTDLSSHDCNTCLQVAIQNISSCCYIGRGQRLLSQSCYFRFELYPFYEGTADSV 227

Query: 252 ----------------GT-LPPVFFSPPSPGSVT-----SSKGGKGKKAT-----WIAIG 284
                           GT +P V  +  +   +        K  +G K +     W+   
Sbjct: 228 YNFPIGETLTILKIVLGTCIPTVVLAFLTASCIIYFRRIRRKETEGNKVSSEELPWMMDL 287

Query: 285 TIITTIT----LFILLGS---------------FVWCRRRINKD--STKGAQLDWKRRIS 323
           ++I   T    +   LG                F  C +RI +    TK A+LDW  RI 
Sbjct: 288 SVIRAATDNFSVSNKLGQGGFGSVYKVNNTSTLFFMCLQRILEKFYPTKRAELDWSSRID 347

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           IINGIA+G+LYLHEDSRLR+IHRDLK SNVLLD+EMNPKISDFGMARIFS N++EANT R
Sbjct: 348 IINGIAKGMLYLHEDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARIFSSNEDEANTAR 407

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW 443
           + GTYGYMAPEYAMEG++S KSDVFSFGVLLLEIISG++ +G++ S+   SLL YAW+LW
Sbjct: 408 IVGTYGYMAPEYAMEGLYSTKSDVFSFGVLLLEIISGRKKAGYHQSKCAPSLLAYAWQLW 467

Query: 444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPP 503
            +G   EL+DP+L  +C   E  + +HIGLLCVQED + RP MSSVV+ML S  + LP P
Sbjct: 468 NEGNKTELIDPMLSDSCNADEFSRYMHIGLLCVQEDASDRPTMSSVVLMLQSQNSFLPQP 527

Query: 504 TQPAF 508
            +PAF
Sbjct: 528 ERPAF 532

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296088918|emb|CBI38478.3| unnamed protein product [Vitis vinifera]

 Score =  420 bits (1080), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 232/536 (43%), Positives = 325/536 (60%), Gaps = 60/536 (11%)

Query: 25  KPTYIYHNCPRT--NFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGHEPNK 82
           +P ++Y+ C     N+T NS Y++NLN LL++L SN      ++   GFYN + G   +K
Sbjct: 25  QPKFLYYRCSNGVGNYTNNSTYKANLNTLLTSLSSN------NEIDYGFYNFSAGQNSDK 78

Query: 83  VYGLFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFFSVLDTS 142
           V  + LCRGD     C++C++ +     +LCP  KE    Y+ C+LRYSN S F    TS
Sbjct: 79  VNAIALCRGDVMPTACRSCINDSRIQLTRLCPNQKEAIGWYDGCMLRYSNDSIFGKAQTS 138

Query: 143 FRLSLWNVEN-SPSRSFDQFVWNSMNEAVNQALSTT--KMFATVKKNYTASQTLYSLVQC 199
              ++WN++N S    F+Q + N M    ++A S    + FAT + N T+ Q++Y L+QC
Sbjct: 139 PTFTMWNLQNVSNVEDFNQVLGNLMASLRSKAASGDWRRKFATEEANVTSFQSIYGLMQC 198

Query: 200 TPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFYNDTSNGTLPPVFF 259
           TPDLS   CS CL  AI+ +  CC+ +  GRV+ PSCN RY  Y FY+            
Sbjct: 199 TPDLSELSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYATYHFYD------------ 246

Query: 260 SPPSPGSVTSSKGGKGKKATWIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWK 319
                  +T++        +       +   T                +D  + AQLDW+
Sbjct: 247 -------ITAANAPPPSPPSADLSPPPLANTT--------------STQDLIRRAQLDWE 285

Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           RR  II GIARGLLYLHEDSRLR+IHRDLK SN+LLD EMNPKISDFGMAR+F  +Q + 
Sbjct: 286 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARLFLVDQTQG 345

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA 439
           +T+R+ GTYGYMAPEYAM G FSVK+DV+SFGVL+LE++SG+RN+ F +SE+ + LL+YA
Sbjct: 346 STSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGVLVLELVSGQRNNCFRVSENIEHLLSYA 405

Query: 440 WKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTAT 499
           WK W +G A  L+DP ++ + + +E+++CIHIGLLCVQE+ A RP M+S+ +ML S + +
Sbjct: 406 WKNWREGTATNLIDPTMRISSI-SEIMRCIHIGLLCVQENEADRPTMASIALMLNSYSLS 464

Query: 500 LPPPTQPAF----SVDRI----------AAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           LP P+ PAF    S++R            A+S    S  S F SVNE ++++ YPR
Sbjct: 465 LPVPSHPAFFMNTSMNRDMSLELEDNSRVAQSNYLPSRSSHF-SVNEASITDPYPR 519

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113927|ref|XP_002316616.1| predicted protein [Populus trichocarpa] gi|222859681|gb|EEE97228.1| predicted protein [Populus trichocarpa]

 Score =  368 bits (945), Expect = 4e-99,   Method: Compositional matrix adjust.
 Identities = 173/232 (74%), Positives = 200/232 (86%), Gaps = 2/232 (0%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S+ G  LDW+RR+SIINGIARGLLYLHEDSRLR+IHRDLKTSN+LLD+EMNPKISDFGMA
Sbjct: 152 SSNGVLLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKTSNILLDYEMNPKISDFGMA 211

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
           RIF GNQ+EANTNR+ GTYGYMAPEYAM G+FSVKSDVFSFGVLLLEIISG++N GF+LS
Sbjct: 212 RIFGGNQSEANTNRIVGTYGYMAPEYAMVGLFSVKSDVFSFGVLLLEIISGEKNVGFHLS 271

Query: 430 EHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
           E G+SLLT+AWKLW  G+ LELMDP+L+++ V  E+L+CIHIGLLCVQEDPA RP MSSV
Sbjct: 272 EEGESLLTFAWKLWSDGQGLELMDPMLEKSGVATEVLRCIHIGLLCVQEDPADRPTMSSV 331

Query: 490 VVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           + MLASDT TLP P QPAFS+ R  A  GQSS+   K CS NE+T+S + PR
Sbjct: 332 LHMLASDTITLPIPKQPAFSIGRFVAMEGQSSN--QKVCSSNELTISVLSPR 381

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356554939|ref|XP_003545798.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max]

 Score =  366 bits (940), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 171/233 (73%), Positives = 199/233 (85%), Gaps = 1/233 (0%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  K  QLDWK R+SIINGIARG+LYLHEDSRLRVIHRDLK SNVLLDH+MNPKISDFG+
Sbjct: 431 DDEKKKQLDWKLRLSIINGIARGILYLHEDSRLRVIHRDLKASNVLLDHDMNPKISDFGL 490

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           AR FS  Q +ANTNRV GTYGYMAPEYAMEG+FSVKSDVFSFGVL+LEII GK+NSGFYL
Sbjct: 491 ARAFSKGQKQANTNRVMGTYGYMAPEYAMEGLFSVKSDVFSFGVLVLEIICGKKNSGFYL 550

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           SE GQ LL YAWK+WC G+ LEL+DPVL+++C+++E++KCIHIGLLCVQED A RPNMS+
Sbjct: 551 SECGQGLLLYAWKIWCAGKFLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPNMST 610

Query: 489 VVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           VVVMLASDT  LP P +PAFSV R+A     +S S +K  S+N+IT+SN+ PR
Sbjct: 611 VVVMLASDTMVLPKPNRPAFSVGRMALGDASTSKSSNKH-SINDITISNILPR 662

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356546303|ref|XP_003541568.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max]

 Score =  358 bits (920), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 165/233 (70%), Positives = 198/233 (84%), Gaps = 1/233 (0%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  K  QLDW  R+SIINGIA+GLLYLHEDSRL+VIHRDLK SN+LLD EMNPKISDFG+
Sbjct: 431 DERKKRQLDWNLRLSIINGIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGL 490

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           AR F   QN+ANTNRV GTYGYM+PEYAMEG+FSVKSDVFS+GVL+LEII GK+NSGFYL
Sbjct: 491 ARAFEKGQNQANTNRVMGTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYL 550

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           SE GQSL  YAWK+WC G++LELMDPVL+++C+++E++KCIHIGLLCVQED A RP MS+
Sbjct: 551 SECGQSLTLYAWKIWCAGKSLELMDPVLEKSCIESEVMKCIHIGLLCVQEDAADRPTMST 610

Query: 489 VVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           VVVMLASD  +LP P QPAFSV R+  + G S+S  SK  S+N++T++N+ PR
Sbjct: 611 VVVMLASDKMSLPEPNQPAFSVGRMTLE-GASTSKSSKNLSINDVTVTNILPR 662

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa]

 Score =  358 bits (920), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 169/233 (72%), Positives = 197/233 (84%), Gaps = 2/233 (0%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           DS    QLDW+RR+SIINGIARGLLYLHEDSRLR+IHRDLK SN+LLD+EMNPKISDFGM
Sbjct: 436 DSAMRVQLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDYEMNPKISDFGM 495

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           ARIF GN +EANTNR+ GTYGYMAPEYAMEG+ SVKSDVFSFGVL+LEIISGKRN GF+L
Sbjct: 496 ARIFGGNHSEANTNRIVGTYGYMAPEYAMEGLSSVKSDVFSFGVLMLEIISGKRNGGFHL 555

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           SE G+SLL + WKLW +G+ LELMD +L+++ V  E+LKCIHIGLLCVQEDP  RP MSS
Sbjct: 556 SEEGKSLLNFTWKLWSEGKGLELMDSLLEKSSVATEVLKCIHIGLLCVQEDPVDRPTMSS 615

Query: 489 VVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           VVVMLA D   +P PT+PAFSV RI A+  +++SS  +  SVN++TLSNV PR
Sbjct: 616 VVVMLAGDNFKIPIPTKPAFSVGRIVAE--ETTSSNQRVSSVNKVTLSNVLPR 666

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356554943|ref|XP_003545800.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max]

 Score =  351 bits (901), Expect = 5e-94,   Method: Compositional matrix adjust.
 Identities = 164/233 (70%), Positives = 194/233 (83%), Gaps = 1/233 (0%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  K  QLDW  R+SIINGIA+GLLYLHEDSRL+VIHRDLK SN+LLD EMNPKISDFG+
Sbjct: 439 DERKKRQLDWNLRLSIINGIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGL 498

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           AR F   QN+ANT RV GTYGYM+PEYAMEG+FSVKSDVFS+GVL+LEII GK+NSGFYL
Sbjct: 499 ARAFEKGQNQANTKRVMGTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYL 558

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           SE GQSL  YAWKLWC G+ LEL+DPVL+++C+++E++KCIHIGLLCVQED A RP MS+
Sbjct: 559 SECGQSLTLYAWKLWCAGKCLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPTMST 618

Query: 489 VVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           VVVMLASD   LP P QPAFSV R+  +   S+S  SK  S+N++T+SN+ PR
Sbjct: 619 VVVMLASDKMPLPKPNQPAFSVGRMTLEDA-STSKSSKNLSINDVTVSNILPR 670

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574376|ref|XP_003555324.1| PREDICTED: LOW QUALITY PROTEIN: cysteine-rich receptor-like protein kinase 15-like [Glycine max]

 Score =  350 bits (899), Expect = 9e-94,   Method: Compositional matrix adjust.
 Identities = 223/551 (40%), Positives = 304/551 (55%), Gaps = 76/551 (13%)

Query: 26  PTYIYHNCPR-TNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGHEPNKVY 84
           P Y  + CP  T++  N  +Q+NL +LL++L SN ++      S G YN+  G     V 
Sbjct: 28  PVYNANYCPNNTSYNSNVTFQTNLRVLLASLVSNVSQ------SDGSYNSAMGMGTTSVA 81

Query: 85  -GLFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISFF-SVLDTS 142
            G FLCRGD    TCQ+C++ A +   +LCP   E+ I Y+EC LR++N  F  + +D  
Sbjct: 82  SGQFLCRGDVSPATCQDCIASAATEITRLCPNKTESIIWYDECTLRFTNRYFAPTSIDPG 141

Query: 143 FRLSL-WNVENSPSRSFDQFVWNSMNEAVNQALST--TKMFATVKKNYTAS---QTLYSL 196
            RLS   N+  S   SF+Q ++  +NE V +A ++   + FAT +  +  S   +T+Y+L
Sbjct: 142 ARLSDDKNISASDLDSFNQTLFGLLNELVEEAANSQSARKFATGESEFAGSSPERTVYAL 201

Query: 197 VQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFYNDTSNG---- 252
            +C P L+   C  CL+ A+S L  CC  K G R +   CN RYEL+QFYN + +     
Sbjct: 202 TECEPSLTIAQCEECLQNAVSTLPSCCGGKQGARALLAWCNVRYELFQFYNTSGSSAPSS 261

Query: 253 ------TLPPVFFSPPSPGSVTSS--------KGGKGK-------KATWIAIGTI----- 286
                 TL  + F  P+  + T          +GG G+           IA+  +     
Sbjct: 262 VGEESDTLESLQFGLPTVEAATKKFSHENRIGEGGFGEVYKGILPDGREIAVKKLSQSSG 321

Query: 287 ---------------ITTITLFILLGSFVWCRRRI-------NK-------DSTKGAQLD 317
                          +    L  LLG  +  + ++       NK       D  K  +LD
Sbjct: 322 QGATEFKNEILLIAKLQHRNLVTLLGFCLEEQEKMLIYEFVSNKSLDYFLFDPRKSCELD 381

Query: 318 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 377
           W  R  II GI  G+LYLHE SRL+VIHRDLK SNVLLD  MNPKISDFGMARI + +Q+
Sbjct: 382 WTTRYKIIEGITHGILYLHEHSRLKVIHRDLKPSNVLLDSIMNPKISDFGMARIVAIDQH 441

Query: 378 EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
           +  TNR+ GTYGYM+PEYAM G FS KSDVFSFGV++LEIIS KRN+    S+H   LL+
Sbjct: 442 QEKTNRIVGTYGYMSPEYAMHGQFSEKSDVFSFGVIVLEIISAKRNTRSVFSDH-DDLLS 500

Query: 438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT 497
           YAWK   +G A  L+D  L  T    E+++CIHIGLL VQ + A RP M+SVV+ L S +
Sbjct: 501 YAWKNCREGTAPNLIDTTL-DTSSRNEMMRCIHIGLLWVQGNLADRPTMASVVLTLNSYS 559

Query: 498 ATLPPPTQPAF 508
            TLP P++ AF
Sbjct: 560 HTLPVPSELAF 570

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356510387|ref|XP_003523920.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max]

 Score =  349 bits (895), Expect = 2e-93,   Method: Compositional matrix adjust.
 Identities = 168/233 (72%), Positives = 194/233 (83%), Gaps = 1/233 (0%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  KG  L+WK R++IINGIA+GLLYLHEDSRLRVIHRDLK SN+LLDHEMNPKISDFG+
Sbjct: 416 DMEKGEHLEWKNRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNILLDHEMNPKISDFGL 475

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           AR F G+Q +ANT RV GTYGYMAPEYAMEG+FSVKSDVFSFGVLLLEIISGKR+S FYL
Sbjct: 476 ARTFGGDQKQANTIRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKRSSKFYL 535

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           S+ GQSLL YAW LWC+ + LELMDP+++++CV +E+LKC+HIGLLCVQED A RP MSS
Sbjct: 536 SDQGQSLLIYAWNLWCERKGLELMDPIIEKSCVRSEVLKCMHIGLLCVQEDAADRPKMSS 595

Query: 489 VVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           VV MLASDT +L  PT+PAFSV R A    + SS+ S   SVNE T+S V PR
Sbjct: 596 VVHMLASDTVSLSVPTRPAFSVGR-AVTERECSSNTSMHYSVNEATVSEVIPR 647

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis]

 Score =  347 bits (891), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 163/233 (69%), Positives = 198/233 (84%), Gaps = 2/233 (0%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           DS  G +LDW+RR+SII+GIARGLLYLHEDSRLR+IHRDLK SN+LLD++MNPKISDFGM
Sbjct: 456 DSHMGVRLDWQRRLSIISGIARGLLYLHEDSRLRIIHRDLKASNILLDYDMNPKISDFGM 515

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           ARIF GN +++ TNR+ GTYGYM+PEYAMEG+FS+KSD+FSFGVLLLEIISG+RN+ FY+
Sbjct: 516 ARIFGGNDSKS-TNRIVGTYGYMSPEYAMEGLFSMKSDIFSFGVLLLEIISGRRNNRFYV 574

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
            E G+SLLT+AWKLW K + LEL+DP +  + V  E+LKC+HIGLLCVQ+DPA RP MSS
Sbjct: 575 EEEGESLLTFAWKLWNKDQGLELLDPAVVNSSVAIEVLKCVHIGLLCVQDDPAERPTMSS 634

Query: 489 VVVMLASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEITLSNVYPR 541
           VVVMLASDT TLP P +PAFS+ +  A+S  +SSS  K  SVN++TLSNV PR
Sbjct: 635 VVVMLASDTITLPQPRKPAFSIGQFVARSA-TSSSNPKVSSVNQVTLSNVSPR 686

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	541
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.430	0.348	0.561	6.6e-121
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.430	0.344	0.561	1.8e-118
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.373	0.306	0.608	3.4e-109
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.430	0.345	0.520	2.4e-108
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.428	0.359	0.547	1.5e-106
TAIR|locus:2121626	830	CRK23 "cysteine-rich RLK (RECE	0.430	0.280	0.525	4.5e-105
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.428	0.343	0.529	7.4e-103
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.430	0.348	0.537	2.3e-93
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.426	0.347	0.510	1.7e-90
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.369	0.299	0.581	7.2e-88

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 715 (256.8 bits), Expect = 6.6e-121, Sum P(2) = 6.6e-121
 Identities = 132/235 (56%), Positives = 172/235 (73%)

Query:   309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
             D  K  QLDW RR  II G+ARG+LYLH+DSRL +IHRDLK SN+LLD +MNPKI+DFGM
Sbjct:   435 DPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGM 494

Query:   369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
             ARIF  +Q E NT+R+ GTYGYM+PEYAM G +S+KSDV+SFGVL+LEIISGK+NS FY 
Sbjct:   495 ARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQ 554

Query:   429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
             ++    L++YAW LW  G  LEL+DP + + C   E+++C+HIGLLCVQEDPA RP +S+
Sbjct:   555 TDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLST 614

Query:   489 VVVMLASDTATLPPPTQPA-FSVDRIAAKXXXXXXXXXKFC-SVNEITLSNVYPR 541
             +V+ML S+T TLP P QP  F   RI                SV++ ++++++PR
Sbjct:   615 IVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 706 (253.6 bits), Expect = 1.8e-118, Sum P(2) = 1.8e-118
 Identities = 133/237 (56%), Positives = 175/237 (73%)

Query:   309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
             D TK  QLDW +R +II GIARG+LYLH+DSRL +IHRDLK SN+LLD ++NPKI+DFGM
Sbjct:   440 DPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGM 499

Query:   369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
             ARIF  +Q + NT+R+ GTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISG++NS F  
Sbjct:   500 ARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDE 559

Query:   429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
             S+  Q LLT+ W+LW    AL+L+DP++   C ++E+++CIHIGLLCVQEDPA RP +S+
Sbjct:   560 SDGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTIST 619

Query:   489 VVVMLASDTATLPPPTQPAFSVDRIAAK--XXXXXXXXXKF--CSVNEITLSNVYPR 541
             V +ML S+T TLP P QP F +     K           K    S+++  ++++YPR
Sbjct:   620 VFMMLTSNTVTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 674 (242.3 bits), Expect = 3.4e-109, Sum P(2) = 3.4e-109
 Identities = 123/202 (60%), Positives = 157/202 (77%)

Query:   309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
             D  K  QL W +R  II GIARG+LYLH+DSRL +IHRDLK SN+LLD +MNPKI+DFGM
Sbjct:   423 DPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGM 482

Query:   369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
             ARIF  +Q + NT+R+ GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISG++N+ F  
Sbjct:   483 ARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIE 542

Query:   429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
             ++  Q L+T+AW+LW  G AL+L+DP +  +C  +E+++C HIGLLCVQEDP  RP MS+
Sbjct:   543 TDDAQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMST 602

Query:   489 VVVMLASDTATLPPPTQPAFSV 510
             + VML S+T  LP P QP F V
Sbjct:   603 ISVMLTSNTMALPAPQQPGFFV 624

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 634 (228.2 bits), Expect = 2.4e-108, Sum P(2) = 2.4e-108
 Identities = 126/242 (52%), Positives = 165/242 (68%)

Query:   309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
             D+ K   LDW+RR  II GIARG+LYLH DSRL +IHRDLK SN+LLD +M+PKISDFGM
Sbjct:   434 DNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGM 493

Query:   369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
             ARIF  +Q +ANT R+ GTYGYM+PEYA+ G +SVKSDV+SFGVL+LE+I+GK+NS FY 
Sbjct:   494 ARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYE 553

Query:   429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
              +    L+TY WKLW +   LEL+D  ++      E+++CIHI LLCVQED + RP+M  
Sbjct:   554 EDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDD 613

Query:   489 VVVMLASDTATLPPPTQPAF-------SVDRIAAKXXXXXXXXXKFC--SVNEITLSNVY 539
             ++VM+ S T TLP P +  F       S D  +           K    SV++ +++ VY
Sbjct:   614 ILVMMNSFTVTLPIPKRSGFLLRTMKDSRDPRSGGSASDHSATSKSLPLSVDDSSITIVY 673

Query:   540 PR 541
             PR
Sbjct:   674 PR 675

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 644 (231.8 bits), Expect = 1.5e-106, Sum P(2) = 1.5e-106
 Identities = 128/234 (54%), Positives = 156/234 (66%)

Query:   309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
             DST   +LDW RR  II GIARG+LYLH+DSRL +IHRDLK  N+LLD +MNPKI+DFGM
Sbjct:   413 DSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGM 472

Query:   369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY- 427
             ARIF  +Q EA T RV GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISG +NS  Y 
Sbjct:   473 ARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQ 532

Query:   428 LSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS 487
             + E   +L+TY W+LW  G   EL+DP        +E+ +CIHI LLCVQED   RP MS
Sbjct:   533 MDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMS 592

Query:   488 SVVVMLASDTATLPPPTQPAFSVDRIAAKXXXXXXXXXKFCSVNEITLSNVYPR 541
             S+V ML +    L  P  P F   R   +           CSV+E +++ V PR
Sbjct:   593 SIVQMLTTSLIALAEPRPPGFFF-RSKQEQAGPSIDSSTHCSVDEASITRVTPR 645

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 641 (230.7 bits), Expect = 4.5e-105, Sum P(2) = 4.5e-105
 Identities = 124/236 (52%), Positives = 160/236 (67%)

Query:   309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
             D+T   QLDW RR  II GIARG+LYLH+DSRL +IHRDLK  N+LLD +MNPK++DFGM
Sbjct:   595 DTTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGM 654

Query:   369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY- 427
             ARIF  +Q EANT RV GTYGYMAPEYAM G FS+KSDV+SFGVL+ EIISG +NS  Y 
Sbjct:   655 ARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQ 714

Query:   428 LSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS 487
             + +   +L+TY W+LW  G  L+L+DP         ++ +CIHI LLCVQED   RPNMS
Sbjct:   715 MDDSVSNLVTYTWRLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMS 774

Query:   488 SVVVMLASDTATLPPPTQPAFSVDRIAAKXXXXXXXXXKF--CSVNEITLSNVYPR 541
             ++V ML + +  L  P QP F       +         +   CS+++ ++++V PR
Sbjct:   775 AIVQMLTTSSIVLAVPKQPGFFFRGRHEQVGEVGSSVDRLALCSIDDASITSVAPR 830

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 626 (225.4 bits), Expect = 7.4e-103, Sum P(2) = 7.4e-103
 Identities = 127/240 (52%), Positives = 159/240 (66%)

Query:   309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
             DST  + LDW RR  II GIARG+LYLH+DSRL +IHRDLK  N+LL  +MN KI+DFGM
Sbjct:   438 DSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGM 497

Query:   369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
             ARIF  +Q EANT R+ GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISGK+NS  Y 
Sbjct:   498 ARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQ 557

Query:   429 SEHGQS---LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN 485
              + G S   L+TY W+LW  G  LEL+DP  +      E+ +CIHI LLCVQE+   RP 
Sbjct:   558 MD-GTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPT 616

Query:   486 MSSVVVMLASDTATLPPPTQPAF----SVDRIAAKXXXXXXXXXKFCSVNEITLSNVYPR 541
             MS++V ML + +  L  P +P F    S                  CSV++ +++NV PR
Sbjct:   617 MSAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVDDASITNVTPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 677 (243.4 bits), Expect = 2.3e-93, Sum P(2) = 2.3e-93
 Identities = 128/238 (53%), Positives = 171/238 (71%)

Query:   309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
             D  K  +LDW RR +II GIARG+LYLH+DSRL +IHRDLK SN+LLD +MNPKI+DFGM
Sbjct:   432 DPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGM 491

Query:   369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY- 427
             ARIF  +Q++ANT R+AGT+GYM+PEYAM G FS+KSDV+SFGVL+LEIISGK+NS FY 
Sbjct:   492 ARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYN 551

Query:   428 LSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS 487
             + + G +L+T+AW+LW  G  LEL+DP + ++   +E  +CIHI LLCVQEDPA RP + 
Sbjct:   552 IDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLP 611

Query:   488 SVVVMLASDTATLPPPTQPAFSVDR--IAAKXXXXXXXXXKFC--SVNEITLSNVYPR 541
             ++++ML S T TL  P  P F +    +            +    S+N+ +++  YPR
Sbjct:   612 AIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 598 (215.6 bits), Expect = 1.7e-90, Sum P(2) = 1.7e-90
 Identities = 121/237 (51%), Positives = 160/237 (67%)

Query:   309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
             D  +G +L+W+ R  II G+ARGLLYLH+DSRLR+IHRDLK SN+LLD EM PKI+DFGM
Sbjct:   431 DPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGM 490

Query:   369 ARIFS-GNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
             AR+F   +  +  TNR+ GT+GYMAPEY M G FS K+DV+SFGVL+LEIISGK+NSGF 
Sbjct:   491 ARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFS 550

Query:   428 LSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAE--LLKCIHIGLLCVQEDPAHRPN 485
               +    L+++AW+ W +G AL L+D +L      +   +++CI+IGLLCVQE  A RP+
Sbjct:   551 SEDSMGDLISFAWRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPS 610

Query:   486 MSSVVVMLASDTATLPPPTQPAF-SVDRIAAKXXXXXXXXXKFCSVNEITLSNVYPR 541
             M+SVV+ML   T  L  P++PAF S     +          K  + N  T   +YPR
Sbjct:   611 MASVVLMLDGHTIALSEPSKPAFFSHSNAVSDSSSSLGHNAKTSNYNSNT--ELYPR 665

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 628 (226.1 bits), Expect = 7.2e-88, Sum P(2) = 7.2e-88
 Identities = 118/203 (58%), Positives = 151/203 (74%)

Query:   309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
             D  K +QLDW RR  II GIARG+LYLH+DSRL++IHRDLK SN+LLD +MNPKI+DFG+
Sbjct:   437 DPEKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGL 496

Query:   369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
             A IF   Q + NTNR+AGTY YM+PEYAM G +S+KSD++SFGVL+LEIISGK+NSG Y 
Sbjct:   497 ATIFGVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQ 556

Query:   429 SEHGQS---LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN 485
              +   +   L+TYA +LW     LEL+DP   +     E+ +CIHI LLCVQE+P  RP 
Sbjct:   557 MDETSTAGNLVTYASRLWRNKSPLELVDPTFGRNYQSNEVTRCIHIALLCVQENPEDRPM 616

Query:   486 MSSVVVMLASDTATLPPPTQPAF 508
             +S++++ML S+T TLP P  P F
Sbjct:   617 LSTIILMLTSNTITLPVPRLPGF 639

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.XI.1866.1 hypothetical protein (532 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	541
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-29
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-28
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-28
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-26
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	3e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-25
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-20
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-20
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-17
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-16
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-14
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-13
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-11
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-09
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-09
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-07
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	6e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-05
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.002
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.002
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.003
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.003
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.003

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 2e-29
 Identities = 60/205 (29%), Positives = 87/205 (42%), Gaps = 44/205 (21%)

Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           + R    S + + L  K  +S    IA+G+ YL      + +HRDL   N L+  ++  K
Sbjct: 89  KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVK 145

Query: 363 ISDFGMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLE 416
           ISDFG++R ++  +     T      R      +MAPE   +G+F+ KSDV+SFGVLL E
Sbjct: 146 ISDFGLSRDVYDDDYYRKKTGGKLPIR------WMAPESLKDGIFTSKSDVWSFGVLLWE 199

Query: 417 IIS-------GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI 469
           I +       G  N         + L         KG  L   +    +     EL+   
Sbjct: 200 IFTLGATPYPGLSNEEVL-----EYLR--------KGYRLPKPEYCPDEL---YELMLS- 242

Query: 470 HIGLLCVQEDPAHRPNMSSVVVMLA 494
                C Q DP  RP  S +V  L 
Sbjct: 243 -----CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  114 bits (289), Expect = 6e-29
 Identities = 62/188 (32%), Positives = 84/188 (44%), Gaps = 27/188 (14%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
             +  +L     +S    IARG+ YL        IHRDL   N L+   +  KISDFG++
Sbjct: 94  KNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLS 150

Query: 370 RIFSGNQNEANTNRVAGT---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSG 425
           R    +  + +  +V G      +MAPE   EG F+ KSDV+SFGVLL EI + G+    
Sbjct: 151 R----DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEE--- 203

Query: 426 FYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN 485
            Y       +L Y  K   KG  L          C      +   + L C  EDP  RP 
Sbjct: 204 PYPGMSNAEVLEYL-K---KGYRLPKPP-----NCPP----ELYKLMLQCWAEDPEDRPT 250

Query: 486 MSSVVVML 493
            S +V +L
Sbjct: 251 FSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  113 bits (284), Expect = 9e-29
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 7/104 (6%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSG 374
           L     + I+  I  GL YLH      +IHRDLK  N+LLD      K++DFG++++ + 
Sbjct: 89  LSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEI 417
           +++   T    GT  YMAPE  +    +S KSD++S GV+L E+
Sbjct: 146 DKSLLKTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (287), Expect = 1e-28
 Identities = 61/183 (33%), Positives = 83/183 (45%), Gaps = 27/183 (14%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +L     +S    IARG+ YL        IHRDL   N L+   +  KISDFG++R    
Sbjct: 98  KLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR---- 150

Query: 375 NQNEANTNRVAGT---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSE 430
           +  + +  R  G      +MAPE   EG F+ KSDV+SFGVLL EI + G++    Y   
Sbjct: 151 DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ---PYPGM 207

Query: 431 HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
             + +L Y  K    G  L          C      +   + L C  EDP  RP  S +V
Sbjct: 208 SNEEVLEYL-K---NGYRLPQPPN-----CPP----ELYDLMLQCWAEDPEDRPTFSELV 254

Query: 491 VML 493
            +L
Sbjct: 255 EIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  112 bits (282), Expect = 5e-28
 Identities = 43/107 (40%), Positives = 56/107 (52%), Gaps = 6/107 (5%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           L       I   I RGL YLH      +IHRDLK  N+LLD     KI+DFG+A+    +
Sbjct: 95  LSEDEAKKIALQILRGLEYLHS---NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS 151

Query: 376 QNEANTNRVAGTYGYMAPE-YAMEGVFSVKSDVFSFGVLLLEIISGK 421
            +   T    GT  YMAPE       +  K DV+S GV+L E+++GK
Sbjct: 152 SSSLTT--FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  107 bits (270), Expect = 2e-26
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 6/94 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      ++HRDLK  N+LLD + + K++DFG+AR     +         GT
Sbjct: 106 ILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             YMAPE  +   +    D++S GV+L E+++GK
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score =  102 bits (256), Expect = 3e-26
 Identities = 44/110 (40%), Positives = 58/110 (52%), Gaps = 8/110 (7%)

Query: 30  YHNCPRTN----FTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGHEPNKVYG 85
           +H C         T NS ++SNLN LLS+L SNA    +    KGF   T+G  P+ VYG
Sbjct: 1   FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNA----ASSSGKGFAAGTSGAAPDTVYG 56

Query: 86  LFLCRGDFGTETCQNCVSVATSYTAQLCPFGKENTIEYEECLLRYSNISF 135
           L  CRGD     C++C++ A S   + CP  K   I Y+ C LRY +  F
Sbjct: 57  LAQCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  105 bits (264), Expect = 1e-25
 Identities = 59/195 (30%), Positives = 78/195 (40%), Gaps = 42/195 (21%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
             G +L  K  + +   IA+G+ YL        +HRDL   N L+   +  KISDFG++R
Sbjct: 94  KHGEKLTLKDLLQMALQIAKGMEYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSR 150

Query: 371 -IFSGNQNEANTN---RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS------- 419
            I+  +           +     +MAPE   +G F+ KSDV+SFGVLL EI +       
Sbjct: 151 DIYEDDYYRKRGGGKLPIK----WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206

Query: 420 GKRNSGFYLS-EHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQE 478
           G  N       E G  L        C  E  ELM                    L C   
Sbjct: 207 GMSNEEVLELLEDGYRLPRPE---NCPDELYELM--------------------LQCWAY 243

Query: 479 DPAHRPNMSSVVVML 493
           DP  RP  S +V  L
Sbjct: 244 DPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 97.6 bits (244), Expect = 8e-23
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 3/95 (3%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL YLH      ++HRD+K +N+L+D +   K++DFG A+     +    T  V GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             +MAPE      +   +D++S G  ++E+ +GK 
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 28/163 (17%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I +GL YLH  ++  +IHRD+K SN+L++ +   KI+DFG++++     ++ NT    GT
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGT 163

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK------RNSGFYLSEHGQSLLTYAWK 441
             YM+PE      +S  +D++S G+ LLE   GK          F+       L+     
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF------ELMQAI-- 215

Query: 442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP 484
             C G    L            E          C+Q+DP  RP
Sbjct: 216 --CDGPPPSLPA-----EEFSPEF---RDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 93.3 bits (233), Expect = 2e-21
 Identities = 47/163 (28%), Positives = 84/163 (51%), Gaps = 23/163 (14%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   L YLH     +++HRD+K  N+ L      K+ DFG++++ S   + A T  V GT
Sbjct: 112 LCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166

Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG 446
             Y++PE   +   ++ KSD++S G +L E+ + K    F     G++LL  A K+  KG
Sbjct: 167 PYYLSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKH--PFE----GENLLELALKI-LKG 218

Query: 447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
           +      P+   +   +EL    ++    +Q+DP  RP+++ +
Sbjct: 219 Q----YPPI--PSQYSSEL---RNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 5e-21
 Identities = 38/94 (40%), Positives = 55/94 (58%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH    L +I+RDLK  N+LLD + + K++DFG+A+  S   +  NT    GT
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE  +   +    D +S GVLL E+++GK
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 51/170 (30%), Positives = 74/170 (43%), Gaps = 34/170 (20%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN--QNEANT 381
           I   + +GL YLHE    ++IHRD+K SN+L++     K+ DFG+    SG    + A T
Sbjct: 105 IAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGV----SGQLVNSLAKT 158

Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK 441
               GT  YMAPE      +SVKSD++S G+ L+E+ +G+    F               
Sbjct: 159 F--VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR----FPYPPENDPPDG---- 208

Query: 442 LWCKGEALELMD-------PVLKQTCVDAELLKCIHIGLLCVQEDPAHRP 484
                   EL+        P L       +         LC+ +DP  RP
Sbjct: 209 ------IFELLQYIVNEPPPRLPSGKFSPDF---QDFVNLCLIKDPRERP 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 6/98 (6%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +   + +GL YLH      +IHRD+K +N+LL  +   K+ DFG++   S  +     N 
Sbjct: 103 VCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---ARNT 156

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           + GT  +MAPE      +  K+D++S G+  +E+  GK
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 84.0 bits (208), Expect = 1e-19
 Identities = 36/77 (46%), Positives = 42/77 (54%), Gaps = 1/77 (1%)

Query: 169 AVNQALSTTKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIG 228
           + N A S+ K FA    +  A  T+Y L QC  DLS  DC  CL  A+S L  CC  K G
Sbjct: 31  SSNAASSSGKGFAAGT-SGAAPDTVYGLAQCRGDLSASDCRSCLATAVSELRRCCPNKKG 89

Query: 229 GRVMYPSCNFRYELYQF 245
           GR+ Y SC  RYE Y F
Sbjct: 90  GRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 37/95 (38%), Positives = 50/95 (52%), Gaps = 6/95 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRD+K  N+LLD + +  I+DF +A   + +     T   +GT
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
            GYMAPE      +SV  D +S GV   E + GKR
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 87.2 bits (216), Expect = 4e-19
 Identities = 39/94 (41%), Positives = 52/94 (55%), Gaps = 6/94 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL +LH   + R+++RDLK  NVLLD   N +ISD G+A    G +        AGT
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGT 157

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            GYMAPE     V+    D F+ G  L E+I+G+
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 38/108 (35%), Positives = 58/108 (53%), Gaps = 6/108 (5%)

Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
            Q++ KR +   + I +G+ YL      R IHRDL   N+L++ E   KISDFG+A++  
Sbjct: 104 DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160

Query: 374 GNQN--EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            +++         +  + Y APE      FS  SDV+SFGV L E+ +
Sbjct: 161 EDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 40/179 (22%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA G+ YL      + +HRDL   N ++  ++  KI DFGM R    +  E +  R  G 
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGK 180

Query: 388 ----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-------GKRNSGFYLSEHGQSLL 436
                 +MAPE   +GVF+ KSDV+SFGV+L E+ +       G  N         + +L
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---------EEVL 231

Query: 437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
            +       G  L+L +      C D    K + +  +C Q +P  RP    +V  L  
Sbjct: 232 KFV----IDGGHLDLPE-----NCPD----KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 38/95 (40%), Positives = 54/95 (56%), Gaps = 10/95 (10%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA G+ YL        IHRDL   N+L+   +  KI+DFG+AR+   ++  A      G 
Sbjct: 112 IAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GA 164

Query: 388 ---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                + APE A  G F++KSDV+SFG+LL EI++
Sbjct: 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 40/110 (36%), Positives = 62/110 (56%), Gaps = 5/110 (4%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S +G  L     I +   +A G+ YL E      IHRDL   N+L+  ++  K++DFG+A
Sbjct: 95  SPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLA 151

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           R+   +   ++  ++   Y + APE A  G FS KSDV+SFG+LL E+ +
Sbjct: 152 RLIKEDVYLSSDKKIP--YKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 36/98 (36%), Positives = 57/98 (58%), Gaps = 5/98 (5%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I+    +GL YLH     + IHRD+K  N+LL+ E   K++DFG++   +    + NT  
Sbjct: 104 ILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           V GT  +MAPE   E  ++ K+D++S G+  +E+  GK
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 25/168 (14%)

Query: 318 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 377
           W+  I I+ G+A    +LH     +++HRD+K+ N+ LD   N KI D G+A++ S N N
Sbjct: 104 WRFFIQILLGLA----HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156

Query: 378 EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
            ANT  + GT  Y++PE   +  ++ KSDV++ GV+L E  +GK    F  +  G  +L 
Sbjct: 157 FANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP--FDANNQGALILK 212

Query: 438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN 485
                  +G    +     +Q     +L+        C+ +D   RP+
Sbjct: 213 II-----RGVFPPVSQMYSQQLA---QLID------QCLTKDYRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 41/115 (35%), Positives = 66/115 (57%), Gaps = 8/115 (6%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           + +G +L   + I +   IA G+ ++    R   IHRDL+ +N+L+   +  KI+DFG+A
Sbjct: 93  TPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLA 149

Query: 370 RIFSGNQNEANTNRVAGTY--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           R+   N+  A   R    +   + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 150 RLIEDNEYTA---REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 81.8 bits (203), Expect = 3e-17
 Identities = 33/95 (34%), Positives = 56/95 (58%), Gaps = 5/95 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  GL YLH +    ++HRD+K SN+L++++   K++DFG+AR ++   +   TNRV  T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164

Query: 388 YGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
             Y  PE  +    +  + D++S G +L E+  GK
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 7/95 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL YLHE     VIHRD+K +N+L   +   K++DFG+A   +    +  +  V GT
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162

Query: 388 YGYMAPE-YAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +MAPE   M G  S  SD++S G  ++E+++G 
Sbjct: 163 PYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 37/98 (37%), Positives = 53/98 (54%), Gaps = 7/98 (7%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I   + +GL YLH     ++IHRD+K SN+LL  +   K+ DFG+    SG    +    
Sbjct: 110 IAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAGT 162

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             GT  YMAPE      +S+ SDV+S G+ LLE+   +
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 80.7 bits (200), Expect = 8e-17
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 5/93 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL YLH      VIHRD+K+ N+LL  + + K++DFG A   +  +++ N+  V GT
Sbjct: 125 VLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +MAPE      +  K D++S G++ +E+  G
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 53/228 (23%)

Query: 283 IGTIITTITLFILL-----GSFV-WCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLH 336
           +G ++    L+I+      GS V + R R     T   QL +   +        G+ YL 
Sbjct: 66  LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV------CEGMEYLE 119

Query: 337 EDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY--GYMAPE 394
           E      +HRDL   NVL+  ++  K+SDFG+A+       EA+  + +G     + APE
Sbjct: 120 EK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPE 169

Query: 395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW-------CKGE 447
              E  FS KSDV+SFG+LL EI S  R    Y     + ++ +  K +       C  E
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPHVEKGYRMEAPEGCPPE 227

Query: 448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             ++M               C  +       DPA RP    +   LA 
Sbjct: 228 VYKVM-------------KDCWEL-------DPAKRPTFKQLREQLAL 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 41/111 (36%), Positives = 59/111 (53%), Gaps = 10/111 (9%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
            G  L   + I +   +A G+ YL   +    IHRDL   NVL+      K++DFG+AR+
Sbjct: 96  AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARV 152

Query: 372 FSGNQNEANTNRVAGT---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
              +  EA      G      + APE A+   FS+KSDV+SFG+LL EI++
Sbjct: 153 IKEDIYEARE----GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 80.6 bits (197), Expect = 3e-16
 Identities = 48/196 (24%), Positives = 81/196 (41%), Gaps = 17/196 (8%)

Query: 304 RRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-PK 362
             + K   +   L     + I+  I   L YLH      +IHRD+K  N+LLD +    K
Sbjct: 86  EDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVK 142

Query: 363 ISDFGMARIFSGNQNEAN----TNRVAGTYGYMAPEYAMEGVF---SVKSDVFSFGVLLL 415
           + DFG+A++     + ++     +   GT GYMAPE  +       S  SD++S G+ L 
Sbjct: 143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202

Query: 416 EIISGKR-NSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL 474
           E+++G     G   S      L    +L         +   L  +  +        +   
Sbjct: 203 ELLTGLPPFEGEKNSSATSQTLKIILEL-----PTPSLASPLSPSNPELISKAASDLLKK 257

Query: 475 CVQEDPAHRPNMSSVV 490
            + +DP +R + SS +
Sbjct: 258 LLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 39/101 (38%), Positives = 58/101 (57%), Gaps = 13/101 (12%)

Query: 327 GIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV-A 385
            I + L YLH   +L VIHRD+K SNVL++     K+ DFG+    SG   ++    + A
Sbjct: 111 SIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGI----SGYLVDSVAKTIDA 164

Query: 386 GTYGYMAPE-----YAMEGVFSVKSDVFSFGVLLLEIISGK 421
           G   YMAPE        +G + VKSDV+S G+ ++E+ +G+
Sbjct: 165 GCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 5/98 (5%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I+  +  GL YLHE+     IHRD+K +N+LL  E + K++DFG++   +   ++ NT  
Sbjct: 103 ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-- 157

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL +LHE     +I+RDLK  NVLLD E + KI+DFGM +   G      T+   GT
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D ++ GVLL E+++G+
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 6/98 (6%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I   +  GL YL+     R++HRD+K SN+L++     K+ DFG+    SG    +  + 
Sbjct: 108 IAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSIADT 161

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             GT  YM+PE    G ++VKSDV+S G+ ++E+  GK
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 46/148 (31%), Positives = 80/148 (54%), Gaps = 20/148 (13%)

Query: 281 IAIGTIITTITLFILLGS---FVWCRRRINKDSTKGAQ--LDWKRRISIINGIARGLLYL 335
           I + + +  IT  + LG    +V    R +KD   G+Q  L+W  +I      A+G+ YL
Sbjct: 77  ICLSSQVQLITQLMPLGCLLDYV----RNHKD-NIGSQYLLNWCVQI------AKGMSYL 125

Query: 336 HEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY 395
            E    R++HRDL   NVL+    + KI+DFG+A++   ++ E +         +MA E 
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 396 AMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
            +  +++ KSDV+S+GV + E+++ G +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 7/95 (7%)

Query: 332 LLYLHE-----DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAG 386
           LL L+E     D    V+HRDLK +N+ LD   N K+ DFG+A+I   + + A T    G
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVG 172

Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  YM+PE      +  KSD++S G L+ E+ +  
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 53/176 (30%), Positives = 74/176 (42%), Gaps = 31/176 (17%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A G+ YL        +HRDL   NVLL +    KISDFGM+R   G  ++      AG 
Sbjct: 104 VAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDYYRATTAGR 159

Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK 445
           +   + APE    G FS KSDV+S+GV L E  S           +G     Y      K
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS-----------YGA--KPYGEM---K 203

Query: 446 G-EALELMDPVLKQTCVDAELLKC----IHIGLLCVQEDPAHRPNMSSVVVMLASD 496
           G E + +++   +    +    +C      I L C +  P  RP  S +      D
Sbjct: 204 GAEVIAMLESGERLPRPE----ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 38/97 (39%), Positives = 62/97 (63%), Gaps = 8/97 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A G+ Y+    R+  IHRDL+++N+L+   +  KI+DFG+AR+   N+  A   R    
Sbjct: 111 VAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA---RQGAK 164

Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           +   + APE A+ G F++KSDV+SFG+LL E+++  R
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 35/112 (31%), Positives = 55/112 (49%), Gaps = 21/112 (18%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVA-- 385
           I   L YLH      +IHRDLK  N+LLD +M+ KI+DFG A++   N +  +    A  
Sbjct: 111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 386 ----------------GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
                           GT  Y++PE   E      SD+++ G ++ ++++GK
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 41/112 (36%), Positives = 66/112 (58%), Gaps = 8/112 (7%)

Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  IHRDL+ +N+L+   +  KI+DFG+AR+ 
Sbjct: 96  GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152

Query: 373 SGNQNEANTNRVAGTY--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A   R    +   + APE A+ G F++KSDV+SFG+LL E+++  R
Sbjct: 153 EDNEYTA---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 32/205 (15%)

Query: 296 LGSFVWCRRRINKDSTK------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 349
           L  F+  RR   + ++          L  K  +S    +ARG+ +L   S+ + IHRDL 
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL--ASK-KCIHRDLA 159

Query: 350 TSNVLL--DHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDV 407
             NVL+  DH M  KI+DFG+AR          T        +MAPE   + V++ +SDV
Sbjct: 160 ARNVLVTEDHVM--KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDV 217

Query: 408 FSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL 465
           +SFGVLL EI +  G    G  + E         +KL  +G  +E   P   Q C   EL
Sbjct: 218 WSFGVLLWEIFTLGGSPYPGIPVEE--------LFKLLKEGYRME--KP---QNCTQ-EL 263

Query: 466 LKCIHIGLLCVQEDPAHRPNMSSVV 490
               H+   C  E P+ RP    +V
Sbjct: 264 Y---HLMRDCWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 57/193 (29%), Positives = 87/193 (45%), Gaps = 37/193 (19%)

Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
               + DS  G +L   + + I   IA G++YL   +    +HRDL T N L+ +++  K
Sbjct: 107 AFLKSPDSPMG-ELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVK 162

Query: 363 ISDFGMAR-IFSGNQNEANTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           I DFGM+R +++      +  RV G       +M PE  M   F+ +SDV+SFGV+L EI
Sbjct: 163 IGDFGMSRDVYT-----TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Query: 418 ISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDP-VLKQ---TCVDAELLKCIHIGL 473
            +  +   + LS                 E +E +    L Q   TC      +   I L
Sbjct: 218 FTYGKQPWYGLSNE---------------EVIECITQGRLLQRPRTCPS----EVYDIML 258

Query: 474 LCVQEDPAHRPNM 486
            C + DP  R N+
Sbjct: 259 GCWKRDPQQRINI 271

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 6/106 (5%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           L+ +R I     I  G+L+LH    + +++RD+K  NVLLD + N ++SD G+A      
Sbjct: 92  LEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +      + AGT GYMAPE   E  +S   D F+ G  + E+++G+
Sbjct: 149 KT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 42/112 (37%), Positives = 64/112 (57%), Gaps = 8/112 (7%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S +G ++   + I     IA G+ Y+    R   IHRDL+ +NVL+   +  KI+DFG+A
Sbjct: 94  SDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLA 150

Query: 370 RIFSGNQNEANTNRVAGTY--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           R+   N+  A   R    +   + APE    G F++KSDV+SFG+LL EI++
Sbjct: 151 RVIEDNEYTA---REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 41/112 (36%), Positives = 60/112 (53%), Gaps = 5/112 (4%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D T  + LD    + I   IA G+ YL   S    +HRDL   N L+   +  KISDFG+
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGL 170

Query: 369 AR-IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           +R I+S +     +  +     +M PE  + G F+ +SD++SFGV+L EI S
Sbjct: 171 SRDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 36/98 (36%), Positives = 58/98 (59%), Gaps = 6/98 (6%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           II  +   L Y+H+     VIHRD+K +N+L+ +  N K+ DFG+A +   NQN +  + 
Sbjct: 106 IIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRST 160

Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISG 420
             GT  +MAPE   EG  +  K+D++S G+ + E+ +G
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 39/94 (41%), Positives = 55/94 (58%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL +LH+    R+I+RDLK  NVLLD++ N +ISD G+A      Q++  T   AGT
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGT 160

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            G+MAPE      +    D F+ GV L E+I+ +
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 2e-14
 Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 18/99 (18%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL Y H  S  R++HRDLK  N+L++ +   K++DFG+AR F        T+ V  T  
Sbjct: 109 RGLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLW 163

Query: 390 YMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE       Y+     +V  D++S G +  E+I+GK
Sbjct: 164 YRAPEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 40/109 (36%), Positives = 61/109 (55%), Gaps = 8/109 (7%)

Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
            +LD ++ +   + I +G+ YL      R +HRDL T N+L++ E   KI DFG+ ++  
Sbjct: 103 ERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159

Query: 374 GNQNEANTNRVAG---TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            ++ E    R  G    + Y APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 160 QDK-EYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 37/97 (38%), Positives = 60/97 (61%), Gaps = 8/97 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+   N+  A   R    
Sbjct: 111 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA---RQGAK 164

Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           +   + APE A+ G F++KSDV+SFG+LL E+ +  R
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 40/115 (34%), Positives = 67/115 (58%), Gaps = 8/115 (6%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S +G++    + I     IA G+ ++ + +    IHRDL+ +N+L+   +  KI+DFG+A
Sbjct: 93  SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 149

Query: 370 RIFSGNQNEANTNRVAGTY--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           R+   N+  A   R    +   + APE    G F++KSDV+SFG+LL+EI++  R
Sbjct: 150 RVIEDNEYTA---REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 38/93 (40%), Positives = 55/93 (59%), Gaps = 5/93 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L++LH+     +I+RDLK  NVLLDHE + K++DFGM +   G  N   T+   GT
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y+APE   E ++    D ++ GVLL E++ G
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 9/96 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--IFSGNQNEANTNRVA 385
           IA GL +LH      +I+RDLK  NV+LD E + KI+DFGM +  IF G      T    
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162

Query: 386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           GT  Y+APE      +    D ++FGVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 71.8 bits (176), Expect = 6e-14
 Identities = 36/106 (33%), Positives = 60/106 (56%), Gaps = 13/106 (12%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR----IFSGNQNE 378
                +  GL YLH      ++HRDLK  N+L+D +   KISDFG+++    I+  +QN 
Sbjct: 112 FFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN- 167

Query: 379 ANTNRVAGTYGYMAPE--YAMEGVFSVKSDVFSFGVLLLEIISGKR 422
                + G+  +MAPE  ++    +S K D++S G ++LE+ +G+R
Sbjct: 168 ---MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 18/162 (11%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   L ++H     R++HRD+K +NV +      K+ D G+ R FS     A++  + GT
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE 447
             YM+PE   E  ++ KSD++S G LL E+ + +  S FY  +   +L +   K+  K +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDK--MNLYSLCKKI-EKCD 224

Query: 448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
                 P L       EL   +     C+  DP  RP++S V
Sbjct: 225 Y-----PPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 37/99 (37%), Positives = 60/99 (60%), Gaps = 5/99 (5%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           +I+  I +GL YLH +   R IHRD+K +NVLL  + + K++DFG+A   +  Q + NT 
Sbjct: 105 TILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT- 160

Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 161 -FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 23/167 (13%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   + Y+H+     ++HRD+KT N+ L      K+ DFG+++I     + A T  V GT
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164

Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG 446
             YM+PE   +GV ++ KSD+++ G +L E+++ KR      +    + L    K+    
Sbjct: 165 PYYMSPELC-QGVKYNFKSDIWALGCVLYELLTLKR------TFDATNPLNLVVKIVQGN 217

Query: 447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
               +       +   +EL+  +H     +Q+DP  RP    V+   
Sbjct: 218 YTPVV-------SVYSSELISLVH---SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 54/175 (30%), Positives = 75/175 (42%), Gaps = 45/175 (25%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I++GIA    YLH   R  ++HRD+K SN+L++   N KI+DFG++RI    Q     N 
Sbjct: 177 ILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNS 227

Query: 384 VAGTYGYMAPE-------------YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE 430
             GT  YM+PE             YA         D++S GV +LE   G+    F +  
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGR--FPFGVGR 277

Query: 431 HGQSLLTYAW-KLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP 484
            G       W  L C   A+ +  P         E    I     C+Q +PA R 
Sbjct: 278 QGD------WASLMC---AICMSQPPEAPATASREFRHFIS---CCLQREPAKRW 320

Length = 353

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 10/103 (9%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I+    RGL YLHE+   +VIHRD+K  N+LL      K+ DFG++          NT  
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-- 172

Query: 384 VAGTYGYMAPE-----YAMEGVFSVKSDVFSFGVLLLEIISGK 421
             GT  +MAPE        +  +  +SDV+S G+  +E+  GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 8/100 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT--NRVA 385
           +  GL YLH      ++HRD+K +N+ LDH    K+ DFG A     N          +A
Sbjct: 108 LLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164

Query: 386 GTYGYMAPEYAMEGVFSVK---SDVFSFGVLLLEIISGKR 422
           GT  YMAPE    G        +D++S G ++LE+ +GKR
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 42/99 (42%), Positives = 58/99 (58%), Gaps = 12/99 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN-QNEANTNRVAG 386
             + L YL E+  L++IHRD+K SN+LLD   N K+ DFG+    SG   +     R AG
Sbjct: 116 TVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGI----SGQLVDSIAKTRDAG 169

Query: 387 TYGYMAPE----YAMEGVFSVKSDVFSFGVLLLEIISGK 421
              YMAPE     A +G + V+SDV+S G+ L E+ +GK
Sbjct: 170 CRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 60/207 (28%), Positives = 82/207 (39%), Gaps = 42/207 (20%)

Query: 296 LGSFV-WCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 354
           L SF+   R R  + S     L  K  +     +A+G  YL E+     IHRD+   N L
Sbjct: 96  LKSFLRENRPRPERPS----SLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCL 148

Query: 355 LDHEMNP----KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSF 410
           L  +  P    KI+DFGMAR            R      +M PE  ++G+F+ K+DV+SF
Sbjct: 149 LTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF 207

Query: 411 GVLLLEIIS-------GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDA 463
           GVLL EI S       G+ N        G   L       C G    +M           
Sbjct: 208 GVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKG--CPGPVYRIMTD--------- 256

Query: 464 ELLKCIHIGLLCVQEDPAHRPNMSSVV 490
                      C Q  P  RPN ++++
Sbjct: 257 -----------CWQHTPEDRPNFATIL 272

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 37/103 (35%), Positives = 66/103 (64%), Gaps = 7/103 (6%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN--QNEAN 380
           + +  I +GL YLH  +R  +IHRD+K +N+L+D++   KISDFG+++    N    + N
Sbjct: 110 NFVRQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166

Query: 381 TNR--VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             R  + G+  +MAPE   +  ++ K+D++S G L++E+++GK
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 52/158 (32%), Positives = 80/158 (50%), Gaps = 18/158 (11%)

Query: 336 HEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY 395
           H  SR RV+HRD+K +NV +      K+ D G+ R FS     A++  + GT  YM+PE 
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 396 AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMD-P 454
             E  ++ KSD++S G LL E+ +    S FY    G  +  Y+    CK   +E  D P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA--LQSPFY----GDKMNLYS---LCK--KIEQCDYP 226

Query: 455 VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM 492
            L       EL + ++   +C+  DP  RP+++ V  +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 40/92 (43%), Positives = 60/92 (65%), Gaps = 4/92 (4%)

Query: 332 LLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           LL LH      ++HRDLKT N+LLD H+M  KI DFG+++I S ++++A T  V GT  Y
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCY 167

Query: 391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           ++PE      ++ KSD+++ G +L E+ S KR
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 37/101 (36%), Positives = 61/101 (60%), Gaps = 8/101 (7%)

Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           +ISI   + RGL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 103 KISI--AVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 154

Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      ++V+SD++S G+ L+E+  G+
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 43/120 (35%), Positives = 66/120 (55%), Gaps = 13/120 (10%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFS 373
           QL   + ++I + IA G++YL   + L  +HRDL T N L+   +  KI DFGM+R I+S
Sbjct: 118 QLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174

Query: 374 GNQNEANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
                 +  RV G       +M PE  +   F+ +SD++SFGV+L EI +  +   + LS
Sbjct: 175 -----TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 8/102 (7%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM-ARIFSGNQNEANT- 381
           ++  + +GL YLH + +   IHRD+K  N+LL  + + KI+DFG+ A +  G        
Sbjct: 107 VLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163

Query: 382 NRVAGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISGK 421
               GT  +MAPE  ME V  +  K+D++SFG+  +E+ +G 
Sbjct: 164 KTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 30/185 (16%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R    
Sbjct: 102 KFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQ 433
           ++    T        + APE      F+  SDV+SFG+++ E++S G+R    Y     Q
Sbjct: 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP---YWDMSNQ 215

Query: 434 SLLTYAWKLWCKGEALE----LMDPVLKQTCVDAELLKCIH-IGLLCVQEDPAHRPNMSS 488
            ++          +A+E    L  P+    C  A     ++ + L C Q+D   RP  S 
Sbjct: 216 DVI----------KAVEDGYRLPPPM---DCPSA-----LYQLMLDCWQKDRNERPTFSQ 257

Query: 489 VVVML 493
           +V  L
Sbjct: 258 IVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 42/106 (39%), Positives = 61/106 (57%), Gaps = 11/106 (10%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL +LH+     +I+RDLK  NVLLD + + KI+DFGM +     + +A+T    GT
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQ 433
             Y+APE      ++   D +SFGVLL E++ G+  S F    HG+
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ--SPF----HGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 69.9 bits (171), Expect = 6e-13
 Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +ARG+ +L   SR + IHRDL   N+LL      KI DFG+AR    + +          
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MAPE   + V++ +SDV+SFGVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 3/105 (2%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL +K  +S    +ARG+ YL  +SR R IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 130 QLSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T+       +MAPE   + V++ +SDV+SFG+L+ EI +
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.8 bits (168), Expect = 8e-13
 Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 3/92 (3%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+RG+ YL E   ++++HRDL   NVL+      KISDFG++R      +    ++    
Sbjct: 136 ISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP 192

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E   + +++ +SDV+SFGVLL EI++
Sbjct: 193 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 35/99 (35%), Positives = 60/99 (60%), Gaps = 5/99 (5%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           +++  I +GL YLH + +   IHRD+K +NVLL  + + K++DFG+A   +  Q + NT 
Sbjct: 105 TMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT- 160

Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 161 -FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 9/99 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG------MARIFSGNQNEANT 381
           I   L YLH      +IHRDLK  N+L+D   + K++DFG      + R  + N +E   
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158

Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            R+ GT  Y+APE  +    S   D +S G +L E + G
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 5/106 (4%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           LD  +  +I+  I +GL YLH + +   IHRD+K +NVLL      K++DFG+A   +  
Sbjct: 98  LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Q     N   GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 155 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 40/122 (32%), Positives = 62/122 (50%), Gaps = 10/122 (8%)

Query: 304 RRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-----DHE 358
           R    +      L  K  + I   +A+G +YL    ++  IHRDL   N L+     D +
Sbjct: 91  RDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDAD 147

Query: 359 MNPKISDFGMAR-IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
              KI DFG+AR I+  +        +     +MAPE  ++G F+ +SDV+SFGVL+ EI
Sbjct: 148 RVVKIGDFGLARDIYKSDYYRKEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEI 206

Query: 418 IS 419
           ++
Sbjct: 207 LT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 42/109 (38%), Positives = 60/109 (55%), Gaps = 21/109 (19%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS----GNQNEA 379
           I+  + + L Y+H  S   VIHRDLK SN+LL+ +   K++DFG+AR  S      +N  
Sbjct: 112 IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 380 NTNRVAGTYGYMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
            T+ VA T  Y APE       Y  +GV     D++S G +L E++ GK
Sbjct: 169 LTDYVA-TRWYRAPEILLGSTRYT-KGV-----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +    IHRDL   NVLL H    KI DFG+AR    + N          
Sbjct: 150 VAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MAPE     V++ +SDV+S+G+LL EI S
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 38/111 (34%), Positives = 60/111 (54%), Gaps = 15/111 (13%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFS 373
            L    ++ I   +A G+ YL E    + +HRDL T N L+   M  KI+DFG++R I+S
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 374 -----GNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 ++N+A   R      +M PE      ++ +SDV+++GV+L EI S
Sbjct: 183 ADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 35/92 (38%), Positives = 57/92 (61%), Gaps = 3/92 (3%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G++YL E    R++HRDL   NVL+    + KI+DFG+AR+  G++ E N +     
Sbjct: 118 IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E      F+ +SDV+S+GV + E+++
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 7/94 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + RGL  LHE    +++HRDLK++N+LL      KI D G++++   N   A T    GT
Sbjct: 112 LLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AKT--QIGT 164

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             YMAPE      +S KSD++S G LL E+ +  
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 37/101 (36%), Positives = 61/101 (60%), Gaps = 8/101 (7%)

Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + RGL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 107 KVSI--AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 158

Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 21/170 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   SR + IHRDL   N+LL      KI DFG+AR    + +          
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 301

Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 302 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 38/95 (40%), Positives = 55/95 (57%), Gaps = 9/95 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I RGL Y+H      V+HRDLK SN+L++   + KI DFG+ARI    Q+   T  V+  
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTR 169

Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
           Y Y APE  +    + V+ D++S G +  E++ GK
Sbjct: 170 Y-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 8/95 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A G+ YL      +++HRDL   N+L+  +   K+SDFG+AR+        + +++   
Sbjct: 109 VAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLP-- 160

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             + APE      FS KSDV+S+GVLL E+ S  R
Sbjct: 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 37/110 (33%), Positives = 54/110 (49%), Gaps = 3/110 (2%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
            K  +L  K+ + +    A G+ YL  +S+   IHRDL   N L+      KISDFGM+R
Sbjct: 85  KKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIHRDLAARNCLVGENNVLKISDFGMSR 141

Query: 371 IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
              G     +         + APE    G ++ +SDV+S+G+LL E  S 
Sbjct: 142 EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL +LH      +++RDLK  N+LLD + + KI+DFGM +       +A T    GT
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE  +   ++   D +SFGVLL E++ G+
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 38/94 (40%), Positives = 58/94 (61%), Gaps = 8/94 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL ++H  +R  V++RDLK +N+LLD   + +ISD G+A  FS  +  A+     GT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 158

Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISG 420
           +GYMAPE   +GV +   +D FS G +L +++ G
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
            G+ +LH++    ++HRDLKTSN+LL++    KI DFG+AR +           V  T  
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLW 171

Query: 390 YMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE  +    +S   D++S G +  E+++ K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 9/95 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQN--EANTNRV 384
           IA G+ YLH   +  VIH+D+   N ++D E+  KI+D  ++R +F  + +    N NR 
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR- 181

Query: 385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                +MA E  +   +S  SDV+SFGVLL E+++
Sbjct: 182 --PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.9 bits (163), Expect = 5e-12
 Identities = 55/168 (32%), Positives = 78/168 (46%), Gaps = 21/168 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +ARG+ +L   SR + IHRDL   N+LL      KI DFG+AR    + +          
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++ +SDV+SFGVLL EI S       G  ++E     L    ++   
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--- 296

Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
             A E   P + +            I L C Q DP  RP  S++V +L
Sbjct: 297 -RAPENATPEIYR------------IMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 35/90 (38%), Positives = 52/90 (57%), Gaps = 5/90 (5%)

Query: 332 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM 391
           L++LH      VI+RDLK  N+LLD E + K++DFGM +   G  N   T    GT  Y+
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYI 163

Query: 392 APEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           APE   E  +    D ++ GVL+ E+++G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 6/104 (5%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           L   + + I   I  GL YLH     R+IHRD+KT N+ ++      I D G A+     
Sbjct: 154 LPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---P 207

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                   +AGT    APE      ++ K+D++S G++L E+++
Sbjct: 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 10/96 (10%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   + YL  +     IHRDL   N L+  +   K+SDFG+AR    +Q  ++     GT
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GT 161

Query: 388 ---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                +  PE      FS KSDV+SFGVL+ E+ S 
Sbjct: 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 133 QMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN 189

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 3/113 (2%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
           N       QL +K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DF
Sbjct: 128 NPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 184

Query: 367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G+AR          T        +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 185 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 66.8 bits (163), Expect = 7e-12
 Identities = 41/108 (37%), Positives = 57/108 (52%), Gaps = 11/108 (10%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +    IHRD+   NVLL      KI DFG+AR    + N          
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR-------NSGFY 427
             +MAPE   + V++V+SDV+S+G+LL EI S GK        NS FY
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 41/122 (33%), Positives = 60/122 (49%), Gaps = 19/122 (15%)

Query: 312 KGAQLDW--KRRISIING---------IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 360
           KG+ +D+   R  S++ G         +   + YL  ++    +HRDL   NVL+  +  
Sbjct: 84  KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNV 140

Query: 361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            K+SDFG+ +  S  Q+            + APE   E  FS KSDV+SFG+LL EI S 
Sbjct: 141 AKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195

Query: 421 KR 422
            R
Sbjct: 196 GR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 38/96 (39%), Positives = 55/96 (57%), Gaps = 9/96 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--IFSGNQNEANTNRVA 385
           IA GL +LH      +I+RDLK  NV+LD E + KI+DFGM +  ++ G      T    
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162

Query: 386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           GT  Y+APE      +    D ++FGVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.2 bits (159), Expect = 9e-12
 Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 7/118 (5%)

Query: 305 RINK---DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 361
           R  K   +  K   L  K+++++   IA G+ +L   S  R +HRDL   N L+  +   
Sbjct: 100 RATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREV 156

Query: 362 KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           K+S   +++    N              ++APE   E  FS KSDV+SFGVL+ E+ +
Sbjct: 157 KVSLLSLSKD-VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  L +LH    L +I+RDLK  N+LLD E + K++DFG+++      +E       GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 161

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             YMAPE       +  +D +SFGVL+ E+++G
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 41/105 (39%), Positives = 58/105 (55%), Gaps = 3/105 (2%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL +K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 130 QLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVLL EI +
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 50/181 (27%), Positives = 81/181 (44%), Gaps = 35/181 (19%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T
Sbjct: 109 VGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165

Query: 382 NRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR------NSGFYLS-EHG 432
            R       + APE      F+  SDV+S+G+++ E++S G+R      N     + E G
Sbjct: 166 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225

Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM 492
             L      + C     +LM                    L C Q+D   RP    +V +
Sbjct: 226 YRLPA---PMDCPAALHQLM--------------------LDCWQKDRNERPKFEQIVSI 262

Query: 493 L 493
           L
Sbjct: 263 L 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H      ++HRDLK  N+L++ E   K++DFG+AR F        T+ V  T
Sbjct: 107 LLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVV-T 161

Query: 388 YGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  + +  +S   D++S G +  E++S +
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 65.6 bits (161), Expect = 1e-11
 Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 7/97 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN--TNRVA 385
           I RGL YLH  +   VIHRDLK SN+L++   + KI DFG+AR    +++E    T  V 
Sbjct: 112 ILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168

Query: 386 GTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            T  Y APE  +    ++   D++S G +  E+++ K
Sbjct: 169 -TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 41/109 (37%), Positives = 60/109 (55%), Gaps = 17/109 (15%)

Query: 319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN--Q 376
           K  ++I+      L YL E     VIHRD+K SN+LLD   N K+ DFG+    SG    
Sbjct: 118 KMTVAIVKA----LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGI----SGRLVD 167

Query: 377 NEANTNRVAGTYGYMAPEY----AMEGVFSVKSDVFSFGVLLLEIISGK 421
           ++A T R AG   YMAPE          + +++DV+S G+ L+E+ +G+
Sbjct: 168 SKAKT-RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 56/185 (30%), Positives = 84/185 (45%), Gaps = 28/185 (15%)

Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IF 372
            +L   + + I + IA G++YL   +    +HRDL T N L+   +  KI DFGM+R ++
Sbjct: 118 GELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 174

Query: 373 SGNQNEANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           S      +  RV G       +M PE  M   F+ +SDV+SFGV+L EI +  +   F L
Sbjct: 175 S-----TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           S       T   +   +G  LE      K+            I L C Q +P  R N+  
Sbjct: 230 SN------TEVIECITQGRVLERPRVCPKEV---------YDIMLGCWQREPQQRLNIKE 274

Query: 489 VVVML 493
           +  +L
Sbjct: 275 IYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 40/114 (35%), Positives = 67/114 (58%), Gaps = 5/114 (4%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
           + D T  + L+    + I+  IA G+ +L   S   V+H+DL T NVL+  ++N KISD 
Sbjct: 112 DDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDL 168

Query: 367 GMAR-IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G+ R +++ +  +   N +     +M+PE  M G FS+ SD++S+GV+L E+ S
Sbjct: 169 GLFREVYAADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 44/138 (31%), Positives = 63/138 (45%), Gaps = 31/138 (22%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ YL   +   VIHRDL   N L+      K+SDFGM R    +Q  ++T    GT
Sbjct: 109 VCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GT 161

Query: 388 ---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR---------------NSGFYL- 428
                + +PE      +S KSDV+SFGVL+ E+ S  +               N+GF L 
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY 221

Query: 429 -----SEHGQSLLTYAWK 441
                S+    L+ + WK
Sbjct: 222 KPRLASQSVYELMQHCWK 239

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 7/95 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV-AG 386
           I+ GL +LH      +I+RDLK  NV+LD E + KI+DFGM +    +  +  T R   G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163

Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  Y+APE      +    D +++GVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 25/219 (11%)

Query: 284 GTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRV 343
           G  +  I  ++ LGS    R  + K     AQL     +     I  G+ YLH       
Sbjct: 80  GKGLQLIMEYVPLGSL---RDYLPKHKLNLAQL-----LLFAQQICEGMAYLHSQ---HY 128

Query: 344 IHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQ----NEANTNRVAGTYGYMAPEYAME 398
           IHRDL   NVLLD++   KI DFG+A+ +  G++     E   + V     + A E   E
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAVECLKE 184

Query: 399 GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQ--SLLTYAWKLWCKGEALELMDPVL 456
             FS  SDV+SFGV L E+++   +     S   +   ++            +EL++  +
Sbjct: 185 NKFSYASDVWSFGVTLYELLT---HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241

Query: 457 KQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
           +  C      +   +   C + +   RP   S++ +L  
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 60/221 (27%), Positives = 88/221 (39%), Gaps = 55/221 (24%)

Query: 299 FVWCRRRINKDSTKGAQLDWKRRI------SIINGIARGLLYLHEDSRLRVIHRDLKTSN 352
           FV  R  I  +   G  LD  R+I       I   + +GL YL     L+++HRD+K SN
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSN 125

Query: 353 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY----GYMAPEYAMEGVFSVKSDVF 408
           +L++     K+ DFG++            N +A TY     YMAPE      + + SDV+
Sbjct: 126 MLVNTRGQVKLCDFGVSTQL--------VNSIAKTYVGTNAYMAPERISGEQYGIHSDVW 177

Query: 409 SFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKC 468
           S G+  +E+  G+          G SL+                 P+        +LL+C
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQG-SLM-----------------PL--------QLLQC 211

Query: 469 IHIGLLCVQEDPAHRP--NMSSVVVMLASDTATLPPPTQPA 507
           I      V EDP   P    S   V   +      P  +PA
Sbjct: 212 I------VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 17/178 (9%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           LD +  +S    +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
            N            +MAPE     V++ +SDV+S+G+LL EI S    S  Y    G  +
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS--LGSSPY---PGMPV 322

Query: 436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
            +  +K+    E   ++ P     C  +E+   +     C   DP  RP    +V ++
Sbjct: 323 DSKFYKMI--KEGYRMLSP----ECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 30/178 (16%)

Query: 319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE 378
           K+ I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYE 171

Query: 379 ANTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
            +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI +       Y     + 
Sbjct: 172 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGMSNEQ 229

Query: 435 LLTYAWKLWCKGEALELMDPVLKQTCVDA--ELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           +L +      +G  L+  D      C D   EL++      +C Q +P  RP+   ++
Sbjct: 230 VLRFV----MEGGLLDKPD-----NCPDMLFELMR------MCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 5/91 (5%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           GL +LH      +I+RDLK  NV+LD + + KI+DFGM +      N A+T    GT  Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDY 162

Query: 391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +APE      ++   D +SFGVLL E++ G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 42/119 (35%), Positives = 62/119 (52%), Gaps = 12/119 (10%)

Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   K   +  K    +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISD 138

Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 139 FGLSKALGADENYYK----AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)

Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + +GL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 107 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 158

Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA  L YLHE     ++HRDLKT NV L      K+ D G+AR+     + A+T  + GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             YM+PE      ++ KSDV++ G  + E+ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 56/198 (28%), Positives = 86/198 (43%), Gaps = 36/198 (18%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
           ++D T  + LD    + I   IA G+ YL   S    +H+DL   N+L+  +++ KISD 
Sbjct: 112 DEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDL 168

Query: 367 GMAR-IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSG 425
           G++R I+S +        +     +M PE  M G FS  SD++SFGV+L EI S      
Sbjct: 169 GLSREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Query: 426 FYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKC--------IHIGLLCVQ 477
           +  S                    E+++ V K+     +LL C          +   C Q
Sbjct: 228 YGFSNQ------------------EVIEMVRKR-----QLLPCSEDCPPRMYSLMTECWQ 264

Query: 478 EDPAHRPNMSSVVVMLAS 495
           E P+ RP    +   L S
Sbjct: 265 EGPSRRPRFKDIHTRLRS 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 37/94 (39%), Positives = 57/94 (60%), Gaps = 8/94 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL ++H  +R  V++RDLK +N+LLD   + +ISD G+A  FS  +  A+     GT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 158

Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISG 420
           +GYMAPE   +G  +   +D FS G +L +++ G
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 16/154 (10%)

Query: 336 HEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY 395
           H  SR RV+HRD+K +NV +      K+ D G+ R FS     A++  + GT  YM+PE 
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 396 AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPV 455
             E  ++ KSD++S G LL E+ +    S FY  +   +L +   K+    E  +   P 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDK--MNLFSLCQKI----EQCDY--PP 227

Query: 456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
           L       +L + +    +C+  DP  RP++  V
Sbjct: 228 LPTEHYSEKLRELVS---MCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 33/91 (36%), Positives = 54/91 (59%)

Query: 332 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM 391
           LL +H      +IHRD+K++N+LL      K+ DFG +++++   ++       GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           APE      +S K+D+FS GVLL E+++ KR
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 17/98 (17%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           +G+ Y+H      ++HRDLK +N+L+  +   KI+DFG+AR+FS  +    +++VA T  
Sbjct: 110 KGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRW 165

Query: 390 YMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISG 420
           Y APE       Y   GV     D+++ G +  E+++G
Sbjct: 166 YRAPELLYGARKYD-PGV-----DLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 33/92 (35%), Positives = 57/92 (61%), Gaps = 3/92 (3%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL E   +R++HRDL   NVL+    + KI+DFG+AR+   ++ E + +     
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +   F+ +SDV+S+GV + E+++
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 6/98 (6%)

Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 384
           I  I   L +LH+   L +I+RD+K  N+LLD E +  ++DFG+++ F     E      
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSF 166

Query: 385 AGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISG 420
            GT  YMAPE    G        D +S GVL  E+++G
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 21/174 (12%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+   +  E   
Sbjct: 110 VGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTY 165

Query: 382 NRVAGTYG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA 439
               G     + APE      F+  SDV+SFG+++ E++S      + +S H        
Sbjct: 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV------ 219

Query: 440 WKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
             +    +   L  P+   + V   +L+C        Q+D A RP    +V +L
Sbjct: 220 --MKAINDGFRLPAPMDCPSAVYQLMLQCW-------QQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 42/128 (32%), Positives = 64/128 (50%), Gaps = 11/128 (8%)

Query: 296 LGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 355
           L S++   R   +++        +  I +   IA G+ YL+     + +HRDL   N ++
Sbjct: 96  LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMV 152

Query: 356 DHEMNPKISDFGMARIFSGNQNEANTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFG 411
            H+   KI DFGM R    +  E +  R  G       +MAPE   +GVF+  SD++SFG
Sbjct: 153 AHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 208

Query: 412 VLLLEIIS 419
           V+L EI S
Sbjct: 209 VVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 28/67 (41%), Positives = 42/67 (62%), Gaps = 7/67 (10%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN---TNRVAGT 387
           GL Y+H   R +++HRD+K +N+L+  +   K++DFG+AR FS ++N      TNRV  T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186

Query: 388 YGYMAPE 394
             Y  PE
Sbjct: 187 LWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 11/96 (11%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA G+ YL     L  +HRDL T N L+      KI+DFGM+R    N   ++  RV G 
Sbjct: 139 IASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSDYYRVQGR 191

Query: 388 ----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 +MA E  + G F+ KSDV++FGV L EI++
Sbjct: 192 APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 33/89 (37%), Positives = 49/89 (55%), Gaps = 8/89 (8%)

Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVAGTYGYMA 392
           YLH      +I+RDLK  N+LLD     K+ DFG A+ + SG +    T    GT  Y+A
Sbjct: 108 YLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK----TWTFCGTPEYVA 160

Query: 393 PEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           PE  +   +    D +S G+LL E+++G+
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 38/94 (40%), Positives = 51/94 (54%), Gaps = 6/94 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL  LH   R R+++RDLK  N+LLD   + +ISD G+A      + E    RV GT
Sbjct: 111 ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV-GT 164

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            GYMAPE      ++   D +  G L+ E+I GK
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL YLH+      +HRD+K +N+L+D     K++DFGMA+        +      G+
Sbjct: 111 ILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SFAKSFKGS 164

Query: 388 YGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG 446
             +MAPE    +G + + +D++S G  +LE+ +GK              +   +K+    
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVAAVFKIGRSK 218

Query: 447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP 484
           E   + D       +  E    I   L C+Q DP+ RP
Sbjct: 219 ELPPIPDH------LSDEAKDFI---LKCLQRDPSLRP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.9 bits (156), Expect = 5e-11
 Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 11/100 (11%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN---TNRV 384
           + RGL Y+H  +   VIHRDLK SN+L++ +   +I DFGMAR  S +  E     T  V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 385 AGTYGYMAPE--YAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           A T  Y APE   ++   ++   D++S G +  E++ G+R
Sbjct: 173 A-TRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 42/131 (32%), Positives = 65/131 (49%), Gaps = 15/131 (11%)

Query: 290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 349
           IT F+  G+ +   R  N+       L     + +   I+  + YL + +    IHRDL 
Sbjct: 80  ITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLEKKN---FIHRDLA 131

Query: 350 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT---YGYMAPEYAMEGVFSVKSD 406
             N L+      K++DFG++R+ +G+   A+    AG      + APE      FS+KSD
Sbjct: 132 ARNCLVGENHLVKVADFGLSRLMTGDTYTAH----AGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 407 VFSFGVLLLEI 417
           V++FGVLL EI
Sbjct: 188 VWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 53/173 (30%), Positives = 78/173 (45%), Gaps = 35/173 (20%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +ARG+ YL   S+ + IHRDL   N+L+      KI+DFG++R       E    +  G 
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 184

Query: 388 YG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSL-LTYAWK- 441
               +MA E     V++  SDV+S+GVLL EI+S  G    G   +E  + L   Y  + 
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 244

Query: 442 -LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
            L C  E  +LM                      C +E P  RP+ + ++V L
Sbjct: 245 PLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQILVSL 277

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 40/114 (35%), Positives = 61/114 (53%), Gaps = 6/114 (5%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           DS+    LD     S +  + +G+ Y H  S  RV+HRDLK  N+L+D E   K++DFG+
Sbjct: 89  DSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGL 145

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGK 421
           AR F G      T+ V  T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 146 ARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 38/108 (35%), Positives = 58/108 (53%), Gaps = 6/108 (5%)

Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           A  +  R +     I  GL  LH++   R+++RDLK  N+LLD   + +ISD G+A    
Sbjct: 97  AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VH 151

Query: 374 GNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             + +    RV GT GYMAPE      ++   D ++ G LL E+I+G+
Sbjct: 152 VPEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 62.6 bits (152), Expect = 9e-11
 Identities = 33/102 (32%), Positives = 61/102 (59%), Gaps = 8/102 (7%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           + L +LH +   +VIHRD+K+ N+LL  + + K++DFG     +  Q++ +T  + GT  
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180

Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
           +MAPE      +  K D++S G++ +E++ G+     YL+E+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 20/162 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVAG 386
           IA G+ YL   + L  +HRDL T N L+ +    KI+DFGM+R ++SG+       R   
Sbjct: 138 IASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ-GRAVL 193

Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR--------------NSGFYLSEHG 432
              +MA E  + G F+  SDV++FGV L E+ +  +              N+G +    G
Sbjct: 194 PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQG 253

Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL 474
           + +      L C     +LM     +   D      IH  L 
Sbjct: 254 RQIYLSQTPL-CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 62.2 bits (151), Expect = 9e-11
 Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 8/97 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAG 386
           I  GL YLH+    +++HRD+K  NVL++ +    KISDFG ++  +G      T    G
Sbjct: 117 ILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTG 171

Query: 387 TYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISGK 421
           T  YMAPE   +G   +   +D++S G  ++E+ +GK
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 5/99 (5%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEAN 380
           + +   IA G+ YL   S L  +HRDL T N L+   +  KI+DFGM+R +++G+     
Sbjct: 141 LHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ 197

Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             R      +MA E  + G F+  SDV++FGV L EI+ 
Sbjct: 198 -GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 31/92 (33%), Positives = 56/92 (60%), Gaps = 5/92 (5%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           + L +LH +   +VIHRD+K+ NVLL  + + K++DFG     +  Q++ +T  + GT  
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180

Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +MAPE      +  K D++S G++ +E++ G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 42/103 (40%), Positives = 56/103 (54%), Gaps = 8/103 (7%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-- 380
           S I  I  GL Y+H  +   V+HRDLK  N+L++ +   KI DFG+AR FS N  E    
Sbjct: 109 SFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165

Query: 381 -TNRVAGTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
            T  VA T  Y APE  +      K+ DV+S G +L E++  K
Sbjct: 166 MTEYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 39/97 (40%), Positives = 55/97 (56%), Gaps = 7/97 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN--TNRVA 385
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+ARI     +     T  VA
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 386 GTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
            T  Y APE  +      K+ D++S G +L E++S +
Sbjct: 172 -TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 3/98 (3%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           +S    +ARG+ +L   +    +HRDL   NVLL      KI DFG+AR    + N  + 
Sbjct: 240 LSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296

Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                   +MAPE   + +++  SDV+S+G+LL EI S
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 6/103 (5%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEAN 380
           I+    + RGL YLHE+   ++IHRD+K +N+L+D      +I+DFG A   +     A 
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162

Query: 381 --TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
               ++ GT  +MAPE      +    DV+S G +++E+ + K
Sbjct: 163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 39/111 (35%), Positives = 61/111 (54%), Gaps = 6/111 (5%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           KG  +D +   S +  I +G+L+ H     RV+HRDLK  N+L+D++   K++DFG+AR 
Sbjct: 94  KGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA 150

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           F G      T+ V  T  Y APE  +    +S   D++S G +  E+ + K
Sbjct: 151 F-GIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 37/96 (38%), Positives = 57/96 (59%), Gaps = 9/96 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L +LHE     +I+RDLK  NVLLD E + K++D+GM +   G +    T+   GT
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGT 159

Query: 388 YGYMAPEY--AMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE     +  FSV  D ++ GVL+ E+++G+
Sbjct: 160 PNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 40/120 (33%), Positives = 59/120 (49%), Gaps = 19/120 (15%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGN---QNEANTNR 383
           IA G+ YL   S    IHRDL   N +L  +M   ++DFG+++ I+SG+   Q       
Sbjct: 122 IALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-------GKRNSGFY-LSEHGQSL 435
           V     ++A E   + V++ KSDV++FGV + EI +       G  N   Y    HG  L
Sbjct: 179 VK----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL 234

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 35/95 (36%), Positives = 47/95 (49%), Gaps = 8/95 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN---RV 384
           IA G+ YL      R IHRDL   N+LL  +   KI DFG+ R    N++        +V
Sbjct: 106 IANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162

Query: 385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
              + + APE      FS  SDV+ FGV L E+ +
Sbjct: 163 P--FAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 4/95 (4%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA-RIFSGNQNEANTNRVAG 386
           I  G+ YLH +    ++HRD+K +N+L D   N K+ DFG + R+ +   +      V G
Sbjct: 113 ILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169

Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  +M+PE      +  K+DV+S G  ++E+++ K
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 40/98 (40%), Positives = 55/98 (56%), Gaps = 12/98 (12%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           +I +G  +GL YLH   R   IHRD+K  N+LL      K++DFG A + S     AN+ 
Sbjct: 119 AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS- 170

Query: 383 RVAGTYGYMAPE--YAM-EGVFSVKSDVFSFGVLLLEI 417
              GT  +MAPE   AM EG +  K DV+S G+  +E+
Sbjct: 171 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 31/92 (33%), Positives = 56/92 (60%), Gaps = 3/92 (3%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL E    R++HRDL   NVL+    + KI+DFG+A++   ++ E +       
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 11/96 (11%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGN---QNEANTNR 383
           IA G+ YL   S    IHRDL   N +L+  M   ++DFG+++ I+SG+   Q  A+   
Sbjct: 122 IASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           V     ++A E   + V++  SDV++FGV + EI++
Sbjct: 179 VK----WLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 33/87 (37%), Positives = 52/87 (59%), Gaps = 6/87 (6%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G+ Y+H+    R++HRDLK  N+ L + +  KI DFG++R+  G+ + A T    GT  Y
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYY 171

Query: 391 MAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           M+PE      +  KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL +LH     RV+HRDLK  N+L+      K++DFG+ARI+S    +     V  T  
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLW 174

Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 29/77 (37%), Positives = 43/77 (55%), Gaps = 8/77 (10%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP----KISDFGMARIF-SGNQN 377
           S++  I  G+ YLH +    V+HRDLK +N+L+  E       KI D G+AR+F +  + 
Sbjct: 112 SLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 378 EANTNRVAGTYGYMAPE 394
            A+ + V  T  Y APE
Sbjct: 169 LADLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 37/195 (18%)

Query: 308 KDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG 367
           K+    + L  ++ +   + +A G+ YL E    + IHRDL   NVL+   +  KI+DFG
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFG 164

Query: 368 MARIFSGNQNEANTNRVAGTYG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRN 423
           ++R       E    +  G     +MA E     V++ KSDV+SFGVLL EI+S  G   
Sbjct: 165 LSR-----GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Query: 424 SGFYLSEHGQSLLTYAWKLW----CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQED 479
            G   +E  +  L   +++     C  E  ELM    +Q                C ++ 
Sbjct: 220 CGMTCAELYEK-LPQGYRMEKPRNCDDEVYELM----RQ----------------CWRDR 258

Query: 480 PAHRPNMSSVVVMLA 494
           P  RP  + + V L+
Sbjct: 259 PYERPPFAQISVQLS 273

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 54/192 (28%), Positives = 86/192 (44%), Gaps = 28/192 (14%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFS 373
           +L   + + I   IA G++YL   +    +HRDL T N L+   +  KI DFGM+R ++S
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 172

Query: 374 GNQNEANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
                 +  RV G       +M PE  M   F+ +SDV+S GV+L EI +  +   + LS
Sbjct: 173 -----TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227

Query: 430 EHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
            +          + C  +   L  P   +TC      +   + L C Q +P  R N+  +
Sbjct: 228 NNEV--------IECITQGRVLQRP---RTCPK----EVYDLMLGCWQREPHMRLNIKEI 272

Query: 490 VVMLASDTATLP 501
             +L +     P
Sbjct: 273 HSLLQNLAKASP 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 43/116 (37%), Positives = 56/116 (48%), Gaps = 17/116 (14%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T+G +L  K  I ++   A G+ YL        IHRDL   N L+  +   KISDFGM+R
Sbjct: 86  TEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142

Query: 371 IFSGNQNEANTNRVAGTYG-------YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                  E      A T G       + APE    G +S +SDV+SFG+LL E  S
Sbjct: 143 -------EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL      + +HRDL   N +LD     K++DFG+AR     +  +  N     
Sbjct: 107 VAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163

Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 8/101 (7%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           S +    RGL YLH      ++HRDLK +N+L+  +   K++DFG+AR F G+ N   T+
Sbjct: 106 SYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTH 161

Query: 383 RVAGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISGK 421
           +V  T  Y APE    G   + V  D++S G +  E++   
Sbjct: 162 QVV-TRWYRAPELLF-GARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L YLHE     +I+RDLK  NVLLD E + K++D+GM +   G +    T+   GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 35/108 (32%), Positives = 57/108 (52%), Gaps = 13/108 (12%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
            DW ++   I  +  G+  LH+     +IHRD+K  N+L+D   + K++DFG++R    N
Sbjct: 96  EDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN 150

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVK-SDVFSFGVLLLEIISGKR 422
           +      +  GT  Y+APE  + GV   K SD +S G ++ E + G  
Sbjct: 151 K------KFVGTPDYLAPE-TILGVGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 60.6 bits (148), Expect = 4e-10
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 18/98 (18%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   L YLH    L +++RDLK  N+LLD +   KI+DFG A+   G      T  + GT
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGT 161

Query: 388 YGYMAPEYAMEGVFSVK-----SDVFSFGVLLLEIISG 420
             Y+APE     +   K      D ++ G+L+ E+++G
Sbjct: 162 PEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 36/114 (31%), Positives = 58/114 (50%), Gaps = 10/114 (8%)

Query: 308 KDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG 367
             ++  + L  ++ +     +ARG+ YL +    + IHRDL   N+L+      KI+DFG
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157

Query: 368 MARIFSGNQNEANTNRVAGTYG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++R       E    +  G     +MA E     V++  SDV+S+GVLL EI+S
Sbjct: 158 LSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 42/139 (30%), Positives = 75/139 (53%), Gaps = 9/139 (6%)

Query: 281 IAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSR 340
           I  G  +  +T    LGS +   R+ ++DS     LD +R ++    IA+G+ YL E   
Sbjct: 77  ICPGASLQLVTQLSPLGSLLDHVRQ-HRDS-----LDPQRLLNWCVQIAKGMYYLEEH-- 128

Query: 341 LRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV 400
            R++HR+L   N+LL  +   +I+DFG+A +   +  +   +       +MA E  + G 
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 401 FSVKSDVFSFGVLLLEIIS 419
           ++ +SDV+S+GV + E++S
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 16/106 (15%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN--QNEANT 381
           I   + +GL +L E+    +IHRD+K +NVL++     K+ DFG+    SGN   + A T
Sbjct: 107 ITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKT 160

Query: 382 NRVAGTYGYMAPEY------AMEGVFSVKSDVFSFGVLLLEIISGK 421
           N   G   YMAPE            ++V+SDV+S G+ +LE+  G+
Sbjct: 161 N--IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 30/92 (32%), Positives = 56/92 (60%), Gaps = 5/92 (5%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           + L +LH +   +VIHRD+K+ N+LL  + + K++DFG     +  Q++ +T  + GT  
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180

Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +MAPE      +  K D++S G++ +E++ G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 38/102 (37%), Positives = 54/102 (52%), Gaps = 12/102 (11%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           +I +G  +GL YLH  +   +IHRD+K  N+LL      K++DFG A I S        N
Sbjct: 129 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS------PAN 179

Query: 383 RVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
              GT  +MAPE  +   EG +  K DV+S G+  +E+   K
Sbjct: 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 15/102 (14%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN---------QNEAN- 380
           G+ YLHE+    ++HRD+K +N+L+D++   KI+DFG+AR + G                
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 381 TNRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
           TN V  T  Y  PE  + E  ++   D++  G +  E+ + +
Sbjct: 184 TNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 60.0 bits (145), Expect = 8e-10
 Identities = 37/102 (36%), Positives = 52/102 (50%), Gaps = 12/102 (11%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           +I +G  +GL YLH  +    IHRD+K  N+LL      K++DFG A   S        N
Sbjct: 125 AITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSS------PAN 175

Query: 383 RVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
              GT  +MAPE  +   EG +  K DV+S G+  +E+   K
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 34/105 (32%), Positives = 62/105 (59%), Gaps = 7/105 (6%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN- 380
           + ++ GIA G+ YL E   +  +HRDL   N+L++  +  K+SDFG++R    + ++   
Sbjct: 109 VGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165

Query: 381 TNRVAGTYG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
           T+ + G     + APE      F+  SDV+S+G+++ E++S G+R
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 5/95 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I RGL YLH      ++HRD+K  N+L++     KI DFG+AR+   ++++  T  V   
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           Y Y APE  M    ++   D++S G +  E++  +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR--VAGT 387
           + L +LH      VIHRD+K+ ++LL  +   K+SDFG    F    ++    R  + GT
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGT 178

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +MAPE      +  + D++S G++++E++ G+
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 14/97 (14%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL YLHE+    +IHRDLK SN+LL  +   KI+DFG+AR +           V  T  
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLW 173

Query: 390 YMAPEYAMEGVFSVKS-----DVFSFGVLLLEIISGK 421
           Y APE     +    +     D+++ G +L E+++ K
Sbjct: 174 YRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 7/96 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I RG+ Y H  S  RV+HRDLK  N+L+D   N  K++DFG+AR F G      T+ V  
Sbjct: 111 ILRGIAYCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV- 165

Query: 387 TYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGK 421
           T  Y APE  +    +S   D++S G +  E+++ K
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 59.4 bits (143), Expect = 1e-09
 Identities = 30/92 (32%), Positives = 55/92 (59%), Gaps = 5/92 (5%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           + L +LH +   +VIHRD+K+ N+LL  + + K++DFG     +  Q++   + + GT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPY 181

Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 38/99 (38%), Positives = 55/99 (55%), Gaps = 5/99 (5%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEAN 380
           I +   IA G+ YL   S L  +HRDL T N L+      KI+DFGM+R ++SG+     
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             R      +M+ E  + G F+  SDV++FGV L EI++
Sbjct: 190 -GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 11/102 (10%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           S I  + + + Y H      +IHRD+K  N+L+      K+ DFG AR          T+
Sbjct: 104 SYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160

Query: 383 RVAGTYGYMAPE----YAMEGVFSVKSDVFSFGVLLLEIISG 420
            VA T  Y APE        G   V  DV++ G ++ E++ G
Sbjct: 161 YVA-TRWYRAPELLVGDTNYG-KPV--DVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 12/93 (12%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM-ARIFSGNQNEANTNRVAGTYG 389
            L +LH     +VIHRDLK  N+LL  + + K++DFG+ A+  S  Q     +   GT  
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPY 168

Query: 390 YMAPEYAMEGVFS-----VKSDVFSFGVLLLEI 417
           +MAPE      F       K+D++S G+ L+E+
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           ++ +G  +GL YLH  +   +IHRD+K  N+LL      K+ DFG A I       A  N
Sbjct: 119 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169

Query: 383 RVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEI 417
              GT  +MAPE  +   EG +  K DV+S G+  +E+
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 39/115 (33%), Positives = 61/115 (53%), Gaps = 14/115 (12%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA-RIFSGNQNEAN 380
           +  +  IA G+ YL   S    IHRDL   N +L+  MN  ++DFG++ +I++G+     
Sbjct: 115 VKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR-- 169

Query: 381 TNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-------GKRNSGFY 427
             R+A     ++A E   + V++ KSDV+SFGV + EI +       G  NS  Y
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 35/100 (35%), Positives = 59/100 (59%), Gaps = 5/100 (5%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           S +  +  GL Y H+ + L   HRD+K SN+LL+++   K++DFG+AR+++  ++   TN
Sbjct: 120 SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176

Query: 383 RVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
           +V  T  Y  PE  + E  +    DV+S G +L E+ + K
Sbjct: 177 KVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 5/90 (5%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           GL YLHE+   ++++RDLK  N+LLD E   KI+DFG+ +   G  +  +T    GT  +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEF 167

Query: 391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           +APE   E  ++   D +  GVL+ E++ G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
            A  L  L    +  VI+RDLK  N+LLD++ +  + DFG+ ++   + ++ NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y+APE  +   ++   D ++ GVLL E+++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 5/106 (4%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           K  +   +R  +I   +   L YLH++ R  ++HRDL  +N++L  +    I+DFG+A+ 
Sbjct: 106 KKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK- 162

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
               Q E+    V GT  Y  PE      +  K+DV++FG +L ++
Sbjct: 163 --QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 8/90 (8%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           +GL YLHE      IHRD+K +N+LL  + + K++DFG++   +    +  +    GT  
Sbjct: 112 KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPY 166

Query: 390 YMAPEYA---MEGVFSVKSDVFSFGVLLLE 416
           +MAPE A    +G +  K D+++ G+  +E
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 6/93 (6%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           +G+ + HE+   RV+HRDLK  N+L++     K++DFG+AR F    N  +   V  T  
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLW 165

Query: 390 YMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGK 421
           Y AP+  +    +S   D++S G ++ E+I+G+
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      V++RD+K  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 8/92 (8%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA-RIFSGNQNEANTNRVAGTYG 389
           GL  LH ++    ++RDLK  N+LLD   + +ISD G+A +I  G   E+   RV GT G
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRV-GTVG 166

Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           YMAPE      +++  D +  G L+ E+I G+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 40/116 (34%), Positives = 57/116 (49%), Gaps = 10/116 (8%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           +TKG  L  +    I   I RGL +LH+    +VIHRD+K  NVLL      K+ DFG++
Sbjct: 102 NTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAM-----EGVFSVKSDVFSFGVLLLEIISG 420
                     NT    GT  +MAPE        +  +  KSD++S G+  +E+  G
Sbjct: 159 AQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + +++ ++ G+ YL   +    +HRDL   NVLL ++   KISDFG+++    + +    
Sbjct: 98  VELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-K 153

Query: 382 NRVAGTY--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            R AG +   + APE      FS +SDV+S+G+ + E  S
Sbjct: 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 6/94 (6%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           ++  + RG+ +LH     R++HRDLK  N+L+  +   KI+DFG+ARI+S    E     
Sbjct: 112 LMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTS 165

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           V  T  Y APE  ++  ++   D++S G +  E+
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 35/88 (39%), Positives = 50/88 (56%), Gaps = 5/88 (5%)

Query: 335 LHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA-RIFSGNQNEANTNRVAGTYGYMAP 393
           L +  R R+++RDLK  N+LLD   + +ISD G+A +I  G   E    RV GT GYMAP
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRV-GTVGYMAP 170

Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           E      ++   D +  G L+ E+I G+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 177

Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 178 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 7/98 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR---IFSGNQNEANTNR- 383
           I  G+ YLH +    V+HRD+K +NV+L      K+ DFG AR       +   +N  + 
Sbjct: 111 ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           + GT  +MAPE   E  +  KSD++S G  + E+ +GK
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL +LH +    ++HRDLK  N+L+      K++DFG+ARI+S    +     V  T  
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLW 172

Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA  L YLH    L +I+RDLK  N+LLD + +  ++DFG+ +   G ++   T+   GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y+APE   +  +    D +  G +L E++ G
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 4/98 (4%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           +S+   +  G+ YL  +S    IHRDL   N L+      K+SDFGM R    ++  +++
Sbjct: 103 LSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159

Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                   +  PE      +S KSDV+SFGVL+ E+ +
Sbjct: 160 G-AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 6/104 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH  S   V++RDLK  N++LD + + KI+DFG+ +   G ++ A      GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 58.7 bits (142), Expect = 6e-09
 Identities = 46/182 (25%), Positives = 85/182 (46%), Gaps = 10/182 (5%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           L W+RR  I  GIA+ L +LH      V+  +L    +++D +  P +         S  
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLP 829

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
                  +   +  Y+APE       + KSD++ FG++L+E+++GK  +      HG S+
Sbjct: 830 GLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SI 888

Query: 436 LTYAWKLWCKGEALELMDPVLK-QTCVDA-ELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
           + +A   +        +DP ++    V+  E+++ +++ L C   DP  RP  + V+  L
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Query: 494 AS 495
            S
Sbjct: 949 ES 950

Length = 968

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 57.3 bits (139), Expect = 7e-09
 Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 11/100 (11%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TN 382
           ++  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR       +   T 
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTG 174

Query: 383 RVAGTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
            VA T  Y APE  +  +   ++ D++S G ++ E+++GK
Sbjct: 175 YVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L +LHE     +I+RDLK  NVLLD + + K++D+GM +   G      T+   GT
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 9/97 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ YL      + IHRDL   N L+D +   K+SDFG++R    ++    T+ V   
Sbjct: 109 VCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSK 162

Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GK 421
           +   +  PE  +   FS KSDV++FGVL+ E+ S GK
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 6/95 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L +LH   +L +I+RD+K  N+LLD   +  ++DFG+++ F  ++ E       GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGT 169

Query: 388 YGYMAPEYAM--EGVFSVKSDVFSFGVLLLEIISG 420
             YMAP+     +G      D +S GVL+ E+++G
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 8e-09
 Identities = 33/120 (27%), Positives = 51/120 (42%), Gaps = 27/120 (22%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA------------------ 369
           IA  +L L    +L  IHRD+K  N+L+D + + K++DFG+                   
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 370 ---------RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                    R     Q     N   GT  Y+APE      + ++ D +S GV+L E++ G
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 29/99 (29%), Positives = 54/99 (54%), Gaps = 5/99 (5%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           ++   + + L YLH      VIHRD+K+ ++LL  +   K+SDFG     S  ++     
Sbjct: 121 TVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--KDVPKRK 175

Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            + GT  +MAPE      +  + D++S G++++E++ G+
Sbjct: 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR  S    +  T  V  T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK-GDFMTEYVV-T 171

Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    ++   DV+S G +  E++  K
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 6/95 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVAG 386
           I+ GL ++H+    +++HRD+K+ N+ L    M  K+ DFG+AR  + +   A T    G
Sbjct: 110 ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVG 164

Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  Y++PE      ++ K+D++S G +L E+ + K
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 8/87 (9%)

Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH      +I+RDLK  N+LLD++ + K++DFG A+     +    T  + GT  Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184

Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E           D ++ GVLL E I+G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L +LH   +L +++RD+K  N+LLD E +  ++DFG+++ F   + E  T    GT
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGT 169

Query: 388 YGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISG 420
             YMAPE    +G      D +S G+L+ E+++G
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 41/118 (34%), Positives = 57/118 (48%), Gaps = 14/118 (11%)

Query: 310 STKGAQL--DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG 367
           +TKG  L  DW   I     I RGL +LH     +VIHRD+K  NVLL      K+ DFG
Sbjct: 112 NTKGNALKEDWIAYIC--REILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFG 166

Query: 368 MARIFSGNQNEANTNRVAGTYGYMAPEYAM-----EGVFSVKSDVFSFGVLLLEIISG 420
           ++          NT    GT  +MAPE        +  +  +SD++S G+  +E+  G
Sbjct: 167 VSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G+ ++HE    RV+HRD+K+ N+ L      K+ DFG AR+ +     A T    GT  Y
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYY 166

Query: 391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           + PE      ++ KSD++S G +L E+ + K
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + R L YLH      VIHRD+K+ ++LL  +   K+SDFG     S  +       + GT
Sbjct: 127 VLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS--KEVPKRKSLVGT 181

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +MAPE      +  + D++S G++++E+I G+
Sbjct: 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 9/95 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--IFSGNQNEANTNRVA 385
           I+  L +LH   +  +I+RDLK  N+LLD + + K++DFG+ +  I  G      T+   
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFC 161

Query: 386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           GT  YMAPE  M        D +S G L+ ++++G
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 9/96 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR--VA 385
           + + L  LH      VIHRD+K+ ++LL H+   K+SDFG    F    ++    R  + 
Sbjct: 125 VLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKSLV 177

Query: 386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           GT  +MAPE      +  + D++S G++++E++ G+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 34/108 (31%), Positives = 60/108 (55%), Gaps = 6/108 (5%)

Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
            +++ K+++     I +G+ YL   SR + +HRDL   NVL++ E   KI DFG+ +   
Sbjct: 104 NKINLKQQLKYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160

Query: 374 GNQN--EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            ++       +  +  + Y APE  ++  F + SDV+SFGV L E+++
Sbjct: 161 TDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.9 bits (134), Expect = 2e-08
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 7/104 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH     ++++RDLK  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 10/91 (10%)

Query: 332 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM 391
           L YLH    +++IHRDLK  NVLL  + + K++DFG++      +     +   GT  +M
Sbjct: 123 LQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWM 177

Query: 392 APEYAM-----EGVFSVKSDVFSFGVLLLEI 417
           APE  M     +  +  K+D++S G+ L+E+
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 9/99 (9%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  + RGL Y+H      +IHRDLK SNV ++ +   +I DFG+AR      ++  T  
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGY 175

Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E++ GK
Sbjct: 176 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 10/92 (10%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
            L YLHE+   ++IHRDLK  N+L   + + K++DFG++      +     +   GT  +
Sbjct: 115 ALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYW 169

Query: 391 MAPEYAM-----EGVFSVKSDVFSFGVLLLEI 417
           MAPE  M     +  +  K+DV+S G+ L+E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 11/106 (10%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           LDW  +I +       L ++H+    +++HRD+K+ N+ L  +   K+ DFG+AR+ +  
Sbjct: 104 LDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              A T    GT  Y++PE      ++ KSD+++ G +L E+ + K
Sbjct: 155 VELART--CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A G+ +L   +    +HRDL   NVL+      KI DFG+AR    + N  +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MAPE     +++  SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 6/92 (6%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T  Y
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWY 166

Query: 391 MAPEYAMEGVF-SVKSDVFSFGVLLLEIISGK 421
            APE  +   + S   D++S G +  E+++ +
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 7/104 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      V++RDLK  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 10/113 (8%)

Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +LD      I+ G   GL +LH +   R+IHRD+K +N+LL  E   K+ DFG++   
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178

Query: 373 SGNQNEANTNRVAGTYGYMAPEY-----AMEGVFSVKSDVFSFGVLLLEIISG 420
           +  +   NT+   GT  +MAPE        +  +  + DV+S G+  +E+  G
Sbjct: 179 TSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 37/114 (32%), Positives = 58/114 (50%), Gaps = 11/114 (9%)

Query: 319 KRRISIINGIA------RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           KR I+I + +A      R + YLHE+   R+IHRD+K  N+ ++H  +  + DFG A  F
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CF 231

Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF 426
             + N       AGT    APE      +    D++S G++L E+ +   +S F
Sbjct: 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH-DSLF 284

Length = 391

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 55.2 bits (133), Expect = 7e-08
 Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 8/88 (9%)

Query: 343 VIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA-----NTNRVAGTYGYMAPE 394
           ++HRDLK  N+++       + K+ DFG+  +  G ++        T  V GT  Y APE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159

Query: 395 YAMEGVFSVKSDVFSFGVLLLEIISGKR 422
                  +  SD++++G++ LE ++G+R
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 4/95 (4%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA-RIFSGNQNEANTNRVAG 386
           I  G+ YLH +    ++HRD+K +N+L D   N K+ DFG + R+ +   +      V G
Sbjct: 115 ILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  +M+PE      +  K+DV+S G  ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 12/98 (12%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN--TNRVAGT 387
           R L Y+H  +   V HRDLK  N+L + +   KI DFG+AR+   +   A   T+ VA T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-T 169

Query: 388 YGYMAPEYAMEGVFSVKS----DVFSFGVLLLEIISGK 421
             Y APE    G F  K     D++S G +  E+++GK
Sbjct: 170 RWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 41/119 (34%), Positives = 54/119 (45%), Gaps = 17/119 (14%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
           R  KD  K  QL     +      A G+ YL   +    IHRDL   N L+      KIS
Sbjct: 84  RKKKDELKTKQL-----VKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKIS 135

Query: 365 DFGMARIFSGNQNEANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           DFGM+R     Q +      +G       + APE    G +S +SDV+S+G+LL E  S
Sbjct: 136 DFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 53.8 bits (129), Expect = 8e-08
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  + YLH    L +I+RDLK  N+LLD + +  ++DFG+ +   G + E  T+   GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y+APE   +  +    D +  G +L E++ G
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.8 bits (129), Expect = 8e-08
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 9/95 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL Y+H      +IHRDLK  N+ ++ +   KI DFG+AR     Q ++       T
Sbjct: 127 MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVT 178

Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
             Y APE  +  + ++   D++S G ++ E+++GK
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 4/95 (4%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA-RIFSGNQNEANTNRVAG 386
           I +G+ YLH +    ++HRD+K +N+L D   N K+ DFG + RI +   +      V G
Sbjct: 115 ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  +M+PE      +  K+DV+S    ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 10/95 (10%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           GL +LH +   + IHRD+K +N+LL  E   K+ DFG++   +  +   NT+   GT  +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190

Query: 391 MAPEY-----AMEGVFSVKSDVFSFGVLLLEIISG 420
           MAPE       ++  +  + DV+S G+  +E+  G
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 32/86 (37%), Positives = 44/86 (51%), Gaps = 8/86 (9%)

Query: 335 LHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE 394
           LH    L  IHRDLK  N L+D   + K++DFG++    G    AN+  V G+  YMAPE
Sbjct: 117 LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANS--VVGSPDYMAPE 168

Query: 395 YAMEGVFSVKSDVFSFGVLLLEIISG 420
                 +    D +S G +L E + G
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 30/91 (32%), Positives = 53/91 (58%)

Query: 332 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM 391
           +L L E    +++HRDLK++N+ L      K+ DFG ++ +S + +    +   GT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           APE      +S K+D++S GV+L E+++  R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 332 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM 391
           L +LH+     +++RDLK  N+LLD   +  + DFG+++  +   +   TN   GT  Y+
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 392 APEYAM-EGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
           APE  + E  ++   D +S GVL+ E+  G   S FY
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGW--SPFY 198

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           LD  R    +  I RG+ + H  +   +IHRD+K  N+L+      K+ DFG AR  +  
Sbjct: 97  LDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA- 152

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISG 420
             E  T+ VA T  Y APE  +      ++ D+++ G L+ E+++G
Sbjct: 153 PGEVYTDYVA-TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G+ +LH      +IHRDLK SN+++  +   KI DFG+AR      +   T  V   Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-Y 183

Query: 391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            APE  +   +    D++S G ++ E+I G 
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 6/106 (5%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 119 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 173

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             N   T  V   Y Y APE  +   +    D++S G ++ E++ G
Sbjct: 174 CTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 12/99 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-----IFSGNQNEANTN 382
           I  G+ YLH +    ++HRD+K +N+L D   N K+ DFG ++       SG        
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSG----TGMK 167

Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            V GT  +M+PE      +  K+D++S G  ++E+++ K
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 16/100 (16%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIF------SGNQNEANTN 382
           RGL Y+H  +   V+HRDLK +NV ++ E +  KI DFG+ARI        G  +E    
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 383 RVAGTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
               T  Y +P   +      K+ D+++ G +  E+++GK
Sbjct: 181 ----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 10/106 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVA-G 386
           IA  +L +H   +L  +HRD+K  NVLLD   + +++DFG       NQ+    + VA G
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC--LKMNQDGTVQSSVAVG 165

Query: 387 TYGYMAPEY--AME---GVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
           T  Y++PE   AME   G +  + D +S GV + E++ G+  + FY
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +++RDLK  N+LLD E + K++DFG A+          T  + GT
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGT 161

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE       +   D ++ G+L+ E++ G 
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 3/101 (2%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I+I   +   L YLH      +IHRD+KT N+ LD   N  + DFG A     + +    
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244

Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
              +GT    +PE      +  K+D++S G++L E+     
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 5e-07
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I RGL Y H   R +V+HRDLK  N+L++     K++DFG+AR  S    +  +N V  T
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS-VPTKTYSNEVV-T 167

Query: 388 YGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
             Y  P+  +    +S + D++  G +  E+ SG+
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 6e-07
 Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL Y+H      ++HRDLK  N+L+ +    K++DFG+AR  S      ++  V  T  
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLW 168

Query: 390 YMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           Y  P+  +    +S   D++  G + +E++ G+
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 45.8 bits (109), Expect = 6e-07
 Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 1/48 (2%)

Query: 495 SDTATLPPPTQPAFSVDRIAAKSGQSSS-SGSKFCSVNEITLSNVYPR 541
           S+T  +P P QP F V R   ++  SSS    +  +VN++T+S +  R
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 5/93 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA  L YLH    L +++RDLK  N+LLD + +  ++DFG+ +     ++   T+   GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y+APE   +  +    D +  G +L E++ G
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 39/124 (31%), Positives = 65/124 (52%), Gaps = 11/124 (8%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--- 361
           R +K + K  QL      S++  I  G+ YLH +    V+HRDLK +N+L+  E  P   
Sbjct: 94  RASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGE-GPERG 149

Query: 362 --KISDFGMARIFSGNQNE-ANTNRVAGTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEI 417
             KI+D G AR+F+      A+ + V  T+ Y APE  +      K+ D+++ G +  E+
Sbjct: 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Query: 418 ISGK 421
           ++ +
Sbjct: 210 LTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 39/124 (31%), Positives = 65/124 (52%), Gaps = 11/124 (8%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--- 361
           R +K + K  QL      S++  I  G+ YLH +    V+HRDLK +N+L+  E  P   
Sbjct: 94  RASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGE-GPERG 149

Query: 362 --KISDFGMARIFSGNQNE-ANTNRVAGTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEI 417
             KI+D G AR+F+      A+ + V  T+ Y APE  +      K+ D+++ G +  E+
Sbjct: 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Query: 418 ISGK 421
           ++ +
Sbjct: 210 LTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 33/182 (18%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG------M 368
           QL   + + ++ G+A G+ YL E   +  +H+ L    VL++ ++  KIS F        
Sbjct: 103 QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFY 427
             I++       T        + APE      FS  SDV+SFG+++ E++S G+R    Y
Sbjct: 160 EAIYT-------TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP---Y 209

Query: 428 LSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS 487
               GQ ++          +   L  P      +   +L C        Q++   RP  S
Sbjct: 210 WDMSGQDVIKAV------EDGFRLPAPRNCPNLLHQLMLDCW-------QKERGERPRFS 256

Query: 488 SV 489
            +
Sbjct: 257 QI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 22/145 (15%)

Query: 291 TLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 350
           TL  LL S VW +  ++K+  +   +     +SI + I   + Y+H  S+  V+HRDLK 
Sbjct: 88  TLKSLLKS-VWQKESLSKELAEKTSV--GAFLSIFHKICATIEYVH--SK-GVLHRDLKP 141

Query: 351 SNVLLDHEMNPKISDFGMARIFSGNQNE----------------ANTNRVAGTYGYMAPE 394
            N+LL       I D+G A      + +                    ++ GT  YMAPE
Sbjct: 142 DNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201

Query: 395 YAMEGVFSVKSDVFSFGVLLLEIIS 419
             +    S  +D+++ GV+L ++++
Sbjct: 202 RLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 5/93 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA  L YLH    + +++RDLK  N+LLD + +  ++DFG+ +   G      T    GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGT 159

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y+APE   +  +    D +  G +L E++ G
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 9/93 (9%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
            GL Y+H      +IHRDLK  N+ ++ +   KI DFG+AR       +A       T  
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRW 179

Query: 390 YMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           Y APE  +  +   ++ D++S G ++ E+++GK
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 26/80 (32%), Positives = 45/80 (56%), Gaps = 5/80 (6%)

Query: 341 LRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV 400
           L +++RDLK  N+LLD +   K++DFG A++      +  T  + GT  Y+APE  +   
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVG 204

Query: 401 FSVKSDVFSFGVLLLEIISG 420
               +D ++ G+ + EI+ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 6/107 (5%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 176

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E+I G 
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 6/93 (6%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL Y H   R +V+HRDLK  N+L++     K++DFG+AR  S    +  +N V  T  
Sbjct: 115 RGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYSNEVV-TLW 169

Query: 390 YMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           Y  P+  +    +S + D++  G +  E+ +G+
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 4/99 (4%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           S I  + + + + H++    ++HRD+K  N+L+ H    K+ DFG AR  S   + AN  
Sbjct: 104 SYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYT 159

Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
               T  Y +PE  +   +    D++S G +L E+  G+
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 6/99 (6%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
            II    + + + H   +   IHRD+K  N+L+  +   K+ DFG ARI +G   +  T+
Sbjct: 104 KIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTD 159

Query: 383 RVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISG 420
            VA T  Y APE  + +  +    DV++ G +  E+++G
Sbjct: 160 YVA-TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 33/105 (31%), Positives = 55/105 (52%), Gaps = 8/105 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  +L +    +L  +HRD+K  NVLLD   + +++DFG       +     +N   GT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GTVQSNVAVGT 166

Query: 388 YGYMAPEY--AME---GVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
             Y++PE   AME   G +  + D +S GV + E++ G+  + FY
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 7/100 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  +L +H   ++  +HRD+K  NVL+D   + K++DFG A   + N+   +   V GT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GT 166

Query: 388 YGYMAPEY--AMEG----VFSVKSDVFSFGVLLLEIISGK 421
             Y+APE    M G     + V+ D +S GV+  E+I G+
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           +G+ + H   +  V+HRDLK  N+L+D +    KI+D G+ R FS    ++ T+ +  T 
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-IPVKSYTHEIV-TL 175

Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISG 420
            Y APE  +    +S   D++S G +  E+   
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.2 bits (114), Expect = 6e-06
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 169

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 170 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 9/113 (7%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
           NK S   A L     I     ++  L YL      R +HRD+   NVL+      K+ DF
Sbjct: 100 NKYSLDLASL-----ILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDF 151

Query: 367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G++R    +++    ++      +MAPE      F+  SDV+ FGV + EI+ 
Sbjct: 152 GLSRYLE-DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 8/91 (8%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           +GL YLH   ++   HRD+K +N+LL    + K++DFG+A   +     A      GT  
Sbjct: 117 QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPY 171

Query: 390 YMAPEYAM---EGVFSVKSDVFSFGVLLLEI 417
           +MAPE A     G ++   D+++ G+  +E+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 47.4 bits (113), Expect = 9e-06
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 18/112 (16%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF----------- 372
           I+  I  GL  LH+      +HRDL  +N+ ++ +   KI+DFG+AR +           
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 373 --SGNQNEANTNRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
             +  + E  T++V  T  Y APE  M    +    D++S G +  E+++GK
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 6/93 (6%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL Y H   + +++HRDLK  N+L++ +   K++DFG+AR  S    +  +N V  T  
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKS-VPTKTYSNEVV-TLW 168

Query: 390 YMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           Y  P+  +    +S   D++  G +L E+ +G+
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 20/41 (48%), Positives = 27/41 (65%), Gaps = 3/41 (7%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           RGL Y H   + RV+HRDLK  N+L+      K++DFG+AR
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 28/91 (30%), Positives = 50/91 (54%), Gaps = 8/91 (8%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           +GL YLH   +   +HRD+K +N+LL    + K++DFG++   +     A      GT  
Sbjct: 117 QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPY 171

Query: 390 YMAPEYAM---EGVFSVKSDVFSFGVLLLEI 417
           +MAPE A    +G ++   D+++ G+  +E+
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 36/129 (27%), Positives = 56/129 (43%), Gaps = 36/129 (27%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM------------ARIFSGN 375
           IA  +L +    +L  IHRD+K  N+LLD + + K+SDFG+             RI S  
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 376 QNEANT------------------NRVA------GTYGYMAPEYAMEGVFSVKSDVFSFG 411
                                   NR A      GT  Y+APE  ++  ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 412 VLLLEIISG 420
           V++ E++ G
Sbjct: 227 VIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 9/127 (7%)

Query: 299 FVWCRRRINK--DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 356
           F +C + + K  DS  G  +D +   S +  + +GL + H      V+HRDLK  N+L++
Sbjct: 78  FEYCDQDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLIN 133

Query: 357 HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLL 415
                K++DFG+AR F G      +  V  T  Y  P+      ++S   D++S G +  
Sbjct: 134 KNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 191

Query: 416 EIISGKR 422
           E+ +  R
Sbjct: 192 ELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)

Query: 325 INGIARGLL----YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           +  +AR LL    Y+H +    +IHRD+KT NVL++   +  + DFG A    G+ +   
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLE 416
              +AGT    APE      ++   D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 37/126 (29%), Positives = 57/126 (45%), Gaps = 33/126 (26%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--------IFSGNQNEA 379
           IA  +L +    +L  IHRD+K  N+LLD + + K+SDFG+           F  N N +
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 380 ----------NTNRVA---------------GTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                     N+ R A               GT  Y+APE  M+  ++   D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 415 LEIISG 420
            E++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 30/102 (29%), Positives = 51/102 (50%), Gaps = 16/102 (15%)

Query: 332 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI----FSGNQNEANTNR---- 383
           L YLH      ++HRDLK  N+L+    + K++DFG+++I     + N  E +  +    
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 384 -----VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                V GT  Y+APE  +   +    D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + RGL Y+H+     ++HRDLK  N+L+      K++DFG+AR  S   +   +N V  T
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS-VPSHTYSNEVV-T 166

Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISG 420
             Y  P+  +    +S   D++  G + +E+I G
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 7/103 (6%)

Query: 329 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY 388
           A  +L L     + +IHRD+K  N+LLD   + K++DFG              +   GT 
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD-ETGMVRCDTAVGTP 207

Query: 389 GYMAPEY----AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
            Y++PE       +G +  + D +S GV L E++ G  ++ FY
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 10/110 (9%)

Query: 316 LDWKRRI------SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
            DWK R       +I+  +   + Y+H+    ++IHRD+K  N+ L+ +    + DFG A
Sbjct: 258 FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTA 314

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             F   + EA      GT    +PE      +   +D++S G++LL+++S
Sbjct: 315 MPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 35/127 (27%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA------------RIFSGN 375
           IA  +L +    +L  IHRD+K  N+LLD + + K+SDFG+             R  + N
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 376 -------QNEANTNRVA---------------GTYGYMAPEYAMEGVFSVKSDVFSFGVL 413
                  QN  N+ R A               GT  Y+APE  M+  ++   D +S GV+
Sbjct: 167 PPSDFSFQN-MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 414 LLEIISG 420
           + E++ G
Sbjct: 226 MYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 43.7 bits (104), Expect = 1e-04
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 9/101 (8%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANT 381
           SII  I +GL ++H   +    HRDLK  N+L+      KI+DFG+AR I S       T
Sbjct: 103 SIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPPYT 156

Query: 382 NRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
           + V  T  Y APE  +    +S   D+++ G ++ E+ + +
Sbjct: 157 DYV-STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)

Query: 344 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY----AMEG 399
           IHRD+K  N+LLD   + K++DFG     +  +     +   GT  Y++PE       +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 400 VFSVKSDVFSFGVLLLEIISGKRNSGFY 427
            +  + D +S GV L E++ G  ++ FY
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 9/89 (10%)

Query: 344 IHRDLKTSNVLLDHEMNPKISDFGMA-RIFSGNQNEANTNRVAGTYGYMAPEYAM----E 398
           IHRD+K  N+LLD   + K++DFG   ++ +      +T    GT  Y++PE       +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGTPDYISPEVLKSQGGD 221

Query: 399 GVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
           G +  + D +S GV L E++ G  ++ FY
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 8/93 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + + L ++H   R  + HRD+K  N+L+  +   K++DFG  R          T  ++ T
Sbjct: 109 LLKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYIS-T 161

Query: 388 YGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIIS 419
             Y APE  + +G +  K D+++ G +  EI+S
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 8/93 (8%)

Query: 340 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY--AM 397
           +L  +HRD+K  N+L+D   + +++DFG             ++   GT  Y++PE   AM
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISPEILQAM 178

Query: 398 E---GVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
           E   G +  + D +S GV + E++ G+  + FY
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.2 bits (99), Expect = 6e-04
 Identities = 19/47 (40%), Positives = 32/47 (68%), Gaps = 3/47 (6%)

Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           I+ +A  L YLH      +IHRDLK  N+L+ +E + K++DFG++++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 30/138 (21%), Positives = 54/138 (39%), Gaps = 45/138 (32%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA-------------RIFSG 374
           +A  +L +    +L  IHRD+K  N+L+D   + K+SDFG++             ++  G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166

Query: 375 --NQNEANTNR------------------------------VAGTYGYMAPEYAMEGVFS 402
             N+N  +                                   GT  Y+APE  ++  + 
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226

Query: 403 VKSDVFSFGVLLLEIISG 420
            + D +S G ++ E + G
Sbjct: 227 QECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           + R L Y+H      + HRDLK  N+L+D   +  K+ DFG A+     Q   + + +  
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR--SVSYICS 233

Query: 387 TYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISG 420
            + Y APE  +    ++   D++S G ++ E+I G
Sbjct: 234 RF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 16/142 (11%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA GLL+LH+++    IH DL   N LL  ++  KI D+G++            +++   
Sbjct: 109 IALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP 165

Query: 388 YGYMAPEYAME--GVFSV-----KSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAW 440
             ++APE   E  G   V     +S+V+S GV + E+         +LS+  + +LTY  
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTYT- 222

Query: 441 KLWCKGEALELMDPVLKQTCVD 462
               + + L+L  P LK    D
Sbjct: 223 ---VREQQLKLPKPRLKLPLSD 241

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 12/98 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A GLL+LH   +   IH DL   N  L  +++ KI D+G+A            +  A  
Sbjct: 109 VASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP 165

Query: 388 YGYMAPEYAMEGVFS--------VKSDVFSFGVLLLEI 417
             ++APE  +E             KS+++S GV + E+
Sbjct: 166 LRWLAPE-LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.1 bits (93), Expect = 0.003
 Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 12/78 (15%)

Query: 296 LGSFVWCRRRINKDSTKGAQLDWKRRISIINGIAR----GLLYLHEDSRLRVIHRDLKTS 351
           L  F+   ++I  +  +      KR I++I G+ R    GL  LH   R+ ++HRD+K  
Sbjct: 287 LEEFMMAGKKIPDNMPQD-----KRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPE 338

Query: 352 NVLLDHEMNPKISDFGMA 369
           N+L+  +   KI DFG A
Sbjct: 339 NLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.1 bits (93), Expect = 0.003
 Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 22/99 (22%)

Query: 342 RVIHRDLKTSNVLLD-------------HEMN----PKISDFGMARIFSGNQNEANTNRV 384
           RV+HRDLK  N+ L              + +N     KI DFG+++       E+  +  
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSC 201

Query: 385 AGTYGYMAPEYAMEGVFSV--KSDVFSFGVLLLEIISGK 421
            GT  Y +PE  +    S   KSD+++ G ++ E+ SGK
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	541
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.95
KOG0578	550	consensus p21-activated serine/threonine protein k	99.95
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.95
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.95
KOG0198	313	consensus MEKK and related serine/threonine protei	99.95
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.94
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.94
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.94
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.94
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.94
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.94
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.94
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.94
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.93
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.93
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.93
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.93
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.93
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.93
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.93
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.93
PHA02988	283	hypothetical protein; Provisional	99.93
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.93
PTZ00283	496	serine/threonine protein kinase; Provisional	99.93
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.93
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.93
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.93
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.93
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.93
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.93
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.92
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.92
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.92
KOG0589	426	consensus Serine/threonine protein kinase [General	99.92
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.92
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.92
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.92
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.92
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.92
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.92
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.92
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.92
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.92
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.92
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.92
PTZ00267	478	NIMA-related protein kinase; Provisional	99.92
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.92
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.92
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.92
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.92
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.92
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.92
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.92
PHA03212	391	serine/threonine kinase US3; Provisional	99.92
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.92
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.92
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.92
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.92
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.92
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.92
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.92
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.92
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.92
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.92
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.92
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.92
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.92
PHA03207	392	serine/threonine kinase US3; Provisional	99.92
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.92
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.92
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.92
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.92
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.92
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.92
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.91
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.91
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.91
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.91
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.91
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.91
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.91
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.91
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.91
PHA02882	294	putative serine/threonine kinase; Provisional	99.91
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.91
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.91
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.91
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.91
PHA03211	461	serine/threonine kinase US3; Provisional	99.91
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.91
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.91
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.91
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.91
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.91
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.91
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.91
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.91
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.91
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.91
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.91
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.91
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.91
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.91
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.91
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.91
KOG0605	550	consensus NDR and related serine/threonine kinases	99.91
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.91
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.91
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.91
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.91
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.91
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.91
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.91
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.91
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.91
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.91
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.91
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.91
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.91
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.91
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.91
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.91
PTZ00036	440	glycogen synthase kinase; Provisional	99.91
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.91
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.91
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.91
PTZ00284	467	protein kinase; Provisional	99.91
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.91
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.91
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.91
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.91
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.91
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.91
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.91
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.91
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.91
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.91
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.91
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.91
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.91
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.91
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.91
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.91
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.91
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.91
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.91
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.91
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.9
PHA03209	357	serine/threonine kinase US3; Provisional	99.9
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.9
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.9
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.9
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.9
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.9
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.9
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.9
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.9
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.9
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.9
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.9
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.9
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.9
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.9
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.9
KOG0610	459	consensus Putative serine/threonine protein kinase	99.9
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.9
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.9
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.9
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.9
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.9
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.9
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.9
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.9
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.9
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.9
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.9
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.9
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.9
KOG0584	632	consensus Serine/threonine protein kinase [General	99.9
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.9
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.9
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.9
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.9
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.9
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.9
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.9
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.9
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.9
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.9
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.9
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.9
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.9
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.9
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.9
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.9
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.9
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.9
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.9
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.9
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.89
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.89
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.89
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.89
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.89
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.89
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.89
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.89
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.89
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.89
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.89
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.89
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.89
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.89
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.89
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.89
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.89
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.89
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.89
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.89
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.89
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.89
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.89
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.89
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.89
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.89
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.89
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.89
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.89
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.89
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.89
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.89
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.89
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.89
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.89
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.89
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.89
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.89
KOG3653	534	consensus Transforming growth factor beta/activin	99.89
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.89
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.89
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.89
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.88
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.88
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.88
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.88
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.88
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.88
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.88
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.88
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.88
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.88
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.88
PHA03210	501	serine/threonine kinase US3; Provisional	99.88
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.88
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.88
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.88
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.88
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.88
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.88
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.88
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.88
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.88
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.88
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.88
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.88
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.88
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.88
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.88
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.88
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.88
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.88
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.88
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.88
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.88
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.88
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.88
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.88
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.88
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.88
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.88
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.88
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.88
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.88
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.88
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.88
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.88
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.88
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.88
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.88
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.87
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.87
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.87
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.87
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.87
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.87
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.87
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.87
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.87
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.87
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.87
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.87
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.87
PLN00181	793	protein SPA1-RELATED; Provisional	99.87
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.87
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.87
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.87
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.87
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.87
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.87
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.87
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.87
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.87
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.87
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.87
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.87
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.87
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.87
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.87
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.87
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.87
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.87
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.87
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.86
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.86
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.86
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.86
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.86
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.86
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.86
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.86
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.86
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.86
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.86
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.86
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.86
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.86
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.86
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.86
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.86
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.86
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.86
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.86
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.86
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.86
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.86
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.86
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.86
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.86
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.85
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.85
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.85
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.85
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.85
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.85
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.85
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.85
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.85
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.85
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.85
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.85
PLN00009	294	cyclin-dependent kinase A; Provisional	99.85
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.85
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.85
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.85
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.85
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.85
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.85
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.84
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.84
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.84
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.84
KOG0586	596	consensus Serine/threonine protein kinase [General	99.83
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.83
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.83
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.83
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.83
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.82
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.82
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.81
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.81
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.8
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.79
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.79
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.79
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.76
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.75
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.75
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.73
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.73
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.72
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.72
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
KOG1152	772	consensus Signal transduction serine/threonine kin	99.63
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.63
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.6
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.6
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.56
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.56
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.55
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.54
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.54
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.47
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.47
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.41
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.39
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.36
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.18
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.17
PRK09188	365	serine/threonine protein kinase; Provisional	99.05
PRK12274	218	serine/threonine protein kinase; Provisional	99.03
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.01
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.98
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	98.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	98.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	98.84
COG4248	637	Uncharacterized protein with protein kinase and he	98.55
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.49
smart00090	237	RIO RIO-like kinase.	98.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.41
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.37
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.33
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.27
PRK10345	210	hypothetical protein; Provisional	98.25
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.24
PRK14879	211	serine/threonine protein kinase; Provisional	98.13
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.11
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.05
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	97.92
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	97.92
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	97.88
KOG1243	690	consensus Protein kinase [General function predict	97.59
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	97.58
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	97.5
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.44
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.44
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	97.3
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	97.28
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.15
KOG3087	229	consensus Serine/threonine protein kinase [General	97.06
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.06
PRK09902	216	hypothetical protein; Provisional	96.91
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	96.79
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	95.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	95.9
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	95.77
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	95.68
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.32
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	95.16
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	93.85
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	92.0
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	91.09
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	90.38
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	89.61
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	89.15
KOG0576	829	consensus Mitogen-activated protein kinase kinase	88.86
PF01636	239	APH: Phosphotransferase enzyme family This family	88.75
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	88.53
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	88.29
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	87.96
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	87.75
PRK05231	319	homoserine kinase; Provisional	87.36
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	87.29
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	87.25
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	87.23
PRK10271	188	thiK thiamine kinase; Provisional	86.84
PHA03111	444	Ser/Thr kinase; Provisional	86.64
COG0661	517	AarF Predicted unusual protein kinase [General fun	86.21
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	85.59
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	85.48
COG2334	331	Putative homoserine kinase type II (protein kinase	85.41
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	85.09
PLN02236	344	choline kinase	84.01
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	83.45
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	83.24
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	82.65
KOG2268	465	consensus Serine/threonine protein kinase [Signal	81.82
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	80.76
KOG1093	725	consensus Predicted protein kinase (contains TBC a	80.39

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=289.77  Aligned_cols=203  Identities=39%  Similarity=0.628  Sum_probs=170.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      .+|.||+..|.|...+....    .. .|+|.+|++|+.++|+||+|||+...++|||||||++|||||+++++||+|||
T Consensus       148 ~LVYEym~nGsL~d~L~~~~----~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG  222 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKK----GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG  222 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCC----CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence            45567777787765554311    11 78999999999999999999999887789999999999999999999999999


Q ss_pred             ccccccCCCCccccccc-ccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRV-AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++.........  ... .||.+|++||++..+..+.|+|||||||+++||++|+++.+.........+.+|.+..+.++
T Consensus       223 La~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  223 LAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             CcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            996543311111  112 79999999999999999999999999999999999999877655555666899999999999


Q ss_pred             Ccccccccccc-CCCCH-HHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          447 EALELMDPVLK-QTCVD-AELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       447 ~~~~~~~~~l~-~~~~~-~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ...+++|+.+. ..... .++.++.+++.+|++.+|.+||+|.||+++|+...
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            99999999987 55554 68899999999999999999999999999996543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-32  Score=260.49  Aligned_cols=232  Identities=25%  Similarity=0.325  Sum_probs=170.4

Q ss_pred             CCccEEEEEEeccCCChhhhHHHHHHHHhcccccCCCccceEEECCCcceeecccccccCCCCCCCCCCCCCCCCCCCcC
Q 009186          189 ASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMYPSCNFRYELYQFYNDTSNGTLPPVFFSPPSPGSVT  268 (541)
Q Consensus       189 ~~~~vyglaQC~~Dls~~~C~~CL~~a~~~~~~~c~~~~g~~v~~~~C~lRye~~~F~~~~~~~~~~p~~~~~~~~~~~~  268 (541)
                      ...++|++=-=..+..+..+++=++.+--.-.-.|++=+                .||+.....                
T Consensus       102 ~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV----------------~~ygaF~~~----------------  149 (364)
T KOG0581|consen  102 PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIV----------------GFYGAFYSN----------------  149 (364)
T ss_pred             CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCee----------------eEeEEEEeC----------------
Confidence            457899998888899999988877765433222333322                233222110                


Q ss_pred             CCCCCCCCcceeeeehhHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhh-cCCCceEecc
Q 009186          269 SSKGGKGKKATWIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRD  347 (541)
Q Consensus       269 ~~~~~~~~~~~ii~i~~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~D  347 (541)
                          +.           .+.++|||+.+|+|-..+++       .+++++...-+|+.+|++||.|||+ ++   |||||
T Consensus       150 ----~~-----------~isI~mEYMDgGSLd~~~k~-------~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRD  204 (364)
T KOG0581|consen  150 ----GE-----------EISICMEYMDGGSLDDILKR-------VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRD  204 (364)
T ss_pred             ----Cc-----------eEEeehhhcCCCCHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeecc
Confidence                00           14568999999999555443       2469999999999999999999996 66   99999


Q ss_pred             cCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 009186          348 LKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY  427 (541)
Q Consensus       348 Lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~  427 (541)
                      |||+|||++..|.+||+|||.+..+...    ......||..||+||.+.+..|+.++||||||+.++|+..|+.|+...
T Consensus       205 IKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  205 IKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             CCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence            9999999999999999999999876544    345688999999999999999999999999999999999999998654


Q ss_pred             CCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          428 LSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      . ......++...... .+.     .|.++..   ....++..++..||++||.+||+++|+++
T Consensus       281 ~-~~~~~~~~Ll~~Iv-~~p-----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  281 N-PPYLDIFELLCAIV-DEP-----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             C-CCCCCHHHHHHHHh-cCC-----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1 11222222221111 111     1222222   24456777888999999999999999985

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-31  Score=266.85  Aligned_cols=189  Identities=31%  Similarity=0.441  Sum_probs=147.5

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEec
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISD  365 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~D  365 (541)
                      ..+|+||+..|+|...+.+.     .+..|++..+++|+.||++||.|||+++.  |||||||++|||++.++ ++||+|
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~-----~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~D  187 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK-----RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIAD  187 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc-----ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECC
Confidence            45778999999997766542     35579999999999999999999999974  99999999999999998 999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAM--EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      ||+++......  .......||+.|||||++.  ...++.|+|||||||++|||++|+.||.....      .+.+....
T Consensus       188 FGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~  259 (362)
T KOG0192|consen  188 FGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVV  259 (362)
T ss_pred             Cccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHH
Confidence            99998754332  2222367999999999999  56899999999999999999999999853321      22222222


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCC
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTAT  499 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~  499 (541)
                      ..+.         +...+......+..++.+||+.||.+||++.+|+..|+.....
T Consensus       260 ~~~~---------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  260 VGGL---------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             hcCC---------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            2211         1122222445677788899999999999999999999865443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.8e-30  Score=239.52  Aligned_cols=191  Identities=25%  Similarity=0.355  Sum_probs=148.9

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcC-CCceEecccCCCcEEEcCCCCcEEe
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDS-RLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~-~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      .+.++||++..|.|.+..++.   .++++.+++..+|+++.|++.||.++|.+- +..|+||||||.||+|+.+|.+||+
T Consensus        94 vlnivmE~c~~GDLsqmIk~~---K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHF---KKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHH---HhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence            478999999999986655442   234667999999999999999999999932 1249999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||+++.+......  ....+||+.||+||.+.+.+|+.|+||||+||++|||..-++||.      ++++.+...+ +.
T Consensus       171 DfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~------g~n~~~L~~K-I~  241 (375)
T KOG0591|consen  171 DFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY------GDNLLSLCKK-IE  241 (375)
T ss_pred             cchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc------cccHHHHHHH-HH
Confidence            99999988655433  345789999999999999999999999999999999999999984      3344433222 22


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .++...     +.   .......+.+|+..|+..||+.||+...+++.+.+.
T Consensus       242 qgd~~~-----~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  242 QGDYPP-----LP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             cCCCCC-----Cc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence            222111     11   134456677788899999999999976666666553

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7.8e-30  Score=260.74  Aligned_cols=177  Identities=24%  Similarity=0.347  Sum_probs=138.2

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      -|++++|+|..+.+.+..++       ++.|++.++..+++||+.||.|||+.+   |||||||..|++|++++++||+|
T Consensus        92 nVYivLELC~~~sL~el~Kr-------rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgD  161 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKR-------RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGD  161 (592)
T ss_pred             ceEEEEEecCCccHHHHHHh-------cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecc
Confidence            46677777777777544432       447999999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+|..+..+...  ..+..||+.|.|||++.....+..+||||+||++|.|+.|++||+..      . ++.....+..
T Consensus       162 FGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk------~-vkety~~Ik~  232 (592)
T KOG0575|consen  162 FGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK------T-VKETYNKIKL  232 (592)
T ss_pred             cceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc------h-HHHHHHHHHh
Confidence            9999887644332  33578999999999999999999999999999999999999998532      1 1111111111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .   +..-       +........+|+..+|+.||.+|||+++|+.
T Consensus       233 ~---~Y~~-------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  233 N---EYSM-------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             c---Cccc-------ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1   1111       1122334556788999999999999999995

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=263.06  Aligned_cols=188  Identities=31%  Similarity=0.428  Sum_probs=150.8

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      .++++|+||+..|+|+.++++     ..+..+...+.+.++.||++|++||++++   +|||||.+.|||++++..+||+
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~-----~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIs  345 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRT-----REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKIS  345 (468)
T ss_pred             CceEEEEEecccCcHHHHhhh-----cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEc
Confidence            468999999999999877765     34667999999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      |||+++.+.++...... ...-+..|.|||.+..+.++.|||||||||+||||+| |+.|++...      ..       
T Consensus       346 DFGLAr~~~d~~Y~~~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~-------  411 (468)
T KOG0197|consen  346 DFGLARLIGDDEYTASE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NE-------  411 (468)
T ss_pred             ccccccccCCCceeecC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HH-------
Confidence            99999965444332222 2233567999999999999999999999999999999 777754221      11       


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                         +..+.++...+-..++..+..+.+||..||+.+|++|||++.+...|+...
T Consensus       412 ---ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  412 ---EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             ---HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence               122333333333445556677888999999999999999999999998754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.95  E-value=4.9e-29  Score=241.61  Aligned_cols=170  Identities=25%  Similarity=0.310  Sum_probs=131.7

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++|++|+.+|.|++.+++       .+.+++..+.-++.+|+.||.|||+++   ||||||||+|||||.+|+++|+||
T Consensus       100 LylVld~~~GGeLf~hL~~-------eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDF  169 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQR-------EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDF  169 (357)
T ss_pred             EEEEEeccCCccHHHHHHh-------cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecc
Confidence            4566677888888776654       556999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++......  ..+.+.+||+.|||||++.+..++..+|.||||+++|||++|.+||...      +........... 
T Consensus       170 gL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~------~~~~~~~~I~~~-  240 (357)
T KOG0598|consen  170 GLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE------DVKKMYDKILKG-  240 (357)
T ss_pred             ccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc------cHHHHHHHHhcC-
Confidence            9998643332  2344589999999999999999999999999999999999999998432      222222222111 


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP  484 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP  484 (541)
                      ..      ...+.   -......+++...|+.||++|.
T Consensus       241 k~------~~~p~---~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  241 KL------PLPPG---YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             cC------CCCCc---cCCHHHHHHHHHHhccCHHHhc
Confidence            10      01111   1233456677799999999995

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-28  Score=248.98  Aligned_cols=162  Identities=24%  Similarity=0.378  Sum_probs=131.6

Q ss_pred             CCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCC
Q 009186          311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY  390 (541)
Q Consensus       311 ~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  390 (541)
                      -....+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+......  ....+||+.|
T Consensus       361 Vt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~TmVGTPYW  435 (550)
T KOG0578|consen  361 VTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RSTMVGTPYW  435 (550)
T ss_pred             hhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc--cccccCCCCc
Confidence            34556899999999999999999999999   999999999999999999999999999887766543  3457899999


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      ||||+.....|++|.||||||++++||+-|++||-.      +..+...+..-.++...      ++  ..+.....+.+
T Consensus       436 MAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln------E~PlrAlyLIa~ng~P~------lk--~~~klS~~~kd  501 (550)
T KOG0578|consen  436 MAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGTPK------LK--NPEKLSPELKD  501 (550)
T ss_pred             cchhhhhhcccCccccchhhhhHHHHHhcCCCCccC------CChHHHHHHHhhcCCCC------cC--CccccCHHHHH
Confidence            999999999999999999999999999999999743      23333334433333322      11  11222345667


Q ss_pred             HHhhhcccCCCCCCCHHHHHH
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ++.+||+.|+++||++.|+|+
T Consensus       502 FL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  502 FLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHHHhhcchhcCCCHHHHhc
Confidence            888999999999999999986

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=247.23  Aligned_cols=180  Identities=23%  Similarity=0.317  Sum_probs=139.7

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++.|++|+..|.|+...+|       -+.+++.....++.+|+.||+|||++|   ||||||||+|||||++|++||+||
T Consensus       149 LYFvLe~A~nGdll~~i~K-------~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK-------YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH-------hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeec
Confidence            5666777777777666654       356999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCc---------ccc--cccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcH
Q 009186          367 GMARIFSGNQNE---------ANT--NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL  435 (541)
Q Consensus       367 g~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~  435 (541)
                      |.++.+......         ...  ..++||-.|.+||+|..+..++.+|||+|||+||+|+.|++||...   .+...
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~---Neyli  295 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA---NEYLI  295 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc---cHHHH
Confidence            999987644322         111  4488999999999999999999999999999999999999998421   11111


Q ss_pred             HHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      ++.+..          ++-.+..+++    ..+.+|+.+.|..||.+|+|.++|.+..
T Consensus       296 FqkI~~----------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 FQKIQA----------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HHHHHH----------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCc
Confidence            111111          1112222222    4566788899999999999999998743

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.4e-29  Score=245.54  Aligned_cols=183  Identities=22%  Similarity=0.272  Sum_probs=139.1

Q ss_pred             hhHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC---CC
Q 009186          284 GTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MN  360 (541)
Q Consensus       284 ~~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~---~~  360 (541)
                      ....++|+||+.+|.|+.+.-.       ++.+.+.....+++|++.||.|||++|   |+||||||+|||+..+   -.
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~-------nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~l  317 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVA-------NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCL  317 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHh-------ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceE
Confidence            3445899999999998766532       345777788899999999999999999   9999999999999776   56


Q ss_pred             cEEecccccccccCCCCcccccccccCCCCCChhhhccCCC---CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHH
Q 009186          361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF---SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT  437 (541)
Q Consensus       361 ~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~  437 (541)
                      +||+|||+++..+..   ....+.+||+.|.|||++.+...   ..++|+||+||+||-+++|.+||.....+.  .+.+
T Consensus       318 lKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e  392 (475)
T KOG0615|consen  318 LKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE  392 (475)
T ss_pred             EEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH
Confidence            899999999986532   22345789999999999987653   347899999999999999999986443322  1111


Q ss_pred             HHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                          .+..+....      .+.....-.++..+++.+||..||++||++.|+++
T Consensus       393 ----QI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  393 ----QILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ----HHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                122222211      11122344566778888999999999999999985

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-28  Score=240.59  Aligned_cols=185  Identities=25%  Similarity=0.347  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-CCCcEEec
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISD  365 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-~~~~kL~D  365 (541)
                      ..+.+||+..|.+....++     ..+ .|++..+.++..||++||+|||+++   |||+||||+|||++. ++.+||+|
T Consensus        91 ~~i~mEy~~~GsL~~~~~~-----~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaD  161 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKR-----YGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLAD  161 (313)
T ss_pred             eEeeeeccCCCcHHHHHHH-----cCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEecc
Confidence            4567899999988655543     122 6999999999999999999999999   999999999999999 79999999


Q ss_pred             ccccccccCC-CCcccccccccCCCCCChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          366 FGMARIFSGN-QNEANTNRVAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       366 fg~a~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      ||+++..... ..........||+.|||||++..+. ...++|||||||++.||+||++||...     ....++.....
T Consensus       162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig  236 (313)
T KOG0198|consen  162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIG  236 (313)
T ss_pred             CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHh
Confidence            9999876541 1112233467999999999998643 345999999999999999999997543     11222222222


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      .....     |.+    +........+++.+|++.||++|||++++++..-
T Consensus       237 ~~~~~-----P~i----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  237 REDSL-----PEI----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             ccCCC-----CCC----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            22211     112    2223345566778999999999999999997553

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.8e-28  Score=236.97  Aligned_cols=180  Identities=25%  Similarity=0.361  Sum_probs=143.9

Q ss_pred             hhHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEE
Q 009186          284 GTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI  363 (541)
Q Consensus       284 ~~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL  363 (541)
                      +.-+.++|||+.+|++...++-       +..+++.++.-|+++++.||.|||.++   .+|||||+.|||+..+|.+||
T Consensus        83 g~~LwiiMey~~gGsv~~lL~~-------~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl  152 (467)
T KOG0201|consen   83 GTKLWIIMEYCGGGSVLDLLKS-------GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKL  152 (467)
T ss_pred             cccHHHHHHHhcCcchhhhhcc-------CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEE
Confidence            3457899999999998765543       334588888899999999999999999   999999999999999999999


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      +|||++..+.......  ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+..            
T Consensus       153 ~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr------------  218 (467)
T KOG0201|consen  153 ADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR------------  218 (467)
T ss_pred             Eecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce------------
Confidence            9999998766554443  56899999999999998899999999999999999999999975433311            


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                          ..-+|...-.+.+.......+.+++..||++||+.||++.++++
T Consensus       219 ----vlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  219 ----VLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ----EEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                11222222222222234456788889999999999999999985

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=234.07  Aligned_cols=197  Identities=24%  Similarity=0.372  Sum_probs=145.4

Q ss_pred             eeeehhHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC
Q 009186          280 WIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM  359 (541)
Q Consensus       280 ii~i~~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~  359 (541)
                      .+++.--+++||-++.+|+++...+..+.+     .+++..+..|++++++||.|||.+|   .||||||+.||||+.+|
T Consensus        92 sFvv~~~LWvVmpfMa~GS~ldIik~~~~~-----Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG  163 (516)
T KOG0582|consen   92 SFVVDSELWVVMPFMAGGSLLDIIKTYYPD-----GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDG  163 (516)
T ss_pred             EEEecceeEEeehhhcCCcHHHHHHHHccc-----cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCC
Confidence            356666778889999999998777665443     2899999999999999999999999   99999999999999999


Q ss_pred             CcEEecccccccccCCCCc-ccc-cccccCCCCCChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcH
Q 009186          360 NPKISDFGMARIFSGNQNE-ANT-NRVAGTYGYMAPEYAME--GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL  435 (541)
Q Consensus       360 ~~kL~Dfg~a~~~~~~~~~-~~~-~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~  435 (541)
                      .+||+|||....+...... ... ....||+.|||||++..  ..|+.|+||||||++..||.+|..||..+.+.     
T Consensus       164 ~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----  238 (516)
T KOG0582|consen  164 TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----  238 (516)
T ss_pred             cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----
Confidence            9999999987654433221 111 45689999999999654  45999999999999999999999998644321     


Q ss_pred             HHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       +.....+ .+......-..+..+........+.+++..||+.||.+|||++++++
T Consensus       239 -kvLl~tL-qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  239 -KVLLLTL-QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             -HHHHHHh-cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence             1111111 11111111111111111222346788999999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=237.71  Aligned_cols=187  Identities=23%  Similarity=0.306  Sum_probs=137.6

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      .+++|+|++...++...++       ++..++++.+..|+.||++||+|+|++|   +.|||+||+|||+..+..+||+|
T Consensus        84 ~L~fVfE~Md~NLYqLmK~-------R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   84 ILYFVFEFMDCNLYQLMKD-------RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             eEeeeHHhhhhhHHHHHhh-------cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecc
Confidence            4567788876544321111       1457999999999999999999999999   99999999999999988999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh--
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL--  442 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~--  442 (541)
                      ||+|+.+......   +..+.|.+|+|||++. .+-|+.+.|+|++|||++|+.+-++-|...      +.++..+++  
T Consensus       154 FGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~------sE~Dqi~KIc~  224 (538)
T KOG0661|consen  154 FGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA------SEIDQIYKICE  224 (538)
T ss_pred             cccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC------cHHHHHHHHHH
Confidence            9999987554433   3457899999999875 567999999999999999999999887532      222232222  


Q ss_pred             ---------hhcCC-c--------cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          443 ---------WCKGE-A--------LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       443 ---------~~~~~-~--------~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                               |.++. +        .....-.+. ...+....++++++.+|+.+||.+|||+.+.+++
T Consensus       225 VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  225 VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhCCCccccchhHHHHHHHhccCCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                     11110 0        000001111 1122356678899999999999999999999975

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-28  Score=244.16  Aligned_cols=196  Identities=28%  Similarity=0.384  Sum_probs=152.8

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      ..+++||||.-|-|...++.       ++.++-...+.|.++|+.|+.|||.+.   |||||||.-||||..+..+||+|
T Consensus       186 cyCIiMEfCa~GqL~~VLka-------~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsD  255 (904)
T KOG4721|consen  186 CYCIIMEFCAQGQLYEVLKA-------GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISD  255 (904)
T ss_pred             eeEEeeeccccccHHHHHhc-------cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEecc
Confidence            45688999998888777754       556889999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||.++.....   ...-.+.||..|||||++++.+.++|+||||||||||||+||.-||......         ..+|.-
T Consensus       256 FGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---------AIIwGV  323 (904)
T KOG4721|consen  256 FGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---------AIIWGV  323 (904)
T ss_pred             ccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---------eeEEec
Confidence            9999875433   2233578999999999999999999999999999999999999997422110         011111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCce
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFS  509 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~P~~~  509 (541)
                      +.      ..+.-..+.....-+.-|+++||+..|..||++.+|+..|+--..++-...+-.|+
T Consensus       324 Gs------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf  381 (904)
T KOG4721|consen  324 GS------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYF  381 (904)
T ss_pred             cC------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHH
Confidence            11      11122223344556667888999999999999999999998766665544444444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=2e-27  Score=232.40  Aligned_cols=128  Identities=31%  Similarity=0.490  Sum_probs=113.1

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC------
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE------  358 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~------  358 (541)
                      ..+++|||||-+|.|..++++       .+.+++.....++.||+.||++||+++   ||||||||+||||+..      
T Consensus        82 ~~i~lVMEyC~gGDLs~yi~~-------~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~  151 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLSDYIRR-------RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTS  151 (429)
T ss_pred             CeEEEEEEeCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCC
Confidence            467889999999999766654       236999999999999999999999999   9999999999999875      


Q ss_pred             CCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 009186          359 MNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSG  425 (541)
Q Consensus       359 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~  425 (541)
                      -.+||+|||+++.+...   ....+..|++.|||||++...+|+.|+|+||+|+++|++++|+.||.
T Consensus       152 ~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  152 PVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             ceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence            45799999999987633   33445789999999999999999999999999999999999999985

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.94  E-value=8.8e-27  Score=238.16  Aligned_cols=166  Identities=31%  Similarity=0.419  Sum_probs=127.3

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...............++..|+|
T Consensus       168 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         168 KSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence            346899999999999999999999998   99999999999999999999999999986543322222223445678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||......      +........+....     .    +......+.++
T Consensus       245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~~~-----~----~~~~~~~l~~l  309 (338)
T cd05102         245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLKDGTRMR-----A----PENATPEIYRI  309 (338)
T ss_pred             cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHhcCCCCC-----C----CCCCCHHHHHH
Confidence            999999899999999999999999997 99998532211      11111112221111     1    11223457789


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||++|||+.+|++.|+..
T Consensus       310 i~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         310 MLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=243.21  Aligned_cols=184  Identities=23%  Similarity=0.293  Sum_probs=140.8

Q ss_pred             eeeehhHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-
Q 009186          280 WIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-  358 (541)
Q Consensus       280 ii~i~~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-  358 (541)
                      ++....-+++||||+.+|.|+.+..+       .+++.+.+..+++.||+.|++|||+++   |+||||||+|||++.+ 
T Consensus        88 v~~t~~~~~ivmEy~~gGdL~~~i~~-------~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~  157 (370)
T KOG0583|consen   88 VFATPTKIYIVMEYCSGGDLFDYIVN-------KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNE  157 (370)
T ss_pred             EEecCCeEEEEEEecCCccHHHHHHH-------cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCC
Confidence            34444457788899888888765543       346889999999999999999999999   9999999999999999 


Q ss_pred             CCcEEecccccccccCCCCcccccccccCCCCCChhhhccCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHH
Q 009186          359 MNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV-FS-VKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLL  436 (541)
Q Consensus       359 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~  436 (541)
                      +++||+|||++....  ..........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||..      .+..
T Consensus       158 ~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~  229 (370)
T KOG0583|consen  158 GNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVP  229 (370)
T ss_pred             CCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHH
Confidence            999999999998763  1222334578999999999999877 76 789999999999999999999864      1111


Q ss_pred             HHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..... +..++..      ++....   ...+..++.+||..||.+|+++.+|+.
T Consensus       230 ~l~~k-i~~~~~~------~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  230 NLYRK-IRKGEFK------IPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             HHHHH-HhcCCcc------CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            11111 1121110      111111   456777888999999999999999993

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.94  E-value=4.2e-27  Score=243.80  Aligned_cols=166  Identities=30%  Similarity=0.432  Sum_probs=125.4

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.++++++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...............++..|+|
T Consensus       206 ~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~a  282 (374)
T cd05106         206 SWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMA  282 (374)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeC
Confidence            346899999999999999999999998   99999999999999999999999999876543322222222335667999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||++.+..++.++||||||+++|||++ |+.||.......      ........+.     ....    +......+.++
T Consensus       283 PE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~-----~~~~----~~~~~~~l~~l  347 (374)
T cd05106         283 PESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGY-----QMSR----PDFAPPEIYSI  347 (374)
T ss_pred             HHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHccc-----CccC----CCCCCHHHHHH
Confidence            999998899999999999999999997 999985332111      1111111110     0000    11113457778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||++||++.+|+++|++.
T Consensus       348 i~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         348 MKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHH
Confidence            8899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.93  E-value=3.3e-27  Score=221.64  Aligned_cols=167  Identities=25%  Similarity=0.294  Sum_probs=131.3

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      ..++++|+|+.+|-++..+|+       .+++++..+.-++.||+.||+|||+.+   |++|||||+|||||.+|.+||.
T Consensus       117 ~~lymvmeyv~GGElFS~Lrk-------~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKit  186 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYLRK-------SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKIT  186 (355)
T ss_pred             CeEEEEEeccCCccHHHHHHh-------cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEE
Confidence            346788899999988777765       446999999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||.++....     .+.+.+||+.|+|||++...+++.++|.|+|||++|||+.|.+||....+      .+. .+.+.
T Consensus       187 DFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~i-Y~KI~  254 (355)
T KOG0616|consen  187 DFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQI-YEKIL  254 (355)
T ss_pred             eccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHH-HHHHH
Confidence            9999987643     24567899999999999999999999999999999999999999853322      111 11111


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCC
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHR  483 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~R  483 (541)
                      +++..          ++.-....+.+|+...|+.|-.+|
T Consensus       255 ~~~v~----------fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  255 EGKVK----------FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             hCccc----------CCcccCHHHHHHHHHHHhhhhHhh
Confidence            21110          111122345556777888888888

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=9.9e-27  Score=247.77  Aligned_cols=184  Identities=22%  Similarity=0.197  Sum_probs=142.8

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +.++||||-+|.|..+.+++.     ...|++.++++|+.|+++|+.+||... ++|||||||.+||||..+++.||+||
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rl-----q~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRL-----QTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHH-----hccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence            456799999777765554311     223999999999999999999999985 67999999999999999999999999


Q ss_pred             cccccccCCCCccc-------ccccccCCCCCChhhh---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHH
Q 009186          367 GMARIFSGNQNEAN-------TNRVAGTYGYMAPEYA---MEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLL  436 (541)
Q Consensus       367 g~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~l---~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~  436 (541)
                      |.+...........       .-...-|+.|++||.+   .+.++++|+|||+|||+||.|+....||+..         
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s---------  261 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES---------  261 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC---------
Confidence            99864322221100       1112358899999976   4677999999999999999999999998521         


Q ss_pred             HHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                                ....++.....-...+.....+.+||..||++||.+||++-+|+..+..
T Consensus       262 ----------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  262 ----------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             ----------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                      1233444444333345778889999999999999999999999987754

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.93  E-value=9.8e-27  Score=215.72  Aligned_cols=181  Identities=24%  Similarity=0.346  Sum_probs=139.0

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      ..+++|.+++.-|-|+.++..       .-.|++++..+|++|+.+|+.|||.++   ||||||||+|||++++.++||+
T Consensus        96 sF~FlVFdl~prGELFDyLts-------~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTS-------KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             chhhhhhhhcccchHHHHhhh-------heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence            567788888888888877743       345899999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHH
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM------EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTY  438 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~  438 (541)
                      |||++..+.....   .....||++|+|||.+.      +..|+..+|+|+.||++|.|+.|.+||-..   ..  +  .
T Consensus       166 DFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQ--m--l  235 (411)
T KOG0599|consen  166 DFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQ--M--L  235 (411)
T ss_pred             ccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HH--H--H
Confidence            9999988755443   33468999999999885      345888999999999999999999997211   00  0  1


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..+.+.+|+.. .     ....-.+......+|+.+||+.||.+|.|++|+++
T Consensus       236 MLR~ImeGkyq-F-----~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  236 MLRMIMEGKYQ-F-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHhcccc-c-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            11122222211 1     11111233445677889999999999999999985

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=236.15  Aligned_cols=174  Identities=28%  Similarity=0.432  Sum_probs=130.2

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +.+++..+.+.|+.||++|+.|||.++   |||||||..||++.++++|||+|||++.....-..........|...|||
T Consensus       482 etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmA  558 (678)
T KOG0193|consen  482 ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMA  558 (678)
T ss_pred             hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhc
Confidence            457999999999999999999999999   99999999999999999999999999865332222222333457788999


Q ss_pred             hhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          393 PEYAME---GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       393 PE~l~~---~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      ||+++.   .+|++.+||||||+++|||++|..||.....  ++       .+|..+.-.-..|....   .......+.
T Consensus       559 PEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dq-------IifmVGrG~l~pd~s~~---~s~~pk~mk  626 (678)
T KOG0193|consen  559 PEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQ-------IIFMVGRGYLMPDLSKI---RSNCPKAMK  626 (678)
T ss_pred             HHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hh-------eEEEecccccCccchhh---hccCHHHHH
Confidence            999974   3589999999999999999999999852111  10       11112222111222111   123345677


Q ss_pred             HHHhhhcccCCCCCCCHHHHHHHHhcCCCCCC
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVVMLASDTATLP  501 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~  501 (541)
                      +|+..||..++++||.+.+|+..|+.....+|
T Consensus       627 ~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p  658 (678)
T KOG0193|consen  627 RLLSDCWKFDREERPLFPQLLSKLEELLPSLP  658 (678)
T ss_pred             HHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence            88889999999999999999998887665443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.93  E-value=1.5e-26  Score=232.82  Aligned_cols=171  Identities=25%  Similarity=0.336  Sum_probs=125.1

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.++++++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|+|
T Consensus       132 ~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~a  208 (304)
T cd05096         132 LPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMA  208 (304)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccC
Confidence            356899999999999999999999999   99999999999999999999999999876543332222333455788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhC--CCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISG--KRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      ||.+.++.++.++||||||+++|||+++  ..||....   ...........+......  ...    ..++.....+.+
T Consensus       209 PE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~  279 (304)
T cd05096         209 WECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT---DEQVIENAGEFFRDQGRQ--VYL----FRPPPCPQGLYE  279 (304)
T ss_pred             HHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC---HHHHHHHHHHHhhhcccc--ccc----cCCCCCCHHHHH
Confidence            9999888999999999999999999975  44543221   111222221111111100  000    011122346788


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ++.+||+.||++|||+.+|.+.|++
T Consensus       280 li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         280 LMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HHHHHccCCchhCcCHHHHHHHHhC
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.93  E-value=1.6e-27  Score=252.64  Aligned_cols=197  Identities=27%  Similarity=0.372  Sum_probs=155.8

Q ss_pred             hhHHHHHHHHHHHhhheeccccc--ccc-CCC----CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc
Q 009186          284 GTIITTITLFILLGSFVWCRRRI--NKD-STK----GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD  356 (541)
Q Consensus       284 ~~~v~~v~~~~~~g~l~~~~~~~--~~~-~~~----~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~  356 (541)
                      +-+.++|+||+..|.|-++++-.  ..+ ...    ...|+..+.+.|+.||+.|++||-++.   +|||||-.+|+|+.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceec
Confidence            46778999999999996655432  111 112    344999999999999999999999998   99999999999999


Q ss_pred             CCCCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcH
Q 009186          357 HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSL  435 (541)
Q Consensus       357 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~  435 (541)
                      ++..+||+|||+++.+-..+......+..-..+|||||.+..++|+.+||||||||+|||+++ |+.|+.....      
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------  711 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------  711 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------
Confidence            999999999999997665555554444455789999999999999999999999999999998 8888643221      


Q ss_pred             HHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCC
Q 009186          436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTAT  499 (541)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~  499 (541)
                       +.+...+..++.+         ..+...+.++.+||+.||+.+|++||+++||-..|+.....
T Consensus       712 -~EVIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  712 -QEVIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -HHHHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence             1223333344432         33455667899999999999999999999999999875533

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.93  E-value=1e-26  Score=241.06  Aligned_cols=165  Identities=29%  Similarity=0.446  Sum_probs=124.9

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..+++++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...............++..|+|
T Consensus       208 ~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  284 (375)
T cd05104         208 ELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMA  284 (375)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeC
Confidence            346899999999999999999999998   99999999999999999999999999986543332222222345667999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||......      ....+.+..+....  .       +.....++.+|
T Consensus       285 PE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~--~-------~~~~~~~l~~l  349 (375)
T cd05104         285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGYRML--S-------PECAPSEMYDI  349 (375)
T ss_pred             hhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCccCC--C-------CCCCCHHHHHH
Confidence            999999999999999999999999998 88887432111      11111222211100  0       11112457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.||++||++.+|+++|+.
T Consensus       350 i~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         350 MKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             HHHHccCChhHCcCHHHHHHHHHh
Confidence            899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.93  E-value=1e-26  Score=213.25  Aligned_cols=172  Identities=24%  Similarity=0.286  Sum_probs=128.5

Q ss_pred             CCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC-----c--ccccc
Q 009186          311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN-----E--ANTNR  383 (541)
Q Consensus       311 ~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-----~--~~~~~  383 (541)
                      .++..+++.++++|+.+|++||++||+.. +++.||||||.|||+.+++.++|.|||.+....-.-.     .  ..-..
T Consensus       119 ~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~  197 (302)
T KOG2345|consen  119 IKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAE  197 (302)
T ss_pred             hcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHH
Confidence            45667999999999999999999999986 4699999999999999999999999998865321100     0  01112


Q ss_pred             cccCCCCCChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCC
Q 009186          384 VAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTC  460 (541)
Q Consensus       384 ~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  460 (541)
                      ...|..|+|||.+.   +...++++|||||||+||+|+.|..||+.... .+..+.            .......+.-..
T Consensus       198 e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla------------LAv~n~q~s~P~  264 (302)
T KOG2345|consen  198 ERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA------------LAVQNAQISIPN  264 (302)
T ss_pred             HhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE------------EeeeccccccCC
Confidence            35688999999885   44578999999999999999999999864433 221111            111111111111


Q ss_pred             CHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          461 VDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       461 ~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .....+.+.+++..|++.||.+||++.+++..+...
T Consensus       265 ~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  265 SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            223566788899999999999999999999988754

>PHA02988 hypothetical protein; Provisional

Probab=99.93  E-value=2.2e-26  Score=229.32  Aligned_cols=179  Identities=20%  Similarity=0.240  Sum_probs=134.1

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++||+..|.|...+++       .+.+++...++++.|++.||.|||+. +   ++||||||+||+++.++.+||+||
T Consensus        98 ~lv~Ey~~~g~L~~~l~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~df  167 (283)
T PHA02988         98 SLILEYCTRGYLREVLDK-------EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICH  167 (283)
T ss_pred             EEEEEeCCCCcHHHHHhh-------CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEccc
Confidence            345677777777555432       23589999999999999999999985 6   889999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAME--GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |+++......     ....++..|+|||.+.+  ..++.++|||||||++|||++|+.||....      ..+.......
T Consensus       168 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~------~~~~~~~i~~  236 (283)
T PHA02988        168 GLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT------TKEIYDLIIN  236 (283)
T ss_pred             chHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHh
Confidence            9987653221     12457889999999976  678999999999999999999999985321      1111111111


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+..     ..+    +......+.+++.+||+.||++|||+.+|++.|+..
T Consensus       237 ~~~~-----~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        237 KNNS-----LKL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             cCCC-----CCC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            1111     111    112234577888899999999999999999999753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.93  E-value=8e-26  Score=212.75  Aligned_cols=174  Identities=18%  Similarity=0.259  Sum_probs=126.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...++.+.+.+++.|++.|+.|+|+++   +|||||||+|||++.++.+||+|||+|+.+....  ..-+..+.|.+|+|
T Consensus        95 p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTDYVATRWYRa  169 (396)
T KOG0593|consen   95 PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTDYVATRWYRA  169 (396)
T ss_pred             cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc--chhhhhhhhhhccC
Confidence            345889999999999999999999999   9999999999999999999999999999876422  22234677999999


Q ss_pred             hhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcH--------HHHHHHhhhcCCcccccc-ccccCC---
Q 009186          393 PEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL--------LTYAWKLWCKGEALELMD-PVLKQT---  459 (541)
Q Consensus       393 PE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-~~l~~~---  459 (541)
                      ||.+.+ .+|...+|||++||++.||++|.+-|+.....+....        ...-...+........+. |.....   
T Consensus       170 PELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epL  249 (396)
T KOG0593|consen  170 PELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPL  249 (396)
T ss_pred             hhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccch
Confidence            999988 6799999999999999999999988754322211111        111122222222222211 111000   


Q ss_pred             --CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          460 --CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       460 --~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                        .-+....-+++++..||+.||.+|++.++++.
T Consensus       250 e~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  250 ERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             hhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence              01112335778999999999999999999874

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.3e-26  Score=246.17  Aligned_cols=182  Identities=24%  Similarity=0.301  Sum_probs=136.8

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..|.|...++..   ......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       116 lV~Ey~~~gsL~~~l~~~---~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        116 LVLDYANAGDLRQEIKSR---AKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             EEEeCCCCCcHHHHHHHh---hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEeccc
Confidence            456777777775444321   123456899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+.||...      ...+..... ..+..
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~------~~~~~~~~~-~~~~~  262 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE------NMEEVMHKT-LAGRY  262 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC------CHHHHHHHH-hcCCC
Confidence            98765433333334467899999999999999999999999999999999999998432      111111111 11111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      .    + +    +......+.+++.+||+.||.+||++.+++..
T Consensus       263 ~----~-~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        263 D----P-L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             C----C-C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            0    0 1    11223457788889999999999999999863

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.93  E-value=5.3e-26  Score=226.13  Aligned_cols=163  Identities=29%  Similarity=0.440  Sum_probs=126.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++...............++..|+||
T Consensus       119 ~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05048         119 SSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP  195 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCH
Confidence            56899999999999999999999999   999999999999999999999999998765433222223334567889999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |..||.....   ..    ....+..+....         .+......+.+|+
T Consensus       196 E~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~----~~~~i~~~~~~~---------~~~~~~~~~~~l~  259 (283)
T cd05048         196 EAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QE----VIEMIRSRQLLP---------CPEDCPARVYALM  259 (283)
T ss_pred             HHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HH----HHHHHHcCCcCC---------CcccCCHHHHHHH
Confidence            99988899999999999999999998 9988743221   11    111122221111         1222345677889


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhc
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .+||+.||.+||++.+|++.|++
T Consensus       260 ~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         260 IECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHccCChhhCcCHHHHHHHHhc
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=254.03  Aligned_cols=194  Identities=27%  Similarity=0.348  Sum_probs=153.0

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      ....+++|||..|.|+.++|+.+-...+...|+..+.+.++.||++|++||++++   +|||||..+|+||+....+||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEc
Confidence            4567888999999998888876555566778999999999999999999999998   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      |||+++.+...+.........-...|||||.+..+.++.|+|||||||++||+++ |..||+.....+   ++    ..+
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~----~~~  917 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VL----LDV  917 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HH----HHH
Confidence            9999995544433333222234568999999999999999999999999999999 788875332211   11    111


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      .++.       ++  +.+.....+++++|+.||+.+|++||++..|++.+....
T Consensus       918 ~~gg-------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  918 LEGG-------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             HhCC-------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence            2222       11  123445567889999999999999999999999887644

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.93  E-value=1.6e-26  Score=229.80  Aligned_cols=183  Identities=26%  Similarity=0.370  Sum_probs=134.3

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++..+.+...+++      +...+++..++.|+.||+.||.|||+++   ++|+||||+||+++.++.+||+|||++
T Consensus        86 i~e~~~~gsL~~~l~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ------HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             EEEeCCCCcHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccc
Confidence            3455555665443322      1235899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      +...............++..|++||.+.++.++.++||||||+++||+++ |+.||.....       ......+..+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~  229 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-------HEVPDLLEKGER  229 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCc
Confidence            86543332222233456778999999998899999999999999999998 9888743211       111112222221


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ..  .+.   .    ....+.+++.+||..||++||++.|+++.|....
T Consensus       230 ~~--~~~---~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         230 LA--QPQ---I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CC--CCC---C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            11  111   1    1234567888999999999999999999998744

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.93  E-value=4.1e-26  Score=230.10  Aligned_cols=192  Identities=25%  Similarity=0.364  Sum_probs=145.8

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++|+||+.+ .|+..+.       ..+.|+++.+..|+.+++.||.|||+.+   |+|||+||.|||++..|.+|++||
T Consensus        76 ~~vVte~a~g-~L~~il~-------~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdF  144 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILE-------QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDF  144 (808)
T ss_pred             EEEEehhhhh-hHHHHHH-------hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechh
Confidence            3445566554 4444443       2456999999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++....+.  .....+.||+.|||||.+.+.+|+..+|.||+|||+||++.|++||-      ...+.+....+..+ 
T Consensus       145 g~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------a~si~~Lv~~I~~d-  215 (808)
T KOG0597|consen  145 GLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------ARSITQLVKSILKD-  215 (808)
T ss_pred             hhhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------HHHHHHHHHHHhcC-
Confidence            9999866543  33456789999999999999999999999999999999999999983      11222222222211 


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcCCCCCCCCCCCCc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASDTATLPPPTQPAF  508 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~l~~p~~P~~  508 (541)
                             +.   ..+......++.++...|++||.+|.+..+++.  ..++.......|..|++
T Consensus       216 -------~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~  269 (808)
T KOG0597|consen  216 -------PV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF  269 (808)
T ss_pred             -------CC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence                   11   112345667888999999999999999999985  44554444444555554

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.93  E-value=7.6e-26  Score=231.14  Aligned_cols=166  Identities=30%  Similarity=0.415  Sum_probs=127.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..+.+++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            446999999999999999999999998   99999999999999999999999999987543332222333455678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++|||||||++|||++ |..||......      +........+....         .+......+.++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------EEFCRRLKEGTRMR---------APEYATPEIYSI  308 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------HHHHHHHhccCCCC---------CCccCCHHHHHH
Confidence            999999999999999999999999998 99887432111      11111111111110         111223467889


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.+|++||++.+|+++|+..
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=229.77  Aligned_cols=183  Identities=23%  Similarity=0.347  Sum_probs=137.9

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      -+++|++|+..|-+.|..-.       ...|++.++++++.+++.||+|||.++   ||||||||+|+||+.+|.+||+|
T Consensus       184 ~~YlVley~s~G~v~w~p~d-------~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  184 KLYLVLEYCSKGEVKWCPPD-------KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             ceEEEEEeccCCccccCCCC-------cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeec
Confidence            46777888877777665532       222999999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCC---CcccccccccCCCCCChhhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHH
Q 009186          366 FGMARIFSGNQ---NEANTNRVAGTYGYMAPEYAMEGV----FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTY  438 (541)
Q Consensus       366 fg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~  438 (541)
                      ||.+..+....   .........||+.|+|||...++.    .+.+.||||+||+||-|+.|+.||-      +...++.
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~------~~~~~~l  327 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF------DDFELEL  327 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc------cchHHHH
Confidence            99998763221   112233468999999999988743    3568999999999999999999983      1122221


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      ..++         +...+.-...+++...+.+|++++|++||++|.++.+|....
T Consensus       328 ~~KI---------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  328 FDKI---------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHH---------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            1111         111222222234566777899999999999999999998765

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.7e-26  Score=235.80  Aligned_cols=175  Identities=25%  Similarity=0.330  Sum_probs=133.0

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++|+||+..|-|+.++.+       +++|++.+..+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||
T Consensus        88 ylvlEyv~gGELFdylv~-------kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFG  157 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVR-------KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFG  157 (786)
T ss_pred             EEEEEecCCchhHHHHHh-------hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccc
Confidence            344455555555444432       467999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFS-VKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +|..-.++.   ...+.+|++.|.+||++.+.+|. .++||||.|||||.|++|+.||+      ++++.....+. ..|
T Consensus       158 MAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------DdNir~LLlKV-~~G  227 (786)
T KOG0588|consen  158 MASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------DDNIRVLLLKV-QRG  227 (786)
T ss_pred             eeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------CccHHHHHHHH-HcC
Confidence            997643332   23346899999999999999985 78999999999999999999985      22222222111 122


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      .. ++         +.....++.+|+.+|+..||++|.|++||++.
T Consensus       228 ~f-~M---------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  228 VF-EM---------PSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cc-cC---------CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            11 11         12223345567789999999999999999973

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.92  E-value=3.9e-26  Score=226.56  Aligned_cols=187  Identities=28%  Similarity=0.374  Sum_probs=130.2

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC---CcEEecc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM---NPKISDF  366 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~---~~kL~Df  366 (541)
                      +++++.++.|....++..........+++..+++++.||+.||+|||+++   ++|+||||+||+++.++   .+||+||
T Consensus        87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~df  163 (277)
T cd05036          87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADF  163 (277)
T ss_pred             EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccC
Confidence            34455445553333222111223346999999999999999999999998   99999999999998765   5899999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      |+++................+..|+|||.+.+..++.++|||||||++|||++ |+.||.....   .....    ....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~----~~~~  236 (277)
T cd05036         164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVME----FVTG  236 (277)
T ss_pred             ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHc
Confidence            99986533222111222233567999999998899999999999999999997 8888753211   11111    1111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ....         ..+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus       237 ~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         237 GGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            1100         0111223467788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=3.1e-26  Score=227.93  Aligned_cols=178  Identities=25%  Similarity=0.346  Sum_probs=126.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aP  393 (541)
                      .+++.+++.++.|++.||+|||+++   |+|+||||+||+++.++.+||+|||+++......... ......++..|++|
T Consensus       103 ~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~P  179 (283)
T cd05080         103 KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV  179 (283)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCH
Confidence            4899999999999999999999998   9999999999999999999999999988654322211 11122345679999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|||++|..|+....... .................+.++.......+......+.+++.
T Consensus       180 E~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  258 (283)
T cd05080         180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMK  258 (283)
T ss_pred             hHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHH
Confidence            99988889999999999999999999999874322110 00000000000001111111111111112223456788999


Q ss_pred             hhcccCCCCCCCHHHHHHHHhcC
Q 009186          474 LCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +||+.||++||++++|+++|+..
T Consensus       259 ~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         259 NCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             HHhccChhhCCCHHHHHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=2.2e-26  Score=232.40  Aligned_cols=180  Identities=24%  Similarity=0.329  Sum_probs=145.6

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +.++|+|+.+|.+.+..++.     ++..++++++++|+.|++.|+.|||++.   |+|||||+.||+++.++.+||+||
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~-----k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDf  150 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQ-----KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDF  150 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHH-----hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecch
Confidence            66788999999986655432     2567999999999999999999999887   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.......  ......||+.|+.||++.+.+|+.|+|||||||++|||.+-+++|....      ......+.... 
T Consensus       151 GlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~~~-  221 (426)
T KOG0589|consen  151 GLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKINRG-  221 (426)
T ss_pred             hhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHhhc-
Confidence            99998766542  3345789999999999999999999999999999999999999984322      22222221111 


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                               .....+......+..++..|++.+|..||++.+++.+
T Consensus       222 ---------~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 ---------LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---------cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                     1122344556677888889999999999999999975

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.92  E-value=3.5e-26  Score=231.52  Aligned_cols=182  Identities=24%  Similarity=0.383  Sum_probs=132.2

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++..|.+....++      ....+++..+++++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        86 v~e~~~~g~l~~~l~~------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          86 ITQLMPFGCLLDYVRE------HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             eeecCCCCCHHHHHHh------ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccc
Confidence            3444555555433322      1235889999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      +.+.............++..|++||.+.+..++.++||||||+++|||++ |+.||....      ..+ .......+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~------~~~-~~~~~~~~~~  229 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------ASE-ISSILEKGER  229 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC------HHH-HHHHHhCCCC
Confidence            87654333222222334668999999999999999999999999999997 898874321      111 1111111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..         .+......+.+++.+||+.||++||++.+++..|...
T Consensus       230 ~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         230 LP---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             CC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00         0111234567888999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.92  E-value=3.7e-26  Score=226.79  Aligned_cols=165  Identities=29%  Similarity=0.394  Sum_probs=125.9

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ....+++.++..++.||+.||.|||+++   ++||||||+||+++.++.+||+|||+++...............++..|+
T Consensus       115 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~  191 (280)
T cd05049         115 PMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM  191 (280)
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceec
Confidence            4456899999999999999999999999   9999999999999999999999999987543332222222334567899


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||.+.+..++.++||||||+++|||++ |+.||.....   .....    ....+....         .+......+.+
T Consensus       192 aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~----~~~~~~~~~---------~~~~~~~~~~~  255 (280)
T cd05049         192 PPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIE----CITQGRLLQ---------RPRTCPSEVYD  255 (280)
T ss_pred             ChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHcCCcCC---------CCCCCCHHHHH
Confidence            9999999999999999999999999998 9998742211   11111    111111111         01122345778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ++.+||+.||++||++.||++.|++
T Consensus       256 li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         256 IMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHcCCCcccCCCHHHHHHHhhC
Confidence            8999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.92  E-value=2.6e-25  Score=205.96  Aligned_cols=190  Identities=22%  Similarity=0.241  Sum_probs=135.4

Q ss_pred             CCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCC
Q 009186          311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY  390 (541)
Q Consensus       311 ~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  390 (541)
                      .+...|+..++..++.++++||+|||++.   |+||||||.|+|++.+|.+||+|||+++.+.........  .+-|.+|
T Consensus        93 d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~--~V~TRWY  167 (318)
T KOG0659|consen   93 DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH--QVVTRWY  167 (318)
T ss_pred             ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccccc--ceeeeec
Confidence            34567889999999999999999999999   999999999999999999999999999998765443322  3678999


Q ss_pred             CChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh---cCCcccc-----------cccc
Q 009186          391 MAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC---KGEALEL-----------MDPV  455 (541)
Q Consensus       391 ~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-----------~~~~  455 (541)
                      +|||.+.+. .|+..+|+||.|||+.||+-|.+-|.....   .+.+....+.+.   ..++.++           ....
T Consensus       168 RAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD---idQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~  244 (318)
T KOG0659|consen  168 RAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD---IDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKP  244 (318)
T ss_pred             cChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch---HHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCC
Confidence            999999875 499999999999999999998876642221   111111111111   1111111           1111


Q ss_pred             ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcee
Q 009186          456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSV  510 (541)
Q Consensus       456 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~P~~~~  510 (541)
                      .....-+......++++..+|..||.+|+++.|.+++=-  ...+|.|..|.-..
T Consensus       245 ~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y--f~~~P~pt~~~~lp  297 (318)
T KOG0659|consen  245 PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY--FKSLPLPTPPSKLP  297 (318)
T ss_pred             ccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh--hhcCCCCCChhhCc
Confidence            111123344556789999999999999999999886422  23356665554443

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.92  E-value=1.3e-25  Score=224.48  Aligned_cols=167  Identities=29%  Similarity=0.398  Sum_probs=128.9

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..+++++.||+.||+|||+++   |+||||||+||+++.++.++|+|||++................++..|+|
T Consensus       117 ~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~a  193 (291)
T cd05094         117 KGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP  193 (291)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecC
Confidence            346899999999999999999999999   99999999999999999999999999876543322222233456788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||......   .    .+..+..+.....         .......+.++
T Consensus       194 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~----~~~~~~~~~~~~~---------~~~~~~~~~~l  257 (291)
T cd05094         194 PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---E----VIECITQGRVLER---------PRVCPKEVYDI  257 (291)
T ss_pred             hHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHhCCCCCCC---------CccCCHHHHHH
Confidence            999998889999999999999999998 99887432211   1    1122222222111         11123457789


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDTA  498 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~~  498 (541)
                      +.+||+.||++||++.+|+++|+....
T Consensus       258 i~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         258 MLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.92  E-value=4.5e-26  Score=222.67  Aligned_cols=181  Identities=29%  Similarity=0.387  Sum_probs=129.2

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+....++      ++..+++.+++.++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||+
T Consensus        70 lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  140 (252)
T cd05084          70 IVMELVQGGDFLTFLRT------EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGM  140 (252)
T ss_pred             EEEeeccCCcHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECcccc
Confidence            34456555555433322      1335889999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +.................+..|+|||.+.++.++.++||||||+++|||++ |..||......      . .........
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~-~~~~~~~~~  213 (252)
T cd05084         141 SREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------Q-TREAIEQGV  213 (252)
T ss_pred             CcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------H-HHHHHHcCC
Confidence            875432211111111123456999999998889999999999999999998 88776422110      1 111111110


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                               ....+......+.+++.+||+.+|++||++.+|+++|+
T Consensus       214 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         214 ---------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                     01111122446778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.92  E-value=1.5e-25  Score=223.88  Aligned_cols=169  Identities=24%  Similarity=0.290  Sum_probs=121.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....   .......|+..|+||
T Consensus       105 ~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aP  178 (290)
T cd07862         105 PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAP  178 (290)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccCh
Confidence            35899999999999999999999999   999999999999999999999999999765433   122335688999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh---cCCcc-------ccccccccC---CC
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC---KGEAL-------ELMDPVLKQ---TC  460 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-------~~~~~~l~~---~~  460 (541)
                      |.+.+..++.++||||||+++|||++|++||......   ..+........   ...+.       ....+....   ..
T Consensus       179 E~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (290)
T cd07862         179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF  255 (290)
T ss_pred             HHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHH
Confidence            9998888999999999999999999999998532211   11111111000   00000       000000000   00


Q ss_pred             CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          461 VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       461 ~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+.....+.+++.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         256 VTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             ccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0112345668899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.92  E-value=4.9e-26  Score=223.25  Aligned_cols=162  Identities=28%  Similarity=0.393  Sum_probs=123.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCccc-ccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aP  393 (541)
                      .+++..+.+++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.......... .....++..|+||
T Consensus        91 ~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  167 (257)
T cd05116          91 HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP  167 (257)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCH
Confidence            5899999999999999999999999   99999999999999999999999999986544332211 1122345789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+....++.++||||||+++|||++ |+.||.....   .....    ....+....     .    +......+.+++
T Consensus       168 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~----~i~~~~~~~-----~----~~~~~~~l~~li  231 (257)
T cd05116         168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQ----MIESGERME-----C----PQRCPPEMYDLM  231 (257)
T ss_pred             hHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHCCCCCC-----C----CCCCCHHHHHHH
Confidence            99988889999999999999999998 9989753211   11111    111111111     1    112234567899


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhc
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .+||+.||++||++.+|.+.|++
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         232 KLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             HHHhccCchhCcCHHHHHHHHhc
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.92  E-value=4.4e-26  Score=231.62  Aligned_cols=174  Identities=22%  Similarity=0.277  Sum_probs=129.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.+...+.+       ...+++.++..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        72 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~  141 (323)
T cd05571          72 FVMEYANGGELFFHLSR-------ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGL  141 (323)
T ss_pred             EEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCC
Confidence            45566666666433322       345899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++......  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....   .....    .....+. 
T Consensus       142 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~----~~~~~~~-  211 (323)
T cd05571         142 CKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLF----ELILMEE-  211 (323)
T ss_pred             CcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHH----HHHHcCC-
Confidence            87532211  11233568999999999999899999999999999999999999984221   11111    1111111 


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                           ..+.    ......+.+++.+||+.||++||     ++.++++
T Consensus       212 -----~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 -----IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -----CCCC----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                 0111    12234567788899999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.92  E-value=1.4e-25  Score=227.84  Aligned_cols=175  Identities=22%  Similarity=0.282  Sum_probs=128.7

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.+...+.+       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        71 ~lv~E~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  140 (323)
T cd05595          71 CFVMEYANGGELFFHLSR-------ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             EEEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccH
Confidence            345667666666433322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....   ....   .... ...
T Consensus       141 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~---~~~~-~~~  211 (323)
T cd05595         141 LCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLF---ELIL-MEE  211 (323)
T ss_pred             HhccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHh-cCC
Confidence            987532211  112235689999999999988999999999999999999999999843211   1111   1111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                      .      .+...    ....+.+++.+||+.||.+||     ++.++++
T Consensus       212 ~------~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 I------RFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             C------CCCCC----CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            0      11111    233566788899999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.92  E-value=1.8e-26  Score=226.85  Aligned_cols=181  Identities=31%  Similarity=0.430  Sum_probs=128.4

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..|.|..+++..     ....+++.+++.|+.||++||.|||+++   ++|+||+++||+++.++.+||+|||+
T Consensus        78 lv~e~~~~g~L~~~L~~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~  149 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSK-----NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGL  149 (259)
T ss_dssp             EEEE--TTEBHHHHHHHT-----CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTT
T ss_pred             cccccccccccccccccc-----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            445666666665555431     3456899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      .....................|+|||.+....++.++||||||+++|||++ |+.|+...   .   ..+.... ..++.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~---~~~~~~~-~~~~~  222 (259)
T PF07714_consen  150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---D---NEEIIEK-LKQGQ  222 (259)
T ss_dssp             GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---C---HHHHHHH-HHTTE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c---ccccccc-ccccc
Confidence            987633322222333446678999999999889999999999999999999 67776322   1   1111111 12222


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      ...         .+......+.+++..||+.||++||++.+|++.|
T Consensus       223 ~~~---------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLP---------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETT---------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cce---------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            111         1111234567889999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.92  E-value=1.6e-25  Score=222.70  Aligned_cols=164  Identities=29%  Similarity=0.409  Sum_probs=124.4

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++..+++++.|++.||+|||+++   |+||||||+||++++++.+||+|||+++...............+++.|+|
T Consensus       118 ~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  194 (283)
T cd05091         118 KSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMS  194 (283)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccC
Confidence            446899999999999999999999999   99999999999999999999999999876543322222223345678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.++.++.++||||||+++|||++ |..||....      ..+. ......+....         .+......+.++
T Consensus       195 PE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~-~~~i~~~~~~~---------~~~~~~~~~~~l  258 (283)
T cd05091         195 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------NQDV-IEMIRNRQVLP---------CPDDCPAWVYTL  258 (283)
T ss_pred             HHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC------HHHH-HHHHHcCCcCC---------CCCCCCHHHHHH
Confidence            999988889999999999999999998 777764221      1111 11111211110         111223446788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +..||+.+|.+||++.+|++.|+.
T Consensus       259 i~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         259 MLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHhCCCcccCCCHHHHHHHhhC
Confidence            899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.92  E-value=2.9e-26  Score=244.99  Aligned_cols=183  Identities=21%  Similarity=0.209  Sum_probs=135.2

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++||+.++.|...+++   .......+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       140 ~~lv~E~~~gg~L~~~l~~---~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DF  213 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQ---RLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDF  213 (478)
T ss_pred             EEEEEECCCCCCHHHHHHH---HHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeC
Confidence            4456677777766443322   1122446889999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....      ..+...... .+
T Consensus       214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~------~~~~~~~~~-~~  286 (478)
T PTZ00267        214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS------QREIMQQVL-YG  286 (478)
T ss_pred             cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHH-hC
Confidence            99987654333223344568999999999999899999999999999999999999974211      111111111 11


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ...    + .    +......+.+++.+||+.||++||++.+++.
T Consensus       287 ~~~----~-~----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        287 KYD----P-F----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCC----C-C----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            110    0 0    1112345778888999999999999999864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.92  E-value=2.1e-25  Score=225.94  Aligned_cols=174  Identities=25%  Similarity=0.311  Sum_probs=128.3

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.++.|...+++       ...+++.++..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        72 ~lv~e~~~gg~L~~~~~~-------~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg  141 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQS-------SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFG  141 (316)
T ss_pred             EEEEcCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCc
Confidence            455667666666444322       235899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......||..|+|||.+.+..++.++|||||||++|||++|+.||....      ..+..... ....
T Consensus       142 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~------~~~~~~~i-~~~~  212 (316)
T cd05592         142 MCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED------EDELFDSI-LNDR  212 (316)
T ss_pred             CCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC------HHHHHHHH-HcCC
Confidence            987543222  22234568999999999998889999999999999999999999985321      11111111 1110


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS-SVV  490 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-evl  490 (541)
                            +.+..    .....+.+++.+||+.||.+||++. +++
T Consensus       213 ------~~~~~----~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         213 ------PHFPR----WISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ------CCCCC----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                  11111    1223456788899999999999875 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.92  E-value=8.9e-26  Score=222.19  Aligned_cols=182  Identities=26%  Similarity=0.383  Sum_probs=131.3

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+....+.     .....+++..++.++.|+++||+|||+++   ++||||||+||+++.++.+||+|||+
T Consensus        79 lv~e~~~~~~L~~~~~~-----~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~  150 (263)
T cd05052          79 IITEFMTYGNLLDYLRE-----CNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL  150 (263)
T ss_pred             EEEEeCCCCcHHHHHHh-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcc
Confidence            34455555555333221     12345899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +......... ......++..|++||.+.+..++.++||||||+++|||++ |..||....      . +..+.......
T Consensus       151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~------~-~~~~~~~~~~~  222 (263)
T cd05052         151 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------L-SQVYELLEKGY  222 (263)
T ss_pred             ccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC------H-HHHHHHHHCCC
Confidence            8765432211 1112233567999999988889999999999999999998 888874321      1 11112211111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                           ..    ..+......+.+++.+||+.||++||++.+++++|+.
T Consensus       223 -----~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         223 -----RM----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             -----CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence                 01    1111223457778899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.92  E-value=8.3e-26  Score=225.29  Aligned_cols=174  Identities=20%  Similarity=0.247  Sum_probs=122.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++......... ......|+..|+||
T Consensus        95 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  170 (287)
T cd07848          95 NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSP  170 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCc
Confidence            35899999999999999999999998   999999999999999999999999999875432221 12235688999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHH--------HHHhh-hcCCccccccccccC------
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTY--------AWKLW-CKGEALELMDPVLKQ------  458 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~~~~l~~------  458 (541)
                      |.+.+..++.++|||||||++|||++|+.||..............        .+..+ ..........+....      
T Consensus       171 E~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T cd07848         171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLER  250 (287)
T ss_pred             HHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHH
Confidence            999988899999999999999999999999854321110000000        00000 000000000000000      


Q ss_pred             CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          459 TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       459 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .........+.+++.+||+.||++|||++++++
T Consensus       251 ~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         251 RYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000112345788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.92  E-value=7.5e-26  Score=224.72  Aligned_cols=165  Identities=27%  Similarity=0.388  Sum_probs=124.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++...............++..|++|
T Consensus       104 ~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05109         104 DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL  180 (279)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCH
Confidence            35899999999999999999999999   999999999999999999999999999876433322222222346689999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |..||.....   ....    ..+..+....         ........+.+++
T Consensus       181 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~~---------~~~~~~~~~~~li  244 (279)
T cd05109         181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIP----DLLEKGERLP---------QPPICTIDVYMIM  244 (279)
T ss_pred             HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHCCCcCC---------CCccCCHHHHHHH
Confidence            99988889999999999999999998 8888743211   1111    1111111111         0112234567888


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      .+||+.||++||++.++++.|+...
T Consensus       245 ~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         245 VKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHhh
Confidence            9999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.92  E-value=3.6e-26  Score=226.81  Aligned_cols=163  Identities=27%  Similarity=0.421  Sum_probs=123.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++...............++..|+||
T Consensus       114 ~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05062         114 APPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  190 (277)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcCh
Confidence            45788999999999999999999998   999999999999999999999999998765433222222223456789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |..||.....   .    .............     .    +......+.+++
T Consensus       191 E~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~----~~~~~~~~~~~~~-----~----~~~~~~~~~~li  254 (277)
T cd05062         191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---E----QVLRFVMEGGLLD-----K----PDNCPDMLFELM  254 (277)
T ss_pred             hHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---H----HHHHHHHcCCcCC-----C----CCCCCHHHHHHH
Confidence            99998889999999999999999999 6778642211   1    1111111111111     1    111234577899


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhc
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .+||+.||++||++.|+++.|++
T Consensus       255 ~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         255 RMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHcCCChhhCcCHHHHHHHhhC
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.92  E-value=7.1e-26  Score=225.85  Aligned_cols=158  Identities=23%  Similarity=0.306  Sum_probs=120.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........   .....|+..|+|||
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE  171 (285)
T cd05631          98 GFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPE  171 (285)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHh
Confidence            5899999999999999999999999   99999999999999999999999999876533221   12346899999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++|||||||++|||++|+.||.......   ..+..........          ..........+.+|+.+
T Consensus       172 ~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~----------~~~~~~~s~~~~~li~~  238 (285)
T cd05631         172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKEDQ----------EEYSEKFSEDAKSICRM  238 (285)
T ss_pred             hhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhccc----------ccCCccCCHHHHHHHHH
Confidence            9999999999999999999999999999985432211   1111111111100          00111123456778889


Q ss_pred             hcccCCCCCCC-----HHHHHH
Q 009186          475 CVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       475 cl~~dP~~RPt-----~~evl~  491 (541)
                      ||+.||.+||+     ++++++
T Consensus       239 ~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         239 LLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HhhcCHHHhcCCCCCCHHHHhc
Confidence            99999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=232.71  Aligned_cols=153  Identities=26%  Similarity=0.331  Sum_probs=122.5

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ....+++..+.-++..|+.||+|||+++   |||||||.+|||||.+|.+||+|||+++.-....  ..+.++.||+.|+
T Consensus       461 ~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~  535 (694)
T KOG0694|consen  461 HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFL  535 (694)
T ss_pred             ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC--CccccccCChhhc
Confidence            3457999999999999999999999999   9999999999999999999999999998643222  2456789999999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |||++.+..|+.++|.|+|||+||||+.|+.||.....   +.+.+-+    ..      .++.    ++.-...+.+.|
T Consensus       536 aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee~FdsI----~~------d~~~----yP~~ls~ea~~i  598 (694)
T KOG0694|consen  536 APEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EEVFDSI----VN------DEVR----YPRFLSKEAIAI  598 (694)
T ss_pred             ChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHH----hc------CCCC----CCCcccHHHHHH
Confidence            99999999999999999999999999999999853221   1111111    01      1111    222334567788


Q ss_pred             HhhhcccCCCCCCCH
Q 009186          472 GLLCVQEDPAHRPNM  486 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~  486 (541)
                      +.++|..||++|.-+
T Consensus       599 l~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  599 MRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHhccCcccccCC
Confidence            889999999999866

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=1e-24  Score=227.00  Aligned_cols=173  Identities=21%  Similarity=0.262  Sum_probs=120.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||
T Consensus       178 ~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE  253 (391)
T PHA03212        178 NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPE  253 (391)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChh
Confidence            5899999999999999999999998   99999999999999999999999999875322211 1122356899999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCc----CcHHHHHHHhhhc--CCc--------cccc--------
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG----QSLLTYAWKLWCK--GEA--------LELM--------  452 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~--------~~~~--------  452 (541)
                      ++.+..++.++|||||||++|||++|+.|+-......+    ...+.........  ...        .+..        
T Consensus       254 ~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (391)
T PHA03212        254 LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSS  333 (391)
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccC
Confidence            99988999999999999999999999987532211110    0111111110000  000        0000        


Q ss_pred             -cccccCCC--CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          453 -DPVLKQTC--VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       453 -~~~l~~~~--~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       .+......  .......+.+++.+||+.||++|||++|+++
T Consensus       334 ~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        334 RKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             CCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             00000000  0112346778999999999999999999985

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=6.1e-26  Score=229.37  Aligned_cols=177  Identities=24%  Similarity=0.288  Sum_probs=128.3

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|....++       ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||
T Consensus        69 ~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg  138 (312)
T cd05585          69 YLVLAFINGGELFHHLQR-------EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFG  138 (312)
T ss_pred             EEEEcCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECc
Confidence            345566666666444322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++.......  ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....      ..+...... ...
T Consensus       139 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~-~~~  209 (312)
T cd05585         139 LCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKIL-QEP  209 (312)
T ss_pred             ccccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHH-cCC
Confidence            9875332221  2234568999999999999899999999999999999999999985321      111111111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      .      .+    +......+.+++.+||+.||.+||+...+.+.|
T Consensus       210 ~------~~----~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         210 L------RF----PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             C------CC----CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            0      11    111234566788899999999998644433333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=5.3e-26  Score=225.30  Aligned_cols=165  Identities=28%  Similarity=0.429  Sum_probs=126.4

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ....+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+.............++..|+
T Consensus       112 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~  188 (277)
T cd05032         112 GLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM  188 (277)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCcccccc
Confidence            3456899999999999999999999998   9999999999999999999999999987654433222223344677899


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||.+.++.++.++||||||+++||+++ |+.||.....   ...    .+....+....     ...    .....+.+
T Consensus       189 aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~----~~~~~~~~~~~-----~~~----~~~~~~~~  252 (277)
T cd05032         189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEV----LKFVIDGGHLD-----LPE----NCPDKLLE  252 (277)
T ss_pred             CHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHH----HHHHhcCCCCC-----CCC----CCCHHHHH
Confidence            9999988889999999999999999998 8888742211   111    11111211111     111    12456778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ++.+||+.+|++|||+.++++.|++
T Consensus       253 li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         253 LMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHHHcCCChhhCCCHHHHHHHhcC
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.92  E-value=3.5e-25  Score=221.12  Aligned_cols=167  Identities=29%  Similarity=0.402  Sum_probs=127.1

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      +...+++.+++.++.||+.||+|||+++   ++||||||+||+++.++.+||+|||+++...............++..|+
T Consensus       113 ~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~  189 (288)
T cd05093         113 RPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM  189 (288)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCcccccc
Confidence            3446999999999999999999999999   9999999999999999999999999987654332222222334567899


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||.+.+..++.++||||||+++|||++ |..||.....   ...    ......+....     ....    ....+.+
T Consensus       190 aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~----~~~i~~~~~~~-----~~~~----~~~~l~~  253 (288)
T cd05093         190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV----IECITQGRVLQ-----RPRT----CPKEVYD  253 (288)
T ss_pred             CHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHHcCCcCC-----CCCC----CCHHHHH
Confidence            9999988889999999999999999998 8888742211   111    11112222111     1111    2245788


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ++.+||+.||.+|||+.+|++.|+...
T Consensus       254 li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         254 LMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.6e-25  Score=220.08  Aligned_cols=183  Identities=30%  Similarity=0.428  Sum_probs=134.0

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.+....++     ..+..+++.++..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||
T Consensus        77 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg  148 (261)
T cd05068          77 YIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFG  148 (261)
T ss_pred             eeeeecccCCcHHHHHhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcc
Confidence            455666666666444322     11346899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++........ .......+..|+|||.+.+..++.++||||||+++|||++ |+.||....   ....    .......
T Consensus       149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~----~~~~~~~  220 (261)
T cd05068         149 LARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEV----LQQVDQG  220 (261)
T ss_pred             eEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHH----HHHHHcC
Confidence            99876532211 1111223457999999988889999999999999999999 888874221   1111    1111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..         ...+......+.+++.+||+.+|.+||++.++++.|++
T Consensus       221 ~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         221 YR---------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CC---------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            10         01111234567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.92  E-value=1.4e-25  Score=220.23  Aligned_cols=182  Identities=30%  Similarity=0.447  Sum_probs=135.0

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.|....++     ..+..+++.++++++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||
T Consensus        78 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g  149 (261)
T cd05148          78 YIITELMEKGSLLAFLRS-----PEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFG  149 (261)
T ss_pred             EEEEeecccCCHHHHHhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEcccc
Confidence            455667766666544432     12346899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      .+..........  ....++..|++||.+.+..++.++||||||+++|+|++ |+.||....   ........    ..+
T Consensus       150 ~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~----~~~  220 (261)
T cd05148         150 LARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQI----TAG  220 (261)
T ss_pred             chhhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHH----HhC
Confidence            987654322111  12345678999999988889999999999999999998 788874321   11111111    111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..         ...+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus       221 ~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         221 YR---------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             Cc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            00         01112233567789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.92  E-value=3.7e-25  Score=218.63  Aligned_cols=164  Identities=25%  Similarity=0.351  Sum_probs=125.3

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.....++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++...............++..|++
T Consensus       106 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T cd05075         106 PQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA  182 (272)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCC
Confidence            345899999999999999999999998   99999999999999999999999999987543322111222345678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||.....   .    ..+.....+.....         .......+.++
T Consensus       183 pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~----~~~~~~~~~~~~~~---------~~~~~~~~~~l  246 (272)
T cd05075         183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---S----EIYDYLRQGNRLKQ---------PPDCLDGLYSL  246 (272)
T ss_pred             HHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---H----HHHHHHHcCCCCCC---------CCCCCHHHHHH
Confidence            999998889999999999999999999 7888743211   1    11122222221110         11123456789


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.||++|||+.+|++.|+.
T Consensus       247 i~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         247 MSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             HHHHcCCCcccCcCHHHHHHHHHh
Confidence            999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.92  E-value=1.3e-25  Score=221.54  Aligned_cols=188  Identities=27%  Similarity=0.361  Sum_probs=132.9

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-----CcEE
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-----NPKI  363 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-----~~kL  363 (541)
                      ++++++..+.+...+++..........+++.+++.++.||+.||+|||+.+   ++|+||||+||+++.++     .++|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEE
Confidence            334555445553333221111113445899999999999999999999998   99999999999999877     8999


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      +|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||.....      .+.... 
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------~~~~~~-  225 (269)
T cd05044         153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------QEVLQH-  225 (269)
T ss_pred             CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------HHHHHH-
Confidence            99999876543322222223345678999999999999999999999999999998 9988743211      111111 


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ...+...         .........+.+++.+||+.+|++||++.+|++.|+.
T Consensus       226 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         226 VTAGGRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HhcCCcc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1111100         0111223467789999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.92  E-value=1.5e-25  Score=222.82  Aligned_cols=183  Identities=25%  Similarity=0.273  Sum_probs=131.1

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|...+..   .......+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus        69 ~lv~e~~~~g~L~~~~~~---~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg  142 (280)
T cd05608          69 CLVMTIMNGGDLRYHIYN---VDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLG  142 (280)
T ss_pred             EEEEeCCCCCCHHHHHHh---ccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCc
Confidence            345566666665332211   1123456899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++..+......  .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........  . ...........
T Consensus       143 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~-~~~~~~~~~~~  217 (280)
T cd05608         143 LAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--N-KELKQRILNDS  217 (280)
T ss_pred             cceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--H-HHHHHhhcccC
Confidence            98765433221  2234688999999999999999999999999999999999999853221110  0 11111100000


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                              .  ..+......+.+++.+||+.||++||     +++++++
T Consensus       218 --------~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         218 --------V--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             --------C--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                    0  11112334567788899999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.92  E-value=2.5e-25  Score=225.27  Aligned_cols=112  Identities=30%  Similarity=0.493  Sum_probs=94.1

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE----cCCCCcEEecccccccccCCCCc-cccccccc
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL----DHEMNPKISDFGMARIFSGNQNE-ANTNRVAG  386 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll----~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~g  386 (541)
                      +...+++..+..++.||+.||+|||+++   |+||||||+|||+    +.++.+||+|||+++.+...... .......+
T Consensus       101 ~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  177 (317)
T cd07868         101 KPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV  177 (317)
T ss_pred             CcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccc
Confidence            3446899999999999999999999999   9999999999999    45678999999999876433221 12234568


Q ss_pred             CCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          387 TYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       387 t~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      |+.|+|||++.+. .++.++|||||||++|||++|++||..
T Consensus       178 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            9999999998764 588999999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.92  E-value=2.9e-25  Score=225.53  Aligned_cols=170  Identities=25%  Similarity=0.338  Sum_probs=126.1

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..|.|.....+       ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~E~~~~g~L~~~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQ-------VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEcCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCC
Confidence            355666666666443322       235889999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.....   .....   . +....
T Consensus       147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~---~-i~~~~  217 (323)
T cd05616         147 MCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ---S-IMEHN  217 (323)
T ss_pred             CceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHH---H-HHhCC
Confidence            987533221  122345689999999999999999999999999999999999999853211   11111   1 11111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM  486 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~  486 (541)
                      .      .+    +......+.+++.+||+.||.+|++.
T Consensus       218 ~------~~----p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 V------AY----PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             C------CC----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            1      01    11223456778899999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.92  E-value=8.3e-26  Score=230.40  Aligned_cols=179  Identities=22%  Similarity=0.260  Sum_probs=128.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.+...+.+       +..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        82 lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~  151 (332)
T cd05614          82 LILDYVSGGEMFTHLYQ-------RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGL  151 (332)
T ss_pred             EEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcC
Confidence            44566666666443322       235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++.+...... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||........   ..........  
T Consensus       152 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~--  225 (332)
T cd05614         152 SKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILK--  225 (332)
T ss_pred             CccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhc--
Confidence            8765333221 12235689999999998765 478899999999999999999999853322111   1111111111  


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                          .++.+..    .....+.+++.+||+.||++||     +++++++
T Consensus       226 ----~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 ----CDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----CCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                1111111    1233566788899999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.92  E-value=1e-25  Score=226.68  Aligned_cols=165  Identities=30%  Similarity=0.406  Sum_probs=125.7

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       131 ~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~a  207 (304)
T cd05101         131 DEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMA  207 (304)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeC
Confidence            456899999999999999999999999   99999999999999999999999999987644332222223345678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||...      ...+ .......+....         .+......+.++
T Consensus       208 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------~~~~-~~~~~~~~~~~~---------~~~~~~~~~~~l  271 (304)
T cd05101         208 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------PVEE-LFKLLKEGHRMD---------KPANCTNELYMM  271 (304)
T ss_pred             chhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC------CHHH-HHHHHHcCCcCC---------CCCCCCHHHHHH
Confidence            999988889999999999999999998 77776321      1111 111111111111         111223457778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.+|++||++.+|++.|+..
T Consensus       272 i~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         272 MRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             HHHHcccChhhCCCHHHHHHHHHHH
Confidence            8999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=8.2e-25  Score=218.88  Aligned_cols=192  Identities=24%  Similarity=0.317  Sum_probs=134.6

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      ..+++|++|+.--+...       ....+-.+++.++..+++||+.||+|+|.++   |+|||||.+|||||.+|.+||+
T Consensus       191 ~siYlVFeYMdhDL~GL-------l~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKia  260 (560)
T KOG0600|consen  191 GSIYLVFEYMDHDLSGL-------LSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIA  260 (560)
T ss_pred             ceEEEEEecccchhhhh-------hcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEec
Confidence            35667777764221100       1223446999999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH--
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK--  441 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~--  441 (541)
                      |||+++.+........+ ..+-|++|+|||++.+. .|+.++|+||.||||.||+.|++.|.......   .++.+.+  
T Consensus       261 DFGLAr~y~~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve---Ql~kIfklc  336 (560)
T KOG0600|consen  261 DFGLARFYTPSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE---QLHKIFKLC  336 (560)
T ss_pred             cccceeeccCCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH---HHHHHHHHh
Confidence            99999987766544433 45679999999999875 59999999999999999999999874322111   1111111  


Q ss_pred             ------hhhcCCcc--ccccc------cccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          442 ------LWCKGEAL--ELMDP------VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       442 ------~~~~~~~~--~~~~~------~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                            .|....+.  ..+.+      .+... -.......++|+..+|..||.+|.|+.++++
T Consensus       337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCCChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                  12211111  11111      11100 0011234667888999999999999999874

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=1.1e-24  Score=227.13  Aligned_cols=176  Identities=22%  Similarity=0.272  Sum_probs=125.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++................||..|+||
T Consensus       180 ~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP  256 (392)
T PHA03207        180 GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSP  256 (392)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCH
Confidence            45899999999999999999999999   999999999999999999999999999765544333333346789999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc--c-----------ccccccccCCC
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA--L-----------ELMDPVLKQTC  460 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~-----------~~~~~~l~~~~  460 (541)
                      |++.+..++.++|||||||++|||++|+.||...........+....+.......  .           .......+...
T Consensus       257 E~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (392)
T PHA03207        257 ELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY  336 (392)
T ss_pred             hHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCc
Confidence            9999889999999999999999999999998443222111111111111000000  0           00000000000


Q ss_pred             C-------HHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          461 V-------DAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       461 ~-------~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      .       ......+.+++.+||+.||++||++.|++..
T Consensus       337 ~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        337 TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0       0112346678889999999999999999864

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.92  E-value=1.4e-25  Score=228.19  Aligned_cols=177  Identities=24%  Similarity=0.350  Sum_probs=129.6

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|.....+       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        72 ~lv~e~~~~~~L~~~~~~-------~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg  141 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQR-------QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYG  141 (327)
T ss_pred             EEEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccc
Confidence            445566666666433322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||............+..........
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  219 (327)
T cd05617         142 MCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP  219 (327)
T ss_pred             cceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC
Confidence            987432211  122345689999999999999999999999999999999999999864433322223333333322211


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM  486 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~  486 (541)
                      .      .+..    .....+.+++.+||+.||.+|+++
T Consensus       220 ~------~~p~----~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         220 I------RIPR----FLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             C------CCCC----CCCHHHHHHHHHHhccCHHHcCCC
Confidence            1      1111    122446678889999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.92  E-value=4.8e-25  Score=220.29  Aligned_cols=166  Identities=28%  Similarity=0.391  Sum_probs=127.0

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++...............++..|++
T Consensus       121 ~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  197 (290)
T cd05045         121 ERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMA  197 (290)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccC
Confidence            456999999999999999999999998   99999999999999999999999999876543332222223345678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||.....       +..+.......         ....+......+.++
T Consensus       198 pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~~~~  261 (290)
T cd05045         198 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-------ERLFNLLKTGY---------RMERPENCSEEMYNL  261 (290)
T ss_pred             HHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCC---------CCCCCCCCCHHHHHH
Confidence            999988889999999999999999998 8888742211       11122211111         011111223467789


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +.+||+.+|++||++.++++.|++..
T Consensus       262 i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         262 MLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHHccCCcccCCCHHHHHHHHHHHH
Confidence            99999999999999999999998643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.92  E-value=1.1e-25  Score=222.08  Aligned_cols=183  Identities=25%  Similarity=0.308  Sum_probs=132.5

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++||+..+.+...+++      ....+++.+++.++.||+.||+|||+.+   ++||||||+||+++.++.+|++||
T Consensus        81 ~~lv~e~~~~~~L~~~l~~------~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~df  151 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRK------HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGF  151 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCC
Confidence            3456677766666444332      1235899999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      |.......... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||.....   .....    ....
T Consensus       152 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~----~~~~  223 (266)
T cd05064         152 RRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIK----AVED  223 (266)
T ss_pred             cccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH----HHHC
Confidence            98765322211 11112234568999999999999999999999999999875 9999743211   11111    1111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +...         ..+......+.+++.+||+.+|.+||++++|++.|+.
T Consensus       224 ~~~~---------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         224 GFRL---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            1110         0111223457778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.92  E-value=1.1e-25  Score=226.39  Aligned_cols=185  Identities=29%  Similarity=0.435  Sum_probs=133.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|....+.     .....+++.+++.++.||+.||+|||+++   |+|+||||+||+++.++.++|+|||
T Consensus       115 ~lv~e~~~~~~L~~~i~~-----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         115 LVITEYCCYGDLLNFLRR-----KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             EEEEEcCCCCcHHHHHHh-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence            445566655655433322     11233899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......      .........+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~~~  260 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIKEG  260 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHHcC
Confidence            9886544322222223345678999999998889999999999999999998 88887432111      1111111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ...         .........+.+++.+||+.+|++||++.+|++.|+.
T Consensus       261 ~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         261 YRM---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             CcC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            100         0011123467789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.92  E-value=9.7e-26  Score=222.23  Aligned_cols=182  Identities=29%  Similarity=0.385  Sum_probs=132.4

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++..+.|....++      ....+++.++++++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++
T Consensus        83 v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          83 ITEYMENGSLDKFLRE------NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             EEEcCCCCCHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchh
Confidence            4555555555333322      1236899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      +...............++..|++||.+.+..++.++||||||+++|||++ |..||.....   ...    ......+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~  226 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDV----IKAVEDGYR  226 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHH----HHHHHcCCC
Confidence            87652222222222334578999999998889999999999999999998 8888732211   111    111111110


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .         ..+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus       227 ~---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 L---------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0         00112234577899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.92  E-value=1.5e-25  Score=228.17  Aligned_cols=177  Identities=25%  Similarity=0.344  Sum_probs=128.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|....++       ...+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus        72 ~lv~E~~~~~~L~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG  141 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQR-------QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG  141 (329)
T ss_pred             EEEEeCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCC
Confidence            445566666666433322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcC--cCcHHHHHHHhhhc
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH--GQSLLTYAWKLWCK  445 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~  445 (541)
                      +++......  .......|+..|+|||++.+..++.++||||||+++|||++|+.||.......  ......+.......
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~  219 (329)
T cd05618         142 MCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  219 (329)
T ss_pred             ccccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence            987532211  12233568999999999999999999999999999999999999985322211  11122222222222


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM  486 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~  486 (541)
                      ...      .+    +......+.+++.+||+.||++||++
T Consensus       220 ~~~------~~----p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         220 KQI------RI----PRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCC------CC----CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            111      11    11223456788899999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.91  E-value=1.4e-25  Score=228.41  Aligned_cols=175  Identities=20%  Similarity=0.242  Sum_probs=129.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.+...+.+       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        72 lv~Ey~~~g~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~  141 (328)
T cd05593          72 FVMEYVNGGELFFHLSR-------ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGL  141 (328)
T ss_pred             EEEeCCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcC
Confidence            44566666665433322       235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++......  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....      ..+...... ... 
T Consensus       142 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~------~~~~~~~~~-~~~-  211 (328)
T cd05593         142 CKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELIL-MED-  211 (328)
T ss_pred             CccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC------HHHHHHHhc-cCC-
Confidence            87532221  12223568999999999998899999999999999999999999984321      111111111 110 


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVVM  492 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~~  492 (541)
                           ..+..    .....+.+++.+||+.||++||     ++.++++.
T Consensus       212 -----~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         212 -----IKFPR----TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -----ccCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                 11111    1233566788899999999997     88998853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.91  E-value=1.7e-25  Score=227.84  Aligned_cols=182  Identities=24%  Similarity=0.333  Sum_probs=131.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.++.|....++       ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||
T Consensus        72 ~lv~e~~~~g~L~~~~~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg  141 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQR-------QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG  141 (329)
T ss_pred             EEEEeCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCc
Confidence            455667766666433322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcC--cCcHHHHHHHhhhc
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH--GQSLLTYAWKLWCK  445 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~  445 (541)
                      +++......  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......  ......+.......
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  219 (329)
T cd05588         142 MCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE  219 (329)
T ss_pred             cccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence            986422111  12234568999999999999899999999999999999999999986432211  11122222222222


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC------HHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN------MSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt------~~evl~  491 (541)
                      ...      .+..    .....+.+++.+||+.||.+||+      ++++++
T Consensus       220 ~~~------~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         220 KQI------RIPR----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCC------CCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            111      1111    12345677888999999999997      567764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.91  E-value=2.5e-25  Score=226.09  Aligned_cols=171  Identities=23%  Similarity=0.243  Sum_probs=126.7

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|...+++       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        72 ~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg  141 (323)
T cd05575          72 YFVLDYVNGGELFFHLQR-------ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG  141 (323)
T ss_pred             EEEEcCCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccC
Confidence            345666666666443322       335899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....      ..+...... .+.
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~-~~~  212 (323)
T cd05575         142 LCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNIL-NKP  212 (323)
T ss_pred             CCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHH-cCC
Confidence            987532211  12233568999999999999899999999999999999999999984321      111111111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS  487 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~  487 (541)
                      .      .+...    ....+.+++.+||+.||.+||++.
T Consensus       213 ~------~~~~~----~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 L------RLKPN----ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C------CCCCC----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence            0      11111    234577888899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.91  E-value=3.4e-25  Score=222.89  Aligned_cols=183  Identities=25%  Similarity=0.361  Sum_probs=132.9

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..|.+......      ....+++..++.++.|++.||+|||+++   |+|+||||+||+++.++.+||+|||+
T Consensus        85 ~v~e~~~~g~l~~~~~~------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          85 LVTQLMPHGCLLDYVHE------HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             eeehhcCCCCHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccc
Confidence            34456655555433321      1235889999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++...............++..|++||.+.+..++.++||||||+++|||++ |+.||....      . .........+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~------~-~~~~~~~~~~~  228 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP------T-REIPDLLEKGE  228 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC------H-HHHHHHHHCCC
Confidence            987643332222223345678999999988889999999999999999997 888874221      1 11111111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ...         ........+.+++..||..+|++||++.++++.|+..
T Consensus       229 ~~~---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         229 RLP---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             CCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            110         0111234577889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.91  E-value=1.4e-25  Score=220.30  Aligned_cols=164  Identities=23%  Similarity=0.348  Sum_probs=123.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCccc-ccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~a  392 (541)
                      ..+++.++++++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||+++.......... .....++..|+|
T Consensus        90 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  166 (257)
T cd05115          90 DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYA  166 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCC
Confidence            35899999999999999999999998   99999999999999999999999999876543322111 111223568999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++||+++ |+.||.....      .+ .......+...         ..+......+.++
T Consensus       167 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~-~~~~~~~~~~~---------~~~~~~~~~l~~l  230 (257)
T cd05115         167 PECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PE-VMSFIEQGKRL---------DCPAECPPEMYAL  230 (257)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HH-HHHHHHCCCCC---------CCCCCCCHHHHHH
Confidence            999988889999999999999999996 9988743211      11 11111121111         1112234567778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||++||++.+|.+.|+..
T Consensus       231 i~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         231 MKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHhhh
Confidence            8999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.91  E-value=6.2e-25  Score=216.91  Aligned_cols=165  Identities=24%  Similarity=0.385  Sum_probs=125.9

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++...............++..|++
T Consensus       107 ~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  183 (273)
T cd05035         107 PEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA  183 (273)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccC
Confidence            346899999999999999999999998   99999999999999999999999999886543332222222334678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||....   .....+..    ..+....         .+......+.++
T Consensus       184 pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~----~~~~~~~---------~~~~~~~~~~~l  247 (273)
T cd05035         184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYL----RHGNRLK---------QPEDCLDELYDL  247 (273)
T ss_pred             HhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HcCCCCC---------CCcCCCHHHHHH
Confidence            999988889999999999999999999 888874321   11111111    1111111         111234467889


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||++||++.+|++.|+..
T Consensus       248 i~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         248 MYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHhh
Confidence            9999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.91  E-value=3.3e-24  Score=204.47  Aligned_cols=207  Identities=24%  Similarity=0.250  Sum_probs=142.7

Q ss_pred             HHHHHHHHHH--HhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEE
Q 009186          286 IITTITLFIL--LGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI  363 (541)
Q Consensus       286 ~v~~v~~~~~--~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL  363 (541)
                      -|++||+|+.  +..+....         .+++...++.-+..|+++||+|||.+.   |+|||||++|+|+...|.+||
T Consensus       151 ~iy~VMe~~EhDLksl~d~m---------~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKi  218 (419)
T KOG0663|consen  151 KIYIVMEYVEHDLKSLMETM---------KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKI  218 (419)
T ss_pred             eeeeeHHHHHhhHHHHHHhc---------cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEe
Confidence            4788899875  33333322         246889999999999999999999999   999999999999999999999


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      +|||+|+.++.....  .+..+-|.+|+|||++.+.. |+...|+||+|||+.||+++++-|......   +.++.+.+.
T Consensus       219 aDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~---dQl~~If~l  293 (419)
T KOG0663|consen  219 ADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI---DQLDKIFKL  293 (419)
T ss_pred             cccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH---HHHHHHHHH
Confidence            999999988755322  23456799999999998765 999999999999999999999887432211   111111111


Q ss_pred             h--------h---cCCccccc------cccccCCCCHH-HHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 009186          443 W--------C---KGEALELM------DPVLKQTCVDA-ELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPT  504 (541)
Q Consensus       443 ~--------~---~~~~~~~~------~~~l~~~~~~~-~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~  504 (541)
                      .        .   .-.....+      -..++..+... ....-.+|+..+|..||.+|.|++|.++.  +...+.|.|.
T Consensus       294 lGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~  371 (419)
T KOG0663|consen  294 LGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPI  371 (419)
T ss_pred             hCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCC
Confidence            1        1   10000000      00011111110 12345567788999999999999987642  3344566666


Q ss_pred             CCCceec
Q 009186          505 QPAFSVD  511 (541)
Q Consensus       505 ~P~~~~~  511 (541)
                      .|.+...
T Consensus       372 ~P~~~Pt  378 (419)
T KOG0663|consen  372 DPSMFPT  378 (419)
T ss_pred             ChhhcCC
Confidence            6666543

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.91  E-value=1.6e-25  Score=226.59  Aligned_cols=166  Identities=30%  Similarity=0.416  Sum_probs=125.1

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.++++++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       128 ~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  204 (314)
T cd05099         128 EEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMA  204 (314)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccC
Confidence            356999999999999999999999998   99999999999999999999999999986543222211212234467999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||.....   ...    ......+...+         .+......+.++
T Consensus       205 PE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~l~~l  268 (314)
T cd05099         205 PEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL----FKLLREGHRMD---------KPSNCTHELYML  268 (314)
T ss_pred             HHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHHcCCCCC---------CCCCCCHHHHHH
Confidence            999998889999999999999999999 8888742211   111    11111111111         111223456788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +.+||+.||++||++.++++.|+...
T Consensus       269 i~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         269 MRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            89999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.91  E-value=2.1e-25  Score=226.37  Aligned_cols=170  Identities=26%  Similarity=0.347  Sum_probs=126.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|....++       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        72 ~iv~Ey~~~g~L~~~i~~-------~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG  141 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQK-------SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG  141 (320)
T ss_pred             EEEEcCCCCchHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCC
Confidence            445677766666443322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....      ..+. ...+..+.
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------~~~~-~~~i~~~~  212 (320)
T cd05590         142 MCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN------EDDL-FEAILNDE  212 (320)
T ss_pred             CCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC------HHHH-HHHHhcCC
Confidence            987532221  12233568999999999998889999999999999999999999985321      1111 11111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM  486 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~  486 (541)
                      ..      +.    ......+.+++.+||+.||++||++
T Consensus       213 ~~------~~----~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 VV------YP----TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CC------CC----CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            10      11    1123356778889999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.91  E-value=1.6e-24  Score=217.09  Aligned_cols=167  Identities=18%  Similarity=0.193  Sum_probs=122.9

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc-----ccccccccCCCC
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-----ANTNRVAGTYGY  390 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y  390 (541)
                      .++..+..|+.|++.||+|||+.+   |+||||||+|||++.++.++|+|||+++.+......     .......||+.|
T Consensus       123 ~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y  199 (294)
T PHA02882        123 KNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYY  199 (294)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccc
Confidence            467888999999999999999998   999999999999999999999999999876432211     112234689999


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +|||...+..++.++|||||||++|||++|+.||......  ..........+..    .+....+..   ......+.+
T Consensus       200 ~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~---~~~~~~~~~  270 (294)
T PHA02882        200 AGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--GNLIHAAKCDFIK----RLHEGKIKI---KNANKFIYD  270 (294)
T ss_pred             cCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--hHHHHHhHHHHHH----Hhhhhhhcc---CCCCHHHHH
Confidence            9999999999999999999999999999999998643211  1111111110000    000000000   011345777


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHh
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      ++..||+.+|++||++.+|++.|+
T Consensus       271 ~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        271 FIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHHhCCCCCCCCHHHHHHhhC
Confidence            888999999999999999998763

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.5e-25  Score=222.65  Aligned_cols=172  Identities=23%  Similarity=0.255  Sum_probs=128.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.|....++       ...+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        78 lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~  147 (291)
T cd05612          78 MLMEYVPGGELFSYLRN-------SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGF  147 (291)
T ss_pred             EEEeCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCc
Confidence            34566666655443322       235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++.....     .....|++.|+|||.+.+..++.++|||||||++|||++|+.||....      ..+..... ..+..
T Consensus       148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~~~~~~i-~~~~~  215 (291)
T cd05612         148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN------PFGIYEKI-LAGKL  215 (291)
T ss_pred             chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH-HhCCc
Confidence            8765322     123468899999999998889999999999999999999999984321      11111111 11110


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-----MSSVVVM  492 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~evl~~  492 (541)
                            .+    +......+.+++.+||+.||.+||+     ++++++.
T Consensus       216 ------~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 ------EF----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ------CC----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                  01    1111335677888999999999995     8887753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.91  E-value=1.2e-25  Score=220.91  Aligned_cols=182  Identities=29%  Similarity=0.451  Sum_probs=131.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+...+++     .....+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+
T Consensus        78 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~  149 (261)
T cd05072          78 IITEYMAKGSLLDFLKS-----DEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGL  149 (261)
T ss_pred             EEEecCCCCcHHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCcc
Confidence            33445545555333322     12346889999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   .....    .+....
T Consensus       150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~----~~~~~~  221 (261)
T cd05072         150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMS----ALQRGY  221 (261)
T ss_pred             ceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHH----HHHcCC
Confidence            9875433221 1122345678999999988889999999999999999998 8888743211   11111    111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..    + .    .......+.+++.+||+.+|++||+++++.+.|+.
T Consensus       222 ~~----~-~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 RM----P-R----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CC----C-C----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            10    0 0    11123457788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-24  Score=209.26  Aligned_cols=188  Identities=26%  Similarity=0.305  Sum_probs=131.7

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ++.|+.....-++.||++||+|+|+.+   |+||||||+|++++.+-.+||+|||+++...........+..+-|.+|+|
T Consensus       119 ~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRA  195 (359)
T KOG0660|consen  119 QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRA  195 (359)
T ss_pred             CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecC
Confidence            445999999999999999999999999   99999999999999999999999999998765422222244677999999


Q ss_pred             hhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHH--------HHhhhcCCcccccc---ccccCC-
Q 009186          393 PEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA--------WKLWCKGEALELMD---PVLKQT-  459 (541)
Q Consensus       393 PE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~~l~~~-  459 (541)
                      ||++.. ..|+.+.||||.|||+.||++|++-|......+...++...        ...+........+.   ..-+.. 
T Consensus       196 PElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f  275 (359)
T KOG0660|consen  196 PELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPF  275 (359)
T ss_pred             HHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCH
Confidence            998865 56999999999999999999999988654322221111110        00111000000010   000000 


Q ss_pred             --CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcCCCCCCCC
Q 009186          460 --CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASDTATLPPP  503 (541)
Q Consensus       460 --~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~l~~p  503 (541)
                        .-+......++|+.+||..||.+|+|++|.++  .|+.......+|
T Consensus       276 ~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  276 SSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence              00112335678888999999999999999996  556555444444

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.91  E-value=4e-25  Score=221.05  Aligned_cols=166  Identities=31%  Similarity=0.379  Sum_probs=126.5

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ....+++..+++++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+
T Consensus       125 ~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~  201 (293)
T cd05053         125 PEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWM  201 (293)
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCcccc
Confidence            3456999999999999999999999998   9999999999999999999999999998654332222222233456799


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||.+.+..++.++||||||+++|||++ |..||.....      . ........+...         ..+......+.+
T Consensus       202 aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~-~~~~~~~~~~~~---------~~~~~~~~~~~~  265 (293)
T cd05053         202 APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------E-ELFKLLKEGYRM---------EKPQNCTQELYH  265 (293)
T ss_pred             CHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH------H-HHHHHHHcCCcC---------CCCCCCCHHHHH
Confidence            9999988889999999999999999997 8888642211      1 111111111111         111122446778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ++.+||+.||++|||+.+|++.|++.
T Consensus       266 li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         266 LMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHcccCcccCcCHHHHHHHHHHh
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=3e-24  Score=226.74  Aligned_cols=107  Identities=25%  Similarity=0.402  Sum_probs=94.0

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...............||..|+|||
T Consensus       256 ~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE  332 (461)
T PHA03211        256 PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPE  332 (461)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHH
Confidence            5899999999999999999999999   9999999999999999999999999998654333222223456899999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNS  424 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~  424 (541)
                      ++.+..++.++|||||||++|||++|..++
T Consensus       333 ~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        333 VLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             HHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            999999999999999999999999987653

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.91  E-value=1.9e-24  Score=220.66  Aligned_cols=172  Identities=23%  Similarity=0.268  Sum_probs=120.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc-ccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~a  392 (541)
                      ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++........ .......|+..|+|
T Consensus        98 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~a  174 (338)
T cd07859          98 DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA  174 (338)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCC
Confidence            35899999999999999999999999   999999999999999999999999998754322211 11223568999999


Q ss_pred             hhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH-----------hhhcCCcccc---ccccc
Q 009186          393 PEYAME--GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK-----------LWCKGEALEL---MDPVL  456 (541)
Q Consensus       393 PE~l~~--~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~---~~~~l  456 (541)
                      ||++.+  ..++.++|||||||++|||++|+.||.......   .......           .+......+.   +.+..
T Consensus       175 PE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  251 (338)
T cd07859         175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQ  251 (338)
T ss_pred             HHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccC
Confidence            999875  578999999999999999999999985322110   0000000           0000000000   00000


Q ss_pred             cCCC---CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          457 KQTC---VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       457 ~~~~---~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ....   .+.....+.+++.+||+.||++||+++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         252 PVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             CCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000   0011234678999999999999999999995

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.91  E-value=2.8e-25  Score=226.46  Aligned_cols=125  Identities=28%  Similarity=0.416  Sum_probs=103.1

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.|...+++       ...+++..+..++.|++.||.|||+++  .|+||||||+||+++.++.+||+|||+
T Consensus        80 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          80 ICMEHMDGGSLDQVLKE-------AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             EEeecCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence            45677766666444332       235899999999999999999999853  299999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      +.......    .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       151 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         151 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             cccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            87653221    2234689999999999988899999999999999999999999853

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.91  E-value=2.1e-25  Score=226.77  Aligned_cols=173  Identities=23%  Similarity=0.261  Sum_probs=127.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.+...+.+       ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        73 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~  142 (325)
T cd05604          73 FVLDFVNGGELFFHLQR-------ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGL  142 (325)
T ss_pred             EEEcCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCC
Confidence            44566666655433322       345899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++......  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||....      ..+..... .....
T Consensus       143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~~-~~~~~  213 (325)
T cd05604         143 CKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD------VAEMYDNI-LHKPL  213 (325)
T ss_pred             cccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC------HHHHHHHH-HcCCc
Confidence            87532211  12234568999999999999999999999999999999999999984321      11111111 11111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV  490 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl  490 (541)
                            .+..    .....+.+++.+||+.||.+||++.+.+
T Consensus       214 ------~~~~----~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         214 ------VLRP----GASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ------cCCC----CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                  0111    1234566788899999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.91  E-value=2.1e-24  Score=216.06  Aligned_cols=171  Identities=26%  Similarity=0.374  Sum_probs=125.6

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||+++...............++..|+|
T Consensus       124 ~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  200 (296)
T cd05051         124 SKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMA  200 (296)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecC
Confidence            346899999999999999999999998   99999999999999999999999999876543332222333456778999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      ||.+.+..++.++||||||+++|||++  +..||....   ...........+.........      ..+......+.+
T Consensus       201 PE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~  271 (296)
T cd05051         201 WESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYE  271 (296)
T ss_pred             HHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC---hHHHHHHHHhccccccccccC------CCccCCCHHHHH
Confidence            999988889999999999999999998  556653211   111122111111111111100      111122356888


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ++.+||+.||++||++.+|++.|+.
T Consensus       272 li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         272 LMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHHhccChhcCCCHHHHHHHhcC
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.91  E-value=9.7e-25  Score=221.81  Aligned_cols=174  Identities=24%  Similarity=0.280  Sum_probs=127.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.++.+....+        ...+++.+++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        78 ~lv~E~~~~~~L~~~~~--------~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05589          78 CFVMEYAAGGDLMMHIH--------TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFG  146 (324)
T ss_pred             EEEEcCCCCCcHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCccc
Confidence            44556666666543332        235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....      .+.... +..+.
T Consensus       147 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~-i~~~~  217 (324)
T cd05589         147 LCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDS-IVNDE  217 (324)
T ss_pred             CCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhCC
Confidence            986432221  122345689999999999998999999999999999999999999853211      111111 11111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                      .      ....    .....+.+++.+||+.||.+||     ++.++++
T Consensus       218 ~------~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 V------RYPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             C------CCCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            1      1111    1234566788899999999999     5666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.91  E-value=3e-25  Score=224.79  Aligned_cols=174  Identities=26%  Similarity=0.330  Sum_probs=127.1

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|....++       ...+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus        72 ~lv~E~~~~g~L~~~i~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQD-------KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFG  141 (316)
T ss_pred             EEEECCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccC
Confidence            345566666665433322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....   ....    ........
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~----~~~~~~~~  212 (316)
T cd05620         142 MCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDEL----FESIRVDT  212 (316)
T ss_pred             CCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHH----HHHHHhCC
Confidence            986432111  12234568999999999999999999999999999999999999985321   1111    11111110


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS-SVV  490 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-evl  490 (541)
                            +.+..    .....+.+++.+||+.||++||++. +++
T Consensus       213 ------~~~~~----~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 ------PHYPR----WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ------CCCCC----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                  11111    1223566788899999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.91  E-value=3.2e-25  Score=217.80  Aligned_cols=162  Identities=28%  Similarity=0.454  Sum_probs=123.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++..+....... .....++..|+||
T Consensus        97 ~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aP  172 (260)
T cd05070          97 RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAP  172 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc-ccCCCCCccccCh
Confidence            45899999999999999999999998   9999999999999999999999999997654332111 1122345679999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||....      ..+... .+..+..         ...+......+.+++
T Consensus       173 E~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------~~~~~~-~~~~~~~---------~~~~~~~~~~~~~li  236 (260)
T cd05070         173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN------NREVLE-QVERGYR---------MPCPQDCPISLHELM  236 (260)
T ss_pred             HHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC------HHHHHH-HHHcCCC---------CCCCCcCCHHHHHHH
Confidence            99988889999999999999999999 888874321      111111 1111110         011122345678899


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhc
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .+||+.+|++|||+.++.+.|+.
T Consensus       237 ~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         237 LQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.91  E-value=1.6e-25  Score=225.67  Aligned_cols=165  Identities=30%  Similarity=0.395  Sum_probs=123.9

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.++++++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||.++...............++..|+|
T Consensus       134 ~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~a  210 (307)
T cd05098         134 EEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA  210 (307)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeC
Confidence            346999999999999999999999998   99999999999999999999999999876543221111112234467999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||....      . +............+         .+......+.++
T Consensus       211 PE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------~-~~~~~~~~~~~~~~---------~~~~~~~~~~~l  274 (307)
T cd05098         211 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V-EELFKLLKEGHRMD---------KPSNCTNELYMM  274 (307)
T ss_pred             hHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------H-HHHHHHHHcCCCCC---------CCCcCCHHHHHH
Confidence            999998889999999999999999998 788864211      1 11111111111111         111223466778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.+|++||++.+|++.|+..
T Consensus       275 i~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         275 MRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHHcccChhhCcCHHHHHHHHHHH
Confidence            8999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.91  E-value=4.9e-25  Score=222.98  Aligned_cols=111  Identities=30%  Similarity=0.489  Sum_probs=93.5

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE----cCCCCcEEecccccccccCCCCc-ccccccccC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL----DHEMNPKISDFGMARIFSGNQNE-ANTNRVAGT  387 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll----~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt  387 (541)
                      ...+++..+..++.||+.||.|||+.+   |+||||||+||++    +.++.+||+|||+++.+...... .......++
T Consensus       102 ~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t  178 (317)
T cd07867         102 PMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT  178 (317)
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceec
Confidence            446899999999999999999999999   9999999999999    56678999999999876443221 122335678


Q ss_pred             CCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          388 YGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       388 ~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      ..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       179 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            999999998764 578999999999999999999999853

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.91  E-value=3.4e-25  Score=225.16  Aligned_cols=170  Identities=25%  Similarity=0.305  Sum_probs=125.5

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|....++       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~E~~~~g~L~~~~~~-------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQ-------VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             EEEEcCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecC
Confidence            445677666666443322       235889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|+..|+|||++.+..++.++|||||||++|||++|+.||....      ..+..... ....
T Consensus       147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~------~~~~~~~i-~~~~  217 (324)
T cd05587         147 MCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED------EDELFQSI-MEHN  217 (324)
T ss_pred             cceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHH-HcCC
Confidence            986432111  12223568999999999999899999999999999999999999985321      11111111 1111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM  486 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~  486 (541)
                            ..+..    .....+.+++.+||+.||.+|++.
T Consensus       218 ------~~~~~----~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 ------VSYPK----SLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ------CCCCC----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence                  01111    123456778889999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.6e-25  Score=226.94  Aligned_cols=181  Identities=22%  Similarity=0.235  Sum_probs=131.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.++.|...+++       ...+++.++..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        77 ~lv~e~~~g~~L~~~l~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN-------LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCc
Confidence            455666666666444322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++.....     ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......   ...... ..+.  .
T Consensus       147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i-~~~~--~  215 (333)
T cd05600         147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWENL-KYWK--E  215 (333)
T ss_pred             CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HHHHHH-Hhcc--c
Confidence            9876433     223456899999999999889999999999999999999999998532211   111110 1110  0


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ...  .+.. ..........+.+++.+||+.+|.+||++.++++.
T Consensus       216 ~~~--~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         216 TLQ--RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccc--CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000  0000 00001223456778889999999999999999964

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.91  E-value=2e-25  Score=218.73  Aligned_cols=160  Identities=27%  Similarity=0.374  Sum_probs=120.9

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++........ ......++..|+|||
T Consensus        96 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe  171 (256)
T cd05059          96 KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPE  171 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHH
Confidence            5899999999999999999999999   999999999999999999999999998765322211 111122345799999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+.+..++.++||||||+++|||++ |+.||.....      .+.... ...+.     ...    .+......+.+++.
T Consensus       172 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~-~~~~~-----~~~----~~~~~~~~~~~li~  235 (256)
T cd05059         172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN------SEVVES-VSAGY-----RLY----RPKLAPTEVYTIMY  235 (256)
T ss_pred             HhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH-HHcCC-----cCC----CCCCCCHHHHHHHH
Confidence            9998889999999999999999999 7888743211      111111 11111     000    11123446778999


Q ss_pred             hhcccCCCCCCCHHHHHHHHh
Q 009186          474 LCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~  494 (541)
                      +||+.+|++||++.++++.|.
T Consensus       236 ~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         236 SCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             HHhcCChhhCcCHHHHHHHhC
Confidence            999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.91  E-value=1.3e-24  Score=223.76  Aligned_cols=169  Identities=21%  Similarity=0.230  Sum_probs=121.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++......   ......++..|+|||
T Consensus       115 ~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE  188 (355)
T cd07874         115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE  188 (355)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHH
Confidence            3788999999999999999999999   9999999999999999999999999997643221   122346889999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH------------------hhhcC--Ccccc---
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK------------------LWCKG--EALEL---  451 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~------------------~~~~~--~~~~~---  451 (541)
                      .+.+..++.++|||||||++|||++|+.||.......   .......                  .+...  .....   
T Consensus       189 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (355)
T cd07874         189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP  265 (355)
T ss_pred             HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccch
Confidence            9998889999999999999999999999985322110   0000000                  00000  00000   


Q ss_pred             --cccc-cc--CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          452 --MDPV-LK--QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       452 --~~~~-l~--~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                        .... ..  ..........+.+++.+||+.||++|||+.|+++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence              0000 00  00111123456789999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.91  E-value=2.8e-25  Score=225.45  Aligned_cols=176  Identities=23%  Similarity=0.284  Sum_probs=129.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|....++       ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||
T Consensus        72 ~lv~E~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg  141 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQR-------SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFG  141 (321)
T ss_pred             EEEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecc
Confidence            345566666666433322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++.......  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....      ..+..... ..+.
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~------~~~~~~~i-~~~~  212 (321)
T cd05591         142 MCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN------EDDLFESI-LHDD  212 (321)
T ss_pred             cceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC------HHHHHHHH-HcCC
Confidence            9875322221  1223568999999999998899999999999999999999999985322      11111111 1111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-------CHHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-------NMSSVVVM  492 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-------t~~evl~~  492 (541)
                      .   .   ..    ......+.+++.+||+.||++||       ++.++++.
T Consensus       213 ~---~---~p----~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 V---L---YP----VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             C---C---CC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            1   0   01    11124567788899999999999       78888753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.91  E-value=9.9e-25  Score=216.92  Aligned_cols=162  Identities=29%  Similarity=0.391  Sum_probs=122.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.||+.||+|||+.+   |+|+||||+||++++++.+||+|||++................++..|+||
T Consensus       117 ~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05092         117 GQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  193 (280)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCH
Confidence            46899999999999999999999999   999999999999999999999999998755433222222233456789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||.....   .....   . ...+....     .    +......+.+++
T Consensus       194 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~---~-~~~~~~~~-----~----~~~~~~~~~~li  257 (280)
T cd05092         194 ESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIE---C-ITQGRELE-----R----PRTCPPEVYAIM  257 (280)
T ss_pred             HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHH---H-HHcCccCC-----C----CCCCCHHHHHHH
Confidence            99998899999999999999999998 8888742111   11111   1 11111110     0    111223466888


Q ss_pred             hhhcccCCCCCCCHHHHHHHHh
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      .+||+.||++||++.+|++.|+
T Consensus       258 ~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         258 QGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHccCChhhCCCHHHHHHHHh
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.91  E-value=1e-24  Score=217.90  Aligned_cols=170  Identities=20%  Similarity=0.253  Sum_probs=119.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......  ......++..|+||
T Consensus        98 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aP  172 (288)
T cd07871          98 NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPP  172 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccCh
Confidence            35789999999999999999999999   99999999999999999999999999876432221  12234578899999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh--------hc----CCccccccccccCC-
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW--------CK----GEALELMDPVLKQT-  459 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~----~~~~~~~~~~l~~~-  459 (541)
                      |.+.+ ..++.++||||||+++|||++|+.||......   ..+.......        ..    .+......+..... 
T Consensus       173 E~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (288)
T cd07871         173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK---EELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQP  249 (288)
T ss_pred             HHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCc
Confidence            98875 45899999999999999999999998533211   1111111110        00    00001111110000 


Q ss_pred             ---CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          460 ---CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       460 ---~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                         ..+.....+++++.+||+.||.+|||++|+++
T Consensus       250 ~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         250 LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               00111245678999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.91  E-value=3.7e-25  Score=223.17  Aligned_cols=181  Identities=19%  Similarity=0.222  Sum_probs=132.9

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      -++++|||+.+|.+.-.+.+       ...|++..+..++.+++.||+-||+.|   +|||||||+|+|||..|++||+|
T Consensus       215 ~LYLiMEylPGGD~mTLL~~-------~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMR-------KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             eeEEEEEecCCccHHHHHHh-------cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecc
Confidence            46788999999988554433       346999999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCC----------------------CCc-----cc------------------ccccccCCCCCChhhhccCC
Q 009186          366 FGMARIFSGN----------------------QNE-----AN------------------TNRVAGTYGYMAPEYAMEGV  400 (541)
Q Consensus       366 fg~a~~~~~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~l~~~~  400 (541)
                      ||++.-+...                      ...     ..                  ....+||+.|+|||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            9997432110                      000     00                  12257999999999999999


Q ss_pred             CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC-ccccccccccCCCCHHHHHHHHHHHhhhcccC
Q 009186          401 FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE-ALELMDPVLKQTCVDAELLKCIHIGLLCVQED  479 (541)
Q Consensus       401 ~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~d  479 (541)
                      |+...|.||||||+|||+.|.+||....+..       .|+.+.... .+..       ........+..+||.+|+. |
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~-------T~rkI~nwr~~l~f-------P~~~~~s~eA~DLI~rll~-d  429 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQE-------TYRKIVNWRETLKF-------PEEVDLSDEAKDLITRLLC-D  429 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHHHhhhccC-------CCcCcccHHHHHHHHHHhc-C
Confidence            9999999999999999999999996443321       111111110 1111       0111122556778888888 9


Q ss_pred             CCCCCC---HHHHHH
Q 009186          480 PAHRPN---MSSVVV  491 (541)
Q Consensus       480 P~~RPt---~~evl~  491 (541)
                      |++|--   ++||.+
T Consensus       430 ~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  430 PENRLGSKGAEEIKK  444 (550)
T ss_pred             HHHhcCcccHHHHhc
Confidence            999975   566554

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.91  E-value=1.4e-25  Score=228.11  Aligned_cols=176  Identities=22%  Similarity=0.279  Sum_probs=129.0

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++|++|+..+.|...+.+       ...+++.++..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+||
T Consensus        71 ~lv~E~~~~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Df  140 (325)
T cd05594          71 CFVMEYANGGELFFHLSR-------ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDF  140 (325)
T ss_pred             EEEEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecC
Confidence            445677766666433322       2358999999999999999999997 67   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.......  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....   ....    ......
T Consensus       141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~----~~i~~~  211 (325)
T cd05594         141 GLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLF----ELILME  211 (325)
T ss_pred             CCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHH----HHHhcC
Confidence            99875322211  12235689999999999998999999999999999999999999843211   1111    111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVVM  492 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~~  492 (541)
                      .      ..+...    ....+.+++.+||+.||++|+     ++.++++.
T Consensus       212 ~------~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 E------IRFPRT----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             C------CCCCCC----CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            1      011111    223466788899999999996     89998853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.91  E-value=3.8e-25  Score=217.29  Aligned_cols=182  Identities=28%  Similarity=0.476  Sum_probs=131.8

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+....++     .....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus        77 ~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~  148 (260)
T cd05069          77 IVTEFMGKGSLLDFLKE-----GDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGL  148 (260)
T ss_pred             EEEEcCCCCCHHHHHhh-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCcc
Confidence            44455555555433322     12345899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +......... ......++..|++||...+..++.++||||||+++|||++ |+.||.....   ...    ........
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~----~~~~~~~~  220 (260)
T cd05069         149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REV----LEQVERGY  220 (260)
T ss_pred             ceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHHcCC
Confidence            9765433211 1112345678999999988889999999999999999999 8888743211   111    11111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..         ..+......+.+++.+||+.||++||++++|++.|+.
T Consensus       221 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 RM---------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CC---------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            00         0111223567788899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.91  E-value=1.9e-25  Score=222.32  Aligned_cols=190  Identities=25%  Similarity=0.364  Sum_probs=130.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.|...+.+      .+..+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~------~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          84 LVMEYLPYGSLRDYLQK------HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             EEEEecCCCCHHHHHHh------cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcc
Confidence            34455555555433321      1235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc-cccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcC------c---CcHHHH
Q 009186          369 ARIFSGNQNEA-NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH------G---QSLLTY  438 (541)
Q Consensus       369 a~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~------~---~~~~~~  438 (541)
                      ++......... ......++..|+|||.+.+..++.++||||||+++|||++|..++.......      .   ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence            98654332211 1111223446999999988889999999999999999999877643211000      0   000000


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ........         ............+.+++.+||+.+|++|||+.+|++.|+..
T Consensus       235 ~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000000         00011112234677899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.91  E-value=2.6e-25  Score=223.11  Aligned_cols=164  Identities=28%  Similarity=0.360  Sum_probs=122.3

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++......   ........+..|++
T Consensus       113 ~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~a  186 (297)
T cd05089         113 ASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMA  186 (297)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccC
Confidence            346999999999999999999999998   999999999999999999999999998642211   11111223457999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+....++.++||||||+++|||++ |+.||.....   ...    ......+.     ....    +......+.++
T Consensus       187 PE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~----~~~~~~~~-----~~~~----~~~~~~~~~~l  250 (297)
T cd05089         187 IESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AEL----YEKLPQGY-----RMEK----PRNCDDEVYEL  250 (297)
T ss_pred             chhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHhcCC-----CCCC----CCCCCHHHHHH
Confidence            999988889999999999999999997 9988743211   111    11111110     0011    11123456788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDTA  498 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~~  498 (541)
                      +.+||+.+|.+||++++|++.|+....
T Consensus       251 i~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         251 MRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.91  E-value=2.6e-25  Score=218.10  Aligned_cols=160  Identities=26%  Similarity=0.384  Sum_probs=121.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||.++........ ......++..|++||
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe  171 (256)
T cd05113          96 RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPE  171 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHH
Confidence            5899999999999999999999999   999999999999999999999999998765432211 111223567799999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+.+..++.++||||||+++|||++ |+.||......   ..    ......+....         ........+.+++.
T Consensus       172 ~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~~~~~li~  235 (256)
T cd05113         172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ET----VEKVSQGLRLY---------RPHLASEKVYAIMY  235 (256)
T ss_pred             HHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HH----HHHHhcCCCCC---------CCCCCCHHHHHHHH
Confidence            9988889999999999999999998 88887432211   11    11111111110         01112356788999


Q ss_pred             hhcccCCCCCCCHHHHHHHHh
Q 009186          474 LCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~  494 (541)
                      +||+.||.+||++.+|++.|+
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHcCCCcccCCCHHHHHHhhC
Confidence            999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=4.9e-25  Score=216.10  Aligned_cols=163  Identities=31%  Similarity=0.442  Sum_probs=124.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCccc-ccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aP  393 (541)
                      .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.......... .....++..|+||
T Consensus        91 ~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aP  167 (257)
T cd05060          91 EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP  167 (257)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCH
Confidence            5899999999999999999999998   99999999999999999999999999886643332211 1112234679999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||....   .......    ........         .+......+.+++
T Consensus       168 E~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~~~----~~~~~~~~---------~~~~~~~~l~~li  231 (257)
T cd05060         168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVIAM----LESGERLP---------RPEECPQEIYSIM  231 (257)
T ss_pred             HHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHHHH----HHcCCcCC---------CCCCCCHHHHHHH
Confidence            99988889999999999999999998 999974321   1111111    11111110         1111234677899


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.+|++||++.+|++.|++.
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         232 LSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             HHHhcCChhhCcCHHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=5.6e-25  Score=226.45  Aligned_cols=184  Identities=26%  Similarity=0.297  Sum_probs=149.2

Q ss_pred             hhHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEE
Q 009186          284 GTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI  363 (541)
Q Consensus       284 ~~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL  363 (541)
                      .-.+.+|+|++.+|+|+.++++.     ++..|.......++.||+.|+.||..++   +|||||..+||||-..-.+||
T Consensus       182 ~qp~mMV~ELaplGSLldrLrka-----~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI  253 (1039)
T KOG0199|consen  182 DQPAMMVFELAPLGSLLDRLRKA-----KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKI  253 (1039)
T ss_pred             cchhhHHhhhcccchHHHHHhhc-----cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeee
Confidence            35788999999999999999762     3446888999999999999999999998   999999999999999989999


Q ss_pred             ecccccccccCCCCccc-ccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHH
Q 009186          364 SDFGMARIFSGNQNEAN-TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      +|||+.+.++.+..... .....-.+.|+|||.+++..++.++|||+|||+||||++ |+.||..      ..       
T Consensus       254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G------~~-------  320 (1039)
T KOG0199|consen  254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG------CR-------  320 (1039)
T ss_pred             ecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC------CC-------
Confidence            99999998876654432 333345678999999999999999999999999999999 6667521      11       


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                         ...+++.+|..-+-..+....++++++++.||..+|++|||+..|.+
T Consensus       321 ---g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  321 ---GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             ---HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence               11233344433333345567889999999999999999999999974

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.91  E-value=3.1e-25  Score=225.98  Aligned_cols=172  Identities=23%  Similarity=0.247  Sum_probs=128.5

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.|...+++       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        94 ~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRK-------AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             EEEEcCCCCChHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeecc
Confidence            445666666666444432       235889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......     ....|++.|+|||.+.+..++.++|||||||++|||++|+.||....      ..+. ......+.
T Consensus       164 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~-~~~i~~~~  231 (329)
T PTZ00263        164 FAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT------PFRI-YEKILAGR  231 (329)
T ss_pred             CceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC------HHHH-HHHHhcCC
Confidence            998653321     23468999999999999889999999999999999999999984221      1111 11111211


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~evl~  491 (541)
                      ..      +..    .....+.+++.+||+.||.+||+     +++++.
T Consensus       232 ~~------~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        232 LK------FPN----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             cC------CCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            10      111    11234667888999999999997     677764

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.91  E-value=2.1e-25  Score=218.56  Aligned_cols=181  Identities=26%  Similarity=0.406  Sum_probs=130.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.+....++      ....+++..++.++.|++.||+|||+++   |+|+||||+||+++.++.+||+|||
T Consensus        75 ~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g  145 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQ------RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFG  145 (256)
T ss_pred             EEEEEcCCCCcHHHHHHh------CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCC
Confidence            344556655655433322      1135899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      .++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....   ........    ..+
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i----~~~  217 (256)
T cd05114         146 MTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMI----SRG  217 (256)
T ss_pred             CccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH----HCC
Confidence            98765332211 1112234567999999988889999999999999999999 888874221   11111111    111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      ...  ..+       ......+.+++.+||+.+|++||++.++++.|.
T Consensus       218 ~~~--~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         218 FRL--YRP-------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCC--CCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            110  011       112345778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.91  E-value=1.1e-24  Score=216.78  Aligned_cols=164  Identities=29%  Similarity=0.416  Sum_probs=124.5

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+.+.++.|++.||+|||+++   |+|+||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       118 ~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  194 (283)
T cd05090         118 KSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMP  194 (283)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecC
Confidence            345899999999999999999999998   99999999999999999999999999976543332222233345678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||....   .....+    .........     .    +......+.++
T Consensus       195 PE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~----~~~~~~~~~-----~----~~~~~~~~~~l  258 (283)
T cd05090         195 PEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIE----MVRKRQLLP-----C----SEDCPPRMYSL  258 (283)
T ss_pred             hHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHH----HHHcCCcCC-----C----CCCCCHHHHHH
Confidence            999988889999999999999999998 888874221   111111    111111111     1    11123456778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.||++||++.+|+++|..
T Consensus       259 i~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         259 MTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcccCcccCcCHHHHHHHhhc
Confidence            889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.91  E-value=4.9e-25  Score=223.41  Aligned_cols=175  Identities=26%  Similarity=0.287  Sum_probs=129.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.++.|....++       ...+++.++..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        72 ~lv~e~~~~~~L~~~~~~-------~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg  141 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQR-------SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFG  141 (318)
T ss_pred             EEEEcCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccC
Confidence            345566666666433322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....      ..+. ........
T Consensus       142 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~------~~~~-~~~i~~~~  212 (318)
T cd05570         142 MCKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD------EDEL-FQSILEDE  212 (318)
T ss_pred             CCeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC------HHHH-HHHHHcCC
Confidence            986432211  11223468899999999999999999999999999999999999985321      1111 11111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH-----HHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM-----SSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~-----~evl~  491 (541)
                      .      .+.    ......+.+++.+||+.||.+||++     .++++
T Consensus       213 ~------~~~----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         213 V------RYP----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             C------CCC----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            1      111    1123456788899999999999999     88775

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.91  E-value=2e-24  Score=215.30  Aligned_cols=169  Identities=24%  Similarity=0.296  Sum_probs=121.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......   .....++..|+||
T Consensus       103 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aP  176 (288)
T cd07863         103 PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAP  176 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCc
Confidence            34899999999999999999999999   99999999999999999999999999876543221   2234578899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc---CCcc-------cccccccc---CCC
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK---GEAL-------ELMDPVLK---QTC  460 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~-------~~~~~~l~---~~~  460 (541)
                      |.+.+..++.++|||||||++|||++|++||......   ............   ..+.       ....+...   ...
T Consensus       177 E~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (288)
T cd07863         177 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSV  253 (288)
T ss_pred             hHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH---HHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHh
Confidence            9999888999999999999999999999997432211   111111111000   0000       00000000   001


Q ss_pred             CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          461 VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       461 ~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+.....+.+++.+||+.||++|||+.+++.
T Consensus       254 ~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         254 VPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1122345678999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.91  E-value=6.7e-25  Score=225.72  Aligned_cols=159  Identities=26%  Similarity=0.402  Sum_probs=116.6

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      +++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.....  ......|+..|+|||.
T Consensus       165 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~  239 (353)
T PLN00034        165 ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPER  239 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccc
Confidence            567788899999999999999999   99999999999999999999999999886543221  1223568999999998


Q ss_pred             hcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          396 AME-----GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       396 l~~-----~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +..     ...+.++|||||||++|||++|+.||.......   ......... ....         ..........+.+
T Consensus       240 ~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~-~~~~---------~~~~~~~~~~l~~  306 (353)
T PLN00034        240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAIC-MSQP---------PEAPATASREFRH  306 (353)
T ss_pred             cccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHh-ccCC---------CCCCCccCHHHHH
Confidence            743     224568999999999999999999986221111   111111100 0000         0111123346778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHH
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ++.+||+.||++||++.||++.
T Consensus       307 li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        307 FISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHHHccCChhhCcCHHHHhcC
Confidence            8899999999999999999863

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.91  E-value=6.2e-25  Score=222.94  Aligned_cols=171  Identities=19%  Similarity=0.222  Sum_probs=125.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.+...+++       ...+++.++..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        72 ~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg  141 (321)
T cd05603          72 YFVLDYVNGGELFFHLQR-------ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG  141 (321)
T ss_pred             EEEEcCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCC
Confidence            345666666665433322       235888999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....      ..+...... ...
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~-~~~  212 (321)
T cd05603         142 LCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNIL-HKP  212 (321)
T ss_pred             CCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHh-cCC
Confidence            987532211  12234568999999999998889999999999999999999999984321      111111111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS  487 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~  487 (541)
                      .          ..+......+.+++.+||+.||.+||+..
T Consensus       213 ~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 L----------QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             C----------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            0          11112234577888999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.91  E-value=2.7e-25  Score=217.82  Aligned_cols=178  Identities=29%  Similarity=0.342  Sum_probs=129.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+....++     .+...+++..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        77 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~  148 (256)
T cd05082          77 IVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGL  148 (256)
T ss_pred             EEEECCCCCcHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCcc
Confidence            44555555555433322     12335899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++......     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....      ..+.. .....+.
T Consensus       149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~-~~~~~~~  216 (256)
T cd05082         149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVV-PRVEKGY  216 (256)
T ss_pred             ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHH-HHHhcCC
Confidence            87543221     12234567999999988889999999999999999997 888874221      11111 1111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..         .........+.+++.+||+.+|++|||+.++++.|+.
T Consensus       217 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         217 KM---------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            11         1111223457788899999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.91  E-value=3.8e-25  Score=224.72  Aligned_cols=174  Identities=24%  Similarity=0.273  Sum_probs=127.9

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.|....++       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        77 lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  146 (323)
T cd05584          77 LILEYLSGGELFMHLER-------EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGL  146 (323)
T ss_pred             EEEeCCCCchHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcC
Confidence            44556555555433322       235788899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++.......  ......|+..|+|||++.+..++.++||||||+++|||++|+.||....      ......... .+..
T Consensus       147 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~------~~~~~~~~~-~~~~  217 (323)
T cd05584         147 CKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN------RKKTIDKIL-KGKL  217 (323)
T ss_pred             CeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC------HHHHHHHHH-cCCC
Confidence            875322221  1223568999999999998889999999999999999999999985321      111111111 1110


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                            .+    +......+.+++.+||+.||++||     ++.++++
T Consensus       218 ------~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 ------NL----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ------CC----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                  11    111234567888999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.91  E-value=2e-24  Score=228.35  Aligned_cols=170  Identities=22%  Similarity=0.246  Sum_probs=120.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEecccccccccCCCCcccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      +..+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.+.....   .....+++.|+
T Consensus       164 ~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~  237 (440)
T PTZ00036        164 NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYR  237 (440)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCcc
Confidence            456899999999999999999999999   99999999999999765 699999999986543221   12346789999


Q ss_pred             ChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC----------Ccc-----cccccc
Q 009186          392 APEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG----------EAL-----ELMDPV  455 (541)
Q Consensus       392 aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~-----~~~~~~  455 (541)
                      |||++.+. .++.++|||||||++|||++|++||......   ..+..........          ...     ......
T Consensus       238 aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  314 (440)
T PTZ00036        238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV---DQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKD  314 (440)
T ss_pred             CHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchh
Confidence            99998764 6899999999999999999999998532211   1111111111000          000     000011


Q ss_pred             ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       456 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +...++......+.+|+.+||+.||.+|||+.|+++
T Consensus       315 l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        315 LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            111111122346788999999999999999999984

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.91  E-value=2.8e-25  Score=221.77  Aligned_cols=192  Identities=26%  Similarity=0.377  Sum_probs=136.5

Q ss_pred             HHHHHHHHHHhhheeccccccc---cCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEE
Q 009186          287 ITTITLFILLGSFVWCRRRINK---DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI  363 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~---~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL  363 (541)
                      .+++++|+..+.|....++...   .......+++..+.+++.||+.||.|||+++   |+||||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            3455666666666544433211   1122345678889999999999999999998   999999999999999999999


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      +|||+++...............++..|++||.+.++.++.++||||||+++|||++ |..||....      ..+. ...
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~------~~~~-~~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS------NEQV-LKF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC------HHHH-HHH
Confidence            99999876543322222222345678999999998889999999999999999998 677764211      1111 111


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ...+....     .    +......+.+++.+||+.||++||++.++++.|++..
T Consensus       234 ~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 VMDGGYLD-----Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHcCCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11111111     0    1112346778899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.91  E-value=1.5e-24  Score=220.41  Aligned_cols=170  Identities=24%  Similarity=0.340  Sum_probs=126.0

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.++.|...+++       ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~Ey~~~g~L~~~i~~-------~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQ-------VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEcCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccc
Confidence            455677766666444322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++.......  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....   ....   .... ...
T Consensus       147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~---~~i~-~~~  217 (323)
T cd05615         147 MCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELF---QSIM-EHN  217 (323)
T ss_pred             cccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHH-hCC
Confidence            9875332211  22235689999999999988899999999999999999999999853211   1111   1111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM  486 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~  486 (541)
                      .      .+    +......+.+++.+||+.||.+|++.
T Consensus       218 ~------~~----p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 V------SY----PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             C------CC----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence            0      01    11123456778889999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.91  E-value=2.7e-25  Score=225.97  Aligned_cols=176  Identities=22%  Similarity=0.230  Sum_probs=127.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+...+++       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        73 lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~  142 (325)
T cd05602          73 FVLDYINGGELFYHLQR-------ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGL  142 (325)
T ss_pred             EEEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCC
Confidence            44566666665443322       234788888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++......  .......|++.|+|||++.+..++.++|||||||++|||++|+.||....      ..+...... ....
T Consensus       143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~-~~~~  213 (325)
T cd05602         143 CKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNIL-NKPL  213 (325)
T ss_pred             CcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC------HHHHHHHHH-hCCc
Confidence            87532221  12234568999999999999999999999999999999999999984221      111111111 1110


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                            .+..    .....+.+++.+||+.||.+||++.+.+..+
T Consensus       214 ------~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         214 ------QLKP----NITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             ------CCCC----CCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence                  0111    1233566788899999999999987544333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PTZ00284 protein kinase; Provisional

Probab=99.91  E-value=2.1e-24  Score=230.27  Aligned_cols=170  Identities=19%  Similarity=0.251  Sum_probs=118.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCC----------------CcEEecccccccccCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEM----------------NPKISDFGMARIFSGNQ  376 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~----------------~~kL~Dfg~a~~~~~~~  376 (541)
                      ..+++.++..|+.||+.||+|||++ +   ||||||||+|||++.++                .+||+|||.+.....  
T Consensus       226 ~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--  300 (467)
T PTZ00284        226 GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--  300 (467)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--
Confidence            3589999999999999999999984 7   99999999999998765                489999998754221  


Q ss_pred             CcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHH-------HH--------
Q 009186          377 NEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA-------WK--------  441 (541)
Q Consensus       377 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~-------~~--------  441 (541)
                         ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+...       |.        
T Consensus       301 ---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~  377 (467)
T PTZ00284        301 ---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEA  377 (467)
T ss_pred             ---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhH
Confidence               123457899999999999999999999999999999999999998543221100000000       00        


Q ss_pred             --hhhc-CCcccccccc-----ccC--CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          442 --LWCK-GEALELMDPV-----LKQ--TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       442 --~~~~-~~~~~~~~~~-----l~~--~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                        .+.. +......++.     ...  .....+...+.+|+.+||++||++|||++|+++
T Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        378 RLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence              0000 0000000000     000  000012345778999999999999999999996

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.91  E-value=2.1e-24  Score=213.18  Aligned_cols=190  Identities=17%  Similarity=0.228  Sum_probs=129.9

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+..+.|...+++.   ......+++..++.++.||++||+|||+.+   ++|+||||+|||++.++.+||+||
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Df  143 (268)
T cd05086          70 YLLVFEYCELGDLKSYLSQE---QWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDY  143 (268)
T ss_pred             cEEEEecCCCCcHHHHHHhh---hcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEeccc
Confidence            45667777767765444321   111334678888999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhcc-------CCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCcCcCcHHHH
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAME-------GVFSVKSDVFSFGVLLLEIISG-KRNSGFYLSEHGQSLLTY  438 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~elltg-~~p~~~~~~~~~~~~~~~  438 (541)
                      |++................++..|+|||++..       ..++.++||||||+++|||+++ ..||....      ..+.
T Consensus       144 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~~  217 (268)
T cd05086         144 GIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS------DREV  217 (268)
T ss_pred             ccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC------HHHH
Confidence            98764322211122223457889999998753       2357899999999999999974 55653211      1111


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      ....+ .+......++.+....    ...+.+++..|| .+|++||++++|++.|.
T Consensus       218 ~~~~~-~~~~~~~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         218 LNHVI-KDQQVKLFKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHH-hhcccccCCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11111 2222333344333322    235666778899 67999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.91  E-value=5.3e-25  Score=216.68  Aligned_cols=183  Identities=25%  Similarity=0.434  Sum_probs=133.4

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+....++     .....+++..++.++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||.
T Consensus        77 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~  148 (262)
T cd05071          77 IVTEYMSKGSLLDFLKG-----EMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL  148 (262)
T ss_pred             EEEEcCCCCcHHHHHhh-----ccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCc
Confidence            44555555555433322     12345899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++.+...... ......++..|++||...+..++.++||||||+++|||++ |+.||.....   ...    ......+.
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~----~~~~~~~~  220 (262)
T cd05071         149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REV----LDQVERGY  220 (262)
T ss_pred             eeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHH----HHHHhcCC
Confidence            9765433221 1122345678999999988889999999999999999999 7777642211   111    11111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..         .........+.+++.+||+.||++||++.++++.|+..
T Consensus       221 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 RM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            00         11122345678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.91  E-value=1.7e-24  Score=213.04  Aligned_cols=186  Identities=23%  Similarity=0.308  Sum_probs=134.8

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++|+..+.|...+++.   ...+..+++.+++.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++
T Consensus        80 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          80 VLELADAGDLSRMIKHF---KKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EEecCCCCCHHHHHHHh---cccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence            45555555554333221   123446899999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcc
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEAL  449 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  449 (541)
                      ..+......  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....    ....... ..+..+...
T Consensus       154 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~-~~~~~~~~~  226 (267)
T cd08224         154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLC-KKIEKCDYP  226 (267)
T ss_pred             eeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHH-hhhhcCCCC
Confidence            765433221  123457888999999988889999999999999999999999974221    1111111 111111110


Q ss_pred             ccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          450 ELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       450 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .     ..   .......+.+++.+||+.+|++||++.+|+++|++.
T Consensus       227 ~-----~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         227 P-----LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             C-----CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            0     00   112334677888999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.91  E-value=1e-24  Score=214.86  Aligned_cols=166  Identities=23%  Similarity=0.332  Sum_probs=126.6

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||++........  ......++..|+|
T Consensus       100 ~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~a  174 (267)
T cd08228         100 KRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMS  174 (267)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccC
Confidence            345899999999999999999999998   99999999999999999999999999876543321  1123457889999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+.+..++.++|+||||+++|||++|+.||....    ......... ......     +   ..........+.+++
T Consensus       175 PE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~-~~~~~~-----~---~~~~~~~~~~~~~li  241 (267)
T cd08228         175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLFSLCQK-IEQCDY-----P---PLPTEHYSEKLRELV  241 (267)
T ss_pred             hhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc----ccHHHHHHH-HhcCCC-----C---CCChhhcCHHHHHHH
Confidence            999988889999999999999999999999974221    111111111 111110     1   011122345678889


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.+|++||++.+|++.|+..
T Consensus       242 ~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         242 SMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHCCCCcccCcCHHHHHHHHHHh
Confidence            999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.91  E-value=9.5e-25  Score=205.17  Aligned_cols=186  Identities=19%  Similarity=0.217  Sum_probs=139.2

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC---CCcE
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPK  362 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~---~~~k  362 (541)
                      .+.+|||.+.+|-|+.+.+.     +..+.+++.++-.|++||..|+.|||+.+   |.||||||+|+|....   -.+|
T Consensus       133 cLLiVmE~meGGeLfsriq~-----~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lK  204 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQD-----RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLK  204 (400)
T ss_pred             eeEeeeecccchHHHHHHHH-----cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceE
Confidence            45577899999998876643     23456999999999999999999999999   9999999999999654   3589


Q ss_pred             EecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       363 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      |+|||+++......   ......-|+.|.|||++....|+...|+||+||++|-|++|.+||..   ..+..+..-....
T Consensus       205 LtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS---~hg~aispgMk~r  278 (400)
T KOG0604|consen  205 LTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAISPGMKRR  278 (400)
T ss_pred             ecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc---cCCccCChhHHhH
Confidence            99999998754322   22234678999999999999999999999999999999999999842   2222222222222


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +..+.. ++-     ........+...++++.+|..+|.+|.|+.+++.
T Consensus       279 I~~gqy-~FP-----~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  279 IRTGQY-EFP-----EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             hhccCc-cCC-----ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            222221 111     1112233455677888999999999999999985

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.91  E-value=1.6e-24  Score=215.28  Aligned_cols=166  Identities=27%  Similarity=0.330  Sum_probs=126.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++.+++.++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+.............++..|+|
T Consensus       111 ~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~a  187 (280)
T cd05043         111 PQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA  187 (280)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccC
Confidence            456999999999999999999999998   99999999999999999999999999986543332222222345678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++||+++ |+.||.....      .+.. .....+....     .    .......+.++
T Consensus       188 pE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~-~~~~~~~~~~-----~----~~~~~~~~~~l  251 (280)
T cd05043         188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMA-AYLKDGYRLA-----Q----PINCPDELFAV  251 (280)
T ss_pred             HHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHH-HHHHcCCCCC-----C----CCcCCHHHHHH
Confidence            999988889999999999999999999 9998743211      1111 1111111100     0    11112457789


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +.+||+.||++|||+.++++.|+...
T Consensus       252 i~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         252 MACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            99999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=1.2e-24  Score=219.33  Aligned_cols=154  Identities=25%  Similarity=0.368  Sum_probs=120.4

Q ss_pred             HHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhhhccC
Q 009186          320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG  399 (541)
Q Consensus       320 ~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~  399 (541)
                      .+..+.+|++.++.++|.++   |||-||||.|+|+- .|.+||+|||++..+..+.........+||+.||+||.+...
T Consensus       461 ~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~  536 (677)
T KOG0596|consen  461 FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM  536 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence            77788999999999999999   99999999999987 568999999999998888777777788999999999998532


Q ss_pred             -----------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCH-HHHHH
Q 009186          400 -----------VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVD-AELLK  467 (541)
Q Consensus       400 -----------~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~  467 (541)
                                 ..++++||||||||||+|+.|+.||+....         .|.     .+..+.+|...-+++. .+...
T Consensus       537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~a-----Kl~aI~~P~~~Iefp~~~~~~~  602 (677)
T KOG0596|consen  537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QIA-----KLHAITDPNHEIEFPDIPENDE  602 (677)
T ss_pred             cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HHH-----HHHhhcCCCccccccCCCCchH
Confidence                       256899999999999999999999853211         111     1122233322111111 11222


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHH
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +++++..||++||.+||++.++|+
T Consensus       603 li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  603 LIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHHHHHHHhcCcccCCCcHHHhc
Confidence            889999999999999999999985

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.91  E-value=7.7e-25  Score=221.75  Aligned_cols=175  Identities=25%  Similarity=0.329  Sum_probs=128.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|...+++       ...+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus        72 ~lv~ey~~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQS-------CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFG  141 (316)
T ss_pred             EEEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCC
Confidence            344566666666444332       235889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....      .+. ........
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~-~~~i~~~~  212 (316)
T cd05619         142 MCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EEL-FQSIRMDN  212 (316)
T ss_pred             cceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHH-HHHHHhCC
Confidence            987532211  122335689999999999988899999999999999999999999853211      111 11111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHH-HHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS-SVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-evl~  491 (541)
                            +.+..    .....+.+++.+||+.||++||++. ++++
T Consensus       213 ------~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         213 ------PCYPR----WLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ------CCCCc----cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence                  11111    1223466788899999999999997 6653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=7.6e-24  Score=212.20  Aligned_cols=170  Identities=22%  Similarity=0.323  Sum_probs=122.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++................++..|+||
T Consensus       124 ~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  200 (295)
T cd05097         124 PSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW  200 (295)
T ss_pred             CcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecCh
Confidence            45789999999999999999999999   999999999999999999999999998765333222222233456789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhC--CCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISG--KRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |.+.++.++.++||||||+++|||+++  ..||....   ...........+.........      ..+......+.+|
T Consensus       201 E~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~l  271 (295)
T cd05097         201 ESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS---DEQVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKL  271 (295)
T ss_pred             hhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---hHHHHHHHHHhhhhccccccC------CCCCCCCHHHHHH
Confidence            999888899999999999999999984  44543211   111111111111111000000      0011123468889


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.||++||++.+|++.|+.
T Consensus       272 i~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         272 MMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHcCCCchhCcCHHHHHHHHhC
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5e-25  Score=226.23  Aligned_cols=181  Identities=22%  Similarity=0.272  Sum_probs=130.7

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|...+.+       ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        77 ~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIR-------KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             EEEEcCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCC
Confidence            345566666666444332       246899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCC---------------------------CcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhC
Q 009186          368 MARIFSGNQ---------------------------NEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG  420 (541)
Q Consensus       368 ~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg  420 (541)
                      ++.......                           .........||..|+|||.+.+..++.++|||||||++|||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            987654332                           00112335689999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-HHHHHHH
Q 009186          421 KRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-MSSVVVM  492 (541)
Q Consensus       421 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~evl~~  492 (541)
                      +.||....      .................  +   .  .......+.+++.+||+ ||.+||+ ++++++.
T Consensus       227 ~~Pf~~~~------~~~~~~~i~~~~~~~~~--p---~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         227 FPPFYSDT------LQETYNKIINWKESLRF--P---P--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCCC------HHHHHHHHhccCCcccC--C---C--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            99985322      11111111110000000  0   0  00123456678888997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.91  E-value=5.4e-25  Score=225.02  Aligned_cols=190  Identities=22%  Similarity=0.289  Sum_probs=138.3

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..|.|...+++       ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       107 ~lv~Ey~~~g~L~~~i~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRR-------NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             EEEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCC
Confidence            455677766766544432       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++.....     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....      .... ......+.
T Consensus       177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~-~~~i~~~~  244 (340)
T PTZ00426        177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE------PLLI-YQKILEGI  244 (340)
T ss_pred             CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC------HHHH-HHHHhcCC
Confidence            99765322     223568999999999998889999999999999999999999985321      1111 11111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHHH--HhcC------CCCCCCCCCCCce
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVVM--LASD------TATLPPPTQPAFS  509 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~~--L~~~------~~~l~~p~~P~~~  509 (541)
                      .      .+...    ....+.+++.+||+.||++|+     +++++++.  +++.      ...+++|..|.+.
T Consensus       245 ~------~~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~  309 (340)
T PTZ00426        245 I------YFPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK  309 (340)
T ss_pred             C------CCCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence            1      01111    123456788899999999995     89988764  3321      2345566666653

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.91  E-value=4.8e-25  Score=219.95  Aligned_cols=163  Identities=29%  Similarity=0.430  Sum_probs=123.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||+++................+..|+||
T Consensus       125 ~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (288)
T cd05050         125 LPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP  201 (288)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence            45899999999999999999999998   999999999999999999999999998764333222222223345679999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |..||....      ..+. ......+....         .+......+.+++
T Consensus       202 E~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~------~~~~-~~~~~~~~~~~---------~~~~~~~~l~~li  265 (288)
T cd05050         202 ESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA------HEEV-IYYVRDGNVLS---------CPDNCPLELYNLM  265 (288)
T ss_pred             HHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHH-HHHHhcCCCCC---------CCCCCCHHHHHHH
Confidence            99988899999999999999999997 777763211      1111 11111222111         1112235678899


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhc
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .+||+.||++||++.||++.|+.
T Consensus       266 ~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         266 RLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHcccCcccCCCHHHHHHHhhC
Confidence            99999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.91  E-value=5.7e-24  Score=213.96  Aligned_cols=171  Identities=21%  Similarity=0.254  Sum_probs=118.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..++++.+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.......  ......+++.|+||
T Consensus        98 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP  172 (303)
T cd07869          98 GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPP  172 (303)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCCh
Confidence            35889999999999999999999999   99999999999999999999999999875432211  11234578899999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC---c-----cccccc-cccC--CCC
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE---A-----LELMDP-VLKQ--TCV  461 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~-~l~~--~~~  461 (541)
                      |.+.+ ..++.++|||||||++|||++|+.||......  ...+...........   +     ....++ ....  ...
T Consensus       173 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (303)
T cd07869         173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKN  250 (303)
T ss_pred             HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhccccccccccccCCcc
Confidence            99865 45788999999999999999999998643211  111111111100000   0     000000 0000  000


Q ss_pred             H-------HHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          462 D-------AELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       462 ~-------~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .       .....+.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         251 LRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             HHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0       01234668889999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.91  E-value=1.6e-24  Score=209.84  Aligned_cols=216  Identities=21%  Similarity=0.276  Sum_probs=146.6

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-CCcEE
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKI  363 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-~~~kL  363 (541)
                      +..-.|+||+....... .+.   -...+.+++...+.-+..||.+||.|||+.+   |+||||||.|||+|.+ |.+||
T Consensus        95 ~~lnlVleymP~tL~~~-~r~---~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKi  167 (364)
T KOG0658|consen   95 VYLNLVLEYMPETLYRV-IRH---YTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKI  167 (364)
T ss_pred             hHHHHHHHhchHHHHHH-HHH---HhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEe
Confidence            45678888887654422 221   1123456888889999999999999999998   9999999999999987 88999


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      +|||.|+.+..+...   .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|......+  .+. ...+.
T Consensus       168 cDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~-eIik~  241 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLV-EIIKV  241 (364)
T ss_pred             ccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHH-HHHHH
Confidence            999999987654433   235678899999999875 59999999999999999999999886432211  111 11111


Q ss_pred             hhc----------CCccccccccccCC-----CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH-----HHhcCCCCCCC
Q 009186          443 WCK----------GEALELMDPVLKQT-----CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV-----MLASDTATLPP  502 (541)
Q Consensus       443 ~~~----------~~~~~~~~~~l~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~-----~L~~~~~~l~~  502 (541)
                      +..          ....+.-.+.+...     .......+.++++.++|+.+|.+|.++.|++.     .|......+|-
T Consensus       242 lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~  321 (364)
T KOG0658|consen  242 LGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPN  321 (364)
T ss_pred             hCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcC
Confidence            111          00011111211111     12233456778889999999999999999885     34443333322


Q ss_pred             --CCCCCceeccc
Q 009186          503 --PTQPAFSVDRI  513 (541)
Q Consensus       503 --p~~P~~~~~~~  513 (541)
                        |-+|-|.+...
T Consensus       322 g~~lp~lf~f~~~  334 (364)
T KOG0658|consen  322 GRPLPPLFNFKRA  334 (364)
T ss_pred             CCcCCCccCchHH
Confidence              44555554443

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.91  E-value=2.8e-24  Score=219.33  Aligned_cols=166  Identities=31%  Similarity=0.401  Sum_probs=125.7

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       128 ~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  204 (334)
T cd05100         128 EEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMA  204 (334)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcC
Confidence            456899999999999999999999999   99999999999999999999999999876543322222222234567999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||....      ..+ .......+....         .+......+.++
T Consensus       205 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~-~~~~~~~~~~~~---------~~~~~~~~l~~l  268 (334)
T cd05100         205 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------VEE-LFKLLKEGHRMD---------KPANCTHELYMI  268 (334)
T ss_pred             HHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------HHH-HHHHHHcCCCCC---------CCCCCCHHHHHH
Confidence            999998889999999999999999998 778763211      111 111111111111         111223467788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +.+||+.+|++||++.++++.|+...
T Consensus       269 i~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         269 MRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHcccChhhCcCHHHHHHHHHHHh
Confidence            99999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.91  E-value=6.2e-25  Score=218.13  Aligned_cols=183  Identities=23%  Similarity=0.282  Sum_probs=130.1

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.++.+.....+     .....+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||
T Consensus        69 ~lv~e~~~g~~L~~~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg  140 (277)
T cd05607          69 CLVMSLMNGGDLKYHIYN-----VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLG  140 (277)
T ss_pred             EEEEecCCCCCHHHHHHh-----ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeece
Confidence            445566655655333221     12334889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++.......   ......|+..|+|||++.+..++.++|||||||++|||++|+.||........  ..+...... ...
T Consensus       141 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~  214 (277)
T cd05607         141 LAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL-EDE  214 (277)
T ss_pred             eeeecCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh-ccc
Confidence            987654322   11234678899999999988899999999999999999999999853322111  111111111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      .    ..  .   .......+.+++.+||+.||++||++.|+++.+
T Consensus       215 ~----~~--~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         215 V----KF--E---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             c----cc--c---cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            0    00  0   011233567888899999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.91  E-value=2.5e-24  Score=210.75  Aligned_cols=163  Identities=33%  Similarity=0.430  Sum_probs=126.7

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||.+................++..|+|
T Consensus        99 ~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  175 (262)
T cd00192          99 KSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA  175 (262)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccC
Confidence            456999999999999999999999998   99999999999999999999999999987654432222334456789999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+....++.++||||||+++|||++ |..||....   .   .+ .......+...         ..+......+.++
T Consensus       176 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~---~~-~~~~~~~~~~~---------~~~~~~~~~~~~l  239 (262)
T cd00192         176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---N---EE-VLEYLRKGYRL---------PKPEYCPDELYEL  239 (262)
T ss_pred             HHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---H---HH-HHHHHHcCCCC---------CCCccCChHHHHH
Confidence            999988889999999999999999999 588875331   1   11 11111111111         1111224567788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHh
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      +.+||+.||.+||++.++++.|+
T Consensus       240 i~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         240 MLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHccCCcccCcCHHHHHHhhC
Confidence            89999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.91  E-value=2.2e-24  Score=209.12  Aligned_cols=171  Identities=23%  Similarity=0.276  Sum_probs=124.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      +.++...+..++.||+.||+|||+++   |+||||||.|||++.+|.+||+|||+++.+.-....  ....++|.+|+||
T Consensus       115 ~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaP  189 (323)
T KOG0594|consen  115 QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAP  189 (323)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCH
Confidence            45777899999999999999999999   999999999999999999999999999976533322  2345689999999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc---CCccccc-----cccc---c--CC
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK---GEALELM-----DPVL---K--QT  459 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-----~~~l---~--~~  459 (541)
                      |++.+. .|+...||||+|||+.||++++.-|.....   ...+..+.+....   ..+....     +...   .  ..
T Consensus       190 EvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~  266 (323)
T KOG0594|consen  190 EVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKD  266 (323)
T ss_pred             HHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccc
Confidence            999887 699999999999999999998887753322   1111122221111   1111110     1000   0  00


Q ss_pred             CCHHH---HHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          460 CVDAE---LLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       460 ~~~~~---~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      .....   .....+++.+||+.+|.+|.+++..+.+
T Consensus       267 l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  267 LSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             hHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            01111   1357789999999999999999999875

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.91  E-value=1.6e-24  Score=213.50  Aligned_cols=165  Identities=25%  Similarity=0.343  Sum_probs=125.6

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........  .....++..|+|
T Consensus       100 ~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~a  174 (267)
T cd08229         100 KRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMS  174 (267)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccC
Confidence            456899999999999999999999999   999999999999999999999999998765433221  123457889999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+.+..++.++|+||||+++|+|++|..||.....    ...... +.....     ..+.+.   .......+.+++
T Consensus       175 pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~-----~~~~~~---~~~~~~~~~~li  241 (267)
T cd08229         175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-KKIEQC-----DYPPLP---SDHYSEELRQLV  241 (267)
T ss_pred             HHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHh-hhhhcC-----CCCCCC---cccccHHHHHHH
Confidence            9999888899999999999999999999999742111    111111 111110     111111   112344677888


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhc
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .+||+.||++|||+.+|++++++
T Consensus       242 ~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         242 NMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             HHhcCCCcccCCCHHHHHHHHhh
Confidence            89999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.91  E-value=2.6e-24  Score=210.70  Aligned_cols=163  Identities=29%  Similarity=0.401  Sum_probs=124.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc-ccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~a  392 (541)
                      ..+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||+++.+...... .......++..|++
T Consensus        92 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~  168 (257)
T cd05040          92 GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA  168 (257)
T ss_pred             ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecC
Confidence            46899999999999999999999998   999999999999999999999999999876543221 11223456788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||....      ..+.............         .+......+.++
T Consensus       169 pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l  233 (257)
T cd05040         169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS------GSQILKKIDKEGERLE---------RPEACPQDIYNV  233 (257)
T ss_pred             HHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhcCCcCC---------CCccCCHHHHHH
Confidence            999998889999999999999999998 999974221      1111111111111100         011123467788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHh
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      +.+||+.+|++||++.+|++.|.
T Consensus       234 i~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         234 MLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHHHhc
Confidence            89999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.91  E-value=6e-25  Score=216.75  Aligned_cols=183  Identities=27%  Similarity=0.399  Sum_probs=131.1

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+...+++      +...+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+
T Consensus        83 lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          83 IITEYMENGALDKYLRD------HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             EEEEcCCCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence            34555555555333321      2245899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccc-cccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          369 ARIFSGNQNEANT-NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       369 a~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +............ .....+..|++||.+.+..++.++||||||+++|||++ |+.||.....      .+ ....+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~-~~~~i~~~  226 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HE-VMKAINDG  226 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HH-HHHHHhcC
Confidence            8765432221111 11123457999999988889999999999999999997 9999743211      11 11111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ...         .........+.+++.+||+.+|++||++.+|++.|++.
T Consensus       227 ~~~---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 FRL---------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            100         01112234677899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-24  Score=224.29  Aligned_cols=173  Identities=21%  Similarity=0.224  Sum_probs=130.6

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE-cCCCCcEE
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-DHEMNPKI  363 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll-~~~~~~kL  363 (541)
                      ..++.|++.+-++.++.++++.        +....++..|+.+|+.++.|||++|   ||||||||+|||+ +..++++|
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~--------~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrl  457 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSK--------PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRL  457 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhc--------chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEE
Confidence            3456777777777776555442        1233778889999999999999999   9999999999999 58899999


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      +|||.++.....     .....-|..|.|||++....+++++|+||||++||+|++|+.||.....+  ..+    ...+
T Consensus       458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i  526 (612)
T KOG0603|consen  458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRI  526 (612)
T ss_pred             EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhh
Confidence            999999876544     22335588999999999999999999999999999999999998543322  111    1111


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..+..            .........+|+.+||+.||.+||++.++..
T Consensus       527 ~~~~~------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  527 QMPKF------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cCCcc------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            11111            1222344566788999999999999999874

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.90  E-value=4.6e-25  Score=219.73  Aligned_cols=191  Identities=24%  Similarity=0.365  Sum_probs=134.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.++.|....++      ....+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus        84 ~lv~e~~~g~~L~~~l~~------~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR------NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             EEEEEccCCCCHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCc
Confidence            345566666666433322      1235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCc-ccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC--------cCcCcHHHH
Q 009186          368 MARIFSGNQNE-ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS--------EHGQSLLTY  438 (541)
Q Consensus       368 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~--------~~~~~~~~~  438 (541)
                      +++.+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|......        .........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR  234 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence            98865433221 112234566789999999888899999999999999999998766421110        001111111


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .......+...         .........+.+++.+||+.||++||++.++++.|+..
T Consensus       235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVRVLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111111110         11112345688899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=6e-24  Score=218.96  Aligned_cols=105  Identities=30%  Similarity=0.431  Sum_probs=91.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......   ......||..|+||
T Consensus       152 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aP  225 (357)
T PHA03209        152 RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAP  225 (357)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCC
Confidence            45899999999999999999999999   9999999999999999999999999987532211   12235689999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNS  424 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~  424 (541)
                      |.+.+..++.++|||||||++|||+++..++
T Consensus       226 E~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        226 EVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             eecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            9999989999999999999999999866553

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.90  E-value=2.9e-24  Score=223.92  Aligned_cols=166  Identities=27%  Similarity=0.394  Sum_probs=127.1

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       231 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~a  307 (400)
T cd05105         231 SEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMA  307 (400)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEC
Confidence            446999999999999999999999998   99999999999999999999999999986543332222333456778999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||......      .........+...         ..+......+.++
T Consensus       308 PE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~~l~~l  372 (400)
T cd05105         308 PESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------STFYNKIKSGYRM---------AKPDHATQEVYDI  372 (400)
T ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh------HHHHHHHhcCCCC---------CCCccCCHHHHHH
Confidence            999988889999999999999999997 88887532111      0111111111110         0111223467789


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||++||++.+|.++|+..
T Consensus       373 i~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         373 MVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             HHHHCccCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.90  E-value=1.7e-23  Score=209.83  Aligned_cols=171  Identities=23%  Similarity=0.341  Sum_probs=123.9

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.++++++.||+.||+|||+.+   ++|+||||+||+++.++.++|+|||+++.+.............++..|++
T Consensus       124 ~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  200 (296)
T cd05095         124 VVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMS  200 (296)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCC
Confidence            446899999999999999999999999   99999999999999999999999999876543322222222334678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      ||....+.++.++||||||+++|||++  |..||.....   ..........+........+ +     .+......+.+
T Consensus       201 pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~  271 (296)
T cd05095         201 WESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD---EQVIENTGEFFRDQGRQVYL-P-----KPALCPDSLYK  271 (296)
T ss_pred             HHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh---HHHHHHHHHHHhhccccccC-C-----CCCCCCHHHHH
Confidence            999888889999999999999999998  5566532211   11111111111111000000 0     01122356778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ++.+||+.||.+||++.+|++.|+.
T Consensus       272 li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         272 LMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHcCCCcccCCCHHHHHHHHhC
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.90  E-value=2.4e-24  Score=212.74  Aligned_cols=190  Identities=26%  Similarity=0.349  Sum_probs=129.7

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.+...++...  ......+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        71 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg  145 (269)
T cd05087          71 LLVMEFCPLGDLKGYLRSCR--KAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYG  145 (269)
T ss_pred             EEEEECCCCCcHHHHHHHhh--hcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcc
Confidence            34566666666644433211  111234678888999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHH
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-------VFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYA  439 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~  439 (541)
                      .++...............++..|+|||++.+.       .++.++||||||+++|||++ |+.||......   ......
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~  222 (269)
T cd05087         146 LSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYT  222 (269)
T ss_pred             ccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH
Confidence            98754333222222334567889999988642       35789999999999999996 99998532211   111111


Q ss_pred             HHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          440 WKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       440 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                         . ........++.+...    ....+.+++..|| .+|++|||+++|++.|+
T Consensus       223 ---~-~~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         223 ---V-REQQLKLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ---h-hcccCCCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence               1 111122222222211    1234566788899 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.90  E-value=2.4e-24  Score=180.93  Aligned_cols=102  Identities=42%  Similarity=0.825  Sum_probs=78.1

Q ss_pred             ccCCC-C--CCC-CCCChHHHHHHHHHHHHhhcccCCCCCCcccCceeeccCCCCCeEEEEEeccCCCChhhhHHHHHHH
Q 009186           30 YHNCP-R--TNF-TPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGHEPNKVYGLFLCRGDFGTETCQNCVSVA  105 (541)
Q Consensus        30 ~~~C~-~--~~~-~~~s~~~~nl~~l~~~l~~~~~~~~~~~~~~~f~~~~~g~~~~~vy~~~~C~~D~~~~~C~~Cl~~a  105 (541)
                      |+.|+ +  .++ +++++|++||+.||+.|..+++..+.    .+|++++.|.+++++||++||++|+++++|..||+.|
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~----~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a   76 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSS----KGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADA   76 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-----TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHH
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccc----cCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHH
Confidence            67898 3  345 57888999999999999999875421    5899998899999999999999999999999999999


Q ss_pred             HHHhhhcCCCCceEEEEccceEEEEcCCcc
Q 009186          106 TSYTAQLCPFGKENTIEYEECLLRYSNISF  135 (541)
Q Consensus       106 ~~~~~~~C~~~~~a~~~~~~C~~ry~~~~f  135 (541)
                      +..+.+.|+.+++|+||++.|+|||++++|
T Consensus        77 ~~~~~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   77 VANISSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HCCHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHHHHHhCCCCceEEEECCCEEEEEECCCC
Confidence            999999999999999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.90  E-value=3.4e-24  Score=211.57  Aligned_cols=190  Identities=22%  Similarity=0.256  Sum_probs=127.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.|...+++..  .......++...+.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        71 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg  145 (269)
T cd05042          71 LLVLEFCPLGDLKNYLRSNR--GMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYG  145 (269)
T ss_pred             EEEEEeCCCCcHHHHHHhcc--ccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccc
Confidence            44566666666644443211  112234578889999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhcc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHH
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAME-------GVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYA  439 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~  439 (541)
                      +++...............++..|+|||++..       ..++.++||||||+++|||++ |..||.....      .+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~  219 (269)
T cd05042         146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQVL  219 (269)
T ss_pred             cccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHH
Confidence            9865432221111222345677999998753       346789999999999999999 7777643211      1111


Q ss_pred             HHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          440 WKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       440 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      ...... .......+.+..    .....+.+++..|| .||++||++++|++.|.
T Consensus       220 ~~~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         220 KQVVRE-QDIKLPKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHHhhc-cCccCCCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111111 111222222221    22334556777888 59999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.90  E-value=8e-24  Score=196.60  Aligned_cols=181  Identities=24%  Similarity=0.308  Sum_probs=129.6

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      -|.+.||.+.-|  .+++.+.-     .+++++...-++...++.||.||.++.  .|+|||+||+|||+|+.|++||+|
T Consensus       165 dV~IcMelMs~C--~ekLlkri-----k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCD  235 (391)
T KOG0983|consen  165 DVFICMELMSTC--AEKLLKRI-----KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCD  235 (391)
T ss_pred             hHHHHHHHHHHH--HHHHHHHh-----cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeec
Confidence            356667765433  22222211     224899989999999999999999875  499999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAME---GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      ||++-.+-....+   ....|-..|||||.+--   ..|+.++||||||+.++||.||+.||.....     .++..-+.
T Consensus       236 FGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-----dFe~ltkv  307 (391)
T KOG0983|consen  236 FGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-----DFEVLTKV  307 (391)
T ss_pred             ccccceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-----cHHHHHHH
Confidence            9998765443332   34578899999998853   4588899999999999999999999853211     11111111


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .. .+     .|.+....  .....+.+++..||+.|+.+||.-.++++
T Consensus       308 ln-~e-----PP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  308 LN-EE-----PPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             Hh-cC-----CCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            11 11     12232211  13456788888999999999999998875

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.90  E-value=1.3e-23  Score=217.11  Aligned_cols=169  Identities=21%  Similarity=0.226  Sum_probs=121.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++......   ......++..|+|||
T Consensus       122 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE  195 (364)
T cd07875         122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE  195 (364)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHH
Confidence            3788899999999999999999999   9999999999999999999999999997653321   122346789999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh------------------hhc--CCcc----c
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL------------------WCK--GEAL----E  450 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~------------------~~~--~~~~----~  450 (541)
                      ++.+..++.++|||||||++|||++|+.||.......   ........                  ...  ....    +
T Consensus       196 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
T cd07875         196 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFE  272 (364)
T ss_pred             HHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChH
Confidence            9999999999999999999999999999985332110   00000000                  000  0000    0


Q ss_pred             ccccccc----CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          451 LMDPVLK----QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       451 ~~~~~l~----~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      .+.+...    ..........+.+++.+||+.||.+|||+.++++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000    00011123467789999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.90  E-value=5.8e-25  Score=218.42  Aligned_cols=170  Identities=28%  Similarity=0.400  Sum_probs=125.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aP  393 (541)
                      .+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||.+.......... ......++..|++|
T Consensus       105 ~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~P  181 (284)
T cd05038         105 QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP  181 (284)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCc
Confidence            5899999999999999999999998   9999999999999999999999999998765332211 11122345679999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcC--------cHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQ--------SLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      |.+.+..++.++||||||+++|||++|+.|+.........        ..............         ....+....
T Consensus       182 e~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~  252 (284)
T cd05038         182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE---------RLPRPPSCP  252 (284)
T ss_pred             HHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC---------cCCCCccCC
Confidence            9998888999999999999999999999886432211100        01111111111111         111111223


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..+.+++.+||+.+|++||++.||+++|+..
T Consensus       253 ~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         253 DEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            5678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=2.6e-25  Score=225.45  Aligned_cols=172  Identities=23%  Similarity=0.242  Sum_probs=126.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|..++.+       ...+++.++..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        74 ~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg  143 (318)
T cd05582          74 YLILDFLRGGDLFTRLSK-------EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG  143 (318)
T ss_pred             EEEEcCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeecc
Confidence            345566666666444322       335899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....      ..+...... ...
T Consensus       144 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~------~~~~~~~i~-~~~  214 (318)
T cd05582         144 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD------RKETMTMIL-KAK  214 (318)
T ss_pred             CCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC------HHHHHHHHH-cCC
Confidence            987643321  12223568999999999998889999999999999999999999985321      111111111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS  488 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~e  488 (541)
                      .      .+    +......+.+++.+||+.||++||++.+
T Consensus       215 ~------~~----p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 L------GM----PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C------CC----CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0      01    1112335667888999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.7e-25  Score=227.98  Aligned_cols=176  Identities=22%  Similarity=0.303  Sum_probs=126.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.+...+++       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        72 ~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg  141 (330)
T cd05586          72 YLVTDYMSGGELFWHLQK-------EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFG  141 (330)
T ss_pred             EEEEcCCCCChHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCC
Confidence            445677766666444332       345899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++.......  ......||..|+|||.+.+. .++.++|||||||++|||++|+.||....      ..+ ....+..+
T Consensus       142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~------~~~-~~~~i~~~  212 (330)
T cd05586         142 LSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED------TQQ-MYRNIAFG  212 (330)
T ss_pred             cCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC------HHH-HHHHHHcC
Confidence            9875322221  22345689999999998764 47899999999999999999999984321      111 11111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC----CHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP----NMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP----t~~evl~  491 (541)
                      ..      .+...   .....+.+++.+||+.||.+||    ++.++++
T Consensus       213 ~~------~~~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         213 KV------RFPKN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CC------CCCCc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            11      11111   1123456788899999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.90  E-value=8.1e-25  Score=214.90  Aligned_cols=163  Identities=29%  Similarity=0.474  Sum_probs=124.2

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......... ......++..|++
T Consensus        96 ~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~  171 (260)
T cd05067          96 GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTA  171 (260)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccC
Confidence            446899999999999999999999998   999999999999999999999999998765422211 1122345678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+....++.++||||||+++||+++ |+.||.....   ...    ......+...         .........+.++
T Consensus       172 pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~----~~~~~~~~~~---------~~~~~~~~~~~~l  235 (260)
T cd05067         172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEV----IQNLERGYRM---------PRPDNCPEELYEL  235 (260)
T ss_pred             HHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHH----HHHHHcCCCC---------CCCCCCCHHHHHH
Confidence            999988889999999999999999999 9999742211   111    1111111100         0111123457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.+|++||++++++..|+.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHccCChhhCCCHHHHHHHhhc
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.90  E-value=5e-24  Score=210.67  Aligned_cols=162  Identities=28%  Similarity=0.373  Sum_probs=121.3

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......   ........+..|+|
T Consensus       106 ~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~a  179 (270)
T cd05047         106 ASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMA  179 (270)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCC
Confidence            446899999999999999999999998   999999999999999999999999998532211   11111223567999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||++....++.++||||||+++|||++ |+.||.....   ...    ......+...+         ........+.++
T Consensus       180 pE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~~~l  243 (270)
T cd05047         180 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL----YEKLPQGYRLE---------KPLNCDDEVYDL  243 (270)
T ss_pred             hHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHH----HHHHhCCCCCC---------CCCcCCHHHHHH
Confidence            999988889999999999999999997 9988742111   111    11111111111         111123457789


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||.+||++.++++.|+..
T Consensus       244 i~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         244 MRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             HHHHcccChhhCCCHHHHHHHHHHh
Confidence            9999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=9.4e-25  Score=238.63  Aligned_cols=183  Identities=26%  Similarity=0.321  Sum_probs=136.9

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      -+.+.||||..|.|...+++       +.-+++.....+..|++.|+.|||++|   ||||||||.||+|+.+|.+|++|
T Consensus      1308 kv~IFMEyC~~GsLa~ll~~-------gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEH-------GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred             HHHHHHHHhccCcHHHHHHh-------cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeec
Confidence            46788999999998665544       334677777888999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCC--CcccccccccCCCCCChhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHH
Q 009186          366 FGMARIFSGNQ--NEANTNRVAGTYGYMAPEYAMEGV---FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAW  440 (541)
Q Consensus       366 fg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~  440 (541)
                      ||.+..+..+.  .........||+.|||||++.+..   ...+.||||||||++||+||++||...+.+         |
T Consensus      1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~ 1448 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------W 1448 (1509)
T ss_pred             ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------h
Confidence            99998876553  122334568999999999997533   457899999999999999999997533321         1


Q ss_pred             HhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          441 KLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       441 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      .+.-+      +...-.+..+......-.+++.+||+.||++|+++.|+++.-
T Consensus      1449 aIMy~------V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1449 AIMYH------VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             HHHhH------HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            11100      000111122222334455677799999999999999887654

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.90  E-value=5.5e-24  Score=208.31  Aligned_cols=179  Identities=25%  Similarity=0.340  Sum_probs=131.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.+....+.     .+...+++.+++.++.|++.||.+||+++   |+|+||||+||+++.++.++|+|||
T Consensus        76 ~lv~e~~~~~~l~~~l~~-----~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          76 YIVMGFCEGGDLYHKLKE-----QKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             EEEecccCCCcHHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEeccc
Confidence            344555555555333321     12346899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++........  ......++..|+|||.+.+..++.++||||||+++++|++|+.||....      ......... .+.
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~-~~~  218 (257)
T cd08223         148 IARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRII-EGK  218 (257)
T ss_pred             ceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHH-hcC
Confidence            9876543222  2223457889999999998889999999999999999999999974221      111111111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ..         ..+......+.+++.+||+.||++||++.++++.
T Consensus       219 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 LP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            10         1112233567789999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.90  E-value=1.3e-24  Score=221.86  Aligned_cols=125  Identities=27%  Similarity=0.417  Sum_probs=102.6

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++|+..+.|...+++       ...+++..+..++.|++.||.|||+. +   |+|+||||+||+++.++.+||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Df  148 (333)
T cd06650          79 SICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF  148 (333)
T ss_pred             EEEEecCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeC
Confidence            345677766666444432       23588999999999999999999975 5   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      |++......    ......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       149 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         149 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             Ccchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            998754322    12234688999999999988899999999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.90  E-value=7.7e-25  Score=216.38  Aligned_cols=178  Identities=28%  Similarity=0.357  Sum_probs=126.9

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+...++.     .+...+++..+..++.|++.||+|||+++   |+|+||||+||+++.++.+||+|||+
T Consensus        86 iv~e~~~~~~L~~~l~~-----~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          86 LVMEFCGAGSVTDLIKN-----TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             EEEEcCCCCcHHHHHHh-----ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            34455555555433322     12346899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      +........  ......|+..|+|||++.     +..++.++|||||||++|||++|+.||.....      ........
T Consensus       158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~~~~  229 (272)
T cd06637         158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIP  229 (272)
T ss_pred             ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHHHh
Confidence            876533221  223356888999999986     33578899999999999999999999742211      11111111


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .. .     .+.+..   ......+.+++.+||+.||.+||++.++++
T Consensus       230 ~~-~-----~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RN-P-----APRLKS---KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cC-C-----CCCCCC---CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11 0     011111   112245778889999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=2.4e-24  Score=210.99  Aligned_cols=205  Identities=19%  Similarity=0.208  Sum_probs=151.3

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      ..+.+|+||.+|.|...+++     +.++.++++.+.-++.+|+.||+|||..|   ||.|||||+||||.++|++.|+|
T Consensus       151 ~~cl~meyCpGGdL~~Lrqk-----Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQK-----QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             eeEEEEecCCCccHHHHHhh-----CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeee
Confidence            35677899999998544433     34567999999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccC---------------------------------C-CC--------------------cccccccccCCCCC
Q 009186          366 FGMARIFSG---------------------------------N-QN--------------------EANTNRVAGTYGYM  391 (541)
Q Consensus       366 fg~a~~~~~---------------------------------~-~~--------------------~~~~~~~~gt~~y~  391 (541)
                      |.++.....                                 . ..                    ......++||-.|+
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl  302 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL  302 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence            987643110                                 0 00                    01123467999999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |||++.+...+.++|.|+|||++|||+.|..||.....  .+.+             ..++...+.-...+.....+.+|
T Consensus       303 APEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~--~~Tl-------------~NIv~~~l~Fp~~~~vs~~akDL  367 (459)
T KOG0610|consen  303 APEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN--KETL-------------RNIVGQPLKFPEEPEVSSAAKDL  367 (459)
T ss_pred             cceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc--hhhH-------------HHHhcCCCcCCCCCcchhHHHHH
Confidence            99999999999999999999999999999999853321  1111             11222222111122445677889


Q ss_pred             HhhhcccCCCCCCC----HHHHHH--HHhcCCCCCCCCCCCCceeccc
Q 009186          472 GLLCVQEDPAHRPN----MSSVVV--MLASDTATLPPPTQPAFSVDRI  513 (541)
Q Consensus       472 ~~~cl~~dP~~RPt----~~evl~--~L~~~~~~l~~p~~P~~~~~~~  513 (541)
                      |++.|.+||.+|.-    +.||.+  .+++....+..-.+|++.....
T Consensus       368 Ir~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~  415 (459)
T KOG0610|consen  368 IRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPV  415 (459)
T ss_pred             HHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcc
Confidence            99999999999998    888875  5677766665555555554433

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.90  E-value=1e-24  Score=212.76  Aligned_cols=180  Identities=28%  Similarity=0.354  Sum_probs=129.5

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+....++      +...+++.+++.++.|++.+|.|||+++   ++|+||||+||+++.++.+||+|||+
T Consensus        69 lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~  139 (250)
T cd05085          69 IVMELVPGGDFLSFLRK------KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGM  139 (250)
T ss_pred             EEEECCCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCcc
Confidence            44455555555433321      1234789999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +......... ......++..|+|||.+.++.++.++||||||+++|++++ |..||.....      .. .......+.
T Consensus       140 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------~~-~~~~~~~~~  211 (250)
T cd05085         140 SRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN------QQ-AREQVEKGY  211 (250)
T ss_pred             ceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------HH-HHHHHHcCC
Confidence            8754322211 1112234567999999988889999999999999999998 8888743211      11 111111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      ..         .........+.+++.+||+.+|++||++.++++.|.
T Consensus       212 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 RM---------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11         011122356788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=9.8e-25  Score=216.69  Aligned_cols=183  Identities=25%  Similarity=0.388  Sum_probs=132.2

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+...+++      ....+++..++.++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||.
T Consensus        85 ~v~e~~~~g~L~~~l~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          85 LITQLMPLGCLLDYVRN------HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             EEEecCCCCcHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcc
Confidence            34445555555433322      1234899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++...............++..|++||.+....++.++||||||+++||+++ |+.||.....      .+.. .....+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~-~~~~~~~  228 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIP-DLLEKGE  228 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHH-HHHhCCC
Confidence            987653332222212223567999999988889999999999999999998 9998743211      1111 1111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..         ..+......+.+++.+||..||++||++.++++.|+..
T Consensus       229 ~~---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         229 RL---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            10         00111223567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.90  E-value=1e-24  Score=213.47  Aligned_cols=178  Identities=26%  Similarity=0.340  Sum_probs=130.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+....+.     .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||.
T Consensus        75 ~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~  146 (254)
T cd05083          75 IVMELMSKGNLVNFLRT-----RGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGL  146 (254)
T ss_pred             EEEECCCCCCHHHHHHh-----cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCcc
Confidence            34455555555433322     12335899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +.......     .....+..|+|||.+.++.++.++|+||||+++|||++ |+.||.....      .+. ......+.
T Consensus       147 ~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~-~~~~~~~~  214 (254)
T cd05083         147 ARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEV-KECVEKGY  214 (254)
T ss_pred             ceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHH-HHHHhCCC
Confidence            87532211     11233567999999988889999999999999999998 8888743211      111 11111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ...         ........+.+++.+||+.+|++||++++|++.|+.
T Consensus       215 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 RME---------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCC---------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            110         111223466789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.90  E-value=5.7e-24  Score=207.54  Aligned_cols=162  Identities=28%  Similarity=0.348  Sum_probs=121.5

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..++.++.+++.||.|||+++   ++||||||+||+++.++.+||+|||++.................+..|+|||
T Consensus        89 ~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE  165 (251)
T cd05041          89 RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE  165 (251)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChH
Confidence            5789999999999999999999998   9999999999999999999999999987654222222212223356799999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+.++.++.++||||||+++|||++ |..||......   ..    ........  .       ...+......+.+++.
T Consensus       166 ~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~----~~~~~~~~--~-------~~~~~~~~~~~~~li~  229 (251)
T cd05041         166 ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QT----RERIESGY--R-------MPAPQLCPEEIYRLML  229 (251)
T ss_pred             hhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HH----HHHHhcCC--C-------CCCCccCCHHHHHHHH
Confidence            9988889999999999999999999 77776432211   01    11111110  0       0011122346778899


Q ss_pred             hhcccCCCCCCCHHHHHHHHhc
Q 009186          474 LCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +||+.+|++||++.||++.|++
T Consensus       230 ~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         230 QCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             HHhccChhhCcCHHHHHHHhhC
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.5e-25  Score=226.33  Aligned_cols=193  Identities=27%  Similarity=0.310  Sum_probs=144.7

Q ss_pred             hhHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEE
Q 009186          284 GTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI  363 (541)
Q Consensus       284 ~~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL  363 (541)
                      ..+++++||++.+|.|..++++.      +..++..++++++.+.+.||+|||+++   +|||||-.+|+|++.++.+||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~------~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKN------KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhC------CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEe
Confidence            35789999999999997777652      226999999999999999999999999   999999999999999999999


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      +|||+++.-..  .........-...|+|||.+..+.++.++|||||||++||+++ |..||...      ...+.....
T Consensus       304 SDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~------~~~~v~~kI  375 (474)
T KOG0194|consen  304 SDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM------KNYEVKAKI  375 (474)
T ss_pred             CccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC------CHHHHHHHH
Confidence            99999875321  1111111234578999999999999999999999999999999 77786422      222222222


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCC
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPP  502 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~  502 (541)
                      ...+....         .+......+..++.+||..||++||+|.++.+.|+........
T Consensus       376 ~~~~~r~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  376 VKNGYRMP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HhcCccCC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            12221111         1112234455566799999999999999999999876554443

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.90  E-value=2e-24  Score=211.51  Aligned_cols=173  Identities=20%  Similarity=0.314  Sum_probs=126.5

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-------Cc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-------NP  361 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-------~~  361 (541)
                      ++++++..+.|...+++.      ...+++..++.++.||+.||+|||+++   |+|+||||+||+++.++       .+
T Consensus        77 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~  147 (259)
T cd05037          77 MVEEYVKFGPLDVFLHRE------KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFI  147 (259)
T ss_pred             EEEEcCCCCcHHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeE
Confidence            455666666664444321      125899999999999999999999998   99999999999999887       79


Q ss_pred             EEecccccccccCCCCcccccccccCCCCCChhhhccC--CCCcchhhHHHHHHHHHHHhC-CCCCCCCCCcCcCcHHHH
Q 009186          362 KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG--VFSVKSDVFSFGVLLLEIISG-KRNSGFYLSEHGQSLLTY  438 (541)
Q Consensus       362 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~elltg-~~p~~~~~~~~~~~~~~~  438 (541)
                      ||+|||++.....      .....++..|+|||.+.+.  .++.++||||||+++|||++| ..|+......   ..   
T Consensus       148 kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~---  215 (259)
T cd05037         148 KLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EK---  215 (259)
T ss_pred             EeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hH---
Confidence            9999999876433      1123456789999999876  789999999999999999994 6665322111   00   


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                       ...+.....       +.    ......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       216 -~~~~~~~~~-------~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         216 -ERFYQDQHR-------LP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -HHHHhcCCC-------CC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             011111000       00    011156778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.90  E-value=5e-24  Score=209.32  Aligned_cols=163  Identities=28%  Similarity=0.355  Sum_probs=119.9

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc--ccccccccCCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVAGTYGYMA  392 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~a  392 (541)
                      .+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++........  .......++..|+|
T Consensus        94 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a  170 (262)
T cd05058          94 NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA  170 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccC
Confidence            3677888999999999999999998   999999999999999999999999998754322111  11112345678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGK-RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++|. .||...      ...+...... .+...     ....    .....+.++
T Consensus       171 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~------~~~~~~~~~~-~~~~~-----~~~~----~~~~~~~~l  234 (262)
T cd05058         171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------DSFDITVYLL-QGRRL-----LQPE----YCPDPLYEV  234 (262)
T ss_pred             hhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHh-cCCCC-----CCCC----cCCHHHHHH
Confidence            99998888999999999999999999954 454321      1111111111 11100     0011    112357789


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +..||+.+|++||++.+|++.|+..
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.90  E-value=8.6e-24  Score=219.07  Aligned_cols=171  Identities=23%  Similarity=0.325  Sum_probs=120.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++........ ......++..|+||
T Consensus        98 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aP  173 (372)
T cd07853          98 QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAP  173 (372)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCH
Confidence            45899999999999999999999999   999999999999999999999999999764332221 12234578899999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcc----------ccc-----c-ccc
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEAL----------ELM-----D-PVL  456 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~-----~-~~l  456 (541)
                      |.+.+. .++.++|||||||++|||++|+.||.......   ...............          ..+     . +..
T Consensus       174 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (372)
T cd07853         174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSL  250 (372)
T ss_pred             HHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCch
Confidence            998774 47899999999999999999999985432111   111110000000000          000     0 000


Q ss_pred             c--CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          457 K--QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       457 ~--~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .  ..........+.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         251 PVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            0  0011112346778999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.90  E-value=5.5e-25  Score=224.15  Aligned_cols=180  Identities=21%  Similarity=0.244  Sum_probs=129.1

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|...+++.      ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        77 ~lv~e~~~~~~L~~~l~~~------~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY------EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCC
Confidence            4556666666665444321      235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAM------EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      ++..+...... ......|++.|+|||++.      ...++.++|||||||++|||++|+.||.....      ......
T Consensus       148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~  220 (330)
T cd05601         148 SAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNN  220 (330)
T ss_pred             CCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHH
Confidence            99865433222 222346899999999986      45678899999999999999999999843211      111111


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ...........+       .......+.+++..||+ +|.+||++.+++.
T Consensus       221 i~~~~~~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         221 IMNFQRFLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            111111111100       01123446677788997 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.6e-24  Score=213.58  Aligned_cols=181  Identities=23%  Similarity=0.282  Sum_probs=131.1

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+..+.+.....+     .....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+||
T Consensus        75 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Df  146 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYN-----MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDL  146 (285)
T ss_pred             EEEEEeccCCCcHHHHHHh-----cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeC
Confidence            3455666666666433321     11235899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |++........   .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......   ...+.........
T Consensus       147 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~~~~~~~~~  220 (285)
T cd05605         147 GLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREEVERRVKED  220 (285)
T ss_pred             CCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHHHHHHhhhc
Confidence            99876532221   12346789999999999888999999999999999999999998532211   1111111111110


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                      .          ..........+.+++.+||+.||++||     +++++++
T Consensus       221 ~----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 Q----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             c----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            0          111122344567888999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.90  E-value=2.8e-24  Score=211.63  Aligned_cols=173  Identities=23%  Similarity=0.345  Sum_probs=123.4

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC-------c
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-------P  361 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~-------~  361 (541)
                      ++++++..+.+...+++      +...+++..+++++.||+.||+|||+++   |+||||||+|||++.++.       +
T Consensus        81 lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR------KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             EEEecccCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCcee
Confidence            45566655554322221      2345899999999999999999999998   999999999999987664       8


Q ss_pred             EEecccccccccCCCCcccccccccCCCCCChhhhc-cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHH
Q 009186          362 KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYA  439 (541)
Q Consensus       362 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~  439 (541)
                      +++|||++......      ....++..|+|||.+. +..++.++||||||+++|||++ |+.|+....      ..+. 
T Consensus       152 ~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~~-  218 (262)
T cd05077         152 KLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT------LAEK-  218 (262)
T ss_pred             EeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc------hhHH-
Confidence            99999988654221      1235678899999887 4568899999999999999984 777753221      1110 


Q ss_pred             HHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          440 WKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       440 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      .... .+.. ..         .......+.+|+.+||+.||.+||++.+|++.|+
T Consensus       219 ~~~~-~~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 ERFY-EGQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHH-hcCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1111 1110 00         0111345678899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.90  E-value=4.9e-24  Score=220.13  Aligned_cols=129  Identities=26%  Similarity=0.337  Sum_probs=105.8

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+.+|.|...+.+       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DF  145 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMK-------KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDF  145 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeec
Confidence            3456777777776544432       245899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCc---------------------------------ccccccccCCCCCChhhhccCCCCcchhhHHHHHH
Q 009186          367 GMARIFSGNQNE---------------------------------ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVL  413 (541)
Q Consensus       367 g~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvl  413 (541)
                      |+++.+......                                 .......||+.|+|||++.+..++.++|||||||+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi  225 (363)
T cd05628         146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI  225 (363)
T ss_pred             cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence            998754321100                                 00123468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCC
Q 009186          414 LLEIISGKRNSG  425 (541)
Q Consensus       414 l~elltg~~p~~  425 (541)
                      +|||++|+.||.
T Consensus       226 l~ell~G~~Pf~  237 (363)
T cd05628         226 MYEMLIGYPPFC  237 (363)
T ss_pred             HHHHHhCCCCCC
Confidence            999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.90  E-value=1.4e-23  Score=216.44  Aligned_cols=106  Identities=30%  Similarity=0.412  Sum_probs=93.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++......   ......+|..|+|||
T Consensus       119 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE  192 (359)
T cd07876         119 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPE  192 (359)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCch
Confidence            3788899999999999999999999   9999999999999999999999999987543221   122346789999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      .+.+..++.++||||||+++|+|++|+.||..
T Consensus       193 ~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             hccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            99998999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=2.6e-24  Score=220.82  Aligned_cols=181  Identities=24%  Similarity=0.364  Sum_probs=135.7

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-CCcEEecc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDF  366 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-~~~kL~Df  366 (541)
                      ..++|++..|.|..++++.       ++++.+.+..|++||++||.|||++. +||||||||-+||+|+.+ |.+||+|+
T Consensus       119 n~iTEL~TSGtLr~Y~kk~-------~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKH-------RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             eeeeecccCCcHHHHHHHh-------ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecch
Confidence            3456777788887666553       34788899999999999999999996 689999999999999765 78999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+|.......    .....||+.|||||.+. ..|++.+||||||+.++||+|+.-||.     ...+..+..++.....
T Consensus       191 GLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~SGi  260 (632)
T KOG0584|consen  191 GLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVTSGI  260 (632)
T ss_pred             hHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHHcCC
Confidence            9998754322    23378999999999875 789999999999999999999999974     2233344333333222


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASD  496 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~  496 (541)
                      .+ ..+.     .....+   +.+|+.+||.. ..+|||+.|+|.  .|..+
T Consensus       261 KP-~sl~-----kV~dPe---vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  261 KP-AALS-----KVKDPE---VREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             CH-HHhh-----ccCCHH---HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            22 1111     112233   44566799998 999999999995  56554

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.90  E-value=2e-24  Score=212.00  Aligned_cols=175  Identities=19%  Similarity=0.296  Sum_probs=126.3

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC------
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN------  360 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~------  360 (541)
                      .+++++|+..+.|....++      .+..+++..++.++.||+.||+|||+++   |+||||||+||+++.++.      
T Consensus        74 ~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~  144 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKK------NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNP  144 (258)
T ss_pred             cEEEEecCCCCcHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCC
Confidence            3456677777766444432      1225899999999999999999999999   999999999999987765      


Q ss_pred             --cEEecccccccccCCCCcccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCC-CCCCCCCCcCcCcHH
Q 009186          361 --PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGK-RNSGFYLSEHGQSLL  436 (541)
Q Consensus       361 --~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~-~p~~~~~~~~~~~~~  436 (541)
                        ++++|||++.....      .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+.....      .
T Consensus       145 ~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------~  212 (258)
T cd05078         145 PFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------Q  212 (258)
T ss_pred             ceEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------H
Confidence              58999998765432      1224567889999999864 4789999999999999999985 44421111      1


Q ss_pred             HHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      ... ..... .      .    ..+.....++.+++.+||+.||++|||+++|++.|+
T Consensus       213 ~~~-~~~~~-~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         213 KKL-QFYED-R------H----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHH-HHHHc-c------c----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            100 00000 0      0    111122345778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.90  E-value=1.7e-24  Score=211.83  Aligned_cols=161  Identities=29%  Similarity=0.410  Sum_probs=121.5

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..++++.++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||.++........ ......++..|+||
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aP  170 (256)
T cd05112          95 GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSP  170 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCH
Confidence            35889999999999999999999998   999999999999999999999999998765332211 11122345689999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.++.++.++||||||+++|||++ |+.||.....      ..... ....+.  ....+..       ....+.+++
T Consensus       171 e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~--~~~~~~~-------~~~~~~~l~  234 (256)
T cd05112         171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVE-TINAGF--RLYKPRL-------ASQSVYELM  234 (256)
T ss_pred             hHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHH-HHhCCC--CCCCCCC-------CCHHHHHHH
Confidence            99988889999999999999999998 8888743211      11111 111110  1111111       235677899


Q ss_pred             hhhcccCCCCCCCHHHHHHHHh
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      .+||+.+|++||++.+++++|+
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHcccChhhCCCHHHHHHhhC
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.90  E-value=1.8e-24  Score=213.41  Aligned_cols=162  Identities=24%  Similarity=0.376  Sum_probs=123.9

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ...+++..+++++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||+|||.+.......   ......++..|+
T Consensus       107 ~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~  180 (269)
T cd08528         107 KQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS  180 (269)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCc
Confidence            3468999999999999999999996 56   9999999999999999999999999997654332   223356788999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      +||.+.+..++.++||||||+++|||++|+.||....      ........ ........     ..   ......+.++
T Consensus       181 ~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~-~~~~~~~~-----~~---~~~~~~l~~l  245 (269)
T cd08528         181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKI-VEAVYEPL-----PE---GMYSEDVTDV  245 (269)
T ss_pred             ChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHH-hhccCCcC-----Cc---ccCCHHHHHH
Confidence            9999998889999999999999999999999974221      11111111 11111100     00   0123456778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.||++||++.||.++|++
T Consensus       246 i~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         246 ITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             HHHHCCCCCccCCCHHHHHHHhcC
Confidence            889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=1.4e-24  Score=212.62  Aligned_cols=157  Identities=31%  Similarity=0.437  Sum_probs=121.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||.++.......     ....+..|++||
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape  169 (256)
T cd05039          98 VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPE  169 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCch
Confidence            5899999999999999999999999   99999999999999999999999999886532221     123456799999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+..+.++.++||||||+++||+++ |+.||.....   ..+..    ....+....         .+......+.+++.
T Consensus       170 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~~---------~~~~~~~~~~~li~  233 (256)
T cd05039         170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP----HVEKGYRME---------APEGCPPEVYKVMK  233 (256)
T ss_pred             hhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHhcCCCCC---------CccCCCHHHHHHHH
Confidence            9988889999999999999999997 8888743211   11111    111111100         11112346778899


Q ss_pred             hhcccCCCCCCCHHHHHHHHhc
Q 009186          474 LCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +||+.+|++||++.+++++|+.
T Consensus       234 ~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         234 DCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HHhccChhhCcCHHHHHHHHhc
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.4e-24  Score=211.44  Aligned_cols=163  Identities=29%  Similarity=0.460  Sum_probs=123.0

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++.++..++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||.+..+...... .......+..|++
T Consensus        97 ~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~  172 (261)
T cd05034          97 GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTA  172 (261)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccCCCccccC
Confidence            346899999999999999999999998   999999999999999999999999998765432211 1112234568999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++||+++ |+.||....   .......    ...+.     ..    ..+......+.++
T Consensus       173 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~----~~~~~-----~~----~~~~~~~~~~~~~  236 (261)
T cd05034         173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQ----VERGY-----RM----PRPPNCPEELYDL  236 (261)
T ss_pred             HHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----HHcCC-----CC----CCCCCCCHHHHHH
Confidence            999998889999999999999999998 898874221   1111111    11110     00    0011113457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.+|++||+++++++.|+.
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHcccCcccCCCHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.90  E-value=1.5e-24  Score=214.12  Aligned_cols=163  Identities=26%  Similarity=0.395  Sum_probs=120.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccc---cCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVA---GTYGY  390 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~---gt~~y  390 (541)
                      ..+++.+++.++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||++................   .+..|
T Consensus       101 ~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y  177 (269)
T cd05065         101 GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW  177 (269)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceee
Confidence            35899999999999999999999998   9999999999999999999999999987654332211111111   13579


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      ++||.+.+..++.++||||||+++||+++ |..||.....   .......    ....     ..    ..+.+....+.
T Consensus       178 ~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i----~~~~-----~~----~~~~~~~~~~~  241 (269)
T cd05065         178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAI----EQDY-----RL----PPPMDCPTALH  241 (269)
T ss_pred             cCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHH----HcCC-----cC----CCcccCCHHHH
Confidence            99999998899999999999999999886 9888742211   1111111    1110     00    00111234567


Q ss_pred             HHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +++.+||+.+|.+||++.+|+..|+.
T Consensus       242 ~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         242 QLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            88899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.90  E-value=3.5e-24  Score=209.69  Aligned_cols=178  Identities=21%  Similarity=0.299  Sum_probs=130.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.+....+.     .+...++++..+.++.||+.||.|||+++   |+|+||||+||+++.++.++|+|||.
T Consensus        75 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~  146 (255)
T cd08219          75 IVMEYCDGGDLMQKIKL-----QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGS  146 (255)
T ss_pred             EEEeeCCCCcHHHHHHh-----ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCc
Confidence            34555555554333221     12345889999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      +........  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...      .......... .+..
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~------~~~~~~~~~~-~~~~  217 (255)
T cd08219         147 ARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN------SWKNLILKVC-QGSY  217 (255)
T ss_pred             ceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC------CHHHHHHHHh-cCCC
Confidence            876543222  122346788999999998888999999999999999999999998422      1111111111 1111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ..     +    +......+.+++.+||+.||++||++.+|+..
T Consensus       218 ~~-----~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 KP-----L----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CC-----C----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            11     1    11123456788899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-25  Score=231.89  Aligned_cols=186  Identities=25%  Similarity=0.416  Sum_probs=150.0

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      -++.++.||+..|.|-.++|+      +.+.+++.+...++++|+.|++||-+.+   +|||||.++|||++.+...|++
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~------~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVs  773 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQ------NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVS  773 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhh------cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEec
Confidence            477889999999999666654      1244999999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCccccccccc--CCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHH
Q 009186          365 DFGMARIFSGNQNEANTNRVAG--TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      |||+++.+.++.. .......|  ..+|.|||.+....++.++|||||||++||.++ |.+|+-.               
T Consensus       774 DFGLSRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd---------------  837 (996)
T KOG0196|consen  774 DFGLSRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD---------------  837 (996)
T ss_pred             cccceeecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc---------------
Confidence            9999997755542 22222222  468999999999999999999999999999887 8888621               


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                       +.+.+..+.+....+-..+.+....+.+||+.||++|-.+||++.+|+..|.+.
T Consensus       838 -mSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  838 -MSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             -cchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence             112223333444444455667788899999999999999999999999999763

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.90  E-value=8.2e-24  Score=216.76  Aligned_cols=165  Identities=28%  Similarity=0.398  Sum_probs=124.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++.+++.||++||+|||+++   |+||||||+||+++.++.+||+|||++................++..|+||
T Consensus       174 ~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  250 (343)
T cd05103         174 KVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  250 (343)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECc
Confidence            35899999999999999999999998   999999999999999999999999998765333222222223456779999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |..||......      .........+....     ...    .....+.+++
T Consensus       251 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~-----~~~----~~~~~~~~~~  315 (343)
T cd05103         251 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRMR-----APD----YTTPEMYQTM  315 (343)
T ss_pred             HHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCCCC-----CCC----CCCHHHHHHH
Confidence            99988889999999999999999997 88887432111      01111111111111     001    1123577888


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..||+.||++||++.+|++.|+..
T Consensus       316 ~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         316 LDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.90  E-value=1.4e-23  Score=205.13  Aligned_cols=158  Identities=27%  Similarity=0.356  Sum_probs=122.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++++++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.+......  .....++..|+||
T Consensus        96 ~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aP  170 (256)
T cd08529          96 RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSP  170 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccCH
Confidence            46899999999999999999999998   999999999999999999999999998865433222  2234578899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |++.+..++.++||||||+++|||++|+.||.....      .... .....+...         .........+.+++.
T Consensus       171 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~---------~~~~~~~~~~~~~i~  234 (256)
T cd08529         171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALI-LKIIRGVFP---------PVSQMYSQQLAQLID  234 (256)
T ss_pred             HHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHH-HHHHcCCCC---------CCccccCHHHHHHHH
Confidence            999998899999999999999999999999853221      1111 111111110         111123346778999


Q ss_pred             hhcccCCCCCCCHHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~  492 (541)
                      +||+.+|++||++.++++.
T Consensus       235 ~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         235 QCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHccCCcccCcCHHHHhhC
Confidence            9999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.90  E-value=7.2e-24  Score=245.92  Aligned_cols=174  Identities=24%  Similarity=0.478  Sum_probs=134.6

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      ++|.++.+|+.||++||+|||......|+||||||+||+++.++.+++. |+.......      .....++..|+|||+
T Consensus       777 l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~  849 (968)
T PLN00113        777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPET  849 (968)
T ss_pred             CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCccc
Confidence            8999999999999999999995533349999999999999999888875 555433211      112357889999999


Q ss_pred             hccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccC--CCCHHHHHHHHHHHh
Q 009186          396 AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQ--TCVDAELLKCIHIGL  473 (541)
Q Consensus       396 l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~~l~~  473 (541)
                      +.+..++.++|||||||++|||++|+.||..... ......++.............+++.+..  ....++..++.+++.
T Consensus       850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  928 (968)
T PLN00113        850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL  928 (968)
T ss_pred             ccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHH
Confidence            9999999999999999999999999999843222 2334555555444444444555665533  234566778899999


Q ss_pred             hhcccCCCCCCCHHHHHHHHhcCC
Q 009186          474 LCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +||+.||++||+|+||+++|+...
T Consensus       929 ~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        929 HCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             hhCcCCchhCcCHHHHHHHHHHhh
Confidence            999999999999999999998754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=3.9e-23  Score=190.63  Aligned_cols=155  Identities=17%  Similarity=0.174  Sum_probs=115.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.|+.||+.||.|||+++         ||+||+++.++.+|+  ||.++......       ..|+..|+||
T Consensus        12 ~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~aP   73 (176)
T smart00750       12 RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMAP   73 (176)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccCh
Confidence            45999999999999999999999875         999999999999999  99987653321       2578999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHH--HHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL--LKCIHI  471 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~l  471 (541)
                      |++.+..++.++|||||||++|||++|+.||.....  ................      +... .......  ..+.++
T Consensus        74 E~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~~~~  144 (176)
T smart00750       74 EVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPADD------PRDR-SNLESVSAARSFADF  144 (176)
T ss_pred             HHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccCC------cccc-ccHHHHHhhhhHHHH
Confidence            999999999999999999999999999999743211  1111111111111100      0000 0011111  258889


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.||.+||++.++++.+..
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHH
Confidence            999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.90  E-value=6.2e-24  Score=213.82  Aligned_cols=162  Identities=28%  Similarity=0.362  Sum_probs=121.0

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   ........+..|+|
T Consensus       118 ~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~a  191 (303)
T cd05088         118 ASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMA  191 (303)
T ss_pred             cCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccC
Confidence            446899999999999999999999998   999999999999999999999999998642111   11111223567999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||.....   .....    ....+....         .+......+.++
T Consensus       192 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~----~~~~~~~~~---------~~~~~~~~~~~l  255 (303)
T cd05088         192 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE----KLPQGYRLE---------KPLNCDDEVYDL  255 (303)
T ss_pred             HHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHH----HHhcCCcCC---------CCCCCCHHHHHH
Confidence            999988889999999999999999998 9988742211   11111    111110000         011122356788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.+|++||+++++++.|+..
T Consensus       256 i~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         256 MRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.90  E-value=1.1e-23  Score=206.25  Aligned_cols=164  Identities=29%  Similarity=0.420  Sum_probs=121.5

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||++||.+||+.+   |+|+||||+||+++.++.++|+|||.+....  ..........++..|+|
T Consensus        92 ~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~~~~~~~y~a  166 (260)
T PF00069_consen   92 NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNPFVGTPEYMA  166 (260)
T ss_dssp             HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSSSSSSGGGSC
T ss_pred             ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccccccccccccccccc
Confidence            446899999999999999999999999   9999999999999999999999999987541  11222334567889999


Q ss_pred             hhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAM-EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~-~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+. +...+.++||||||+++|+|++|..||.......   ...........    .. ......  .......+.++
T Consensus       167 PE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~----~~-~~~~~~--~~~~~~~l~~l  236 (260)
T PF00069_consen  167 PEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEKILKR----PL-PSSSQQ--SREKSEELRDL  236 (260)
T ss_dssp             HHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHHHHHT----HH-HHHTTS--HTTSHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccchh---hhhhhhhcccc----cc-cccccc--cchhHHHHHHH
Confidence            99998 7889999999999999999999999975331111   11111110000    00 000000  00012677889


Q ss_pred             HhhhcccCCCCCCCHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+||+.||++||++.++++
T Consensus       237 i~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHccCChhHCcCHHHHhc
Confidence            99999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.8e-24  Score=222.03  Aligned_cols=181  Identities=19%  Similarity=0.199  Sum_probs=127.7

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++|++..+.|...+++       +..+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df  145 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMK-------KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDF  145 (364)
T ss_pred             EEEEECCCCCcHHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeec
Confidence            3455677767766544432       235899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcc------------------------------------cccccccCCCCCChhhhccCCCCcchhhHHH
Q 009186          367 GMARIFSGNQNEA------------------------------------NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSF  410 (541)
Q Consensus       367 g~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSl  410 (541)
                      |++..+.......                                    ......||+.|+|||++.+..++.++|||||
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  225 (364)
T cd05599         146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL  225 (364)
T ss_pred             ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence            9987543211100                                    0012358999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC---HH
Q 009186          411 GVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN---MS  487 (541)
Q Consensus       411 Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt---~~  487 (541)
                      ||++|||++|+.||....      ..+...............     ..  ......+.+++.+|+. +|.+|++   +.
T Consensus       226 G~il~el~~G~~Pf~~~~------~~~~~~~i~~~~~~~~~~-----~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~  291 (364)
T cd05599         226 GVIMYEMLVGYPPFCSDN------PQETYRKIINWKETLQFP-----DE--VPLSPEAKDLIKRLCC-EAERRLGNNGVN  291 (364)
T ss_pred             hhHHHHhhcCCCCCCCCC------HHHHHHHHHcCCCccCCC-----CC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence            999999999999985322      111111111111111100     00  0112345567778886 9999998   88


Q ss_pred             HHHH
Q 009186          488 SVVV  491 (541)
Q Consensus       488 evl~  491 (541)
                      ++++
T Consensus       292 ~ll~  295 (364)
T cd05599         292 EIKS  295 (364)
T ss_pred             HHhc
Confidence            8876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=1.9e-24  Score=210.10  Aligned_cols=173  Identities=21%  Similarity=0.300  Sum_probs=134.6

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      +||||...|-|+.+..       ..+.|++.+...+++||+.|+.|+|.++   ++|||||.+|||||.++++||+|||+
T Consensus       130 ivMEYaS~GeLYDYiS-------er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGL  199 (668)
T KOG0611|consen  130 IVMEYASGGELYDYIS-------ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGL  199 (668)
T ss_pred             EEEEecCCccHHHHHH-------HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccch
Confidence            3456666666655443       2557999999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +..+.....   ..+++|++-|.+||++.+.+| .+.+|.|||||+||.|+.|..||+..+..       ...+.+..+.
T Consensus       200 SNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~Ga  269 (668)
T KOG0611|consen  200 SNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGA  269 (668)
T ss_pred             hhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhccc
Confidence            987654433   335789999999999999887 47899999999999999999998543221       1122223333


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ..+-           +.......|+++||..||++|.|+.+|...
T Consensus       270 YrEP-----------~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  270 YREP-----------ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ccCC-----------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            2221           122334558889999999999999999864

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.90  E-value=2.3e-24  Score=211.72  Aligned_cols=163  Identities=27%  Similarity=0.468  Sum_probs=123.9

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++.+++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||.+..+...... ......++..|++
T Consensus        96 ~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~  171 (260)
T cd05073          96 GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTA  171 (260)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccC
Confidence            445889999999999999999999998   999999999999999999999999998765432211 1222345677999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+....++.++|+||||+++|++++ |+.||.....   ....    .....+....         ........+.++
T Consensus       172 PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~----~~~~~~~~~~---------~~~~~~~~~~~~  235 (260)
T cd05073         172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVI----RALERGYRMP---------RPENCPEELYNI  235 (260)
T ss_pred             HhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHhCCCCCC---------CcccCCHHHHHH
Confidence            999988889999999999999999998 8888742211   1111    1111111110         111223457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.+|++||++.++++.|+.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.90  E-value=4.7e-24  Score=212.07  Aligned_cols=176  Identities=24%  Similarity=0.270  Sum_probs=128.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.|...+++       ...+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||+
T Consensus        74 lv~e~~~~~~L~~~i~~-------~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~  143 (279)
T cd05633          74 FILDLMNGGDLHYHLSQ-------HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL  143 (279)
T ss_pred             EEEecCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCc
Confidence            44566666655433322       235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +.......    .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.........    ........  
T Consensus       144 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~--  213 (279)
T cd05633         144 ACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT--  213 (279)
T ss_pred             ceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc--
Confidence            87543221    123458899999998864 45789999999999999999999998533221111    11111000  


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVVM  492 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~~  492 (541)
                          ....+    +......+.+++.+||+.||++||     +++++++.
T Consensus       214 ----~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 ----VNVEL----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ----CCcCC----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                01111    122234567788899999999999     59999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-23  Score=191.91  Aligned_cols=158  Identities=23%  Similarity=0.315  Sum_probs=119.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC---CcEEecccccccccCCCCcccccccccCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM---NPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ..++..+-..+.||+++|.|+|.++   |||||+||+|+++....   -+||+|||++..++   ....-....||++||
T Consensus       106 ~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fm  179 (355)
T KOG0033|consen  106 FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYL  179 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC---CccccccccCCCccc
Confidence            4678888899999999999999999   99999999999995443   47999999998876   222334578999999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      +||++...+++..+|||+-||+||-|+.|.+||-.   +....+.+.+.    .+. .++ +    ....+.......+|
T Consensus       180 aPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~----~g~-yd~-~----~~~w~~is~~Ak~L  246 (355)
T KOG0033|consen  180 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIK----AGA-YDY-P----SPEWDTVTPEAKSL  246 (355)
T ss_pred             CHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHh----ccc-cCC-C----CcccCcCCHHHHHH
Confidence            99999999999999999999999999999999832   12222222221    111 111 1    11112223445667


Q ss_pred             HhhhcccCCCCCCCHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+||..||.+|.|+.|.+.
T Consensus       247 vrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  247 IRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHHhccChhhhccHHHHhC
Confidence            88999999999999998764

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.90  E-value=3.1e-24  Score=210.53  Aligned_cols=181  Identities=22%  Similarity=0.269  Sum_probs=134.3

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhh-----hcCCCceEecccCCCcEEEcCCCCcE
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLH-----EDSRLRVIHRDLKTSNVLLDHEMNPK  362 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH-----~~~~~~ivH~DLkp~NIll~~~~~~k  362 (541)
                      +++++++..+.+....+..   ......+++.+++.++.||+.||.|||     +.+   ++|+||||+||+++.++.+|
T Consensus        77 ~~~~e~~~~~~L~~~l~~~---~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~k  150 (265)
T cd08217          77 YIVMEYCEGGDLAQLIQKC---KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVK  150 (265)
T ss_pred             EEEehhccCCCHHHHHHHH---hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEE
Confidence            3456666666554333321   123456999999999999999999999     777   99999999999999999999


Q ss_pred             EecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       363 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      |+|||++.........  .....++..|++||.+.+..++.++|+||||+++|+|++|+.||....   ....    ...
T Consensus       151 l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~----~~~  221 (265)
T cd08217         151 LGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQL----ASK  221 (265)
T ss_pred             EecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHH----HHH
Confidence            9999999876543321  123467889999999988889999999999999999999999975322   1111    111


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ...+..         ...+......+.+++.+||+.+|++||++.+|+++
T Consensus       222 ~~~~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         222 IKEGKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HhcCCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            111111         11122334567889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.90  E-value=9.7e-24  Score=211.65  Aligned_cols=178  Identities=22%  Similarity=0.322  Sum_probs=130.5

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      .+++++|+..+.+....+        +..+++.++..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+||
T Consensus        92 ~~lv~e~~~~~~L~~~~~--------~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVT--------ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             EEEeecccCCCCHHHHHH--------hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECcc
Confidence            355667766666644332        124789999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |++.........  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....      ...........
T Consensus       161 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~------~~~~~~~~~~~  232 (296)
T cd06654         161 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNG  232 (296)
T ss_pred             ccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH------HHhHHHHhcCC
Confidence            998764332211  1224578899999999888899999999999999999999999843221      11111111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..      .+  ..+......+.+++.+||+.||++||++.+|++
T Consensus       233 ~~------~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         233 TP------EL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CC------CC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            10      00  011122345678889999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.90  E-value=2.7e-24  Score=212.10  Aligned_cols=182  Identities=26%  Similarity=0.404  Sum_probs=130.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.|...+++      +...+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus        82 lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd05066          82 IVTEYMENGSLDAFLRK------HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGL  152 (267)
T ss_pred             EEEEcCCCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCc
Confidence            34555555555333322      1235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCccc-ccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          369 ARIFSGNQNEAN-TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       369 a~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      ++.+........ .....++..|++||.+.+..++.++||||||+++||+++ |+.||.....   .....    ...++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~----~~~~~  225 (267)
T cd05066         153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIK----AIEEG  225 (267)
T ss_pred             ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHH----HHhCC
Confidence            987644322111 111223467999999998889999999999999999886 9988743211   11111    11111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..     .    .........+.+++.+||+.+|.+||++.++++.|+.
T Consensus       226 ~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         226 YR-----L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             Cc-----C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            10     0    0011123456788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.89  E-value=1e-23  Score=208.44  Aligned_cols=163  Identities=24%  Similarity=0.378  Sum_probs=124.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++...++++.||+.||+|||+++   |+|+||||+||+++.++.+||+|||+++...............++..|++||
T Consensus       109 ~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  185 (273)
T cd05074         109 TLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE  185 (273)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHh
Confidence            5899999999999999999999998   9999999999999999999999999988654332222222334567899999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+.+..++.++||||||+++|||++ |+.||.....   .....+    +.......         ........+.+++.
T Consensus       186 ~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~----~~~~~~~~---------~~~~~~~~~~~l~~  249 (273)
T cd05074         186 SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY----LIKGNRLK---------QPPDCLEDVYELMC  249 (273)
T ss_pred             HHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH----HHcCCcCC---------CCCCCCHHHHHHHH
Confidence            9988889999999999999999999 7888642211   111111    11111110         01122356888999


Q ss_pred             hhcccCCCCCCCHHHHHHHHhcC
Q 009186          474 LCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +||+.+|++||++.++++.|++.
T Consensus       250 ~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         250 QCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHcCCChhhCcCHHHHHHHHHhh
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.89  E-value=3e-23  Score=212.54  Aligned_cols=165  Identities=24%  Similarity=0.287  Sum_probs=118.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.....     .....++..|+||
T Consensus       113 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aP  184 (343)
T cd07878         113 QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAP  184 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCc
Confidence            35899999999999999999999999   999999999999999999999999998765322     1234678999999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccc-----------cccccCCCC
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELM-----------DPVLKQTCV  461 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~l~~~~~  461 (541)
                      |.+.+ ..++.++||||||+++|+|++|+.||......   ..+....... .....+..           ...+. ..+
T Consensus       185 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~  259 (343)
T cd07878         185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---DQLKRIMEVV-GTPSPEVLKKISSEHARKYIQSLP-HMP  259 (343)
T ss_pred             hHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHh-CCCCHHHHHhcchhhHHHHhhccc-ccc
Confidence            99876 46889999999999999999999998532211   0111100000 00000000           00000 000


Q ss_pred             H--------HHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          462 D--------AELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       462 ~--------~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .        .....+.+++.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         260 QQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             chhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0        01224678999999999999999999995

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.89  E-value=2.3e-23  Score=215.69  Aligned_cols=109  Identities=28%  Similarity=0.335  Sum_probs=94.2

Q ss_pred             CCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC--CcEEecccccccccCCCCcccccccccC
Q 009186          310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM--NPKISDFGMARIFSGNQNEANTNRVAGT  387 (541)
Q Consensus       310 ~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~gt  387 (541)
                      .++-..|+...+..|+.||+.||.+||+.+   |||+||||+||||...+  .+||+|||.+........     ....+
T Consensus       280 ~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQS  351 (586)
T KOG0667|consen  280 NNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQS  351 (586)
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeec
Confidence            344556999999999999999999999999   99999999999997544  689999999987533222     45668


Q ss_pred             CCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       388 ~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      ..|+|||++.+.+|+.+.||||||||+.||++|.+-|..
T Consensus       352 RfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  352 RFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             cccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            899999999999999999999999999999999877643

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.89  E-value=3.2e-23  Score=205.93  Aligned_cols=162  Identities=25%  Similarity=0.388  Sum_probs=121.3

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      +++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++..+...    ......++..|+|||.
T Consensus        92 ~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~  164 (279)
T cd06619          92 IPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPER  164 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCcee
Confidence            678888999999999999999999   999999999999999999999999998765322    1223468889999999


Q ss_pred             hccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhh
Q 009186          396 AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLC  475 (541)
Q Consensus       396 l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~c  475 (541)
                      +.+..++.++||||||+++|+|++|+.||..................+....     .+.+..   ......+.+++.+|
T Consensus       165 ~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~---~~~~~~~~~li~~~  236 (279)
T cd06619         165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPV---GQFSEKFVHFITQC  236 (279)
T ss_pred             ecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCC---CcCCHHHHHHHHHH
Confidence            9988899999999999999999999999854332221111111111111111     111111   11233567888899


Q ss_pred             cccCCCCCCCHHHHHHH
Q 009186          476 VQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       476 l~~dP~~RPt~~evl~~  492 (541)
                      |+.||++||+++++++.
T Consensus       237 l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         237 MRKQPKERPAPENLMDH  253 (279)
T ss_pred             hhCChhhCCCHHHHhcC
Confidence            99999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.89  E-value=6.1e-24  Score=219.89  Aligned_cols=181  Identities=19%  Similarity=0.217  Sum_probs=129.9

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+.+|.|...+++        ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~Df  186 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN--------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  186 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEec
Confidence            4556677777766544322        24788889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG----VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      |++......... ......|++.|+|||.+.+.    .++.++|||||||++|||++|+.||....      ........
T Consensus       187 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~i  259 (370)
T cd05596         187 GTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKI  259 (370)
T ss_pred             cceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC------HHHHHHHH
Confidence            998765432211 12235689999999998653    37889999999999999999999985321      11111111


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCC--CCCHHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAH--RPNMSSVVVM  492 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~evl~~  492 (541)
                      .........     ..  .......+.+++.+||+.+|.+  ||+++++++.
T Consensus       260 ~~~~~~~~~-----~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         260 MDHKNSLTF-----PD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HcCCCcCCC-----CC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111111110     01  0112345667888999999987  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.9e-24  Score=211.05  Aligned_cols=175  Identities=25%  Similarity=0.303  Sum_probs=127.8

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      +|+.++-+|.|.+.+-.     ..+..++++.++-++.+|+.||++||+..   ||.|||||+|||||+.|+++|+|+|+
T Consensus       262 lVLtlMNGGDLkfHiyn-----~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGL  333 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYN-----HGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGL  333 (591)
T ss_pred             EEEEeecCCceeEEeec-----cCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccce
Confidence            33444556666433321     22356999999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      |..+...+...   ..+||.+|||||++.++.|+...|.|+|||+||||+.|+.||..+........++   +...+   
T Consensus       334 Avei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---rr~~~---  404 (591)
T KOG0986|consen  334 AVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---RRTLE---  404 (591)
T ss_pred             EEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---HHHhc---
Confidence            99876655433   2389999999999999999999999999999999999999985433222211111   10000   


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS  487 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~  487 (541)
                          +   ...+++.-..+...|....|+.||++|.-..
T Consensus       405 ----~---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 ----D---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ----c---hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                0   0112222334455566688999999986443

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.89  E-value=9.6e-24  Score=219.40  Aligned_cols=182  Identities=21%  Similarity=0.270  Sum_probs=124.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+..|.|...+++       ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~E~~~gg~L~~~l~~-------~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR-------MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             EEEEecCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCc
Confidence            345666666666444322       235889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCc---------------------------------------------ccccccccCCCCCChhhhccCCCC
Q 009186          368 MARIFSGNQNE---------------------------------------------ANTNRVAGTYGYMAPEYAMEGVFS  402 (541)
Q Consensus       368 ~a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~s  402 (541)
                      +++.+......                                             .......||..|+|||.+.+..++
T Consensus       147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  226 (381)
T cd05626         147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT  226 (381)
T ss_pred             CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence            97543211000                                             001234689999999999988899


Q ss_pred             cchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh--hcccCC
Q 009186          403 VKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL--CVQEDP  480 (541)
Q Consensus       403 ~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~--cl~~dP  480 (541)
                      .++|||||||++|||++|+.||......      +.............. ..  ....    ...+.+++.+  |+..++
T Consensus       227 ~~~DiwSlG~il~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~~-~~--~~~~----s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         227 QLCDWWSVGVILFEMLVGQPPFLAPTPT------ETQLKVINWENTLHI-PP--QVKL----SPEAVDLITKLCCSAEER  293 (381)
T ss_pred             CccceeehhhHHHHHHhCCCCCcCCCHH------HHHHHHHccccccCC-CC--CCCC----CHHHHHHHHHHccCcccc
Confidence            9999999999999999999998532211      111111110000000 00  0011    1234445544  567777


Q ss_pred             CCCCCHHHHHHH
Q 009186          481 AHRPNMSSVVVM  492 (541)
Q Consensus       481 ~~RPt~~evl~~  492 (541)
                      ..||++.+++..
T Consensus       294 ~~R~~~~~~l~h  305 (381)
T cd05626         294 LGRNGADDIKAH  305 (381)
T ss_pred             cCCCCHHHHhcC
Confidence            789999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.89  E-value=3.8e-24  Score=210.94  Aligned_cols=181  Identities=22%  Similarity=0.297  Sum_probs=127.1

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+....++       +..+++.++..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+
T Consensus        83 iv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~  152 (267)
T cd06646          83 ICMEYCGGGSLQDIYHV-------TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGV  152 (267)
T ss_pred             EEEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcc
Confidence            34555555555433321       235899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      +..+.....  ......++..|+|||.+.   ...++.++||||||+++|||++|+.||........      .. .+..
T Consensus       153 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~------~~-~~~~  223 (267)
T cd06646         153 AAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LF-LMSK  223 (267)
T ss_pred             ceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh------he-eeec
Confidence            886532221  112345788999999874   34578899999999999999999998732211100      00 0000


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      ..   ...+....  .......+.+++.+||+.+|++||++++|++.|
T Consensus       224 ~~---~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         224 SN---FQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CC---CCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00   00011110  112234677889999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=6.2e-24  Score=218.41  Aligned_cols=160  Identities=28%  Similarity=0.454  Sum_probs=125.5

Q ss_pred             cHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc-CCCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          317 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       317 ~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      .+...--+.+||++||+|||++.   |||||||-+|||++ ..|.+||+|||.++.+..-.  ..++++.||..|||||+
T Consensus       673 NEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETFTGTLQYMAPEv  747 (1226)
T KOG4279|consen  673 NESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEV  747 (1226)
T ss_pred             chhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--ccccccccchhhhChHh
Confidence            56677788999999999999998   99999999999995 57889999999998765443  34556889999999999


Q ss_pred             hccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          396 AMEGV--FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       396 l~~~~--~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      +-.++  |..++|||||||++.||.||++||......+.     .   .+.-|    +.  ...+..+.+...+...+++
T Consensus       748 IDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----A---MFkVG----my--KvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  748 IDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----A---MFKVG----MY--KVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             hccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----h---hhhhc----ce--ecCCCCcHHHHHHHHHHHH
Confidence            98765  88999999999999999999999843222111     0   00000    00  1123445667778889999


Q ss_pred             hhcccCCCCCCCHHHHHH--HHhc
Q 009186          474 LCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      +|+.+||.+||++.++++  .|+.
T Consensus       814 rcFepd~~~R~sA~~LL~DpFlq~  837 (1226)
T KOG4279|consen  814 RCFEPDPCDRPSAKDLLQDPFLQH  837 (1226)
T ss_pred             HHcCCCcccCccHHHhccCccccc
Confidence            999999999999999985  4543

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.89  E-value=3.3e-24  Score=211.80  Aligned_cols=163  Identities=25%  Similarity=0.336  Sum_probs=123.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++......... .....++..|+|||
T Consensus       103 ~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE  178 (270)
T cd05056         103 SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPE  178 (270)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChh
Confidence            5899999999999999999999998   9999999999999999999999999987654432211 11223456799999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+....++.++||||||+++||+++ |+.||.....   ....   .. ...+....     ..    ......+.+++.
T Consensus       179 ~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~---~~-~~~~~~~~-----~~----~~~~~~~~~li~  242 (270)
T cd05056         179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVI---GR-IENGERLP-----MP----PNCPPTLYSLMT  242 (270)
T ss_pred             hhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHH---HH-HHcCCcCC-----CC----CCCCHHHHHHHH
Confidence            9988889999999999999999986 9999743221   1111   11 11111111     11    122346777888


Q ss_pred             hhcccCCCCCCCHHHHHHHHhcCC
Q 009186          474 LCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +||..+|.+|||+.++++.|++..
T Consensus       243 ~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         243 KCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             HHcCCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.89  E-value=1.2e-23  Score=212.24  Aligned_cols=173  Identities=22%  Similarity=0.298  Sum_probs=119.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++........  .....++..|+||
T Consensus        99 ~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aP  173 (309)
T cd07872          99 NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPP  173 (309)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccccCC
Confidence            35789999999999999999999999   999999999999999999999999998764332211  1224568899999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHH--------HHHHhhhcCCcccccc-ccccC----C
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT--------YAWKLWCKGEALELMD-PVLKQ----T  459 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-~~l~~----~  459 (541)
                      |.+.+ ..++.++||||||+++|||++|+.||......+......        ..|..+.........+ +....    .
T Consensus       174 E~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (309)
T cd07872         174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLIN  253 (309)
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhh
Confidence            98865 458899999999999999999999985432211100000        0111110000000000 00000    0


Q ss_pred             CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          460 CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       460 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ........+.+++.+||+.||.+|||+.|+++
T Consensus       254 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         254 HAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00112335678899999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.2e-23  Score=206.71  Aligned_cols=160  Identities=23%  Similarity=0.315  Sum_probs=120.3

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCccc-ccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aP  393 (541)
                      .+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||+++.......... .....++..|+||
T Consensus       100 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  176 (263)
T cd06625         100 ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP  176 (263)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCc
Confidence            4788999999999999999999999   99999999999999999999999999876533221111 1234567899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|||++|+.||....      ..............     .    ..+......+.+++.
T Consensus       177 E~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~-----~----~~~~~~~~~~~~li~  241 (263)
T cd06625         177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE------AMAAIFKIATQPTN-----P----QLPSHVSPDARNFLR  241 (263)
T ss_pred             ceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc------hHHHHHHHhccCCC-----C----CCCccCCHHHHHHHH
Confidence            99998889999999999999999999999974211      11111111111110     1    111122345677888


Q ss_pred             hhcccCCCCCCCHHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~  492 (541)
                      +||+.+|.+|||+.++++.
T Consensus       242 ~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         242 RTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHhhcCcccCCCHHHHhhC
Confidence            9999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.89  E-value=4.2e-24  Score=213.11  Aligned_cols=159  Identities=26%  Similarity=0.329  Sum_probs=119.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........   .....|+..|+||
T Consensus        97 ~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aP  170 (285)
T cd05630          97 AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAP  170 (285)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccCh
Confidence            35899999999999999999999998   99999999999999999999999999875432221   1234688999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|+|++|+.||........   ..........      .......    .....+.+++.
T Consensus       171 E~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~~~------~~~~~~~----~~~~~~~~li~  237 (285)
T cd05630         171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKE------VQEEYSE----KFSPDARSLCK  237 (285)
T ss_pred             HHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhhhh------hhhhcCc----cCCHHHHHHHH
Confidence            999998999999999999999999999999854221111   0111111100      0001111    12234667888


Q ss_pred             hhcccCCCCCCC-----HHHHHH
Q 009186          474 LCVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt-----~~evl~  491 (541)
                      .||+.||++||+     ++|+++
T Consensus       238 ~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         238 MLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HHhhcCHHHccCCCCCchHHHHc
Confidence            999999999999     788886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.89  E-value=2.9e-24  Score=213.57  Aligned_cols=178  Identities=28%  Similarity=0.353  Sum_probs=125.6

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+....+.     .+...+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||+
T Consensus        96 iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          96 LVMEFCGAGSVTDLVKN-----TKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             EEEEeCCCCcHHHHHHH-----ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcc
Confidence            34455555555333322     12345888999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      +........  ......++..|+|||.+.     +..++.++||||||+++|||++|+.||......      ...... 
T Consensus       168 ~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------~~~~~~-  238 (282)
T cd06636         168 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------RALFLI-  238 (282)
T ss_pred             hhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------hhhhhH-
Confidence            875432221  122356788999999875     345788999999999999999999997432111      000000 


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ....     .+.+.   .......+.+++.+||+.||.+||++.||++
T Consensus       239 ~~~~-----~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         239 PRNP-----PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhCC-----CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0000     01111   1112346778899999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.89  E-value=1.9e-23  Score=217.68  Aligned_cols=167  Identities=25%  Similarity=0.345  Sum_probs=126.1

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ....+++..+++++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus       232 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~  308 (401)
T cd05107         232 ESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM  308 (401)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCcee
Confidence            3456899999999999999999999998   9999999999999999999999999997654332222222335678899


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +||.+.+..++.++||||||+++|||++ |+.||.....      .+........+...         ..+......+.+
T Consensus       309 aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~------~~~~~~~~~~~~~~---------~~p~~~~~~l~~  373 (401)
T cd05107         309 APESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM------NEQFYNAIKRGYRM---------AKPAHASDEIYE  373 (401)
T ss_pred             ChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc------hHHHHHHHHcCCCC---------CCCCCCCHHHHH
Confidence            9999988889999999999999999998 8888743211      11111111111111         011112346778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ++.+||+.+|.+||++++|++.|+..
T Consensus       374 li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         374 IMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            88899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.89  E-value=7e-24  Score=210.24  Aligned_cols=173  Identities=21%  Similarity=0.325  Sum_probs=123.3

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-------Cc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-------NP  361 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-------~~  361 (541)
                      +|++|+..+.+...+++      ....+++..+++++.||++||+|||+++   |+||||||+||+++..+       .+
T Consensus        93 lv~ey~~~g~L~~~l~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~  163 (274)
T cd05076          93 MVEEFVEHGPLDVCLRK------EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFI  163 (274)
T ss_pred             EEEecCCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCcccee
Confidence            45666666655333322      2345899999999999999999999998   99999999999997654       37


Q ss_pred             EEecccccccccCCCCcccccccccCCCCCChhhhcc-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCcCcCcHHHHH
Q 009186          362 KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEII-SGKRNSGFYLSEHGQSLLTYA  439 (541)
Q Consensus       362 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~ell-tg~~p~~~~~~~~~~~~~~~~  439 (541)
                      |++|||.+......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......   ...  
T Consensus       164 kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~--  232 (274)
T cd05076         164 KLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---KER--  232 (274)
T ss_pred             eecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---HHH--
Confidence            99999987543211      12346778999998875 55889999999999999995 6888874322111   111  


Q ss_pred             HHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          440 WKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       440 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                        .....       ..+..    .....+.+++.+||+.+|++||++.+|++.|+
T Consensus       233 --~~~~~-------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 --FYEKK-------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHHhc-------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              01000       00111    11235778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.7e-23  Score=210.49  Aligned_cols=172  Identities=27%  Similarity=0.384  Sum_probs=135.5

Q ss_pred             HHHHHHHHHHh--hheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          287 ITTITLFILLG--SFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       287 v~~v~~~~~~g--~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      .++||+||++.  .++...+|         +|.+.++..|..+.+.||.|||+.+   .||||||..|||+++.|.+||+
T Consensus       101 aWLVMEYClGSAsDlleVhkK---------plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLa  168 (948)
T KOG0577|consen  101 AWLVMEYCLGSASDLLEVHKK---------PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLA  168 (948)
T ss_pred             HHHHHHHHhccHHHHHHHHhc---------cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeec
Confidence            68999999753  34544443         6889999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      |||.+.+..+      ...++||+.|||||++.   .+.|+-++|||||||+..||.-.++|.-      .++.......
T Consensus       169 DFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF------nMNAMSALYH  236 (948)
T KOG0577|consen  169 DFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------NMNAMSALYH  236 (948)
T ss_pred             cccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc------CchHHHHHHH
Confidence            9999876432      34578999999999886   5779999999999999999999998841      1122222221


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +-      ..-.|.+.   ..+....|..++..||+.-|.+|||.++++.
T Consensus       237 IA------QNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  237 IA------QNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HH------hcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            11      11123333   3456677888888999999999999998875

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.89  E-value=1.3e-23  Score=206.99  Aligned_cols=159  Identities=26%  Similarity=0.414  Sum_probs=120.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc----cccccccCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA----NTNRVAGTYG  389 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~----~~~~~~gt~~  389 (541)
                      ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.++.........    ......++..
T Consensus       101 ~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (267)
T cd06628         101 GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF  177 (267)
T ss_pred             cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcC
Confidence            35889999999999999999999998   9999999999999999999999999987664322111    1122457889


Q ss_pred             CCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       390 y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      |+|||.+.+..++.++||||||+++|+|++|+.||....      ......... .     ...+.+    +......+.
T Consensus       178 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~-----~~~~~~----~~~~~~~~~  241 (267)
T cd06628         178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT------QLQAIFKIG-E-----NASPEI----PSNISSEAI  241 (267)
T ss_pred             ccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc------HHHHHHHHh-c-----cCCCcC----CcccCHHHH
Confidence            999999988889999999999999999999999985321      111111110 1     111111    122234567


Q ss_pred             HHHhhhcccCCCCCCCHHHHHH
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +++.+||+.||.+||++.+|++
T Consensus       242 ~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         242 DFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhh
Confidence            7888999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.89  E-value=8.9e-24  Score=206.59  Aligned_cols=158  Identities=35%  Similarity=0.492  Sum_probs=120.8

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      +++.++..++.|++.||.+||+.+   ++|+||||+||+++.++.++|+|||++............ ...++..|++||.
T Consensus       100 ~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~  175 (258)
T smart00219      100 LSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPES  175 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHH
Confidence            899999999999999999999998   999999999999999999999999999876544222211 2236788999999


Q ss_pred             hccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          396 AMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       396 l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      +.+..++.++||||||+++++|++ |+.||...   ......    .....+.....         .......+.+++.+
T Consensus       176 ~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~----~~~~~~~~~~~---------~~~~~~~~~~~i~~  239 (258)
T smart00219      176 LKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVL----EYLKKGYRLPK---------PENCPPEIYKLMLQ  239 (258)
T ss_pred             hccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHH----HHHhcCCCCCC---------CCcCCHHHHHHHHH
Confidence            988889999999999999999998 77776431   111111    11111111110         11134467778999


Q ss_pred             hcccCCCCCCCHHHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~~L  493 (541)
                      ||+.||++|||+.++++.|
T Consensus       240 ~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      240 CWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HCcCChhhCcCHHHHHhhC
Confidence            9999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.89  E-value=3.5e-23  Score=206.48  Aligned_cols=161  Identities=30%  Similarity=0.438  Sum_probs=121.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..+..++.|++.||+|||+. +   |+||||||+||+++.++.+||+|||+++.+.....   .....++..|+|
T Consensus       102 ~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~a  175 (288)
T cd06616         102 SVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMA  175 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccC
Confidence            4689999999999999999999975 7   99999999999999999999999999876533221   122357889999


Q ss_pred             hhhhccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          393 PEYAMEG---VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       393 PE~l~~~---~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      ||.+.+.   .++.++||||||+++|||++|+.||....     ...+...+.. .+.     .+.+...........+.
T Consensus       176 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~l~  244 (288)
T cd06616         176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVV-KGD-----PPILSNSEEREFSPSFV  244 (288)
T ss_pred             HHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhc-CCC-----CCcCCCcCCCccCHHHH
Confidence            9998766   58899999999999999999999985322     1111111111 111     11111111122345678


Q ss_pred             HHHhhhcccCCCCCCCHHHHHH
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +++.+||+.||++||++++|++
T Consensus       245 ~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         245 NFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            8999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-23  Score=208.99  Aligned_cols=196  Identities=21%  Similarity=0.297  Sum_probs=145.0

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      -.++++||.|++|-++-.+++       ++.++.....-++..+++|++|||+++   ||.|||||+|++|+.+|-+||.
T Consensus       493 kyvYmLmEaClGGElWTiLrd-------Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLV  562 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRD-------RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLV  562 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhh-------cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEe
Confidence            356778888888877655554       456888888999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||+++.+....   .+.++.||+.|.|||++.+...+.++|.|+||+++|||++|.+||...++-.   ....+.    
T Consensus       563 DFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---tYn~IL----  632 (732)
T KOG0614|consen  563 DFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---TYNLIL----  632 (732)
T ss_pred             ehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHH----
Confidence            999999876443   4567899999999999999999999999999999999999999986433221   111111    


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH--HHhcC------CCCCCCCCCCCc
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-----MSSVVV--MLASD------TATLPPPTQPAF  508 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~evl~--~L~~~------~~~l~~p~~P~~  508 (541)
                           +.+|..   .++........+++++....+|.+|.-     +.+|.+  ++++.      ...+++|-.|..
T Consensus       633 -----kGid~i---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~v  701 (732)
T KOG0614|consen  633 -----KGIDKI---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSV  701 (732)
T ss_pred             -----hhhhhh---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccC
Confidence                 111110   111222334556777888899999975     666654  33332      234555555544

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.89  E-value=1.5e-23  Score=208.85  Aligned_cols=183  Identities=23%  Similarity=0.286  Sum_probs=129.1

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|....+.   ....+..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        96 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          96 WLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             EEEEeecCCCCHHHHHHH---hhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCC
Confidence            344566666655433322   1122346899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAME-----GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      +++.......  ......|+..|+|||.+..     ..++.++|||||||++|||++|+.||.....      ...... 
T Consensus       170 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~------~~~~~~-  240 (286)
T cd06638         170 VSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP------MRALFK-  240 (286)
T ss_pred             ceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch------hHHHhh-
Confidence            9876543221  1223468899999998853     4478899999999999999999999743211      111111 


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ..........++       ......+.+++.+||+.||++||++.||++.
T Consensus       241 ~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 IPRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ccccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            011111111111       1112357788999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-24  Score=219.57  Aligned_cols=187  Identities=25%  Similarity=0.364  Sum_probs=146.1

Q ss_pred             hhHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEE
Q 009186          284 GTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI  363 (541)
Q Consensus       284 ~~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL  363 (541)
                      ..+++++.||+..|.|+.++|+-     .+..++--..+.++.||..|++||..++   +|||||...|+|+.++..+|+
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRec-----nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLREC-----NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHh-----chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEe
Confidence            35678888999999998888653     3445788888999999999999999999   999999999999999999999


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      +|||+++.+..+...... ...-...|.|||-+....++.|+|||+|||+||||.| |-.||...      ++. .+..+
T Consensus       407 ADFGLsRlMtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------dlS-qVY~L  478 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLS-QVYGL  478 (1157)
T ss_pred             eccchhhhhcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc------cHH-HHHHH
Confidence            999999987655432222 1223567999999999999999999999999999998 66776322      121 22222


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +         ....+-+-+.....++.+||+.||+++|.+||++.||-+.++.
T Consensus       479 L---------EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  479 L---------EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             H---------hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            2         2233333344556688999999999999999999999887753

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.89  E-value=6.5e-23  Score=203.99  Aligned_cols=170  Identities=21%  Similarity=0.250  Sum_probs=118.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+......  .....++..|+||
T Consensus        94 ~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aP  168 (284)
T cd07839          94 GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPP  168 (284)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcCh
Confidence            45899999999999999999999999   999999999999999999999999998765432211  1223567899999


Q ss_pred             hhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh-----------hhcCCccccccccccC---
Q 009186          394 EYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL-----------WCKGEALELMDPVLKQ---  458 (541)
Q Consensus       394 E~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~---  458 (541)
                      |.+.+.. ++.++||||||+++|||++|+.|+.....  ...........           .......... +....   
T Consensus       169 E~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  245 (284)
T cd07839         169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY-PMYPATTS  245 (284)
T ss_pred             HHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHHhhhccccccc-CCCCCcch
Confidence            9987654 68999999999999999999988532111  11111111100           0000000000 00000   


Q ss_pred             --CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          459 --TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       459 --~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                        ...+.....+.+++.+||+.||.+|||++++++
T Consensus       246 ~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         246 LVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence              001112345678899999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.89  E-value=1.3e-23  Score=209.85  Aligned_cols=161  Identities=26%  Similarity=0.354  Sum_probs=119.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++..++.++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++.........  .....++..|++
T Consensus       122 ~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a  196 (291)
T cd06639         122 GQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMA  196 (291)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccC
Confidence            446899999999999999999999998   999999999999999999999999998765432221  123457889999


Q ss_pred             hhhhccCC-----CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          393 PEYAMEGV-----FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       393 PE~l~~~~-----~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      ||.+....     ++.++||||||+++|||++|+.||.....      ...... +.........+       .......
T Consensus       197 PE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------~~~~~~-~~~~~~~~~~~-------~~~~~~~  262 (291)
T cd06639         197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------VKTLFK-IPRNPPPTLLH-------PEKWCRS  262 (291)
T ss_pred             hhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------HHHHHH-HhcCCCCCCCc-------ccccCHH
Confidence            99886433     67899999999999999999999743211      111111 11111111111       1122345


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      +.+++.+||+.+|++||++.++++.
T Consensus       263 l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         263 FNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHHHHHHhhcChhhCcCHHHHhcC
Confidence            7789999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.89  E-value=3.2e-23  Score=225.78  Aligned_cols=182  Identities=25%  Similarity=0.357  Sum_probs=129.8

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccc-cHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEE
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQL-DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI  363 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L-~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL  363 (541)
                      ..+++-|+||....+.+..++..       .. .-...++++.+|++||.|+|+.|   ||||||||.||+|+.+..+||
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~N~-------~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKI  738 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRRNH-------FNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKI  738 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHhcc-------cchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeee
Confidence            34677889998877755544311       11 46788999999999999999999   999999999999999999999


Q ss_pred             eccccccccc----------------CCCCcccccccccCCCCCChhhhccCC---CCcchhhHHHHHHHHHHHhCCCCC
Q 009186          364 SDFGMARIFS----------------GNQNEANTNRVAGTYGYMAPEYAMEGV---FSVKSDVFSFGVLLLEIISGKRNS  424 (541)
Q Consensus       364 ~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~elltg~~p~  424 (541)
                      +|||++....                ........+..+||.-|+|||++.+..   |+.|+|+||||||++||+.   ||
T Consensus       739 GDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF  815 (1351)
T KOG1035|consen  739 GDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PF  815 (1351)
T ss_pred             cccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cC
Confidence            9999987611                001111344578999999999997654   9999999999999999985   34


Q ss_pred             CCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          425 GFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +..     +.. ......++++.+...      .++..++...-.+++.++++.||.+|||+.|++.
T Consensus       816 ~Ts-----MER-a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  816 GTS-----MER-ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             Cch-----HHH-HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            211     111 111222333333322      1122233344456888999999999999999873

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.89  E-value=3.7e-23  Score=205.79  Aligned_cols=173  Identities=24%  Similarity=0.266  Sum_probs=118.1

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++.++..++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||++........  ......++..|+|
T Consensus        95 ~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~a  169 (285)
T cd07861          95 GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRA  169 (285)
T ss_pred             CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccC
Confidence            346899999999999999999999998   99999999999999999999999999876433221  1122356788999


Q ss_pred             hhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCc-HH-------HHHHHhhhcCC-----ccccccccccC
Q 009186          393 PEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS-LL-------TYAWKLWCKGE-----ALELMDPVLKQ  458 (541)
Q Consensus       393 PE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~-~~-------~~~~~~~~~~~-----~~~~~~~~l~~  458 (541)
                      ||.+.+. .++.++||||||+++|||++|+.||.......... ..       ...|..+....     ........+. 
T Consensus       170 PE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  248 (285)
T cd07861         170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLR-  248 (285)
T ss_pred             hHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhH-
Confidence            9988654 47889999999999999999999985321110000 00       00000000000     0000000000 


Q ss_pred             CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          459 TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       459 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ........++.+++.+||+.||.+|||+.+|+.
T Consensus       249 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         249 SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000012345668899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.89  E-value=1.6e-23  Score=211.39  Aligned_cols=188  Identities=23%  Similarity=0.327  Sum_probs=129.6

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++|+..+.|...+++       ...+++..+..++.||++||.|||+ .+   ++|+||||+||+++.++.+||+||
T Consensus        75 ~lv~ey~~~~~L~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~df  144 (308)
T cd06615          75 SICMEHMDGGSLDQVLKK-------AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF  144 (308)
T ss_pred             EEEeeccCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccC
Confidence            345677776666544432       2358999999999999999999998 46   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |++......    ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......................
T Consensus       145 g~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  220 (308)
T cd06615         145 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAK  220 (308)
T ss_pred             CCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcccccccc
Confidence            998654322    1223467889999999988889999999999999999999999975322111000000000000000


Q ss_pred             Cc-----------------cccc-------cccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          447 EA-----------------LELM-------DPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       447 ~~-----------------~~~~-------~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ..                 .+..       .+.+..   ......+.+++.+||+.||++||++.+|++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         221 ESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00                 0000       000000   0123357789999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.89  E-value=2.9e-23  Score=208.11  Aligned_cols=190  Identities=20%  Similarity=0.203  Sum_probs=128.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++ .+.+....++      +...+++..++.++.||++||.|||+++   |+|+||||+||+++.++.++|+|||
T Consensus        78 ~lv~e~~-~~~L~~~i~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg  147 (298)
T cd07841          78 NLVFEFM-ETDLEKVIKD------KSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFG  147 (298)
T ss_pred             EEEEccc-CCCHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccce
Confidence            3456666 5555433322      1135899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      ++.........  .....++..|+|||.+.+ ..++.++||||||+++|||++|.++|.....   ..............
T Consensus       148 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~---~~~~~~~~~~~~~~  222 (298)
T cd07841         148 LARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD---IDQLGKIFEALGTP  222 (298)
T ss_pred             eeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc---HHHHHHHHHHcCCC
Confidence            99765433211  122345778999998865 4578999999999999999999777642221   11111111100000


Q ss_pred             ---------CccccccccccCC-----CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          447 ---------EALELMDPVLKQT-----CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       447 ---------~~~~~~~~~l~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                               .............     ........+.+++.+||+.||++||++.||++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                     0000000000000     111224567889999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.89  E-value=2.2e-23  Score=205.40  Aligned_cols=180  Identities=22%  Similarity=0.276  Sum_probs=127.5

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.+....++       ...+++.+++.++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd06645          82 WICMEFCGGGSLQDIYHV-------TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFG  151 (267)
T ss_pred             EEEEeccCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcce
Confidence            345666666666443322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      ++.......  .......|+..|+|||.+.   ...++.++|||||||++|+|++|+.||.......      ...... 
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------~~~~~~-  222 (267)
T cd06645         152 VSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------ALFLMT-  222 (267)
T ss_pred             eeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------hHHhhh-
Confidence            987653222  1123346889999999874   4558889999999999999999999874221110      001100 


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .....   .+.....  ......+.+++.+||+.+|++||++++|++
T Consensus       223 ~~~~~---~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         223 KSNFQ---PPKLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccCCC---CCccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00000   0111000  011235677889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.89  E-value=2.5e-23  Score=211.71  Aligned_cols=129  Identities=19%  Similarity=0.241  Sum_probs=97.6

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.+.....+.     ....+++..++.++.||+.||+|||+++   |+||||||+||+++.++.+++.||+.
T Consensus        76 lv~e~~~~~~l~~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~  147 (327)
T cd08227          76 VVTSFMAYGSAKDLICTH-----FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRS  147 (327)
T ss_pred             EEEeccCCCcHHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccch
Confidence            344566555554333221     1234899999999999999999999999   99999999999999999999999986


Q ss_pred             cccccCCCCc-----ccccccccCCCCCChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 009186          369 ARIFSGNQNE-----ANTNRVAGTYGYMAPEYAME--GVFSVKSDVFSFGVLLLEIISGKRNSG  425 (541)
Q Consensus       369 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltg~~p~~  425 (541)
                      ..........     .......++..|+|||.+.+  ..++.++|||||||++|||++|+.||.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  211 (327)
T cd08227         148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  211 (327)
T ss_pred             hhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            5432211110     01112345678999999876  458899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.89  E-value=1.4e-23  Score=216.97  Aligned_cols=181  Identities=19%  Similarity=0.213  Sum_probs=127.4

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+.+|.|....++        ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~--------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN--------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEec
Confidence            4566777777777554432        24788999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV----FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      |++........ .......||+.|+|||.+.+..    ++.++|||||||++|||++|+.||....      ........
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~------~~~~~~~i  259 (370)
T cd05621         187 GTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS------LVGTYSKI  259 (370)
T ss_pred             ccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC------HHHHHHHH
Confidence            99986543221 1223456899999999987543    7889999999999999999999985321      11111111


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCC--CCCCHHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPA--HRPNMSSVVVM  492 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~--~RPt~~evl~~  492 (541)
                      .........     ..  .......+.+++..||+.++.  .|+++.|+++.
T Consensus       260 ~~~~~~~~~-----p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         260 MDHKNSLNF-----PE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HhCCcccCC-----CC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            111111111     00  011123455667778875554  38899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.89  E-value=7.5e-23  Score=200.05  Aligned_cols=159  Identities=27%  Similarity=0.407  Sum_probs=121.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........  ......++..|++|
T Consensus        94 ~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~P  168 (256)
T cd06612          94 KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAP  168 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCH
Confidence            45899999999999999999999998   99999999999999999999999999886543321  12234578899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|+|++|+.||........      .. ......     .+.+.  .+......+.+++.
T Consensus       169 E~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~-~~~~~~-----~~~~~--~~~~~~~~~~~~i~  234 (256)
T cd06612         169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IF-MIPNKP-----PPTLS--DPEKWSPEFNDFVK  234 (256)
T ss_pred             HHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hh-hhccCC-----CCCCC--chhhcCHHHHHHHH
Confidence            999988899999999999999999999999753221110      00 000000     00010  11122345778889


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+.||++||++.+|++
T Consensus       235 ~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHhcChhhCcCHHHHhc
Confidence            999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.89  E-value=1.7e-23  Score=208.24  Aligned_cols=170  Identities=21%  Similarity=0.293  Sum_probs=119.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..++.++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||++........  ......++..|++||
T Consensus        96 ~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE  170 (286)
T cd07847          96 GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPE  170 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHH
Confidence            5899999999999999999999998   99999999999999999999999999987543321  112245678899999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHH----------HHhhhcCCccc-cccccccCCCC-
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA----------WKLWCKGEALE-LMDPVLKQTCV-  461 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~~~-~~~~~l~~~~~-  461 (541)
                      .+.+ ..++.++||||||+++|||++|+.||........  .....          ...+....... ...+....... 
T Consensus       171 ~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (286)
T cd07847         171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPL  248 (286)
T ss_pred             HHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChHHhhhcccccccccccCCCcccccCH
Confidence            9876 4578999999999999999999999853221111  10000          00010111000 00000000000 


Q ss_pred             ----HHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          462 ----DAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       462 ----~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                          +.....+.+++.+||+.||++||++.|++.
T Consensus       249 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         249 ESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                112356778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.89  E-value=7.7e-24  Score=220.24  Aligned_cols=129  Identities=24%  Similarity=0.335  Sum_probs=103.0

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+..|.|...+++       ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~E~~~gg~L~~~l~~-------~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR-------MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECC
Confidence            445677766666444332       235889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCC---------------------------------------------cccccccccCCCCCChhhhccCCCC
Q 009186          368 MARIFSGNQN---------------------------------------------EANTNRVAGTYGYMAPEYAMEGVFS  402 (541)
Q Consensus       368 ~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s  402 (541)
                      ++..+.....                                             ........||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  226 (382)
T cd05625         147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT  226 (382)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence            9753311000                                             0001224689999999999998999


Q ss_pred             cchhhHHHHHHHHHHHhCCCCCCC
Q 009186          403 VKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       403 ~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      .++|||||||++|||++|+.||..
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~  250 (382)
T cd05625         227 QLCDWWSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             CeeeEEechHHHHHHHhCCCCCCC
Confidence            999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.89  E-value=9e-24  Score=209.18  Aligned_cols=189  Identities=23%  Similarity=0.303  Sum_probs=131.9

Q ss_pred             HHHHHHHHHhhheecccccc--ccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          288 TTITLFILLGSFVWCRRRIN--KDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~--~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      +++++++..+.|....+...  ....+...+++..++.++.||+.||+|||+.+   |+|+||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence            34455555555543332211  11122336899999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      ||++........ .......++..|++||.+.+...+.++||||||+++|+|++ |..||....   ....    .....
T Consensus       161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~----~~~~~  232 (275)
T cd05046         161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEV----LNRLQ  232 (275)
T ss_pred             cccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHH----HHHHH
Confidence            999865432221 11222345677999999988888999999999999999998 777763211   1111    11111


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .+.....    .    .......+.+++.+||+.+|++||++.++++.|++
T Consensus       233 ~~~~~~~----~----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         233 AGKLELP----V----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             cCCcCCC----C----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1111100    0    11123467788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.89  E-value=3.2e-23  Score=204.86  Aligned_cols=183  Identities=25%  Similarity=0.362  Sum_probs=129.8

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+...+++       ...+++..+..++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          85 IFLEYVPGGSIGSCLRT-------YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             EEEecCCCCcHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence            44556655555444332       245899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      ++...............++..|++||.+....  ++.++|+||||+++||+++|..||...      ...+........ 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~-  227 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE------EAIAAMFKLGNK-  227 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc------chHHHHHHhhcc-
Confidence            87644322222223345788999999987654  789999999999999999999997421      111111111111 


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      .....+....    .......+.+++.+||+.+|++||++.+|++.
T Consensus       228 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         228 RSAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ccCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            1111111111    11224567778889999999999999998863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.89  E-value=1.7e-23  Score=207.66  Aligned_cols=176  Identities=26%  Similarity=0.372  Sum_probs=131.0

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.+....+.        ..+++.++..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        78 ~lv~e~~~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg  146 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             EEEEecCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccc
Confidence            445566666655433321        24788999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++........  ......++..|+|||.+.+..++.++|+||||+++|||++|+.||......      .... .     
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~-~-----  212 (277)
T cd06640         147 VAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------RVLF-L-----  212 (277)
T ss_pred             cceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------hHhh-h-----
Confidence            9876543321  122345778899999998888999999999999999999999997432111      0000 0     


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                          +...............+.+++.+||+.+|++||++.++++.
T Consensus       213 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         213 ----IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ----hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                00011112223445667889999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-22  Score=200.94  Aligned_cols=183  Identities=27%  Similarity=0.349  Sum_probs=133.6

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcC------CCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccc
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDS------RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVA  385 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~------~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  385 (541)
                      +...++|....+|+..+++||+|||+.-      +++|+|||||.+|||+..|+...|+|||++..+............+
T Consensus       300 ~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qV  379 (534)
T KOG3653|consen  300 KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQV  379 (534)
T ss_pred             HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhh
Confidence            4557899999999999999999999853      4579999999999999999999999999999988777776667789


Q ss_pred             cCCCCCChhhhccCC-CC-----cchhhHHHHHHHHHHHhCCCCCCCCCCcCcC----------cHHHHHHHhh-hcCCc
Q 009186          386 GTYGYMAPEYAMEGV-FS-----VKSDVFSFGVLLLEIISGKRNSGFYLSEHGQ----------SLLTYAWKLW-CKGEA  448 (541)
Q Consensus       386 gt~~y~aPE~l~~~~-~s-----~~sDVwSlGvll~elltg~~p~~~~~~~~~~----------~~~~~~~~~~-~~~~~  448 (541)
                      ||.+|||||++.+.. +.     .+.||||+|.|+|||+++-.-+......+.+          .-++..+... .++..
T Consensus       380 GT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~R  459 (534)
T KOG3653|consen  380 GTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQR  459 (534)
T ss_pred             hhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccC
Confidence            999999999997643 22     4689999999999999865433111111111          1112222221 11122


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCC
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTA  498 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~  498 (541)
                      ..+.+.....    ..+.-+.+.+..||+.||+-|.|+.=+.+++.....
T Consensus       460 P~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  460 PKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             CCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            2222222111    335567788889999999999999999999887653

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=214.62  Aligned_cols=189  Identities=21%  Similarity=0.310  Sum_probs=149.2

Q ss_pred             eeehhHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC
Q 009186          281 IAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN  360 (541)
Q Consensus       281 i~i~~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~  360 (541)
                      |.+.-++++|||++..|-|..+++.      ....|+......++.||..||.|||++.   +|||||..+|||+....-
T Consensus       459 v~~e~P~WivmEL~~~GELr~yLq~------nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~C  529 (974)
T KOG4257|consen  459 VCVEQPMWIVMELAPLGELREYLQQ------NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQC  529 (974)
T ss_pred             eeeccceeEEEecccchhHHHHHHh------ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcce
Confidence            3445688899999988888665543      2346899999999999999999999998   999999999999999999


Q ss_pred             cEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHH
Q 009186          361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYA  439 (541)
Q Consensus       361 ~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~  439 (541)
                      +||+|||+++.+......... ...-...||+||.+.-.+++.++|||-|||.+||++. |..||......+        
T Consensus       530 VKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------  600 (974)
T KOG4257|consen  530 VKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------  600 (974)
T ss_pred             eeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------
Confidence            999999999988765544333 3344677999999999999999999999999999987 899975332221        


Q ss_pred             HHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          440 WKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       440 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                              ..-.+...-+...++.....+..|+.+||.++|.+||.+.+|...|..
T Consensus       601 --------VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  601 --------VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             --------eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence                    222222222333455566678899999999999999999999887753

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.89  E-value=3.6e-23  Score=209.57  Aligned_cols=195  Identities=25%  Similarity=0.329  Sum_probs=150.2

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      -++.++++|+..|.|..++.+   +.  -..+.-+..++|+.||+.|++||.+-+   +|||||.+.|+|++.++++||+
T Consensus       608 ePicmI~EYmEnGDLnqFl~a---he--apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKia  679 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSA---HE--LPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIA  679 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHh---cc--CcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEec
Confidence            477899999999988655543   11  111556677889999999999999998   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCcCcCcHHHHHHHh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt--g~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      |||+++.+-.......+.+.+-..+|||+|.+..++++.++|||+||+++||+++  ..+||+...   .+..++.....
T Consensus       680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~  756 (807)
T KOG1094|consen  680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEF  756 (807)
T ss_pred             CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhh
Confidence            9999997766666666667777899999999999999999999999999999865  677764322   22233333333


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ...+.....+      ..+......+.+++++||..|-++||+++++...|++.
T Consensus       757 ~~~~~~~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  757 FRDQGRQVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cCCCCcceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            3222222111      12334456778999999999999999999999999864

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.89  E-value=1.4e-22  Score=201.49  Aligned_cols=159  Identities=24%  Similarity=0.324  Sum_probs=118.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++........  ......++..|++|
T Consensus        98 ~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  172 (282)
T cd06643          98 RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAP  172 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCH
Confidence            35899999999999999999999999   99999999999999999999999999876432221  12234678899999


Q ss_pred             hhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHH
Q 009186          394 EYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKC  468 (541)
Q Consensus       394 E~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  468 (541)
                      |.+.     +..++.++|||||||++|||++|+.||.....      .+...... .........       +......+
T Consensus       173 E~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~~-------~~~~~~~~  238 (282)
T cd06643         173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIA-KSEPPTLAQ-------PSRWSSEF  238 (282)
T ss_pred             hhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHh-hcCCCCCCC-------ccccCHHH
Confidence            9884     34577899999999999999999999743221      11111111 111111100       11123457


Q ss_pred             HHHHhhhcccCCCCCCCHHHHHH
Q 009186          469 IHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       469 ~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+++.+||+.||.+||++.++++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            78889999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.88  E-value=1.4e-22  Score=202.80  Aligned_cols=159  Identities=23%  Similarity=0.348  Sum_probs=120.0

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.||+.||+|||+++   |+||||||+||+++.++.++|+|||++........  ......++..|+|||
T Consensus       114 ~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  188 (292)
T cd06658         114 RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPE  188 (292)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHH
Confidence            4789999999999999999999998   99999999999999999999999999876433222  122346788999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++||||||+++|||++|+.||.....      ...... ...     .+.+.+..  .......+.+++.+
T Consensus       189 ~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~-~~~-----~~~~~~~~--~~~~~~~~~~li~~  254 (292)
T cd06658         189 VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------LQAMRR-IRD-----NLPPRVKD--SHKVSSVLRGFLDL  254 (292)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHh-----cCCCcccc--ccccCHHHHHHHHH
Confidence            99888899999999999999999999999742211      111111 110     01111111  01122346678889


Q ss_pred             hcccCCCCCCCHHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~~  492 (541)
                      ||+.||++|||++++++.
T Consensus       255 ~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         255 MLVREPSQRATAQELLQH  272 (292)
T ss_pred             HccCChhHCcCHHHHhhC
Confidence            999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=1.2e-23  Score=218.32  Aligned_cols=182  Identities=19%  Similarity=0.201  Sum_probs=125.6

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++||+.++.|...+.+       ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~Df  145 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIK-------YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDF  145 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeec
Confidence            3456677766666444322       235889999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCc------------c---------------------------------cccccccCCCCCChhhhccCCC
Q 009186          367 GMARIFSGNQNE------------A---------------------------------NTNRVAGTYGYMAPEYAMEGVF  401 (541)
Q Consensus       367 g~a~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~l~~~~~  401 (541)
                      |+++.+......            .                                 ......||+.|+|||++.+..+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  225 (377)
T cd05629         146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY  225 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence            998643211000            0                                 0012468999999999998899


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCC
Q 009186          402 SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPA  481 (541)
Q Consensus       402 s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~  481 (541)
                      +.++|||||||++|||++|+.||.....      .+..............     ...  ......+.+++.+||+ +|.
T Consensus       226 ~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~~-----p~~--~~~s~~~~dli~~lL~-~~~  291 (377)
T cd05629         226 GQECDWWSLGAIMFECLIGWPPFCSENS------HETYRKIINWRETLYF-----PDD--IHLSVEAEDLIRRLIT-NAE  291 (377)
T ss_pred             CCceeeEecchhhhhhhcCCCCCCCCCH------HHHHHHHHccCCccCC-----CCC--CCCCHHHHHHHHHHhc-CHh
Confidence            9999999999999999999999853221      1111111111111110     000  0112345667778887 666


Q ss_pred             CC---CCHHHHHHH
Q 009186          482 HR---PNMSSVVVM  492 (541)
Q Consensus       482 ~R---Pt~~evl~~  492 (541)
                      +|   +++.++++.
T Consensus       292 ~r~~r~~~~~~l~h  305 (377)
T cd05629         292 NRLGRGGAHEIKSH  305 (377)
T ss_pred             hcCCCCCHHHHhcC
Confidence            65   599998864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.88  E-value=4.9e-24  Score=221.23  Aligned_cols=181  Identities=20%  Similarity=0.242  Sum_probs=125.1

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|...+++       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~E~~~~g~L~~~i~~-------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR-------LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCC
Confidence            345677777776554433       235888999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCC-----------------------------------------cccccccccCCCCCChhhhccCCCCcchh
Q 009186          368 MARIFSGNQN-----------------------------------------EANTNRVAGTYGYMAPEYAMEGVFSVKSD  406 (541)
Q Consensus       368 ~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sD  406 (541)
                      ++..+.....                                         ........||+.|+|||++.+..++.++|
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  226 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  226 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence            9753311000                                         00011246899999999999989999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC--
Q 009186          407 VFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP--  484 (541)
Q Consensus       407 VwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP--  484 (541)
                      ||||||++|||++|+.||.....      .+..............  +. ...    ....+.+++.+|+ .+|.+|+  
T Consensus       227 iwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~--~~-~~~----~s~~~~~li~~l~-~~p~~R~~~  292 (376)
T cd05598         227 WWSVGVILYEMLVGQPPFLADTP------AETQLKVINWETTLHI--PS-QAK----LSREASDLILRLC-CGAEDRLGK  292 (376)
T ss_pred             eeeccceeeehhhCCCCCCCCCH------HHHHHHHhccCccccC--CC-CCC----CCHHHHHHHHHHh-cCHhhcCCC
Confidence            99999999999999999853221      1111111110000000  00 011    1223445555655 5999999  


Q ss_pred             -CHHHHHHH
Q 009186          485 -NMSSVVVM  492 (541)
Q Consensus       485 -t~~evl~~  492 (541)
                       ++.++++.
T Consensus       293 ~t~~ell~h  301 (376)
T cd05598         293 NGADEIKAH  301 (376)
T ss_pred             CCHHHHhCC
Confidence             88888854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.88  E-value=1e-23  Score=206.46  Aligned_cols=160  Identities=26%  Similarity=0.404  Sum_probs=123.4

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........  ......++..|+|
T Consensus        95 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~a  169 (256)
T cd08221          95 GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMS  169 (256)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccC
Confidence            346899999999999999999999998   99999999999999999999999999876543332  2233567899999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+.+..++.++||||||+++|||++|+.||....      ..+...... .+.....         .......+.+++
T Consensus       170 pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~-~~~~~~~---------~~~~~~~~~~~i  233 (256)
T cd08221         170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------PLNLVVKIV-QGNYTPV---------VSVYSSELISLV  233 (256)
T ss_pred             HhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHH-cCCCCCC---------ccccCHHHHHHH
Confidence            999988888999999999999999999999974321      111111111 1111110         112234577788


Q ss_pred             hhhcccCCCCCCCHHHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L  493 (541)
                      .+||+.+|.+||++.++++.+
T Consensus       234 ~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         234 HSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HHHcccCcccCCCHHHHhhCc
Confidence            899999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1e-23  Score=210.56  Aligned_cols=161  Identities=23%  Similarity=0.362  Sum_probs=127.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE-cCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-DHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..|.++...+++.||+.|+.|+|+..   +|||||||+||.+ ..-|.+||.|||++..+.+.+.   .....|++.|.|
T Consensus       113 ~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSA  186 (864)
T KOG4717|consen  113 EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSA  186 (864)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccC
Confidence            35899999999999999999999987   9999999999865 5668899999999987765443   345689999999


Q ss_pred             hhhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFS-VKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s-~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||++.+..|+ +++||||||||||.|++|+.||......  +.             +..++|-..  ..+.....++.+|
T Consensus       187 PEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--ET-------------LTmImDCKY--tvPshvS~eCrdL  249 (864)
T KOG4717|consen  187 PEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--ET-------------LTMIMDCKY--TVPSHVSKECRDL  249 (864)
T ss_pred             chhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--hh-------------hhhhhcccc--cCchhhhHHHHHH
Confidence            9999999986 6899999999999999999998532211  11             111222211  2344556788899


Q ss_pred             HhhhcccCCCCCCCHHHHHH--HHhcCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVV--MLASDT  497 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~--~L~~~~  497 (541)
                      +..||..||++|.+.+||+.  +|+...
T Consensus       250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  250 IQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             HHHHHhcCchhhccHHHHhccccccCCC
Confidence            99999999999999999984  565543

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.88  E-value=1.8e-23  Score=211.17  Aligned_cols=175  Identities=23%  Similarity=0.274  Sum_probs=121.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC----CCCcEEecccccccccCCCC-cccccccccCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH----EMNPKISDFGMARIFSGNQN-EANTNRVAGTY  388 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~----~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt~  388 (541)
                      ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.    ++.+||+|||++........ ........++.
T Consensus       103 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  179 (316)
T cd07842         103 VSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI  179 (316)
T ss_pred             cCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccc
Confidence            46899999999999999999999999   999999999999999    89999999999886543322 11223345788


Q ss_pred             CCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcC-c-----HHHHHHHhhh-----------c-CCcc
Q 009186          389 GYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQ-S-----LLTYAWKLWC-----------K-GEAL  449 (541)
Q Consensus       389 ~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~-~-----~~~~~~~~~~-----------~-~~~~  449 (541)
                      .|+|||.+.+. .++.++||||||+++++|++|+.||......... .     .+......+.           + ....
T Consensus       180 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (316)
T cd07842         180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYD  259 (316)
T ss_pred             cccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccch
Confidence            99999988764 5789999999999999999999998643322200 0     0000000000           0 0000


Q ss_pred             ccccccccCCCC----H-------HHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          450 ELMDPVLKQTCV----D-------AELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       450 ~~~~~~l~~~~~----~-------~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ...+........    .       .....+.+++.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         260 TLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             hhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000000    0       22346788999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.88  E-value=7e-23  Score=203.14  Aligned_cols=157  Identities=29%  Similarity=0.455  Sum_probs=121.0

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++..+.....  ......++..|++||
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  171 (277)
T cd06642          97 PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPE  171 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHH
Confidence            5889999999999999999999998   99999999999999999999999999876543221  112245788899999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++||||||+++|||++|+.|+......   ...   . ......     .+.    ........+.+++.+
T Consensus       172 ~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~---~-~~~~~~-----~~~----~~~~~~~~~~~li~~  235 (277)
T cd06642         172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVL---F-LIPKNS-----PPT----LEGQYSKPFKEFVEA  235 (277)
T ss_pred             HhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHH---h-hhhcCC-----CCC----CCcccCHHHHHHHHH
Confidence            999888999999999999999999999997422111   010   0 011111     111    112234557788899


Q ss_pred             hcccCCCCCCCHHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~~  492 (541)
                      ||+.+|++||++.+|++.
T Consensus       236 ~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         236 CLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HccCCcccCcCHHHHHHh
Confidence            999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.88  E-value=1.7e-23  Score=232.15  Aligned_cols=186  Identities=20%  Similarity=0.255  Sum_probs=129.5

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCC----CceEecccCCCcEEEcC------
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSR----LRVIHRDLKTSNVLLDH------  357 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~----~~ivH~DLkp~NIll~~------  357 (541)
                      +++++|+..+.|...+++.   ......|++..++.|+.||+.||.|||+.+.    ..||||||||+||||+.      
T Consensus        90 yIVMEY~~gGSL~~lL~k~---~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKC---YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHH---hhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            4456676666664444321   1123469999999999999999999998431    23999999999999964      


Q ss_pred             -----------CCCcEEecccccccccCCCCcccccccccCCCCCChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 009186          358 -----------EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAME--GVFSVKSDVFSFGVLLLEIISGKRNS  424 (541)
Q Consensus       358 -----------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltg~~p~  424 (541)
                                 .+.+||+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||+||||++|+.||
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                       2348999999997654322   1223568999999999864  45889999999999999999999998


Q ss_pred             CCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHH--HHHhc
Q 009186          425 GFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV--VMLAS  495 (541)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl--~~L~~  495 (541)
                      ....     .... ....+....       .+..   ......+.+|+..||+.+|.+||++.+++  ..+..
T Consensus       244 ~~~~-----~~~q-li~~lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        244 HKAN-----NFSQ-LISELKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             CcCC-----cHHH-HHHHHhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            4321     1111 111111111       0100   11234577888999999999999999998  45543

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.88  E-value=3.5e-23  Score=211.13  Aligned_cols=184  Identities=16%  Similarity=0.216  Sum_probs=126.3

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+..|.|...+++.      +..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~------~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~Df  146 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKF------EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  146 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeec
Confidence            34556777777775444321      235899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      |++..+..... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...      ...+....
T Consensus       147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~------~~~~~~~~  219 (332)
T cd05623         147 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGK  219 (332)
T ss_pred             chheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC------CHHHHHHH
Confidence            99876433222 1122356899999999986     345788999999999999999999998422      12222222


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhccc--CCCCCCCHHHHHHH
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQE--DPAHRPNMSSVVVM  492 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~--dP~~RPt~~evl~~  492 (541)
                      .......... ...     .......+.+++.+|+..  ++-.|++++++++.
T Consensus       220 i~~~~~~~~~-p~~-----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         220 IMNHKERFQF-PAQ-----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HhCCCccccC-CCc-----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            2211111110 000     011123455566676654  44447899998865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.88  E-value=1.8e-23  Score=206.47  Aligned_cols=176  Identities=21%  Similarity=0.261  Sum_probs=129.0

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEec
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISD  365 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~D  365 (541)
                      .+++++++..+.|....++       +..+++.++..++.||++||.|||+.+   ++||||||+||+++.++ .++|+|
T Consensus        84 ~~iv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKK-------EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence            3455666666666444322       226899999999999999999999999   99999999999999998 999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||++.......      ...++..|+|||.+.+..++.++||||||+++|||++|+.||...... ......+....   
T Consensus       154 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---  223 (267)
T PHA03390        154 YGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ---  223 (267)
T ss_pred             CccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh---
Confidence            99987653221      235788999999999888999999999999999999999998622211 11111111111   


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-HHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-MSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~evl~  491 (541)
                      .....         ........+.+++.+||+.||.+||+ ++++++
T Consensus       224 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 QKKLP---------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cccCC---------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            00000         11123445777888999999999996 688874

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=6.8e-24  Score=209.45  Aligned_cols=160  Identities=29%  Similarity=0.429  Sum_probs=119.5

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||.+........  ......++..|+|
T Consensus       107 ~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~a  181 (275)
T cd06608         107 GKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMA  181 (275)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccC
Confidence            456899999999999999999999998   99999999999999999999999999876433221  1223457889999


Q ss_pred             hhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          393 PEYAME-----GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       393 PE~l~~-----~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      ||.+..     ..++.++||||||+++|+|++|+.||.....      ...... ......     +.+.  ........
T Consensus       182 PE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~-----~~~~--~~~~~~~~  247 (275)
T cd06608         182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP------MRALFK-IPRNPP-----PTLK--SPENWSKK  247 (275)
T ss_pred             HhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch------HHHHHH-hhccCC-----CCCC--chhhcCHH
Confidence            998753     3467889999999999999999999842111      111111 111111     1111  11123456


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHH
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+++.+||..||++|||+.+|++
T Consensus       248 ~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         248 FNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHHHHHHHhhcChhhCcCHHHHhc
Confidence            778999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=1.2e-22  Score=218.10  Aligned_cols=104  Identities=25%  Similarity=0.406  Sum_probs=89.8

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      ....++..|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...... ......|+..|+|||+
T Consensus       264 ~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~  339 (501)
T PHA03210        264 PLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEI  339 (501)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchh
Confidence            346677899999999999999999   999999999999999999999999999876433221 1223568999999999


Q ss_pred             hccCCCCcchhhHHHHHHHHHHHhCCCC
Q 009186          396 AMEGVFSVKSDVFSFGVLLLEIISGKRN  423 (541)
Q Consensus       396 l~~~~~s~~sDVwSlGvll~elltg~~p  423 (541)
                      +.+..++.++|||||||++|||++|..+
T Consensus       340 ~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        340 LAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999998754

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=6e-23  Score=209.31  Aligned_cols=129  Identities=22%  Similarity=0.331  Sum_probs=102.9

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+.++.|...+++      ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Df  146 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSK------FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADF  146 (331)
T ss_pred             EEEEEecCCCCcHHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEEC
Confidence            3455667666666444332      1235899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAME-----GVFSVKSDVFSFGVLLLEIISGKRNSG  425 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltg~~p~~  425 (541)
                      |++..+...... ......|++.|+|||++.+     ..++.++|||||||++|||++|+.||.
T Consensus       147 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  209 (331)
T cd05597         147 GSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             CceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence            998765432221 1122468999999999863     457889999999999999999999984

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.88  E-value=1.7e-23  Score=216.51  Aligned_cols=182  Identities=20%  Similarity=0.228  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+.++.|...+++        ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence            4556677777766544422        24788889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG----VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      |+++........ ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||....      ........
T Consensus       187 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i  259 (371)
T cd05622         187 GTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKI  259 (371)
T ss_pred             CceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC------HHHHHHHH
Confidence            999865432221 22345689999999998753    37889999999999999999999985321      11111222


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCC--CCCHHHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAH--RPNMSSVVVML  493 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~evl~~L  493 (541)
                      ..........+       .......+.+++..||..++.+  |+++.+|++..
T Consensus       260 ~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         260 MNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11111111111       0112334566777888744432  78999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.88  E-value=5.3e-23  Score=206.72  Aligned_cols=169  Identities=21%  Similarity=0.296  Sum_probs=118.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||++........  ......++..|+|||
T Consensus       100 ~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE  174 (301)
T cd07873         100 SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPD  174 (301)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcH
Confidence            5789999999999999999999999   99999999999999999999999999875432221  112234678999999


Q ss_pred             hhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHH-----------HHhhhcCCcc-ccccccccCCC-
Q 009186          395 YAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA-----------WKLWCKGEAL-ELMDPVLKQTC-  460 (541)
Q Consensus       395 ~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-~~~~~~l~~~~-  460 (541)
                      .+.+. .++.++||||||+++|||++|+.||......   ......           |..+...... ..-.+...... 
T Consensus       175 ~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (301)
T cd07873         175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCL  251 (301)
T ss_pred             HHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhhccccccccccCccccccH
Confidence            88654 4788999999999999999999998533211   111111           1110000000 00001000000 


Q ss_pred             ---CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          461 ---VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       461 ---~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                         .......+.+++.+||+.||.+|||++|+++
T Consensus       252 ~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         252 HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               0111234667899999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.88  E-value=4.9e-23  Score=205.98  Aligned_cols=158  Identities=25%  Similarity=0.348  Sum_probs=117.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++........  ......++..|+|||
T Consensus       106 ~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  180 (292)
T cd06644         106 GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPE  180 (292)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc--ccceecCCccccCce
Confidence            5899999999999999999999998   99999999999999999999999998865432211  122345788999999


Q ss_pred             hhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          395 YAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       395 ~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      .+.     ...++.++||||||+++|||++|+.||.....      ....... .........       .+......+.
T Consensus       181 ~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~-~~~~~~~~~-------~~~~~~~~~~  246 (292)
T cd06644         181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKI-AKSEPPTLS-------QPSKWSMEFR  246 (292)
T ss_pred             eeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHH-hcCCCccCC-------CCcccCHHHH
Confidence            884     34467899999999999999999999743211      1111111 111110000       0112234577


Q ss_pred             HHHhhhcccCCCCCCCHHHHHH
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +++.+||+.||++||++.++++
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHhc
Confidence            8899999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.88  E-value=8.6e-23  Score=206.32  Aligned_cols=172  Identities=20%  Similarity=0.254  Sum_probs=118.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC-----cccccccccCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN-----EANTNRVAGTYG  389 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-----~~~~~~~~gt~~  389 (541)
                      .+++..+..++.||+.||+|||+++   |+|+||||+||+++.++.+||+|||.+........     ........++..
T Consensus        97 ~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (314)
T cd08216          97 GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP  173 (314)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccccc
Confidence            4889999999999999999999998   99999999999999999999999998865432211     111123446778


Q ss_pred             CCChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh----hhcC-------Cccc----cc
Q 009186          390 YMAPEYAME--GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL----WCKG-------EALE----LM  452 (541)
Q Consensus       390 y~aPE~l~~--~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~-------~~~~----~~  452 (541)
                      |+|||.+.+  ..++.++||||||+++|||++|+.||......  ....+.....    +...       ....    ..
T Consensus       174 y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
T cd08216         174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE  251 (314)
T ss_pred             ccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence            999999876  35789999999999999999999998532111  1111110000    0000       0000    00


Q ss_pred             ccc----ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          453 DPV----LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       453 ~~~----l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ++.    ............+.+++.+||+.||++|||++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            000    001111223456788999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.88  E-value=2.3e-23  Score=206.95  Aligned_cols=175  Identities=25%  Similarity=0.284  Sum_probs=128.1

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+.++.|...+++       ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+
T Consensus        74 ~v~e~~~g~~L~~~l~~-------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~  143 (278)
T cd05606          74 FILDLMNGGDLHYHLSQ-------HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL  143 (278)
T ss_pred             EEEecCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcC
Confidence            44566666655333321       235999999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +..+....    .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.........   . .......  
T Consensus       144 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---~-~~~~~~~--  213 (278)
T cd05606         144 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMTLT--  213 (278)
T ss_pred             ccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---H-HHHHhhc--
Confidence            87553221    2234688999999998754 5889999999999999999999998543221111   1 1111100  


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                          ....+.    ......+.+++.+||+.+|.+||     ++.++++
T Consensus       214 ----~~~~~~----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 ----MAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ----cCCCCC----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                011111    11234677788899999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.88  E-value=6.8e-23  Score=202.00  Aligned_cols=158  Identities=25%  Similarity=0.364  Sum_probs=115.3

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC-cccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN-EANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aP  393 (541)
                      .+++..++.++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+++....... ........++..|+||
T Consensus       102 ~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (266)
T cd06651         102 ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP  178 (266)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCH
Confidence            4789999999999999999999998   99999999999999999999999999875432211 1111234578899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|||++|+.||....      ............     ..+.+    +......+..++ 
T Consensus       179 E~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~------~~~~~~~~~~~~-----~~~~~----~~~~~~~~~~li-  242 (266)
T cd06651         179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE------AMAAIFKIATQP-----TNPQL----PSHISEHARDFL-  242 (266)
T ss_pred             HHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc------hHHHHHHHhcCC-----CCCCC----chhcCHHHHHHH-
Confidence            99988889999999999999999999999985321      111111111110     01111    111122333344 


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||..+|++||+++||++
T Consensus       243 ~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         243 GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHhcCChhhCcCHHHHhc
Confidence            688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.88  E-value=3e-23  Score=206.17  Aligned_cols=158  Identities=27%  Similarity=0.387  Sum_probs=118.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..++.++.||+.||+|||++ +   ++||||||+||+++.++.+||+|||++.......   ......++..|+|
T Consensus        98 ~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~a  171 (283)
T cd06617          98 LTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMA  171 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccC
Confidence            5699999999999999999999997 7   9999999999999999999999999987653221   1122457888999


Q ss_pred             hhhhcc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHH
Q 009186          393 PEYAME----GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKC  468 (541)
Q Consensus       393 PE~l~~----~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  468 (541)
                      ||.+.+    ..++.++|+||||+++|||++|+.||.....     ..+...... .+.     .+.+..   ......+
T Consensus       172 PE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~-----~~~~~~---~~~~~~l  237 (283)
T cd06617         172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQLKQVV-EEP-----SPQLPA---EKFSPEF  237 (283)
T ss_pred             hhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHHHHHHH-hcC-----CCCCCc---cccCHHH
Confidence            998864    4468899999999999999999999742111     111111111 111     111111   1123457


Q ss_pred             HHHHhhhcccCCCCCCCHHHHHH
Q 009186          469 IHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       469 ~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+++.+||+.+|++||++.+|++
T Consensus       238 ~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            78889999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.88  E-value=4.9e-23  Score=210.38  Aligned_cols=177  Identities=24%  Similarity=0.290  Sum_probs=122.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~a  392 (541)
                      ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......... ......++..|+|
T Consensus       101 ~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (336)
T cd07849         101 QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA  177 (336)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccC
Confidence            35899999999999999999999999   9999999999999999999999999987654322211 1223467889999


Q ss_pred             hhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc---cccccc-------cc--cCC
Q 009186          393 PEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA---LELMDP-------VL--KQT  459 (541)
Q Consensus       393 PE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------~l--~~~  459 (541)
                      ||.+.+ ..++.++||||||+++|+|++|+.||......   ...............   ....+.       ..  ...
T Consensus       178 PE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T cd07849         178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPK  254 (336)
T ss_pred             hHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCc
Confidence            998755 46889999999999999999999998432110   001101000000000   000000       00  000


Q ss_pred             -----CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH--HhcC
Q 009186          460 -----CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM--LASD  496 (541)
Q Consensus       460 -----~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~--L~~~  496 (541)
                           ..+.....+.+++.+||+.||++|||+.++++.  ++..
T Consensus       255 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         255 VPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             ccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                 001123457789999999999999999999975  5543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.88  E-value=3.8e-23  Score=207.44  Aligned_cols=177  Identities=21%  Similarity=0.323  Sum_probs=128.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.+....+        ...+++.++..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||
T Consensus        92 ~lv~e~~~~~~L~~~~~--------~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg  160 (297)
T cd06656          92 WVVMEYLAGGSLTDVVT--------ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFG  160 (297)
T ss_pred             EEeecccCCCCHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCc
Confidence            45566666665543332        124788999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++.........  .....++..|++||.+.+..++.++||||||+++|++++|+.||........      .......+.
T Consensus       161 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~------~~~~~~~~~  232 (297)
T cd06656         161 FCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGT  232 (297)
T ss_pred             cceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh------eeeeccCCC
Confidence            98765433221  2234578899999999988899999999999999999999999843221110      000000000


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                            +.+  ..+......+.+++.+||+.||++||++.+|++
T Consensus       233 ------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         233 ------PEL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ------CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  000  011122344667888999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.88  E-value=3.9e-23  Score=203.46  Aligned_cols=160  Identities=28%  Similarity=0.344  Sum_probs=119.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC----cccccccccCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN----EANTNRVAGTYGY  390 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~----~~~~~~~~gt~~y  390 (541)
                      .+++..+..++.|++.||+|||+.+   |+|+||+|+||+++.++.++|+|||++........    ........++..|
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (265)
T cd06631          98 PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW  174 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccc
Confidence            4789999999999999999999998   99999999999999999999999999876432111    1112234578899


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +|||.+.+..++.++||||||+++|+|++|+.||.....      ............    ..+.+.    ......+.+
T Consensus       175 ~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~----~~~~~~----~~~~~~~~~  240 (265)
T cd06631         175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR------LAAMFYIGAHRG----LMPRLP----DSFSAAAID  240 (265)
T ss_pred             cChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh------HHHHHHhhhccC----CCCCCC----CCCCHHHHH
Confidence            999999888899999999999999999999999853211      111100000000    011111    122345677


Q ss_pred             HHhhhcccCCCCCCCHHHHHH
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ++.+||+.+|++||++.++++
T Consensus       241 ~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         241 FVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHhcCCcccCCCHHHHhc
Confidence            889999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.88  E-value=2.3e-22  Score=201.78  Aligned_cols=159  Identities=21%  Similarity=0.336  Sum_probs=120.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++..+.....  ......++..|+|||
T Consensus       113 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  187 (297)
T cd06659         113 RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPE  187 (297)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHH
Confidence            4889999999999999999999998   99999999999999999999999999875543221  122356788999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++||||||+++|||++|+.||.....      .+.... +.......     ...  .......+.+++.+
T Consensus       188 ~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~-~~~~~~~~-----~~~--~~~~~~~l~~~i~~  253 (297)
T cd06659         188 VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKR-LRDSPPPK-----LKN--AHKISPVLRDFLER  253 (297)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HhccCCCC-----ccc--cCCCCHHHHHHHHH
Confidence            99988899999999999999999999999742211      111111 11111000     000  01112346678889


Q ss_pred             hcccCCCCCCCHHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~~  492 (541)
                      ||+.+|++||++.+|++.
T Consensus       254 ~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         254 MLTREPQERATAQELLDH  271 (297)
T ss_pred             HhcCCcccCcCHHHHhhC
Confidence            999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.88  E-value=1.3e-23  Score=216.86  Aligned_cols=130  Identities=25%  Similarity=0.328  Sum_probs=105.1

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+.++.|...+++       ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~Df  145 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMK-------KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDF  145 (360)
T ss_pred             EEEEEeCCCCccHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeec
Confidence            3455677777766544432       235899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCc---------------------------------ccccccccCCCCCChhhhccCCCCcchhhHHHHHH
Q 009186          367 GMARIFSGNQNE---------------------------------ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVL  413 (541)
Q Consensus       367 g~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvl  413 (541)
                      |++..+......                                 .......||..|+|||++.+..++.++|||||||+
T Consensus       146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi  225 (360)
T cd05627         146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI  225 (360)
T ss_pred             cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence            998754321100                                 00113468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCC
Q 009186          414 LLEIISGKRNSGF  426 (541)
Q Consensus       414 l~elltg~~p~~~  426 (541)
                      +|||++|+.||..
T Consensus       226 lyel~tG~~Pf~~  238 (360)
T cd05627         226 MYEMLIGYPPFCS  238 (360)
T ss_pred             eeecccCCCCCCC
Confidence            9999999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=7.4e-23  Score=207.05  Aligned_cols=180  Identities=20%  Similarity=0.201  Sum_probs=127.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++.++.|...+++     ..+..+++..+..++.||+.||+|||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus        78 lv~e~~~~~~L~~~~~~-----~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          78 LVMDYCPGGELFRLLQR-----QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             EEEEecCCCCHHHHHHh-----CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecch
Confidence            34445555555333321     12346899999999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCCc---------------------------ccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCC
Q 009186          369 ARIFSGNQNE---------------------------ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK  421 (541)
Q Consensus       369 a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~  421 (541)
                      +.........                           .......|+..|+|||.+.+..++.++||||||+++|+|++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~  229 (316)
T cd05574         150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT  229 (316)
T ss_pred             hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence            8654322110                           0112345788999999999888999999999999999999999


Q ss_pred             CCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC----HHHHHH
Q 009186          422 RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN----MSSVVV  491 (541)
Q Consensus       422 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt----~~evl~  491 (541)
                      .||......      ......... .        ............+.+++.+||+.||++||+    +++++.
T Consensus       230 ~pf~~~~~~------~~~~~~~~~-~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         230 TPFKGSNRD------ETFSNILKK-E--------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCCCchH------HHHHHHhcC-C--------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            997532211      111111111 0        000001113456778889999999999999    777775

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.88  E-value=2.3e-22  Score=201.74  Aligned_cols=158  Identities=24%  Similarity=0.366  Sum_probs=119.9

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.........  .....++..|+|||
T Consensus       111 ~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  185 (296)
T cd06655         111 CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPE  185 (296)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcc
Confidence            4899999999999999999999999   999999999999999999999999998765433221  22345788999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++|||||||++|+|++|+.||.....      ........... ......       +......+.+++.+
T Consensus       186 ~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~------~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~li~~  251 (296)
T cd06655         186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNG-TPELQN-------PEKLSPIFRDFLNR  251 (296)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC-CcccCC-------cccCCHHHHHHHHH
Confidence            99888899999999999999999999999843221      11111111111 000000       11122356678889


Q ss_pred             hcccCCCCCCCHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~  491 (541)
                      ||+.||++||++.+|+.
T Consensus       252 ~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         252 CLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HhhcChhhCCCHHHHhh
Confidence            99999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.88  E-value=7.8e-24  Score=198.80  Aligned_cols=181  Identities=23%  Similarity=0.307  Sum_probs=140.1

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++|||||..|+.....|.      +++.|++.++..+++..+.||+|||...   -||||||..|||++.+|..||+||
T Consensus       103 LWIVMEYCGAGSiSDI~R~------R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADF  173 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRA------RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADF  173 (502)
T ss_pred             eEeehhhcCCCcHHHHHHH------hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhc
Confidence            4567899988887544432      2347999999999999999999999987   899999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |.+-.+......  .+...||+.|||||++..-.|+.++||||||+...||..|++|+....+-.....       +   
T Consensus       174 GVAGQLTDTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------I---  241 (502)
T KOG0574|consen  174 GVAGQLTDTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------I---  241 (502)
T ss_pred             cccchhhhhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------c---
Confidence            999776543332  3457899999999999999999999999999999999999999743221111000       0   


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                        .....|.++  .+......+-++++.||-.+|++|-|+.++++.
T Consensus       242 --PT~PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  242 --PTKPPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             --cCCCCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence              000112222  134556778899999999999999999888763

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3e-22  Score=196.51  Aligned_cols=161  Identities=24%  Similarity=0.339  Sum_probs=120.5

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||.+..+.....  ......++..|++|
T Consensus        96 ~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~P  170 (262)
T cd06613          96 GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAP  170 (262)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCc
Confidence            35899999999999999999999998   99999999999999999999999999876543221  11234577889999


Q ss_pred             hhhccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          394 EYAMEG---VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       394 E~l~~~---~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |.+.+.   .++.++||||||+++|||++|+.||......      ...... .....   ..+.+.  ........+.+
T Consensus       171 e~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~------~~~~~~-~~~~~---~~~~~~--~~~~~~~~~~~  238 (262)
T cd06613         171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM------RALFLI-SKSNF---PPPKLK--DKEKWSPVFHD  238 (262)
T ss_pred             hhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-HhccC---CCcccc--chhhhhHHHHH
Confidence            998776   7889999999999999999999997432111      111111 01100   001111  11233456788


Q ss_pred             HHhhhcccCCCCCCCHHHHHH
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ++.+||+.+|.+||++.+|+.
T Consensus       239 li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         239 FIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHhc
Confidence            999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.88  E-value=1.4e-22  Score=204.41  Aligned_cols=170  Identities=23%  Similarity=0.264  Sum_probs=118.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||++.........  .....++..|+||
T Consensus       103 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aP  177 (309)
T cd07845         103 TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAP  177 (309)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccCh
Confidence            35899999999999999999999999   999999999999999999999999998865433211  1122347789999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc-----------CCcccccc--ccccCC
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK-----------GEALELMD--PVLKQT  459 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~--~~l~~~  459 (541)
                      |.+.+ ..++.++||||||+++|||++|+.||.....   .............           ........  ......
T Consensus       178 E~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (309)
T cd07845         178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNN  254 (309)
T ss_pred             hhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCc
Confidence            99875 4578999999999999999999999853221   1111111111000           00000000  000000


Q ss_pred             C---CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          460 C---VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       460 ~---~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .   .......+.+++.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         255 LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0   0012345678899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.88  E-value=2.2e-23  Score=204.06  Aligned_cols=157  Identities=21%  Similarity=0.342  Sum_probs=121.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++++++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.........  .....++..|+||
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p  170 (256)
T cd08218          96 VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSP  170 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCH
Confidence            35789999999999999999999998   999999999999999999999999998765432211  1234578889999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+...+.++|+||||+++++|++|+.||....      ..+...... .+...     .    .+......+.+++.
T Consensus       171 e~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~-~~~~~-----~----~~~~~~~~~~~li~  234 (256)
T cd08218         171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKII-RGSYP-----P----VSSHYSYDLRNLVS  234 (256)
T ss_pred             HHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHh-cCCCC-----C----CcccCCHHHHHHHH
Confidence            99988889999999999999999999999974221      111111111 11111     0    11122445778888


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+.+|.+||++.+|++
T Consensus       235 ~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         235 QLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HHhhCChhhCcCHHHHhh
Confidence            999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.88  E-value=1.9e-22  Score=207.54  Aligned_cols=170  Identities=23%  Similarity=0.275  Sum_probs=121.0

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      +++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......   .....++..|+|||.
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~  188 (353)
T cd07850         115 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEV  188 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHH
Confidence            788899999999999999999998   99999999999999999999999999976543221   223457889999999


Q ss_pred             hccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCc------------CcHHHH---HHHhhhcCC-------cccccc
Q 009186          396 AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG------------QSLLTY---AWKLWCKGE-------ALELMD  453 (541)
Q Consensus       396 l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~------------~~~~~~---~~~~~~~~~-------~~~~~~  453 (541)
                      +.+..++.++||||||+++|+|++|+.||........            ......   ....+....       ..+.+.
T Consensus       189 ~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (353)
T cd07850         189 ILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFP  268 (353)
T ss_pred             HhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCc
Confidence            9999999999999999999999999999853321100            000000   000000000       001111


Q ss_pred             cccc----CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          454 PVLK----QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       454 ~~l~----~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..+.    ..........+.+++.+||+.||++|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         269 DVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             ccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1000    0001123456778999999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.88  E-value=1.2e-22  Score=202.44  Aligned_cols=171  Identities=22%  Similarity=0.287  Sum_probs=122.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......... ......++..|+||
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~P  170 (288)
T cd07833          95 GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAP  170 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCC
Confidence            34899999999999999999999998   999999999999999999999999998775543321 12234578889999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh-----------hhcCC------cccccccc
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL-----------WCKGE------ALELMDPV  455 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~------~~~~~~~~  455 (541)
                      |.+.+. .++.++||||||+++|+|++|+.||......   ..+......           +....      ..+..++.
T Consensus       171 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (288)
T cd07833         171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPE  247 (288)
T ss_pred             chhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcH
Confidence            999887 7899999999999999999999987532211   011000000           00000      00000000


Q ss_pred             -ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          456 -LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       456 -l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       +....+......+.+++.+||+.+|++||+++++++
T Consensus       248 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         248 SLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             000111112466788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.88  E-value=1.1e-22  Score=204.76  Aligned_cols=169  Identities=22%  Similarity=0.323  Sum_probs=119.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc--ccccccccCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVAGTYGYM  391 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~  391 (541)
                      ..+++.+++.++.||+.||+|||+++   ++|+||||+||+++.++.+||+|||++..+......  .......++..|+
T Consensus       114 ~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~  190 (310)
T cd07865         114 VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR  190 (310)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCcccc
Confidence            35899999999999999999999998   999999999999999999999999998765433221  1112345678899


Q ss_pred             ChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh--------cCCccc------------
Q 009186          392 APEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC--------KGEALE------------  450 (541)
Q Consensus       392 aPE~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~------------  450 (541)
                      |||.+.+.. ++.++||||||+++|||++|+.||.......   ..........        .....+            
T Consensus       191 aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (310)
T cd07865         191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQK  267 (310)
T ss_pred             CcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhcccccchhhhhhccCCCccc
Confidence            999886644 6889999999999999999999875332211   1111111100        000000            


Q ss_pred             -cccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          451 -LMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       451 -~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       .+...+...   .+...+.+++.+||+.||++|||++++++
T Consensus       268 ~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         268 RKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence             000000000   11235668999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=4.6e-23  Score=205.28  Aligned_cols=183  Identities=26%  Similarity=0.391  Sum_probs=131.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++|+..+.+....++       .+.+++..+..++.+++.||.|||+ .+   ++|+||||+||+++.++.++|+||
T Consensus        79 ~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~  148 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKK-------GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDF  148 (284)
T ss_pred             EEEEecCCCCCHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccC
Confidence            345566666655433322       2358999999999999999999997 46   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCc-----CcHHHHHHH
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG-----QSLLTYAWK  441 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~-----~~~~~~~~~  441 (541)
                      |++.......    .....++..|++||.+.+..++.++||||||+++|++++|+.||........     .........
T Consensus       149 gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd06620         149 GVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ  224 (284)
T ss_pred             Ccccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence            9886542221    2234688999999999888899999999999999999999999864332111     111111111


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      .... .     .+.+..   ......+.+++.+||+.||++||++.|++++.
T Consensus       225 ~~~~-~-----~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         225 IVQE-P-----PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             Hhhc-c-----CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1111 0     011111   11234577888999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.88  E-value=2.5e-23  Score=229.97  Aligned_cols=167  Identities=23%  Similarity=0.298  Sum_probs=121.0

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC---------------
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN---------------  377 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---------------  377 (541)
                      ...+++..+++++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.......               
T Consensus       107 ~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s  183 (932)
T PRK13184        107 AEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS  183 (932)
T ss_pred             hcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccccccccc
Confidence            345788899999999999999999998   99999999999999999999999999986521110               


Q ss_pred             -cccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccc
Q 009186          378 -EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVL  456 (541)
Q Consensus       378 -~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  456 (541)
                       ........||+.|+|||.+.+..++.++|||||||++|||++|+.||....   ...... . ...  ...... .+  
T Consensus       184 ~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~---~~ki~~-~-~~i--~~P~~~-~p--  253 (932)
T PRK13184        184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK---GRKISY-R-DVI--LSPIEV-AP--  253 (932)
T ss_pred             ccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc---hhhhhh-h-hhc--cChhhc-cc--
Confidence             011123468999999999999999999999999999999999999985311   111100 0 000  000000 00  


Q ss_pred             cCCCCHHHHHHHHHHHhhhcccCCCCCC-CHHHHHHHHhcC
Q 009186          457 KQTCVDAELLKCIHIGLLCVQEDPAHRP-NMSSVVVMLASD  496 (541)
Q Consensus       457 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP-t~~evl~~L~~~  496 (541)
                          .......+.+++.+||+.||++|| +++++++.|+..
T Consensus       254 ----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        254 ----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             ----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                011223466788899999999996 566777766543

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.88  E-value=5.8e-23  Score=209.40  Aligned_cols=183  Identities=17%  Similarity=0.216  Sum_probs=126.6

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+.+|.|...+++.      +..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF------EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEecc
Confidence            4566777777775444321      235889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAME-----GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      +++........ ......|++.|+|||++.+     +.++.++||||||+++|||++|+.||....      ..+.....
T Consensus       148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~i  220 (331)
T cd05624         148 SCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKI  220 (331)
T ss_pred             ceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC------HHHHHHHH
Confidence            98765433221 1223468999999999875     467889999999999999999999984221      11111121


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCC--CCCHHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAH--RPNMSSVVVM  492 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~evl~~  492 (541)
                      ........ +...+     ......+.+++.+|+..++.+  |++++++++.
T Consensus       221 ~~~~~~~~-~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         221 MNHEERFQ-FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HcCCCccc-CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            11111111 01111     112345666777888765543  4688888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=9.8e-23  Score=201.70  Aligned_cols=157  Identities=28%  Similarity=0.447  Sum_probs=121.3

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.......  ......++..|++||
T Consensus        94 ~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE  168 (274)
T cd06609          94 KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPE  168 (274)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChh
Confidence            6899999999999999999999998   99999999999999999999999999987654321  222346788899999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++||||||+++|+|++|+.||.....      ...... .....     .+.+...   .....+.+++.+
T Consensus       169 ~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~------~~~~~~-~~~~~-----~~~~~~~---~~~~~~~~~l~~  233 (274)
T cd06609         169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP------MRVLFL-IPKNN-----PPSLEGN---KFSKPFKDFVSL  233 (274)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch------HHHHHH-hhhcC-----CCCCccc---ccCHHHHHHHHH
Confidence            99988899999999999999999999999843221      111111 11111     1111111   023356778899


Q ss_pred             hcccCCCCCCCHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~  491 (541)
                      ||..+|++||+++++++
T Consensus       234 ~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         234 CLNKDPKERPSAKELLK  250 (274)
T ss_pred             HhhCChhhCcCHHHHhh
Confidence            99999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.88  E-value=3.7e-23  Score=202.11  Aligned_cols=178  Identities=25%  Similarity=0.301  Sum_probs=131.2

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+....++   ....+..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        76 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~  149 (256)
T cd08530          76 IVMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGI  149 (256)
T ss_pred             EEehhcCCCCHHHHHHH---HHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccc
Confidence            34455544544333222   1122456899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++.....    ......++..|++||.+.+..++.++|+||||+++|||++|+.||.....      .+... ....+..
T Consensus       150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~-~~~~~~~  218 (256)
T cd08530         150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM------QDLRY-KVQRGKY  218 (256)
T ss_pred             hhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH-HHhcCCC
Confidence            8776443    11224577899999999988899999999999999999999999743221      11111 1111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                               ..........+.+++.+||+.+|++||++.++++.
T Consensus       219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 ---------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ---------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                     11122344568889999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=8e-23  Score=203.00  Aligned_cols=179  Identities=23%  Similarity=0.286  Sum_probs=127.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.+....++      .+..+++.+++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||
T Consensus        78 ~lv~e~~~~~~L~~~~~~------~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g  148 (280)
T cd06611          78 WILIEFCDGGALDSIMLE------LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFG  148 (280)
T ss_pred             EEEeeccCCCcHHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCc
Confidence            445667666666443322      1235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      ++........  ......++..|++||.+.     ...++.++||||||+++|||++|+.||.....      ...... 
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------~~~~~~-  219 (280)
T cd06611         149 VSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------MRVLLK-  219 (280)
T ss_pred             cchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------HHHHHH-
Confidence            8765432221  122345788999999875     34467899999999999999999999753211      111111 


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +......     .+.  .+......+.+++.+||+.+|.+||++.+|++
T Consensus       220 ~~~~~~~-----~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         220 ILKSEPP-----TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HhcCCCC-----CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            1111111     110  01112335677888999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.88  E-value=2e-22  Score=200.91  Aligned_cols=159  Identities=25%  Similarity=0.307  Sum_probs=118.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........   .....|+..|+||
T Consensus        97 ~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aP  170 (285)
T cd05632          97 PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAP  170 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccCh
Confidence            35999999999999999999999999   99999999999999999999999999865432211   1234688999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++|+||||+++|||++|+.||.......   ..+..........      .....    .....+.+|+.
T Consensus       171 E~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~------~~~~~----~~~~~~~~li~  237 (285)
T cd05632         171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLETE------EVYSA----KFSEEAKSICK  237 (285)
T ss_pred             HHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhccc------cccCc----cCCHHHHHHHH
Confidence            99988889999999999999999999999985321110   1111111111110      01111    12234567888


Q ss_pred             hhcccCCCCCCC-----HHHHHH
Q 009186          474 LCVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt-----~~evl~  491 (541)
                      .||+.||++||+     +.+++.
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHc
Confidence            999999999999     667665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.88  E-value=5.8e-23  Score=206.84  Aligned_cols=185  Identities=19%  Similarity=0.184  Sum_probs=129.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++.++.|...++.       ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        77 ~lv~e~~~g~~L~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN-------IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             EEEEecCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCC
Confidence            344555555555333322       235899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCC-------------cccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCc
Q 009186          368 MARIFSGNQN-------------EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS  434 (541)
Q Consensus       368 ~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~  434 (541)
                      +++.......             ........++..|+|||.+.+..++.++||||||+++|||++|+.||....      
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~------  220 (305)
T cd05609         147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT------  220 (305)
T ss_pred             CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------
Confidence            8864211000             001112356788999999988889999999999999999999999974211      


Q ss_pred             HHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          435 LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..+.... ...+...   .+....    .....+.+++.+||+.||++||+..++.+.|+..
T Consensus       221 ~~~~~~~-~~~~~~~---~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         221 PEELFGQ-VISDDIE---WPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHHHHHH-HHhcccC---CCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            1111111 1111110   111111    1233467788899999999999988888777764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.88  E-value=1.6e-22  Score=200.76  Aligned_cols=170  Identities=21%  Similarity=0.241  Sum_probs=121.5

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||.+........  ......++..|++|
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~P  167 (283)
T cd05118          93 RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAP  167 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCc
Confidence            46899999999999999999999999   99999999999999999999999999876654331  11224567889999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC---Ccccccc------ccc-------
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG---EALELMD------PVL-------  456 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~------~~l-------  456 (541)
                      |.+.+. .++.++||||||+++|+|++|+.||......   .............   ......+      ...       
T Consensus       168 E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T cd05118         168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMP  244 (283)
T ss_pred             HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccC
Confidence            998876 6889999999999999999999987432211   1111000000000   0000000      000       


Q ss_pred             cCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          457 KQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       457 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .....+.....+.+++.+||+.||.+||++.+++.
T Consensus       245 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         245 LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             HHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00011223457788999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2.4e-23  Score=190.31  Aligned_cols=176  Identities=25%  Similarity=0.291  Sum_probs=131.7

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++||...|.++..++     ..+...+++.....++.|++.||.|+|.++   ||||||||+|+|++.++.+||+||
T Consensus        97 iyLilEya~~gel~k~L~-----~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQ-----EGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             eEEEEEecCCchHHHHHH-----hcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence            344445555555544333     123556888999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |.+..-.    ........||..|.+||...+...+..+|+|++|++.||++.|.+||....   .....    +.+.+ 
T Consensus       169 GwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etY----krI~k-  236 (281)
T KOG0580|consen  169 GWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETY----KRIRK-  236 (281)
T ss_pred             CceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHH----HHHHH-
Confidence            9987643    222335689999999999999999999999999999999999999985432   11111    11111 


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                        .+..+|       ........+++.+|+..+|.+|.+..|++.
T Consensus       237 --~~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  237 --VDLKFP-------STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             --ccccCC-------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence              111111       122334556788999999999999999986

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.88  E-value=1.7e-22  Score=202.12  Aligned_cols=172  Identities=22%  Similarity=0.254  Sum_probs=120.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||+|||+++   ++|+||||+||+++.++.+||+|||++..+......  .....++..|+|||
T Consensus       102 ~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE  176 (293)
T cd07843         102 PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPE  176 (293)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--cccccccccccCch
Confidence            5899999999999999999999999   999999999999999999999999998865443211  12245678899999


Q ss_pred             hhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHH--------HHHHHhhhc------CCccccccccccCC
Q 009186          395 YAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLL--------TYAWKLWCK------GEALELMDPVLKQT  459 (541)
Q Consensus       395 ~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~l~~~  459 (541)
                      .+.+.. ++.++||||||+++|||++|+.||............        ...|..+..      ..........+...
T Consensus       177 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (293)
T cd07843         177 LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKK  256 (293)
T ss_pred             hhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcc
Confidence            987644 688999999999999999999998543221100000        000111100      00000101111111


Q ss_pred             CCHH-HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          460 CVDA-ELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       460 ~~~~-~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +... ....+.+++.+||+.||++|||+.|++.
T Consensus       257 ~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         257 FPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111 2455678899999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.88  E-value=5.6e-23  Score=204.48  Aligned_cols=191  Identities=19%  Similarity=0.269  Sum_probs=128.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++ .+.+....++      ....+++.+++.++.||+.||+|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        75 ~~v~e~~-~~~L~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg  144 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRD------EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFG  144 (286)
T ss_pred             EEEeccc-CCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeee
Confidence            3445666 5555433322      1245899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      .+........ .......++..|+|||.+.+. .++.++||||||++++||++|+++|.....   ..............
T Consensus       145 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~  220 (286)
T cd07832         145 LARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTP  220 (286)
T ss_pred             ecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCC
Confidence            9886643322 112234578899999988654 468999999999999999999777642211   11111111110000


Q ss_pred             C------------cccccccccc----CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          447 E------------ALELMDPVLK----QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       447 ~------------~~~~~~~~l~----~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      .            ......+...    ....+.....+.+++.+||+.||++||+++++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0            0000000000    00011223677889999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.88  E-value=1.1e-22  Score=207.80  Aligned_cols=173  Identities=26%  Similarity=0.292  Sum_probs=122.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||+++......  .......++..|+||
T Consensus       103 ~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aP  177 (337)
T cd07858         103 QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAP  177 (337)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccCh
Confidence            45899999999999999999999998   9999999999999999999999999987654322  112234568899999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh-----------cCCccccc-------cc
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC-----------KGEALELM-------DP  454 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~-------~~  454 (541)
                      |.+.. ..++.++||||||+++|+|++|+.||......   ...........           .....+.+       ++
T Consensus       178 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (337)
T cd07858         178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQ  254 (337)
T ss_pred             HHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCccccc
Confidence            98865 46889999999999999999999998532211   11111111000           00000000       00


Q ss_pred             cccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH--Hhc
Q 009186          455 VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM--LAS  495 (541)
Q Consensus       455 ~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~--L~~  495 (541)
                      ... ...+.....+.+++.+||+.||++||+++++++.  ++.
T Consensus       255 ~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         255 SFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             CHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence            000 0011224567889999999999999999999975  544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=4.8e-23  Score=202.22  Aligned_cols=179  Identities=20%  Similarity=0.201  Sum_probs=129.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|...+++       ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||
T Consensus        73 ~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  142 (260)
T cd05611          73 YLVMEYLNGGDCASLIKT-------LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFG  142 (260)
T ss_pred             EEEEeccCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecc
Confidence            344566655555333322       235899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++....      .....++..|++||.+.+..++.++||||||+++|||++|..||.....      .+ .+.....+.
T Consensus       143 ~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~  209 (260)
T cd05611         143 LSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DA-VFDNILSRR  209 (260)
T ss_pred             cceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HH-HHHHHHhcc
Confidence            8875432      2234577889999999888889999999999999999999999843211      11 111111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..      ............+.+++.+||+.||++||++.++.+.|+.
T Consensus       210 ~~------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         210 IN------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             cC------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            10      0000111223457788899999999999988777666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=1.2e-22  Score=202.70  Aligned_cols=167  Identities=26%  Similarity=0.313  Sum_probs=122.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........    ....++..|++
T Consensus        99 ~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~  171 (287)
T cd06621          99 GGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMA  171 (287)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccC
Confidence            445899999999999999999999999   99999999999999999999999999865432211    12356788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+.+..++.++||||||+++|+|++|+.||........ ...+.... ........+ ......  .......+.+++
T Consensus       172 pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~-~~~~~~--~~~~~~~~~~li  246 (287)
T cd06621         172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSY-IVNMPNPEL-KDEPGN--GIKWSEEFKDFI  246 (287)
T ss_pred             HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHH-HhcCCchhh-ccCCCC--CCchHHHHHHHH
Confidence            9999888899999999999999999999999864422111 11111111 111111111 111100  011245678899


Q ss_pred             hhhcccCCCCCCCHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~  491 (541)
                      .+||+.||.+|||+.||++
T Consensus       247 ~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         247 KQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             HHHcCCCcccCCCHHHHHh
Confidence            9999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.87  E-value=6.5e-22  Score=196.81  Aligned_cols=168  Identities=21%  Similarity=0.278  Sum_probs=120.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||.+.........   ....++..|++||
T Consensus       103 ~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE  176 (287)
T cd07838         103 GLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPE  176 (287)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChH
Confidence            5899999999999999999999998   999999999999999999999999998775433211   2234678899999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc-CC--c-------ccccccccc---CCCC
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK-GE--A-------LELMDPVLK---QTCV  461 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~--~-------~~~~~~~l~---~~~~  461 (541)
                      .+.+..++.++||||||+++|||++|+.||......   ............ ..  .       .........   ....
T Consensus       177 ~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T cd07838         177 VLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFV  253 (287)
T ss_pred             HhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhh
Confidence            999888999999999999999999998887532211   111111110000 00  0       000000000   1111


Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          462 DAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       462 ~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.....+.+++.+||+.||.+||++.+++.
T Consensus       254 ~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         254 PEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            123456678999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.1e-22  Score=205.23  Aligned_cols=160  Identities=24%  Similarity=0.369  Sum_probs=124.5

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..|++.++.-+++|++.||.|||+++   |||||||..|||++-+|.++|+|||.+....  ........+.||+.|||
T Consensus       124 ~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFIGTPYWMA  198 (1187)
T KOG0579|consen  124 GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFIGTPYWMA  198 (1187)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHHhhhccccCCccccc
Confidence            346899999999999999999999999   9999999999999999999999999976432  12223445789999999


Q ss_pred             hhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          393 PEYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       393 PE~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      ||+..     ..+|+.++||||||++|.||..+.+|...      .+.+....+ +.+.+..-++.       +......
T Consensus       199 PEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllK-iaKSePPTLlq-------PS~Ws~~  264 (1187)
T KOG0579|consen  199 PEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLK-IAKSEPPTLLQ-------PSHWSRS  264 (1187)
T ss_pred             chheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHH-HhhcCCCcccC-------cchhhhH
Confidence            99875     56799999999999999999999988421      112221111 12222222222       3345667


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHH
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+++.+||..||..||++.++++
T Consensus       265 F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  265 FSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHHHHhcCCccCCCHHHHhh
Confidence            888999999999999999999875

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.87  E-value=7.2e-23  Score=209.39  Aligned_cols=180  Identities=22%  Similarity=0.242  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC----CCc
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE----MNP  361 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~----~~~  361 (541)
                      .+++|+|++.+|-|+.+..+.        .+++..+..++.||+.+++|||+.+   |+||||||+|+|+...    +.+
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i  178 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI  178 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence            456677888888887666542        2899999999999999999999999   9999999999999644    469


Q ss_pred             EEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH
Q 009186          362 KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       362 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      |++|||++.....   .......+||+.|+|||++....++..+||||+||++|.|++|.+||.......   ...    
T Consensus       179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~---~~~----  248 (382)
T KOG0032|consen  179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE---IFL----  248 (382)
T ss_pred             EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH---HHH----
Confidence            9999999998765   334456789999999999999999999999999999999999999984322111   111    


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ....++.      .......+.....+.+++..++..||.+|+|+.++++.
T Consensus       249 ~i~~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 AILRGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHHcCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1122222      12222233345567778889999999999999999983

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.87  E-value=6e-23  Score=202.18  Aligned_cols=158  Identities=22%  Similarity=0.307  Sum_probs=117.9

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc-ccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aP  393 (541)
                      .+++...++++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||+++........ .......++..|+||
T Consensus       102 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (265)
T cd06652         102 ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP  178 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccCh
Confidence            4788899999999999999999998   999999999999999999999999998764322111 112234578899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|||++|+.||....     .... ........     .    ....+......+.+++.
T Consensus       179 E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~-~~~~~~~~-----~----~~~~~~~~~~~~~~~i~  243 (265)
T cd06652         179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-----AMAA-IFKIATQP-----T----NPVLPPHVSDHCRDFLK  243 (265)
T ss_pred             hhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-----hHHH-HHHHhcCC-----C----CCCCchhhCHHHHHHHH
Confidence            99988889999999999999999999999974221     1111 11111000     0    11122333456677888


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||. +|++||++++|++
T Consensus       244 ~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         244 RIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHhc-ChhhCCCHHHHhc
Confidence            8884 9999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.87  E-value=2e-22  Score=201.56  Aligned_cols=168  Identities=24%  Similarity=0.290  Sum_probs=118.4

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-CCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      +..+++..++.++.||+.||.|||+++   |+||||||+||+++. ++.+||+|||+++.+......  .....+++.|+
T Consensus       104 ~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~  178 (295)
T cd07837         104 GRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYR  178 (295)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCC
Confidence            456899999999999999999999998   999999999999998 889999999998765332211  11234578899


Q ss_pred             Chhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh---cCC--cc-cc---cc----cccc
Q 009186          392 APEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC---KGE--AL-EL---MD----PVLK  457 (541)
Q Consensus       392 aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~--~~-~~---~~----~~l~  457 (541)
                      |||.+.+ ..++.++||||||+++|+|++|..||.....      .........   ...  .. ..   .+    +...
T Consensus       179 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (295)
T cd07837         179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE------LQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWK  252 (295)
T ss_pred             ChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHHhCCCChhhCcchhhccchhhcCccc
Confidence            9998865 4578999999999999999999999853211      111111100   000  00 00   00    0000


Q ss_pred             ----CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          458 ----QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       458 ----~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                          ....+.....+.+++.+||+.||.+||++.|++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         253 PQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             chhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                0000122345778999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.87  E-value=4e-22  Score=196.07  Aligned_cols=163  Identities=26%  Similarity=0.443  Sum_probs=122.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc--cccccccCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA--NTNRVAGTYGYM  391 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~  391 (541)
                      ..+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++..+.......  ......++..|+
T Consensus        97 ~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~  173 (267)
T cd06610          97 GGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM  173 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhc
Confidence            45899999999999999999999998   9999999999999999999999999987655433221  223345788999


Q ss_pred             ChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCC-CHHHHHHHH
Q 009186          392 APEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTC-VDAELLKCI  469 (541)
Q Consensus       392 aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~  469 (541)
                      +||.+... .++.++|+||||+++|||++|+.||......      ......... .     .+.+.... .......+.
T Consensus       174 ~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~  241 (267)
T cd06610         174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQN-D-----PPSLETGADYKKYSKSFR  241 (267)
T ss_pred             ChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcC-C-----CCCcCCccccccccHHHH
Confidence            99998877 7889999999999999999999998532111      111111111 0     01111110 012235677


Q ss_pred             HHHhhhcccCCCCCCCHHHHHH
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +++.+||+.||++||++.+|++
T Consensus       242 ~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         242 KMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHcCCChhhCcCHHHHhh
Confidence            8899999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.87  E-value=4.1e-22  Score=200.73  Aligned_cols=172  Identities=22%  Similarity=0.280  Sum_probs=119.5

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCccc---------cccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN---------TNRV  384 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~---------~~~~  384 (541)
                      ..+++.++..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++..........         ....
T Consensus       110 ~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (311)
T cd07866         110 VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL  186 (311)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccc
Confidence            35899999999999999999999999   99999999999999999999999999876543221111         1223


Q ss_pred             ccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc-----------CCccc--
Q 009186          385 AGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK-----------GEALE--  450 (541)
Q Consensus       385 ~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~--  450 (541)
                      .++..|+|||.+.+. .++.++||||||+++|||++|++||......   ...+..+.....           .....  
T Consensus       187 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (311)
T cd07866         187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI---DQLHLIFKLCGTPTEETWPGWRSLPGCEGV  263 (311)
T ss_pred             eeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhchhhhhccccccc
Confidence            567889999988654 4789999999999999999999997532211   111111111000           00000  


Q ss_pred             cccccccCC---CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          451 LMDPVLKQT---CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       451 ~~~~~l~~~---~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .........   ........+.+++.+||+.||++|||+.+++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         264 HSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             ccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000000000   00111246778999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.87  E-value=7.9e-23  Score=200.91  Aligned_cols=178  Identities=23%  Similarity=0.286  Sum_probs=129.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.|...+++       ...+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        69 ~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~  138 (262)
T cd05572          69 YMLMEYCLGGELWTILRD-------RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFG  138 (262)
T ss_pred             EEEEecCCCCcHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCC
Confidence            345556555555443332       224899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++.......   ......++..|++||.+.+..++.++|+||||+++|+|++|..||.....+    .............
T Consensus       139 ~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~  211 (262)
T cd05572         139 FAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNG  211 (262)
T ss_pred             cccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCC
Confidence            988764332   122345788999999998888999999999999999999999998543321    1111111110000


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~evl~  491 (541)
                               ....+......+.+++.+||+.||++||+     ++|+++
T Consensus       212 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         212 ---------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ---------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence                     01111122456788999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.87  E-value=2.9e-22  Score=198.93  Aligned_cols=168  Identities=20%  Similarity=0.232  Sum_probs=119.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||||+||+++. +.+||+|||+++........   ....++..|+||
T Consensus        95 ~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aP  167 (282)
T cd07831          95 RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAP  167 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCCh
Confidence            35899999999999999999999999   999999999999999 99999999999765433221   123568899999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH-----------hhhcCCcccccccc-cc---
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK-----------LWCKGEALELMDPV-LK---  457 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-l~---  457 (541)
                      |.+.. ..++.++|||||||++|||++|+.||......   ........           ............+. ..   
T Consensus       168 E~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (282)
T cd07831         168 ECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGL  244 (282)
T ss_pred             hHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccH
Confidence            97754 45788999999999999999999998532211   11111111           00000000000000 00   


Q ss_pred             CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          458 QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       458 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..........+.+++.+||+.||++||+++++++
T Consensus       245 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         245 RKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0001123567888999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.87  E-value=1.1e-22  Score=204.89  Aligned_cols=154  Identities=29%  Similarity=0.417  Sum_probs=117.5

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.||+.||.|||+.+   |+|+||+|+||+++.++.++|+|||++......      ....++..|+|||
T Consensus       111 ~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE  181 (307)
T cd06607         111 PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPE  181 (307)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCce
Confidence            5899999999999999999999998   999999999999999999999999998754322      2245678899999


Q ss_pred             hhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          395 YAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       395 ~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      .+.   ...++.++||||||+++|||++|+.||....      ......... ....     +.+.   .......+.++
T Consensus       182 ~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~------~~~~~~~~~-~~~~-----~~~~---~~~~~~~~~~l  246 (307)
T cd06607         182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIA-QNDS-----PTLS---SNDWSDYFRNF  246 (307)
T ss_pred             eeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc------HHHHHHHHh-cCCC-----CCCC---chhhCHHHHHH
Confidence            874   3568889999999999999999999973211      111111111 1110     1110   11234467889


Q ss_pred             HhhhcccCCCCCCCHHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~  492 (541)
                      +.+||+.||++||++.+|+..
T Consensus       247 i~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         247 VDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHhcCChhhCcCHHHHhcC
Confidence            999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.87  E-value=9.1e-23  Score=200.96  Aligned_cols=162  Identities=25%  Similarity=0.390  Sum_probs=120.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEecccccccccCCCCc--ccccccccCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNE--ANTNRVAGTYGYM  391 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~  391 (541)
                      .+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++ .+||+|||.+.........  .......++..|+
T Consensus        99 ~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (268)
T cd06630          99 AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM  175 (268)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccccccccee
Confidence            5889999999999999999999999   99999999999998776 5899999998765433211  1122345788999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |||.+.+..++.++||||||+++++|++|+.||......   ..............         ....+......+.++
T Consensus       176 ~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~  243 (268)
T cd06630         176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS---NHLALIFKIASATT---------APSIPEHLSPGLRDV  243 (268)
T ss_pred             CHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc---chHHHHHHHhccCC---------CCCCchhhCHHHHHH
Confidence            999998888999999999999999999999997532211   11111111110000         111222334567789


Q ss_pred             HhhhcccCCCCCCCHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+||+.+|.+||++.+++.
T Consensus       244 i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         244 TLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHcCCCcccCcCHHHHhc
Confidence            99999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.87  E-value=6.5e-22  Score=197.24  Aligned_cols=158  Identities=23%  Similarity=0.354  Sum_probs=120.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.|++.||+|||+.+   |+||||+|+||+++.++.++|+|||.+.........  .....++..|++||
T Consensus       111 ~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE  185 (285)
T cd06648         111 RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPE  185 (285)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccccCCccccCHH
Confidence            4889999999999999999999999   999999999999999999999999987754432211  12345788999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++||||||+++|||++|+.||....      ........ .....     +.+..  .......+.+++.+
T Consensus       186 ~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~------~~~~~~~~-~~~~~-----~~~~~--~~~~~~~l~~li~~  251 (285)
T cd06648         186 VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP------PLQAMKRI-RDNLP-----PKLKN--LHKVSPRLRSFLDR  251 (285)
T ss_pred             HhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC------HHHHHHHH-HhcCC-----CCCcc--cccCCHHHHHHHHH
Confidence            9988889999999999999999999999974211      11111111 11110     11111  11123467789999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~  491 (541)
                      ||+.+|++||++.++++
T Consensus       252 ~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         252 MLVRDPAQRATAAELLN  268 (285)
T ss_pred             HcccChhhCcCHHHHcc
Confidence            99999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.87  E-value=1.4e-22  Score=229.46  Aligned_cols=157  Identities=17%  Similarity=0.206  Sum_probs=110.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-------------------CCCcEEecccccccccC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-------------------EMNPKISDFGMARIFSG  374 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-------------------~~~~kL~Dfg~a~~~~~  374 (541)
                      ..+++.+++.++.||++||.|||+++   |+||||||+||||+.                   ++.+|++|||+++....
T Consensus        75 ~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~  151 (793)
T PLN00181         75 RSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEI  151 (793)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccccc
Confidence            45999999999999999999999999   999999999999954                   44566666776654211


Q ss_pred             CCC--------------cccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHH
Q 009186          375 NQN--------------EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAW  440 (541)
Q Consensus       375 ~~~--------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~  440 (541)
                      ...              ........||+.|+|||++.+..++.++|||||||+||||++|..|+...    . ...    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~----~-~~~----  222 (793)
T PLN00181        152 LSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK----S-RTM----  222 (793)
T ss_pred             ccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH----H-HHH----
Confidence            000              00011135788899999999999999999999999999999988775211    0 000    


Q ss_pred             HhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          441 KLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       441 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..+...    .+.+..     .....+...++.+||+.||.+||++.||++
T Consensus       223 ~~~~~~----~~~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        223 SSLRHR----VLPPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHh----hcChhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            000000    011110     111233456778999999999999999985

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.87  E-value=4.9e-23  Score=201.33  Aligned_cols=158  Identities=29%  Similarity=0.405  Sum_probs=119.3

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEecccccccccCCCCcccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      +..+++..++.++.|++.||+|||+++   ++|+||||+||+++.++ .+||+|||.+........   .....++..|+
T Consensus        95 ~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~  168 (256)
T cd08220          95 NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYI  168 (256)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCccc
Confidence            345899999999999999999999998   99999999999998654 579999999886543321   22345788999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |||.+.+..++.++||||||+++|+|++|+.||.....      ........ ......         ........+.++
T Consensus       169 aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~-~~~~~~---------~~~~~~~~l~~l  232 (256)
T cd08220         169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIM-SGTFAP---------ISDRYSPDLRQL  232 (256)
T ss_pred             CchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHH-hcCCCC---------CCCCcCHHHHHH
Confidence            99999888889999999999999999999999743211      11111111 111111         111123456788


Q ss_pred             HhhhcccCCCCCCCHHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~  492 (541)
                      +.+||+.||.+|||+.++++.
T Consensus       233 i~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         233 ILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHHHccCChhhCCCHHHHhhC
Confidence            899999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.87  E-value=8.5e-23  Score=222.93  Aligned_cols=192  Identities=27%  Similarity=0.360  Sum_probs=142.1

Q ss_pred             HHHHHHHHHHHhhheecccccc-cc--CC----CC--ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc
Q 009186          286 IITTITLFILLGSFVWCRRRIN-KD--ST----KG--AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD  356 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~-~~--~~----~~--~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~  356 (541)
                      .+.+++||+..|.+..++++.+ ..  ..    ..  ..|+..+.+.++.||+.|++||++..   +|||||-.+|||+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence            4566777887777765555433 11  11    11  34999999999999999999999998   99999999999999


Q ss_pred             CCCCcEEecccccccccCCCCccccccc-ccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCc
Q 009186          357 HEMNPKISDFGMARIFSGNQNEANTNRV-AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQS  434 (541)
Q Consensus       357 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~  434 (541)
                      .+..+||+|||+++.............. .-...|||||.+....|+.++|||||||+||||++ |..|+...      .
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~------~  526 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI------P  526 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC------C
Confidence            9999999999999965544333222111 12455999999999999999999999999999999 77776431      1


Q ss_pred             HHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          435 LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .....++.+..|...+         .+.....++.++|+.||+.+|++||++.++++.|+.
T Consensus       527 ~~~~l~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  527 PTEELLEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             cHHHHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            0111123333333322         222335567789999999999999999999999987

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.87  E-value=2.8e-22  Score=199.58  Aligned_cols=169  Identities=24%  Similarity=0.347  Sum_probs=118.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+.+   |+|+||+|+||+++.++.++|+|||++.........  .....++..|++||
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  170 (286)
T cd07846          96 GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPE  170 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--cCcccceeeccCcH
Confidence            4899999999999999999999998   999999999999999999999999998765433211  12245788999999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH-----------hhhcCCcc-ccccccccC---
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK-----------LWCKGEAL-ELMDPVLKQ---  458 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~-~~~~~~l~~---  458 (541)
                      ++.+ ..++.++||||||+++|||++|++||......   ........           .+...... ....+....   
T Consensus       171 ~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (286)
T cd07846         171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI---DQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEP  247 (286)
T ss_pred             HhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcch
Confidence            9875 34778999999999999999999887532211   00000000           00000000 000000000   


Q ss_pred             --CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          459 --TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       459 --~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                        ...+.....+.+++.+||+.+|++||++.+|++
T Consensus       248 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         248 LEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence              001122456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.87  E-value=2.6e-22  Score=204.84  Aligned_cols=172  Identities=24%  Similarity=0.330  Sum_probs=120.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc--cccccccCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA--NTNRVAGTYGYM  391 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~  391 (541)
                      ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..........  ......++..|+
T Consensus       102 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~  178 (334)
T cd07855         102 QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR  178 (334)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccccccccccc
Confidence            34899999999999999999999998   9999999999999999999999999987654332211  112346788999


Q ss_pred             Chhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh-----------hhcCCcccccccc-ccC
Q 009186          392 APEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL-----------WCKGEALELMDPV-LKQ  458 (541)
Q Consensus       392 aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~-l~~  458 (541)
                      +||.+.+ ..++.++||||||+++|||++|+.||.......   ........           .......+..+.. ...
T Consensus       179 ~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (334)
T cd07855         179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQ  255 (334)
T ss_pred             ChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCC
Confidence            9998865 458899999999999999999999985322110   00000000           0000000000000 000


Q ss_pred             CC-----CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          459 TC-----VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       459 ~~-----~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..     .+.....+.+++.+||+.+|.+||++.+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         256 PVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             CCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00     1122456788999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.87  E-value=2.4e-22  Score=199.81  Aligned_cols=171  Identities=20%  Similarity=0.275  Sum_probs=120.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||++.......... .....++..|+||
T Consensus        95 ~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~P  170 (287)
T cd07840          95 VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD-YTNRVITLWYRPP  170 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc-ccccccccccCCc
Confidence            46899999999999999999999998   9999999999999999999999999988664433211 1223467789999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc---CCcc--------------cccccc
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK---GEAL--------------ELMDPV  455 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~--------------~~~~~~  455 (541)
                      |.+.+ ..++.++||||||+++|||++|+.||......   ............   ....              ......
T Consensus       171 E~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (287)
T cd07840         171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRR  247 (287)
T ss_pred             eeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhccccccchhhhhccccccchhH
Confidence            97765 45789999999999999999999997533221   111111110000   0000              000000


Q ss_pred             ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       456 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.......+...+.+++.+||+.+|.+||++.++++
T Consensus       248 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         248 LREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             HHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            100001112456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.87  E-value=2.6e-22  Score=204.28  Aligned_cols=194  Identities=23%  Similarity=0.300  Sum_probs=126.7

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.+...+++.     ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+++.||+
T Consensus        75 ~~v~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~  146 (328)
T cd08226          75 WVISPFMAYGSANSLLKTY-----FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLS  146 (328)
T ss_pred             EEEEecccCCCHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechH
Confidence            3455555555553333221     1234899999999999999999999998   9999999999999999999999997


Q ss_pred             ccccccCCCCcc-----cccccccCCCCCChhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHH
Q 009186          368 MARIFSGNQNEA-----NTNRVAGTYGYMAPEYAMEG--VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAW  440 (541)
Q Consensus       368 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~  440 (541)
                      ............     ......++..|++||++.+.  .++.++||||||+++|||++|+.||.......  .......
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~  224 (328)
T cd08226         147 HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLK  224 (328)
T ss_pred             HHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhc
Confidence            654322111100     01112345679999998764  47899999999999999999999985332110  0000000


Q ss_pred             ----------------Hhh----------------hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHH
Q 009186          441 ----------------KLW----------------CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS  488 (541)
Q Consensus       441 ----------------~~~----------------~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~e  488 (541)
                                      ..+                .........+..+...........+.+++.+||+.||++|||+.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e  304 (328)
T cd08226         225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASS  304 (328)
T ss_pred             CCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHH
Confidence                            000                000000111111122222345567889999999999999999999


Q ss_pred             HHH
Q 009186          489 VVV  491 (541)
Q Consensus       489 vl~  491 (541)
                      +++
T Consensus       305 ~l~  307 (328)
T cd08226         305 LLS  307 (328)
T ss_pred             Hhh
Confidence            985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.87  E-value=4e-22  Score=198.31  Aligned_cols=170  Identities=21%  Similarity=0.250  Sum_probs=118.1

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++.........  .....++..|+|
T Consensus        94 ~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~a  168 (284)
T cd07860          94 LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRA  168 (284)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccC
Confidence            346899999999999999999999998   999999999999999999999999998765432211  122346788999


Q ss_pred             hhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC----------------Ccccccccc
Q 009186          393 PEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG----------------EALELMDPV  455 (541)
Q Consensus       393 PE~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~  455 (541)
                      ||.+.+.. ++.++||||||+++|||++|+.||......  ...... .......                .........
T Consensus       169 PE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (284)
T cd07860         169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRI-FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQD  245 (284)
T ss_pred             CeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH-HHHhCCCChhhhhhhhHHHHHHhhcccccccC
Confidence            99887644 588999999999999999999998532211  011110 0000000                000000000


Q ss_pred             ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       456 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.. ........+.+++.+||+.||.+||+++++++
T Consensus       246 ~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         246 FSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000 00111234667899999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.87  E-value=5.2e-22  Score=195.21  Aligned_cols=161  Identities=27%  Similarity=0.416  Sum_probs=121.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..+..++.|++.||+|||+ .+   ++|+||||+||+++.++.++|+|||.+........    ....++..|++
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~  167 (265)
T cd06605          95 GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMA  167 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccC
Confidence            468899999999999999999999 88   99999999999999999999999999865432211    11567889999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+.+..++.++||||||+++|+|++|+.||...... .....+...... ....     +.+...   .....+.+++
T Consensus       168 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~-----~~~~~~---~~~~~~~~li  237 (265)
T cd06605         168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIV-NEPP-----PRLPSG---KFSPDFQDFV  237 (265)
T ss_pred             HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHh-cCCC-----CCCChh---hcCHHHHHHH
Confidence            99999889999999999999999999999998543211 111222211111 1111     111111   1334577888


Q ss_pred             hhhcccCCCCCCCHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~  491 (541)
                      .+||..||++|||+.+++.
T Consensus       238 ~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         238 NLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHcCCCchhCcCHHHHhh
Confidence            8999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.87  E-value=3e-22  Score=168.18  Aligned_cols=90  Identities=40%  Similarity=0.702  Sum_probs=75.0

Q ss_pred             CchhHHHHHHHHHHHHHHhhcc-ccceeeeeeccCCCccEEEEEEeccCCChhhhHHHHHHHHhcccccCCCccceEEEC
Q 009186          155 SRSFDQFVWNSMNEAVNQALST-TKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMY  233 (541)
Q Consensus       155 ~~~f~~~~~~l~~~l~~~a~~~-~~~~a~~~~~~~~~~~vyglaQC~~Dls~~~C~~CL~~a~~~~~~~c~~~~g~~v~~  233 (541)
                      ++.|++++..||..|++.++.+ +.+|++++. ..+.++||||+||++||++.||+.||+.++.++..+|++++||+|++
T Consensus        16 ~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~   94 (106)
T PF01657_consen   16 NSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWY   94 (106)
T ss_dssp             T-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEE
T ss_pred             CchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEEC
Confidence            3559999999999999998765 578999986 46788999999999999999999999999999999999999999999


Q ss_pred             CCcceeeccccc
Q 009186          234 PSCNFRYELYQF  245 (541)
Q Consensus       234 ~~C~lRye~~~F  245 (541)
                      ++|+||||.|+|
T Consensus        95 ~~C~lRY~~~~F  106 (106)
T PF01657_consen   95 DSCFLRYENYPF  106 (106)
T ss_dssp             SSEEEEEESS--
T ss_pred             CCEEEEEECCCC
Confidence            999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.87  E-value=6.3e-23  Score=198.86  Aligned_cols=162  Identities=17%  Similarity=0.108  Sum_probs=119.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.|.....+       ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||.
T Consensus        62 lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~  131 (237)
T cd05576          62 LVLQHAEGGKLWSHISK-------FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSR  131 (237)
T ss_pred             EEEecCCCCCHHHHHHH-------hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccc
Confidence            44566666666443322       124899999999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      +.......     ....++..|++||.+.+..++.++||||+|+++|||++|+.|+.......            ..   
T Consensus       132 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~---  191 (237)
T cd05576         132 WSEVEDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT---  191 (237)
T ss_pred             hhcccccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc---
Confidence            76543321     12345667999999988888999999999999999999998753211000            00   


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM  486 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~  486 (541)
                        .....+    +......+.+++.+||+.||++||++
T Consensus       192 --~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         192 --HTTLNI----PEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             --ccccCC----cccCCHHHHHHHHHHccCCHHHhcCC
Confidence              000001    11123456778889999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.87  E-value=2.3e-22  Score=205.48  Aligned_cols=172  Identities=23%  Similarity=0.282  Sum_probs=120.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc---ccccccccCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE---ANTNRVAGTYGYM  391 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~  391 (541)
                      .+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.........   .......++..|+
T Consensus       103 ~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~  179 (337)
T cd07852         103 ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR  179 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhccccccccc
Confidence            5788999999999999999999998   999999999999999999999999998865433221   1223356788999


Q ss_pred             Chhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh-----------hhcCCcccccc---ccc
Q 009186          392 APEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL-----------WCKGEALELMD---PVL  456 (541)
Q Consensus       392 aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~---~~l  456 (541)
                      +||.+.+ ..++.++||||||+++|+|++|+.||.......   ........           +......++++   ..-
T Consensus       180 aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (337)
T cd07852         180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRP  256 (337)
T ss_pred             CceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhccccc
Confidence            9998765 457889999999999999999999985322111   01000000           00000000000   000


Q ss_pred             c---CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          457 K---QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       457 ~---~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      .   ..........+.+++.+||+.||++|||+.++++.
T Consensus       257 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         257 RKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             ccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0   00001123467789999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.87  E-value=3.8e-22  Score=193.89  Aligned_cols=158  Identities=25%  Similarity=0.427  Sum_probs=121.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+........   .....++..|++|
T Consensus        93 ~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~P  166 (253)
T cd05122          93 QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAP  166 (253)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCH
Confidence            45899999999999999999999998   99999999999999999999999999876544322   2345678899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+...+.++||||||+++|+|++|+.||.....      ....... ..........     .  ......+.+++.
T Consensus       167 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~~~~~~~~-----~--~~~~~~~~~~i~  232 (253)
T cd05122         167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKI-ATNGPPGLRN-----P--EKWSDEFKDFLK  232 (253)
T ss_pred             HHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHH-HhcCCCCcCc-----c--cccCHHHHHHHH
Confidence            999888889999999999999999999999743211      1111111 1111111110     0  001345778888


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+.||++|||+.++++
T Consensus       233 ~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHccCChhhCCCHHHHhc
Confidence            999999999999999885

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.87  E-value=2e-22  Score=201.46  Aligned_cols=153  Identities=23%  Similarity=0.277  Sum_probs=118.5

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||.|||+.+   |+|+||+|+||+++.++.+||+|||++......     .....++..|++|
T Consensus        96 ~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aP  167 (290)
T cd05580          96 GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAP  167 (290)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccCh
Confidence            46899999999999999999999998   999999999999999999999999998865433     2234578899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+...+.++||||||+++|+|++|+.||....      .. ........+..      .+    +......+.+++.
T Consensus       168 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~-~~~~~~~~~~~------~~----~~~~~~~l~~li~  230 (290)
T cd05580         168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN------PI-QIYEKILEGKV------RF----PSFFSPDAKDLIR  230 (290)
T ss_pred             hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------HH-HHHHHHhcCCc------cC----CccCCHHHHHHHH
Confidence            99988888999999999999999999999974322      11 11111111111      11    1112345677888


Q ss_pred             hhcccCCCCCC-----CHHHHHH
Q 009186          474 LCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RP-----t~~evl~  491 (541)
                      +||+.||.+|+     +++++++
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHc
Confidence            99999999999     6777663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.87  E-value=1.2e-22  Score=201.53  Aligned_cols=179  Identities=27%  Similarity=0.310  Sum_probs=126.6

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+..+.+...+.+     .+...+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.
T Consensus        70 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~  141 (277)
T cd05577          70 LVMTLMNGGDLKYHIYN-----VGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGL  141 (277)
T ss_pred             EEEecCCCCcHHHHHHH-----cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcc
Confidence            44455555555333322     11235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      +.......   ......++..|++||.+.+..++.++||||||+++|+|++|+.||..........   ........   
T Consensus       142 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~---  212 (277)
T cd05577         142 AVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTLE---  212 (277)
T ss_pred             hhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhcccc---
Confidence            87654321   1123456788999999988889999999999999999999999985432211111   11110000   


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                         ...    ..+......+.+++.+||+.||.+||     ++.+++.
T Consensus       213 ---~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         213 ---MAV----EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ---ccc----cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence               000    11112234567888899999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.87  E-value=1.7e-22  Score=197.55  Aligned_cols=158  Identities=23%  Similarity=0.333  Sum_probs=119.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC-cEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-PKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~-~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++. +||+|||.+.........  .....|+..|+|
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~a  170 (257)
T cd08225          96 VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLS  170 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCccc--ccccCCCccccC
Confidence            35899999999999999999999998   999999999999998864 699999998765433221  122457889999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+.+..++.++|+||||+++|||++|+.||....      ..+...... ...... +        .+.....+.+++
T Consensus       171 pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~-~--------~~~~~~~~~~~i  234 (257)
T cd08225         171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKIC-QGYFAP-I--------SPNFSRDLRSLI  234 (257)
T ss_pred             HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHh-cccCCC-C--------CCCCCHHHHHHH
Confidence            999988889999999999999999999999974221      111222111 111110 1        112234577888


Q ss_pred             hhhcccCCCCCCCHHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~  492 (541)
                      .+||+.+|++|||+.+|++.
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             HHHhccChhhCcCHHHHhhC
Confidence            99999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.87  E-value=7e-22  Score=194.93  Aligned_cols=156  Identities=28%  Similarity=0.436  Sum_probs=114.6

Q ss_pred             cHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-CCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          317 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       317 ~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      ++..+..++.||+.||+|||+++   |+||||||+||+++. ++.++|+|||.+.........  .....++..|+|||.
T Consensus       106 ~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~  180 (268)
T cd06624         106 NEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEV  180 (268)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--cccCCCCccccChhh
Confidence            78888999999999999999998   999999999999976 678999999998765432221  122357889999999


Q ss_pred             hccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          396 AMEGV--FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       396 l~~~~--~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      +.+..  ++.++||||||+++|+|++|+.||.......     ...+.....     ...+.+    +......+.+++.
T Consensus       181 ~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-----~~~~~~~~~-----~~~~~~----~~~~~~~~~~li~  246 (268)
T cd06624         181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-----AAMFKVGMF-----KIHPEI----PESLSAEAKNFIL  246 (268)
T ss_pred             hccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-----hhHhhhhhh-----ccCCCC----CcccCHHHHHHHH
Confidence            86644  7889999999999999999999974321110     000100000     001111    1222345677889


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+.+|++||++.+|++
T Consensus       247 ~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         247 RCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHcCCCchhCCCHHHHHh
Confidence            999999999999999885

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.87  E-value=1.1e-21  Score=191.37  Aligned_cols=160  Identities=26%  Similarity=0.393  Sum_probs=124.3

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+................++..|++||
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE  173 (260)
T cd06606          97 KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE  173 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHh
Confidence            6899999999999999999999998   9999999999999999999999999988765543321223356788999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+...+.++||||||+++++|++|+.||....     ......+.........         ..+......+.+++.+
T Consensus       174 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~~i~~  239 (260)
T cd06606         174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP---------EIPEHLSEEAKDFLRK  239 (260)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc---------CCCcccCHHHHHHHHH
Confidence            9988889999999999999999999999985433     1222222221111111         1112224567788889


Q ss_pred             hcccCCCCCCCHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~  491 (541)
                      ||+.||.+||++.++++
T Consensus       240 ~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         240 CLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hCcCChhhCCCHHHHhh
Confidence            99999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.87  E-value=4.5e-22  Score=197.86  Aligned_cols=170  Identities=24%  Similarity=0.290  Sum_probs=118.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.|+++||+|||+++   ++|+||+|+||+++.++.++|+|||+++........  .....++..|+||
T Consensus        94 ~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aP  168 (283)
T cd07835          94 TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAP  168 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCC
Confidence            45899999999999999999999998   999999999999999999999999998765332211  1223457889999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHH----------HHhhhc-CC----cccccccccc
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA----------WKLWCK-GE----ALELMDPVLK  457 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~-~~----~~~~~~~~l~  457 (541)
                      |.+.+. .++.++||||||+++|+|++|+.||......  .......          |..... ..    ......... 
T Consensus       169 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  245 (283)
T cd07835         169 EILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDL-  245 (283)
T ss_pred             ceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccch-
Confidence            987664 4788999999999999999999997532211  0011100          000000 00    000000000 


Q ss_pred             CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          458 QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       458 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..........+.+++.+||+.||++||+++++++
T Consensus       246 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         246 SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0001112346778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.87  E-value=9.3e-22  Score=197.17  Aligned_cols=159  Identities=28%  Similarity=0.399  Sum_probs=117.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      .+++..+..++.||+.||+|||+ .+   |+||||+|+||+++.++.+||+|||++..+......   ....++..|+||
T Consensus       110 ~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aP  183 (296)
T cd06618         110 PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAP  183 (296)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCH
Confidence            68999999999999999999997 47   999999999999999999999999998765432221   123467889999


Q ss_pred             hhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          394 EYAMEGV----FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       394 E~l~~~~----~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      |.+.+..    ++.++||||||+++|+|++|+.||.....     ..+........ ....     +...  ......+.
T Consensus       184 E~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~-~~~~-----~~~~--~~~~~~l~  250 (296)
T cd06618         184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----EFEVLTKILQE-EPPS-----LPPN--EGFSPDFC  250 (296)
T ss_pred             hhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----HHHHHHHHhcC-CCCC-----CCCC--CCCCHHHH
Confidence            9987543    78899999999999999999999743211     11111111111 1000     1000  01234577


Q ss_pred             HHHhhhcccCCCCCCCHHHHHHH
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      +++.+||+.||++||++.++++.
T Consensus       251 ~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         251 SFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHHHccCChhhCCCHHHHhcC
Confidence            88899999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.86  E-value=5.2e-22  Score=187.64  Aligned_cols=110  Identities=32%  Similarity=0.438  Sum_probs=96.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC----CCcEEecccccccccCCCC-cccccccccCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE----MNPKISDFGMARIFSGNQN-EANTNRVAGTY  388 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~----~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt~  388 (541)
                      +.++-..+..|+.||+.|+.|||++.   |+||||||.|||+..+    |.+||+|||+++.+...-. .......+-|.
T Consensus       127 ~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTi  203 (438)
T KOG0666|consen  127 KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTI  203 (438)
T ss_pred             ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEE
Confidence            47999999999999999999999999   9999999999999887    8999999999998765432 22445567899


Q ss_pred             CCCChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       389 ~y~aPE~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      +|+|||.+.+.. |+++.|||++|||+.||++-++-|..
T Consensus       204 WYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  204 WYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             EecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            999999998765 89999999999999999998877743

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.86  E-value=1e-21  Score=196.19  Aligned_cols=170  Identities=20%  Similarity=0.235  Sum_probs=116.9

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||+++........  .....++..|+|||
T Consensus        99 ~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  173 (291)
T cd07870          99 GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPD  173 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCc
Confidence            4788889999999999999999998   999999999999999999999999998754322111  12234688999999


Q ss_pred             hhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC---------ccccccccc----cCCC
Q 009186          395 YAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE---------ALELMDPVL----KQTC  460 (541)
Q Consensus       395 ~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l----~~~~  460 (541)
                      .+.+. .++.++||||||+++|||++|+.||......  ...+...+..+....         .........    ....
T Consensus       174 ~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T cd07870         174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQL  251 (291)
T ss_pred             eeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcch
Confidence            88754 4788999999999999999999998532211  111111111110000         000000000    0000


Q ss_pred             -----CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          461 -----VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       461 -----~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                           .......+.+++.+|++.||.+|||+.+++.
T Consensus       252 ~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         252 RVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                 0011345667889999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.86  E-value=5.1e-22  Score=202.54  Aligned_cols=171  Identities=26%  Similarity=0.294  Sum_probs=119.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc--ccccccccCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVAGTYGYM  391 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~  391 (541)
                      ..+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+......  .......|+..|+
T Consensus       100 ~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~  176 (332)
T cd07857         100 QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR  176 (332)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCcccc
Confidence            45899999999999999999999999   999999999999999999999999999765432211  1122346889999


Q ss_pred             Chhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH-----------hhhcCCcccc---cc---
Q 009186          392 APEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK-----------LWCKGEALEL---MD---  453 (541)
Q Consensus       392 aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~---~~---  453 (541)
                      |||.+.+ ..++.++||||||+++|+|++|+.||......   ........           .+........   ..   
T Consensus       177 aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (332)
T cd07857         177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIP  253 (332)
T ss_pred             CcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccC
Confidence            9998765 45889999999999999999999987532210   01110000           0000000000   00   


Q ss_pred             -ccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          454 -PVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       454 -~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       ..+. ...+.....+.+++.+||+.||++|||+.+++.
T Consensus       254 ~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         254 KKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             0000 000111345778999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.86  E-value=7e-22  Score=197.37  Aligned_cols=170  Identities=21%  Similarity=0.269  Sum_probs=117.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++........  .....++..|+|||
T Consensus        99 ~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE  173 (291)
T cd07844          99 GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPD  173 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcH
Confidence            5889999999999999999999998   999999999999999999999999998754321111  11224578899999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC---c---------cc----cc-cccc
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE---A---------LE----LM-DPVL  456 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---------~~----~~-~~~l  456 (541)
                      .+.+ ..++.++||||||+++|+|++|+.||......  .......+.......   .         ..    .. ...+
T Consensus       174 ~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T cd07844         174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPL  251 (291)
T ss_pred             HhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhH
Confidence            8875 45789999999999999999999998532210  111111111110000   0         00    00 0000


Q ss_pred             cCCC-CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          457 KQTC-VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       457 ~~~~-~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .... .......+.+++.+||+.+|++||++.++++
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         252 INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0000 0001245678899999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.86  E-value=1e-21  Score=201.22  Aligned_cols=172  Identities=22%  Similarity=0.276  Sum_probs=120.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....     .....++..|+|||
T Consensus       113 ~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE  184 (342)
T cd07879         113 PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPE  184 (342)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChh
Confidence            5899999999999999999999998   999999999999999999999999998754221     12245678899999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh-----------hcCCcccccc--ccc-cCC
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW-----------CKGEALELMD--PVL-KQT  459 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~--~~l-~~~  459 (541)
                      .+.+ ..++.++||||||+++|||++|+.||.....   .......+...           ........+.  +.. ...
T Consensus       185 ~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (342)
T cd07879         185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKD  261 (342)
T ss_pred             hhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccch
Confidence            9876 4588999999999999999999999853211   11111111100           0000000000  000 000


Q ss_pred             C---CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcCC
Q 009186          460 C---VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASDT  497 (541)
Q Consensus       460 ~---~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~  497 (541)
                      .   .+.....+.+++.+||+.||++||++++++.  .+++..
T Consensus       262 ~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         262 FSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            0   0012345778999999999999999999994  466544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.86  E-value=8.6e-23  Score=199.33  Aligned_cols=158  Identities=26%  Similarity=0.408  Sum_probs=122.9

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++.+++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......  .......++..|++
T Consensus        97 ~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~  171 (258)
T cd08215          97 GKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLS  171 (258)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccC
Confidence            467999999999999999999999998   9999999999999999999999999987654433  12223467888999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+.+..++.++|+||||+++++|++|+.||....      ..+...... .....     .+    +......+.+++
T Consensus       172 pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~-----~~----~~~~~~~~~~~i  235 (258)
T cd08215         172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKIL-KGQYP-----PI----PSQYSSELRNLV  235 (258)
T ss_pred             hhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHh-cCCCC-----CC----CCCCCHHHHHHH
Confidence            999988889999999999999999999999974322      111111111 11111     11    112234577888


Q ss_pred             hhhcccCCCCCCCHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~  491 (541)
                      .+||..+|++||++.++++
T Consensus       236 ~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         236 SSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHHcCCChhhCcCHHHHhc
Confidence            9999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.86  E-value=2.1e-22  Score=200.88  Aligned_cols=166  Identities=23%  Similarity=0.311  Sum_probs=122.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||+++.+...... ......++..|++|
T Consensus       100 ~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  175 (288)
T cd05583         100 EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAP  175 (288)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCH
Confidence            35889999999999999999999998   999999999999999999999999998765433221 12234578899999


Q ss_pred             hhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          394 EYAMEGV--FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       394 E~l~~~~--~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |.+.+..  .+.++||||||+++|||++|..||.......  ...+........       .+....    .....+.++
T Consensus       176 E~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~-------~~~~~~----~~~~~l~~l  242 (288)
T cd05583         176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS-------KPPFPK----TMSAEARDF  242 (288)
T ss_pred             HHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-------CCCCCc----ccCHHHHHH
Confidence            9987655  7889999999999999999999975321111  111111111111       011111    122346678


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||++|||+.++.+.|+..
T Consensus       243 i~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         243 IQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHHHhcCCHhhccCcchHHHHhcCc
Confidence            8899999999999999998887763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.86  E-value=1.1e-22  Score=199.61  Aligned_cols=163  Identities=26%  Similarity=0.329  Sum_probs=121.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC------cccccccccCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN------EANTNRVAGTY  388 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~------~~~~~~~~gt~  388 (541)
                      .+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........      ........++.
T Consensus        89 ~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (265)
T cd05579          89 SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP  165 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCc
Confidence            5899999999999999999999998   99999999999999999999999999875432211      11223345778


Q ss_pred             CCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHH
Q 009186          389 GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKC  468 (541)
Q Consensus       389 ~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  468 (541)
                      .|++||...+...+.++||||||+++|++++|+.||.....      .+..... ..+...      .....  .....+
T Consensus       166 ~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~-~~~~~~------~~~~~--~~~~~~  230 (265)
T cd05579         166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNI-LNGKIE------WPEDV--EVSDEA  230 (265)
T ss_pred             cccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-hcCCcC------CCccc--cCCHHH
Confidence            89999999888889999999999999999999999753221      1111111 111100      00000  013456


Q ss_pred             HHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          469 IHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       469 ~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .+++.+||+.+|.+|||+.++.+.|+.
T Consensus       231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         231 IDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             HHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            788889999999999999777776664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=9.4e-23  Score=193.47  Aligned_cols=152  Identities=25%  Similarity=0.307  Sum_probs=116.5

Q ss_pred             CCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCC
Q 009186          311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY  390 (541)
Q Consensus       311 ~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  390 (541)
                      .+...+++....-+-..|+.||.|||+++   ||.||||.+|+|+|.+|++||.|||+++.--  ........+.||+.|
T Consensus       260 srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t~kTFCGTPEY  334 (516)
T KOG0690|consen  260 SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDTTKTFCGTPEY  334 (516)
T ss_pred             hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--cccceeccccCChhh
Confidence            44566888888889999999999999999   9999999999999999999999999997522  223345568999999


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +|||++....|..++|.|.+||++|||++|+.||...+.+   .+.+.+..  .        +-..+...    ..+...
T Consensus       335 LAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl~--e--------d~kFPr~l----s~eAkt  397 (516)
T KOG0690|consen  335 LAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELILM--E--------DLKFPRTL----SPEAKT  397 (516)
T ss_pred             cCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHHh--h--------hccCCccC----CHHHHH
Confidence            9999999999999999999999999999999998533222   22221110  0        11111222    223445


Q ss_pred             HHhhhcccCCCCCC
Q 009186          471 IGLLCVQEDPAHRP  484 (541)
Q Consensus       471 l~~~cl~~dP~~RP  484 (541)
                      |+...|..||.+|.
T Consensus       398 LLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRL  411 (516)
T ss_pred             HHHHHhhcChHhhc
Confidence            66678999999995

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.86  E-value=1.3e-21  Score=194.87  Aligned_cols=158  Identities=25%  Similarity=0.402  Sum_probs=117.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..+..++.||+.||.|||+. +   |+|+||||+||+++.++.+||+|||.+..+....    .....++..|++
T Consensus        97 ~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~a  169 (286)
T cd06622          97 EGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMA  169 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccC
Confidence            4689999999999999999999974 6   9999999999999999999999999987653222    122357788999


Q ss_pred             hhhhccCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHH
Q 009186          393 PEYAMEGV------FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELL  466 (541)
Q Consensus       393 PE~l~~~~------~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  466 (541)
                      ||.+.+..      ++.++|||||||++|+|++|+.||.....   ........ ....+..     +    ..+.....
T Consensus       170 PE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~-~~~~~~~-----~----~~~~~~~~  236 (286)
T cd06622         170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLS-AIVDGDP-----P----TLPSGYSD  236 (286)
T ss_pred             cchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHH-HHhhcCC-----C----CCCcccCH
Confidence            99986543      47899999999999999999999853211   11111111 1111111     1    11222345


Q ss_pred             HHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          467 KCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       467 ~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+.+++.+||+.+|++||++.+++.
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         237 DAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhc
Confidence            5677889999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.86  E-value=4.8e-22  Score=198.13  Aligned_cols=178  Identities=24%  Similarity=0.351  Sum_probs=128.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.|...+++.      ...+++.+++.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          92 VVMEYMDGGSLTDIITQN------FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             EEEeccCCCcHHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccch
Confidence            344555555554433321      136899999999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      +........  ......++..|++||.+.+..++.++||||||+++|+|++|+.||.....      ....... .....
T Consensus       163 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~------~~~~~~~-~~~~~  233 (286)
T cd06614         163 AAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP------LRALFLI-TTKGI  233 (286)
T ss_pred             hhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhcCC
Confidence            765433221  11234567889999999888899999999999999999999999742211      1111111 11111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .....       .......+.+++.+||+.+|.+||++.+|++
T Consensus       234 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         234 PPLKN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCCcc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11000       1112345677889999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.86  E-value=4e-22  Score=202.96  Aligned_cols=189  Identities=25%  Similarity=0.310  Sum_probs=129.5

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc-ccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aP  393 (541)
                      .+++..++.++.||+.||+|||+.+   |+|+||||+||+++.++.++|+|||++......... .......++..|+||
T Consensus        99 ~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  175 (330)
T cd07834          99 PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP  175 (330)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCc
Confidence            6999999999999999999999999   999999999999999999999999999875443210 112234578889999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh-----------hcCCccccccc---ccc-
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW-----------CKGEALELMDP---VLK-  457 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~---~l~-  457 (541)
                      |.+.+. .++.++||||||+++|+|++|+.||.......   .........           ......+.+..   ... 
T Consensus       176 E~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (330)
T cd07834         176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKK  252 (330)
T ss_pred             eeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcc
Confidence            999887 78999999999999999999999985432111   011000000           00000000000   000 


Q ss_pred             --CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcCC-CCCCCCCCCCce
Q 009186          458 --QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASDT-ATLPPPTQPAFS  509 (541)
Q Consensus       458 --~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~-~~l~~p~~P~~~  509 (541)
                        ....+.....+.+++.+||+.+|.+||++.++++  .+++.. .....|..+.+.
T Consensus       253 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~  309 (330)
T cd07834         253 PLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFD  309 (330)
T ss_pred             hhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccc
Confidence              0001112456778999999999999999999997  355432 223334444443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=6.4e-22  Score=196.12  Aligned_cols=157  Identities=27%  Similarity=0.427  Sum_probs=119.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..++.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++.........  .....|+..|+|||
T Consensus        97 ~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  171 (277)
T cd06917          97 PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPE  171 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHH
Confidence            5899999999999999999999999   999999999999999999999999998776543321  22346788999999


Q ss_pred             hhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+.++ .++.++|+||||+++|+|++|+.||.....      ..... ......     .+.+...   .....+.+++.
T Consensus       172 ~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~~-~~~~~~-----~~~~~~~---~~~~~~~~~i~  236 (277)
T cd06917         172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAMM-LIPKSK-----PPRLEDN---GYSKLLREFVA  236 (277)
T ss_pred             HhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhhh-ccccCC-----CCCCCcc---cCCHHHHHHHH
Confidence            88754 468899999999999999999999853211      11110 000110     1111111   12345778888


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+.||++||++.+++.
T Consensus       237 ~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         237 ACLDEEPKERLSAEELLK  254 (277)
T ss_pred             HHcCCCcccCcCHHHHhh
Confidence            999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.4e-22  Score=195.98  Aligned_cols=196  Identities=23%  Similarity=0.322  Sum_probs=139.6

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      .||||+-+|.|.+..+.       -+++.+..++-++.+|+.||-+||+++   ||.||||.+|||||.+|++||+|||+
T Consensus       427 FVMEyvnGGDLMyhiQQ-------~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQ-------VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             eEEEEecCchhhhHHHH-------hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccc
Confidence            44555556666544433       445788889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      .+.--  .....+....||+.|+|||++...+|+.++|.|||||+||||+.|++||+..+   .+.+.+.+..       
T Consensus       497 cKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI~e-------  564 (683)
T KOG0696|consen  497 CKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAIME-------  564 (683)
T ss_pred             ccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHH-------
Confidence            87421  22334556899999999999999999999999999999999999999985332   2222222111       


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH-----HHHHH--------HHhcCCCCCCCCCCCCceeccc
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM-----SSVVV--------MLASDTATLPPPTQPAFSVDRI  513 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~-----~evl~--------~L~~~~~~l~~p~~P~~~~~~~  513 (541)
                           ..  -.++.....+.+.+....|...|.+|.-.     .+|..        +-+-+..+++||-.|.....+.
T Consensus       565 -----hn--vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~  635 (683)
T KOG0696|consen  565 -----HN--VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRD  635 (683)
T ss_pred             -----cc--CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCc
Confidence                 10  11233344556667778888999988532     12211        1122345677777777754443

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.86  E-value=1.2e-21  Score=192.23  Aligned_cols=160  Identities=28%  Similarity=0.432  Sum_probs=123.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..++.++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||.+..........  ....++..|+|
T Consensus        94 ~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~  168 (264)
T cd06623          94 GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMS  168 (264)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--cceeecccccC
Confidence            458999999999999999999999 88   9999999999999999999999999988654333221  23457889999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHH-HHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDA-ELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~l  471 (541)
                      ||.+.+..++.++|+||||+++|+|++|+.||.......   ..+...... ....     +.+    ... ....+.++
T Consensus       169 pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~-~~~~-----~~~----~~~~~~~~l~~l  235 (264)
T cd06623         169 PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAIC-DGPP-----PSL----PAEEFSPEFRDF  235 (264)
T ss_pred             HhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHh-cCCC-----CCC----CcccCCHHHHHH
Confidence            999998889999999999999999999999975433211   111111111 1111     111    111 34567788


Q ss_pred             HhhhcccCCCCCCCHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+||+.+|++||++.++++
T Consensus       236 i~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HHHHccCChhhCCCHHHHHh
Confidence            89999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.86  E-value=9.5e-22  Score=197.40  Aligned_cols=170  Identities=22%  Similarity=0.295  Sum_probs=119.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||++.......... .....++..|++|
T Consensus       111 ~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~P  186 (302)
T cd07864         111 VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTNKVITLWYRPP  186 (302)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCcccc-cccceeccCccCh
Confidence            35899999999999999999999998   9999999999999999999999999987654332211 1123457789999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC---cccc--------cc------cc
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE---ALEL--------MD------PV  455 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------~~------~~  455 (541)
                      |.+.+. .++.++||||||+++|||++|+.||.....   ...+....+......   ....        .+      ..
T Consensus       187 E~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (302)
T cd07864         187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRR  263 (302)
T ss_pred             HHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhhcccccccccccccccccccccc
Confidence            988653 478899999999999999999999853221   111111111110000   0000        00      00


Q ss_pred             ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       456 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.... ......+.+++.+||+.||.+||++.+|+.
T Consensus       264 ~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         264 LREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000 011346788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.86  E-value=8.5e-22  Score=199.54  Aligned_cols=156  Identities=29%  Similarity=0.398  Sum_probs=118.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.||+.||.|||+.+   |+|+||+|+||+++.++.+||+|||++.....      .....++..|+|||
T Consensus       121 ~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE  191 (317)
T cd06635         121 PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPE  191 (317)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChh
Confidence            4899999999999999999999998   99999999999999999999999998865432      12345788999999


Q ss_pred             hhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          395 YAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       395 ~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      .+.   .+.++.++||||||+++|||++|+.||....      ......... .....     ..   ........+.++
T Consensus       192 ~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~~~~~~~~-~~~~~-----~~---~~~~~~~~l~~l  256 (317)
T cd06635         192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIA-QNESP-----TL---QSNEWSDYFRNF  256 (317)
T ss_pred             hhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH-hccCC-----CC---CCccccHHHHHH
Confidence            874   4568899999999999999999999974211      111111111 11110     00   011223456788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHh
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      +.+||+.+|.+||++.+|++.+-
T Consensus       257 i~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         257 VDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             HHHHccCCcccCcCHHHHHhChh
Confidence            88999999999999999997554

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.86  E-value=1.3e-21  Score=191.32  Aligned_cols=156  Identities=26%  Similarity=0.355  Sum_probs=119.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.||+.||.|||+.+   |+|+||+|+||+++.++.+||+|||++.......   ......++..|++||
T Consensus        98 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe  171 (258)
T cd06632          98 SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPE  171 (258)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHH
Confidence            4889999999999999999999998   9999999999999999999999999987653332   122345788899999


Q ss_pred             hhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+.... ++.++|+||||+++|+|++|+.||....      .....+.........     .    .+......+.+++.
T Consensus       172 ~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~-----~----~~~~~~~~~~~li~  236 (258)
T cd06632         172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVFKIGRSKELP-----P----IPDHLSDEAKDFIL  236 (258)
T ss_pred             HhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc------HHHHHHHHHhcccCC-----C----cCCCcCHHHHHHHH
Confidence            987766 8999999999999999999999985322      111111111101110     1    11112345667888


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+.+|.+||++.+++.
T Consensus       237 ~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         237 KCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHhhcCcccCcCHHHHhc
Confidence            999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.86  E-value=2.9e-22  Score=196.42  Aligned_cols=157  Identities=27%  Similarity=0.294  Sum_probs=120.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..|++|
T Consensus        95 ~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~P  168 (258)
T cd05578          95 VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAP  168 (258)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCH
Confidence            46899999999999999999999998   9999999999999999999999999987654332   12234577889999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++|+||||+++|+|++|+.||......    ...........  ..        ...+......+.+++.
T Consensus       169 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~--------~~~~~~~~~~~~~~i~  234 (258)
T cd05578         169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--AD--------VLYPATWSTEAIDAIN  234 (258)
T ss_pred             HHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--cc--------ccCcccCcHHHHHHHH
Confidence            9998888999999999999999999999998543322    11111111110  00        0111122356778899


Q ss_pred             hhcccCCCCCCCH--HHHH
Q 009186          474 LCVQEDPAHRPNM--SSVV  490 (541)
Q Consensus       474 ~cl~~dP~~RPt~--~evl  490 (541)
                      +||+.||.+||++  +|++
T Consensus       235 ~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHccCChhHcCCccHHHHh
Confidence            9999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.86  E-value=3.5e-22  Score=209.28  Aligned_cols=186  Identities=24%  Similarity=0.350  Sum_probs=148.6

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      ..+.+|++++.+|.|+.+.+.      .+..|..+..+.|..||++||.|||++.   ++||||-.+|||+..-..+|+.
T Consensus       770 s~~qlvtq~mP~G~LlDyvr~------hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkit  840 (1177)
T KOG1025|consen  770 STLQLVTQLMPLGCLLDYVRE------HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKIT  840 (1177)
T ss_pred             chHHHHHHhcccchHHHHHHH------hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEE
Confidence            345677788888888766654      2346888999999999999999999988   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      |||+++....+..+.......-.+.|||-|.+....++.++|||||||++||++| |..|+...       ..+.+...+
T Consensus       841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi-------~~~eI~dll  913 (1177)
T KOG1025|consen  841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI-------PAEEIPDLL  913 (1177)
T ss_pred             ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC-------CHHHhhHHH
Confidence            9999999887776666555555678999999999999999999999999999998 88885321       111222222


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..++         +-..++.....++.++.+||..|+..||+++++...+.+
T Consensus       914 e~ge---------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  914 EKGE---------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             hccc---------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            2222         223355667788899999999999999999999987765

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.86  E-value=1.7e-21  Score=193.72  Aligned_cols=170  Identities=25%  Similarity=0.331  Sum_probs=119.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+......  .....++..|++|
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~P  169 (284)
T cd07836          95 GALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAP  169 (284)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--cccccccccccCh
Confidence            45899999999999999999999998   999999999999999999999999998765332211  1223567889999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC--------Ccccccccccc-------
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG--------EALELMDPVLK-------  457 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~-------  457 (541)
                      |.+.+. .++.++||||||+++|+|++|+.||......   .............        ...........       
T Consensus       170 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (284)
T cd07836         170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE---DQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDL  246 (284)
T ss_pred             HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHH
Confidence            988664 4688999999999999999999998543221   1111111100000        00000000000       


Q ss_pred             CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          458 QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       458 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ....+.....+.+++.+||+.||.+||++.++++
T Consensus       247 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         247 QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0001122345778999999999999999999885

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.86  E-value=2.3e-22  Score=195.36  Aligned_cols=172  Identities=21%  Similarity=0.257  Sum_probs=125.4

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC--------------------CCCcEEeccccccc
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH--------------------EMNPKISDFGMARI  371 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~--------------------~~~~kL~Dfg~a~~  371 (541)
                      +-.+++...+..|..|+++++++||+.+   ++|.||||+|||+..                    +..++|+|||.+..
T Consensus       185 ~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf  261 (415)
T KOG0671|consen  185 NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATF  261 (415)
T ss_pred             CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcce
Confidence            3446889999999999999999999998   999999999999932                    23489999999986


Q ss_pred             ccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHH------------
Q 009186          372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA------------  439 (541)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~------------  439 (541)
                      .....     ..++.|..|+|||++.+-.++..+||||+||||+|+.+|..-|......+...+++.+            
T Consensus       262 ~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~  336 (415)
T KOG0671|consen  262 DHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKT  336 (415)
T ss_pred             eccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhh
Confidence            43222     4567899999999999999999999999999999999999887654422211121111            


Q ss_pred             --HHhhhcCCc--cc---------cc---cc-cccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          440 --WKLWCKGEA--LE---------LM---DP-VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       440 --~~~~~~~~~--~~---------~~---~~-~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                        .+....+.+  .+         ..   .+ .......+.+..++.+|+..||..||.+|+|+.|++.
T Consensus       337 ~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  337 RKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             hhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence              011111100  00         00   00 0011224566778999999999999999999999875

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.86  E-value=2.8e-21  Score=198.02  Aligned_cols=167  Identities=25%  Similarity=0.317  Sum_probs=118.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||++......     .....++..|+||
T Consensus       113 ~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aP  184 (343)
T cd07851         113 QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP  184 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCH
Confidence            35899999999999999999999998   999999999999999999999999998765332     1223567889999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh-----------hcCCcccccc---ccccC
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW-----------CKGEALELMD---PVLKQ  458 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~---~~l~~  458 (541)
                      |.+.+ ..++.++||||||+++||+++|+.||......   ..+.......           ........+.   .....
T Consensus       185 E~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (343)
T cd07851         185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKK  261 (343)
T ss_pred             HHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCC
Confidence            98865 35788999999999999999999998532211   1111100000           0000000000   00000


Q ss_pred             CC---CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          459 TC---VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       459 ~~---~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..   .......+.+++.+||+.||++|||+.+|++
T Consensus       262 ~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         262 DFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00   0112456788999999999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.86  E-value=1.3e-21  Score=192.13  Aligned_cols=161  Identities=29%  Similarity=0.435  Sum_probs=119.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCccc--ccccccCCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN--TNRVAGTYGYMA  392 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~--~~~~~gt~~y~a  392 (541)
                      .+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++...........  .....++..|++
T Consensus        95 ~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T cd06626          95 ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA  171 (264)
T ss_pred             CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccC
Confidence            4789999999999999999999999   99999999999999999999999999877544332211  112456789999


Q ss_pred             hhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          393 PEYAMEGV---FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       393 PE~l~~~~---~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      ||.+.+..   .+.++||||||+++||+++|+.||.....     ......... .+.     .+.+...  ......+.
T Consensus       172 PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~~~~~~~~-~~~-----~~~~~~~--~~~~~~~~  238 (264)
T cd06626         172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EFQIMFHVG-AGH-----KPPIPDS--LQLSPEGK  238 (264)
T ss_pred             hhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hHHHHHHHh-cCC-----CCCCCcc--cccCHHHH
Confidence            99998766   88999999999999999999999853221     111111111 011     1111110  01134556


Q ss_pred             HHHhhhcccCCCCCCCHHHHHH
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +++.+||+.+|.+||++.+++.
T Consensus       239 ~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         239 DFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHccCCcccCCCHHHHhc
Confidence            7888999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=3.7e-21  Score=190.85  Aligned_cols=173  Identities=25%  Similarity=0.291  Sum_probs=120.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.|++.||+|||+.+   |+|+||+|+||+++.++.++|+|||.++........  .....++..|+||
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aP  167 (282)
T cd07829          93 GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAP  167 (282)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCcCCh
Confidence            35899999999999999999999998   999999999999999999999999998765433221  1123456789999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCc-H-------HHHHHHhhhcCCccccccccccC----CC
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS-L-------LTYAWKLWCKGEALELMDPVLKQ----TC  460 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~l~~----~~  460 (541)
                      |.+.+. .++.++||||||+++|||++|+.||.......... .       ....|..+..-...+..-+....    ..
T Consensus       168 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (282)
T cd07829         168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKV  247 (282)
T ss_pred             HHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHh
Confidence            998776 78899999999999999999998875322110000 0       00011111000000000000000    00


Q ss_pred             CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          461 VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       461 ~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+.....+.+++.+||+.||++||++.+++.
T Consensus       248 ~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         248 LPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            1112456888999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=1.9e-21  Score=193.18  Aligned_cols=169  Identities=23%  Similarity=0.271  Sum_probs=119.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||.+.........   ....++..|+||
T Consensus        94 ~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aP  167 (283)
T cd07830          94 KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---TDYVSTRWYRAP  167 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc---CCCCCcccccCc
Confidence            46899999999999999999999998   999999999999999999999999998765432221   224577889999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH--------hhhcCC-cccccccccc------
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK--------LWCKGE-ALELMDPVLK------  457 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~-~~~~~~~~l~------  457 (541)
                      |.+.. ..++.++|+||||++++||++|+.||........   ......        .|.+.. ....++..+.      
T Consensus       168 E~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T cd07830         168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTS  244 (283)
T ss_pred             eeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH---HHHHHHhcCCCChhhhhhHhhhhcccccccccccccc
Confidence            98754 4578999999999999999999988753321110   000000        000000 0000000000      


Q ss_pred             -CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          458 -QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       458 -~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       ..........+.+++.+||+.||++||+++|++.
T Consensus       245 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         245 LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             HHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence             0001111356888999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.85  E-value=2.4e-21  Score=209.61  Aligned_cols=165  Identities=20%  Similarity=0.214  Sum_probs=109.1

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-CCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      ..+..+..++.||+.||+|||+++   |+||||||+|||++. ++.+||+|||+++.+...... ......+++.|+|||
T Consensus       252 r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE  327 (566)
T PLN03225        252 RENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPE  327 (566)
T ss_pred             hhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChH
Confidence            345567789999999999999998   999999999999986 578999999999765432221 223457889999999


Q ss_pred             hhccC----------------------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC----c
Q 009186          395 YAMEG----------------------VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE----A  448 (541)
Q Consensus       395 ~l~~~----------------------~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~  448 (541)
                      .+...                      .+..++|||||||++|||+++..++..       ............+.    +
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~  400 (566)
T PLN03225        328 QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAW  400 (566)
T ss_pred             HhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHH
Confidence            76422                      234467999999999999987655321       11111110000000    0


Q ss_pred             ccccccc----ccC--CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          449 LELMDPV----LKQ--TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       449 ~~~~~~~----l~~--~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ...+.+.    +..  ..........++|+.+||+.||++|||+.++++
T Consensus       401 ~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        401 RKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence            0001110    000  000111224557999999999999999999996

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.85  E-value=2.2e-21  Score=194.24  Aligned_cols=159  Identities=23%  Similarity=0.356  Sum_probs=120.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........  .....++..|++||
T Consensus       111 ~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE  185 (293)
T cd06647         111 CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPE  185 (293)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc--cccccCChhhcCch
Confidence            4788999999999999999999999   999999999999999999999999988765433221  22345788899999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++||||||+++|++++|+.||........      .......+.      +..  .........+.+++.+
T Consensus       186 ~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~~------~~~--~~~~~~~~~l~~li~~  251 (293)
T cd06647         186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGT------PEL--QNPEKLSAIFRDFLNR  251 (293)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCCC------CCC--CCccccCHHHHHHHHH
Confidence            99888899999999999999999999999853221110      000000100      000  0111123456678899


Q ss_pred             hcccCCCCCCCHHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~~  492 (541)
                      ||+.+|++||++.+++.+
T Consensus       252 ~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         252 CLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HccCChhhCcCHHHHhcC
Confidence            999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.85  E-value=4.2e-22  Score=195.52  Aligned_cols=157  Identities=25%  Similarity=0.409  Sum_probs=119.7

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++. +.++|+|||.+........  ......++..|++
T Consensus       100 ~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~  173 (260)
T cd08222         100 GKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMS  173 (260)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccC
Confidence            456999999999999999999999998   999999999999975 5699999999876543322  1223457788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+.+..++.++|+||||+++|+|++|+.||...      .......... .+.     .+.    .+......+.+++
T Consensus       174 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~------~~~~~~~~~~-~~~-----~~~----~~~~~~~~~~~li  237 (260)
T cd08222         174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ------NFLSVVLRIV-EGP-----TPS----LPETYSRQLNSIM  237 (260)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHH-cCC-----CCC----CcchhcHHHHHHH
Confidence            99998888899999999999999999999997421      1111111111 111     111    1223345677889


Q ss_pred             hhhcccCCCCCCCHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~  491 (541)
                      .+||+.||++||++.++++
T Consensus       238 ~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         238 QSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHhcCChhhCcCHHHHhh
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.85  E-value=1.5e-21  Score=196.90  Aligned_cols=155  Identities=29%  Similarity=0.414  Sum_probs=117.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......      ....++..|+|||
T Consensus       111 ~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE  181 (308)
T cd06634         111 PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPE  181 (308)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHH
Confidence            4789999999999999999999998   999999999999999999999999998754321      2345788999999


Q ss_pred             hhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          395 YAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       395 ~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      .+.   ...++.++||||||+++|+|++|+.||.....      ...... +..+..     +...   .......+.++
T Consensus       182 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~-~~~~~~-----~~~~---~~~~~~~~~~l  246 (308)
T cd06634         182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH-IAQNES-----PALQ---SGHWSEYFRNF  246 (308)
T ss_pred             HHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHH-HhhcCC-----CCcC---cccccHHHHHH
Confidence            875   35578899999999999999999998642211      111111 111111     1111   11233456778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      +.+||+.+|++||++.+++...
T Consensus       247 i~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         247 VDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             HHHHhhCCcccCCCHHHHhhCc
Confidence            8899999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.85  E-value=6.1e-21  Score=195.69  Aligned_cols=166  Identities=24%  Similarity=0.301  Sum_probs=117.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+++.....     .....++..|+|||
T Consensus       116 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE  187 (345)
T cd07877         116 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE  187 (345)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHH
Confidence            4899999999999999999999999   999999999999999999999999998754221     12345788899999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh--cCCcc------------ccccccccCC
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC--KGEAL------------ELMDPVLKQT  459 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~------------~~~~~~l~~~  459 (541)
                      .+.+ ..++.++||||||+++|||++|+.||......   ...........  .....            ..+.......
T Consensus       188 ~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (345)
T cd07877         188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN  264 (345)
T ss_pred             HHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcc
Confidence            8866 46788999999999999999999998432211   11111000000  00000            0000000000


Q ss_pred             C---CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          460 C---VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       460 ~---~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .   .......+.+++.+||+.||.+||++.+++.
T Consensus       265 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         265 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             hhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            0   0012345678999999999999999999885

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.85  E-value=1.3e-21  Score=194.08  Aligned_cols=157  Identities=28%  Similarity=0.446  Sum_probs=120.3

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.|++.+|.+||+.+   ++|+||||+||+++.++.++|+|||++..+.....  ......++..|++||
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE  171 (277)
T cd06641          97 PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPE  171 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChh
Confidence            4889999999999999999999998   99999999999999999999999999876543221  112245778899999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++|+||||+++|+|++|..||....      ....... ......     +.+    .......+.+++.+
T Consensus       172 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------~~~~~~~-~~~~~~-----~~~----~~~~~~~~~~~i~~  235 (277)
T cd06641         172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELH------PMKVLFL-IPKNNP-----PTL----EGNYSKPLKEFVEA  235 (277)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc------hHHHHHH-HhcCCC-----CCC----CcccCHHHHHHHHH
Confidence            9988888999999999999999999999974221      1111111 111111     111    11223456778899


Q ss_pred             hcccCCCCCCCHHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~~  492 (541)
                      ||+.+|.+||++.++++.
T Consensus       236 ~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         236 CLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HccCChhhCcCHHHHHhC
Confidence            999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-21  Score=186.83  Aligned_cols=158  Identities=25%  Similarity=0.350  Sum_probs=124.4

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ++.+|+++.+.-+...|..||.|||++|   ||.||||.+|+|+|..|.+||.|+|+.+.--  .....+..+.||+.|.
T Consensus       344 rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l--~~gd~tstfcgtpnyi  418 (593)
T KOG0695|consen  344 RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYI  418 (593)
T ss_pred             hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC--CCCcccccccCCCccc
Confidence            3556999999999999999999999999   9999999999999999999999999987532  2233455689999999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc-CcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE-HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||++++..|...+|.|+|||+++||+.|+.||+....+ ..++..++..+.+.+.++.      +    +.....+.-.
T Consensus       419 apeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir------i----prslsvkas~  488 (593)
T KOG0695|consen  419 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR------I----PRSLSVKASH  488 (593)
T ss_pred             chhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc------c----cceeehhhHH
Confidence            999999999999999999999999999999999754433 3344445555554443321      1    1112233445


Q ss_pred             HHhhhcccCCCCCC
Q 009186          471 IGLLCVQEDPAHRP  484 (541)
Q Consensus       471 l~~~cl~~dP~~RP  484 (541)
                      ++..-|++||.+|.
T Consensus       489 vlkgflnkdp~erl  502 (593)
T KOG0695|consen  489 VLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHhhcCCcHHhc
Confidence            66778899999885

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.85  E-value=9.7e-22  Score=201.34  Aligned_cols=176  Identities=19%  Similarity=0.269  Sum_probs=117.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-CCCcEEecccccccccCCCCcc-cccccccCCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMA  392 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~a  392 (541)
                      .+++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||.+.......... ......++..|+|
T Consensus       110 ~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  186 (342)
T cd07854         110 PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS  186 (342)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccC
Confidence            5899999999999999999999998   999999999999975 4568999999987653321111 1122356788999


Q ss_pred             hhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh-----cCCcc----cccc-ccccCCC-
Q 009186          393 PEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC-----KGEAL----ELMD-PVLKQTC-  460 (541)
Q Consensus       393 PE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~----~~~~-~~l~~~~-  460 (541)
                      ||.+.. ..++.++|||||||++|+|++|+.||........  ..........     .....    ..+. ....... 
T Consensus       187 PE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (342)
T cd07854         187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRP  264 (342)
T ss_pred             HHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCC
Confidence            998754 4578899999999999999999999843221000  0000000000     00000    0000 0000000 


Q ss_pred             ----CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          461 ----VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       461 ----~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                          .......+.+++.+||+.||.+||++.+++.  .++.
T Consensus       265 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         265 LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                0112345778999999999999999999984  4554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.85  E-value=7.7e-22  Score=195.41  Aligned_cols=157  Identities=27%  Similarity=0.324  Sum_probs=120.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc----------------
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE----------------  378 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----------------  378 (541)
                      .+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.........                
T Consensus        98 ~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (280)
T cd05581          98 SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK  174 (280)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccc
Confidence            6999999999999999999999999   999999999999999999999999998765443321                


Q ss_pred             --ccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccc
Q 009186          379 --ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVL  456 (541)
Q Consensus       379 --~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  456 (541)
                        .......++..|++||.+....++.++||||||++++++++|+.||....      ......... ..      ..  
T Consensus       175 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~-~~------~~--  239 (280)
T cd05581         175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN------EYLTFQKIL-KL------EY--  239 (280)
T ss_pred             cccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH-hc------CC--
Confidence              12223457789999999988889999999999999999999999975322      111111111 00      00  


Q ss_pred             cCCCCHHHHHHHHHHHhhhcccCCCCCCCH----HHHHH
Q 009186          457 KQTCVDAELLKCIHIGLLCVQEDPAHRPNM----SSVVV  491 (541)
Q Consensus       457 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~----~evl~  491 (541)
                        ..+......+.+++.+||+.+|.+||++    +++++
T Consensus       240 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         240 --SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              1111224457788999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-21  Score=212.28  Aligned_cols=186  Identities=22%  Similarity=0.271  Sum_probs=140.2

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +|+||+|+++|.|+..+.+.       .++++.-+.-++..|+.||.-||+.|   +|||||||+|||||..|++||+||
T Consensus       150 LYlVMdY~pGGDlltLlSk~-------~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKF-------DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             eEEEEecccCchHHHHHhhc-------CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence            67899999999987666441       25899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhc----c-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAM----E-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      |.+..+..+... .....+||+-|.+||++.    + +.|++..|.||+||++|||+.|..||.      .+.+++-..+
T Consensus       220 GsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~K  292 (1317)
T KOG0612|consen  220 GSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGK  292 (1317)
T ss_pred             hhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHH
Confidence            998876654433 234568999999999996    2 568999999999999999999999983      3345554445


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC---HHHHHH--HHhcCC
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN---MSSVVV--MLASDT  497 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt---~~evl~--~L~~~~  497 (541)
                      +....+...+.+...    ..++...   |+.+.+ -+|+.|..   ++++..  ++.++.
T Consensus       293 Im~hk~~l~FP~~~~----VSeeakd---LI~~ll-~~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  293 IMNHKESLSFPDETD----VSEEAKD---LIEALL-CDREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             HhchhhhcCCCcccc----cCHHHHH---HHHHHh-cChhhhcccccHHHHHhCccccCCC
Confidence            544444444331111    2334444   444444 47888887   888875  345543

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.85  E-value=8e-21  Score=194.62  Aligned_cols=184  Identities=20%  Similarity=0.286  Sum_probs=125.0

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++......     .....++..|++||
T Consensus       114 ~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE  185 (343)
T cd07880         114 KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPE  185 (343)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHH
Confidence            5899999999999999999999998   999999999999999999999999998764322     12235678899999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHH----------HHhhhcCCcccccc--ccccC---
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA----------WKLWCKGEALELMD--PVLKQ---  458 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~--~~l~~---  458 (541)
                      .+.+ ..++.++|+||||+++|++++|+.||......  .......          ...+........+.  +....   
T Consensus       186 ~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (343)
T cd07880         186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF  263 (343)
T ss_pred             HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH
Confidence            9876 45789999999999999999999998532211  0000000          00000000000000  00000   


Q ss_pred             -CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHH--HHHhcCCCCCCCCCCCCc
Q 009186          459 -TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV--VMLASDTATLPPPTQPAF  508 (541)
Q Consensus       459 -~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl--~~L~~~~~~l~~p~~P~~  508 (541)
                       .........+.+++.+|++.||++|||+.+++  ..++........+..|+|
T Consensus       264 ~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~  316 (343)
T cd07880         264 RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPY  316 (343)
T ss_pred             HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCc
Confidence             00011233577899999999999999999999  455554433334444443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.85  E-value=6.9e-21  Score=190.60  Aligned_cols=158  Identities=23%  Similarity=0.349  Sum_probs=118.5

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|++||
T Consensus       112 ~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE  186 (292)
T cd06657         112 RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPE  186 (292)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHH
Confidence            4789999999999999999999998   99999999999999999999999998875543221  122345788999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++|+||||+++|+|++|+.||.....   ......    ....     ..+.+..  .......+.+++.+
T Consensus       187 ~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~----~~~~-----~~~~~~~--~~~~~~~l~~li~~  252 (292)
T cd06657         187 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKM----IRDN-----LPPKLKN--LHKVSPSLKGFLDR  252 (292)
T ss_pred             HhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHhh-----CCcccCC--cccCCHHHHHHHHH
Confidence            99888889999999999999999999999743211   111111    1110     0011100  01122345678889


Q ss_pred             hcccCCCCCCCHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~  491 (541)
                      ||+.||.+||++.++++
T Consensus       253 ~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         253 LLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHhCCcccCcCHHHHhc
Confidence            99999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.85  E-value=2.4e-21  Score=193.90  Aligned_cols=169  Identities=24%  Similarity=0.289  Sum_probs=115.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-CCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      .+++.....++.||+.||+|||+++   ++|+||+|+||+++. ++.+||+|||++.........  .....++..|++|
T Consensus        98 ~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~P  172 (294)
T PLN00009         98 AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAP  172 (294)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccCceeecccCH
Confidence            3578888999999999999999998   999999999999985 456899999998765332111  1223567899999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC--Ccc-------cc--ccccccC---
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG--EAL-------EL--MDPVLKQ---  458 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~--~~~~l~~---  458 (541)
                      |.+.+. .++.++||||||+++|+|++|+.||......   .........+...  ...       +.  ..+....   
T Consensus       173 E~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (294)
T PLN00009        173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDL  249 (294)
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCH
Confidence            988764 5789999999999999999999998532211   1111111100000  000       00  0000000   


Q ss_pred             -CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          459 -TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       459 -~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       ...+.....+.+++.+||+.+|++||++.++++
T Consensus       250 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        250 ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             001112345778999999999999999999986

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.85  E-value=2.9e-22  Score=185.62  Aligned_cols=166  Identities=25%  Similarity=0.349  Sum_probs=124.1

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ++..++++-.-+|..-.+.||.||-+.-  .|||||+||+|||++..|.+||+|||++-.+...   .......|-..||
T Consensus       160 q~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYm  234 (361)
T KOG1006|consen  160 QKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYM  234 (361)
T ss_pred             HhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCcccc
Confidence            4456999999999999999999998864  5999999999999999999999999998654322   2233457888999


Q ss_pred             Chhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          392 APEYAME--GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       392 aPE~l~~--~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      |||.+..  ..|+.++||||||++|+|+.||+.|+..+.+     .++..... ..+....+..+.    ........++
T Consensus       235 APERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~V-v~gdpp~l~~~~----~~~~~s~~~~  304 (361)
T KOG1006|consen  235 APERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQV-VIGDPPILLFDK----ECVHYSFSMV  304 (361)
T ss_pred             ChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHH-HcCCCCeecCcc----cccccCHHHH
Confidence            9999853  3488999999999999999999999753322     33322222 223322222111    1122455778


Q ss_pred             HHHhhhcccCCCCCCCHHHHHHH
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      +++-.||.+|-.+||...+++++
T Consensus       305 ~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  305 RFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHHHHhhcccccCcchhhhhcC
Confidence            88889999999999999987753

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=4e-21  Score=176.72  Aligned_cols=176  Identities=21%  Similarity=0.352  Sum_probs=121.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc--cccccccCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA--NTNRVAGTYGYM  391 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~  391 (541)
                      .+++..++.++++++..||.|+|+..   |+|||+|+.|+||+.++.+||+|||+++.+.......  .-...+-|.+|+
T Consensus       119 vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYr  195 (376)
T KOG0669|consen  119 VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYR  195 (376)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecC
Confidence            35899999999999999999999998   9999999999999999999999999998765443222  223345689999


Q ss_pred             ChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHH--------HHhhhcCCccccc--cccccCCC
Q 009186          392 APEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA--------WKLWCKGEALELM--DPVLKQTC  460 (541)
Q Consensus       392 aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~--~~~l~~~~  460 (541)
                      +||.+.+. .++++.|||.-|||+.||+++.+-+..........++...        |....+-.+.+.+  .|...+..
T Consensus       196 ppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~  275 (376)
T KOG0669|consen  196 PPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQK  275 (376)
T ss_pred             CHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchh
Confidence            99998875 5899999999999999999998775432221111111111        1111111111111  11000000


Q ss_pred             --CHHHH------HHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          461 --VDAEL------LKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       461 --~~~~~------~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                        ..+..      ....+|+..++..||.+|+++++++..
T Consensus       276 rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  276 RKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             hhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence              00111      145677888999999999999998753

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.85  E-value=2.7e-21  Score=195.50  Aligned_cols=155  Identities=28%  Similarity=0.383  Sum_probs=116.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....      .....++..|+||
T Consensus       116 ~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aP  186 (313)
T cd06633         116 KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAP  186 (313)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccCh
Confidence            35899999999999999999999998   99999999999999999999999998764221      1234678899999


Q ss_pred             hhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          394 EYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       394 E~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |.+.   ...++.++||||||+++|||++|+.||....      ........... ......        .......+.+
T Consensus       187 E~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~------~~~~~~~~~~~-~~~~~~--------~~~~~~~l~~  251 (313)
T cd06633         187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQN-DSPTLQ--------SNEWTDSFRG  251 (313)
T ss_pred             hhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhc-CCCCCC--------ccccCHHHHH
Confidence            9974   4568889999999999999999999974221      11111111111 111110        1111234677


Q ss_pred             HHhhhcccCCCCCCCHHHHHHH
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ++.+||+.+|.+||++.+++..
T Consensus       252 li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         252 FVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHHHHccCChhhCcCHHHHhcC
Confidence            8889999999999999998853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.85  E-value=9.6e-22  Score=196.35  Aligned_cols=179  Identities=22%  Similarity=0.274  Sum_probs=124.8

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+...+.+       ...+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.+||+|||+
T Consensus        82 lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  151 (290)
T cd05613          82 LILDYINGGELFTHLSQ-------RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  151 (290)
T ss_pred             EEEecCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcc
Confidence            44555555555333322       235889999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEG--VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +......... ......++..|++||.+.+.  .++.++||||||+++|+|++|+.||......  ..............
T Consensus       152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~  228 (290)
T cd05613         152 SKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE  228 (290)
T ss_pred             ceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC
Confidence            8765432211 12234578899999998753  4678999999999999999999997532211  11111111111110


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                             +.    .+......+.+++.+||+.||++||     ++++++.
T Consensus       229 -------~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 -------PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -------CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                   10    1111234566788899999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.85  E-value=3e-21  Score=197.05  Aligned_cols=171  Identities=22%  Similarity=0.251  Sum_probs=119.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC------------ccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN------------EANTN  382 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~------------~~~~~  382 (541)
                      .+++.....++.||+.||+|||+.+   |+|+||+|+||+++.++.++|+|||.++.......            .....
T Consensus       115 ~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (335)
T PTZ00024        115 RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT  191 (335)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccc
Confidence            5899999999999999999999999   99999999999999999999999999876541110            01111


Q ss_pred             ccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC---cccc-------
Q 009186          383 RVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE---ALEL-------  451 (541)
Q Consensus       383 ~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-------  451 (541)
                      ...++..|+|||.+.+. .++.++||||||+++|||++|+.||......   ..............   +...       
T Consensus       192 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (335)
T PTZ00024        192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI---DQLGRIFELLGTPNEDNWPQAKKLPLYT  268 (335)
T ss_pred             ccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCchhhCcchhhccccc
Confidence            23457789999998764 3688999999999999999999998533211   11111111111000   0000       


Q ss_pred             -ccccccC---CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          452 -MDPVLKQ---TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       452 -~~~~l~~---~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       .......   .........+.+++.+||+.+|++||++++++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        269 EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence             0000000   001112355778999999999999999999996

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.85  E-value=1.2e-21  Score=203.85  Aligned_cols=196  Identities=19%  Similarity=0.253  Sum_probs=141.7

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc--CCCC--c
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD--HEMN--P  361 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~--~~~~--~  361 (541)
                      .-+++|+||.+|+|...+++    .+....|++.+.+.++.++..||.|||+++   |+||||||.||++-  .+|+  .
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~----PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~Iy  163 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNS----PENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIY  163 (732)
T ss_pred             cceEEEeecCCCcHHHHhcC----cccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEE
Confidence            34567899999999777764    445567999999999999999999999999   99999999999983  3343  6


Q ss_pred             EEecccccccccCCCCcccccccccCCCCCChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHH
Q 009186          362 KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAW  440 (541)
Q Consensus       362 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~  440 (541)
                      ||+|||.|+.+..+.   ......||..|++||.+.. +.|+..+|.|||||++|+.+||..||........  ..+..|
T Consensus       164 KLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~--~~~~~~  238 (732)
T KOG4250|consen  164 KLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN--NKEIMW  238 (732)
T ss_pred             eeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc--cchhhh
Confidence            999999999876554   3446789999999999984 7899999999999999999999999965544322  222233


Q ss_pred             HhhhcCCcc--ccccc----------cc--cCCCCHHHHHHHHHHHhhhcccCCCCCC--CHHHHHHHH
Q 009186          441 KLWCKGEAL--ELMDP----------VL--KQTCVDAELLKCIHIGLLCVQEDPAHRP--NMSSVVVML  493 (541)
Q Consensus       441 ~~~~~~~~~--~~~~~----------~l--~~~~~~~~~~~~~~l~~~cl~~dP~~RP--t~~evl~~L  493 (541)
                      ....+..-.  -...+          .+  ..........++-..+..+|..+|.+|.  ...+....+
T Consensus       239 ~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~  307 (732)
T KOG4250|consen  239 HIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV  307 (732)
T ss_pred             hhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence            332221110  00010          01  1222334556667777788899999998  444444433

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.84  E-value=2e-21  Score=188.75  Aligned_cols=168  Identities=22%  Similarity=0.286  Sum_probs=130.8

Q ss_pred             cCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCC
Q 009186          309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY  388 (541)
Q Consensus       309 ~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~  388 (541)
                      +.+..+.++-.+.+.++.|++.|++|||+++   |||.||..+|.+||+..++||+|=.+++.+-+.+.+.-....-.+.
T Consensus       386 ~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPv  462 (563)
T KOG1024|consen  386 DPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPV  462 (563)
T ss_pred             CCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcc
Confidence            3444566888899999999999999999999   9999999999999999999999999988755444443333344567


Q ss_pred             CCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          389 GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       389 ~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      .||+||.+.+..|+.++|||||||++|||++ |+.|+...++.   +..    ..+.+|...         ..+.....+
T Consensus       463 kWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf---Em~----~ylkdGyRl---------aQP~NCPDe  526 (563)
T KOG1024|consen  463 KWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF---EME----HYLKDGYRL---------AQPFNCPDE  526 (563)
T ss_pred             cccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---HHH----HHHhcccee---------cCCCCCcHH
Confidence            8999999999999999999999999999998 88886432221   111    111222111         112334557


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +..++.-||..+|++||++++++.-|.+
T Consensus       527 Lf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  527 LFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             HHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            7889999999999999999999999875

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=3.4e-21  Score=189.67  Aligned_cols=158  Identities=23%  Similarity=0.315  Sum_probs=117.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC-cccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN-EANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aP  393 (541)
                      .+++...++++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||+++....... ........++..|+||
T Consensus       102 ~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (264)
T cd06653         102 ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP  178 (264)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCH
Confidence            4788999999999999999999999   99999999999999999999999999876532211 1111234578899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++|+||||+++|+|++|+.||....      ......+.... ..        ....+......+.+++.
T Consensus       179 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~--------~~~~p~~~~~~~~~~i~  243 (264)
T cd06653         179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE------AMAAIFKIATQ-PT--------KPMLPDGVSDACRDFLK  243 (264)
T ss_pred             hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC------HHHHHHHHHcC-CC--------CCCCCcccCHHHHHHHH
Confidence            99988888999999999999999999999974221      11111111111 00        01112223345777888


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+ +|..||+..+++.
T Consensus       244 ~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         244 QIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHhc-CcccCccHHHHhc
Confidence            9998 5799999998775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.9e-21  Score=188.07  Aligned_cols=152  Identities=29%  Similarity=0.333  Sum_probs=117.0

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......  .......++..|++||
T Consensus        89 ~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe  163 (250)
T cd05123          89 RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPE  163 (250)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChH
Confidence            5899999999999999999999998   9999999999999999999999999987654332  1123356788999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      ...+...+.++|+||||+++|++++|+.||.....      .+...... ...      ..    .+......+.+++.+
T Consensus       164 ~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~------~~----~~~~~~~~l~~~i~~  226 (250)
T cd05123         164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKIL-KDP------LR----FPEFLSPEARDLISG  226 (250)
T ss_pred             HhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh-cCC------CC----CCCCCCHHHHHHHHH
Confidence            99888889999999999999999999999843221      11111111 100      01    111113456788999


Q ss_pred             hcccCCCCCCCHHH
Q 009186          475 CVQEDPAHRPNMSS  488 (541)
Q Consensus       475 cl~~dP~~RPt~~e  488 (541)
                      ||..||++||++.+
T Consensus       227 ~l~~~p~~R~~~~~  240 (250)
T cd05123         227 LLQKDPTKRLGSGG  240 (250)
T ss_pred             HhcCCHhhCCCccc
Confidence            99999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.8e-21  Score=188.48  Aligned_cols=157  Identities=26%  Similarity=0.398  Sum_probs=120.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.|++.||.+||+.+   |+|+||||+||+++.++.++|+|||.+.........  .....++..|++|
T Consensus        94 ~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~p  168 (254)
T cd06627          94 GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAP  168 (254)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCH
Confidence            45899999999999999999999998   999999999999999999999999999876543322  1234578899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+...+.++|||+||+++|+|++|+.||....      .....+..... ..     +.+    +......+.+++.
T Consensus       169 e~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~-~~-----~~~----~~~~~~~~~~~i~  232 (254)
T cd06627         169 EVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN------PMAALFRIVQD-DH-----PPL----PEGISPELKDFLM  232 (254)
T ss_pred             hhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc-CC-----CCC----CCCCCHHHHHHHH
Confidence            99988788999999999999999999999974221      11111221111 10     111    1112345678888


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+.+|++||++.+++.
T Consensus       233 ~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHhCChhhCcCHHHHhc
Confidence            999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.83  E-value=8.6e-22  Score=202.15  Aligned_cols=175  Identities=23%  Similarity=0.320  Sum_probs=135.3

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      .-++.|+||...|-++.++.+       ..++.+.+...++.|++++++|||+++   |+|||||++||||+.++++||+
T Consensus       128 ~~lylV~eya~~ge~~~yl~~-------~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIa  197 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVK-------HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIA  197 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHh-------cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeee
Confidence            345677788877777666654       344667888999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      |||++..+....   ......|++.|.|||++.+..+ .+.+|+||+|+++|-|+.|..||+...      +.       
T Consensus       198 DfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~------lk-------  261 (596)
T KOG0586|consen  198 DFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN------LK-------  261 (596)
T ss_pred             ccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc------cc-------
Confidence            999998876332   2335689999999999998776 578999999999999999999985221      11       


Q ss_pred             hcCCccccccccccCC--CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          444 CKGEALELMDPVLKQT--CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~--~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                            ++-++.+...  .+......+.+++.++|-.+|.+|+++++|.+
T Consensus       262 ------~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  262 ------ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ------cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                  1111111111  11222345667888999999999999999986

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.83  E-value=3.9e-21  Score=172.09  Aligned_cols=111  Identities=32%  Similarity=0.436  Sum_probs=94.8

Q ss_pred             CCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCC
Q 009186          311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY  390 (541)
Q Consensus       311 ~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  390 (541)
                      .+++.+++...-+|+..+++||.|||++-  .+||||+||+|||++.+|++|++|||.+-.+.+.-.   .....|-..|
T Consensus       140 ~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---kt~daGCkpY  214 (282)
T KOG0984|consen  140 KKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA---KTMDAGCKPY  214 (282)
T ss_pred             hcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH---HHHhcCCCcc
Confidence            35778999999999999999999999974  599999999999999999999999999876543322   2224577899


Q ss_pred             CChhhhcc----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          391 MAPEYAME----GVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       391 ~aPE~l~~----~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      +|||.+..    ..|+.++||||||+.+.||.+++.|++.
T Consensus       215 maPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  215 MAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             CChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            99998853    3689999999999999999999999753

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.7e-21  Score=191.48  Aligned_cols=186  Identities=25%  Similarity=0.347  Sum_probs=134.3

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC---CCCc
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH---EMNP  361 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~---~~~~  361 (541)
                      ..++.|+|||.+..|-++++.       .+.++++++..|+.||+.||.||.+.. ++|||-||||.||||..   -|.+
T Consensus       541 dsFCTVLEYceGNDLDFYLKQ-------hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQ-------HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             ccceeeeeecCCCchhHHHHh-------hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccccee
Confidence            356678888888887555543       456899999999999999999999985 67999999999999953   4679


Q ss_pred             EEecccccccccCCCCc-----ccccccccCCCCCChhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCc
Q 009186          362 KISDFGMARIFSGNQNE-----ANTNRVAGTYGYMAPEYAMEG----VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG  432 (541)
Q Consensus       362 kL~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~  432 (541)
                      ||.|||+++++..+...     ..+....||++|++||.+.-+    ..+.|+||||+|||+|..+.|+.||+...... 
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-  691 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-  691 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-
Confidence            99999999987655332     224457899999999988644    37889999999999999999999997543321 


Q ss_pred             CcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHH
Q 009186          433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV  489 (541)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev  489 (541)
                       .+++       ...+...-...++.  .+........++++||++.-++|....++
T Consensus       692 -dILq-------eNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  692 -DILQ-------ENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             -HHHh-------hhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence             1221       22222211111111  11112334456779999999999876654

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.83  E-value=1.6e-20  Score=191.25  Aligned_cols=170  Identities=26%  Similarity=0.352  Sum_probs=117.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.....++.||++||+|||+.+   |+|+||+|+||+++.++.++|+|||.+......     .....++..|++||
T Consensus       104 ~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE  175 (328)
T cd07856         104 PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPE  175 (328)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCce
Confidence            4788888999999999999999999   999999999999999999999999998754321     12235678899999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHH--------HHHHhhhcCCcccccccc-ccCCCCH--
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT--------YAWKLWCKGEALELMDPV-LKQTCVD--  462 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-l~~~~~~--  462 (541)
                      .+.+ ..++.++||||||+++|+|++|+.||.............        ..+..+......+.+... .....+.  
T Consensus       176 ~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (328)
T cd07856         176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSE  255 (328)
T ss_pred             eeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHH
Confidence            8766 568899999999999999999999985432211000000        000000000101110000 0000011  


Q ss_pred             ---HHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          463 ---AELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       463 ---~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                         .....+.+++.+||+.+|++||++.+++..
T Consensus       256 ~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         256 KFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               123567788999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.83  E-value=1.9e-20  Score=178.13  Aligned_cols=187  Identities=20%  Similarity=0.206  Sum_probs=132.4

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      .-+++|+|++....+.-..          ..++-+....|+.|++.|++|||+.+   |+||||||+||++..+..+||.
T Consensus        94 ~e~y~v~e~m~~nl~~vi~----------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   94 QEVYLVMELMDANLCQVIL----------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             HhHHHHHHhhhhHHHHHHH----------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeec
Confidence            4567888887655542111          23788889999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh--
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL--  442 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~--  442 (541)
                      |||+++.-+..   ......+.+..|.|||++.+..+.+.+||||+||++.||+.|+--|....     .+-+|.+..  
T Consensus       161 dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~  232 (369)
T KOG0665|consen  161 DFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQ  232 (369)
T ss_pred             cchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHH
Confidence            99999864332   23334667889999999999889999999999999999999987664221     111111100  


Q ss_pred             ------------------hhc-------CCccccc-cccccC--CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          443 ------------------WCK-------GEALELM-DPVLKQ--TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       443 ------------------~~~-------~~~~~~~-~~~l~~--~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                                        ..+       -...+.+ |.....  +.+........+++.+||..||++|.+++++++.
T Consensus       233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                              000       0000111 111110  0112234456678889999999999999999873

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.1e-20  Score=184.73  Aligned_cols=196  Identities=24%  Similarity=0.295  Sum_probs=142.3

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhh-----cCCCceEecccCCCcEEEcCCCCcE
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHE-----DSRLRVIHRDLKTSNVLLDHEMNPK  362 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~-----~~~~~ivH~DLkp~NIll~~~~~~k  362 (541)
                      +++.+|-..|+|+.++.+        ..++.+..++++..++.||+|||.     +|++.|.|||||+.|||+..++..-
T Consensus       285 wLvTdYHe~GSL~DyL~r--------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR--------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             EEeeecccCCcHHHHHhh--------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence            344566777777766643        468999999999999999999996     4677899999999999999999999


Q ss_pred             EecccccccccCCC--CcccccccccCCCCCChhhhccCC----C--CcchhhHHHHHHHHHHHhC----------CCCC
Q 009186          363 ISDFGMARIFSGNQ--NEANTNRVAGTYGYMAPEYAMEGV----F--SVKSDVFSFGVLLLEIISG----------KRNS  424 (541)
Q Consensus       363 L~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~----~--s~~sDVwSlGvll~elltg----------~~p~  424 (541)
                      |+|+|++.......  .....+..+||.+|||||++....    +  -..+||||||.|+||+...          +.||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            99999998765542  223445678999999999986432    1  2469999999999999753          2444


Q ss_pred             CCCCCcCcCcHHHHHHHhhhcCCccccccccccCCC-CHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          425 GFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTC-VDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ....+.+.  -.+...+.    ...+.+.|.+.... ..+.+..+.+||..||..||.-|-|+-.|.+.|.+..
T Consensus       437 yd~Vp~DP--s~eeMrkV----VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  437 YDVVPSDP--SFEEMRKV----VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             ccCCCCCC--CHHHHhcc----eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            32222211  12222221    22233333333222 3456778889999999999999999999999998765

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.82  E-value=2.6e-20  Score=179.52  Aligned_cols=157  Identities=28%  Similarity=0.332  Sum_probs=120.0

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      +++..++.++.+++.+|.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..|++||.
T Consensus        84 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~  157 (244)
T smart00220       84 LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEV  157 (244)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHH
Confidence            889999999999999999999998   9999999999999999999999999988754432   2223457788999999


Q ss_pred             hccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhh
Q 009186          396 AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLC  475 (541)
Q Consensus       396 l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~c  475 (541)
                      +.+..++.++|||+||+++++|++|..||...  ....    ............. ...      .......+.+++.+|
T Consensus       158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~----~~~~~~~~~~~~~-~~~------~~~~~~~~~~~i~~~  224 (244)
T smart00220      158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLL----ELFKKIGKPKPPF-PPP------EWKISPEAKDLIRKL  224 (244)
T ss_pred             HccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHH----HHHHHHhccCCCC-ccc------cccCCHHHHHHHHHH
Confidence            98888999999999999999999999987432  1111    1111111111110 000      000234677899999


Q ss_pred             cccCCCCCCCHHHHHH
Q 009186          476 VQEDPAHRPNMSSVVV  491 (541)
Q Consensus       476 l~~dP~~RPt~~evl~  491 (541)
                      |..+|++||++.++++
T Consensus       225 l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      225 LVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCchhccCHHHHhh
Confidence            9999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.81  E-value=1.4e-20  Score=198.48  Aligned_cols=153  Identities=28%  Similarity=0.466  Sum_probs=115.7

Q ss_pred             HHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC---C--CCcEEecccccccccCCCCcc-cccccccCCCCCCh
Q 009186          320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH---E--MNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMAP  393 (541)
Q Consensus       320 ~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~---~--~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aP  393 (541)
                      ..+.++.|++.||+|||+-+   ||||||||.||||+.   +  ..++|+|||+++....+.... ......||-+|+||
T Consensus       607 ~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~AP  683 (903)
T KOG1027|consen  607 DPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAP  683 (903)
T ss_pred             cHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCH
Confidence            45778899999999999998   999999999999976   3  458999999999887665433 24456799999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISG-KRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |++....-+.++|||||||++|+.++| .+||+.....+        -.+.........+.+      ..++  ...+|+
T Consensus       684 E~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~L~~------~~d~--eA~dLI  747 (903)
T KOG1027|consen  684 EQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVHLEP------LPDC--EAKDLI  747 (903)
T ss_pred             HHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceeeecc------CchH--HHHHHH
Confidence            999998888899999999999999996 89986432211        111111111111111      1111  566788


Q ss_pred             hhhcccCCCCCCCHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~  491 (541)
                      .+|++.+|..||++.+|+.
T Consensus       748 ~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  748 SRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             HHhcCCCcccCCCHHHHhC
Confidence            8999999999999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.9e-20  Score=173.98  Aligned_cols=179  Identities=23%  Similarity=0.298  Sum_probs=123.4

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      .+.|+-..+.-++.||++||+|||+.+   |+||||||.|+|++.|-.+||+|||+++....++....+ ..+-|..|+|
T Consensus       150 PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMT-qEVVTQYYRA  225 (449)
T KOG0664|consen  150 PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMT-HEVVTQYYRA  225 (449)
T ss_pred             CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhhhH-HHHHHHHhcc
Confidence            456888889999999999999999999   999999999999999999999999999976544433333 3456789999


Q ss_pred             hhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHH--------HHHhhhcCCccccccc--------c
Q 009186          393 PEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTY--------AWKLWCKGEALELMDP--------V  455 (541)
Q Consensus       393 PE~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~--------~  455 (541)
                      ||++.+.. |+.+.||||.|||+.|++..+--|.-..+.+...++..        ..+.-.++-...++..        .
T Consensus       226 PEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~v  305 (449)
T KOG0664|consen  226 PELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQR  305 (449)
T ss_pred             HHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccc
Confidence            99999864 89999999999999999987766643332222111110        0111111111111111        1


Q ss_pred             cc-CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          456 LK-QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       456 l~-~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +. -..+...-...+.+..+++..||.+|.+..+.+..+-.
T Consensus       306 LYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  306 LYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             eeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            10 00111222334556677899999999999998876643

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=4.7e-20  Score=188.49  Aligned_cols=135  Identities=23%  Similarity=0.315  Sum_probs=108.4

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      ..++.||+|+.+|.++-.+.+       .+.+.++.+.-++.++..|+++.|..|   +|||||||+|||||.+|++||.
T Consensus       702 dnLYFVMdYIPGGDmMSLLIr-------mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLT  771 (1034)
T KOG0608|consen  702 DNLYFVMDYIPGGDMMSLLIR-------MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLT  771 (1034)
T ss_pred             CceEEEEeccCCccHHHHHHH-------hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeee
Confidence            345677888888877544433       345788888899999999999999999   9999999999999999999999


Q ss_pred             ccccccccc---------CCCCc-------------------------------ccccccccCCCCCChhhhccCCCCcc
Q 009186          365 DFGMARIFS---------GNQNE-------------------------------ANTNRVAGTYGYMAPEYAMEGVFSVK  404 (541)
Q Consensus       365 Dfg~a~~~~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~  404 (541)
                      |||++.-+.         .....                               ......+||..|+|||++....++..
T Consensus       772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~  851 (1034)
T KOG0608|consen  772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL  851 (1034)
T ss_pred             eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence            999974321         10000                               00133579999999999999999999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCCCCC
Q 009186          405 SDVFSFGVLLLEIISGKRNSGFYLS  429 (541)
Q Consensus       405 sDVwSlGvll~elltg~~p~~~~~~  429 (541)
                      .|.||.|||||||+.|+.||....+
T Consensus       852 cdwws~gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  852 CDWWSVGVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             chhhHhhHHHHHHhhCCCCccCCCC
Confidence            9999999999999999999864443

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.79  E-value=9.8e-20  Score=172.83  Aligned_cols=171  Identities=22%  Similarity=0.279  Sum_probs=117.4

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC---cEEecccccccccCCC-----Ccccccc
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN---PKISDFGMARIFSGNQ-----NEANTNR  383 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~---~kL~Dfg~a~~~~~~~-----~~~~~~~  383 (541)
                      +++-+++.++.+++++|+.||.+||.+|   |.||||||+|||-.....   +||+||.+..-+..+.     .......
T Consensus       169 ~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~t  245 (463)
T KOG0607|consen  169 KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLT  245 (463)
T ss_pred             HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccC
Confidence            3556899999999999999999999999   999999999999976654   6999998865432221     1122334


Q ss_pred             cccCCCCCChhhhc---c--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcC-----cCcHHHHHH---HhhhcCCccc
Q 009186          384 VAGTYGYMAPEYAM---E--GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH-----GQSLLTYAW---KLWCKGEALE  450 (541)
Q Consensus       384 ~~gt~~y~aPE~l~---~--~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~  450 (541)
                      .+|+..|||||+..   +  .-|+.+.|.||||||+|-|++|.+||......+     ++.=.....   ..+.++. .+
T Consensus       246 PvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk-Ye  324 (463)
T KOG0607|consen  246 PVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK-YE  324 (463)
T ss_pred             cccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC-Cc
Confidence            57888999999763   2  348899999999999999999999996544321     111111111   1111111 11


Q ss_pred             cccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          451 LMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       451 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.|...     ........+++...+..|+.+|-++.+++.
T Consensus       325 FPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  325 FPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            111111     111234456777788899999999998886

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.79  E-value=9.4e-20  Score=201.86  Aligned_cols=74  Identities=28%  Similarity=0.467  Sum_probs=60.7

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+.++.|...+++       ...+++..++.|+.||+.||+|||.++   |+||||||+|||++.++.+||+||
T Consensus        79 ~~lVmEy~~g~~L~~li~~-------~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DF  148 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHI-------YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDF  148 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeC
Confidence            3455666666665433322       234788999999999999999999998   999999999999999999999999


Q ss_pred             cccc
Q 009186          367 GMAR  370 (541)
Q Consensus       367 g~a~  370 (541)
                      |+++
T Consensus       149 Gls~  152 (669)
T cd05610         149 GLSK  152 (669)
T ss_pred             CCCc
Confidence            9875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.79  E-value=3.5e-20  Score=196.39  Aligned_cols=182  Identities=26%  Similarity=0.318  Sum_probs=140.3

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      -+++|||||.+|+.-...++..     +.++.|..+..|++.++.||.|||.+.   ++|||||-.|||++.++.+||.|
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~-----g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK-----GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc-----ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence            3556788888888755554422     678999999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHH
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-----VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAW  440 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~  440 (541)
                      ||++..+....  .......||+.|||||++...     .|+..+|+||||++..||--|.+|+-..-+      .....
T Consensus       167 FGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mraLF  238 (953)
T KOG0587|consen  167 FGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MRALF  238 (953)
T ss_pred             eeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hhhhc
Confidence            99998764333  334557899999999998643     377889999999999999999999632111      11111


Q ss_pred             HhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          441 KLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       441 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .      +...-.|.+.  .+....+++.+++..||..|-++||++.++++
T Consensus       239 ~------IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 L------IPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             c------CCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1      1111122222  24566788999999999999999999998874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.8e-18  Score=172.77  Aligned_cols=107  Identities=18%  Similarity=0.243  Sum_probs=74.2

Q ss_pred             ccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc---CcCcHHHHHHH--------hhhcCCc-cccc
Q 009186          385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE---HGQSLLTYAWK--------LWCKGEA-LELM  452 (541)
Q Consensus       385 ~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~---~~~~~~~~~~~--------~~~~~~~-~~~~  452 (541)
                      ..|..|++||++.+..|+..+||||++|++|||+||...|+....+   .+++.+.....        +...|.. .+++
T Consensus       412 IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFF  491 (590)
T KOG1290|consen  412 IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFF  491 (590)
T ss_pred             hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhh
Confidence            3477899999999999999999999999999999999887654332   22222222211        1111111 1111


Q ss_pred             cc-----------------cc--cCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          453 DP-----------------VL--KQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       453 ~~-----------------~l--~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..                 .|  .-.+..++..++.+++.-||+.+|++|||+.+.++
T Consensus       492 nr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  492 NRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             ccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence            10                 01  11346678889999999999999999999999884

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.75  E-value=4.1e-18  Score=180.28  Aligned_cols=166  Identities=19%  Similarity=0.173  Sum_probs=111.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....... .......+++.|++|
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence            45789999999999999999999998   99999999999999999999999999875433221 111122347899999


Q ss_pred             hhhccCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCCCCCcCc----CcHHHHHHHhhhcC
Q 009186          394 EYAMEGVF----------------------SVKSDVFSFGVLLLEIISGKR-NSGFYLSEHG----QSLLTYAWKLWCKG  446 (541)
Q Consensus       394 E~l~~~~~----------------------s~~sDVwSlGvll~elltg~~-p~~~~~~~~~----~~~~~~~~~~~~~~  446 (541)
                      |.+.....                      ..+.||||+||++++|++|.. |+........    .......|+.+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98754321                      134799999999999999875 5431110000    00011112222111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCC---CCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDP---AHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP---~~RPt~~evl~  491 (541)
                      ..    +-    ...+.......+++.++|..+|   .+|+|++|+++
T Consensus       460 ~~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KY----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CC----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11    00    0111223456778888888765   68999999985

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.75  E-value=2.6e-19  Score=179.61  Aligned_cols=161  Identities=25%  Similarity=0.285  Sum_probs=122.4

Q ss_pred             CCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC---CCcEEecccccccccCCCCccccccccc
Q 009186          310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKISDFGMARIFSGNQNEANTNRVAG  386 (541)
Q Consensus       310 ~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~~~g  386 (541)
                      ..+.++|++....-++.||+.||.|||-++   |+|.||||+|||+...   -++||+|||.++++++.....   ..+|
T Consensus       655 SsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr---sVVG  728 (888)
T KOG4236|consen  655 SSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR---SVVG  728 (888)
T ss_pred             HhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh---hhcC
Confidence            345667999999999999999999999999   9999999999999654   368999999999987655433   4689


Q ss_pred             CCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHH
Q 009186          387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELL  466 (541)
Q Consensus       387 t~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  466 (541)
                      |+.|+|||+++...|+..-|+||.|||+|--++|..||....     ++-+.+.    +   ..++-|   .....+...
T Consensus       729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQIQ----N---AaFMyP---p~PW~eis~  793 (888)
T KOG4236|consen  729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQIQ----N---AAFMYP---PNPWSEISP  793 (888)
T ss_pred             CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHhh----c---cccccC---CCchhhcCH
Confidence            999999999999999999999999999999999999984221     1111110    1   111111   111223334


Q ss_pred             HHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          467 KCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       467 ~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..++++...|+..-.+|-+.++-+.
T Consensus       794 ~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  794 EAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             HHHHHHHHHHHHHHHHhcchHhhcc
Confidence            5667777888888888888877653

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.73  E-value=6.1e-18  Score=148.39  Aligned_cols=172  Identities=22%  Similarity=0.210  Sum_probs=118.0

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ++.++.+....++.|+++||.++|+++   ++||||||.|++|+.+|..||+|||+++.++-.....  ...+-|.+|.+
T Consensus        95 ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy--saevvtlwyrp  169 (292)
T KOG0662|consen   95 NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRP  169 (292)
T ss_pred             CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee--eceeeeeeccC
Confidence            445888999999999999999999999   9999999999999999999999999999876443222  22456899999


Q ss_pred             hhhhccCC-CCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHh--hhcCCcccc---ccccccCCCC----
Q 009186          393 PEYAMEGV-FSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKL--WCKGEALEL---MDPVLKQTCV----  461 (541)
Q Consensus       393 PE~l~~~~-~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~~l~~~~~----  461 (541)
                      |.++.+.. |+...|+||-||++.|+.. |++-|+..+-  .+.+....|..  ..+.++..+   .|-...+.++    
T Consensus       170 pdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypatts  247 (292)
T KOG0662|consen  170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTS  247 (292)
T ss_pred             cceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCccccCCCCcccCCccccch
Confidence            99998865 8899999999999999987 4544432211  11111111111  112222211   1111111111    


Q ss_pred             -----HHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          462 -----DAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       462 -----~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                           +....+=.+++...+.-+|.+|.++++.++
T Consensus       248 wsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  248 WSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             HHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                 111122345677778889999999988775

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.73  E-value=1.4e-17  Score=151.47  Aligned_cols=166  Identities=19%  Similarity=0.256  Sum_probs=117.3

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      .|+...+...+.+++.||.|+|+.|   |.|||+||.|++||... .++|+|+|++..........   -.+.+..|--|
T Consensus       128 tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn---VRVASRyfKGP  201 (338)
T KOG0668|consen  128 TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGP  201 (338)
T ss_pred             hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCceee---eeeehhhcCCc
Confidence            3677788899999999999999999   99999999999999754 58999999998765443322   23456678899


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh--------------------------hhcC
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL--------------------------WCKG  446 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~--------------------------~~~~  446 (541)
                      |.+..- .|+.+-|+|||||++..|+..+.||- ...++.+.++..+.-+                          ..+.
T Consensus       202 ELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF-hG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk  280 (338)
T KOG0668|consen  202 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-HGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRK  280 (338)
T ss_pred             hheeechhccccHHHHHHHHHHHHHHhccCccc-CCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccc
Confidence            999865 48889999999999999999999973 2333333333322110                          0011


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+..++.+.-.. ..   ..+.++++...|..|-++|+|++|.+.
T Consensus       281 ~w~~Fi~~~n~h-l~---~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  281 PWSRFINSENQH-LV---SPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             cHHHhCCccccc-cC---ChHHHHHHHHHHhhccccccchHHHhc
Confidence            111111111111 11   245667778899999999999999874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.72  E-value=4e-18  Score=158.72  Aligned_cols=163  Identities=19%  Similarity=0.281  Sum_probs=114.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc--CCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD--HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~--~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ..+.+.-..+++.|+++||.|||+++   +||||||.+||||-  +...+||+|||..+..+..-.     ....+..|.
T Consensus       116 ~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~-----~~~~~~~y~  187 (378)
T KOG1345|consen  116 AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK-----YLEYVNNYH  187 (378)
T ss_pred             ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceeh-----hhhhhcccC
Confidence            45788888999999999999999999   99999999999993  234799999999876443221     223456799


Q ss_pred             Chhhhcc---C--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHH
Q 009186          392 APEYAME---G--VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELL  466 (541)
Q Consensus       392 aPE~l~~---~--~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  466 (541)
                      +||....   +  ...+.+|||.||+++|.+++|..|+.-...   +...-+.|..|..+......+  .-.    ....
T Consensus       188 ~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---~d~~Y~~~~~w~~rk~~~~P~--~F~----~fs~  258 (378)
T KOG1345|consen  188 APELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---MDKPYWEWEQWLKRKNPALPK--KFN----PFSE  258 (378)
T ss_pred             CcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---cCchHHHHHHHhcccCccCch--hhc----ccCH
Confidence            9997643   2  256889999999999999999999862221   222334555565554442211  111    1234


Q ss_pred             HHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          467 KCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       467 ~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      ++.++..+-|..++++|-.+.++.++-
T Consensus       259 ~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  259 KALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             HHHHHHHHhcCCcccccchhHHHHHHH
Confidence            555666788999999995555544433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.72  E-value=2.5e-17  Score=154.54  Aligned_cols=127  Identities=35%  Similarity=0.608  Sum_probs=108.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-CCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..++.++.+++++|++||+.+   ++|+||+|.||+++. ++.++|+|||.+........  ......+...|++
T Consensus        87 ~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~  161 (215)
T cd00180          87 GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMA  161 (215)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccC
Confidence            35899999999999999999999998   999999999999999 89999999999876543321  1222446778999


Q ss_pred             hhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+... ..+.+.|+|+||+++++|                                                ..+.++
T Consensus       162 pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~~~~  193 (215)
T cd00180         162 PEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PELKDL  193 (215)
T ss_pred             hhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HHHHHH
Confidence            9998877 788999999999999998                                                456778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L  493 (541)
                      +..|++.||++||++.++++.|
T Consensus       194 l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         194 IRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHhhCCcccCcCHHHHhhCC
Confidence            8899999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.70  E-value=3.6e-18  Score=171.43  Aligned_cols=175  Identities=22%  Similarity=0.183  Sum_probs=124.2

Q ss_pred             CCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEecccccccccCCCCcccccccccCC
Q 009186          310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVAGTY  388 (541)
Q Consensus       310 ~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~  388 (541)
                      ..++-.|....+..++.|+..||..|-.-+   |+|.||||+|||+++.- .+||+|||.|.....+....    ..-+.
T Consensus       527 yG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSR  599 (752)
T KOG0670|consen  527 YGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEITP----YLVSR  599 (752)
T ss_pred             hCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccccccH----HHHHH
Confidence            344556888899999999999999999999   99999999999998765 46999999998765544322    33456


Q ss_pred             CCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHH-----HHhhhcCCcc--------------
Q 009186          389 GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA-----WKLWCKGEAL--------------  449 (541)
Q Consensus       389 ~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~--------------  449 (541)
                      .|.|||++.+-+|+...|+||.||.||||.||+-.|+.....+-..+....     .+++.++...              
T Consensus       600 FYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e  679 (752)
T KOG0670|consen  600 FYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIE  679 (752)
T ss_pred             hccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEe
Confidence            799999999999999999999999999999999877543322211111110     0111111110              


Q ss_pred             -------------ccccc------ccc-----CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          450 -------------ELMDP------VLK-----QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       450 -------------~~~~~------~l~-----~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                                   ..+.|      .+.     .+.....+..+.+|+..||..||++|.|..+.|+
T Consensus       680 ~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  680 VDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             ccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                         01111      011     1112334567888999999999999999998775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=2.1e-17  Score=178.56  Aligned_cols=172  Identities=22%  Similarity=0.287  Sum_probs=128.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc--ccccccccCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVAGTYGYM  391 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~  391 (541)
                      ..+...++..+++|++.|++|||+.|   |.|||||++|+++..++.+||+|||.+..+......  .......|+-.|+
T Consensus       415 ~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~  491 (601)
T KOG0590|consen  415 GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYL  491 (601)
T ss_pred             cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCc
Confidence            46888999999999999999999999   999999999999999999999999998876544433  4556678999999


Q ss_pred             ChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVK-SDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~-sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||.+.+..|.+. .||||.|+++..|++|+.||......+... .+.     ...........  ..........+...
T Consensus       492 apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~-----~~~~~~~~~~~--~~~~~~~lp~~~~~  563 (601)
T KOG0590|consen  492 APEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTN-----NYSDQRNIFEG--PNRLLSLLPRETRI  563 (601)
T ss_pred             CcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhh-----ccccccccccC--hHHHHHhchhhHHH
Confidence            9999999998865 899999999999999999975433332221 000     00000000000  01112233445667


Q ss_pred             HHhhhcccCCCCCCCHHHHHH--HHhcC
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV--MLASD  496 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~--~L~~~  496 (541)
                      ++.++|+.||.+|.|+++|++  ++++.
T Consensus       564 ~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  564 IIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             HHHHHccCChhheecHHHHhhChHhhhc
Confidence            888999999999999999985  44443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.63  E-value=1.1e-16  Score=162.81  Aligned_cols=107  Identities=26%  Similarity=0.423  Sum_probs=94.2

Q ss_pred             CCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCC
Q 009186          311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY  390 (541)
Q Consensus       311 ~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  390 (541)
                      +.+..+++.+...|++||+.|+++||+.+   |||||||-+|+.++.+|-+||+|||.+.......    ...++||..|
T Consensus       662 E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~  734 (772)
T KOG1152|consen  662 EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDY  734 (772)
T ss_pred             hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccc
Confidence            34567999999999999999999999999   9999999999999999999999999987643322    3357899999


Q ss_pred             CChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCC
Q 009186          391 MAPEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNS  424 (541)
Q Consensus       391 ~aPE~l~~~~~-s~~sDVwSlGvll~elltg~~p~  424 (541)
                      .|||++.+..| ...-|||+||++||.++....||
T Consensus       735 aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  735 AAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99999998886 45689999999999999988886

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.63  E-value=6e-16  Score=152.82  Aligned_cols=173  Identities=24%  Similarity=0.352  Sum_probs=117.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-CCcEEecccccccccCCC-----------------
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQ-----------------  376 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-~~~kL~Dfg~a~~~~~~~-----------------  376 (541)
                      .++..++..++..++.||.++|.+|   ||||||||+|+|.+.. +.-.|.|||++.......                 
T Consensus       128 ~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~  204 (418)
T KOG1167|consen  128 SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAM  204 (418)
T ss_pred             cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccc
Confidence            3778899999999999999999999   9999999999999865 456899999987211000                 


Q ss_pred             -------------------------CcccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCc
Q 009186          377 -------------------------NEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSE  430 (541)
Q Consensus       377 -------------------------~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~  430 (541)
                                               .........||++|+|||++... ..++++||||-|||++.+++++.||-. ..+
T Consensus       205 g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~-a~d  283 (418)
T KOG1167|consen  205 GKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK-AKD  283 (418)
T ss_pred             cCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccccccc-Ccc
Confidence                                     00011225689999999998764 468899999999999999999999732 222


Q ss_pred             CcCcHHHHHHH-----------------hhhcCCc---cc------ccc-ccccC---------CCCHHHHHHHHHHHhh
Q 009186          431 HGQSLLTYAWK-----------------LWCKGEA---LE------LMD-PVLKQ---------TCVDAELLKCIHIGLL  474 (541)
Q Consensus       431 ~~~~~~~~~~~-----------------~~~~~~~---~~------~~~-~~l~~---------~~~~~~~~~~~~l~~~  474 (541)
                      +...+.+.+-.                 .|....+   .+      -++ ..+..         ...+.....+++++.+
T Consensus       284 d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk  363 (418)
T KOG1167|consen  284 DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDK  363 (418)
T ss_pred             ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHH
Confidence            33333322110                 1110000   00      000 00000         0011112367889999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~  491 (541)
                      |++.||.+|.|+++.|+
T Consensus       364 ~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  364 CLELNPQKRITAEDALK  380 (418)
T ss_pred             HccCChhhcccHHHHhc
Confidence            99999999999999875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.60  E-value=6e-16  Score=157.32  Aligned_cols=174  Identities=23%  Similarity=0.333  Sum_probs=122.1

Q ss_pred             hHHHHHHHHHHHhhh-eeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEE
Q 009186          285 TIITTITLFILLGSF-VWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI  363 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l-~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL  363 (541)
                      +..++.|.++-...| .|.++     .......++...+.++.|++.|++|   ++   .+|+|+||.||++..+..+||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~r-----r~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRR-----RRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhC-----CCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhh
Confidence            456788888776665 33332     2234567889999999999999999   66   999999999999999999999


Q ss_pred             ecccccccccCCC----CcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCcCcCcHHHH
Q 009186          364 SDFGMARIFSGNQ----NEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG-KRNSGFYLSEHGQSLLTY  438 (541)
Q Consensus       364 ~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg-~~p~~~~~~~~~~~~~~~  438 (541)
                      +|||+........    .........||..||+||.+.+..|+.|+|||+||+||+|++.- ...+          ....
T Consensus       398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~----------er~~  467 (516)
T KOG1033|consen  398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF----------ERIA  467 (516)
T ss_pred             hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH----------HHHH
Confidence            9999987654433    12233456799999999999999999999999999999999972 1111          0011


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHH
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS  488 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~e  488 (541)
                      ....+..+.+.    +....+.     ..-..++++++...|.+||++.+
T Consensus       468 t~~d~r~g~ip----~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  468 TLTDIRDGIIP----PEFLQDY-----PEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hhhhhhcCCCC----hHHhhcC-----cHHHHHHHHhcCCCcccCchHHH
Confidence            11122222222    1111111     12235777899999999995444

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.60  E-value=1.6e-15  Score=147.93  Aligned_cols=142  Identities=19%  Similarity=0.266  Sum_probs=98.5

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+....++.+..|+++.+++||..|   ++|+||||+|++++.+|.++|+||+.....+.....     ...+..|.|
T Consensus       139 ~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~P  210 (288)
T PF14531_consen  139 HSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTP  210 (288)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-
T ss_pred             cchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCC
Confidence            345777788899999999999999999   999999999999999999999999887654322111     223577999


Q ss_pred             hhhhccC--------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHH
Q 009186          393 PEYAMEG--------VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAE  464 (541)
Q Consensus       393 PE~l~~~--------~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  464 (541)
                      ||.....        .++.+.|.|+||+++|.|++++.||+...+......                   .+ ..+. +.
T Consensus       211 Pe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~  269 (288)
T PF14531_consen  211 PELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------------------DF-SRCR-DM  269 (288)
T ss_dssp             HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------------------GG-TTSS---
T ss_pred             hhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------------------cc-hhcC-Cc
Confidence            9977542        478899999999999999999999875433322111                   11 2233 55


Q ss_pred             HHHHHHHHhhhcccCCCCC
Q 009186          465 LLKCIHIGLLCVQEDPAHR  483 (541)
Q Consensus       465 ~~~~~~l~~~cl~~dP~~R  483 (541)
                      .+.+..|+..+|++||.+|
T Consensus       270 Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  270 PEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -HHHHHHHHHHT-SSGGGS
T ss_pred             CHHHHHHHHHHccCCcccC
Confidence            6667778889999999988

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.56  E-value=1.2e-15  Score=157.66  Aligned_cols=161  Identities=25%  Similarity=0.340  Sum_probs=118.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...|++.++....+..++||+|||+.+   -+|||||-.||++++.|.+|++|||.+-.+...-.  ....+.||+.|||
T Consensus       106 TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~--KrksfiGtpywma  180 (829)
T KOG0576|consen  106 TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--KRKSFIGTPYWMA  180 (829)
T ss_pred             cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh--hhhcccCCccccc
Confidence            457999999999999999999999999   89999999999999999999999999876543322  2334789999999


Q ss_pred             hhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccc-cccCCCCHHHHHHH
Q 009186          393 PEYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDP-VLKQTCVDAELLKC  468 (541)
Q Consensus       393 PE~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~~  468 (541)
                      ||+..   .+.|..++|||++|+...|+-.-++|- +..      .-..+..+..+.    ..++ .++.  .......+
T Consensus       181 pEvaaverkggynqlcdiwa~gitAiel~eLqppl-fdl------hpmr~l~LmTkS----~~qpp~lkD--k~kws~~f  247 (829)
T KOG0576|consen  181 PEVAAVERKGGYNQLCDIWALGITAIELGELQPPL-FDL------HPMRALFLMTKS----GFQPPTLKD--KTKWSEFF  247 (829)
T ss_pred             hhHHHHHhcccccccccccccccchhhhhhcCCcc-ccc------chHHHHHHhhcc----CCCCCcccC--CccchHHH
Confidence            99763   577999999999999999987666652 100      111111111111    1111 1111  12344567


Q ss_pred             HHHHhhhcccCCCCCCCHHHHHH
Q 009186          469 IHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       469 ~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      -++++.++..+|++||+++.+++
T Consensus       248 h~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhhee
Confidence            77888999999999999988764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.56  E-value=1e-14  Score=151.03  Aligned_cols=191  Identities=21%  Similarity=0.329  Sum_probs=131.8

Q ss_pred             HHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          292 LFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       292 ~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      .|+..|.+......      ....++|.....++++|+.||+|||...  ...|+.+++.|.++|....+||+|||+...
T Consensus        27 ~~c~rGsl~D~i~~------~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~   98 (484)
T KOG1023|consen   27 EYCSRGSLLDILSN------EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSL   98 (484)
T ss_pred             eeecCccHHhHHhc------cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccccceeeeeEEEEechhhhccc
Confidence            34445555443322      3446899999999999999999999875  239999999999999999999999999876


Q ss_pred             ccCCCCcccccccccCCCCCChhhhccCC-------CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCc-CcHHHHHHHhh
Q 009186          372 FSGNQNEANTNRVAGTYGYMAPEYAMEGV-------FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG-QSLLTYAWKLW  443 (541)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~s~~sDVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~  443 (541)
                      ..............-..-|.|||.+....       .+.+.||||||++++|+++.+.||+....... ..++.....  
T Consensus        99 ~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~--  176 (484)
T KOG1023|consen   99 LEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK--  176 (484)
T ss_pred             ccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh--
Confidence            54311111111223456799999997631       46779999999999999999999875433222 122222211  


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                         .....+.|.+....  +....++.++..||.++|++||++++|-..++...
T Consensus       177 ---~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  177 ---GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             ---cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence               12222333332111  22225778889999999999999999998887644

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.55  E-value=1.1e-14  Score=138.87  Aligned_cols=106  Identities=32%  Similarity=0.464  Sum_probs=91.2

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      +++..+..++.+++.+|.+||+.+   ++|+||+++||+++.++.++|+|||.+......... ......++..|++||.
T Consensus        95 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~  170 (225)
T smart00221       95 LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEV  170 (225)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhH
Confidence            789999999999999999999998   999999999999999999999999998876443211 1223456778999999


Q ss_pred             h-ccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 009186          396 A-MEGVFSVKSDVFSFGVLLLEIISGKRNSG  425 (541)
Q Consensus       396 l-~~~~~s~~sDVwSlGvll~elltg~~p~~  425 (541)
                      + ....++.++|+|+||++++||++|+.||.
T Consensus       171 ~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      171 LLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             hcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            8 56667889999999999999999999983

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.54  E-value=1.4e-14  Score=157.45  Aligned_cols=171  Identities=19%  Similarity=0.224  Sum_probs=116.6

Q ss_pred             cccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccc--cCCCCccc---c
Q 009186          307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF--SGNQNEAN---T  381 (541)
Q Consensus       307 ~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~~---~  381 (541)
                      +.+...+.-|..-+...|+.||+.||..+|+.|   |+|||||.+|||++.-+.+.|+||...+..  .++....-   .
T Consensus       108 yDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFF  184 (1431)
T KOG1240|consen  108 YDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFF  184 (1431)
T ss_pred             hhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEE
Confidence            334455677888999999999999999999999   999999999999999999999999876531  11111110   0


Q ss_pred             cccccCCCCCChhhhccC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCcc
Q 009186          382 NRVAGTYGYMAPEYAMEG----------V-FSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEAL  449 (541)
Q Consensus       382 ~~~~gt~~y~aPE~l~~~----------~-~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  449 (541)
                      .+...-..|+|||.+...          . .+++-||||+||++.||++ |+++|...      .++.+.     .+. .
T Consensus       185 DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr-----~~~-~  252 (1431)
T KOG1240|consen  185 DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR-----SGN-A  252 (1431)
T ss_pred             ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh-----ccC-c
Confidence            111122469999988641          1 6788999999999999998 57776421      111111     110 0


Q ss_pred             ccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          450 ELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       450 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ......++.    .+...+.++++.|++.||.+|.++++.++.-.+.
T Consensus       253 ~~~e~~Le~----Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  253 DDPEQLLEK----IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             cCHHHHHHh----CcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            000000100    1112456788999999999999999999875543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.54  E-value=4.9e-15  Score=138.17  Aligned_cols=174  Identities=22%  Similarity=0.304  Sum_probs=124.6

Q ss_pred             HHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe--ccccc
Q 009186          292 LFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS--DFGMA  369 (541)
Q Consensus       292 ~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~--Dfg~a  369 (541)
                      .|+..|+|+..++     ...+..++..+.++++.+|++|+.|||+... -|.---|+...+++|++...+|.  |--++
T Consensus       267 q~mp~gslynvlh-----e~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfs  340 (448)
T KOG0195|consen  267 QYMPFGSLYNVLH-----EQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFS  340 (448)
T ss_pred             eeccchHHHHHHh-----cCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceee
Confidence            4667777776663     3456678899999999999999999999863 24455689999999999888764  32111


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCC---CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF---SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                               .........+.|++||.+...+-   -.++|+|||++++||+.|...||....+-+      ...+.    
T Consensus       341 ---------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme------cgmki----  401 (448)
T KOG0195|consen  341 ---------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME------CGMKI----  401 (448)
T ss_pred             ---------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh------hhhhh----
Confidence                     11122345678999999987653   357999999999999999999985433221      11111    


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                       ..+.    ++...++.....+.+++.-|+.+||.+||.++.|+..|++
T Consensus       402 -aleg----lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  402 -ALEG----LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             -hhcc----ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence             1122    2233344445567778888999999999999999999886

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.47  E-value=5.4e-13  Score=133.53  Aligned_cols=172  Identities=26%  Similarity=0.342  Sum_probs=122.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEecccccccccCCCCcc----cccccccCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEA----NTNRVAGTY  388 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~----~~~~~~gt~  388 (541)
                      ..++......++.|++.++.|+|+.+   ++|||+||+||+++..+ .+++.|||.++.+.......    ......++.
T Consensus        96 ~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~  172 (384)
T COG0515          96 GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP  172 (384)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccccccccccc
Confidence            36889999999999999999999999   99999999999999998 69999999998655443221    234567899


Q ss_pred             CCCChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          389 GYMAPEYAME---GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       389 ~y~aPE~l~~---~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      .|++||.+.+   ...+...|+|++|+++++++.|..||......   ......+......... ...............
T Consensus       173 ~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  248 (384)
T COG0515         173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SLASPLSPSNPELIS  248 (384)
T ss_pred             ccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-ccccccCccccchhh
Confidence            9999999987   57889999999999999999999995433221   0111111111111110 000000000001223


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ..+.+++..++..+|..|.+..+....
T Consensus       249 ~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         249 KAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            456678888999999999998887763

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.47  E-value=5.2e-13  Score=135.49  Aligned_cols=172  Identities=20%  Similarity=0.194  Sum_probs=120.4

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-----CCcEEecccccc--cccCCCC------cc
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-----MNPKISDFGMAR--IFSGNQN------EA  379 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-----~~~kL~Dfg~a~--~~~~~~~------~~  379 (541)
                      .+.++..+.++|+.|++.+|++||+.|   ++||||||.|+++...     ..+.|.|||+++  .+.....      ..
T Consensus       116 ~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~  192 (322)
T KOG1164|consen  116 PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRP  192 (322)
T ss_pred             CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCC
Confidence            457999999999999999999999999   9999999999999865     358999999998  3222221      11


Q ss_pred             cccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCC
Q 009186          380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQT  459 (541)
Q Consensus       380 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  459 (541)
                      ......||..|.++....+...+.+.|+||++.++.|++.|..|+........   ..........    .....  ...
T Consensus       193 ~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~~~~~~----~~~~~--~~~  263 (322)
T KOG1164|consen  193 QKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFEKDPRK----LLTDR--FGD  263 (322)
T ss_pred             CccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHHHHhhh----hcccc--ccC
Confidence            12335699999999999999999999999999999999999998743322211   1111111000    00000  112


Q ss_pred             CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCC
Q 009186          460 CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTAT  499 (541)
Q Consensus       460 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~  499 (541)
                      ..+.+...+..   .+-..+..++|....+...|+.....
T Consensus       264 ~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  264 LKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             CChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            23334444443   34447899999999999888664433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.41  E-value=1.9e-13  Score=141.80  Aligned_cols=169  Identities=23%  Similarity=0.225  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++.+.-+|.++.++.+       ....++.....+...++.+++++|+.+   |+|||+|++||+++.+|.+++.||
T Consensus        72 l~l~ld~~rgg~lft~l~~-------~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdf  141 (612)
T KOG0603|consen   72 LYLILDFLRGGDLFTRLSK-------EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDF  141 (612)
T ss_pred             hhHhhhhcccchhhhcccc-------CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCc
Confidence            4555666666666544433       344677778888899999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++..-....      ..||..|||||+.+  ....+.|.||||++.+||++|..||..          +....+..  
T Consensus       142 glske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~--  201 (612)
T KOG0603|consen  142 GLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILK--  201 (612)
T ss_pred             hhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhh--
Confidence            99986432221      27899999999988  556789999999999999999999853          11111111  


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH--HHHHHHHh
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM--SSVVVMLA  494 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~--~evl~~L~  494 (541)
                               .....+.+.......++..++..+|..|--.  ..+.+.++
T Consensus       202 ---------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  202 ---------AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             ---------hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence                     0111223333444556667788888888754  34444443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.39  E-value=3.3e-13  Score=146.79  Aligned_cols=94  Identities=29%  Similarity=0.456  Sum_probs=81.0

Q ss_pred             HHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCC-------------CcccccccccCCCCCChhh
Q 009186          329 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ-------------NEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       329 ~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~-------------~~~~~~~~~gt~~y~aPE~  395 (541)
                      +.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+.++.....             .+.......||+.|.|||+
T Consensus       153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            78999999999   9999999999999999999999999987532111             1112334689999999999


Q ss_pred             hccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 009186          396 AMEGVFSVKSDVFSFGVLLLEIISGKRNSG  425 (541)
Q Consensus       396 l~~~~~s~~sDVwSlGvll~elltg~~p~~  425 (541)
                      +....|...+|.|++|+|+||.+.|..||.
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpff  259 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFF  259 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence            999999999999999999999999999974

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=2.9e-12  Score=125.81  Aligned_cols=161  Identities=23%  Similarity=0.310  Sum_probs=106.1

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc--CCC--CcEEecccccccccCCC----CcccccccccC
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD--HEM--NPKISDFGMARIFSGNQ----NEANTNRVAGT  387 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~--~~~--~~kL~Dfg~a~~~~~~~----~~~~~~~~~gt  387 (541)
                      .+.....-|+.|+++|+.|||++|   |.|||+|.+|||+.  +|+  .+.|+|||.+---....    .........|.
T Consensus       338 ~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGN  414 (598)
T KOG4158|consen  338 RSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGN  414 (598)
T ss_pred             CchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCc
Confidence            455667789999999999999999   99999999999983  444  35789999864322111    11122234567


Q ss_pred             CCCCChhhhccCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCC
Q 009186          388 YGYMAPEYAMEGV------FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCV  461 (541)
Q Consensus       388 ~~y~aPE~l~~~~------~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  461 (541)
                      -..||||+....+      --.|+|.|+.|.+.||++....||..    .++..++..  ...+.+.     |.+...++
T Consensus       415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~----rGem~L~~r--~Yqe~qL-----Palp~~vp  483 (598)
T KOG4158|consen  415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK----RGEMLLDTR--TYQESQL-----PALPSRVP  483 (598)
T ss_pred             ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc----cchheechh--hhhhhhC-----CCCcccCC
Confidence            7789999886432      12589999999999999999999743    222221111  0111111     22222222


Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          462 DAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       462 ~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                          ..+.+++...|+.||.+|++..-....|.
T Consensus       484 ----p~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  484 ----PVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             ----hHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence                23455677889999999998766555554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=5.5e-11  Score=131.95  Aligned_cols=108  Identities=19%  Similarity=0.158  Sum_probs=91.0

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-------CCCcEEecccccccccCCCCccccccc
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-------EMNPKISDFGMARIFSGNQNEANTNRV  384 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-------~~~~kL~Dfg~a~~~~~~~~~~~~~~~  384 (541)
                      ..+.++|..++.++.|++.-+++||..+   |||+||||+|+||..       +..++|+|||.+..+..-.........
T Consensus       787 ~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~  863 (974)
T KOG1166|consen  787 TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAV  863 (974)
T ss_pred             cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeee
Confidence            5667999999999999999999999999   999999999999942       335899999998654332233333446


Q ss_pred             ccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCC
Q 009186          385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR  422 (541)
Q Consensus       385 ~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~  422 (541)
                      ++|-.+-.+|...+.+++...|.|.|+.+++-|+.|+.
T Consensus       864 ~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  864 WHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            67888999999999999999999999999999999974

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.17  E-value=2.6e-10  Score=109.94  Aligned_cols=110  Identities=23%  Similarity=0.340  Sum_probs=94.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-----CcEEecccccccccCCCCcc-----ccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-----NPKISDFGMARIFSGNQNEA-----NTNRV  384 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-----~~kL~Dfg~a~~~~~~~~~~-----~~~~~  384 (541)
                      +++.++++.+++|++.-++|+|++.   +|.|||||+|+||...+     .+.++|||+++.+.+.....     +....
T Consensus       120 ~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSL  196 (449)
T KOG1165|consen  120 RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSL  196 (449)
T ss_pred             cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccccc
Confidence            3899999999999999999999999   99999999999997544     47899999999865544322     23446


Q ss_pred             ccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 009186          385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY  427 (541)
Q Consensus       385 ~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~  427 (541)
                      .||.+||+-....+.+.+.+.|+=|||-+++..+-|..||...
T Consensus       197 sGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  197 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             ccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            7899999988888888899999999999999999999998543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.05  E-value=1.4e-10  Score=118.15  Aligned_cols=75  Identities=21%  Similarity=0.271  Sum_probs=60.6

Q ss_pred             HHHHHhHHHHHHHhhhcCCCceEeccc-CCCcEEEcCCCCcEEecccccccccCCCCccc------ccccccCCCCCChh
Q 009186          322 ISIINGIARGLLYLHEDSRLRVIHRDL-KTSNVLLDHEMNPKISDFGMARIFSGNQNEAN------TNRVAGTYGYMAPE  394 (541)
Q Consensus       322 ~~i~~qi~~gL~~LH~~~~~~ivH~DL-kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE  394 (541)
                      ..++.|++++|.|||+.+   |+|||| ||+|||++.++.+||+|||+++.+........      -....+++.|.+||
T Consensus       114 ~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe  190 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD  190 (365)
T ss_pred             HHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence            467889999999999999   999999 99999999999999999999987654332111      12456788899999


Q ss_pred             hhccC
Q 009186          395 YAMEG  399 (541)
Q Consensus       395 ~l~~~  399 (541)
                      .+...
T Consensus       191 ~~~~~  195 (365)
T PRK09188        191 ALTPR  195 (365)
T ss_pred             cCChh
Confidence            88643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.03  E-value=4.5e-10  Score=104.48  Aligned_cols=100  Identities=20%  Similarity=0.175  Sum_probs=76.1

Q ss_pred             HHHHHhHHHHHHHhhhcCCCceEeccc-CCCcEEEcCCCCcEEecccccccccCCCCc----c-------cccccccCCC
Q 009186          322 ISIINGIARGLLYLHEDSRLRVIHRDL-KTSNVLLDHEMNPKISDFGMARIFSGNQNE----A-------NTNRVAGTYG  389 (541)
Q Consensus       322 ~~i~~qi~~gL~~LH~~~~~~ivH~DL-kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----~-------~~~~~~gt~~  389 (541)
                      ..++.|++.+|+++|+.|   |+|||| ||+|||++.++.++|+|||++.........    .       .......++.
T Consensus        94 ~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~  170 (218)
T PRK12274         94 LAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPA  170 (218)
T ss_pred             HHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCC
Confidence            357889999999999999   999999 799999999999999999999865543321    0       0112235778


Q ss_pred             CCChhhhccC-CCC-cchhhHHHHHHHHHHHhCCCCC
Q 009186          390 YMAPEYAMEG-VFS-VKSDVFSFGVLLLEIISGKRNS  424 (541)
Q Consensus       390 y~aPE~l~~~-~~s-~~sDVwSlGvll~elltg~~p~  424 (541)
                      |+.|+...-- ..+ ...+.++.|.-+|.++|++.++
T Consensus       171 ~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        171 ALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             CCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            8888754321 233 4567889999999999998874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.01  E-value=4.2e-10  Score=103.97  Aligned_cols=110  Identities=21%  Similarity=0.295  Sum_probs=90.9

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC---CCcEEecccccccccCCCCc-----cccccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKISDFGMARIFSGNQNE-----ANTNRVAG  386 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~-----~~~~~~~g  386 (541)
                      .++.++++.++.|++.-++|+|.++   +|||||||+|+|..-.   ..+.|+|||+++.+-.....     .......|
T Consensus       107 ~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltG  183 (341)
T KOG1163|consen  107 RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTG  183 (341)
T ss_pred             hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccce
Confidence            3788899999999999999999999   9999999999998643   45789999999876543322     22334568


Q ss_pred             CCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 009186          387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY  427 (541)
Q Consensus       387 t~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~  427 (541)
                      |..|.+-....+...+.+.|+=|+|.+|...--|..||...
T Consensus       184 TaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  184 TARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             eeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            89998887777777788999999999999999999998543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.98  E-value=7.2e-11  Score=128.09  Aligned_cols=162  Identities=26%  Similarity=0.370  Sum_probs=118.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhh-hcCCCceEecccCCCcEEEcCCC-CcEEecccccccccC-CCCccccccccc-CCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLH-EDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSG-NQNEANTNRVAG-TYGY  390 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH-~~~~~~ivH~DLkp~NIll~~~~-~~kL~Dfg~a~~~~~-~~~~~~~~~~~g-t~~y  390 (541)
                      ..+....-.++.|+..++.|+| ..+   +.|+||||+|.+++..+ ..+++|||++..+.. ...........| ++.|
T Consensus       119 ~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y  195 (601)
T KOG0590|consen  119 GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPY  195 (601)
T ss_pred             CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCC
Confidence            4566777889999999999999 888   99999999999999999 999999999988776 455555555677 9999


Q ss_pred             CChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          391 MAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       391 ~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      ++||...+. -..+..|+||.|+++.-+++|..|+......... ..     .|.+..  ....    ............
T Consensus       196 ~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~-----~~~~~~--~~~~----~~~~~~~~~~~~  263 (601)
T KOG0590|consen  196 GAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YS-----SWKSNK--GRFT----QLPWNSISDQAH  263 (601)
T ss_pred             CCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ce-----eecccc--cccc----cCccccCChhhh
Confidence            999998874 4567899999999999999999997654433311 00     111111  0000    000111122345


Q ss_pred             HHHhhhcccCCCCCCCHHHHHH
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ++...++..+|..|.+.+++..
T Consensus       264 ~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  264 DLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             hcccccccCCchhccccccccc
Confidence            5666788899999999888764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.93  E-value=4.3e-10  Score=108.34  Aligned_cols=178  Identities=20%  Similarity=0.222  Sum_probs=110.8

Q ss_pred             HHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc--cc
Q 009186          292 LFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG--MA  369 (541)
Q Consensus       292 ~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg--~a  369 (541)
                      +|+.-|.+..++++.++   .+..+......+|+.||+.||.|||+-. ++|+|+++..+.|++..++-+|++--.  ..
T Consensus       152 eymssgs~~~fLkrt~~---~~~a~~~~~wkkw~tqIlsal~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~  227 (458)
T KOG1266|consen  152 EYMSSGSLKQFLKRTKK---NQKALFQKAWKKWCTQILSALSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDST  227 (458)
T ss_pred             ecccchhHHHHHHHHHH---hhhhhhHHHHHHHHHHHHhhhhhhhccC-CccccCCcchhheeecCCceEEecccCcccc
Confidence            45555555444444322   3446788888899999999999999986 679999999999999999988875311  11


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcc
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEAL  449 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  449 (541)
                      ...-............+-++|.+||.-.....+..+|||+||+..+||..+.--.......   ...+....     ...
T Consensus       228 h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~---~~~ee~ia-----~~i  299 (458)
T KOG1266|consen  228 HPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESK---VEVEENIA-----NVI  299 (458)
T ss_pred             chhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcce---eehhhhhh-----hhe
Confidence            1100111111222334567899999876667788999999999999998876431111100   00000000     000


Q ss_pred             ccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          450 ELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       450 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ..+...+..           .++..|++..|..||+|.+++..
T Consensus       300 ~~len~lqr-----------~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  300 IGLENGLQR-----------GSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eeccCcccc-----------CcCcccccCCCCCCcchhhhhcC
Confidence            111111111           24557999999999999987653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=98.86  E-value=2.4e-09  Score=99.82  Aligned_cols=55  Identities=18%  Similarity=0.181  Sum_probs=49.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHh-hhcCCCceEecccCCCcEEEcCCCCcEEecccccccc
Q 009186          314 AQLDWKRRISIINGIARGLLYL-HEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF  372 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~L-H~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~  372 (541)
                      ..+++.+...++.|++.+|.+| |+.+   |+||||||+||+++ ++.++|+|||++...
T Consensus       112 ~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         112 APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            3588999999999999999999 6888   99999999999998 478999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=98.85  E-value=8.9e-10  Score=104.60  Aligned_cols=77  Identities=17%  Similarity=0.285  Sum_probs=59.9

Q ss_pred             HHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCc
Q 009186          324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSV  403 (541)
Q Consensus       324 i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~  403 (541)
                      ...+++.+|..+|+.|   ++|||+||+||+++.++ ++|+|||...........              ..+.....+..
T Consensus       140 ~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~  201 (232)
T PRK10359        140 VKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGI  201 (232)
T ss_pred             HHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcc
Confidence            4569999999999999   99999999999999988 999999987654211110              11334445667


Q ss_pred             chhhHHHHHHHHHHH
Q 009186          404 KSDVFSFGVLLLEII  418 (541)
Q Consensus       404 ~sDVwSlGvll~ell  418 (541)
                      ++|+|+||+.+....
T Consensus       202 ~~di~~lg~~~~~~~  216 (232)
T PRK10359        202 KNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccccceeEeehHHH
Confidence            999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=98.84  E-value=3.6e-09  Score=98.85  Aligned_cols=55  Identities=20%  Similarity=0.291  Sum_probs=50.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEeccccccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS  373 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~  373 (541)
                      .++..+...++.|++.+|.+||. .+   |+||||||+||+++ ++.++|+|||++....
T Consensus       113 ~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         113 PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            47788999999999999999999 88   99999999999999 7899999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.55  E-value=5.8e-07  Score=90.00  Aligned_cols=107  Identities=16%  Similarity=0.252  Sum_probs=85.5

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ....|...++..+.|+.+.+-||+.|   .+-+|++++|+|+.+++.+.|.|-...........   ..-.+|...|.+|
T Consensus       112 P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~---~~cpVg~~eftPP  185 (637)
T COG4248         112 PHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTL---HLCPVGVSEFTPP  185 (637)
T ss_pred             CccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCCce---EecccCccccCCH
Confidence            34789999999999999999999999   88899999999999999999988554333222211   1224678899999


Q ss_pred             hhhc-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCC
Q 009186          394 EYAM-----EGVFSVKSDVFSFGVLLLEIISG-KRNSGF  426 (541)
Q Consensus       394 E~l~-----~~~~s~~sDVwSlGvll~elltg-~~p~~~  426 (541)
                      |.-.     +..-+...|.|.||+++++++.| ++||..
T Consensus       186 ElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         186 ELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             HHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            9754     33456789999999999999986 899853

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=3.9e-08  Score=104.07  Aligned_cols=158  Identities=20%  Similarity=0.312  Sum_probs=100.9

Q ss_pred             HHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-------cccccccCCCCC
Q 009186          319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-------NTNRVAGTYGYM  391 (541)
Q Consensus       319 ~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~  391 (541)
                      +....-+.+++.||.|+|..-  .+||++|.|++|.++.++..||+.|+.+..........       ...-......|.
T Consensus        99 e~~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~  176 (700)
T KOG2137|consen   99 EDGFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFL  176 (700)
T ss_pred             cHhhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccc
Confidence            344455667779999999875  59999999999999999999999999876543311111       111122346799


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRN-SGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +||++.+...+.++|+||||+++|.+..|..+ +...     .....+.......+-..        .........++.+
T Consensus       177 apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-----~~~~~~~~~~~~~~~~~--------~~~s~~~p~el~~  243 (700)
T KOG2137|consen  177 APEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAAN-----GGLLSYSFSRNLLNAGA--------FGYSNNLPSELRE  243 (700)
T ss_pred             cchhhccccccccccceeeeeEEEEEecCCcchhhcc-----CCcchhhhhhccccccc--------ccccccCcHHHHH
Confidence            99999988888999999999999999955544 2111     01111111111000000        0111122233444


Q ss_pred             HHhhhcccCCCCCCCHHHHHH
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~  491 (541)
                      =+.+++..++..||++.++..
T Consensus       244 ~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  244 SLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHHHhcCCcccCcchhhhhc
Confidence            555788999999998777654

>smart00090 RIO RIO-like kinase

Probab=98.46  E-value=2.2e-07  Score=89.74  Aligned_cols=55  Identities=16%  Similarity=0.268  Sum_probs=48.3

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF  372 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~  372 (541)
                      .+...+...++.||+.+|.+||+.+  .|+|+||||+||+++ ++.++|+|||.+...
T Consensus       144 ~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      144 EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            3556677899999999999999986  499999999999999 889999999998753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.41  E-value=1.6e-07  Score=98.10  Aligned_cols=157  Identities=22%  Similarity=0.312  Sum_probs=108.7

Q ss_pred             cccHHHHHHHHHhHHH----HHHHhhhcCCCceEecccCCCcEEEcCC-CCcEEecccccccccCCCCcccc---ccccc
Q 009186          315 QLDWKRRISIINGIAR----GLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEANT---NRVAG  386 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~----gL~~LH~~~~~~ivH~DLkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~---~~~~g  386 (541)
                      .++....+..+.+..+    ||.++|..+   |+|-|+||.||++..+ ...+++|||+...+.........   .+..+
T Consensus       214 ~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~  290 (524)
T KOG0601|consen  214 FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEG  290 (524)
T ss_pred             cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCC
Confidence            4677777888888888    999999998   9999999999999999 78899999999887665433221   22256


Q ss_pred             CCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHH
Q 009186          387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELL  466 (541)
Q Consensus       387 t~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  466 (541)
                      ...|++||.. .+.++.+.|||++|.++.+..++..........        .|.....+.+        ..++...-..
T Consensus       291 ~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~~r~~~i--------p~e~~~~~s~  353 (524)
T KOG0601|consen  291 DCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQLRQGYI--------PLEFCEGGSS  353 (524)
T ss_pred             CceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC--------CccccccccC--------chhhhcCcch
Confidence            6789999976 456788999999999999999887653221100        1111111111        1111111112


Q ss_pred             HHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          467 KCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       467 ~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ++-..+.++++++|-.|++.+.+..
T Consensus       354 ~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  354 SLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             hhhhHHHHhcCcchhhhhHHHHHhc
Confidence            2233667899999999998777654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.37  E-value=3.9e-07  Score=85.65  Aligned_cols=51  Identities=20%  Similarity=0.272  Sum_probs=46.0

Q ss_pred             HHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccccc
Q 009186          320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS  373 (541)
Q Consensus       320 ~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~  373 (541)
                      ....++.+++.++.++|+.+   |+|+||||+||+++.++.++|+|||.+..+.
T Consensus       126 ~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         126 DPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            34578899999999999998   9999999999999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.33  E-value=4.5e-07  Score=87.73  Aligned_cols=44  Identities=27%  Similarity=0.422  Sum_probs=41.1

Q ss_pred             HHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       325 ~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      +.+|+.+|.+||+.|   |+|+||||.|||++.++.++|+|||.+..
T Consensus       148 ~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        148 WQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            568999999999999   99999999999999988999999998865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.27  E-value=7.6e-07  Score=82.63  Aligned_cols=50  Identities=22%  Similarity=0.226  Sum_probs=46.0

Q ss_pred             HHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEecccccccc
Q 009186          319 KRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF  372 (541)
Q Consensus       319 ~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~  372 (541)
                      .+...++.+++.++.++|. .+   |+|+||||+||+++ ++.++|+|||.+...
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         114 EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            5678899999999999999 88   99999999999999 889999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK10345 hypothetical protein; Provisional

Probab=98.25  E-value=1e-06  Score=83.23  Aligned_cols=49  Identities=18%  Similarity=0.321  Sum_probs=39.2

Q ss_pred             ccHHHHHHHHHhHHHHH-HHhhhcCCCceEecccCCCcEEEcCC----CCcEEeccccc
Q 009186          316 LDWKRRISIINGIARGL-LYLHEDSRLRVIHRDLKTSNVLLDHE----MNPKISDFGMA  369 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL-~~LH~~~~~~ivH~DLkp~NIll~~~----~~~kL~Dfg~a  369 (541)
                      +++.  ..++.+++.++ +|||+++   |+||||||+|||++..    ..++|+||+.+
T Consensus       103 ~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        103 YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            4444  35678888888 9999999   9999999999999743    37999995443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.24  E-value=7.3e-07  Score=98.30  Aligned_cols=132  Identities=23%  Similarity=0.248  Sum_probs=97.4

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      +..++++++-.+.+.-++++       -..++.+-....+..+..++++||...   ++|+|++|.|+++..++..++.|
T Consensus       878 P~~L~~~~~~~~~~~Skl~~-------~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~  947 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHN-------SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTD  947 (1205)
T ss_pred             CcchhhHHhccCCchhhhhc-------CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCc
Confidence            44566666655555444433       113444555566777889999999987   89999999999999999999999


Q ss_pred             ccccccccCC-------------------------CCc----ccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHH
Q 009186          366 FGMARIFSGN-------------------------QNE----ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLE  416 (541)
Q Consensus       366 fg~a~~~~~~-------------------------~~~----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~e  416 (541)
                      |+.....+..                         ...    .......+|..|.+||.+.+......+|.|++|++++|
T Consensus       948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen  948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred             cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence            9843321100                         000    11234568999999999999999999999999999999


Q ss_pred             HHhCCCCCCCC
Q 009186          417 IISGKRNSGFY  427 (541)
Q Consensus       417 lltg~~p~~~~  427 (541)
                      .++|.+||...
T Consensus      1028 ~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1028 VLTGIPPFNAE 1038 (1205)
T ss_pred             hhcCCCCCCCc
Confidence            99999998543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.13  E-value=2.7e-06  Score=80.60  Aligned_cols=48  Identities=33%  Similarity=0.492  Sum_probs=44.9

Q ss_pred             HHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       320 ~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ++..++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++|+|||.+..
T Consensus        96 ~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         96 EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            77899999999999999999   99999999999999 78899999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.11  E-value=3.1e-06  Score=79.36  Aligned_cols=45  Identities=29%  Similarity=0.544  Sum_probs=42.4

Q ss_pred             HHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       323 ~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||.+..
T Consensus        94 ~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            78999999999999999   99999999999999 78999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.05  E-value=2.9e-06  Score=92.20  Aligned_cols=47  Identities=23%  Similarity=0.471  Sum_probs=43.7

Q ss_pred             HHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       321 ~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ...++.+++++|.+||+.+   ++||||||+||++ .++.++|+|||+++.
T Consensus       430 ~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            6789999999999999999   9999999999999 577899999999875

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=97.92  E-value=6.7e-06  Score=86.19  Aligned_cols=153  Identities=23%  Similarity=0.259  Sum_probs=101.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-CCcEEecccccccccCCCCcccccccccCCCC-CC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVAGTYGY-MA  392 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y-~a  392 (541)
                      .+++..++++..|++.++.++|+..   ++|+|+||+||++..+ +..+++||+.+..+.-..    ......+..| .+
T Consensus       362 ~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~  434 (524)
T KOG0601|consen  362 MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIA  434 (524)
T ss_pred             hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceec----ccccccccccccc
Confidence            4667788999999999999999998   9999999999999887 677999999886422111    1111123334 35


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ++......+..+.|+++||.-+.|.+++..--.     ...   +  |..+..+..     +.+.     .....+..+.
T Consensus       435 ~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-----~~~---~--~~~i~~~~~-----p~~~-----~~~~~~q~~~  494 (524)
T KOG0601|consen  435 EILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-----SGV---Q--SLTIRSGDT-----PNLP-----GLKLQLQVLL  494 (524)
T ss_pred             hhhccccccccccccccccccccccccCcccCc-----ccc---c--ceeeecccc-----cCCC-----chHHhhhhhh
Confidence            555566778899999999999999998875321     000   0  000111111     1111     1113444566


Q ss_pred             hhhcccCCCCCCCHHHHHHHHh
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~  494 (541)
                      ..+..+++..||.+.++..+..
T Consensus       495 kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  495 KVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             hhhcCCccccchhhhhhcccch
Confidence            6788899999998888765543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=97.92  E-value=1.7e-05  Score=69.94  Aligned_cols=55  Identities=27%  Similarity=0.282  Sum_probs=47.7

Q ss_pred             cHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          317 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       317 ~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      +......++.+++++|++||......++|+|++|.||+++..+.+++.|||.+..
T Consensus        84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            5567788999999999999986333499999999999999988999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=97.88  E-value=1.8e-05  Score=73.62  Aligned_cols=53  Identities=17%  Similarity=0.102  Sum_probs=45.4

Q ss_pred             ccHHHHHHHHHhHHHHHHHh-hhcCCCceEecccCCCcEEEcCCCCcEEecccccccc
Q 009186          316 LDWKRRISIINGIARGLLYL-HEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF  372 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~L-H~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~  372 (541)
                      ++.++...+..+++.+|..| |+.+   |||+||++.||+++ ++.+.|+|||.+...
T Consensus       121 ~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         121 LNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            44556677889999999998 8888   99999999999997 468999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=97.59  E-value=0.00016  Score=77.03  Aligned_cols=97  Identities=16%  Similarity=0.225  Sum_probs=70.2

Q ss_pred             HHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhhhc
Q 009186          318 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM  397 (541)
Q Consensus       318 ~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~  397 (541)
                      .......+.||+.||.|||.++  .++|++|..+.|+++..|.-||++|.++........  .......-..|..|+.+.
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence            4455667899999999999765  499999999999999999999999988765332221  011111223466666432


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhC
Q 009186          398 EGVFSVKSDVFSFGVLLLEIISG  420 (541)
Q Consensus       398 ~~~~s~~sDVwSlGvll~elltg  420 (541)
                      ...  -..|.|-||++++|++.|
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCc
Confidence            211  346999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=97.58  E-value=7.3e-05  Score=67.94  Aligned_cols=48  Identities=31%  Similarity=0.351  Sum_probs=40.4

Q ss_pred             HHHHhHHHHHHHhhhcC--CCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          323 SIINGIARGLLYLHEDS--RLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       323 ~i~~qi~~gL~~LH~~~--~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      .+..+++++|..||..+  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        87 ~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          87 ENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             HHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            45678999999999987  22359999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=97.50  E-value=9.4e-05  Score=51.46  Aligned_cols=46  Identities=43%  Similarity=0.671  Sum_probs=35.3

Q ss_pred             CCCCCCCCCCCCceeccccccCCCCCCCC-CCccccCcccccccCCC
Q 009186          496 DTATLPPPTQPAFSVDRIAAKSGQSSSSG-SKFCSVNEITLSNVYPR  541 (541)
Q Consensus       496 ~~~~l~~p~~P~~~~~~~~~~~~~~~~~~-~~~~s~~~~~~~~~~~r  541 (541)
                      +...||.|.+|+|...+...+.+.+++.. ....|+|+||+|.+++|
T Consensus         2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            45689999999999998865554222222 25799999999999998

; GO: 0004674 protein serine/threonine kinase activity

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.44  E-value=0.00016  Score=70.97  Aligned_cols=53  Identities=23%  Similarity=0.298  Sum_probs=46.4

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-------CCCcEEeccccccc
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-------EMNPKISDFGMARI  371 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-------~~~~kL~Dfg~a~~  371 (541)
                      .+...+..++.+++..+.-||..|   |+|+|++++|||++.       +..+.|+||+.+..
T Consensus       135 ~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        135 PDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            456677899999999999999999   999999999999975       45789999998753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.44  E-value=0.00015  Score=68.57  Aligned_cols=53  Identities=30%  Similarity=0.458  Sum_probs=47.8

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC---CcEEeccccccc
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM---NPKISDFGMARI  371 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~---~~kL~Dfg~a~~  371 (541)
                      ++......++.+++..+.-||+.|   |+|+|+++.|||++.+.   .+.|+||+.++.
T Consensus       115 ~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  115 LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            566677899999999999999999   99999999999999887   789999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.30  E-value=0.00031  Score=63.67  Aligned_cols=47  Identities=30%  Similarity=0.502  Sum_probs=41.5

Q ss_pred             HHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       321 ~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ...++..+-.-+.-||..+   |+|+||.++||++.... +.++|||++..
T Consensus        94 ~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          94 RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            3567888888899999999   99999999999998764 99999999864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=97.28  E-value=0.00032  Score=74.09  Aligned_cols=49  Identities=24%  Similarity=0.337  Sum_probs=41.5

Q ss_pred             HHHHHhHHH-HHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccccc
Q 009186          322 ISIINGIAR-GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS  373 (541)
Q Consensus       322 ~~i~~qi~~-gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~  373 (541)
                      .+++.+++. .+..+|..|   ++|+|+||.||+++.++.++|.|||++..+.
T Consensus       259 ~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       259 KALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            456666665 478899998   9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.15  E-value=0.0027  Score=65.92  Aligned_cols=92  Identities=20%  Similarity=0.352  Sum_probs=73.7

Q ss_pred             CCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCC
Q 009186          310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG  389 (541)
Q Consensus       310 ~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~  389 (541)
                      ...+.++++...|.++.|+..||.++|+.|   +.-+-|.+.+|+++.+.+++|+..|....+..+....          
T Consensus       384 ~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~~----------  450 (655)
T KOG3741|consen  384 PSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTEP----------  450 (655)
T ss_pred             ccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCCcc----------
Confidence            445677999999999999999999999999   8889999999999999999998888766544333111          


Q ss_pred             CCChhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 009186          390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRN  423 (541)
Q Consensus       390 y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p  423 (541)
                            +..   ..+-|.=.||.+++.|.+|...
T Consensus       451 ------le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  451 ------LES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             ------hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence                  111   2356888999999999999754

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=97.06  E-value=0.0012  Score=59.83  Aligned_cols=47  Identities=36%  Similarity=0.621  Sum_probs=41.2

Q ss_pred             HHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC---cEEeccccccc
Q 009186          322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN---PKISDFGMARI  371 (541)
Q Consensus       322 ~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~---~kL~Dfg~a~~  371 (541)
                      ..++..|-+.+.-||.++   |+|+||..+||++..++.   +.++|||++..
T Consensus       116 ~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            678888999999999999   999999999999976654   47999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.06  E-value=0.00093  Score=61.86  Aligned_cols=51  Identities=27%  Similarity=0.406  Sum_probs=38.8

Q ss_pred             HHHHHHHHHhHHHHHHH-hhhcCCCceEecccCCCcEEEcCCCCcEEecccccccc
Q 009186          318 WKRRISIINGIARGLLY-LHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF  372 (541)
Q Consensus       318 ~~~~~~i~~qi~~gL~~-LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~  372 (541)
                      .+....++.+++..+.. +|..|   |+|+||.+.||+++++ .+.|+|||.+...
T Consensus       105 ~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  105 PEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             GSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             chhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence            34566778888885555 57888   9999999999999987 8999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=96.91  E-value=0.0012  Score=61.82  Aligned_cols=54  Identities=13%  Similarity=0.130  Sum_probs=48.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC--cEEeccccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN--PKISDFGMARI  371 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~--~kL~Dfg~a~~  371 (541)
                      ..+..++..++.+++..|.-||+.|   +.|+|+.+.||+++.++.  ++++||.-.+.
T Consensus       124 ~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        124 PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            4577788899999999999999999   999999999999987777  89999987654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=96.79  E-value=0.00028  Score=75.72  Aligned_cols=50  Identities=16%  Similarity=0.256  Sum_probs=38.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC----CcEEecccccccccC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM----NPKISDFGMARIFSG  374 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~----~~kL~Dfg~a~~~~~  374 (541)
                      .+.......++.|+.       ..|   ++|+|+||.||+++.++    .+++.|||++..+..
T Consensus       263 ~la~~~v~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        263 LLAERGVEVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHHHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            355555555555554       467   99999999999999988    899999999876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=95.99  E-value=0.0081  Score=56.58  Aligned_cols=44  Identities=23%  Similarity=0.346  Sum_probs=37.4

Q ss_pred             HHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       324 i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      +...|.+.+..||+.|   ++|+|.+|.|++++.+ .++++||+..+.
T Consensus       140 ~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             HHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccccc
Confidence            4566778899999999   9999999999999965 599999986543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=95.90  E-value=0.0075  Score=58.17  Aligned_cols=51  Identities=18%  Similarity=0.207  Sum_probs=38.9

Q ss_pred             HHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          318 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       318 ~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      .+..-.++..|++-+..+-..|   |||+|+++-||+++++|.+.++||-.+..
T Consensus       201 ~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         201 VENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCccccc
Confidence            3344455555555555555677   99999999999999999999999976643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=95.77  E-value=0.016  Score=53.72  Aligned_cols=57  Identities=18%  Similarity=0.138  Sum_probs=50.5

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      .-+|..|.+|+.++++.+++|+......+...|++++|+-+++++++|+.|...+..
T Consensus        55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            358999999999999999999985444588899999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=95.68  E-value=0.023  Score=53.65  Aligned_cols=31  Identities=23%  Similarity=0.381  Sum_probs=26.4

Q ss_pred             CceEecccCCCcEEEcC--CCCcEEeccccccc
Q 009186          341 LRVIHRDLKTSNVLLDH--EMNPKISDFGMARI  371 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~--~~~~kL~Dfg~a~~  371 (541)
                      ..++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            45999999999999998  56678999987753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.32  E-value=0.036  Score=64.93  Aligned_cols=135  Identities=13%  Similarity=0.018  Sum_probs=96.6

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcC--CCceEecccCCCcEEEcCCCCcE
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDS--RLRVIHRDLKTSNVLLDHEMNPK  362 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~--~~~ivH~DLkp~NIll~~~~~~k  362 (541)
                      ..-+..++++..|.++...-|   ..++...++..-+.....+.+....-.|+..  ....+|+++|+-|.+|..+.++|
T Consensus      1304 ~ee~~r~~~~~~g~~f~iIik---g~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~ 1380 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIK---GLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVK 1380 (2724)
T ss_pred             hHHHHHHHHHHHhHHHHHHHh---ccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccc
Confidence            345677888888887655544   3334445555555555555466666655432  23579999999999999999999


Q ss_pred             EecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 009186          363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNS  424 (541)
Q Consensus       363 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~  424 (541)
                      ++++|+.++..+..  .......+++.|+.|++..+-.++.++|+|..|+.+|+.-.|..+|
T Consensus      1381 ~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1381 LGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             ccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            99999998432222  1222345677889999988888998999999999999998887764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=95.16  E-value=0.057  Score=61.70  Aligned_cols=150  Identities=21%  Similarity=0.214  Sum_probs=97.1

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCC---cEEEcCCCCcEEe--cccccccccCCCCccccccccc
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS---NVLLDHEMNPKIS--DFGMARIFSGNQNEANTNRVAG  386 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~---NIll~~~~~~kL~--Dfg~a~~~~~~~~~~~~~~~~g  386 (541)
                      .-..++....+.+..++.+||.++|+..   ..|.-+..+   +--.+..+....+  ||+..+..........   ...
T Consensus       279 ~v~~i~~~~~r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~  352 (1351)
T KOG1035|consen  279 SVGSIPLETLRILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLL  352 (1351)
T ss_pred             hccccCHHHHHHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcC
Confidence            3456788889999999999999999986   666665555   4444555666665  8887766543332221   223


Q ss_pred             CCCCCChhhhccCCCCc--chhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHH
Q 009186          387 TYGYMAPEYAMEGVFSV--KSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAE  464 (541)
Q Consensus       387 t~~y~aPE~l~~~~~s~--~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  464 (541)
                      +..+.++|.........  ..|+|.+|.+...+..|..+-....                  ....+++.    ....  
T Consensus       353 ~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~----~~~~--  408 (1351)
T KOG1035|consen  353 AEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA------------------VPVSLLDV----LSTS--  408 (1351)
T ss_pred             ccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc------------------chhhhhcc----ccch--
Confidence            45677888776655444  4799999999999998876521100                  00111111    1111  


Q ss_pred             HHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 009186          465 LLKCIHIGLLCVQEDPAHRPNMSSVVVML  493 (541)
Q Consensus       465 ~~~~~~l~~~cl~~dP~~RPt~~evl~~L  493 (541)
                        ........|+..++++|+...+++...
T Consensus       409 --~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  409 --ELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             --hhhhhhhhhcchhhhhccchhhhhhch
Confidence              233455679999999999999998754

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=93.85  E-value=0.1  Score=49.89  Aligned_cols=53  Identities=19%  Similarity=0.306  Sum_probs=44.3

Q ss_pred             cHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEeccccccccc
Q 009186          317 DWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS  373 (541)
Q Consensus       317 ~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~  373 (541)
                      ..++...+..++++.+.-|-. .+   +||+||+.=|||+. ++.+.++||+.+....
T Consensus       164 e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         164 ELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            334677888888888888887 55   99999999999999 7899999999887543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=92.00  E-value=0.3  Score=48.88  Aligned_cols=31  Identities=29%  Similarity=0.384  Sum_probs=27.0

Q ss_pred             CCceEecccCCCcEEEcCC----CCcEEecccccc
Q 009186          340 RLRVIHRDLKTSNVLLDHE----MNPKISDFGMAR  370 (541)
Q Consensus       340 ~~~ivH~DLkp~NIll~~~----~~~kL~Dfg~a~  370 (541)
                      ...++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            4569999999999999985    789999998774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=91.09  E-value=0.6  Score=47.30  Aligned_cols=54  Identities=26%  Similarity=0.312  Sum_probs=47.0

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ...+++.+.++.+.+.-+.-+..+-  +.=|||+...||||+ +|++.|+||-+++.
T Consensus       317 ~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         317 ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence            3568999999999888777777654  589999999999999 99999999999984

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=90.38  E-value=0.38  Score=46.07  Aligned_cols=30  Identities=23%  Similarity=0.419  Sum_probs=26.2

Q ss_pred             CceEecccCCCcEEEcC-CCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDH-EMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~-~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+.+.|||++. ++.+.|+||..+.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            35999999999999998 5779999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=89.61  E-value=0.46  Score=45.61  Aligned_cols=31  Identities=26%  Similarity=0.332  Sum_probs=25.5

Q ss_pred             CCceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          340 RLRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       340 ~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ...++|+|+.+.||+++.+...-|+||+.+.
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            3459999999999999876555799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=89.15  E-value=0.46  Score=47.73  Aligned_cols=29  Identities=41%  Similarity=0.489  Sum_probs=25.7

Q ss_pred             ceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          342 RVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       342 ~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      .++|+|+++.||+++.++...|+||+.+.
T Consensus       188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       188 GVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             ccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            49999999999999988767899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=88.86  E-value=0.17  Score=54.42  Aligned_cols=92  Identities=24%  Similarity=0.256  Sum_probs=70.9

Q ss_pred             HHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhhhccCC
Q 009186          321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV  400 (541)
Q Consensus       321 ~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~  400 (541)
                      ...+...-.++|++||+..   -+|+|    ||+..+ +..|+.||+....+....   ......++..+++||......
T Consensus       338 ~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~  406 (829)
T KOG0576|consen  338 FAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENT  406 (829)
T ss_pred             hhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccc
Confidence            3455566677899999875   58888    777665 578999999887665443   234467899999999999999


Q ss_pred             CCcchhhHHHHHHHHHHHhCCCC
Q 009186          401 FSVKSDVFSFGVLLLEIISGKRN  423 (541)
Q Consensus       401 ~s~~sDVwSlGvll~elltg~~p  423 (541)
                      +..+.|+|++|+---++--|-+|
T Consensus       407 ~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  407 IDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cccCCCccCCCcchhhcCCCCCC
Confidence            99999999999876677666665

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=88.75  E-value=0.56  Score=44.35  Aligned_cols=31  Identities=35%  Similarity=0.430  Sum_probs=20.8

Q ss_pred             CCceEecccCCCcEEEc-CCCCcEEecccccc
Q 009186          340 RLRVIHRDLKTSNVLLD-HEMNPKISDFGMAR  370 (541)
Q Consensus       340 ~~~ivH~DLkp~NIll~-~~~~~kL~Dfg~a~  370 (541)
                      ...++|+|+.+.||+++ .++.+-|+||+.+.
T Consensus       165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             CcEEEEeccccccceeeeccceeEEEecccce
Confidence            34599999999999999 55555799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=88.53  E-value=0.8  Score=45.85  Aligned_cols=28  Identities=25%  Similarity=0.376  Sum_probs=24.4

Q ss_pred             ceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          342 RVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       342 ~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      .++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            4999999999999987 578899998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=88.29  E-value=0.74  Score=45.27  Aligned_cols=52  Identities=23%  Similarity=0.271  Sum_probs=39.9

Q ss_pred             HHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       319 ~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ....+.+..+-..+.-.|... ..++|+|+.+.|+++++.+.++|+||..+..
T Consensus       132 ~~~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         132 HLLRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            334456666666676666651 2499999999999999989999999987753

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=87.96  E-value=0.44  Score=45.61  Aligned_cols=29  Identities=17%  Similarity=0.218  Sum_probs=25.6

Q ss_pred             CceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+.|.||++++++ +.|+||+.+.
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            3579999999999999887 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=87.75  E-value=0.62  Score=43.90  Aligned_cols=30  Identities=33%  Similarity=0.539  Sum_probs=21.2

Q ss_pred             CceEecccCCCcEEE-cCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLL-DHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll-~~~~~~kL~Dfg~a~  370 (541)
                      ..+.|+|+.+.||++ +.++.++|+||..+.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            359999999999999 888899999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK05231 homoserine kinase; Provisional

Probab=87.36  E-value=0.88  Score=45.85  Aligned_cols=29  Identities=38%  Similarity=0.438  Sum_probs=24.7

Q ss_pred             ceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          342 RVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       342 ~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      .++|+|+++.||+++.+...-|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            39999999999999966555799998764

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=87.29  E-value=0.44  Score=45.97  Aligned_cols=30  Identities=27%  Similarity=0.305  Sum_probs=26.2

Q ss_pred             CceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+.|.|||++.+....|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            459999999999999987777899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02721 ycfN_thiK thiamine kinase

Probab=87.25  E-value=0.47  Score=46.18  Aligned_cols=30  Identities=23%  Similarity=0.317  Sum_probs=25.8

Q ss_pred             CceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ..++|+|+.|.||+++.++ +.|+||+.+..
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            3599999999999999876 78999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=87.23  E-value=0.69  Score=46.03  Aligned_cols=29  Identities=41%  Similarity=0.481  Sum_probs=25.6

Q ss_pred             ceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          342 RVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       342 ~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      .++|+|+.|.||+++.++.+.|.||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            49999999999999987767899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10271 thiK thiamine kinase; Provisional

Probab=86.84  E-value=0.5  Score=43.59  Aligned_cols=29  Identities=17%  Similarity=0.243  Sum_probs=25.4

Q ss_pred             ceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          342 RVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       342 ~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ..+|+|+.|.||++++++ ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            479999999999998776 99999998753

>PHA03111 Ser/Thr kinase; Provisional

Probab=86.64  E-value=0.88  Score=45.45  Aligned_cols=38  Identities=26%  Similarity=0.187  Sum_probs=24.3

Q ss_pred             HHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCC
Q 009186          321 RISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHE  358 (541)
Q Consensus       321 ~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~  358 (541)
                      +.-++.||+.-.-...+ .+....+|-||||+|||+-+.
T Consensus       281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            34566777654433322 223459999999999998443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=86.21  E-value=0.93  Score=48.73  Aligned_cols=40  Identities=25%  Similarity=0.370  Sum_probs=33.1

Q ss_pred             HHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccC
Q 009186          332 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG  374 (541)
Q Consensus       332 L~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~  374 (541)
                      +..+-..|   ++|.|.+|.||+++.++.+.+.|||+...+.+
T Consensus       278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            33444466   99999999999999999999999999876543

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=85.59  E-value=0.72  Score=43.51  Aligned_cols=76  Identities=18%  Similarity=0.216  Sum_probs=51.0

Q ss_pred             HHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhH
Q 009186          329 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVF  408 (541)
Q Consensus       329 ~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVw  408 (541)
                      +..|.-.|+.+ ...+|+|..|+||+-|..|.+||.|=+....        .+      ..|.--|   ....++++++=
T Consensus       151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------~~------V~~vN~~---Y~~lT~~aE~~  212 (308)
T PF07387_consen  151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------NQ------VNMVNIE---YESLTQEAEVK  212 (308)
T ss_pred             HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------he------eeEEeee---ccccChHHHHH
Confidence            46678889654 3599999999999999999999999654321        00      1111111   12346777877


Q ss_pred             HHHHHHHHHHhCCC
Q 009186          409 SFGVLLLEIISGKR  422 (541)
Q Consensus       409 SlGvll~elltg~~  422 (541)
                      +|=.-+++++...+
T Consensus       213 ~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  213 VFVKSCLKLVEKQR  226 (308)
T ss_pred             HHHHHHHHHHHHHh
Confidence            77777777776543

The function of this family is unknown.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=85.48  E-value=0.7  Score=45.69  Aligned_cols=31  Identities=23%  Similarity=0.500  Sum_probs=25.5

Q ss_pred             CceEecccCCCcEEEcCCCCc-EEeccccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNP-KISDFGMARI  371 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~-kL~Dfg~a~~  371 (541)
                      ..++|+|+++.||+++.++.+ -|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            459999999999999975554 6999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=85.41  E-value=1.6  Score=44.20  Aligned_cols=28  Identities=39%  Similarity=0.635  Sum_probs=25.2

Q ss_pred             eEecccCCCcEEEcCCCC-cEEecccccc
Q 009186          343 VIHRDLKTSNVLLDHEMN-PKISDFGMAR  370 (541)
Q Consensus       343 ivH~DLkp~NIll~~~~~-~kL~Dfg~a~  370 (541)
                      +||+|+.|.||+++.+.. ..+.||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999998875 8899998764

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=85.09  E-value=1.3  Score=44.45  Aligned_cols=31  Identities=23%  Similarity=0.290  Sum_probs=27.5

Q ss_pred             CceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ..++|+|+.++||+++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            3599999999999999998999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02236 choline kinase

Probab=84.01  E-value=1.4  Score=45.12  Aligned_cols=30  Identities=27%  Similarity=0.468  Sum_probs=25.7

Q ss_pred             CceEecccCCCcEEEcC-CCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDH-EMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~-~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+++.||++++ ++.+.|+||..+.
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            35999999999999986 4679999998775

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=83.45  E-value=1.2  Score=44.72  Aligned_cols=48  Identities=31%  Similarity=0.420  Sum_probs=29.7

Q ss_pred             HHHHHhHHHHHHH--hhhc-CCCceEecccCCCcEEEcCCC------------------CcEEeccccccc
Q 009186          322 ISIINGIARGLLY--LHED-SRLRVIHRDLKTSNVLLDHEM------------------NPKISDFGMARI  371 (541)
Q Consensus       322 ~~i~~qi~~gL~~--LH~~-~~~~ivH~DLkp~NIll~~~~------------------~~kL~Dfg~a~~  371 (541)
                      .-++.||+  |.|  ..+. +....+|-||||+|||+-+..                  ..+|.||.+++.
T Consensus       278 kfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  278 KFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             HHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence            34455654  444  2222 233599999999999994332                  256777777664

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=83.24  E-value=1.9  Score=28.67  Aligned_cols=31  Identities=19%  Similarity=0.312  Sum_probs=20.9

Q ss_pred             CCcceeeeehhHHHHHHHHHHHhhheecccc
Q 009186          275 GKKATWIAIGTIITTITLFILLGSFVWCRRR  305 (541)
Q Consensus       275 ~~~~~ii~i~~~v~~v~~~~~~g~l~~~~~~  305 (541)
                      ....+.+++++++.+++..+...++++++|+
T Consensus         9 ~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~   39 (40)
T PF08693_consen    9 NTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK   39 (40)
T ss_pred             ceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence            3444567778888888877777777666553

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=82.65  E-value=1  Score=41.95  Aligned_cols=30  Identities=20%  Similarity=0.378  Sum_probs=24.9

Q ss_pred             ceEecccCCCcEEEcCCC-----CcEEeccccccc
Q 009186          342 RVIHRDLKTSNVLLDHEM-----NPKISDFGMARI  371 (541)
Q Consensus       342 ~ivH~DLkp~NIll~~~~-----~~kL~Dfg~a~~  371 (541)
                      .++|||+.+.||++..++     .+.|.||..++.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            599999999999997654     578999987753

subfamily of choline kinases

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=81.82  E-value=1.7  Score=43.57  Aligned_cols=43  Identities=16%  Similarity=0.285  Sum_probs=33.8

Q ss_pred             HhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          326 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       326 ~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ..+..-+--|-.+|   +||+|.+-=||++++++.++++||-....
T Consensus       209 ~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  209 DDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             HHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeechHhhc
Confidence            33334445566778   99999999999999999999999975543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=80.76  E-value=1.4  Score=44.28  Aligned_cols=33  Identities=18%  Similarity=0.402  Sum_probs=28.9

Q ss_pred             CCCceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          339 SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       339 ~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      +...++|+|+++.||+++....+-|.||+++..
T Consensus       196 ~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         196 GPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            345799999999999999988888999998864

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=80.39  E-value=0.45  Score=50.21  Aligned_cols=21  Identities=43%  Similarity=0.646  Sum_probs=18.6

Q ss_pred             cchhhHHHHHHHHHHHhCCCC
Q 009186          403 VKSDVFSFGVLLLEIISGKRN  423 (541)
Q Consensus       403 ~~sDVwSlGvll~elltg~~p  423 (541)
                      +|+|||++|.++.|+.-|..-
T Consensus       110 pKsdVwsl~~i~~el~L~~~l  130 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISL  130 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHH
Confidence            599999999999999988654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	541
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-31
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-30
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-21
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-21
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-21
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-13
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		1e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		6e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		8e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-04
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		8e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-04
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		8e-04
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-04
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		8e-04
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		8e-04
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-04
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-04
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 74/183 (40%), Positives = 104/183 (56%), Gaps = 3/183 (1%)
Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           LDW +R  I  G ARGL YLH+    ++IHRD+K +N+LLD E    + DFG+A++    
Sbjct: 136 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-Y 194
Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
           ++      V GT G++APEY   G  S K+DVF +GV+LLE+I+G+R        +   +
Sbjct: 195 KDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 254
Query: 436 LTYAW-KLWCKGEALE-LMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
           +   W K   K + LE L+D  L+    D E+ + I + LLC Q  P  RP MS VV ML
Sbjct: 255 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314
Query: 494 ASD 496
             D
Sbjct: 315 EGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 73/183 (39%), Positives = 103/183 (56%), Gaps = 3/183 (1%)
Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           LDW +R  I  G ARGL YLH+    ++IHRD+K +N+LLD E    + DFG+A++    
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-Y 186
Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
           ++      V G  G++APEY   G  S K+DVF +GV+LLE+I+G+R        +   +
Sbjct: 187 KDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 436 LTYAW-KLWCKGEALE-LMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
           +   W K   K + LE L+D  L+    D E+ + I + LLC Q  P  RP MS VV ML
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 494 ASD 496
             D
Sbjct: 307 EGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 93/175 (53%), Gaps = 3/175 (1%)
Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           + W++R+ I  G ARGL YLH  +   +IHRD+K+ N+LLD    PKI+DFG+++  +  
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
                   V GT GY+ PEY ++G  + KSDV+SFGV+L E++  +      L     +L
Sbjct: 193 DQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
             +A +    G+  +++DP L        L K     + C+      RP+M  V+
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 93/175 (53%), Gaps = 3/175 (1%)
Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           + W++R+ I  G ARGL YLH  +   +IHRD+K+ N+LLD    PKI+DFG+++  +  
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
                   V GT GY+ PEY ++G  + KSDV+SFGV+L E++  +      L     +L
Sbjct: 193 GQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
             +A +    G+  +++DP L        L K     + C+      RP+M  V+
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/186 (35%), Positives = 99/186 (53%), Gaps = 10/186 (5%)
Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
                 +R+ GT  YMAPE A+ G  + KSD++SFGV+LLEII+G       + EH +  
Sbjct: 187 AQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP----AVDEHREPQ 241
Query: 436 LTYAWKLWCKGEALELMDPVLKQ-TCVDAELLKCIH-IGLLCVQEDPAHRPNMSSVVVML 493
           L    K   + E   + D + K+    D+  ++ ++ +   C+ E    RP++  V  +L
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 494 ASDTAT 499
              TA+
Sbjct: 302 QEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/186 (35%), Positives = 98/186 (52%), Gaps = 10/186 (5%)
Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDFG+AR     
Sbjct: 124 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
                  R+ GT  YMAPE A+ G  + KSD++SFGV+LLEII+G       + EH +  
Sbjct: 181 AQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP----AVDEHREPQ 235
Query: 436 LTYAWKLWCKGEALELMDPVLKQ-TCVDAELLKCIH-IGLLCVQEDPAHRPNMSSVVVML 493
           L    K   + E   + D + K+    D+  ++ ++ +   C+ E    RP++  V  +L
Sbjct: 236 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295
Query: 494 ASDTAT 499
              TA+
Sbjct: 296 QEMTAS 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/186 (35%), Positives = 98/186 (52%), Gaps = 10/186 (5%)
Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
                  R+ GT  YMAPE A+ G  + KSD++SFGV+LLEII+G       + EH +  
Sbjct: 187 AQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP----AVDEHREPQ 241
Query: 436 LTYAWKLWCKGEALELMDPVLKQ-TCVDAELLKCIH-IGLLCVQEDPAHRPNMSSVVVML 493
           L    K   + E   + D + K+    D+  ++ ++ +   C+ E    RP++  V  +L
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 494 ASDTAT 499
              TA+
Sbjct: 302 QEMTAS 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/186 (34%), Positives = 97/186 (52%), Gaps = 10/186 (5%)
Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDFG+AR     
Sbjct: 121 LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
                 +R+ GT  Y APE A+ G  + KSD++SFGV+LLEII+G       + EH +  
Sbjct: 178 AQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLP----AVDEHREPQ 232
Query: 436 LTYAWKLWCKGEALELMDPVLKQTC-VDAELLKCIH-IGLLCVQEDPAHRPNMSSVVVML 493
           L    K   + E   + D + K+    D+  ++  + +   C+ E    RP++  V  +L
Sbjct: 233 LLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292
Query: 494 ASDTAT 499
              TA+
Sbjct: 293 QEXTAS 298

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 94/178 (52%), Gaps = 31/178 (17%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--------KISDFGMARIFSGNQNEA 379
           IARG+ YLH+++ + +IHRDLK+SN+L+  ++          KI+DFG+AR      +  
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRT 169
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA 439
                AG Y +MAPE     +FS  SDV+S+GVLL E+++G+      +   G   L  A
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVA 223
Query: 440 WKLWCKGEALELMDPVLKQTCVD--AELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
           +     G A+  +   +  TC +  A+L++       C   DP  RP+ ++++  L +
Sbjct: 224 Y-----GVAMNKLALPIPSTCPEPFAKLMED------CWNPDPHSRPSFTNILDQLTT 270

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 73/121 (60%), Gaps = 3/121 (2%)
Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
           R+   S    QLD +RR+S+   +A+G+ YLH +    ++HRDLK+ N+L+D +   K+ 
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVC 181
Query: 365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNS 424
           DFG++R+ +       +   AGT  +MAPE   +   + KSDV+SFGV+L E+ + ++  
Sbjct: 182 DFGLSRLKASXF--LXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239
Query: 425 G 425
           G
Sbjct: 240 G 240

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/121 (35%), Positives = 74/121 (61%), Gaps = 3/121 (2%)
Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
           R+   S    QLD +RR+S+   +A+G+ YLH +    ++HR+LK+ N+L+D +   K+ 
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVC 181
Query: 365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNS 424
           DFG++R+ +      ++   AGT  +MAPE   +   + KSDV+SFGV+L E+ + ++  
Sbjct: 182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239
Query: 425 G 425
           G
Sbjct: 240 G 240

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 19/196 (9%)
Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           +G  L     + +   +A G+ Y+    R+  IHRDL+++N+L+ + +  KI+DFG+AR+
Sbjct: 98  EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARL 154
Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
              N+  A          + APE A+ G F++KSDV+SFG+LL E+++  R     ++  
Sbjct: 155 IEDNEXTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 213
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
                          E LE ++   +  C     +    + + C ++DP  RP    +  
Sbjct: 214 ---------------EVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQS 258
Query: 492 MLASDTATLPPPTQPA 507
            L        P  QP 
Sbjct: 259 FLEDYFTATEPQYQPG 274

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+ R+ 
Sbjct: 275 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLI 331
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 332 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 390
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 391 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 434
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 435 FLEDYFTSTEPQXQPG 450

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 164
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 165 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 223
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 224 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 267
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 268 FLEDYFTSTEPQYQPG 283

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 331 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 389
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C +++P  RP    +  
Sbjct: 390 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQA 433
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 434 FLEDYFTSTEPQXQPG 449

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 164
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 165 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 223
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 224 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 267
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 268 FLEDYFTSTEPQYQPG 283

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 99  GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 155
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 156 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 214
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 215 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 258
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 259 FLEDYFTSTEPQYQPG 274

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 97  GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 153
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 154 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 212
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 213 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 256
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 257 FLEDYFTSTEPQYQPG 272

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 164
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 165 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 223
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 224 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 267
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 268 FLEDYFTSTEPQYQPG 283

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 331 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 389
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C +++P  RP    +  
Sbjct: 390 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQA 433
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 434 FLEDYFTSTEPQXQPG 449

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 164
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 165 EDNEXTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 223
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 224 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 267
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 268 FLEDYFTSTEPQYQPG 283

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 21/169 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +ARG+ +L   S  + IHRDL   N+LL      KI DFG+AR    N +          
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + ++S KSDV+S+GVLL EI S  G    G  + E   S L    ++   
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRM--- 321
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA 494
             A E   P + Q  +D            C   DP  RP  + +V  L 
Sbjct: 322 -RAPEYSTPEIYQIMLD------------CWHRDPKERPRFAELVEKLG 357

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 164
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 165 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 223
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 224 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 267
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 268 FLEDYFTSTEPQYQPG 283

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 331 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 389
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C +++P  RP    +  
Sbjct: 390 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQA 433
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 434 FLEDYFTSTEPQYQPG 449

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 164
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 165 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 223
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 224 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 267
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 268 FLEDYFTSTEPQYQPG 283

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 63/110 (57%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 98  GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 154
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ +  R
Sbjct: 155 EDNEXTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 164
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 165 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 223
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 224 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 267
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 268 FLEDYFTSTEPQYQPG 283

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 357 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 413
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 414 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 472
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C +++P  RP    +  
Sbjct: 473 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQA 516
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 517 FLEDYFTSTEPQXQPG 532

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 111 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 167
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 168 EDNEXTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 109 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 165
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 166 EDNEXTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 112 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 168
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 169 EDNEXTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 63/110 (57%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 101 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 157
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ +  R
Sbjct: 158 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 105 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 161
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 162 EDNEXTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 160 EDNEXTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 104 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 160
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 161 EDNEXTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 160 EDNEXTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 109 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 165
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 166 EDNEYTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 108 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 164
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 165 EDNEYTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/110 (37%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S +G ++   + I     IA G+ Y+    R   IHRDL+ +NVL+   +  KI+DFG+A
Sbjct: 101 SDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLA 157
Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           R+   N+  A          + APE    G F++KSDV+SFG+LL EI++
Sbjct: 158 RVIEDNEYTAREG-AKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 65/110 (59%), Gaps = 6/110 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           + + K+ I I    ARG+ YLH  S   +IHRDLK++N+ L  +   KI DFG+A + S 
Sbjct: 104 KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSR 160
Query: 375 NQNEANTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
                   +++G+  +MAPE         +S +SDV++FG++L E+++G+
Sbjct: 161 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 113 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 169
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 170 EDNEYTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 21/196 (10%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL  +N+L+   +  K++DFG+AR+ 
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLI 164
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ + G+      ++  
Sbjct: 165 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 223
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
               +   +++ C  E  E +  ++ Q                C ++DP  RP    +  
Sbjct: 224 VLDQVERGYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQA 267
Query: 492 MLASDTATLPPPTQPA 507
            L     +  P  QP 
Sbjct: 268 FLEDYFTSTEPQYQPG 283

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 160 EDNEYTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 63/110 (57%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+ 
Sbjct: 105 GKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 161
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE A+ G F++KSDV+SFG+LL E+ +  R
Sbjct: 162 EDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 98  GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 154
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 155 EDNEYTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 58/95 (61%), Gaps = 4/95 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+   N+  A        
Sbjct: 120 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQG-AKFP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             + APE A+ G F++KSDV+SFG+LL E+ +  R
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/124 (34%), Positives = 64/124 (51%), Gaps = 14/124 (11%)
Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHED-------SRLRVIHRDLKTSNVLLDHEMNP 361
           D  K   + W     I   +ARGL YLHED        +  + HRD+K+ NVLL + +  
Sbjct: 111 DFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 362 KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVF------SFGVLLL 415
            I+DFG+A  F   ++  +T+   GT  YMAPE  +EG  + + D F      + G++L 
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 416 EIIS 419
           E+ S
Sbjct: 230 ELAS 233

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/123 (34%), Positives = 63/123 (51%), Gaps = 16/123 (13%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           +Q  W +R+S    IA G+ YLH    + +IHRDL + N L+    N  ++DFG+AR+  
Sbjct: 103 SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159
Query: 374 GNQNEANTNR------------VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             + +    R            V G   +MAPE      +  K DVFSFG++L EII G+
Sbjct: 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GR 218
Query: 422 RNS 424
            N+
Sbjct: 219 VNA 221

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 6/103 (5%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A + S        
Sbjct: 109 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 165
Query: 382 NRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
            +++G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 166 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 64/105 (60%), Gaps = 6/105 (5%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A + S      
Sbjct: 105 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161
Query: 380 NTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
              +++G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 64/105 (60%), Gaps = 6/105 (5%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A + S      
Sbjct: 110 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 166
Query: 380 NTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
              +++G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 167 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 64/105 (60%), Gaps = 6/105 (5%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A + S      
Sbjct: 105 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161
Query: 380 NTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
              +++G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E   S  SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 6/103 (5%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A + S        
Sbjct: 112 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 382 NRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
            +++G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 6/103 (5%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A + S        
Sbjct: 134 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 190
Query: 382 NRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
            +++G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 191 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 6/103 (5%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A + S        
Sbjct: 135 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 191
Query: 382 NRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
            +++G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 192 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 66/112 (58%), Gaps = 8/112 (7%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159
Query: 373 SGNQNEANTNRVAGTY--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
              ++   T R    +   + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 160 ---EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 64/125 (51%), Gaps = 15/125 (12%)
Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHED--------SRLRVIHRDLKTSNVLLDHEMN 360
           D  KG  + W     +   ++RGL YLHED         +  + HRD K+ NVLL  ++ 
Sbjct: 102 DYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLT 161
Query: 361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVF------SFGVLL 414
             ++DFG+A  F   +   +T+   GT  YMAPE  +EG  + + D F      + G++L
Sbjct: 162 AVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVL 220
Query: 415 LEIIS 419
            E++S
Sbjct: 221 WELVS 225

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S +G ++   + I     IA G+ Y+    R   IHRDL+ +NVL+   +  KI+DFG+A
Sbjct: 100 SDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLA 156
Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           R+   N+  A          + APE    G F++KS+V+SFG+LL EI++
Sbjct: 157 RVIEDNEYTAREG-AKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L   + + +   IA G+ ++ E +    IHR+L+ +N+L+   ++ KI+DFG+AR+ 
Sbjct: 99  GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLI 155
Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
             N+  A          + APE    G F++KSDV+SFG+LL EI++  R
Sbjct: 156 EDNEYTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 6/110 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           + + K+ I I    ARG+ YLH  S   +IHRDLK++N+ L  +   KI DFG+A   S 
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172
Query: 375 NQNEANTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
                   +++G+  +MAPE         +S +SDV++FG++L E+++G+
Sbjct: 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  +   LD  +  +I+  I +GL YLH + +   IHRD+K +NVLL      K++DFG+
Sbjct: 94  DLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV 150
Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           A   +  Q + NT    GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 151 AGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 65/113 (57%), Gaps = 4/113 (3%)
Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S +G++    + I     IA G+ ++ + +    IHRDL+ +N+L+   +  KI+DFG+A
Sbjct: 102 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 158
Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           R+   N+  A          + APE    G F++KSDV+SFG+LL+EI++  R
Sbjct: 159 RVIEDNEYTAREG-AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  +   LD  +  +I+  I +GL YLH + +   IHRD+K +NVLL      K++DFG+
Sbjct: 114 DLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV 170
Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           A   +  Q + NT    GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 171 AGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 5/99 (5%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           +I+  I +GL YLH +   R IHRD+K +NVLL  + + K++DFG+A   +  Q     N
Sbjct: 120 TILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 174
Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 175 XFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 64/110 (58%), Gaps = 6/110 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           + + K+ I I    ARG+ YLH  S   +IHRDLK++N+ L  +   KI DFG+A   S 
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172
Query: 375 NQNEANTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
                   +++G+  +MAPE         +S +SDV++FG++L E+++G+
Sbjct: 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   S    +HRDL   NVL+ H    KI DFG+AR    + N          
Sbjct: 181 VAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MAPE   EG++++KSDV+S+G+LL EI S
Sbjct: 238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 60/99 (60%), Gaps = 5/99 (5%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           +++  I +GL YLH + +   IHRD+K +NVLL  + + K++DFG+A   +  Q + NT 
Sbjct: 124 TMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT- 179
Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 180 -FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 65/113 (57%), Gaps = 4/113 (3%)
Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S +G++    + I     IA G+ ++ + +    IHRDL+ +N+L+   +  KI+DFG+A
Sbjct: 275 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331
Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           R+   N+  A          + APE    G F++KSDV+SFG+LL+EI++  R
Sbjct: 332 RVIEDNEYTAREG-AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 115 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           G++YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 391 MAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  +   LD  +  +I+  I +GL YLH + +   IHRD+K +NVLL      K++DFG+
Sbjct: 109 DLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV 165
Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           A   +  Q     N   GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 166 AGQLTDTQ--IKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 146 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A   S        
Sbjct: 107 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 163
Query: 382 NRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
            +++G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D  +   LD  +  +I+  I +GL YLH + +   IHRD+K +NVLL      K++DFG+
Sbjct: 94  DLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV 150
Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           A   +  Q     N   GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 151 AGQLTDTQ--IKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A   S        
Sbjct: 127 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 183
Query: 382 NRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
            +++G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 184 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 270
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 271 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 307

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 270
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 271 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 307

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 261
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 262 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 298

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 28/196 (14%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + K   K   LD     +I+  +  GL YLH++ +   IHRD+K  N+LL  + + +I+D
Sbjct: 103 VAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIAD 159
Query: 366 FGMARIFSGNQNEANTNRV----AGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIIS 419
           FG++  F     +   N+V     GT  +MAPE  ME V  +  K+D++SFG+  +E+ +
Sbjct: 160 FGVS-AFLATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFGITAIELAT 217
Query: 420 GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL-----L 474
           G   +  Y       +L            L+   P L+    D E+LK           L
Sbjct: 218 G---AAPYHKYPPMKVLML---------TLQNDPPSLETGVQDKEMLKKYGKSFRKMISL 265
Query: 475 CVQEDPAHRPNMSSVV 490
           C+Q+DP  RP  + ++
Sbjct: 266 CLQKDPEKRPTAAELL 281

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A   S        
Sbjct: 135 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 191
Query: 382 NRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
            +++G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 192 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRM--- 266
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 267 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 303

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 28/196 (14%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + K   K   LD     +I+  +  GL YLH++ +   IHRD+K  N+LL  + + +I+D
Sbjct: 108 VAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIAD 164
Query: 366 FGMARIFSGNQNEANTNRV----AGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIIS 419
           FG++  F     +   N+V     GT  +MAPE  ME V  +  K+D++SFG+  +E+ +
Sbjct: 165 FGVS-AFLATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFGITAIELAT 222
Query: 420 GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL-----L 474
           G   +  Y       +L            L+   P L+    D E+LK           L
Sbjct: 223 G---AAPYHKYPPMKVLML---------TLQNDPPSLETGVQDKEMLKKYGKSFRKMISL 270
Query: 475 CVQEDPAHRPNMSSVV 490
           C+Q+DP  RP  + ++
Sbjct: 271 CLQKDPEKRPTAAELL 286

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 261
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 262 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 298

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 61/105 (58%), Gaps = 5/105 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G++YL E    R++HRDL   NVL+    + KI+DFG+AR+  G++ E N +     
Sbjct: 149 IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 205
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSE 430
             +MA E      F+ +SDV+S+GV + E+++  GK   G    E
Sbjct: 206 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 250

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 270
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 271 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 307

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/102 (39%), Positives = 56/102 (54%), Gaps = 5/102 (4%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           R I     I  GL +LH+ +   +I+RDLK  NVLLD + N +ISD G+A      Q + 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            T   AGT G+MAPE  +   +    D F+ GV L E+I+ +
Sbjct: 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/102 (39%), Positives = 56/102 (54%), Gaps = 5/102 (4%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           R I     I  GL +LH+ +   +I+RDLK  NVLLD + N +ISD G+A      Q + 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            T   AGT G+MAPE  +   +    D F+ GV L E+I+ +
Sbjct: 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/102 (39%), Positives = 56/102 (54%), Gaps = 5/102 (4%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           R I     I  GL +LH+ +   +I+RDLK  NVLLD + N +ISD G+A      Q + 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            T   AGT G+MAPE  +   +    D F+ GV L E+I+ +
Sbjct: 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/102 (39%), Positives = 56/102 (54%), Gaps = 5/102 (4%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           R I     I  GL +LH+ +   +I+RDLK  NVLLD + N +ISD G+A      Q + 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            T   AGT G+MAPE  +   +    D F+ GV L E+I+ +
Sbjct: 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 61/105 (58%), Gaps = 5/105 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G++YL E    R++HRDL   NVL+    + KI+DFG+AR+  G++ E N +     
Sbjct: 126 IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSE 430
             +MA E      F+ +SDV+S+GV + E+++  GK   G    E
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 227

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP 213
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 270
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 271 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 307

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 5/99 (5%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           +I+    +GL YLH    +R IHRD+K  N+LL+ E + K++DFG+A   +     A  N
Sbjct: 129 TILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXM--AKRN 183
Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            V GT  +MAPE   E  ++  +D++S G+  +E+  GK
Sbjct: 184 XVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 261
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 262 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 298

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 261
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 262 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 298

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 67/114 (58%), Gaps = 5/114 (4%)
Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
           + D T  + L+    + ++  IA G+ YL   S   V+H+DL T NVL+  ++N KISD 
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDL 172
Query: 367 GMAR-IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G+ R +++ +  +   N +     +MAPE  M G FS+ SD++S+GV+L E+ S
Sbjct: 173 GLFREVYAADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 270
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 271 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 307

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 159 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 216 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 272
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 273 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 309

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 67/114 (58%), Gaps = 5/114 (4%)
Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
           + D T  + L+    + ++  IA G+ YL   S   V+H+DL T NVL+  ++N KISD 
Sbjct: 133 DDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDL 189
Query: 367 GMAR-IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G+ R +++ +  +   N +     +MAPE  M G FS+ SD++S+GV+L E+ S
Sbjct: 190 GLFREVYAADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I I    A+G+ YLH  +   +IHRD+K++N+ L   +  KI DFG+A + S        
Sbjct: 135 IDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191
Query: 382 NRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
            +  G+  +MAPE         FS +SDV+S+G++L E+++G+
Sbjct: 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 266
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 267 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 303

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 320
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 321 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 357

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 313
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 314 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 350

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 194 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 251 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 307
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 308 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 344

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 315
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 316 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 352

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    + +          
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE   + V++++SDV+SFGVLL EI S       G  + E     L    ++   
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 322
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
             A +   P + QT +D            C   +P+ RP  S +V  L +
Sbjct: 323 -RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGN 359

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 18/155 (11%)
Query: 336 HEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY 395
           H  SR RV+HRD+K +NV +      K+ D G+ R FS     A++  + GT  YM+PE 
Sbjct: 151 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 207
Query: 396 AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMD-P 454
             E  ++ KSD++S G LL E+ +    S FY    G  +  Y+    CK   +E  D P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAA--LQSPFY----GDKMNLYS---LCK--KIEQCDYP 256
Query: 455 VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
            L       EL + ++   +C+  DP  RP+++ V
Sbjct: 257 PLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 59/104 (56%), Gaps = 4/104 (3%)
Query: 319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE 378
           KR I +I    + L + H++    +IHRD+K +N+L+      K+ DFG+AR  + + N 
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNS 172
Query: 379 A-NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              T  V GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 21/185 (11%)
Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T   Q    + + ++ G+  G+ YL   S L  +HRDL   NVL+D  +  K+SDFG++R
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199
Query: 371 IFSGNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYL 428
           +   + + A T         + APE      FS  SDV+SFGV++ E+++ G+R    Y 
Sbjct: 200 VLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP---YW 256
Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           +   + +++         E   L  P+     +   +L C H       +D A RP  S 
Sbjct: 257 NMTNRDVISSV------EEGYRLPAPMGCPHALHQLMLDCWH-------KDRAQRPRFSQ 303
Query: 489 VVVML 493
           +V +L
Sbjct: 304 IVSVL 308

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/93 (40%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L++LH+     +I+RDLK  NVLLDHE + K++DFGM +   G  N   T    GT
Sbjct: 133 IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGT 187
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y+APE   E ++    D ++ GVLL E++ G
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 63/119 (52%), Gaps = 5/119 (4%)
Query: 303 RRRINKDSTK--GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 360
           RR+   D  K  G  L+ +  +   + +A+G+ +L   +    IHRD+   NVLL +   
Sbjct: 134 RRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHV 190
Query: 361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            KI DFG+AR    + N            +MAPE   + V++V+SDV+S+G+LL EI S
Sbjct: 191 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 4/114 (3%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHE--DSRLRVIHRDLKTSNVLLDHEMNPKI 363
           I K + +   LD +  + ++  +   L   H   D    V+HRDLK +NV LD + N K+
Sbjct: 98  ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157
Query: 364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
            DFG+ARI   N +E       GT  YM+PE      ++ KSD++S G LL E+
Sbjct: 158 GDFGLARIL--NHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 21/185 (11%)
Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T   Q    + + ++ G+  G+ YL   S L  +HRDL   NVL+D  +  K+SDFG++R
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199
Query: 371 IFSGNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYL 428
           +   + + A T         + APE      FS  SDV+SFGV++ E+++ G+R    Y 
Sbjct: 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP---YW 256
Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           +   + +++         E   L  P+     +   +L C H       +D A RP  S 
Sbjct: 257 NMTNRDVIS------SVEEGYRLPAPMGCPHALHQLMLDCWH-------KDRAQRPRFSQ 303
Query: 489 VVVML 493
           +V +L
Sbjct: 304 IVSVL 308

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 63/119 (52%), Gaps = 5/119 (4%)
Query: 303 RRRINKDSTK--GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 360
           RR+   D  K  G  L+ +  +   + +A+G+ +L   +    IHRD+   NVLL +   
Sbjct: 142 RRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHV 198
Query: 361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            KI DFG+AR    + N            +MAPE   + V++V+SDV+S+G+LL EI S
Sbjct: 199 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 59/104 (56%), Gaps = 4/104 (3%)
Query: 319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE 378
           KR I +I    + L + H++    +IHRD+K +N+++      K+ DFG+AR  + + N 
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 379 A-NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              T  V GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 59/104 (56%), Gaps = 4/104 (3%)
Query: 319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE 378
           KR I +I    + L + H++    +IHRD+K +N+++      K+ DFG+AR  + + N 
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 379 A-NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              T  V GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 59/104 (56%), Gaps = 4/104 (3%)
Query: 319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE 378
           KR I +I    + L + H++    +IHRD+K +N+++      K+ DFG+AR  + + N 
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 379 A-NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              T  V GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 59/104 (56%), Gaps = 4/104 (3%)
Query: 319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE 378
           KR I +I    + L + H++    +IHRD+K +N+++      K+ DFG+AR  + + N 
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 379 A-NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              T  V GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 59/105 (56%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                NT        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 26/179 (14%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I +   IA G+ YL+     + +HRDL   N ++ H+   KI DFGM R    +  E + 
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDX 185
Query: 382 NRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
            R  G       +MAPE   +GVF+  SD++SFGV+L EI S       Y     + +L 
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLK 243
Query: 438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD 496
           +       G  L+  D      C +    +   +  +C Q +P  RP    +V +L  D
Sbjct: 244 FV----MDGGYLDQPD-----NCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/107 (39%), Positives = 60/107 (56%), Gaps = 11/107 (10%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL +LH      +++RDLK  N+LLD + + KI+DFGM +       +A TN   GT
Sbjct: 128 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGT 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
             Y+APE  +   ++   D +SFGVLL E++ G+  S F    HGQ 
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPF----HGQD 223

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I+  N I  G+ + H+   +R++HRD+K  N+L+D     KI DFG+A+  S   +   T
Sbjct: 114 INFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQT 169
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           N V GT  Y +PE A        +D++S G++L E++ G+
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D   G  L+ +  +   + +A+G+ +L   +    IHRD+   NVLL +    KI DFG+
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           AR    + N            +MAPE   + V++V+SDV+S+G+LL EI S
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 59/104 (56%), Gaps = 4/104 (3%)
Query: 319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE 378
           KR I +I    + L + H++    +IHRD+K +N+++      K+ DFG+AR  + + N 
Sbjct: 133 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 189
Query: 379 A-NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
              T  V GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 18/175 (10%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I +   IA G+ YL+     + +HRDL   N ++ H+   KI DFGM R           
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 186
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK 441
            +      +MAPE   +GVF+  SD++SFGV+L EI S       Y     + +L +   
Sbjct: 187 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV-- 242
Query: 442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD 496
               G  L+  D      C +    +   +  +C Q +P  RP    +V +L  D
Sbjct: 243 --MDGGYLDQPD-----NCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 286

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/107 (39%), Positives = 60/107 (56%), Gaps = 11/107 (10%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL +LH      +++RDLK  N+LLD + + KI+DFGM +       +A TN   GT
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGT 181
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
             Y+APE  +   ++   D +SFGVLL E++ G+  S F    HGQ 
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPF----HGQD 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 3/98 (3%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I +   IA G+ YL+     + +HRDL   N ++ H+   KI DFGM R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            +      +MAPE   +GVF+  SD++SFGV+L EI S
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + RGL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 118 KVSI--AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 169
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YMAPE      +SV+SD++S G+ L+E+  G+
Sbjct: 170 ANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 62/114 (54%), Gaps = 4/114 (3%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHE--DSRLRVIHRDLKTSNVLLDHEMNPKI 363
           I K + +   LD +  + ++  +   L   H   D    V+HRDLK +NV LD + N K+
Sbjct: 98  ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157
Query: 364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
            DFG+ARI + + + A T    GT  YM+PE      ++ KSD++S G LL E+
Sbjct: 158 GDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 64/107 (59%), Gaps = 4/107 (3%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           A+LD  R +   + I +G+ YL   SR R +HRDL   N+L++ E + KI+DFG+A++  
Sbjct: 106 ARLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLP 162
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            +++         +   + APE   + +FS +SDV+SFGV+L E+ +
Sbjct: 163 LDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG+AR+  
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE 198
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 255
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 256 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 492 ML 493
           +L
Sbjct: 303 IL 304

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL  K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 203 IDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 58/94 (61%), Gaps = 8/94 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL ++H  +R  V++RDLK +N+LLD   + +ISD G+A  FS  +  A+     GT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 353
Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISG 420
           +GYMAPE   +GV +   +D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 58/94 (61%), Gaps = 8/94 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL ++H  +R  V++RDLK +N+LLD   + +ISD G+A  FS  +  A+     GT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 353
Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISG 420
           +GYMAPE   +GV +   +D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 58/94 (61%), Gaps = 8/94 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL ++H  +R  V++RDLK +N+LLD   + +ISD G+A  FS  +  A+     GT
Sbjct: 300 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 352
Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISG 420
           +GYMAPE   +GV +   +D FS G +L +++ G
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 58/94 (61%), Gaps = 8/94 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL ++H  +R  V++RDLK +N+LLD   + +ISD G+A  FS  +  A+     GT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 353
Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISG 420
           +GYMAPE   +GV +   +D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 255
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 256 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 492 ML 493
           +L
Sbjct: 303 IL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 169
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 170 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 226
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 227 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 273
Query: 492 ML 493
           +L
Sbjct: 274 IL 275

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 6/142 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    + N          
Sbjct: 154 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE     V++ +SDV+S+G+ L E+ S       G  +      ++   +++   
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 270
Query: 446 GEALELMDPVLKQTCVDAELLK 467
             A   M  ++K TC DA+ LK
Sbjct: 271 EHAPAEMYDIMK-TCWDADPLK 291

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 6/142 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    + N          
Sbjct: 170 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE     V++ +SDV+S+G+ L E+ S       G  +      ++   +++   
Sbjct: 227 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 286
Query: 446 GEALELMDPVLKQTCVDAELLK 467
             A   M  ++K TC DA+ LK
Sbjct: 287 EHAPAEMYDIMK-TCWDADPLK 307

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 60/114 (52%), Gaps = 4/114 (3%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHE--DSRLRVIHRDLKTSNVLLDHEMNPKI 363
           I K + +   LD +  + ++  +   L   H   D    V+HRDLK +NV LD + N K+
Sbjct: 98  ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157
Query: 364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
            DFG+ARI   N + +      GT  YM+PE      ++ KSD++S G LL E+
Sbjct: 158 GDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL  K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 131 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 6/142 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    + N          
Sbjct: 177 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE     V++ +SDV+S+G+ L E+ S       G  +      ++   +++   
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 293
Query: 446 GEALELMDPVLKQTCVDAELLK 467
             A   M  ++K TC DA+ LK
Sbjct: 294 EHAPAEMYDIMK-TCWDADPLK 314

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 169
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 170 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 226
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 227 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 273
Query: 492 ML 493
           +L
Sbjct: 274 IL 275

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 26/179 (14%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I +   IA G+ YL+     + +HRDL   N ++ H+   KI DFGM R    +  E + 
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDY 185
Query: 382 NRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
            R  G       +MAPE   +GVF+  SD++SFGV+L EI S       Y     + +L 
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLK 243
Query: 438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD 496
           +       G  L+  D      C +    +   +  +C Q +P  RP    +V +L  D
Sbjct: 244 FV----MDGGYLDQPD-----NCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 6/142 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    + N          
Sbjct: 177 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE     V++ +SDV+S+G+ L E+ S       G  +      ++   +++   
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 293
Query: 446 GEALELMDPVLKQTCVDAELLK 467
             A   M  ++K TC DA+ LK
Sbjct: 294 EHAPAEMYDIMK-TCWDADPLK 314

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 64/107 (59%), Gaps = 4/107 (3%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           A+LD  R +   + I +G+ YL   SR R +HRDL   N+L++ E + KI+DFG+A++  
Sbjct: 122 ARLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            +++         +   + APE   + +FS +SDV+SFGV+L E+ +
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 140 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINN 196
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 197 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 142 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 198
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 199 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 255
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 256 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 492 ML 493
           +L
Sbjct: 303 IL 304

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 6/142 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    + N          
Sbjct: 172 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLWCK 445
             +MAPE     V++ +SDV+S+G+ L E+ S       G  +      ++   +++   
Sbjct: 229 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 288
Query: 446 GEALELMDPVLKQTCVDAELLK 467
             A   M  ++K TC DA+ LK
Sbjct: 289 EHAPAEMYDIMK-TCWDADPLK 309

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 130 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 186
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 187 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 243
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 244 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 290
Query: 492 ML 493
           +L
Sbjct: 291 IL 292

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 145 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 201
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 202 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 64/107 (59%), Gaps = 4/107 (3%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           A+LD  R +   + I +G+ YL   SR R +HRDL   N+L++ E + KI+DFG+A++  
Sbjct: 110 ARLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLP 166
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            +++         +   + APE   + +FS +SDV+SFGV+L E+ +
Sbjct: 167 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL  K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 135 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 191
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 192 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL  K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 64/107 (59%), Gaps = 4/107 (3%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           A+LD  R +   + I +G+ YL   SR R +HRDL   N+L++ E + KI+DFG+A++  
Sbjct: 109 ARLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLP 165
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            +++         +   + APE   + +FS +SDV+SFGV+L E+ +
Sbjct: 166 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL  K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 139 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 195
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 196 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 140 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 196
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 197 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 253
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 254 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 300
Query: 492 ML 493
           +L
Sbjct: 301 IL 302

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL  K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 138 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 194
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 195 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL  K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL  K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 255
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 256 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 492 ML 493
           +L
Sbjct: 303 IL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 255
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 256 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 492 ML 493
           +L
Sbjct: 303 IL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 255
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 256 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 492 ML 493
           +L
Sbjct: 303 IL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 255
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 256 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 492 ML 493
           +L
Sbjct: 303 IL 304

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 5/93 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A GL +LH    L +I+RDLK  N+LLD E + K++DFG+++      +E       GT
Sbjct: 139 LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGT 193
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             YMAPE       S  +D +S+GVL+ E+++G
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+  
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 255
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 256 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 492 ML 493
           +L
Sbjct: 303 IL 304

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 18/175 (10%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I +   IA G+ YL+     + +HRDL   N ++ H+   KI DFGM R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKG 189
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK 441
            +      +MAPE   +GVF+  SD++SFGV+L EI S       Y     + +L +   
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV-- 245
Query: 442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD 496
               G  L+  D      C +    +   +  +C Q +P  RP    +V +L  D
Sbjct: 246 --MDGGYLDQPD-----NCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL  K  +S    +ARG+ YL   +  + IHRDL   NVL+  +   KI+DFG+AR    
Sbjct: 187 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + +GL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 170 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 221
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 222 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DFG+AR  + 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 373
           AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG+ R+  
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 374 GNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEH 431
            +   A T R       + +PE      F+  SDV+S+G++L E++S G+R    Y    
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS 255
Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
            Q ++          E   L  P+    C  A       + L C Q+D  +RP    +V 
Sbjct: 256 NQDVIKAV------DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 492 ML 493
           +L
Sbjct: 303 IL 304

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 5/103 (4%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++ GI  G+ YL   S +  +HRDL   N+L++  +  K+SDFGM+R+   +   A T
Sbjct: 134 VGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 190
Query: 382 NRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
            R       + APE      F+  SDV+S+G+++ E++S G+R
Sbjct: 191 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 233

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 30/181 (16%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I +   IA G+ YL+     + +HRDL   N ++ H+   KI DFGM R    +  E + 
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDY 184
Query: 382 NRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
            R  G       +MAPE   +GVF+  SD++SFGV+L EI S        L+E     L+
Sbjct: 185 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------LAEQPYQGLS 236
Query: 438 --YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
                K    G  L+  D      C +    +   +  +C Q +P  RP    +V +L  
Sbjct: 237 NEQVLKFVMDGGYLDQPD-----NCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLKD 287
Query: 496 D 496
           D
Sbjct: 288 D 288

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 12/118 (10%)
Query: 301 WCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 360
           W  +R      +G +LD    + +   I +G+ Y+H     ++IHRDLK SN+ L     
Sbjct: 124 WIEKR------RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQ 174
Query: 361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
            KI DFG+    +  +N+    R  GT  YM+PE      +  + D+++ G++L E++
Sbjct: 175 VKIGDFGLV---TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + +GL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 159
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 59/111 (53%), Gaps = 13/111 (11%)
Query: 319 KRRISIINGIAR--------GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           KRR ++    AR        G+ YLH +   RVIHRDLK  N+ L+ +M+ KI DFG+A 
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT 190
Query: 371 IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
               +     T  + GT  Y+APE   +   S + D++S G +L  ++ GK
Sbjct: 191 KIEFDGERKKT--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + +GL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 135 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 186
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 63/113 (55%), Gaps = 14/113 (12%)
Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S +G++    + I     IA G+ ++ + +    IHRDL+ +N+L+   +  KI+DFG+A
Sbjct: 269 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 325
Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           R+ +                + APE    G F++KSDV+SFG+LL+EI++  R
Sbjct: 326 RVGA-----------KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + +GL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 159
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 120 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           QL  +  +   + +A+G+ +L   +    IHRD+   NVLL +    KI DFG+AR    
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 218
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           + N            +MAPE   + V++V+SDV+S+G+LL EI S
Sbjct: 219 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + +GL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 159
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + +GL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 159
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + +GL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 159
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 136 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +    IHRD+   NVLL +    KI DFG+AR    + N          
Sbjct: 173 VAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MAPE   + V++V+SDV+S+G+LL EI S
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 132 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +    IHRD+   NVLL +    KI DFG+AR    + N          
Sbjct: 173 VAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MAPE   + V++V+SDV+S+G+LL EI S
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 384
           ++ I  G+LYLH      ++HRDL  SN+LL   MN KI+DFG+A        +  T  +
Sbjct: 118 MHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--L 172
Query: 385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            GT  Y++PE A      ++SDV+S G +   ++ G+
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 160 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 5/103 (4%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++ GI  G+ YL   S +  +HRDL   N+L++  +  K+SDFGM+R+   +   A T
Sbjct: 119 VGMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 175
Query: 382 NRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
            R       + APE      F+  SDV+S+G+++ E++S G+R
Sbjct: 176 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 218

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 60/101 (59%), Gaps = 8/101 (7%)
Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + +GL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   +  
Sbjct: 111 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDEM 162
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 163 ANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 141 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 198 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           ++SI   + +GL YL E  + +++HRD+K SN+L++     K+ DFG+    SG   ++ 
Sbjct: 127 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 178
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            N   GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 179 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 127 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 130 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 5/103 (4%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++ GI  G+ YL   S +  +HRDL   N+L++  +  K+SDFGM+R+   +   A T
Sbjct: 113 VGMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 169
Query: 382 NRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
            R       + APE      F+  SDV+S+G+++ E++S G+R
Sbjct: 170 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
             ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++ 
Sbjct: 111 AERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167
Query: 373 SGNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 168 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 151 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 127 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 110 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 167 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 108 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 164
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 165 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEA 379
           ++++ I+  L YLHE+   R+IHRDLK  N++L      +  KI D G A+    +Q E 
Sbjct: 125 TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGEL 179
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
            T  V GT  Y+APE   +  ++V  D +SFG L  E I+G R
Sbjct: 180 CTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 115 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 171
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 172 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEA 379
           ++++ I+  L YLHE+   R+IHRDLK  N++L      +  KI D G A+    +Q E 
Sbjct: 126 TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGEL 180
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
            T  V GT  Y+APE   +  ++V  D +SFG L  E I+G R
Sbjct: 181 CTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 62/116 (53%), Gaps = 5/116 (4%)
Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
           R    S     L    ++ I   +A G+ YL E    + +HRDL T N L+   M  KI+
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIA 216
Query: 365 DFGMAR-IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           DFG++R I+S +  +A+ N  A    +M PE      ++ +SDV+++GV+L EI S
Sbjct: 217 DFGLSRNIYSADYYKADGND-AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 113 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 109 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 165
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 166 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 113 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 117 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 173
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 174 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 114 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 170
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 171 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 110 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 167 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 63/113 (55%), Gaps = 17/113 (15%)
Query: 319 KRRISIINGIAR--------GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA- 369
           KRR ++    AR        G+ YLH +   RVIHRDLK  N+ L+ +M+ KI DFG+A 
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT 190
Query: 370 RI-FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +I F G + +     + GT  Y+APE   +   S + D++S G +L  ++ GK
Sbjct: 191 KIEFDGERKKX----LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 116 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 172
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 173 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      +I+DFG+AR  + 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINN 209
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                 T        +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 128 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 185 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 128 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 185 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--IFSGNQNEANTNRVA 385
           IA GL +L       +I+RDLK  NV+LD E + KI+DFGM +  I+ G      T    
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFC 503
Query: 386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           GT  Y+APE      +    D ++FGVLL E+++G+
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 57/92 (61%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL +   +R++HRDL   NVL+    + KI+DFG+AR+   ++ E + +     
Sbjct: 128 IAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +   F+ +SDV+S+GV + E+++
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 63/113 (55%), Gaps = 17/113 (15%)
Query: 319 KRRISIINGIAR--------GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA- 369
           KRR ++    AR        G+ YLH +   RVIHRDLK  N+ L+ +M+ KI DFG+A 
Sbjct: 118 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT 174
Query: 370 RI-FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +I F G + +     + GT  Y+APE   +   S + D++S G +L  ++ GK
Sbjct: 175 KIEFDGERKKD----LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           +++ + +A G++YL   + L  +HRDL T N L+   +  KI DFGM+R           
Sbjct: 138 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
            R      +M PE  +   F+ +SDV+SFGV+L EI +  +   + LS
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 242

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 63/113 (55%), Gaps = 17/113 (15%)
Query: 319 KRRISIINGIAR--------GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA- 369
           KRR ++    AR        G+ YLH +   RVIHRDLK  N+ L+ +M+ KI DFG+A 
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT 190
Query: 370 RI-FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +I F G + +     + GT  Y+APE   +   S + D++S G +L  ++ GK
Sbjct: 191 KIEFDGERKKD----LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 3/98 (3%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           IS    I++G+ YL E   ++++HRDL   N+L+      KISDFG++R      +    
Sbjct: 153 ISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKR 209
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++      +MA E   + +++ +SDV+SFGVLL EI++
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   +   +  K  I +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 154
Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 155 FGLSKALRADENXYK----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++    + E +       
Sbjct: 123 IAEGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           +++ + +A G++YL   + L  +HRDL T N L+   +  KI DFGM+R           
Sbjct: 132 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
            R      +M PE  +   F+ +SDV+SFGV+L EI +  +   + LS
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 236

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 51/91 (56%), Gaps = 9/91 (9%)
Query: 336 HEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN-QNEANTNRVAGTYGYMAPE 394
           H    L++IHRD+K SN+LLD   N K+ DFG+    SG   +     R AG   YMAPE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI----SGQLVDSIAKTRDAGCRPYMAPE 195
Query: 395 Y----AMEGVFSVKSDVFSFGVLLLEIISGK 421
                A    + V+SDV+S G+ L E+ +G+
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXET 185
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 56/92 (60%), Gaps = 5/92 (5%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           + L +LH +   +VIHRD+K+ N+LL  + + K++DFG     +  Q++ +T  + GT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 181
Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 26/175 (14%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXET 176
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI +       Y     + +
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQV 234
Query: 436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           L +      +G  L+  D      C D  LL+ +    +C Q +P  RP+   ++
Sbjct: 235 LRFV----MEGGLLDKPD-----NCPDM-LLELMR---MCWQYNPKMRPSFLEII 276

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 60/100 (60%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEAN 380
           II  +  G+ Y+H+ +   ++HRDLK  N+LL+    + + KI DFG++  F   QN   
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKM 180
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            +R+ GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   +   +  K  I +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 170
Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 171 FGLSKALRADENYYK----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   +   +  K  I +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 170
Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 171 FGLSKALRADENYYK----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 60/100 (60%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEAN 380
           II  +  G+ Y+H+ +   ++HRDLK  N+LL+    + + KI DFG++  F   QN   
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKM 180
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            +R+ GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 21/174 (12%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++ GIA G+ YL   + +  +HRDL   N+L++  +  K+SDFG++R+   +  EA  
Sbjct: 150 VGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATY 205
Query: 382 NRVAGTYG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA 439
               G     + APE      F+  SDV+SFG+++ E+++      + LS H        
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------ 259
Query: 440 WKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
             +    +   L  P+    C  A       + + C Q++ A RP  + +V +L
Sbjct: 260 --MKAINDGFRLPTPM---DCPSA----IYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   +   +  K  I +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 150
Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 151 FGLSKALRADENYYK----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+ GL +LH+     +I+RDLK  NV+LD E + KI+DFGM +      +   T    GT
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGT 183
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D +++GVLL E+++G+
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++    + E +       
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++    + E +       
Sbjct: 130 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 3/98 (3%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           IS    I++G+ YL E   ++++HRDL   N+L+      KISDFG++R      +    
Sbjct: 153 ISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR 209
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++      +MA E   + +++ +SDV+SFGVLL EI++
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--IFSGNQNEANTNRVA 385
           IA GL +L       +I+RDLK  NV+LD E + KI+DFGM +  I+ G      T    
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFC 182
Query: 386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           GT  Y+APE      +    D ++FGVLL E+++G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++    + E +       
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           GL  LH   R R+++RDLK  N+LLD   + +ISD G+A      + +    RV GT GY
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGY 351
Query: 391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           MAPE      ++   D ++ G LL E+I+G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 28/193 (14%)
Query: 314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IF 372
            +L   + + I + IA G++YL   +    +HRDL T N L+   +  KI DFGM+R ++
Sbjct: 128 GELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 373 SGNQNEANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           S      +  RV G       +M PE  M   F+ +SDV+SFGV+L EI +  +   F L
Sbjct: 185 S-----TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           S       T   +   +G  LE      +      E+   +   L C Q +P  R N+  
Sbjct: 240 SN------TEVIECITQGRVLE------RPRVCPKEVYDVM---LGCWQREPQQRLNIKE 284
Query: 489 VVVMLASDTATLP 501
           +  +L +     P
Sbjct: 285 IYKILHALGKATP 297

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           +++ + +A G++YL   + L  +HRDL T N L+   +  KI DFGM+R           
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
            R      +M PE  +   F+ +SDV+SFGV+L EI +  +   + LS
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   +   +  K  I +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 154
Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 155 FGLSKALRADENYYK----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   +   +  K  I +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 168
Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 169 FGLSKALRADENYYK----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 26/179 (14%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I +   IA G+ YL+     + +HR+L   N ++ H+   KI DFGM R    +  E + 
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDY 185
Query: 382 NRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
            R  G       +MAPE   +GVF+  SD++SFGV+L EI S       Y     + +L 
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLK 243
Query: 438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD 496
           +       G  L+  D      C +    +   +  +C Q +P  RP    +V +L  D
Sbjct: 244 FV----MDGGYLDQPD-----NCPE----RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++    + E +       
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   +   +  K  I +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 148
Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 149 FGLSKALRADENYYK----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++    + E +       
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 60/103 (58%), Gaps = 5/103 (4%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++ GI+ G+ YL   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T
Sbjct: 127 VGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 183
Query: 382 NRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
            R       + APE      F+  SDV+S+G+++ E++S G+R
Sbjct: 184 TRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGER 226

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++    + E +       
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 189
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   +   +  K  I +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 160
Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 161 FGLSKALRADENYYK----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 26/179 (14%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           I +   IA G+ YL+     + +HR+L   N ++ H+   KI DFGM R    +  E + 
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDY 186
Query: 382 NRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
            R  G       +MAPE   +GVF+  SD++SFGV+L EI S       Y     + +L 
Sbjct: 187 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLK 244
Query: 438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD 496
           +       G  L+  D      C +    +   +  +C Q +P  RP    +V +L  D
Sbjct: 245 FV----MDGGYLDQPD-----NCPE----RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 290

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
           GL  LH   R R+++RDLK  N+LLD   + +ISD G+A      + +    RV GT GY
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGY 351
Query: 391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           MAPE      ++   D ++ G LL E+I+G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  L +LH    L +I+RDLK  N+LLD E + K++DFG+++      +E       GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 189
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             YMAPE       +  +D +SFGVL+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 20/179 (11%)
Query: 329 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGT 387
           ++G+ YLH      +IHRDLK  N+LL       KI DFG A      Q     N+  G+
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNK--GS 166
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE 447
             +MAPE      +S K DVFS+G++L E+I+ ++       E G       W +     
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTR 222
Query: 448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQP 506
                 P++K      E L        C  +DP+ RP+M  +V ++       P   +P
Sbjct: 223 P-----PLIKNLPKPIESLMT-----RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 20/179 (11%)
Query: 329 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGT 387
           ++G+ YLH      +IHRDLK  N+LL       KI DFG A      Q     N+  G+
Sbjct: 113 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNK--GS 167
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE 447
             +MAPE      +S K DVFS+G++L E+I+ ++       E G       W +     
Sbjct: 168 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTR 223
Query: 448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQP 506
                 P++K      E L        C  +DP+ RP+M  +V ++       P   +P
Sbjct: 224 P-----PLIKNLPKPIESLMT-----RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 272

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   +   +  K  I +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 512
Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 513 FGLSKALRADENYYK----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +NK   +   +  K  I +++ ++ G+ YL E +    +HRDL   NVLL  +   KISD
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 513
Query: 366 FGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FG+++    ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 514 FGLSKALRADENYYK----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ ++   
Sbjct: 110 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  L +LH    L +I+RDLK  N+LLD E + K++DFG+++      +E       GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 189
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             YMAPE       +  +D +SFGVL+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  L +LH    L +I+RDLK  N+LLD E + K++DFG+++      +E       GT
Sbjct: 136 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 190
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             YMAPE       +  +D +SFGVL+ E+++G
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 3/98 (3%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           IS    I++G+ YL E S   ++HRDL   N+L+      KISDFG++R      +    
Sbjct: 153 ISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKR 209
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++      +MA E   + +++ +SDV+SFGVLL EI++
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 302 CRRR--INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 359
           CRRR  +     + A  + + R   +  I  G  YLH   R RVIHRDLK  N+ L+ ++
Sbjct: 103 CRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDL 158
Query: 360 NPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             KI DFG+A     +     T  + GT  Y+APE   +   S + DV+S G ++  ++ 
Sbjct: 159 EVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 216
Query: 420 GK 421
           GK
Sbjct: 217 GK 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 302 CRRR--INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 359
           CRRR  +     + A  + + R   +  I  G  YLH   R RVIHRDLK  N+ L+ ++
Sbjct: 99  CRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDL 154
Query: 360 NPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             KI DFG+A     +     T  + GT  Y+APE   +   S + DV+S G ++  ++ 
Sbjct: 155 EVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 212
Query: 420 GK 421
           GK
Sbjct: 213 GK 214

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 56/109 (51%), Gaps = 3/109 (2%)
Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T+GA+L  K  + ++   A G+ YL        IHRDL   N L+  +   KISDFGM+R
Sbjct: 205 TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261
Query: 371 IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +     A+         + APE    G +S +SDV+SFG+LL E  S
Sbjct: 262 EEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 302 CRRR--INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 359
           CRRR  +     + A  + + R   +  I  G  YLH   R RVIHRDLK  N+ L+ ++
Sbjct: 99  CRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDL 154
Query: 360 NPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             KI DFG+A     +     T  + GT  Y+APE   +   S + DV+S G ++  ++ 
Sbjct: 155 EVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 212
Query: 420 GK 421
           GK
Sbjct: 213 GK 214

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 59/110 (53%), Gaps = 7/110 (6%)
Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           K  +LD K    +   I  G+ Y H   R  V+HRDLK  NVLLD  MN KI+DFG++ +
Sbjct: 109 KNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165
Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFS-VKSDVFSFGVLLLEIISG 420
            S  +    +    G+  Y APE     +++  + D++S GV+L  ++ G
Sbjct: 166 MSDGEFLRXS---CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 60/100 (60%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEAN 380
           II  +  G+ Y+H+ +   ++HRDLK  N+LL+    + + KI DFG++  F   QN   
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKM 180
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            +R+ GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 12/100 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA-RIFSGNQNEANTNRVAG 386
           I + L YL E  +  VIHRD+K SN+LLD     K+ DFG++ R+     ++   +R AG
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRSAG 186
Query: 387 TYGYMAPEY-----AMEGVFSVKSDVFSFGVLLLEIISGK 421
              YMAPE        +  + +++DV+S G+ L+E+ +G+
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEAN 380
           II  +  G+ Y+H++   +++HRDLK  N+LL+    + N +I DFG++  F  ++   +
Sbjct: 137 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 193
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 194 K---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 59/119 (49%), Gaps = 7/119 (5%)
Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           R  + K+  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      K
Sbjct: 97  RGEVYKELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 153
Query: 363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           I+DFG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 154 IADFG----WSVHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL   +  + +HRDL   N +LD +   K++DFG+AR     +  +  N+    
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAK 197
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           + L +LH +   +VIHRD+K+ N+LL  + + K++DFG     +  Q  +  + + GT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSEMVGTPY 181
Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 59/119 (49%), Gaps = 7/119 (5%)
Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           R  + K+  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      K
Sbjct: 97  RGEVYKELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 153
Query: 363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           I+DFG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 154 IADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 62/113 (54%), Gaps = 5/113 (4%)
Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
           D     +L+ ++  ++   + + L YLH      VIHRD+K+ ++LL  +   K+SDFG 
Sbjct: 131 DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGF 187
Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
               S  ++      + GT  +MAPE     +++ + D++S G++++E++ G+
Sbjct: 188 CAQIS--KDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 129 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 181
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI
Sbjct: 182 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 185
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI
Sbjct: 186 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 184
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 191
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 56/109 (51%), Gaps = 3/109 (2%)
Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T+GA+L  K  + ++   A G+ YL        IHRDL   N L+  +   KISDFGM+R
Sbjct: 205 TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261
Query: 371 IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +     A+         + APE    G +S +SDV+SFG+LL E  S
Sbjct: 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 178
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 191
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 130 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 182
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI
Sbjct: 183 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/79 (41%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 344 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSV 403
           +HRDL   NVL+  +   K+SDFG+ +  S  Q+            + APE   E  FS 
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREAAFST 184
Query: 404 KSDVFSFGVLLLEIISGKR 422
           KSDV+SFG+LL EI S  R
Sbjct: 185 KSDVWSFGILLWEIYSFGR 203

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 298 SFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD- 356
            FV C    ++   K   + W  ++ ++  IA G+ Y+ ++    ++HRDL++ N+ L  
Sbjct: 101 EFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQS 159
Query: 357 -HEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY--AMEGVFSVKSDVFSF 410
             E  P   K++DFG+++     Q+  + + + G + +MAPE   A E  ++ K+D +SF
Sbjct: 160 LDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214
Query: 411 GVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH 470
            ++L  I++G+        E+    + +   +  +G     + P + + C    L   I 
Sbjct: 215 AMILYTILTGEGP----FDEYSYGKIKFINMIREEG-----LRPTIPEDC-PPRLRNVIE 264
Query: 471 IGLLCVQEDPAHRPNMSSVVVMLAS 495
              LC   DP  RP+ S +V  L+ 
Sbjct: 265 ---LCWSGDPKKRPHFSYIVKELSE 286

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           + L +LH +   +VIHRD+K+ N+LL  + + K++DFG     +  Q++ +   + GT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPY 181
Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 184
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEAN 380
           II  +  G+ Y+H++   +++HRDLK  N+LL+    + N +I DFG++  F  ++   +
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 188 K---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 61/105 (58%), Gaps = 7/105 (6%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN- 380
           + ++ GIA G+ YL E   +  +HRDL   N+L++  +  K+SDFG++R    N ++   
Sbjct: 119 VGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY 175
Query: 381 TNRVAGTYG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
           T+ + G     + APE      F+  SD +S+G+++ E++S G+R
Sbjct: 176 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGER 220

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           + L +LH +   +VIHRD+K+ N+LL  + + K++DFG     +  Q  +  + + GT  
Sbjct: 128 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSXMVGTPY 182
Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 56/92 (60%), Gaps = 5/92 (5%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           + L +LH +   +VIHR++K+ N+LL  + + K++DFG     +  Q++ +T  + GT  
Sbjct: 128 QALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 182
Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 60/118 (50%), Gaps = 12/118 (10%)
Query: 301 WCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 360
           W  +R      +G +LD    + +   I +G+ Y+H     ++I+RDLK SN+ L     
Sbjct: 110 WIEKR------RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160
Query: 361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
            KI DFG+    +  +N+    R  GT  YM+PE      +  + D+++ G++L E++
Sbjct: 161 VKIGDFGLV---TSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N ++  +   KI DFGM R    +  E 
Sbjct: 161 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 213
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI
Sbjct: 214 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++D  + +   + I +G+ YL      R IHR+L T N+L+++E   KI DFG+ ++   
Sbjct: 111 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ 167
Query: 375 NQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++          +   + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 168 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 150 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 202
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 203 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 258
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 259 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 303

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 135 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 187
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 188 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 243
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 244 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 288

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 266
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 267 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 196
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 252
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 253 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 266
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 267 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 77/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 184 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 236
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A   R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 292
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 293 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 337

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 61/105 (58%), Gaps = 7/105 (6%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-AN 380
           + ++ GIA G+ YL E   +  +HRDL   N+L++  +  K+SDFG++R    N ++   
Sbjct: 121 VGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE 177
Query: 381 TNRVAGTYG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
           T+ + G     + APE      F+  SD +S+G+++ E++S G+R
Sbjct: 178 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGER 222

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L YLHE     +I+RDLK  NVLLD E + K++D+GM +   G +    T+   GT
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 184
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 196
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 252
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 253 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 266
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 267 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 160 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 212
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 213 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 268
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 269 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 313

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEAN 380
           II  +  G+ Y H++   +++HRDLK  N+LL+    + N +I DFG++  F  ++   +
Sbjct: 131 IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKD 187
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 188 K---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 143 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 195
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 251
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 252 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 296

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 77/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 161 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 213
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A   R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 214 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 269
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 270 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 314

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEAN 380
           II  +  G+ Y+H++   +++HRDLK  N+LL+    + N +I DFG++  F  ++   +
Sbjct: 154 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 210
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 211 K---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 143 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 195
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 251
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 252 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 296

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 151
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 152 FG----WSVHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 152
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +  + + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 153 FG----WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMAR    +   
Sbjct: 170 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 222
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 223 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 278
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 279 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 323

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEAN 380
           II  +  G+ Y+H++   +++HRDLK  N+LL+    + N +I DFG++  F  ++   +
Sbjct: 155 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 211
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 212 K---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L YLHE     +I+RDLK  NVLLD E + K++D+GM +   G +    T+   GT
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 173
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L YLHE     +I+RDLK  NVLLD E + K++D+GM +   G +    T+   GT
Sbjct: 115 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 169
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 177
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +  + + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 178 FG----WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFS 373
           +L   + + I   IA G++YL   +    +HRDL T N L+   +  KI DFGM+R ++S
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 180
Query: 374 GNQNEANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
                 +  RV G       +M PE  M   F+ +SDV+S GV+L EI +  +   + LS
Sbjct: 181 -----TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235
Query: 430 EHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
            +          + C  +   L  P   +TC      +   + L C Q +P  R N+  +
Sbjct: 236 NNE--------VIECITQGRVLQRP---RTCPQ----EVYELMLGCWQREPHMRKNIKGI 280
Query: 490 VVMLASDTATLP 501
             +L +     P
Sbjct: 281 HTLLQNLAKASP 292

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL   +  + +HRDL   N +LD +   K++DFG+AR     +  +  N+    
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL   +  + +HRDL   N +LD +   K++DFG+AR     +  +  N+    
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 197
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL   +  + +HRDL   N +LD +   K++DFG+AR     +  +  N+    
Sbjct: 134 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL   +  + +HRDL   N +LD +   K++DFG+AR     +  +  N+    
Sbjct: 137 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 26/175 (14%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 379
           + I +   IA G+ YL+ +   + +HRDL   N  +  +   KI DFGM R    +  E 
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYET 178
Query: 380 NTNRVAGT----YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
           +  R  G       +M+PE   +GVF+  SDV+SFGV+L EI +       Y     + +
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQV 236
Query: 436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           L +      +G  L+  D      C D  LL+ +    +C Q +P  RP+   ++
Sbjct: 237 LRFV----MEGGLLDKPD-----NCPDM-LLELMR---MCWQYNPKMRPSFLEII 278

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL   +  + +HRDL   N +LD +   K++DFG+AR     +  +  N+    
Sbjct: 140 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL   +  + +HRDL   N +LD +   K++DFG+AR     +  +  N+    
Sbjct: 139 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L YLHE     +I+RDLK  NVLLD E + K++D+GM +   G +    T+   GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 216
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 64/124 (51%), Gaps = 12/124 (9%)
Query: 302 CRRR--INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 359
           CRRR  +     + A  + + R   +  I  G  YLH   R RVIHRDLK  N+ L+ ++
Sbjct: 123 CRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDL 178
Query: 360 NPKISDFGMARI--FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
             KI DFG+A    + G + +     + GT  Y+APE   +   S + DV+S G ++  +
Sbjct: 179 EVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234
Query: 418 ISGK 421
           + GK
Sbjct: 235 LVGK 238

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL   +  + +HRDL   N +LD +   K++DFG+AR     +  +  N+    
Sbjct: 161 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 217
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 152
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    ++GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 153 FG----WSCHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL   +  + +HRDL   N +LD +   K++DFG+AR     +  +  N+    
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 64/124 (51%), Gaps = 12/124 (9%)
Query: 302 CRRR--INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 359
           CRRR  +     + A  + + R   +  I  G  YLH   R RVIHRDLK  N+ L+ ++
Sbjct: 97  CRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDL 152
Query: 360 NPKISDFGMARI--FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
             KI DFG+A    + G + +     + GT  Y+APE   +   S + DV+S G ++  +
Sbjct: 153 EVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 208
Query: 418 ISGK 421
           + GK
Sbjct: 209 LVGK 212

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 64/124 (51%), Gaps = 12/124 (9%)
Query: 302 CRRR--INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 359
           CRRR  +     + A  + + R   +  I  G  YLH   R RVIHRDLK  N+ L+ ++
Sbjct: 121 CRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDL 176
Query: 360 NPKISDFGMARI--FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
             KI DFG+A    + G + +     + GT  Y+APE   +   S + DV+S G ++  +
Sbjct: 177 EVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 232
Query: 418 ISGK 421
           + GK
Sbjct: 233 LVGK 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + +HRDL   N +LD +   K++DFG+AR     + ++  N+    
Sbjct: 140 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 196
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ YL   +  + +HRDL   N +LD +   K++DFG+AR     +  +  N+    
Sbjct: 160 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 216
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           ++ +G  +GL YLH  +   +IHRD+K  N+LL      K+ DFG A I       A  N
Sbjct: 158 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 208
Query: 383 RVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
              GT  +MAPE  +   EG +  K DV+S G+  +E+   K
Sbjct: 209 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEAN 380
           II  +  G+ YLH+ +   ++HRDLK  N+LL+ +      KI DFG++ +F   +N+  
Sbjct: 141 IIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKK 194
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                GT  Y+APE  +   +  K DV+S GV+L  +++G
Sbjct: 195 MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           ++ +G  +GL YLH  +   +IHRD+K  N+LL      K+ DFG A I       A  N
Sbjct: 119 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169
Query: 383 RVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGK 421
              GT  +MAPE  +   EG +  K DV+S G+  +E+   K
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 154
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +  + + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 FG----WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/79 (41%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 344 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSV 403
           +HRDL   NVL+  +   K+SDFG+ +  S  Q+            + APE   E  FS 
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFST 365
Query: 404 KSDVFSFGVLLLEIISGKR 422
           KSDV+SFG+LL EI S  R
Sbjct: 366 KSDVWSFGILLWEIYSFGR 384

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + +HRDL   N +LD +   K++DFG+AR     + ++  N+    
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + +HRDL   N +LD +   K++DFG+AR     + ++  N+    
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 154
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 151
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 152 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + +HRDL   N +LD +   K++DFG+AR     + ++  N+    
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 199
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 298 SFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD- 356
            FV C    ++   K   + W  ++ ++  IA G+ Y+ ++    ++HRDL++ N+ L  
Sbjct: 101 EFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQS 159
Query: 357 -HEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY--AMEGVFSVKSDVFSF 410
             E  P   K++DFG ++     Q+  + + + G + +MAPE   A E  ++ K+D +SF
Sbjct: 160 LDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214
Query: 411 GVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH 470
            ++L  I++G+        E+    + +   +  +G     + P + + C    L   I 
Sbjct: 215 AMILYTILTGEGP----FDEYSYGKIKFINMIREEG-----LRPTIPEDC-PPRLRNVIE 264
Query: 471 IGLLCVQEDPAHRPNMSSVVVMLAS 495
              LC   DP  RP+ S +V  L+ 
Sbjct: 265 ---LCWSGDPKKRPHFSYIVKELSE 286

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + +HRDL   N +LD +   K++DFG+AR     + ++  N+    
Sbjct: 201 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + +HRDL   N +LD +   K++DFG+AR     + ++  N+    
Sbjct: 147 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 203
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A+G+ +L   +  + +HRDL   N +LD +   K++DFG+AR     + ++  N+    
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAK 199
Query: 388 Y--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 100 VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 156
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 157 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 151
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 152 FG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/79 (41%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 344 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSV 403
           +HRDL   NVL+  +   K+SDFG+ +  S  Q+            + APE   E  FS 
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFST 178
Query: 404 KSDVFSFGVLLLEIISGKR 422
           KSDV+SFG+LL EI S  R
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + RGL +LH     RV+HRDLK  N+L+      K++DFG+ARI+S    +     V  T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVT 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  ++  ++   D++S G +  E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 177
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 178 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 151
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 152 FG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 152
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 153 FG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 97  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 153
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 154 FG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 151
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 152 FG----WSVHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ YL E S   VIHRDL   N L+      K+SDFGM R    +Q  ++T      
Sbjct: 112 VCEGMAYLEEAS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFP 167
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + +PE      +S KSDV+SFGVL+ E+ S
Sbjct: 168 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/79 (41%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 344 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSV 403
           +HRDL   NVL+  +   K+SDFG+ +  S  Q+            + APE   E  FS 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFST 193
Query: 404 KSDVFSFGVLLLEIISGKR 422
           KSDV+SFG+LL EI S  R
Sbjct: 194 KSDVWSFGILLWEIYSFGR 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + RGL +LH     RV+HRDLK  N+L+      K++DFG+ARI+S    +     V  T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVT 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  ++  ++   D++S G +  E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + RGL +LH     RV+HRDLK  N+L+      K++DFG+ARI+S    +     V  T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVT 182
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  ++  ++   D++S G +  E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 92  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 148
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 149 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 94  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 150
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 151 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 100 VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 156
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 157 FG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 112 VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 168
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 169 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 59/105 (56%), Gaps = 7/105 (6%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++ GIA G+ YL +   +  +HRDL   N+L++  +  K+SDFG++R    + ++   
Sbjct: 138 VGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 194
Query: 382 NRVAG---TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
               G      + APE      F+  SDV+S+G+++ E++S G+R
Sbjct: 195 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 239

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 61/107 (57%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +++ K+++     I +G+ YL   SR + +HRDL   NVL++ E   KI DFG+ +    
Sbjct: 122 KINLKQQLKYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 375 NQNE--ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++       +R +  + Y APE  M+  F + SDV+SFGV L E+++
Sbjct: 179 DKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 154
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 151
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 152 FG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 99  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 155
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 156 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 154
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 FG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 61/107 (57%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +++ K+++     I +G+ YL   SR + +HRDL   NVL++ E   KI DFG+ +    
Sbjct: 110 KINLKQQLKYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 166
Query: 375 NQNE--ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++       +R +  + Y APE  M+  F + SDV+SFGV L E+++
Sbjct: 167 DKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 29/170 (17%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +ARG+ YL   S+ + IHRDL   N+L+      KI+DFG++R       E    +  G 
Sbjct: 141 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 192
Query: 388 YG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLW 443
               +MA E     V++  SDV+S+GVLL EI+S  G    G   +E  + L        
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------- 244
Query: 444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
            +G  LE      K    D E+   +     C +E P  RP+ + ++V L
Sbjct: 245 PQGYRLE------KPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSL 285

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 154
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 FG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 151
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 152 FG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 57/116 (49%), Gaps = 10/116 (8%)
Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           +TKG  L  +    I   I RGL +LH+    +VIHRD+K  NVLL      K+ DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAM-----EGVFSVKSDVFSFGVLLLEIISG 420
                     NT    GT  +MAPE        +  +  KSD++S G+  +E+  G
Sbjct: 177 AQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 29/170 (17%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +ARG+ YL   S+ + IHRDL   N+L+      KI+DFG++R       E    +  G 
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 202
Query: 388 YG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLW 443
               +MA E     V++  SDV+S+GVLL EI+S  G    G   +E  + L        
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------- 254
Query: 444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
            +G  LE      K    D E+   +     C +E P  RP+ + ++V L
Sbjct: 255 PQGYRLE------KPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSL 295

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 57/116 (49%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 100 VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 156
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE         K D++S GVL  E + GK
Sbjct: 157 FG----WSVHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           + +   IA G  YL E+     IHRD+   N LL         KI DFGMA+    +   
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYR 196
Query: 379 ANTNRVAG----TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF--YLSEHG 432
           A+  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S     G+  Y S+  
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN 252
Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           Q +L +         +   MDP   + C          I   C Q  P  RPN + ++
Sbjct: 253 QEVLEFV-------TSGGRMDP--PKNCPGP----VYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 139 ISSAMEYLEKKN---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAG-AKFP 194
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 195 IKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 139 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 130 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 60/104 (57%), Gaps = 7/104 (6%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++ GIA G+ YL +   +  +HRDL   N+L++  +  K+SDFG++R+   +  EA  
Sbjct: 148 VGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVY 203
Query: 382 NRVAGTYG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
               G     + APE      F+  SDV+S+G+++ E++S G+R
Sbjct: 204 TTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 247

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 56/99 (56%), Gaps = 6/99 (6%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
            +++ ++ G+ YL E +    +HRDL   NVLL +    KISDFG+++   G  +   T 
Sbjct: 114 ELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTA 169
Query: 383 RVAGTY--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           R AG +   + APE      FS +SDV+S+GV + E +S
Sbjct: 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 125 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG-AKFP 180
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 141 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVAG 386
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +          
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 387 TYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
           T  Y APE  +      KS D++S G +L E++S +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 319 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQN 377
           K  IS    +ARG+ YL E    + +HRDL   N +LD     K++DFG+AR I      
Sbjct: 124 KDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180
Query: 378 EANTNRVAG-TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +R A     + A E      F+ KSDV+SFGVLL E+++
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 118 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG-AKFP 173
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 121 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG-AKFP 176
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 55/97 (56%), Gaps = 7/97 (7%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN--TNRVA 385
           I RGL Y+H  +   V+HRDLK SN+L++   + KI DFG+ARI     +     T  VA
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 386 GTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
            T  Y APE  +      KS D++S G +L E++S +
Sbjct: 210 -TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 298 SFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD- 356
            FV C    ++   K   + W  ++ ++  IA G+ Y+ ++    ++HRDL++ N+ L  
Sbjct: 101 EFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQS 159
Query: 357 -HEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY--AMEGVFSVKSDVFSF 410
             E  P   K++DF +++     Q+  + + + G + +MAPE   A E  ++ K+D +SF
Sbjct: 160 LDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214
Query: 411 GVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH 470
            ++L  I++G+        E+    + +   +  +G     + P + + C    L   I 
Sbjct: 215 AMILYTILTGEGP----FDEYSYGKIKFINMIREEG-----LRPTIPEDC-PPRLRNVIE 264
Query: 471 IGLLCVQEDPAHRPNMSSVVVMLAS 495
              LC   DP  RP+ S +V  L+ 
Sbjct: 265 ---LCWSGDPKKRPHFSYIVKELSE 286

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 118 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG-AKFP 173
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 59/97 (60%), Gaps = 8/97 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +G+ YLH     ++IHRD+K SN+L+  + + KI+DFG++  F G  ++A  +   GT
Sbjct: 146 LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGT 200
Query: 388 YGYMAPEYAME--GVFSVKS-DVFSFGVLLLEIISGK 421
             +MAPE   E   +FS K+ DV++ GV L   + G+
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 125 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 180
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 66/119 (55%), Gaps = 13/119 (10%)
Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           ++ I+K  T    +  K  +SI+    + L +LH  S+L VIHRD+K SNVL++     K
Sbjct: 97  KQVIDKGQTIPEDILGKIAVSIV----KALEHLH--SKLSVIHRDVKPSNVLINALGQVK 150
Query: 363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV----FSVKSDVFSFGVLLLEI 417
           + DFG++       ++   +  AG   YMAPE     +    +SVKSD++S G+ ++E+
Sbjct: 151 MCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + HE+   +++HRDLK  N+L++     K+ DFG+AR F    N  ++  V  T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--T 171
Query: 388 YGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGK 421
             Y AP+  M    +S   D++S G +L E+I+GK
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 7/115 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 99  VYRELQKLSRFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIAD 155
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           FG    +S +   +  + + GT  Y+ PE     +   K D++S GVL  E + G
Sbjct: 156 FG----WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 125 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 180
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 124 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 179
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ YL E     VIHRDL   N L+      K+SDFGM R    +Q  ++T      
Sbjct: 113 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFP 168
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + +PE      +S KSDV+SFGVL+ E+ S
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 125 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 180
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ YL E     VIHRDL   N L+      K+SDFGM R    +Q  ++T      
Sbjct: 115 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFP 170
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + +PE      +S KSDV+SFGVL+ E+ S
Sbjct: 171 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI++
Sbjct: 97  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAN 153
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 154 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 125 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 180
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 122 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 177
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 122 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 177
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 133 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 188
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 189 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++NGIA    Y H+    RV+HRDLK  N+L++ E   KI+DFG+AR F G      T
Sbjct: 107 LQLLNGIA----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYT 158
Query: 382 NRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISG 420
           + V  T  Y AP+  M    +S   D++S G +  E+++G
Sbjct: 159 HEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++NGIA    Y H+    RV+HRDLK  N+L++ E   KI+DFG+AR F G      T
Sbjct: 107 LQLLNGIA----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYT 158
Query: 382 NRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISG 420
           + V  T  Y AP+  M    +S   D++S G +  E+++G
Sbjct: 159 HEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 6/104 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH  S   V++RDLK  N++LD + + KI+DFG+ +   G ++ A      GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 312
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 354

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ YL E     VIHRDL   N L+      K+SDFGM R    +Q  ++T      
Sbjct: 112 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFP 167
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + +PE      +S KSDV+SFGVL+ E+ S
Sbjct: 168 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVAG 386
           I  G+ YLH       IHRDL   NVLLD++   KI DFG+A+ +  G++          
Sbjct: 143 ICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDS 199
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
              + APE   E  F   SDV+SFGV L E+++
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ YL E     VIHRDL   N L+      K+SDFGM R    +Q  ++T      
Sbjct: 110 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFP 165
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + +PE      +S KSDV+SFGVL+ E+ S
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 67/120 (55%), Gaps = 15/120 (12%)
Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           ++ I+K  T    +  K  +SI+    + L +LH  S+L VIHRD+K SNVL++     K
Sbjct: 141 KQVIDKGQTIPEDILGKIAVSIV----KALEHLH--SKLSVIHRDVKPSNVLINALGQVK 194
Query: 363 ISDFGMARIFSGNQNEANTNRV-AGTYGYMAPEYAMEGV----FSVKSDVFSFGVLLLEI 417
           + DFG+    SG   ++    + AG   YMAPE     +    +SVKSD++S G+ ++E+
Sbjct: 195 MCDFGI----SGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 6/104 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH  S   V++RDLK  N++LD + + KI+DFG+ +   G ++ A      GT
Sbjct: 119 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 174
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 175 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 59/99 (59%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 211
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + +++  D++S G ++ E+++G+
Sbjct: 212 VA-TRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A+       
Sbjct: 118 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAG-AKFP 173
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 6/104 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH  S   V++RDLK  N++LD + + KI+DFG+ +   G ++ A      GT
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 315
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 316 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 357

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + RG+ + H+    R++HRDLK  N+L++ +   K++DFG+AR F G    + T+ V  T
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-T 182
Query: 388 YGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
             Y AP+  M    +S   D++S G +  E+I+GK
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     +VIHRD+K  N+LL      KI+D
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIAD 151
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 152 FG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 6/104 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH  S   V++RDLK  N++LD + + KI+DFG+ +   G ++ A      GT
Sbjct: 117 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 172
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 173 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 214

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 6/104 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH  S   V++RDLK  N++LD + + KI+DFG+ +   G ++ A      GT
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 173
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 215

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 60/121 (49%), Gaps = 12/121 (9%)
Query: 304 RRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-- 361
            RI     +G  L       ++  +   L Y H      V+H+DLK  N+L   + +P  
Sbjct: 109 ERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILF-QDTSPHS 164
Query: 362 --KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             KI DFG+A +F  +++  N    AGT  YMAPE     V + K D++S GV++  +++
Sbjct: 165 PIKIIDFGLAELFKSDEHSTNA---AGTALYMAPEVFKRDV-TFKCDIWSAGVVMYFLLT 220
Query: 420 G 420
           G
Sbjct: 221 G 221

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 57/115 (49%), Gaps = 7/115 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+D
Sbjct: 99  VYRELQKLSRFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIAD 155
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + G
Sbjct: 156 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           + ++  K ++ D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI++
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAN 154
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           FG    +S +   +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 FG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + RG+ + H+    R++HRDLK  N+L++ +   K++DFG+AR F G    + T+ V  T
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-T 182
Query: 388 YGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
             Y AP+  M    +S   D++S G +  E+I+GK
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++NGIA    Y H+    RV+HRDLK  N+L++ E   KI+DFG+AR F G      T
Sbjct: 107 LQLLNGIA----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYT 158
Query: 382 NRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISG 420
           + +  T  Y AP+  M    +S   D++S G +  E+++G
Sbjct: 159 HEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ YL E     VIHRDL   N L+      K+SDFGM R    +Q  ++T      
Sbjct: 132 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFP 187
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + +PE      +S KSDV+SFGVL+ E+ S
Sbjct: 188 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/84 (38%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY--AMEG 399
           R+IHRD+K  N+LLD   +  I+DF +A +      E     +AGT  YMAPE   + +G
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAPEMFSSRKG 191
Query: 400 V-FSVKSDVFSFGVLLLEIISGKR 422
             +S   D +S GV   E++ G+R
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
            L YLH      +I+RDLK  N+LLD   + KI+DFG A+          T  + GT  Y
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDY 169
Query: 391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           +APE      ++   D +SFG+L+ E+++G
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + R L YLH      VIHRD+K+ ++LL  +   K+SDFG     S  +       + GT
Sbjct: 150 VLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS--KEVPKRKXLVGT 204
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +MAPE      +  + D++S G++++E+I G+
Sbjct: 205 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 79/170 (46%), Gaps = 29/170 (17%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +ARG+ YL   S+ + IHR+L   N+L+      KI+DFG++R       E    +  G 
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 199
Query: 388 YG--YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSEHGQSLLTYAWKLW 443
               +MA E     V++  SDV+S+GVLL EI+S  G    G   +E  + L        
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------- 251
Query: 444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
            +G  LE      K    D E+   +     C +E P  RP+ + ++V L
Sbjct: 252 PQGYRLE------KPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL +LH +    ++HRDLK  N+L+      K++DFG+ARI+S    +   + V  T  
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVVTLW 176
Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAG 386
           I  GL YLH++   +++HRD+K  NVL++ +    KISDFG ++  +G      T    G
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTG 185
Query: 387 TYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISGK 421
           T  YMAPE   +G   +   +D++S G  ++E+ +GK
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   + Y H+    R++HRDLK  N+LLD +MN KI+DFG +  F+        +   G+
Sbjct: 120 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDTFCGS 173
Query: 388 YGYMAPE-YAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y APE +  +     + DV+S GV+L  ++SG
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A        
Sbjct: 121 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAG-AKFP 176
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS-GNQNEANTNRVAG 386
           I   + Y H+    R++HRDLK  N+LLD +MN KI+DFG +  F+ G + +A      G
Sbjct: 123 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA----FCG 175
Query: 387 TYGYMAPE-YAMEGVFSVKSDVFSFGVLLLEIISG 420
              Y APE +  +     + DV+S GV+L  ++SG
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGY 187
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 188 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/80 (41%), Positives = 49/80 (61%), Gaps = 6/80 (7%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFS-GNQNEANTNRVAGTYGYMAPE-YAMEGV 400
           ++HRDLK  N+LLD +MN KI+DFG +  F+ GN+ +A      G   Y APE +  +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKY 189
Query: 401 FSVKSDVFSFGVLLLEIISG 420
              + DV+S GV+L  ++SG
Sbjct: 190 DGPEVDVWSLGVILYTLVSG 209

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGY 187
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 188 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L +LH+     +I+RDLK  N++L+H+ + K++DFG+ +      +   T+   GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGT 184
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             YMAPE  M    +   D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHRDL   N L+      K++DFG++R+ +G+   A        
Sbjct: 122 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAG-AKFP 177
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           ++  + RGL Y+H      +IHRDLK SNV ++ +   +I DFG+AR      +E  T  
Sbjct: 128 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGY 180
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E++ GK
Sbjct: 181 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L +LH+     +I+RDLK  N++L+H+ + K++DFG+ +      +   T+   GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGT 184
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             YMAPE  M    +   D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           ++  + RGL Y+H      +IHRDLK SNV ++ +   +I DFG+AR      +E  T  
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGY 188
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E++ GK
Sbjct: 189 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGY 193
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 194 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           ++  + RGL Y+H      +IHRDLK SNV ++ +   +I DFG+AR      +E  T  
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGY 188
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E++ GK
Sbjct: 189 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGX 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL +LH +    ++HRDLK  N+L+      K++DFG+ARI+S     A    V  T  
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVVTLW 176
Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 6/99 (6%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
            +++ ++ G+ YL E +    +HR+L   NVLL +    KISDFG+++   G  +   T 
Sbjct: 440 ELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTA 495
Query: 383 RVAGTY--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           R AG +   + APE      FS +SDV+S+GV + E +S
Sbjct: 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 58/105 (55%), Gaps = 7/105 (6%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 381
           + ++ GIA G+ YL +   +  +HR L   N+L++  +  K+SDFG++R    + ++   
Sbjct: 112 VGMLRGIAAGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 168
Query: 382 NRVAG---TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
               G      + APE      F+  SDV+S+G+++ E++S G+R
Sbjct: 169 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 213

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 49/80 (61%), Gaps = 6/80 (7%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFS-GNQNEANTNRVAGTYGYMAPE-YAMEGV 400
           ++HRDLK  N+LLD +MN KI+DFG +  F+ GN+     +   G+  Y APE +  +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDEFCGSPPYAAPELFQGKKY 189
Query: 401 FSVKSDVFSFGVLLLEIISG 420
              + DV+S GV+L  ++SG
Sbjct: 190 DGPEVDVWSLGVILYTLVSG 209

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL +LH +    ++HRDLK  N+L+      K++DFG+ARI+S    +     V  T  
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALTPVVVTLW 184
Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAG 386
           I  GL YLH++   +++HRD+K  NVL++ +    KISDFG ++  +G      T    G
Sbjct: 117 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTG 171
Query: 387 TYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISGK 421
           T  YMAPE   +G   +   +D++S G  ++E+ +GK
Sbjct: 172 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGY 184
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 185 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGY 188
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 189 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 179
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 180 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           R  + K+  K  + D +R  + +  +A  L Y HE    +VIHRD+K  N+L+ ++   K
Sbjct: 98  RGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 154
Query: 363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           I+DFG    +S +        + GT  Y+ PE         K D++  GVL  E + G
Sbjct: 155 IADFG----WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 4/114 (3%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 365
           +N   + G  L+  + + +   +  G+ +L      + IHRDL   N L+D ++  K+SD
Sbjct: 91  LNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSD 147
Query: 366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           FGM R    +Q  ++         + APE      +S KSDV++FG+L+ E+ S
Sbjct: 148 FGMTRYVLDDQYVSSVG-TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 128 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 180
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 181 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 178
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 179 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 189
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 190 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 178
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 179 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 178
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 179 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 179
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 180 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 187
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 188 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 129 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 181
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 187
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 188 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHR+L   N L+      K++DFG++R+ +G+   A+       
Sbjct: 327 ISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 382
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE 447
             + APE      FS+KSDV++FGVLL EI +      + +S +    L+  ++L  K  
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDY 436
Query: 448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
            +E       + C +    K   +   C Q +P+ RP+ + +
Sbjct: 437 RME-----RPEGCPE----KVYELMRACWQWNPSDRPSFAEI 469

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 184
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 185 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           R  + K+  K  + D +R  + +  +A  L Y HE    +VIHRD+K  N+L+ ++   K
Sbjct: 99  RGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 155
Query: 363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           I+DFG    +S +        + GT  Y+ PE         K D++  GVL  E + G
Sbjct: 156 IADFG----WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 184
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 185 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVAG 386
           I  G+ YLH       IHR+L   NVLLD++   KI DFG+A+ +  G++          
Sbjct: 126 ICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
              + APE   E  F   SDV+SFGV L E+++
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 184
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 185 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 140 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 192
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 193 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 194
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 195 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 194
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 195 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 49/80 (61%), Gaps = 6/80 (7%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFS-GNQNEANTNRVAGTYGYMAPE-YAMEGV 400
           ++HRDLK  N+LLD +MN KI+DFG +  F+ GN+     +   G+  Y APE +  +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKY 189
Query: 401 FSVKSDVFSFGVLLLEIISG 420
              + DV+S GV+L  ++SG
Sbjct: 190 DGPEVDVWSLGVILYTLVSG 209

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 188
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 189 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 194
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 195 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 49/80 (61%), Gaps = 6/80 (7%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFS-GNQNEANTNRVAGTYGYMAPE-YAMEGV 400
           ++HRDLK  N+LLD +MN KI+DFG +  F+ GN+     +   G+  Y APE +  +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKY 189
Query: 401 FSVKSDVFSFGVLLLEIISG 420
              + DV+S GV+L  ++SG
Sbjct: 190 DGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 49/80 (61%), Gaps = 6/80 (7%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFS-GNQNEANTNRVAGTYGYMAPE-YAMEGV 400
           ++HRDLK  N+LLD +MN KI+DFG +  F+ GN+     +   G+  Y APE +  +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKY 189
Query: 401 FSVKSDVFSFGVLLLEIISG 420
              + DV+S GV+L  ++SG
Sbjct: 190 DGPEVDVWSLGVILYTLVSG 209

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  +AGT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 188
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 189 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 193
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 194 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 201
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 202 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  + YL + +    IHR+L   N L+      K++DFG++R+ +G+   A+       
Sbjct: 366 ISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 421
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE 447
             + APE      FS+KSDV++FGVLL EI +      + +S +    L+  ++L  K  
Sbjct: 422 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDY 475
Query: 448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
            +E       + C +    K   +   C Q +P+ RP+ + +
Sbjct: 476 RME-----RPEGCPE----KVYELMRACWQWNPSDRPSFAEI 508

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 201
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 202 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 205
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 206 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 55/90 (61%), Gaps = 6/90 (6%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           +GL YLH+     ++HRDLK +N+LLD     K++DFG+A+ F G+ N A  ++V  T  
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVV-TRW 177
Query: 390 YMAPEYAMEG-VFSVKSDVFSFGVLLLEII 418
           Y APE      ++ V  D+++ G +L E++
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 202
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 203 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVAG 386
           I  G+ YLH       IHR+L   NVLLD++   KI DFG+A+ +  G++          
Sbjct: 126 ICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
              + APE   E  F   SDV+SFGV L E+++
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 202
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 203 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 49/80 (61%), Gaps = 6/80 (7%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFS-GNQNEANTNRVAGTYGYMAPE-YAMEGV 400
           ++HRDLK  N+LLD +MN KI+DFG +  F+ GN+     +   G+  Y APE +  +  
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKY 182
Query: 401 FSVKSDVFSFGVLLLEIISG 420
              + DV+S GV+L  ++SG
Sbjct: 183 DGPEVDVWSLGVILYTLVSG 202

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 58/122 (47%), Gaps = 13/122 (10%)
Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHED-----SRLRVIHRDLKTSNVLLDHEMNPKI 363
           D  K   LD K  + +      GL +LH +      +  + HRDLK+ N+L+       I
Sbjct: 124 DYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183
Query: 364 SDFGMARIFSGNQNEANT--NRVAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLLL 415
           +D G+A  F  + NE +   N   GT  YM PE   E +        + +D++SFG++L 
Sbjct: 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243
Query: 416 EI 417
           E+
Sbjct: 244 EV 245

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 49/80 (61%), Gaps = 6/80 (7%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFS-GNQNEANTNRVAGTYGYMAPE-YAMEGV 400
           ++HRDLK  N+LLD +MN KI+DFG +  F+ GN+     +   G+  Y APE +  +  
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK----LDTFCGSPPYAAPELFQGKKY 190
Query: 401 FSVKSDVFSFGVLLLEIISG 420
              + DV+S GV+L  ++SG
Sbjct: 191 DGPEVDVWSLGVILYTLVSG 210

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    + ++  T  
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 188
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 189 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 17/131 (12%)
Query: 302 CRRRINKDSTKGA-QLDWKRR---ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 357
           CR+   KD   G   ++ + R   + I   IA  + +LH      ++HRDLK SN+    
Sbjct: 97  CRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTM 153
Query: 358 EMNPKISDFGMARIFSGNQNE----------ANTNRVAGTYGYMAPEYAMEGVFSVKSDV 407
           +   K+ DFG+      ++ E          A      GT  YM+PE      +S K D+
Sbjct: 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213
Query: 408 FSFGVLLLEII 418
           FS G++L E++
Sbjct: 214 FSLGLILFELL 224

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 327 GIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAG 386
            + + L  LH      VIHRD+K+ ++LL H+   K+SDFG     S  +       + G
Sbjct: 255 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVG 309
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  +MAPE      +  + D++S G++++E++ G+
Sbjct: 310 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 63/117 (53%), Gaps = 14/117 (11%)
Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T+   L  K   SI+  +   + +LH ++   ++HRDLK  N+LLD  M  ++SDFG   
Sbjct: 192 TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG--- 245
Query: 371 IFSGNQNEANTNR-VAGTYGYMAPEY---AMEGV---FSVKSDVFSFGVLLLEIISG 420
            FS +       R + GT GY+APE    +M+     +  + D+++ GV+L  +++G
Sbjct: 246 -FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVAG 386
           I  G+ YLH       IHR L   NVLLD++   KI DFG+A+ +  G++          
Sbjct: 121 ICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
              + APE   E  F   SDV+SFGV L E+++
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 327 GIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAG 386
            + + L  LH      VIHRD+K+ ++LL H+   K+SDFG     S  +       + G
Sbjct: 133 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVG 187
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  +MAPE      +  + D++S G++++E++ G+
Sbjct: 188 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVAG 386
           I  G+ YLH       IHR L   NVLLD++   KI DFG+A+ +  G++          
Sbjct: 120 ICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
              + APE   E  F   SDV+SFGV L E+++
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 327 GIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAG 386
            + + L  LH      VIHRD+K+ ++LL H+   K+SDFG     S  +       + G
Sbjct: 135 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVG 189
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  +MAPE      +  + D++S G++++E++ G+
Sbjct: 190 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 60/101 (59%), Gaps = 10/101 (9%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKISDFGMARIFSGNQNEA 379
           +I+  I  G+ YLH+ +   ++HRD+K  N+LL+++   +N KI DFG++  FS    + 
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDY 203
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                 GT  Y+APE  ++  ++ K DV+S GV++  ++ G
Sbjct: 204 KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 327 GIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAG 386
            + + L  LH      VIHRD+K+ ++LL H+   K+SDFG     S  +       + G
Sbjct: 124 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVG 178
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  +MAPE      +  + D++S G++++E++ G+
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL +LH +    ++HRDLK  N+L+      K++DFG+ARI+S    +     V  T  
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALFPVVVTLW 176
Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 327 GIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAG 386
            + + L  LH      VIHRD+K+ ++LL H+   K+SDFG     S  +       + G
Sbjct: 128 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVG 182
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  +MAPE      +  + D++S G++++E++ G+
Sbjct: 183 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 46/79 (58%), Gaps = 2/79 (2%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFS 402
           VIHRD+K+ ++LL H+   K+SDFG     S  +       + GT  +MAPE      + 
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKXLVGTPYWMAPELISRLPYG 248
Query: 403 VKSDVFSFGVLLLEIISGK 421
            + D++S G++++E++ G+
Sbjct: 249 PEVDIWSLGIMVIEMVDGE 267

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   K++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 14/117 (11%)
Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T+   L  K    I+  +   +  LH   +L ++HRDLK  N+LLD +MN K++DFG   
Sbjct: 103 TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG--- 156
Query: 371 IFSGNQNEANTNR-VAGTYGYMAPEYAMEGV------FSVKSDVFSFGVLLLEIISG 420
            FS   +     R V GT  Y+APE     +      +  + D++S GV++  +++G
Sbjct: 157 -FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    +  +  T  
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGY 189
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 190 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    +  +  T  
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGY 189
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 190 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR    +  +  T  
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGY 189
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 190 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 14/117 (11%)
Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T+   L  K    I+  +   +  LH   +L ++HRDLK  N+LLD +MN K++DFG   
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG--- 169
Query: 371 IFSGNQNEANTNR-VAGTYGYMAPEYAMEGV------FSVKSDVFSFGVLLLEIISG 420
            FS   +     R V GT  Y+APE     +      +  + D++S GV++  +++G
Sbjct: 170 -FSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 13/109 (11%)
Query: 322 ISIINGIARGLLYLHED-----SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG-- 374
           + I+  IA GL +LH +      +  + HRDLK+ N+L+       I+D G+A + S   
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLLLEI 417
           NQ +   N   GT  YMAPE   E +         + D+++FG++L E+
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 13/109 (11%)
Query: 322 ISIINGIARGLLYLHED-----SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG-- 374
           + I+  IA GL +LH +      +  + HRDLK+ N+L+       I+D G+A + S   
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLLLEI 417
           NQ +   N   GT  YMAPE   E +         + D+++FG++L E+
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 322 ISIINGIARGLLYLHED-----SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG-- 374
           + I+  IA GL +LH +      +  + HRDLK+ N+L+       I+D G+A + S   
Sbjct: 137 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 196
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGV----FSV--KSDVFSFGVLLLEI 417
           NQ +   N   GT  YMAPE   E +    F    + D+++FG++L E+
Sbjct: 197 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 14/117 (11%)
Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T+   L  K    I+  +   +  LH   +L ++HRDLK  N+LLD +MN K++DFG   
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG--- 169
Query: 371 IFSGNQNEANTNR-VAGTYGYMAPEYAMEGV------FSVKSDVFSFGVLLLEIISG 420
            FS   +     R V GT  Y+APE     +      +  + D++S GV++  +++G
Sbjct: 170 -FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI D+G+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   K++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   K++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   K++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+++D +   K++DFG+A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 48/80 (60%), Gaps = 6/80 (7%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFS-GNQNEANTNRVAGTYGYMAPE-YAMEGV 400
           ++HRDLK  N+LLD + N KI+DFG +  F+ GN+ +A      G   Y APE +  +  
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKY 189
Query: 401 FSVKSDVFSFGVLLLEIISG 420
              + DV+S GV+L  ++SG
Sbjct: 190 DGPEVDVWSLGVILYTLVSG 209

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 23/122 (18%)
Query: 317 DWKRRISIINGIARGLLYLH------EDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           DW     + + + RGL YLH      +  +  + HRDL + NVL+ ++    ISDFG++ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 371 IFSGN-------QNEANTNRVAGTYGYMAPEYAMEGVFSVKS--------DVFSFGVLLL 415
             +GN       ++ A  + V GT  YMAPE  +EG  +++         D+++ G++  
Sbjct: 169 RLTGNRLVRPGEEDNAAISEV-GTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 416 EI 417
           EI
Sbjct: 227 EI 228

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH  SR  V++RD+K  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 114 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 55/101 (54%), Gaps = 9/101 (8%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA 379
           ++I  +   + YLH   R+ ++HRDLK  N+L    D E    ISDFG++++  G  +  
Sbjct: 124 TLIRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EGKGDVM 179
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           +T    GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 180 ST--ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/82 (37%), Positives = 49/82 (59%), Gaps = 4/82 (4%)
Query: 340 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG 399
           R  V+HRDLK  NVLLD  MN KI+DFG++ + S  +   ++    G+  Y APE     
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISGR 185
Query: 400 VFS-VKSDVFSFGVLLLEIISG 420
           +++  + D++S GV+L  ++ G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCG 207

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH  SR  V++RD+K  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 119 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 173
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 215

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      V++RD+K  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      V++RD+K  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 210

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      V++RD+K  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 168
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR       +     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 177
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
              T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR       +     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
              T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      V++RD+K  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 168
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR       +     
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXG 201
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
              T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR       +     
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXG 204
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
              T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR       +     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
              T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      V++RD+K  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 117 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 171
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             Y+APE   +  +    D +  GV++ E++ G+    FY  +H
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 213

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 59/123 (47%), Gaps = 22/123 (17%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--------DHEMNPK-----ISDFGM 368
           IS++  IA G+ +LH    L++IHRDLK  N+L+        D +   +     ISDFG+
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 369 ARIFSGNQN--EANTNRVAGTYGYMAPEYAMEGV---FSVKSDVFSFGVLLLEIIS-GKR 422
            +     Q     N N  +GT G+ APE   E      +   D+FS G +   I+S GK 
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252
Query: 423 NSG 425
             G
Sbjct: 253 PFG 255

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 59/123 (47%), Gaps = 22/123 (17%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--------DHEMNPK-----ISDFGM 368
           IS++  IA G+ +LH    L++IHRDLK  N+L+        D +   +     ISDFG+
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 369 ARIFSGNQN--EANTNRVAGTYGYMAPEYAMEGV---FSVKSDVFSFGVLLLEIIS-GKR 422
            +     Q     N N  +GT G+ APE   E      +   D+FS G +   I+S GK 
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252
Query: 423 NSG 425
             G
Sbjct: 253 PFG 255

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+++D +   K++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLXGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +   T  V   Y Y APE  +   +    D++S GV++ E+I G
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+++D +   K++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+++D +   K++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+++D +   K++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+++D +   K++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+++D +   K++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+ R    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/82 (37%), Positives = 48/82 (58%), Gaps = 4/82 (4%)
Query: 340 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG 399
           R  V+HRDLK  NVLLD  MN KI+DFG++ + S  +    +    G+  Y APE     
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGR 185
Query: 400 VFS-VKSDVFSFGVLLLEIISG 420
           +++  + D++S GV+L  ++ G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCG 207

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +   T  V   Y Y APE  +   +    D++S GV++ E+I G
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 13/107 (12%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--- 378
           + I   IA  + +LH      ++HRDLK SN+    +   K+ DFG+      ++ E   
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 379 -------ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
                  A      GT  YM+PE      +S K D+FS G++L E++
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL E     ++HR+L   NVLL      +++DFG+A +   +  +   +     
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSE 430
             +MA E    G ++ +SDV+S+GV + E+++   +  +G  L+E
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 63/119 (52%), Gaps = 13/119 (10%)
Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           ++ I+K  T    +  K  +SI+    + L +LH  S+L VIHRD+K SNVL++     K
Sbjct: 124 KQVIDKGQTIPEDILGKIAVSIV----KALEHLH--SKLSVIHRDVKPSNVLINALGQVK 177
Query: 363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV----FSVKSDVFSFGVLLLEI 417
             DFG++       ++   +  AG   Y APE     +    +SVKSD++S G+  +E+
Sbjct: 178 XCDFGISGYLV---DDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA+G+ YL E     ++HR+L   NVLL      +++DFG+A +   +  +   +     
Sbjct: 142 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 198
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS--GKRNSGFYLSE 430
             +MA E    G ++ +SDV+S+GV + E+++   +  +G  L+E
Sbjct: 199 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 243

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 31/181 (17%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-----EMNPKISDFGMARIFS-GN 375
           I+++     GL +LH    L ++HRDLK  N+L+       ++   ISDFG+ +  + G 
Sbjct: 121 ITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 376 QNEANTNRVAGTYGYMAPEYAMEG-----VFSVKSDVFSFGVLLLEIIS-GKRNSGFYLS 429
            + +  + V GT G++APE   E       ++V  D+FS G +   +IS G    G  L 
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV--DIFSAGCVFYYVISEGSHPFGKSLQ 235
Query: 430 EHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
                LL           +L+ + P   +  +  EL++ +      +  DP  RP+   V
Sbjct: 236 RQANILLGAC--------SLDCLHPEKHEDVIARELIEKM------IAMDPQKRPSAKHV 281
Query: 490 V 490
           +
Sbjct: 282 L 282

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 202
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 29/175 (16%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGN---QNEANTNR 383
           IA G+ YL   S    IHRDL   N +L  +M   ++DFG++R I+SG+   Q  A+   
Sbjct: 146 IACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEII-------SGKRNSGFYLSEHGQSLL 436
           V     ++A E   + +++V SDV++FGV + EI+       +G  N+  Y    G + L
Sbjct: 203 VK----WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL 258
Query: 437 TYAWKLWCKGEALELM------DPVLKQ--TCVDAELLKCI-HIGLLCVQEDPAH 482
               +  C  E  +LM      DP  +   TC+  EL   + H+ +L   +DP +
Sbjct: 259 KQPPE--CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             N   T  V   Y Y APE  +   ++   D++S G ++ E++ G
Sbjct: 177 CTNFMMTPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 200
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 200
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+++D +   +++DFG+A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 6/98 (6%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 384
           +  I   L +LH   +L +I+RD+K  N+LLD   +  ++DFG+++ F  ++ E   +  
Sbjct: 165 VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-F 220
Query: 385 AGTYGYMAPEYAMEG--VFSVKSDVFSFGVLLLEIISG 420
            GT  YMAP+    G        D +S GVL+ E+++G
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 228
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 194
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 228
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAP 193
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI  FG+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAP 208
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 120 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 174
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           + N   T  V   Y Y APE  +   +    D++S G ++ E++ G
Sbjct: 175 STNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVL-LDHEMNPKI--SDFGMARIFSGNQNEAN 380
           +I  +   + YLHE+    ++HRDLK  N+L L  E N KI  +DFG++++    +    
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGI 163
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            +   GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           ++  + +GL Y+H      +IHRDLK  N+ ++ +   KI DFG+AR     Q ++    
Sbjct: 133 LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXG 184
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
              T  Y APE  +  + ++   D++S G ++ E+I+GK
Sbjct: 185 XVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI D G+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 166
Query: 388 YGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 173
Query: 388 YGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPEYLAP 228
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+++D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 165
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 65/132 (49%), Gaps = 9/132 (6%)
Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           R  + K+  K    D +R  +I+  +A  L+Y H     +VIHRD+K  N+LL  +   K
Sbjct: 107 RGELYKELQKSCTFDEQRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELK 163
Query: 363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           I+DFG    +S +        + GT  Y+ PE     + + K D++  GVL  E++ G  
Sbjct: 164 IADFG----WSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG-- 217
Query: 423 NSGFYLSEHGQS 434
           N  F  + H ++
Sbjct: 218 NPPFESASHNET 229

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 66/125 (52%), Gaps = 11/125 (8%)
Query: 304 RRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-- 361
            R +K + K  QL      S++  I  G+ YLH +    V+HRDLK +N+L+  E  P  
Sbjct: 113 HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGE-GPER 168
Query: 362 ---KISDFGMARIF-SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLE 416
              KI+D G AR+F S  +  A+ + V  T+ Y APE  +      K+ D+++ G +  E
Sbjct: 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 228
Query: 417 IISGK 421
           +++ +
Sbjct: 229 LLTSE 233

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANT 381
           I  I   +L+ H+   + V+HRDLK  N+LL  +      K++DFG+A    G+Q     
Sbjct: 109 IQQILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
              AGT GY++PE   +  +    D+++ GV+L  ++ G
Sbjct: 166 --FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 165
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI D G+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 166
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 165
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 166
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 165
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 167
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 173
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 5/80 (6%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG--YMAPEYAMEG 399
           + +HRDL   N L++ +   K+SDFG++R      ++  T+ V   +   +  PE  M  
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEETSSVGSKFPVRWSPPEVLMYS 196
Query: 400 VFSVKSDVFSFGVLLLEIIS 419
            FS KSD+++FGVL+ EI S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 166
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 10/92 (10%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
            L YLH++   ++IHRDLK  N+L   + + K++DFG++      +     +   GT  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYW 201
Query: 391 MAPEYAM-----EGVFSVKSDVFSFGVLLLEI 417
           MAPE  M     +  +  K+DV+S G+ L+E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI DF +AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 60/127 (47%), Gaps = 26/127 (20%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--------DHEMNPK-----ISDFGM 368
           IS++  IA G+ +LH    L++IHRDLK  N+L+        D +   +     ISDFG+
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 369 ARIFSGNQN--EANTNRVAGTYGYMAPEYAMEG-------VFSVKSDVFSFGVLLLEIIS 419
            +     Q+    N N  +GT G+ APE   E          +   D+FS G +   I+S
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 420 -GKRNSG 425
            GK   G
Sbjct: 235 KGKHPFG 241

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 48/76 (63%), Gaps = 4/76 (5%)
Query: 340 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG 399
           R +++HRDLK  N+LLD  +N KI+DFG++ I + + N   T+   G+  Y APE     
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYAAPEVISGK 186
Query: 400 VFS-VKSDVFSFGVLL 414
           +++  + DV+S GV+L
Sbjct: 187 LYAGPEVDVWSCGVIL 202

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+++D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 48/76 (63%), Gaps = 4/76 (5%)
Query: 340 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG 399
           R +++HRDLK  N+LLD  +N KI+DFG++ I + + N   T+   G+  Y APE     
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYAAPEVISGK 177
Query: 400 VFS-VKSDVFSFGVLL 414
           +++  + DV+S GV+L
Sbjct: 178 LYAGPEVDVWSCGVIL 193

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I  I RGL Y+H      +IHRDLK SN+ ++ +   KI D G+AR    + ++  T  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGY 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
           VA T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 183 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 48/76 (63%), Gaps = 4/76 (5%)
Query: 340 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG 399
           R +++HRDLK  N+LLD  +N KI+DFG++ I + + N   T+   G+  Y APE     
Sbjct: 125 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYAAPEVISGK 181
Query: 400 VFS-VKSDVFSFGVLL 414
           +++  + DV+S GV+L
Sbjct: 182 LYAGPEVDVWSCGVIL 197

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 170
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA  L YLH    L +++RDLK  N+LLD + +  ++DFG+ +     ++ + T+   GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGT 202
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y+APE   +  +    D +  G +L E++ G
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 52/83 (62%), Gaps = 4/83 (4%)
Query: 340 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG 399
           R +++HRDLK  N+LLD  +N KI+DFG++ I + + N   T+   G+  Y APE     
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYAAPEVINGK 182
Query: 400 VFS-VKSDVFSFGVLLLEIISGK 421
           +++  + DV+S G++L  ++ G+
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 48/76 (63%), Gaps = 4/76 (5%)
Query: 340 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG 399
           R +++HRDLK  N+LLD  +N KI+DFG++ I + + N   T+   G+  Y APE     
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYAAPEVISGK 187
Query: 400 VFS-VKSDVFSFGVLL 414
           +++  + DV+S GV+L
Sbjct: 188 LYAGPEVDVWSCGVIL 203

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 10/92 (10%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
            L YLH++   ++IHRDLK  N+L   + + K++DFG++      +     +   GT  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYW 201
Query: 391 MAPEYAM-----EGVFSVKSDVFSFGVLLLEI 417
           MAPE  M     +  +  K+DV+S G+ L+E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           LDW  +I +       L ++H+    +++HRD+K+ N+ L  +   ++ DFG+AR+ +  
Sbjct: 128 LDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178
Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
              A      GT  Y++PE      ++ KSD+++ G +L E+
Sbjct: 179 VELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 10/92 (10%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY 390
            L YLH++   ++IHRDLK  N+L   + + K++DFG++      +     +   GT  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYW 201
Query: 391 MAPEYAM-----EGVFSVKSDVFSFGVLLLEI 417
           MAPE  M     +  +  K+DV+S G+ L+E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +   T  V   Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 GTSFMMTPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA-RIFSGNQNEANTNRVAG 386
           IA G+ YL   S    +HRDL   N +L  +M   ++DFG++ +I+SG+       R+A 
Sbjct: 156 IALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY--YRQGRIAK 210
Query: 387 T-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK 445
               ++A E   + V++ KSDV++FGV + EI +  R    Y       +  Y       
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEMYDYL----LH 264
Query: 446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLP 501
           G  L+       + C+D EL + ++    C + DP  RP  S + + L     +LP
Sbjct: 265 GHRLK-----QPEDCLD-ELYEIMYS---CWRTDPLDRPTFSVLRLQLEKLLESLP 311

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G      T+ V  T
Sbjct: 112 LLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-T 166
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT-- 381
           ++  +  GL Y+H   R +++HRD+K +NVL+  +   K++DFG+AR FS  +N      
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 382 -NRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEI 417
            NRV  T  Y  PE  + E  +    D++  G ++ E+
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANT 381
           I  I   +L+ H+   + V+HRDLK  N+LL  ++     K++DFG+A    G Q     
Sbjct: 127 IQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 183
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
              AGT GY++PE   +  +    D+++ GV+L  ++ G
Sbjct: 184 --FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF--SGNQNEANTNRVA 385
           + RGL Y+H     +VIHRDLK SN+L++     KI DFGMAR    S  +++       
Sbjct: 168 LLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 224
Query: 386 GTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKR 422
            T  Y APE  +    ++   D++S G +  E+++ ++
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT-- 381
           ++  +  GL Y+H   R +++HRD+K +NVL+  +   K++DFG+AR FS  +N      
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 382 -NRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEI 417
            NRV  T  Y  PE  + E  +    D++  G ++ E+
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 5/80 (6%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY--GYMAPEYAMEG 399
           + +HRDL   N L++ +   K+SDFG++R    ++    T+ V   +   +  PE  M  
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYS 180
Query: 400 VFSVKSDVFSFGVLLLEIIS 419
            FS KSD+++FGVL+ EI S
Sbjct: 181 KFSSKSDIWAFGVLMWEIYS 200

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT-- 381
           ++  +  GL Y+H   R +++HRD+K +NVL+  +   K++DFG+AR FS  +N      
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 382 -NRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEI 417
            NRV  T  Y  PE  + E  +    D++  G ++ E+
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT-- 381
           ++  +  GL Y+H   R +++HRD+K +NVL+  +   K++DFG+AR FS  +N      
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 382 -NRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEI 417
            NRV  T  Y  PE  + E  +    D++  G ++ E+
Sbjct: 186 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 59/127 (46%), Gaps = 26/127 (20%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--------DHEMNPK-----ISDFGM 368
           IS++  IA G+ +LH    L++IHRDLK  N+L+        D +   +     ISDFG+
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 369 ARIFSGNQN--EANTNRVAGTYGYMAPEYAMEG-------VFSVKSDVFSFGVLLLEIIS 419
            +     Q     N N  +GT G+ APE   E          +   D+FS G +   I+S
Sbjct: 175 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 420 -GKRNSG 425
            GK   G
Sbjct: 235 KGKHPFG 241

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 5/80 (6%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG--YMAPEYAMEG 399
           + +HRDL   N L++ +   K+SDFG++R      ++  T+ V   +   +  PE  M  
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 400 VFSVKSDVFSFGVLLLEIIS 419
            FS KSD+++FGVL+ EI S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 5/80 (6%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY--GYMAPEYAMEG 399
           + +HRDL   N L++ +   K+SDFG++R    ++    T+ V   +   +  PE  M  
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYS 181
Query: 400 VFSVKSDVFSFGVLLLEIIS 419
            FS KSD+++FGVL+ EI S
Sbjct: 182 KFSSKSDIWAFGVLMWEIYS 201

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 5/80 (6%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY--GYMAPEYAMEG 399
           + +HRDL   N L++ +   K+SDFG++R    ++    T+ V   +   +  PE  M  
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYS 187
Query: 400 VFSVKSDVFSFGVLLLEIIS 419
            FS KSD+++FGVL+ EI S
Sbjct: 188 KFSSKSDIWAFGVLMWEIYS 207

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +   T  V   Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 5/80 (6%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY--GYMAPEYAMEG 399
           + +HRDL   N L++ +   K+SDFG++R    ++    T+ V   +   +  PE  M  
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYS 176
Query: 400 VFSVKSDVFSFGVLLLEIIS 419
            FS KSD+++FGVL+ EI S
Sbjct: 177 KFSSKSDIWAFGVLMWEIYS 196

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF--SGNQNEANTNRVAGT 387
           RGL Y+H     +VIHRDLK SN+L++     KI DFGMAR    S  +++        T
Sbjct: 169 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKR 422
             Y APE  +    ++   D++S G +  E+++ ++
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +   T  V   Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 177
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +   T  V   Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 178 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 46/81 (56%), Gaps = 7/81 (8%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM---- 397
           R+IHRDLK  NVL+  E + +++DFG++      +     +   GT  +MAPE  M    
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 398 -EGVFSVKSDVFSFGVLLLEI 417
            +  +  K+D++S G+ L+E+
Sbjct: 187 KDTPYDYKADIWSLGITLIEM 207

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           ++  + +GL Y+H      V+HRDLK  N+ ++ +   KI DFG+AR       +A    
Sbjct: 131 LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTG 182
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
              T  Y APE  +  + ++   D++S G ++ E+++GK
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 46/81 (56%), Gaps = 7/81 (8%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM---- 397
           R+IHRDLK  NVL+  E + +++DFG++      +     +   GT  +MAPE  M    
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 398 -EGVFSVKSDVFSFGVLLLEI 417
            +  +  K+D++S G+ L+E+
Sbjct: 195 KDTPYDYKADIWSLGITLIEM 215

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
              +   ++   D ++ GVL+ E+ +G
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +   T  V   Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 115 ELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TA 169
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 170 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +   T  V   Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           ++  + +GL Y+H      V+HRDLK  N+ ++ +   KI DFG+AR       +A    
Sbjct: 149 LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTG 200
Query: 384 VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
              T  Y APE  +  + ++   D++S G ++ E+++GK
Sbjct: 201 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRV 384
           I   L Y H+++   +IHRD+K  NVLL  + N    K+ DFG+A I  G        RV
Sbjct: 139 ILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVAGGRV 194
Query: 385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            GT  +MAPE      +    DV+  GV+L  ++SG
Sbjct: 195 -GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +   T  V   Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH---EMNPKISDFGMARIFSGNQNEANT 381
           +  I   + YLHE+    ++HRDLK  N+L      +   KI+DFG+++I    +++   
Sbjct: 154 VKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLM 207
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             V GT GY APE      +  + D++S G++   ++ G
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 169
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 166
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 20/134 (14%)
Query: 301 WCRRRINKDSTKGAQLDWKRR--ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 358
           +C  R   D      L+ +R     +   I   L Y+H      +IHRDLK  N+ +D  
Sbjct: 96  YCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES 152
Query: 359 MNPKISDFGMAR--------IFSGNQN----EANTNRVAGTYGYMAPEYAMEGV--FSVK 404
            N KI DFG+A+        +   +QN      N     GT  Y+A E  ++G   ++ K
Sbjct: 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEK 211
Query: 405 SDVFSFGVLLLEII 418
            D++S G++  E+I
Sbjct: 212 IDMYSLGIIFFEMI 225

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 169
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 168
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 169
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +   T  V   Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 168
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 169
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 167
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 168
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 165
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 166
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 166
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 170
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 167
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 165
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 168
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 169
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 167
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 166
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 167
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 166
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    +S   D++S G +  E+++ +
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAG-TYGYMAPEYAMEGV 400
           + +HRDL   N L++ +   K+SDFG++R      +E  ++R +     +  PE  M   
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 401 FSVKSDVFSFGVLLLEIIS 419
           FS KSD+++FGVL+ EI S
Sbjct: 183 FSSKSDIWAFGVLMWEIYS 201

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F G       + V  T
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-T 169
Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIIS 419
             Y APE  +    +S   D++S G +  E+++
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 18/105 (17%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--------IFSGNQN-- 377
           I   L Y+H      +IHRDLK  N+ +D   N KI DFG+A+        +   +QN  
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 378 --EANTNRVAGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEII 418
               N     GT  Y+A E  ++G   ++ K D++S G++  E+I
Sbjct: 182 GSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 11/101 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVL---LDHEMNPKISDFGMARIFSGNQNEAN 380
           +I  +   + YLH+   L ++HRDLK  N+L   LD +    ISDFG++++    ++  +
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGS 173
Query: 381 TNRVA-GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               A GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 11/101 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVL---LDHEMNPKISDFGMARIFSGNQNEAN 380
           +I  +   + YLH+   L ++HRDLK  N+L   LD +    ISDFG++++    ++  +
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGS 173
Query: 381 TNRVA-GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               A GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVL---LDHEMNPKISDFGMARIFSGNQNEAN 380
           +I  +   + YLH+   L ++HRDLK  N+L   LD +    ISDFG++++       + 
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            +   GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
           YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT   +AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEALAP 207
Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISG 420
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVL---LDHEMNPKISDFGMARIFSGNQNEAN 380
           +I  +   + YLH+   L ++HRDLK  N+L   LD +    ISDFG++++       + 
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            +   GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 46/84 (54%), Gaps = 9/84 (10%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIF--SGNQNEANTNRVAG------TYGYMAPE 394
           VIHRDLK SN+L++   + K+ DFG+ARI   S   N   T + +G      T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 395 YAMEGV-FSVKSDVFSFGVLLLEI 417
             +    +S   DV+S G +L E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 46/84 (54%), Gaps = 9/84 (10%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIF--SGNQNEANTNRVAG------TYGYMAPE 394
           VIHRDLK SN+L++   + K+ DFG+ARI   S   N   T + +G      T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 395 YAMEGV-FSVKSDVFSFGVLLLEI 417
             +    +S   DV+S G +L E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 61/119 (51%), Gaps = 25/119 (21%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF----------- 372
           ++  + + + YLH      ++HRD+K SN+LL+ E + K++DFG++R F           
Sbjct: 114 VVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 373 -SGNQNEAN--------TNRVAGTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
            S N+N  N        T+ VA T  Y APE  +      K  D++S G +L EI+ GK
Sbjct: 171 LSINENTENFDDDQPILTDYVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAG 386
           +A G+ YL      R IHRDL   N+LL      KI DFG+ R    N +          
Sbjct: 124 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            + + APE      FS  SD + FGV L E+ +
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANT 381
           I  I   +L+ H+   + V+HR+LK  N+LL  ++     K++DFG+A    G Q     
Sbjct: 116 IQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
              AGT GY++PE   +  +    D+++ GV+L  ++ G
Sbjct: 173 --FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 214
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 215 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 46/84 (54%), Gaps = 9/84 (10%)
Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIF--SGNQNEANTNRVAG------TYGYMAPE 394
           VIHRDLK SN+L++   + K+ DFG+ARI   S   N   T + +G      T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 395 YAMEGV-FSVKSDVFSFGVLLLEI 417
             +    +S   DV+S G +L E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A G+ YL      R IHRDL   N+LL      KI DFG+ R    N +          
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 176
Query: 388 -YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            + + APE      FS  SD + FGV L E+ +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANT 381
           I  I   + Y H +    ++HR+LK  N+LL  +      K++DFG+A     N +EA  
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-W 164
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           +  AGT GY++PE   +  +S   D+++ GV+L  ++ G
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANT 381
           I  I   + Y H +    ++HR+LK  N+LL  +      K++DFG+A     N +EA  
Sbjct: 110 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-W 163
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           +  AGT GY++PE   +  +S   D+++ GV+L  ++ G
Sbjct: 164 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 61/110 (55%), Gaps = 16/110 (14%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH--EMNP-KISDFGMAR--IFSGNQNE 378
           ++  +A  L +LH      + HRDLK  N+L +H  +++P KI DFG+      +G+ + 
Sbjct: 116 VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSP 172
Query: 379 ANTNRV---AGTYGYMAPE----YAMEG-VFSVKSDVFSFGVLLLEIISG 420
            +T  +    G+  YMAPE    ++ E  ++  + D++S GV+L  ++SG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 9/101 (8%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVL-LDHEMNP---KISDFGMARIFSGNQNEA 379
           +++ I + + YLH      V+HRDLK SN+L +D   NP   +I DFG A+         
Sbjct: 126 VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            T     T  ++APE      +    D++S G+LL  +++G
Sbjct: 183 MTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAG 386
           +A G+ YL      R IHRDL   N+LL      KI DFG+ R    N +          
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            + + APE      FS  SD + FGV L E+ +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANT 381
           I  I   + Y H +    ++HR+LK  N+LL  +      K++DFG+A     N +EA  
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-W 164
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           +  AGT GY++PE   +  +S   D+++ GV+L  ++ G
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAG 386
           +A G+ YL      R IHRDL   N+LL      KI DFG+ R    N +          
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            + + APE      FS  SD + FGV L E+ +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAG 386
           +A G+ YL      R IHRDL   N+LL      KI DFG+ R    N +          
Sbjct: 124 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            + + APE      FS  SD + FGV L E+ +
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A G+ YL      R IHRDL   N+LL      KI DFG+ R    N +          
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 186
Query: 388 -YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            + + APE      FS  SD + FGV L E+ +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 214
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 215 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 59/118 (50%), Gaps = 17/118 (14%)
Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP----KISDFGMARIFSGNQN 377
           I +I  I  G+ YLH+++   ++H DLK  N+LL   + P    KI DFGM+R      +
Sbjct: 134 IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIG---H 186
Query: 378 EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS------GKRNSGFYLS 429
                 + GT  Y+APE       +  +D+++ G++   +++      G+ N   YL+
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 9/101 (8%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVL-LDHEMNP---KISDFGMARIFSGNQNEA 379
           +++ I + + YLH      V+HRDLK SN+L +D   NP   +I DFG A+         
Sbjct: 126 VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            T     T  ++APE      +    D++S G+LL  +++G
Sbjct: 183 MTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAG 386
           +A G+ YL      R IHRDL   N+LL      KI DFG+ R    N +          
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            + + APE      FS  SD + FGV L E+ +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 116 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 170
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 171 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 116 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 170
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 171 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 169
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 170 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 177
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 178 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 121 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 175
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 176 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 177
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 178 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           II  +     Y+H +    + HRD+K SN+L+D     K+SDFG +      + + +   
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 384 VAGTYGYMAPE-YAMEGVFS-VKSDVFSFGVLL 414
             GTY +M PE ++ E  ++  K D++S G+ L
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 12/93 (12%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGY 390
           YLHE+    +IHRDLK  NVLL  +      KI+DFG ++I  G  +   T  + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTY 182
Query: 391 MAPEYAME---GVFSVKSDVFSFGVLLLEIISG 420
           +APE  +      ++   D +S GV+L   +SG
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 12/93 (12%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGY 390
           YLHE+    +IHRDLK  NVLL  +      KI+DFG ++I  G  +   T  + GT  Y
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTY 181
Query: 391 MAPEYAME---GVFSVKSDVFSFGVLLLEIISG 420
           +APE  +      ++   D +S GV+L   +SG
Sbjct: 182 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 12/93 (12%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGY 390
           YLHE+    +IHRDLK  NVLL  +      KI+DFG ++I  G  +   T  + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTY 182
Query: 391 MAPEYAME---GVFSVKSDVFSFGVLLLEIISG 420
           +APE  +      ++   D +S GV+L   +SG
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 12/93 (12%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGY 390
           YLHE+    +IHRDLK  NVLL  +      KI+DFG ++I  G  +   T  + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTY 182
Query: 391 MAPEYAME---GVFSVKSDVFSFGVLLLEIISG 420
           +APE  +      ++   D +S GV+L   +SG
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANT 381
           I  I   + Y H +    ++HR+LK  N+LL  +      K++DFG+A     N +EA  
Sbjct: 134 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-W 187
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           +  AGT GY++PE   +  +S   D+++ GV+L  ++ G
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 9/102 (8%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVL-LDHEMNP---KISDFGMARIFSGNQNE 378
           +++  I + + YLH      V+HRDLK SN+L +D   NP   +I DFG A+        
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 379 ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             T     T  ++APE      +    D++S GVLL  +++G
Sbjct: 177 LMTP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 124 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 178
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             +      V   Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 179 GTSFMMVPFVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANT 381
           I+ I   + ++H+     ++HRDLK  N+LL  +      K++DFG+A    G Q     
Sbjct: 136 IHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG 192
Query: 382 NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
              AGT GY++PE   +  +    D+++ GV+L  ++ G
Sbjct: 193 --FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 12/93 (12%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGY 390
           YLHE+    +IHRDLK  NVLL  +      KI+DFG ++I  G  +   T  + GT  Y
Sbjct: 135 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTY 188
Query: 391 MAPEYAME---GVFSVKSDVFSFGVLLLEIISG 420
           +APE  +      ++   D +S GV+L   +SG
Sbjct: 189 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 12/93 (12%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGY 390
           YLHE+    +IHRDLK  NVLL  +      KI+DFG ++I  G  +   T  + GT  Y
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTY 321
Query: 391 MAPEYAME---GVFSVKSDVFSFGVLLLEIISG 420
           +APE  +      ++   D +S GV+L   +SG
Sbjct: 322 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 12/93 (12%)
Query: 334 YLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGY 390
           YLHE+    +IHRDLK  NVLL  +      KI+DFG ++I  G  +   T  + GT  Y
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTY 307
Query: 391 MAPEYAME---GVFSVKSDVFSFGVLLLEIISG 420
           +APE  +      ++   D +S GV+L   +SG
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + RGL Y H   R +V+HRDLK  N+L++     K++DFG+AR  S      +   V  T
Sbjct: 109 LLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--T 163
Query: 388 YGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
             Y  P+  +    +S + D++  G +  E+ +G+
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 9/102 (8%)
Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVL-LDHEMNP---KISDFGMARIFSGNQNE 378
           +++  I + + YLH      V+HRDLK SN+L +D   NP   +I DFG A+        
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 379 ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
             T     T  ++APE      +    D++S GVLL   ++G
Sbjct: 177 LXTP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 13/100 (13%)
Query: 331 GLLYLHED-----SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN--EANTNR 383
           GL +LH +      +  + HRD K+ NVL+   +   I+D G+A + S   +  +   N 
Sbjct: 117 GLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNP 176
Query: 384 VAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLLLEI 417
             GT  YMAPE   E + +        +D+++FG++L EI
Sbjct: 177 RVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 8/101 (7%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKISDFGMARIFSGNQNEAN 380
           I+  +   + ++H+   + V+HRDLK  N+L   E   +  KI DFG AR+   +     
Sbjct: 111 IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T     T  Y APE   +  +    D++S GV+L  ++SG+
Sbjct: 168 T--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 15/115 (13%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNV-LLDHEM-NPKIS--DFGMA-RIFSGNQNEANTN 382
           I  G+ YLH     R+ H DLK  N+ LLD  + NP+I   DFG+A +I +GN+      
Sbjct: 124 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FK 176
Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
            + GT  ++APE        +++D++S GV+   ++SG   +  +L E  Q  LT
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGETKQETLT 228

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 15/115 (13%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNV-LLDHEM-NPKIS--DFGMA-RIFSGNQNEANTN 382
           I  G+ YLH     R+ H DLK  N+ LLD  + NP+I   DFG+A +I +GN+      
Sbjct: 117 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FK 169
Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
            + GT  ++APE        +++D++S GV+   ++SG   +  +L E  Q  LT
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGETKQETLT 221

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEAN 380
           I+  +  G  YLH+ +   ++HRDLK  N+LL+ +      KI DFG++  F        
Sbjct: 126 IMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GK 179
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                GT  Y+APE  +   +  K DV+S GV+L  ++ G
Sbjct: 180 MKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 116 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 170
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 171 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 127 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 181
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +   T  V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 182 GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 15/115 (13%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNV-LLDHEM-NPKIS--DFGMA-RIFSGNQNEANTN 382
           I  G+ YLH     R+ H DLK  N+ LLD  + NP+I   DFG+A +I +GN+      
Sbjct: 138 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FK 190
Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
            + GT  ++APE        +++D++S GV+   ++SG   +  +L E  Q  LT
Sbjct: 191 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGETKQETLT 242

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEAN 380
           I+  +  G  YLH+ +   ++HRDLK  N+LL+ +      KI DFG++  F        
Sbjct: 109 IMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GK 162
Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                GT  Y+APE  +   +  K DV+S GV+L  ++ G
Sbjct: 163 MKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 343 VIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG 399
           ++HRDLK  N+LL  +      K++DFG+A    G+Q        AGT GY++PE   + 
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKD 181
Query: 400 VFSVKSDVFSFGVLLLEIISG 420
            +    D+++ GV+L  ++ G
Sbjct: 182 PYGKPVDMWACGVILYILLVG 202

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 18/105 (17%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--------IFSGNQN-- 377
           I   L Y+H      +IHR+LK  N+ +D   N KI DFG+A+        +   +QN  
Sbjct: 125 ILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 378 --EANTNRVAGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEII 418
               N     GT  Y+A E  ++G   ++ K D +S G++  E I
Sbjct: 182 GSSDNLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 343 VIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG 399
           ++HRDLK  N+LL  +      K++DFG+A    G+Q        AGT GY++PE   + 
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKD 181
Query: 400 VFSVKSDVFSFGVLLLEIISG 420
            +    D+++ GV+L  ++ G
Sbjct: 182 PYGKPVDMWACGVILYILLVG 202

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMARIFSGNQNEANTNRVAGTY 388
           G+ Y H    ++V HRDLK  N LLD    P  KI+DFG ++    +   +      GT 
Sbjct: 127 GVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTP 180
Query: 389 GYMAPEYAMEGVFSVK-SDVFSFGVLLLEIISG 420
            Y+APE  ++  +  K +DV+S GV L  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +      V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GTSFMMEPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 53/108 (49%), Gaps = 10/108 (9%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           Q+  K    IINGI  G  + H      +IHRD+K  N+L+      K+ DFG AR  + 
Sbjct: 124 QVVQKYLFQIINGI--GFCHSH-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
              E   + VA T  Y APE  +  V +    DV++ G L+ E+  G+
Sbjct: 177 -PGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 60/110 (54%), Gaps = 16/110 (14%)
Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH--EMNP-KISDF--GMARIFSGNQNE 378
           ++  +A  L +LH      + HRDLK  N+L +H  +++P KI DF  G     +G+ + 
Sbjct: 116 VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 379 ANTNRV---AGTYGYMAPE----YAMEG-VFSVKSDVFSFGVLLLEIISG 420
            +T  +    G+  YMAPE    ++ E  ++  + D++S GV+L  ++SG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVAG 386
           I + + YL     +  +HRD+   N+L+      K+ DFG++R I   +  +A+  R+  
Sbjct: 118 ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP- 173
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
              +M+PE      F+  SDV+ F V + EI+S  +   F+L 
Sbjct: 174 -IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 215

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 119 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 172
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 173 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVAG 386
           I + + YL     +  +HRD+   N+L+      K+ DFG++R I   +  +A+  R+  
Sbjct: 122 ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP- 177
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
              +M+PE      F+  SDV+ F V + EI+S  +   F+L 
Sbjct: 178 -IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVAG 386
           I + + YL     +  +HRD+   N+L+      K+ DFG++R I   +  +A+  R+  
Sbjct: 134 ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP- 189
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
              +M+PE      F+  SDV+ F V + EI+S  +   F+L 
Sbjct: 190 -IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 231

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           +LD +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR  + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 176
Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             +      V   Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GTSFMMEPEVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 119 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 172
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 173 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   +L +    +L  +HRD+K  NVLLD   + +++DFG   +   +     ++   GT
Sbjct: 181 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 239
Query: 388 YGYMAPEY--AME---GVFSVKSDVFSFGVLLLEIISGK 421
             Y++PE   AME   G +  + D +S GV + E++ G+
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 9/87 (10%)
Query: 332 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG-MARIFSGNQNEANTNRVAGTYGY 390
           L +LH      ++H D+K +N+ L      K+ DFG +  + +    E       G   Y
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRY 222
Query: 391 MAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           MAPE  ++G +   +DVFS G+ +LE+
Sbjct: 223 MAPEL-LQGSYGTAADVFSLGLTILEV 248

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   +L +    +L  +HRD+K  NVLLD   + +++DFG   +   +     ++   GT
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 255
Query: 388 YGYMAPEY--AME---GVFSVKSDVFSFGVLLLEIISGK 421
             Y++PE   AME   G +  + D +S GV + E++ G+
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 325 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEA 379
           +  I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+   
Sbjct: 120 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 174 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           ++  L YL      R +HRD+   NVL+      K+ DFG++R +  +      ++    
Sbjct: 120 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
             +MAPE      F+  SDV+ FGV + EI+
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFSGNQNEANTN 382
           I  G+ YLH    L++ H DLK  N++L     PK    I DFG+A +I  GN+      
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FK 175
Query: 383 RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 329 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY 388
           A  +L L     + +IHRD+K  N+LLD   + K++DFG            + +   GT 
Sbjct: 181 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD-ETGMVHCDTAVGTP 239
Query: 389 GYMAPEY----AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
            Y++PE       +G +  + D +S GV L E++ G  ++ FY
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY 280

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMARIFSGNQNEANTNRVAGTY 388
           G+ Y H    +++ HRDLK  N LLD    P  KI DFG ++    +    +T    GT 
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTP 181
Query: 389 GYMAPEYAMEGVFSVK-SDVFSFGVLLLEIISG 420
            Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 311 TKGAQLDWKRRISI--------INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           T  AQ+   +RI I        +  I  GL  LHE     V+HRDL   N+LL    +  
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDIT 174
Query: 363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
           I DF +AR    +  +AN         Y APE  M+   F+   D++S G ++ E+ + K
Sbjct: 175 ICDFNLAR---EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 422 ---RNSGFY 427
              R S FY
Sbjct: 232 ALFRGSTFY 240

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 311 TKGAQLDWKRRISI--------INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 362
           T  AQ+   +RI I        +  I  GL  LHE     V+HRDL   N+LL    +  
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDIT 174
Query: 363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
           I DF +AR    +  +AN         Y APE  M+   F+   D++S G ++ E+ + K
Sbjct: 175 ICDFNLAR---EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 422 ---RNSGFY 427
              R S FY
Sbjct: 232 ALFRGSTFY 240

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMARIFSGNQNEANTNRVAGTY 388
           G+ Y H    ++V HRDLK  N LLD    P  KI DFG ++    +    +T    GT 
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTP 180
Query: 389 GYMAPEYAMEGVFSVK-SDVFSFGVLLLEIISG 420
            Y+APE  ++  +  K +DV+S GV L  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMARIFSGNQNEANTNRVAGTY 388
           G+ Y H    ++V HRDLK  N LLD    P  KI DFG ++    +    +T    GT 
Sbjct: 126 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTP 179
Query: 389 GYMAPEYAMEGVFSVK-SDVFSFGVLLLEIISG 420
            Y+APE  ++  +  K +DV+S GV L  ++ G
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 9/127 (7%)
Query: 299 FVWCRRRINK--DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 356
           F +C + + K  DS  G  LD +   S +  + +GL + H  +   V+HRDLK  N+L++
Sbjct: 80  FEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLIN 135
Query: 357 HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLL 415
                K++DFG+AR F G      +  V  T  Y  P+      ++S   D++S G +  
Sbjct: 136 RNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 416 EIISGKR 422
           E+ +  R
Sbjct: 194 ELANAAR 200

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           ++  L YL      R +HRD+   NVL+      K+ DFG++R +  +      ++    
Sbjct: 120 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
             +MAPE      F+  SDV+ FGV + EI+
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           ++  L YL      R +HRD+   NVL+      K+ DFG++R +  +      ++    
Sbjct: 120 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
             +MAPE      F+  SDV+ FGV + EI+
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           ++  L YL      R +HRD+   NVL+      K+ DFG++R +  +      ++    
Sbjct: 148 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLP 203
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
             +MAPE      F+  SDV+ FGV + EI+
Sbjct: 204 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           ++  L YL      R +HRD+   NVL+      K+ DFG++R +  +      ++    
Sbjct: 122 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLP 177
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
             +MAPE      F+  SDV+ FGV + EI+
Sbjct: 178 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           ++  L YL      R +HRD+   NVL+      K+ DFG++R +  +      ++    
Sbjct: 125 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLP 180
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
             +MAPE      F+  SDV+ FGV + EI+
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF 401
           R +HRD+   NVL+      K+ DFG++R +  +      ++      +MAPE      F
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 402 SVKSDVFSFGVLLLEII 418
           +  SDV+ FGV + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           ++  L YL      R +HRD+   NVL+      K+ DFG++R +  +      ++    
Sbjct: 123 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLP 178
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
             +MAPE      F+  SDV+ FGV + EI+
Sbjct: 179 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 344 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM-EGVFS 402
           IHRD+K  N+L+      K+ DFG AR+ +G  +  +      T  Y +PE  + +  + 
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELLVGDTQYG 181
Query: 403 VKSDVFSFGVLLLEIISG 420
              DV++ G +  E++SG
Sbjct: 182 PPVDVWAIGCVFAELLSG 199

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           ++  L YL      R +HRD+   NVL+      K+ DFG++R +  +      ++    
Sbjct: 120 LSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLP 175
Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
             +MAPE      F+  SDV+ FGV + EI+
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           + R L Y+H    + + HRD+K  N+LLD      K+ DFG A+I      E N + +  
Sbjct: 150 LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA--GEPNVSXICS 204
Query: 387 TYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y Y APE       ++   D++S G ++ E++ G+
Sbjct: 205 RY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  ++ +    +L  +HRD+K  N+L+D   + +++DFG       +     ++   GT
Sbjct: 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGT 239
Query: 388 YGYMAPEY--AME---GVFSVKSDVFSFGVLLLEIISGK 421
             Y++PE   AME   G +  + D +S GV + E++ G+
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 329 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY 388
           A  +L L     +  IHRD+K  N+LLD   + K++DFG     +  +     +   GT 
Sbjct: 175 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTP 233
Query: 389 GYMAPEY----AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
            Y++PE       +G +  + D +S GV L E++ G  ++ FY
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 274

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 221
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-PKISDFGMARIFSGN---QNEANTNRVAG 386
           GL YLH     R++H D+K  NVLL  + +   + DFG A     +   ++    + + G
Sbjct: 162 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           T  +MAPE  M      K D++S   ++L +++G
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGN---QNEANTNRVAG 386
           GL YLH  SR R++H D+K  NVLL  +  +  + DFG A     +   ++    + + G
Sbjct: 178 GLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPG 234
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           T  +MAPE  +      K DV+S   ++L +++G
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 329 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY 388
           A  +L L     +  IHRD+K  N+LLD   + K++DFG     +  +     +   GT 
Sbjct: 180 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTP 238
Query: 389 GYMAPEY----AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
            Y++PE       +G +  + D +S GV L E++ G  ++ FY
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 279

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NVL+DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 329 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTY 388
           A  +L L     +  IHRD+K  N+LLD   + K++DFG     +  +     +   GT 
Sbjct: 180 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTP 238
Query: 389 GYMAPEY----AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
            Y++PE       +G +  + D +S GV L E++ G  ++ FY
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 279

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRV 384
           I   L Y H+++   +IHRD+K   VLL  + N    K+  FG+A I  G        RV
Sbjct: 141 ILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRV 196
Query: 385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            GT  +MAPE      +    DV+  GV+L  ++SG
Sbjct: 197 -GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 7/105 (6%)
Query: 320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-PKISDFGMARIFSGN--- 375
           R +  +     GL YLH     R++H D+K  NVLL  + +   + DFG A     +   
Sbjct: 165 RALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           ++    + + GT  +MAPE  M      K D++S   ++L +++G
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRV 384
           I   L Y H+++   +IHRD+K   VLL  + N    K+  FG+A I  G        RV
Sbjct: 139 ILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRV 194
Query: 385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            GT  +MAPE      +    DV+  GV+L  ++SG
Sbjct: 195 -GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-PKISDFGMARIFSGN---QNEANTNRVAG 386
           GL YLH     R++H D+K  NVLL  + +   + DFG A     +   ++    + + G
Sbjct: 178 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 234
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           T  +MAPE  M      K D++S   ++L +++G
Sbjct: 235 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 171 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 225
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 226 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 141 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 195
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 196 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 145 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 199
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 200 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 169 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 223
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 224 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 221
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 161 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 215
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 216 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 152 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 206
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 207 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 145 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 199
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 200 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 187
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 331 GLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGN---QNEANTNRVAG 386
           GL YLH  SR R++H D+K  NVLL  +  +  + DFG A     +   ++    + + G
Sbjct: 197 GLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG 253
Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
           T  +MAPE  +      K DV+S   ++L +++G
Sbjct: 254 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 187
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 138 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 192
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 193 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 134 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 188
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 189 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 187
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 187
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 212 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 266
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 267 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 137 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 191
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 192 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 81/192 (42%), Gaps = 35/192 (18%)
Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK--ISDFGM---AR 370
           LD  +   I   I +G+ YLH      ++H+DLK+ NV  D   N K  I+DFG+   + 
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD---NGKVVITDFGLFSISG 180
Query: 371 IFSGNQNEANTNRVAGTYGYMAPEYAMEGV---------FSVKSDVFSFGVLLLEIISGK 421
           +    + E       G   ++APE   +           FS  SDVF+ G +  E+ +  
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-- 238
Query: 422 RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPA 481
           R   F  ++  +++      +W  G     M P L Q  +  E+   +   L C   +  
Sbjct: 239 REWPFK-TQPAEAI------IWQMGTG---MKPNLSQIGMGKEISDIL---LFCWAFEQE 285
Query: 482 HRPNMSSVVVML 493
            RP  + ++ ML
Sbjct: 286 ERPTFTKLMDML 297

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGN-QNEANTNRVA 385
           + RGL Y+H  +   V+HRDLK +N+ ++ E +  KI DFG+ARI   +  ++ + +   
Sbjct: 129 LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 386 GTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK 421
            T  Y +P   +      K+ D+++ G +  E+++GK
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 342 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF 401
           R +HRD+   NVL+      K+ DFG++R +  +      ++      +MAPE      F
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 402 SVKSDVFSFGVLLLEII 418
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 146 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 200
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 201 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 61/121 (50%), Gaps = 15/121 (12%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---- 361
           I K   +G  L + ++IS    +  GL Y+H   R  +IH D+K  NVL++   +P    
Sbjct: 120 IKKYEHRGIPLIYVKQIS--KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 175
Query: 362 --KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             KI+D G A  +    +E  TN +  T  Y +PE  +   +   +D++S   L+ E+I+
Sbjct: 176 QIKIADLGNACWY----DEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
Query: 420 G 420
           G
Sbjct: 231 G 231

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 138 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 192
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 193 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 139 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 193
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 194 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 61/121 (50%), Gaps = 15/121 (12%)
Query: 306 INKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---- 361
           I K   +G  L + ++IS    +  GL Y+H   R  +IH D+K  NVL++   +P    
Sbjct: 120 IKKYEHRGIPLIYVKQIS--KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 175
Query: 362 --KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             KI+D G A  +    +E  TN +  T  Y +PE  +   +   +D++S   L+ E+I+
Sbjct: 176 QIKIADLGNACWY----DEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
Query: 420 G 420
           G
Sbjct: 231 G 231

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 139 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 193
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 194 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 187
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 140 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 194
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 195 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 187
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAGTY 388
           R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 187
Query: 389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            Y APE       ++   DV+S G +L E++ G+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +   Q E N  RVA 
Sbjct: 145 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVAS 199
Query: 387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            Y +  PE  ++  ++    D++S G +L  +I  K
Sbjct: 200 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 234

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	541
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-92
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-87
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-71
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-62
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-48
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-39
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-38
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-37
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-37
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-36
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-32
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-31
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	5e-28
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	2e-24
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-25
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-23
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-23
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-23
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-22
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-21
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-21
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-21
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-20
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-19
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-19
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-19
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-19
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-19
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-18
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-18
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-18
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-18
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-18
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-18
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-18
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-17
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-17
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-17
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-17
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-17
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-17
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-17
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-16
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-16
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-16
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-15
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-15
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-14
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-14
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-14
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-14
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-14
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-14
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-13
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-13
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-13
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-13
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-13
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-12
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-10
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  284 bits (728), Expect = 2e-92
 Identities = 63/192 (32%), Positives = 94/192 (48%), Gaps = 8/192 (4%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
                  L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDFG+
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGL 179

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           AR          T+R+ GT  YMAPE  + G  + KSD++SFGV+LLEII+G      + 
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

Query: 429 SEHGQSLLTYAWKLWCKGEALE-LMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS 487
               Q LL    ++  + + +E  +D  +        +     +   C+ E    RP++ 
Sbjct: 239 EP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIK 295

Query: 488 SVVVMLASDTAT 499
            V  +L   TA+
Sbjct: 296 KVQQLLQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  270 bits (694), Expect = 4e-87
 Identities = 73/184 (39%), Positives = 102/184 (55%), Gaps = 3/184 (1%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
            LDW +R  I  G ARGL YLH+    ++IHRD+K +N+LLD E    + DFG+A++   
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRN--SGFYLSEHG 432
                 T  V GT G++APEY   G  S K+DVF +GV+LLE+I+G+R        ++  
Sbjct: 187 KDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM 492
             LL +   L  + +   L+D  L+    D E+ + I + LLC Q  P  RP MS VV M
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305

Query: 493 LASD 496
           L  D
Sbjct: 306 LEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  229 bits (585), Expect = 6e-71
 Identities = 62/179 (34%), Positives = 97/179 (54%), Gaps = 5/179 (2%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF-SG 374
           + W++R+ I  G ARGL YLH  +   +IHRD+K+ N+LLD    PKI+DFG+++     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
           +Q   +T  V GT GY+ PEY ++G  + KSDV+SFGV+L E++  +      L     +
Sbjct: 193 DQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251

Query: 435 LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
           L  +A +    G+  +++DP L        L K     + C+      RP+M  V+  L
Sbjct: 252 LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  205 bits (524), Expect = 5e-62
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 24/205 (11%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHED-------SRLRVIHRDLKTSNVLLDHEMNPKIS 364
           K   + W     I   +ARGL YLHED        +  + HRD+K+ NVLL + +   I+
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173

Query: 365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV-----FSVKSDVFSFGVLLLEIIS 419
           DFG+A  F   ++  +T+   GT  YMAPE     +       ++ D+++ G++L E+ S
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

Query: 420 GKRNSGFYLSEHGQSLLTYAWKLWCKGEALEL--------MDPVLKQTCVDAELLKCI-H 470
               +   + E+   +L +  ++       ++          PVL+        +  +  
Sbjct: 234 RCTAADGPVDEY---MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290

Query: 471 IGLLCVQEDPAHRPNMSSVVVMLAS 495
               C   D   R +   V   +  
Sbjct: 291 TIEECWDHDAEARLSAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  170 bits (433), Expect = 1e-48
 Identities = 40/228 (17%), Positives = 75/228 (32%), Gaps = 30/228 (13%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHED------SRLRVIHRDLKTSNVLLDHEMNPK 362
                   DW     + + + RGL YLH +       +  + HRDL + NVL+ ++    
Sbjct: 101 KYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160

Query: 363 ISDFGMARIFSGN------QNEANTNRVAGTYGYMAPEYAMEGV-------FSVKSDVFS 409
           ISDFG++   +GN      + +       GT  YMAPE     V          + D+++
Sbjct: 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220

Query: 410 FGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMD--------PVLKQTCV 461
            G++  EI     +         +  + +  ++       ++          P   +   
Sbjct: 221 LGLIYWEIFMRCTDLFPG-ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK 279

Query: 462 DAELLKCIHIGLL--CVQEDPAHRPNMSSVVVMLASDTATLPPPTQPA 507
           +  L        +  C  +D   R         +A            +
Sbjct: 280 ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  145 bits (368), Expect = 1e-39
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)

Query: 309 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 368
            S    QLD +RR+S+   +A+G+ YLH      ++HR+LK+ N+L+D +   K+ DFG+
Sbjct: 127 KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           +R+ +      ++   AGT  +MAPE   +   + KSDV+SFGV+L E+ + ++    + 
Sbjct: 186 SRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ---PW- 239

Query: 429 SEHGQSLLTYAWKLWCKGEALEL---MDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN 485
                +       +  K + LE+   ++P +                  C   +P  RP+
Sbjct: 240 --GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG------------CWTNEPWKRPS 285

Query: 486 MSSVVVMLAS-DTATLPPPTQPAF 508
            ++++ +L     + +PPP +   
Sbjct: 286 FATIMDLLRPLIKSAVPPPNRSDL 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  144 bits (365), Expect = 3e-39
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 26/196 (13%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-PKISDFGMARIFS 373
                  +S     ++G+ YLH      +IHRDLK  N+LL       KI DFG A    
Sbjct: 98  YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-- 155

Query: 374 GNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQ 433
               + +     G+  +MAPE      +S K DVFS+G++L E+I+ ++    +  E G 
Sbjct: 156 ---IQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK---PF-DEIGG 208

Query: 434 SLLTYAWKLWCKGEALEL---MDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
                 W +   G    L   +   ++       L+        C  +DP+ RP+M  +V
Sbjct: 209 PAFRIMWAV-HNGTRPPLIKNLPKPIE------SLMTR------CWSKDPSQRPSMEEIV 255

Query: 491 VMLASDTATLPPPTQP 506
            ++       P   +P
Sbjct: 256 KIMTHLMRYFPGADEP 271

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  142 bits (360), Expect = 2e-38
 Identities = 55/212 (25%), Positives = 78/212 (36%), Gaps = 33/212 (15%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           +  +Q  W +R+S    IA G+ YLH    + +IHRDL + N L+    N  ++DFG+AR
Sbjct: 100 SMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLAR 156

Query: 371 IFSGNQNEANTNR------------VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
           +    + +    R            V G   +MAPE      +  K DVFSFG++L EII
Sbjct: 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

Query: 419 SGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQE 478
                   YL       L               +D      C            + C   
Sbjct: 217 GRVNADPDYLPRTMDFGLNVR----------GFLDRYCPPNC-PPSFFPIT---VRCCDL 262

Query: 479 DPAHRPNMSSVVVML----ASDTATLPPPTQP 506
           DP  RP+   +   L          LP   Q 
Sbjct: 263 DPEKRPSFVKLEHWLETLRMHLAGHLPLGPQL 294

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  137 bits (348), Expect = 4e-37
 Identities = 43/192 (22%), Positives = 88/192 (45%), Gaps = 32/192 (16%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-----HEMNPKISDF 366
           K   + W  ++ ++  IA G+ Y+  +    ++HRDL++ N+ L        +  K++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 367 GMARIFSGNQNEANTNRVAGTYGYMAPE--YAMEGVFSVKSDVFSFGVLLLEIISGKRNS 424
           G+++    +      + + G + +MAPE   A E  ++ K+D +SF ++L  I++G+   
Sbjct: 174 GLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-- 226

Query: 425 GFYLSEHGQSLLTYAWKLWCKGEALEL---MDPVLKQTCVDAELLKCIHIGLLCVQEDPA 481
             +  E+    + +   +  +G    +     P L        +++      LC   DP 
Sbjct: 227 -PF-DEYSYGKIKFINMIREEGLRPTIPEDCPPRL------RNVIE------LCWSGDPK 272

Query: 482 HRPNMSSVVVML 493
            RP+ S +V  L
Sbjct: 273 KRPHFSYIVKEL 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  137 bits (346), Expect = 6e-37
 Identities = 56/193 (29%), Positives = 95/193 (49%), Gaps = 33/193 (17%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--------KI 363
            G ++     ++    IARG+ YLH+++ + +IHRDLK+SN+L+  ++          KI
Sbjct: 98  SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157

Query: 364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRN 423
           +DFG+AR +      +     AG Y +MAPE     +FS  SDV+S+GVLL E+++G+  
Sbjct: 158 TDFGLAREWHRTTKMSA----AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV- 212

Query: 424 SGFYLSEHGQSLLTYAWKLWCKGEALEL---MDPVLKQTCVDAELLKCIHIGLLCVQEDP 480
              +    G   L  A+ +     AL +              A+L++       C   DP
Sbjct: 213 --PF---RGIDGLAVAYGVAMNKLALPIPSTCPEPF------AKLME------DCWNPDP 255

Query: 481 AHRPNMSSVVVML 493
             RP+ ++++  L
Sbjct: 256 HSRPSFTNILDQL 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  137 bits (347), Expect = 7e-37
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 23/188 (12%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
              + + K+ I I    ARG+ YLH      +IHRDLK++N+ L  +   KI DFG+A  
Sbjct: 113 SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169

Query: 372 FSGNQNEANTNRVAGTYGYMAPE---YAMEGVFSVKSDVFSFGVLLLEIISGK---RNSG 425
            S         +++G+  +MAPE         +S +SDV++FG++L E+++G+    N  
Sbjct: 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN-- 227

Query: 426 FYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN 485
             ++   Q +             L      ++  C    + + +     C+++    RP+
Sbjct: 228 --INNRDQIIEMVGRGS------LSPDLSKVRSNC-PKRMKRLM---AECLKKKRDERPS 275

Query: 486 MSSVVVML 493
              ++  +
Sbjct: 276 FPRILAEI 283

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  135 bits (343), Expect = 1e-36
 Identities = 40/188 (21%), Positives = 77/188 (40%), Gaps = 28/188 (14%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
                 +D  + +     +ARG+ +LH    L +    L + +V++D +M  +IS   + 
Sbjct: 102 EGTNFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVK 160

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEG----VFSVKSDVFSFGVLLLEIISGKRNSG 425
             F        +        ++APE A++          +D++SF VLL E+++ +    
Sbjct: 161 FSFQ-------SPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREV--- 209

Query: 426 FYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN 485
            +      S +    K+  +G    +  P      +   + K + I   C+ EDPA RP 
Sbjct: 210 PF---ADLSNMEIGMKVALEGLRPTI--P----PGISPHVSKLMKI---CMNEDPAKRPK 257

Query: 486 MSSVVVML 493
              +V +L
Sbjct: 258 FDMIVPIL 265

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  131 bits (332), Expect = 1e-34
 Identities = 47/194 (24%), Positives = 75/194 (38%), Gaps = 31/194 (15%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
               LD  +   I   I +G+ YLH      ++H+DLK+ NV  D      I+DFG+  I
Sbjct: 123 AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178

Query: 372 FSGNQNEANTNR---VAGTYGYMAPE---------YAMEGVFSVKSDVFSFGVLLLEIIS 419
               Q     ++     G   ++APE            +  FS  SDVF+ G +  E+ +
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238

Query: 420 GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQED 479
            +           Q      W++   G     M P L Q  +  E+   +   L C   +
Sbjct: 239 RE------WPFKTQPAEAIIWQM-GTG-----MKPNLSQIGMGKEISDIL---LFCWAFE 283

Query: 480 PAHRPNMSSVVVML 493
              RP  + ++ ML
Sbjct: 284 QEERPTFTKLMDML 297

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  125 bits (317), Expect = 1e-32
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 30/208 (14%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLR-----VIHRDLKTSNVLLDHEMNPKISDF 366
           +   LD    + I+  IA GL +LH +         + HRDLK+ N+L+       I+D 
Sbjct: 98  QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157

Query: 367 GMARIFSGNQNEANT--NRVAGTYGYMAPE------YAMEGVFSVKSDVFSFGVLLLEII 418
           G+A + S + N+ +   N   GT  YMAPE               + D+++FG++L E+ 
Sbjct: 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

Query: 419 SGKRNSG--------FYLSEHGQSLLTYAWKLWC-KGEALELMDPVLKQTCVD--AELLK 467
               ++G        FY             K+ C   +   + +       +   A+L+K
Sbjct: 218 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277

Query: 468 CIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
                  C  ++P+ R     +   L  
Sbjct: 278 ------ECWYQNPSARLTALRIKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  124 bits (314), Expect = 6e-32
 Identities = 48/204 (23%), Positives = 81/204 (39%), Gaps = 22/204 (10%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLR-----VIHRDLKTSNVLLDHEMNPKISDF 366
           K   LD K  + +      GL +LH +         + HRDLK+ N+L+       I+D 
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186

Query: 367 GMARIFSGNQNEAN--TNRVAGTYGYMAPEYAMEGVFSV-------KSDVFSFGVLLLEI 417
           G+A  F  + NE +   N   GT  YM PE  ++   +         +D++SFG++L E+
Sbjct: 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEV 245

Query: 418 ISGKRNSGFYLSE----HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL 473
                + G         H       +++   +   ++ + P         E L+ +   L
Sbjct: 246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM-GKL 304

Query: 474 L--CVQEDPAHRPNMSSVVVMLAS 495
           +  C   +PA R     V   LA 
Sbjct: 305 MTECWAHNPASRLTALRVKKTLAK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  123 bits (311), Expect = 2e-31
 Identities = 42/204 (20%), Positives = 78/204 (38%), Gaps = 30/204 (14%)

Query: 316 LDWKRRISIINGIARGLLYLHED-----SRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           +  +  I +    A GL +LH +      +  + HRDLK+ N+L+       I+D G+A 
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195

Query: 371 IFSGNQNE---ANTNRVAGTYGYMAPEYAMEGVFSV-------KSDVFSFGVLLLEIISG 420
                 +    A  +RV GT  YMAPE  ++   ++       ++D+++ G++  EI   
Sbjct: 196 RHDSATDTIDIAPNHRV-GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

Query: 421 KRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTC---VDAELLKCIHIGLL--- 474
               G +        L Y   +       E+   V +Q     +      C  + ++   
Sbjct: 254 CSIGGIHEDYQ----LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 309

Query: 475 ---CVQEDPAHRPNMSSVVVMLAS 495
              C   + A R     +   L+ 
Sbjct: 310 MRECWYANGAARLTALRIKKTLSQ 333

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  104 bits (261), Expect = 3e-25
 Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 20/188 (10%)

Query: 304 RRINKDSTKGAQLDWKRRISIINGIARGLLYLHE--DSRLRVIHRDLKTSNVLLDHEMNP 361
             I K + +   LD +  + ++  +   L   H   D    V+HRDLK +NV LD + N 
Sbjct: 96  SVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155

Query: 362 KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           K+ DFG+ARI + + + A T    GT  YM+PE      ++ KSD++S G LL E+ +  
Sbjct: 156 KLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

Query: 422 RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPA 481
               F       S    A K+  +G+   +            EL + I      +     
Sbjct: 214 P--PFT----AFSQKELAGKI-REGKFRRIPY------RYSDELNEIIT---RMLNLKDY 257

Query: 482 HRPNMSSV 489
           HRP++  +
Sbjct: 258 HRPSVEEI 265

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  103 bits (258), Expect = 1e-24
 Identities = 40/162 (24%), Positives = 68/162 (41%), Gaps = 27/162 (16%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I +G+ Y+H     ++I+RDLK SN+ L      KI DFG+        N+    R  GT
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDGKRTRSKGT 184

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE 447
             YM+PE      +  + D+++ G++L E++     + F  S           K +    
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETS-----------KFFTD-- 230

Query: 448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
              L D ++     D +    +      + + P  RPN S +
Sbjct: 231 ---LRDGII-SDIFDKKEKTLLQ---KLLSKKPEDRPNTSEI 265

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  103 bits (259), Expect = 2e-24
 Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 50/223 (22%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
              A+LD  R +   + I +G+ YL      R +HRDL   N+L++ E + KI+DFG+A+
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK 175

Query: 371 IFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSG 425
           +   +++      V    G     + APE   + +FS +SDV+SFGV+L E+        
Sbjct: 176 LLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL-------- 223

Query: 426 FYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG------------- 472
                      TY  K          M    +     + LL+ +  G             
Sbjct: 224 ----------FTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEV 273

Query: 473 ----LLCVQEDPAHRPNMSSVVVML---ASDTATLPPPTQPAF 508
                LC    P  RP+ S++   L    S +         A 
Sbjct: 274 HELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAH 316

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  104 bits (261), Expect = 2e-24
 Identities = 40/109 (36%), Positives = 56/109 (51%), Gaps = 3/109 (2%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T+GA+L  K  + ++   A G+ YL        IHRDL   N L+  +   KISDFGM+R
Sbjct: 205 TEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261

Query: 371 IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             +     A+         + APE    G +S +SDV+SFG+LL E  S
Sbjct: 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  102 bits (256), Expect = 2e-24
 Identities = 40/197 (20%), Positives = 79/197 (40%), Gaps = 31/197 (15%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
               +++ K+++     I +G+ YL      + +HRDL   NVL++ E   KI DFG+ +
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174

Query: 371 IFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNS 424
               ++                  + APE  M+  F + SDV+SFGV L E+++    +S
Sbjct: 175 AIETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230

Query: 425 GFYLSEHGQSLLTYAWKLWCKGEALELMDPVLK-------QTCVDAELLKCIH-IGLLCV 476
                       T+            L++ + +         C D      ++ +   C 
Sbjct: 231 SPMALFLKMIGPTHGQMTVT-----RLVNTLKEGKRLPCPPNCPDE-----VYQLMRKCW 280

Query: 477 QEDPAHRPNMSSVVVML 493
           +  P++R +  +++   
Sbjct: 281 EFQPSNRTSFQNLIEGF 297

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  102 bits (256), Expect = 4e-24
 Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 21/136 (15%)

Query: 296 LGSFVWCRR------RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 349
           L  ++  RR        + +     Q+ +K  +S    +ARG+ YL   +  + IHRDL 
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLA 184

Query: 350 TSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSV 403
             NVL+      KI+DFG+AR I + +  +  TN     +      +MAPE   + V++ 
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTH 238

Query: 404 KSDVFSFGVLLLEIIS 419
           +SDV+SFGVL+ EI +
Sbjct: 239 QSDVWSFGVLMWEIFT 254

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  101 bits (254), Expect = 5e-24
 Identities = 46/195 (23%), Positives = 74/195 (37%), Gaps = 31/195 (15%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
            +   + +     I  G+ YLH       IHRDL   NVLLD++   KI DFG+A+    
Sbjct: 130 SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186

Query: 375 NQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYL 428
                         G     + APE   E  F   SDV+SFGV L E+++    +     
Sbjct: 187 GHEYY----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242

Query: 429 SEHGQSLLTY-------AWKLWCKGEALELMDPVLKQTCVDAELLKCIH-IGLLCVQEDP 480
                  +           +L  +GE L   D      C        ++ +   C + + 
Sbjct: 243 KFLELIGIAQGQMTVLRLTELLERGERLPRPD-----KCPAE-----VYHLMKNCWETEA 292

Query: 481 AHRPNMSSVVVMLAS 495
           + RP   +++ +L +
Sbjct: 293 SFRPTFENLIPILKT 307

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  100 bits (252), Expect = 7e-24
 Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 28/196 (14%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
               ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ +
Sbjct: 106 KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162

Query: 371 IFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSG 425
           +   ++            G     + APE   E  FSV SDV+SFGV+L E+ +    S 
Sbjct: 163 VLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218

Query: 426 FYLSEHGQSLLTYAWKLWCKGEALELMD-------PVLKQTCVDAELLKCIH-IGLLCVQ 477
              +E  + +             +EL+        P     C D      I+ I   C  
Sbjct: 219 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP---DGCPDE-----IYMIMTECWN 270

Query: 478 EDPAHRPNMSSVVVML 493
            +   RP+   + + +
Sbjct: 271 NNVNQRPSFRDLALRV 286

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  102 bits (255), Expect = 8e-24
 Identities = 41/119 (34%), Positives = 65/119 (54%), Gaps = 15/119 (12%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
           + +     Q+ +K  +S    +ARG+ YL   +  + IHRDL   NVL+      KI+DF
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 247

Query: 367 GMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G+AR I + +  +  TN     +      +MAPE   + V++ +SDV+SFGVL+ EI +
Sbjct: 248 GLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  101 bits (254), Expect = 9e-24
 Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 21/162 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L ++H+    +++HRD+K+ N+ L  +   ++ DFG+AR+ +     A      GT
Sbjct: 134 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE 447
             Y++PE      ++ KSD+++ G +L E+ + K    F       S+     K+   G 
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH--AFE----AGSMKNLVLKI-ISGS 241

Query: 448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
                 PV        +L   +       + +P  RP+++S+
Sbjct: 242 ----FPPV--SLHYSYDLRSLVS---QLFKRNPRDRPSVNSI 274

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  100 bits (252), Expect = 1e-23
 Identities = 32/121 (26%), Positives = 59/121 (48%), Gaps = 15/121 (12%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
             ++  T    +  +  +  +  IA G+ YL   S    +HRDL   N +L  +M   ++
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVA 189

Query: 365 DFGMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
           DFG+++ I+SG+            +      ++A E   + V++ KSDV++FGV + EI 
Sbjct: 190 DFGLSKKIYSGDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIA 243

Query: 419 S 419
           +
Sbjct: 244 T 244

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  100 bits (252), Expect = 1e-23
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 15/130 (11%)

Query: 296 LGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 355
           L S++   R    ++   A     + I +   IA G+ YL+     + +HRDL   N ++
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 171

Query: 356 DHEMNPKISDFGMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFS 409
             +   KI DFGM R I+  +            R      +M+PE   +GVF+  SDV+S
Sbjct: 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWS 225

Query: 410 FGVLLLEIIS 419
           FGV+L EI +
Sbjct: 226 FGVVLWEIAT 235

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  101 bits (253), Expect = 1e-23
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 19/134 (14%)

Query: 296 LGSFVWCRRRI----NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 351
           L +F+  + R+       +   +    +  +   + +A+G+ +L   +    IHRD+   
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAAR 193

Query: 352 NVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKS 405
           NVLL +    KI DFG+AR I + +      N     +      +MAPE   + V++V+S
Sbjct: 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFDCVYTVQS 247

Query: 406 DVFSFGVLLLEIIS 419
           DV+S+G+LL EI S
Sbjct: 248 DVWSYGILLWEIFS 261

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  100 bits (252), Expect = 1e-23
 Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 28/196 (14%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
               ++D  + +   + I +G+ YL      R IHRDL T N+L+++E   KI DFG+ +
Sbjct: 137 KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 193

Query: 371 IFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSG 425
           +   ++            G     + APE   E  FSV SDV+SFGV+L E+ +    S 
Sbjct: 194 VLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249

Query: 426 FYLSEHGQSLLTYAWKLWCKGEALELMD-------PVLKQTCVDAELLKCIH-IGLLCVQ 477
              +E  + +             +EL+        P     C D      I+ I   C  
Sbjct: 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP---DGCPDE-----IYMIMTECWN 301

Query: 478 EDPAHRPNMSSVVVML 493
            +   RP+   + + +
Sbjct: 302 NNVNQRPSFRDLALRV 317

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  100 bits (250), Expect = 2e-23
 Identities = 34/164 (20%), Positives = 56/164 (34%), Gaps = 39/164 (23%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
               L +LH      ++H D+K +N+ L      K+ DFG+                 G 
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGD 219

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE 447
             YMAPE  ++G +   +DVFS G+ +LE+                       +L   GE
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACN-------------------MELPHGGE 259

Query: 448 ALELM-----DPVLKQTCVDA--ELLKCIHIGLLCVQEDPAHRP 484
             + +      P            +L       + ++ DP  R 
Sbjct: 260 GWQQLRQGYLPPEFTAGLSSELRSVLV------MMLEPDPKLRA 297

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  100 bits (251), Expect = 2e-23
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 21/136 (15%)

Query: 296 LGSFVWCRR------RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 349
           L +++  +R      ++  +      L  +  I     +A+G+ +L   +  + IHRDL 
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLA 175

Query: 350 TSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSV 403
             N+LL  +   KI DFG+AR I+         +     +      +MAPE   + V+++
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTI 229

Query: 404 KSDVFSFGVLLLEIIS 419
           +SDV+SFGVLL EI S
Sbjct: 230 QSDVWSFGVLLWEIFS 245

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  100 bits (250), Expect = 2e-23
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)

Query: 283 IGTIITTITLFILL-----GSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHE 337
             + I    L I+L     G      R I     +   +  +        +   L ++H 
Sbjct: 98  YASFIEDNELNIVLELADAGD---LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154

Query: 338 DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM 397
               RV+HRD+K +NV +      K+ D G+ R FS     A++  + GT  YM+PE   
Sbjct: 155 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIH 209

Query: 398 EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLK 457
           E  ++ KSD++S G LL E+ + +    FY      +L +   K+  + +      P L 
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQS--PFY--GDKMNLYSLCKKI-EQCDY-----PPLP 259

Query: 458 QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
                 EL + ++   +C+  DP  RP+++ V
Sbjct: 260 SDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 99.2 bits (248), Expect = 3e-23
 Identities = 35/119 (29%), Positives = 62/119 (52%), Gaps = 15/119 (12%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
           + D      L     IS    I++G+ YL   + ++++HRDL   N+L+      KISDF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDF 194

Query: 367 GMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G++R ++  +     +      +      +MA E   + +++ +SDV+SFGVLL EI++
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 14/115 (12%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
                ++     + +   I+  + YL    +   IHRDL   N L+      K++DFG++
Sbjct: 102 ECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLS 158

Query: 370 RIFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           R+ +G+   A+       +      + APE      FS+KSDV++FGVLL EI +
Sbjct: 159 RLMTGDTYTAHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 15/121 (12%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
             ++       L  +  +  +  IA G+ YL   S    IHRDL   N +L  +M   ++
Sbjct: 123 LASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVA 179

Query: 365 DFGMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
           DFG++R I+SG+            +      ++A E   + +++V SDV++FGV + EI+
Sbjct: 180 DFGLSRKIYSGDYYRQGCASKLPVK------WLALESLADNLYTVHSDVWAFGVTMWEIM 233

Query: 419 S 419
           +
Sbjct: 234 T 234

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 98.4 bits (246), Expect = 5e-23
 Identities = 42/119 (35%), Positives = 67/119 (56%), Gaps = 15/119 (12%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
           + D T  + L+    + ++  IA G+ YL   S   V+H+DL T NVL+  ++N KISD 
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDL 172

Query: 367 GMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G+ R +++ +  +   N     R      +MAPE  M G FS+ SD++S+GV+L E+ S
Sbjct: 173 GLFREVYAADYYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 38/119 (31%), Positives = 60/119 (50%), Gaps = 15/119 (12%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
            +      +L   + + I + IA G++YL   +    +HRDL T N L+   +  KI DF
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDF 177

Query: 367 GMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           GM+R ++S +      +     R      +M PE  M   F+ +SDV+SFGV+L EI +
Sbjct: 178 GMSRDVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  100 bits (250), Expect = 5e-23
 Identities = 46/136 (33%), Positives = 68/136 (50%), Gaps = 21/136 (15%)

Query: 296 LGSFVWCRR------RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 349
           L  ++  RR        N       QL  K  +S    +ARG+ YL   +  + IHRDL 
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLA 218

Query: 350 TSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSV 403
             NVL+  +   KI+DFG+AR I   +  +  TN     +      +MAPE   + +++ 
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTH 272

Query: 404 KSDVFSFGVLLLEIIS 419
           +SDV+SFGVLL EI +
Sbjct: 273 QSDVWSFGVLLWEIFT 288

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 99.2 bits (247), Expect = 5e-23
 Identities = 35/173 (20%), Positives = 60/173 (34%), Gaps = 33/173 (19%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVA-- 385
           IA  + +LH      ++HRDLK SN+    +   K+ DFG+      ++ E         
Sbjct: 173 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229

Query: 386 --------GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
                   GT  YM+PE      +S K D+FS G++L E++              Q    
Sbjct: 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS---------TQMERV 280

Query: 438 YAWKLWCKGEALELMDPVLKQTCVD-AELLKCIHIGLLCVQEDPAHRPNMSSV 489
                    +       +  Q       +++        +   P  RP  + +
Sbjct: 281 RIITDVRNLK----FPLLFTQKYPQEHMMVQ------DMLSPSPTERPEATDI 323

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 98.2 bits (245), Expect = 6e-23
 Identities = 44/218 (20%), Positives = 77/218 (35%), Gaps = 42/218 (19%)

Query: 288 TTITLFILLGSFVWCRR-----RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 342
             + L+I +     CR+      +N   T   + +    + I   IA  + +LH      
Sbjct: 86  PKVYLYIQMQ---LCRKENLKDWMNGRCTIE-ERERSVCLHIFLQIAEAVEFLHS---KG 138

Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVA----------GTYGYMA 392
           ++HRDLK SN+    +   K+ DFG+      ++ E                 GT  YM+
Sbjct: 139 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS 198

Query: 393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELM 452
           PE      +S K D+FS G++L E++       F      Q             +     
Sbjct: 199 PEQIHGNSYSHKVDIFSLGLILFELL-----YPFS----TQMERVRTLTDVRNLK----F 245

Query: 453 DPVLKQTCVDA-ELLKCIHIGLLCVQEDPAHRPNMSSV 489
            P+  Q       +++        +   P  RP   ++
Sbjct: 246 PPLFTQKYPCEYVMVQ------DMLSPSPMERPEAINI 277

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 99.5 bits (248), Expect = 6e-23
 Identities = 33/98 (33%), Positives = 57/98 (58%), Gaps = 6/98 (6%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +   + +GL YL E    +++HRD+K SN+L++     K+ DFG++     +   AN+  
Sbjct: 136 VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSF- 190

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 191 -VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 37/119 (31%), Positives = 57/119 (47%), Gaps = 15/119 (12%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
                    LD +  +S    +A+G+ +L   +    IHRDL   N+LL H    KI DF
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDF 189

Query: 367 GMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G+AR I + +      N     +      +MAPE     V++ +SDV+S+G+ L E+ S
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 97.3 bits (243), Expect = 8e-23
 Identities = 38/113 (33%), Positives = 63/113 (55%), Gaps = 10/113 (8%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           +  G +L   + + +   IA G+ ++        IHRDL+ +N+L+   ++ KI+DFG+A
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLA 156

Query: 370 RIFSGNQNEANTNRVAGT---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           R+   N+  A      G      + APE    G F++KSDV+SFG+LL EI++
Sbjct: 157 RLIEDNEYTARE----GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 40/117 (34%), Positives = 61/117 (52%), Gaps = 13/117 (11%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           +   +  K  I +++ ++ G+ YL        +HRDL   NVLL  +   KISDFG+++ 
Sbjct: 110 QNRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166

Query: 372 FSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
              ++N       A T+G     + APE      FS KSDV+SFGVL+ E  S G++
Sbjct: 167 LRADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 99.8 bits (249), Expect = 1e-22
 Identities = 39/113 (34%), Positives = 64/113 (56%), Gaps = 10/113 (8%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S +G++    + I     IA G+ ++    +   IHRDL+ +N+L+   +  KI+DFG+A
Sbjct: 275 SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLA 331

Query: 370 RIFSGNQNEANTNRVAGT---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           R+   N+  A      G      + APE    G F++KSDV+SFG+LL+EI++
Sbjct: 332 RVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 39/119 (32%), Positives = 61/119 (51%), Gaps = 15/119 (12%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
              S     L    ++ I   +A G+ YL   S  + +HRDL T N L+   M  KI+DF
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADF 218

Query: 367 GMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G++R I+S +  +A+ N     R      +M PE      ++ +SDV+++GV+L EI S
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 41/119 (34%), Positives = 64/119 (53%), Gaps = 15/119 (12%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T   Q    + + ++ G+  G+ YL   S L  +HRDL   NVL+D  +  K+SDFG++R
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199

Query: 371 IFSGNQNEANTNRVAGTYG------YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
           +   + + A T     T G      + APE      FS  SDV+SFGV++ E+++ G+R
Sbjct: 200 VLEDDPDAAYT-----TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 32/230 (13%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
              AQ    + + ++ GIA G+ YL   S +  +HRDL   N+L++  +  K+SDFG+ R
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195

Query: 371 IFSGNQNEANTNRVAGT---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGF 426
           +   +   A T R  G      + +PE      F+  SDV+S+G++L E++S G+R    
Sbjct: 196 VLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--- 250

Query: 427 YLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH-IGLLCVQEDPAHRPN 485
           Y     Q ++    K   +G  L          C  A     ++ + L C Q+D  +RP 
Sbjct: 251 YWEMSNQDVI----KAVDEGYRLPPPM-----DCPAA-----LYQLMLDCWQKDRNNRPK 296

Query: 486 MSSVVVML---ASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNE 532
              +V +L     +  +L   T  A           QS+   + F +  +
Sbjct: 297 FEQIVSILDKLIRNPGSLKIITSAAARPSN--LLLDQSNVDITTFRTTGD 344

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 37/118 (31%), Positives = 60/118 (50%), Gaps = 13/118 (11%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
             +      L   + +++ + +A G++YL   + L  +HRDL T N L+   +  KI DF
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDF 202

Query: 367 GMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           GM+R    +    +  RV G        +M PE  +   F+ +SDV+SFGV+L EI +
Sbjct: 203 GMSR----DIYSTDYYRV-GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 4/111 (3%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
               L     I+  N I  G+ + H    +R++HRD+K  N+L+D     KI DFG+A+ 
Sbjct: 104 SHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
            S       TN V GT  Y +PE A        +D++S G++L E++ G+ 
Sbjct: 161 LSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 15/98 (15%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN---- 382
           +A+G+ +L        +HRDL   NVL+ H    KI DFG+AR I S +      N    
Sbjct: 181 VAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237

Query: 383 -RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
            +      +MAPE   EG++++KSDV+S+G+LL EI S
Sbjct: 238 VK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 99.1 bits (247), Expect = 3e-22
 Identities = 44/187 (23%), Positives = 80/187 (42%), Gaps = 25/187 (13%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
                ++     + +   I+  + YL    +   IHR+L   N L+      K++DFG++
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLS 365

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRN--SGFY 427
           R+ +G+   A+         + APE      FS+KSDV++FGVLL EI +   +   G  
Sbjct: 366 RLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424

Query: 428 LSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH-IGLLCVQEDPAHRPNM 486
           LS+  + L         K   +E  +      C +      ++ +   C Q +P+ RP+ 
Sbjct: 425 LSQVYELLE--------KDYRMERPE-----GCPEK-----VYELMRACWQWNPSDRPSF 466

Query: 487 SSVVVML 493
           + +    
Sbjct: 467 AEIHQAF 473

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 19/124 (15%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
           R +KD+     L     ++    IA+G+ YL      R++HRDL   NVL+    + KI+
Sbjct: 108 REHKDNIGSQYL-----LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKIT 159

Query: 365 DFGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           DFG+A++    + E +        G     +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 160 DFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

Query: 420 -GKR 422
            G +
Sbjct: 215 FGSK 218

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 9/102 (8%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I   I + L +LH  S+L VIHRD+K SNVL++     K+ DFG++       ++   + 
Sbjct: 114 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDI 168

Query: 384 VAGTYGYMAPE----YAMEGVFSVKSDVFSFGVLLLEIISGK 421
            AG   YMAPE       +  +SVKSD++S G+ ++E+   +
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 15/119 (12%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
            K  +    + + ++ GIA G+ YL   + +  +HRDL   N+L++  +  K+SDFG++R
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195

Query: 371 IFSGNQNEANTNRVAGTYG------YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
           +   +     T     T G      + APE      F+  SDV+SFG+++ E+++ G+R
Sbjct: 196 VLEDDPEATYT-----TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 39/118 (33%), Positives = 60/118 (50%), Gaps = 16/118 (13%)

Query: 307 NKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 366
              ++  + L  ++ +     +ARG+ YL   S+ + IHRDL   N+L+      KI+DF
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 186

Query: 367 GMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           G++R     Q       V  T G     +MA E     V++  SDV+S+GVLL EI+S
Sbjct: 187 GLSR----GQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 94.9 bits (237), Expect = 5e-22
 Identities = 35/112 (31%), Positives = 58/112 (51%), Gaps = 10/112 (8%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           + G  L+  + + +   +  G+ +L      + IHRDL   N L+D ++  K+SDFGM R
Sbjct: 96  SHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152

Query: 371 IFSGNQNEANTNRVAGT---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               +Q  ++     GT     + APE      +S KSDV++FG+L+ E+ S
Sbjct: 153 YVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 13/118 (11%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
            K  ++       +++ ++ G+ YL        +HRDL   NVLL +    KISDFG+++
Sbjct: 102 GKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158

Query: 371 IFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
               + +       A + G     + APE      FS +SDV+S+GV + E +S G++
Sbjct: 159 ALGADDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 13/111 (11%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
               K  I     +A+G+ YL      + +HRDL   N +LD +   K++DFG+AR    
Sbjct: 124 NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-- 178

Query: 375 NQNEANTNRVAGTYG------YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
              +     V    G      +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 179 --YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 35/120 (29%), Positives = 48/120 (40%), Gaps = 10/120 (8%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
           R ++       L           +A G+ YL      R IHRDL   N+LL      KI 
Sbjct: 112 RKHQGHFLLGTL-----SRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIG 163

Query: 365 DFGMARIFSGNQNEANTNRVAGT-YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
           DFG+ R    N +           + + APE      FS  SD + FGV L E+ + G+ 
Sbjct: 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 94.6 bits (236), Expect = 9e-22
 Identities = 30/114 (26%), Positives = 54/114 (47%), Gaps = 14/114 (12%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
               +   ++ + +   +   + YL      + +HRDL   N L++ +   K+SDFG++R
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168

Query: 371 IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               ++  ++       R      +  PE  M   FS KSD+++FGVL+ EI S
Sbjct: 169 YVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 4/112 (3%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
               +  KR I +I    + L + H   +  +IHRD+K +N+++      K+ DFG+AR 
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165

Query: 372 FSGNQNE-ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
            + + N    T  V GT  Y++PE A       +SDV+S G +L E+++G+ 
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 39/116 (33%), Positives = 56/116 (48%), Gaps = 11/116 (9%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           T+      +  + +   +  G+ YL       VIHRDL   N L+      K+SDFGM R
Sbjct: 96  TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTR 152

Query: 371 IFSGNQNEANTNRVAGT---YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKR 422
               +Q  ++T    GT     + +PE      +S KSDV+SFGVL+ E+ S GK 
Sbjct: 153 FVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 11/114 (9%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
           +       K  IS    +ARG+ YL   +  + +HRDL   N +LD     K++DFG+AR
Sbjct: 116 SPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

Query: 371 IFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                  E  + +    +      + A E      F+ KSDV+SFGVLL E+++
Sbjct: 173 DI--LDREYYSVQ-QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 97.6 bits (243), Expect = 1e-21
 Identities = 41/200 (20%), Positives = 65/200 (32%), Gaps = 36/200 (18%)

Query: 313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
           G +L     I+ +  I   L YLH    + +++ DLK  N++L  E   K+ D G     
Sbjct: 176 GQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231

Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG 432
           +          + GT G+ APE    G  +V +D+++ G  L  +             + 
Sbjct: 232 NS------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLP---TRNGRYV 281

Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM 492
             L           +   L             L + I         DP  R   ++   M
Sbjct: 282 DGLPE---------DDPVLKTYDS----YGRLLRRAID-------PDPRQRF--TTAEEM 319

Query: 493 LASDTATLPPPTQPAFSVDR 512
            A  T  L         V R
Sbjct: 320 SAQLTGVLREVVAQDTGVPR 339

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 12/112 (10%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S   + L     +     +   + YL        +HRDL   NVL+  +   K+SDFG+ 
Sbjct: 280 SRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336

Query: 370 RIFSGNQNEANTNRVAGTYGY--MAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           +       EA++ +  G       APE   E  FS KSDV+SFG+LL EI S
Sbjct: 337 K-------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 12/112 (10%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S   + L     +     +   + YL        +HRDL   NVL+  +   K+SDFG+ 
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164

Query: 370 RIFSGNQNEANTNRVAGTYGY--MAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           +       EA++ +  G       APE   E  FS KSDV+SFG+LL EI S
Sbjct: 165 K-------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 9/102 (8%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I     + L +L E+  L++IHRD+K SN+LLD   N K+ DFG++     +  +     
Sbjct: 130 ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-- 185

Query: 384 VAGTYGYMAPE----YAMEGVFSVKSDVFSFGVLLLEIISGK 421
            AG   YMAPE     A    + V+SDV+S G+ L E+ +G+
Sbjct: 186 -AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 95.1 bits (236), Expect = 3e-21
 Identities = 27/243 (11%), Positives = 65/243 (26%), Gaps = 53/243 (21%)

Query: 304 RRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 363
             +   S+    L    R+ +   + R L  LH      ++H  L+  +++LD      +
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFL 252

Query: 364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEY----------AMEGVFSVKSDVFSFGVL 413
           + F           +  +       G+  PE               + +   D ++ G+ 
Sbjct: 253 TGFEHLVR------DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306

Query: 414 LLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVD--AELLKCIHI 471
           +  I                             +A       + ++C +    +   +  
Sbjct: 307 IYWIWCAD--LPNT------------------DDAALGGSEWIFRSCKNIPQPVRALLE- 345

Query: 472 GLLCVQEDPAHRPNMSSVVV---------MLASDTATLPPPTQPAFSVDRIAAKSGQSSS 522
           G L  +     R      +           L++         +P        + + Q   
Sbjct: 346 GFL--RYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDE 403

Query: 523 SGS 525
           +G+
Sbjct: 404 AGA 406

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 34/117 (29%), Positives = 51/117 (43%), Gaps = 13/117 (11%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
           ++ K S   A L     I     ++  L YL      R +HRD+   NVL+      K+ 
Sbjct: 107 QVRKYSLDLASL-----ILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLG 158

Query: 365 DFGMARIFSGNQNEANTNRVAGTY--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           DFG++R     ++        G     +MAPE      F+  SDV+ FGV + EI+ 
Sbjct: 159 DFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 41/125 (32%), Positives = 55/125 (44%), Gaps = 18/125 (14%)

Query: 304 RRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMN 360
           R      ++ + L     + +   IA G  YL        IHRD+   N LL        
Sbjct: 125 RETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRV 181

Query: 361 PKISDFGMAR-IFSGNQNEANTN-----RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
            KI DFGMAR I+  +            +      +M PE  MEG+F+ K+D +SFGVLL
Sbjct: 182 AKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLL 235

Query: 415 LEIIS 419
            EI S
Sbjct: 236 WEIFS 240

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 94.0 bits (234), Expect = 5e-21
 Identities = 42/125 (33%), Positives = 53/125 (42%), Gaps = 18/125 (14%)

Query: 304 RRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMN 360
           R      ++ + L     + +   IA G  YL        IHRD+   N LL        
Sbjct: 166 RETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRV 222

Query: 361 PKISDFGMAR-IFSGNQNEANTNRVAGTYGY-----MAPEYAMEGVFSVKSDVFSFGVLL 414
            KI DFGMAR I+             G         M PE  MEG+F+ K+D +SFGVLL
Sbjct: 223 AKIGDFGMARDIYRAGY------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276

Query: 415 LEIIS 419
            EI S
Sbjct: 277 WEIFS 281

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 23/159 (14%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVAG 386
           I +GL +LH  +   +IHRDLK  N+ +     + KI D G+A +   +        V G
Sbjct: 138 ILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIG 192

Query: 387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG 446
           T  +MAPE   E       DV++FG+ +LE+ + +     Y      + +        K 
Sbjct: 193 TPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKP 248

Query: 447 EAL-ELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP 484
            +  ++  P +K      E+++       C++++   R 
Sbjct: 249 ASFDKVAIPEVK------EIIE------GCIRQNKDERY 275

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 94.8 bits (236), Expect = 5e-21
 Identities = 37/108 (34%), Positives = 62/108 (57%), Gaps = 4/108 (3%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
            G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+
Sbjct: 273 TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARL 329

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
              N+  A          + APE A+ G F++KSDV+SFG+LL E+ +
Sbjct: 330 IEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 92.7 bits (231), Expect = 6e-21
 Identities = 28/107 (26%), Positives = 48/107 (44%), Gaps = 4/107 (3%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           L   R ++I+  I   L   H        HRD+K  N+L+  +    + DFG+A   +  
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           +         GT  YMAPE   E   + ++D+++   +L E ++G  
Sbjct: 188 KLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 94.9 bits (236), Expect = 8e-21
 Identities = 37/110 (33%), Positives = 62/110 (56%), Gaps = 4/110 (3%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
              G  L   + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+A
Sbjct: 354 GETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLA 410

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           R+   N+  A          + APE A+ G F++KSDV+SFG+LL E+ +
Sbjct: 411 RLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 91.5 bits (228), Expect = 8e-21
 Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 21/121 (17%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
             NK+S K   L     +     I + + YL     +  +HRD+   N+L+      K+ 
Sbjct: 104 ERNKNSLKVLTL-----VLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLG 155

Query: 365 DFGMARIFSGNQNEANTNRVAGTYG------YMAPEYAMEGVFSVKSDVFSFGVLLLEII 418
           DFG++R          +              +M+PE      F+  SDV+ F V + EI+
Sbjct: 156 DFGLSRYIEDEDYYKAS-------VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 208

Query: 419 S 419
           S
Sbjct: 209 S 209

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 92.4 bits (230), Expect = 8e-21
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 8/115 (6%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
           R +KD+     L     ++    IA+G+ YL      R++HRDL   NVL+    + KI+
Sbjct: 108 REHKDNIGSQYL-----LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKIT 159

Query: 365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           DFG+A++    + E +         +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.0 bits (229), Expect = 9e-21
 Identities = 37/104 (35%), Positives = 56/104 (53%), Gaps = 12/104 (11%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN-QNEANTN 382
           +   I + L YL E     VIHRD+K SN+LLD     K+ DFG     SG   ++   +
Sbjct: 129 MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFG----ISGRLVDDKAKD 182

Query: 383 RVAGTYGYMAPE-----YAMEGVFSVKSDVFSFGVLLLEIISGK 421
           R AG   YMAPE        +  + +++DV+S G+ L+E+ +G+
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 13/114 (11%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR- 370
           +      K  I     +A+G+ +L   +  + +HRDL   N +LD +   K++DFG+AR 
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241

Query: 371 IFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           ++    +  +      T       +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 242 MYDKEFDSVHN----KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 29/120 (24%), Positives = 58/120 (48%), Gaps = 18/120 (15%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
           R ++ +     L     ++    IA+G+ YL       ++HR+L   NVLL      +++
Sbjct: 106 RQHRGALGPQLL-----LNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVA 157

Query: 365 DFGMARIFSGNQNEANTNRVAGTYG-----YMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
           DFG+A +   +  +     +  +       +MA E    G ++ +SDV+S+GV + E+++
Sbjct: 158 DFGVADLLPPDDKQ-----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 46/201 (22%), Positives = 77/201 (38%), Gaps = 5/201 (2%)

Query: 221 GCCSIKIGGRVMYPSCNFRYELYQFYNDTSNGTLPPVF--FSPPSPGSVTSSKGGKGKKA 278
           G C+   G  ++         L  +     N  +P                +     K+ 
Sbjct: 93  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRR 152

Query: 279 TWIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHED 338
                 +  +  + F+   S          +      L  +  I     +A+G+ +L   
Sbjct: 153 LDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--- 209

Query: 339 SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAME 398
           +  + IHRDL   N+LL  +   KI DFG+AR    + +            +MAPE   +
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269

Query: 399 GVFSVKSDVFSFGVLLLEIIS 419
            V++++SDV+SFGVLL EI S
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFS 290

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 16/106 (15%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT------ 381
           I   L Y+H      +IHRDLK  N+ +D   N KI DFG+A+    + +          
Sbjct: 125 ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 382 ------NRVAGTYGYMAPE-YAMEGVFSVKSDVFSFGVLLLEIISG 420
                     GT  Y+A E     G ++ K D++S G++  E+I  
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.5 bits (232), Expect = 3e-20
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 6/111 (5%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
            K  ++       +++ ++ G+ YL        +HR+L   NVLL +    KISDFG+++
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSK 484

Query: 371 IFSGNQNEANTNRVAGTYGY--MAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
               + +     R AG +     APE      FS +SDV+S+GV + E +S
Sbjct: 485 ALGADDSYYTA-RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 90.1 bits (223), Expect = 1e-19
 Identities = 9/120 (7%), Positives = 27/120 (22%), Gaps = 10/120 (8%)

Query: 304 RRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 363
             ++                +   + R    L       ++H      N+ +  +    +
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLML 235

Query: 364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM--EGVFSVKSDVFSFGVLLLEIISGK 421
            D                   +    Y   E+       F+   + +  G+ +  +    
Sbjct: 236 GDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 90.6 bits (225), Expect = 1e-19
 Identities = 32/118 (27%), Positives = 56/118 (47%), Gaps = 12/118 (10%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-----DHEMNPKISDF 366
           K         I+++     GL +LH    L ++HRDLK  N+L+       ++   ISDF
Sbjct: 111 KDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDF 167

Query: 367 GMARIFSGNQNE-ANTNRVAGTYGYMAPEY---AMEGVFSVKSDVFSFGVLLLEIISG 420
           G+ +  +  ++  +  + V GT G++APE      +   +   D+FS G +   +IS 
Sbjct: 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 48/239 (20%), Positives = 84/239 (35%), Gaps = 53/239 (22%)

Query: 288 TTITLFILLGSFVWCRR-----RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 342
                ++LL    + +R      I +   KG  L   + + ++ GI RGL  +H      
Sbjct: 101 AKHEAWLLLP---FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KG 154

Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVA-------GTYGYMAPE- 394
             HRDLK +N+LL  E  P + D G       +   +              T  Y APE 
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214

Query: 395 -----YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF-YLSEHGQSLL-----TYAWKLW 443
                + +      ++DV+S G +L  ++ G+    +  + + G S+        +    
Sbjct: 215 FSVQSHCVID---ERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSVALAVQNQLSIPQS 269

Query: 444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPP 502
            +          L Q      LL         +  DP  RP++  ++  L +     P 
Sbjct: 270 PR------HSSALWQ------LLNS------MMTVDPHQRPHIPLLLSQLEALQPPAPG 310

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 91.1 bits (226), Expect = 2e-19
 Identities = 32/111 (28%), Positives = 48/111 (43%), Gaps = 8/111 (7%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 370
            +   LD    I     ++  L YL      R +HRD+   NVL+      K+ DFG++R
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539

Query: 371 IFSGNQNEANTNRVAGTY--GYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
                ++        G     +MAPE      F+  SDV+ FGV + EI+ 
Sbjct: 540 YM---EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 27/101 (26%), Positives = 43/101 (42%), Gaps = 18/101 (17%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +     Y+H  +   + HRD+K SN+L+D     K+SDFG +      +         GT
Sbjct: 160 VLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGT 213

Query: 388 YGYMAPEYAMEGVFSVK-------SDVFSFGVLLLEIISGK 421
           Y +M PE      FS +        D++S G+ L  +    
Sbjct: 214 YEFMPPE-----FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 15/105 (14%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   +  +H+     ++H DLK +N L+  +   K+ DFG+A     +      +   GT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 388 YGYMAPE-----------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
             YM PE              +   S KSDV+S G +L  +  GK
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 86.8 bits (216), Expect = 4e-19
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR---V 384
           I  G+LYLH      ++HRDL  SN+LL   MN KI+DFG+A      Q +    +   +
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTL 172

Query: 385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            GT  Y++PE A      ++SDV+S G +   ++ G+
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 15/105 (14%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   +  +H+     ++H DLK +N L+  +   K+ DFG+A     +      +   GT
Sbjct: 117 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 388 YGYMAPE-----------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
             YM PE              +   S KSDV+S G +L  +  GK
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 87.9 bits (218), Expect = 6e-19
 Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 15/105 (14%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   +  +H+     ++H DLK +N L+  +   K+ DFG+A     +      +   G 
Sbjct: 164 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219

Query: 388 YGYMAPE-----------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
             YM PE              +   S KSDV+S G +L  +  GK
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 87.8 bits (217), Expect = 6e-19
 Identities = 18/123 (14%), Positives = 40/123 (32%), Gaps = 20/123 (16%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S+    L    R+ +   + R L  LH      ++H  L+  +++LD      ++ F   
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEY-----------AMEGVFSVKSDVFSFGVLLLEII 418
                          + + G+  PE                + +   D ++ G+++  I 
Sbjct: 254 VRDG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 419 SGK 421
              
Sbjct: 308 CAD 310

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 12/101 (11%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I GI     YLH     ++IHRD+K SN+L+  + + KI+DFG++  F G+    +   
Sbjct: 146 LIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN-- 196

Query: 384 VAGTYGYMAPE--YAMEGVFS-VKSDVFSFGVLLLEIISGK 421
             GT  +MAPE       +FS    DV++ GV L   + G+
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 29/99 (29%), Positives = 46/99 (46%), Gaps = 7/99 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNR--- 383
              GL YLH     R++H D+K  NVLL  + +   + DFG A     +    +      
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           + GT  +MAPE  M      K D++S   ++L +++G  
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 11/97 (11%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR---V 384
           I  G  YLH   R RVIHRDLK  N+ L+ ++  KI DFG+A      + E +  R   +
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVL 175

Query: 385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            GT  Y+APE   +   S + DV+S G ++  ++ GK
Sbjct: 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 22/122 (18%), Positives = 43/122 (35%), Gaps = 28/122 (22%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--------KI 363
               ++   ++ +   +A  + +L       +IH ++   N+LL  E +         K+
Sbjct: 106 NKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162

Query: 364 SDFGMARIFSGNQNEANTNRVAGTYGY-----MAPEYAMEG-VFSVKSDVFSFGVLLLEI 417
           SD G++                          + PE        ++ +D +SFG  L EI
Sbjct: 163 SDPGISITVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211

Query: 418 IS 419
            S
Sbjct: 212 CS 213

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 87.6 bits (217), Expect = 3e-18
 Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 12/97 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL ++H      V++RDLK +N+LLD   + +ISD G+A  FS  +     +   GT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353

Query: 388 YGYMAPEYAMEGV---FSVKSDVFSFGVLLLEIISGK 421
           +GYMAPE   +GV    S   D FS G +L +++ G 
Sbjct: 354 HGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 11/97 (11%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR---V 384
           I  G  YLH   R RVIHRDLK  N+ L+ ++  KI DFG+A      + E +  R   +
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVL 201

Query: 385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            GT  Y+APE   +   S + DV+S G ++  ++ GK
Sbjct: 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 36/98 (36%), Positives = 57/98 (58%), Gaps = 5/98 (5%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I+  I +GL YLH +   + IHRD+K +NVLL      K++DFG+A   +  Q + NT  
Sbjct: 124 ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-- 178

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             GT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 87.0 bits (215), Expect = 3e-18
 Identities = 43/172 (25%), Positives = 63/172 (36%), Gaps = 22/172 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEANTNRV 384
           I+  L YLHE    R+IHRDLK  N++L      +  KI D G A+     +        
Sbjct: 130 ISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTE--F 183

Query: 385 AGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR-------NSGFYLSEHGQSLLT 437
            GT  Y+APE   +  ++V  D +SFG L  E I+G R          ++     +S   
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243

Query: 438 YAWKLWCKGEA---LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM 486
                   G       L  P      +  +L + +   L         R   
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTD 292

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 86.4 bits (214), Expect = 4e-18
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL +LH+     +I+RDLK  NVLLD + N +ISD G+A      Q +      AGT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGT 352

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            G+MAPE  +   +    D F+ GV L E+I+ +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 8/98 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAG 386
           I  GL YLH++   +++HRD+K  NVL++ +    KISDFG ++  +G      T    G
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTG 185

Query: 387 TYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISGKR 422
           T  YMAPE   +G   +   +D++S G  ++E+ +GK 
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 83.0 bits (206), Expect = 7e-18
 Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 7/94 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  L Y H     RVIHRD+K  N+LL      KI+DFG    +S +   +    + GT
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGT 170

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+ PE     +   K D++S GVL  E + GK
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 37/98 (37%), Positives = 57/98 (58%), Gaps = 5/98 (5%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I+    +GL YLH     R IHRD+K  N+LL+ E + K++DFG+A   +    + NT  
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-- 184

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           V GT  +MAPE   E  ++  +D++S G+  +E+  GK
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 32/101 (31%), Positives = 59/101 (58%), Gaps = 6/101 (5%)

Query: 322 ISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 380
           I+ +     + L +LH +   +VIHRD+K+ N+LL  + + K++DFG     +  Q++ +
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174

Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           T  + GT  +MAPE      +  K D++S G++ +E+I G+
Sbjct: 175 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 27/161 (16%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   L YL      R+IHRD+K  N+LLD   +  I+DF +A +      +  T  +AGT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT--MAGT 177

Query: 388 YGYMAPE--YAMEGV---FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL 442
             YMAPE   + +G    F+V  D +S GV   E++ G+R   +++     S        
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRRP--YHIRSSTSSKEIVHTFE 233

Query: 443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHR 483
                          Q  V   LLK     LL  + +P  R
Sbjct: 234 TTVVT----YPSAWSQEMVS--LLK----KLL--EPNPDQR 262

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 23/106 (21%), Positives = 46/106 (43%), Gaps = 18/106 (16%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLL----DHEMNPKISDFGMARIFSGNQNEANTNR 383
           +  G+ +L E     ++HR++K  N++     D +   K++DFG AR    ++    +  
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS-- 174

Query: 384 VAGTYGYMAPE--------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
           + GT  Y+ P+           +  +    D++S GV      +G 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.1 bits (208), Expect = 3e-17
 Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL  LH     R+++RDLK  N+LLD   + +ISD G+A      Q         GT
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGT 348

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            GYMAPE      ++   D ++ G LL E+I+G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 39/226 (17%), Positives = 73/226 (32%), Gaps = 57/226 (25%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I     R + ++H   +  +IHRDLK  N+LL ++   K+ DFG A   S   + + + +
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199

Query: 384 VA----------GTYGYMAPEYAMEGVFSV--------KSDVFSFGVLLLEIISGKRNSG 425
                        T  Y  PE     +  +        K D+++ G +L  +   +    
Sbjct: 200 RRALVEEEITRNTTPMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ--HP 252

Query: 426 FYLSEHGQSLL-----TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDP 480
           F       + L      Y+               V         L++        +Q +P
Sbjct: 253 FE----DGAKLRIVNGKYSIPPHDT------QYTVFHS------LIRA------MLQVNP 290

Query: 481 AHRPNMSSVV----VMLASDTATLPPPTQPAFSVDRIAAKSGQSSS 522
             R +++ VV     + A+       P       +     +  S  
Sbjct: 291 EERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRG 336

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 3/94 (3%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S    +A  N   GT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y++PE   E      SD+++ G ++ ++++G 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 80.3 bits (199), Expect = 5e-17
 Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 32/166 (19%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           ++ G+     YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N+
Sbjct: 114 LMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 384 VAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
           + GT  Y+APE     +           DV+S G++L  +++G       L     S   
Sbjct: 167 MCGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAG------ELPWDQPSDSC 215

Query: 438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHR 483
             +  W + +        +    +   LL  I    L    +P+ R
Sbjct: 216 QEYSDWKEKKTYLNPWKKIDSAPLA--LLHKI----LVE--NPSAR 253

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 82.2 bits (203), Expect = 5e-17
 Identities = 23/106 (21%), Positives = 46/106 (43%), Gaps = 18/106 (16%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLL----DHEMNPKISDFGMARIFSGNQNEANTNR 383
           +  G+ +L E     ++HR++K  N++     D +   K++DFG AR    ++    +  
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS-- 174

Query: 384 VAGTYGYMAPE--------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
           + GT  Y+ P+           +  +    D++S GV      +G 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 25/121 (20%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-------------KISDFGM 368
           IS++  IA G+ +LH    L++IHRDLK  N+L+                    ISDFG+
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174

Query: 369 ARIFSGNQN--EANTNRVAGTYGYMAPEYAMEGVFSV-------KSDVFSFGVLLLEIIS 419
            +     Q+    N N  +GT G+ APE   E              D+FS G +   I+S
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

Query: 420 G 420
            
Sbjct: 235 K 235

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 80.3 bits (199), Expect = 5e-17
 Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 7/94 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  L Y H     +VIHRD+K  N+L+ ++   KI+DFG    +S +        + GT
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRTMCGT 175

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+ PE         K D++  GVL  E + G 
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I   I RGL +LH+    +VIHRD+K  NVLL      K+ DFG++          NT  
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 188

Query: 384 VAGTYGYMAPE-----YAMEGVFSVKSDVFSFGVLLLEIISGK 421
             GT  +MAPE        +  +  KSD++S G+  +E+  G 
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 29/98 (29%), Positives = 56/98 (57%), Gaps = 5/98 (5%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +   + + L YLH      VIHRD+K+ ++LL  +   K+SDFG     S +  +  +  
Sbjct: 146 VCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-- 200

Query: 384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           + GT  +MAPE     +++ + D++S G++++E++ G+
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 52/221 (23%), Positives = 83/221 (37%), Gaps = 39/221 (17%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           ++ G+     YLH    + + HRD+K  N+LLD   N KISDFG+A +F  N  E   N+
Sbjct: 114 LMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 384 VAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLLLEIISGKRNSGFYL--SEHGQSL 435
           + GT  Y+APE     +           DV+S G++L  +++G       L   +   S 
Sbjct: 167 MCGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAG------ELPWDQPSDSC 215

Query: 436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV---M 492
             Y    W + +        +    +   LL  I    L    +P+ R  +  +      
Sbjct: 216 QEY--SDWKEKKTYLNPWKKIDSAPLA--LLHKI----LVE--NPSARITIPDIKKDRWY 265

Query: 493 LASDTATLPPPTQPAFSVDRIAAKSGQSSSSGSKFCSVNEI 533
                     P   +  V    +   +   S   F  VN  
Sbjct: 266 NKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSA 306

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 79.7 bits (197), Expect = 9e-17
 Identities = 35/181 (19%), Positives = 58/181 (32%), Gaps = 54/181 (29%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-------------------KISDFGM 368
           + RGL Y+H      ++H D+K SN+ +     P                   KI D G 
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFY 427
               S      +     G   ++A E   E      K+D+F+  + ++     +      
Sbjct: 181 VTRIS------SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP----- 229

Query: 428 LSEHGQSLLTYAWKLWCKGEALELMD---PVLKQTCVDAELLKCIHIGLLCVQEDPAHRP 484
           L  +G       W    +G    +               ELLK      + +  DP  RP
Sbjct: 230 LPRNGDQ-----WHEIRQGRLPRIPQVLSQEFT------ELLK------VMIHPDPERRP 272

Query: 485 N 485
           +
Sbjct: 273 S 273

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 27/129 (20%), Positives = 48/129 (37%), Gaps = 30/129 (23%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   + YL       +IHRD+K  N+++  +   K+ DFG A      +         GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGT 192

Query: 388 YGYMAPEYAMEGVFSVKS------DVFSFGVLLLEIISG--------KRNSG-----FYL 428
             Y APE     V           +++S GV L  ++          +         + +
Sbjct: 193 IEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247

Query: 429 SEHGQSLLT 437
           S+   SL++
Sbjct: 248 SKELMSLVS 256

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 19/105 (18%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +I+G+     YLH      ++H+D+K  N+LL      KIS  G+A        +     
Sbjct: 118 LIDGLE----YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170

Query: 384 VAGTYGYMAPEYAMEGVFS-------VKSDVFSFGVLLLEIISGK 421
             G+  +  PE     + +        K D++S GV L  I +G 
Sbjct: 171 SQGSPAFQPPE-----IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 10/103 (9%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA 379
            II  +  G+ YLH+     ++HRDLK  N+LL   + +   KI DFG++ +F   +   
Sbjct: 140 VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--- 193

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
                 GT  Y+APE  +   +  K DV+S GV+L  +++G  
Sbjct: 194 KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 35/101 (34%), Positives = 56/101 (55%), Gaps = 10/101 (9%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA 379
            II  +  G+ Y+H+    +++HRDLK  N+LL     + N +I DFG++  F  ++   
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--- 183

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                 GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 184 KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 79.7 bits (197), Expect = 5e-16
 Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 10/103 (9%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA 379
           +I+  I  G+ YLH+     ++HRD+K  N+LL   +  +N KI DFG++  FS +    
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--- 203

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
                 GT  Y+APE  ++  ++ K DV+S GV++  ++ G  
Sbjct: 204 KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 29/103 (28%), Positives = 53/103 (51%), Gaps = 10/103 (9%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +   +   L +LH     R+IHRDLK  NVL+  E + +++DFG++        + ++  
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-- 176

Query: 384 VAGTYGYMAPE-----YAMEGVFSVKSDVFSFGVLLLEIISGK 421
             GT  +MAPE        +  +  K+D++S G+ L+E+   +
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 32/105 (30%), Positives = 47/105 (44%), Gaps = 9/105 (8%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--DHEMNPKISDFGMARIFSGNQNEAN 380
           +I+  I   L YLH      + HRD+K  N L   +     K+ DFG+++ F    N   
Sbjct: 172 NIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228

Query: 381 T--NRVAGTYGYMAPE--YAMEGVFSVKSDVFSFGVLLLEIISGK 421
                 AGT  ++APE        +  K D +S GVLL  ++ G 
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 18/102 (17%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           + R +  LH  S + V HRD+K  NVL++      K+ DFG A+  S   +E N   +  
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS--PSEPNVAYICS 194

Query: 387 TYGYMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
            Y Y APE       Y      +   D++S G +  E++ G+
Sbjct: 195 RY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 77.8 bits (192), Expect = 9e-16
 Identities = 35/101 (34%), Positives = 50/101 (49%), Gaps = 12/101 (11%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           + +G  +GL YLH      +IHRD+K  N+LL      K+ DFG     +     AN+  
Sbjct: 159 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS-- 209

Query: 384 VAGTYGYMAPE---YAMEGVFSVKSDVFSFGVLLLEIISGK 421
             GT  +MAPE      EG +  K DV+S G+  +E+   K
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 77.7 bits (192), Expect = 9e-16
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 21/104 (20%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I++ +     Y H   + R++HRDLK  N+LLD +MN KI+DFG +  F+        + 
Sbjct: 123 IVSAVQ----YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DA 172

Query: 384 VAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLLLEIISGK 421
             G   Y APE     +F        + DV+S GV+L  ++SG 
Sbjct: 173 FCGAPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 8/96 (8%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN---TNRVAG 386
            GL Y+H +   +++HRD+K +NVL+  +   K++DFG+AR FS  +N      TNRV  
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190

Query: 387 TYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
           T  Y  PE  + E  +    D++  G ++ E+ +  
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 20/105 (19%), Positives = 43/105 (40%), Gaps = 10/105 (9%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT-- 381
           I+ G+ + L Y+H       +HR +K S++L+  +    +S          +        
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189

Query: 382 ---NRVAGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISGK 421
                      +++PE   + +  +  KSD++S G+   E+ +G 
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 10/101 (9%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA 379
            II  +  G+ Y+H+     ++HRDLK  N+LL   + + + KI DFG++  F  N    
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--- 178

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
                 GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 179 KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
            I+  +   +  LH+   L ++HRDLK  N+LLD +MN K++DFG +      +      
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLR 181

Query: 383 RVAGTYGYMAPE------YAMEGVFSVKSDVFSFGVLL 414
            V GT  Y+APE            +  + D++S GV++
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 7/103 (6%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM-ARIFSGNQNEANT 381
           +I+  +  GL YLH++     IHRD+K  N+LL  + + +I+DFG+ A + +G     N 
Sbjct: 125 TILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181

Query: 382 NR--VAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
            R    GT  +MAPE   +   +  K+D++SFG+  +E+ +G 
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 29/95 (30%), Positives = 41/95 (43%), Gaps = 8/95 (8%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEA 379
             +  I   L Y H+     +IHRD+K   VLL  + N    K+  FG+A     +   A
Sbjct: 134 HYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                 GT  +MAPE      +    DV+  GV+L
Sbjct: 191 GG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 74.9 bits (185), Expect = 6e-15
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 18/99 (18%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RG+ + H+    R++HRDLK  N+L++ +   K++DFG+AR F G    + T+ V  T  
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLW 184

Query: 390 YMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y AP+       Y      S   D++S G +  E+I+GK
Sbjct: 185 YRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 12/98 (12%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           SI+  +   + +LH      ++HRDLK  N+LLD  M  ++SDFG +      +      
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLR 257

Query: 383 RVAGTYGYMAPE------YAMEGVFSVKSDVFSFGVLL 414
            + GT GY+APE            +  + D+++ GV+L
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 74.1 bits (183), Expect = 8e-15
 Identities = 22/65 (33%), Positives = 34/65 (52%), Gaps = 5/65 (7%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           +GL + H      V+HRDLK  N+L++     K+++FG+AR F G      +  V  T  
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLW 166

Query: 390 YMAPE 394
           Y  P+
Sbjct: 167 YRPPD 171

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 18/99 (18%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           +GL YLH+     ++HRDLK +N+LLD     K++DFG+A+ F G+ N A T++V  T  
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRW 177

Query: 390 YMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE       Y       V  D+++ G +L E++   
Sbjct: 178 YRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 18/99 (18%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           +GL + HE+   +++HRDLK  N+L++     K+ DFG+AR F G      ++ V  T  
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLW 173

Query: 390 YMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y AP+       Y      S   D++S G +L E+I+GK
Sbjct: 174 YRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 72.9 bits (180), Expect = 2e-14
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 18/99 (18%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
            G+ Y H+    RV+HRDLK  N+L++ E   KI+DFG+AR F G      T+ +  T  
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLW 165

Query: 390 YMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y AP+       Y      S   D++S G +  E+++G 
Sbjct: 166 YRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 9/96 (9%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-DHEMNP---KISDFGMARIFSGNQNE 378
           +++  I + + YLH      V+HRDLK SN+L  D   NP   +I DFG A+        
Sbjct: 120 AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176

Query: 379 ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
             T     T  ++APE      +    D++S GVLL
Sbjct: 177 LMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL Y H     +V+HRDLK  N+L++     K++DFG+AR       +   N V  T  
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLW 165

Query: 390 YMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
           Y  P+  +    +S + D++  G +  E+ +G+
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 6/92 (6%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL +LH     RV+HRDLK  N+L+      K++DFG+ARI+S       T+ V  T  
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV-TLW 184

Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 21/104 (20%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           II  I     Y H   R +++HRDLK  N+LLD  +N KI+DFG++ I +       T+ 
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS- 167

Query: 384 VAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLLLEIISGK 421
             G+  Y APE     V +       + DV+S G++L  ++ G+
Sbjct: 168 -CGSPNYAAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 12/98 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           + R + ++H    L + HRD+K  N+L++ + N  K+ DFG A+      +E +   +  
Sbjct: 150 LFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICS 204

Query: 387 TYGYMAPEY---AMEGVFSVKSDVFSFGVLLLEIISGK 421
            + Y APE    A E  ++   D++S G +  E+I GK
Sbjct: 205 RF-YRAPELMLGATE--YTPSIDLWSIGCVFGELILGK 239

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG 389
           RGL +LH +    ++HRDLK  N+L+      K++DFG+ARI+S       T  V  T  
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVV-TLW 184

Query: 390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 34/113 (30%), Positives = 53/113 (46%), Gaps = 10/113 (8%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNP 361
           RI     +G  L       ++  +   L Y H      V+H+DLK  N+L          
Sbjct: 110 RIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPI 166

Query: 362 KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
           KI DFG+A +F  ++   ++   AGT  YMAPE   +   + K D++S GV++
Sbjct: 167 KIIDFGLAELFKSDE---HSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 10/95 (10%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA 379
            I+  +   + Y H+   L V HRDLK  N L      +   K+ DFG+A  F   +   
Sbjct: 110 RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--- 163

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                 GT  Y++P+  +EG++  + D +S GV++
Sbjct: 164 MMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 21/104 (20%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I++ +     Y H   R  V+HRDLK  NVLLD  MN KI+DFG++ + S       T  
Sbjct: 120 ILSAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT-- 169

Query: 384 VAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLLLEIISGK 421
             G+  Y APE     V S       + D++S GV+L  ++ G 
Sbjct: 170 SCGSPNYAAPE-----VISGRLYAGPEVDIWSCGVILYALLCGT 208

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 6/100 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH  S   V++RDLK  N++LD + + KI+DFG+ +   G ++ A      GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 312

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
             Y+APE   +  +    D +  GV++ E++ G+    FY
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFY 350

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 30/129 (23%), Positives = 45/129 (34%), Gaps = 32/129 (24%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVAG 386
           +   + + H      V+HRD+K  N+L+D      K+ DFG   +              G
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 210

Query: 387 TYGYMAPEYAMEGVFS------VKSDVFSFGVLL-------------LEIISGKRNSGFY 427
           T  Y  PE                + V+S G+LL              EII G+      
Sbjct: 211 TRVYSPPE-----WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 265

Query: 428 LSEHGQSLL 436
           +S   Q L+
Sbjct: 266 VSSECQHLI 274

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 8/95 (8%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA 379
            I+  +   + ++H+   + V+HRDLK  N+L    +  +  KI DFG AR+   +    
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
            T     T  Y APE   +  +    D++S GV+L
Sbjct: 167 KT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 28/129 (21%), Positives = 48/129 (37%), Gaps = 32/129 (24%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           +   + + H      V+HRD+K  N+L+D      K+ DFG   +              G
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDG 200

Query: 387 TYGYMAPEYAMEGVFS------VKSDVFSFGVLL-------------LEIISGKRNSGFY 427
           T  Y  PE       S      + + V+S G+LL              EI+  + +   +
Sbjct: 201 TRVYSPPE-----WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAH 255

Query: 428 LSEHGQSLL 436
           +S    +L+
Sbjct: 256 VSPDCCALI 264

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 20/102 (19%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           + R L Y+H      + HRD+K  N+LLD +    K+ DFG A+     + E N + +  
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICS 219

Query: 387 TYGYMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
            Y Y APE       Y      +   DV+S G +L E++ G+
Sbjct: 220 RY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 10/95 (10%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA 379
            II  +  G+ Y+H+     ++HRDLK  N+LL   + + + KI DFG++  F  N    
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--- 178

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                 GT  Y+APE  + G +  K DV+S GV+L
Sbjct: 179 KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 71.8 bits (177), Expect = 6e-14
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 10/94 (10%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEAN 380
           +I  +   + YLHE     ++HRDLK  N+L    +      I+DFG++++         
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---- 163

Query: 381 TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
            +   GT GY+APE   +  +S   D +S GV+ 
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.8 bits (177), Expect = 6e-14
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 7/100 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +A  L +LH    L +I+RDLK  N+LLD E + K++DFG+++    ++ +A +    GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
             YMAPE       +  +D +SFGVL+ E+++G     F 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT--LPFQ 227

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 32/101 (31%), Positives = 46/101 (45%), Gaps = 18/101 (17%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  G+ + H      +IHRD+K  N+L+      K+ DFG AR       E   + VA T
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-T 187

Query: 388 YGYMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y APE       Y      +V  DV++ G L+ E+  G+
Sbjct: 188 RWYRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 28/97 (28%), Positives = 44/97 (45%), Gaps = 10/97 (10%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP----KISDFGMARIFSGNQN 377
              +  I  G+ YLH    L++ H DLK  N++L     P    KI DFG+A        
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 172

Query: 378 EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                 + GT  ++APE        +++D++S GV+ 
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 71.9 bits (176), Expect = 9e-14
 Identities = 20/129 (15%), Positives = 39/129 (30%), Gaps = 15/129 (11%)

Query: 305 RINK-DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-- 361
            IN   +T    +     IS    +   +  +H+     +IH D+K  N +L +      
Sbjct: 157 AINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQD 213

Query: 362 ---------KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGV 412
                     + D G +                 T G+   E      ++ + D F    
Sbjct: 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAA 273

Query: 413 LLLEIISGK 421
            +  ++ G 
Sbjct: 274 TVYCMLFGT 282

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 71.4 bits (176), Expect = 1e-13
 Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L +LH+     +I+RDLK  N++L+H+ + K++DFG+ +    +    +T    GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             YMAPE  M    +   D +S G L+ ++++G 
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 10/97 (10%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP----KISDFGMARIFSGNQN 377
            S I  I  G+ YLH     ++ H DLK  N++L  +  P    K+ DFG+A        
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV- 173

Query: 378 EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                 + GT  ++APE        +++D++S GV+ 
Sbjct: 174 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 8/95 (8%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEA 379
             I  I   +L+ H+   + V+HR+LK  N+LL  ++     K++DFG+A    G Q   
Sbjct: 114 HCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                AGT GY++PE   +  +    D+++ GV+L
Sbjct: 171 FG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 36/111 (32%), Positives = 58/111 (52%), Gaps = 12/111 (10%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L +LH+   L +I+RD+K  N+LLD   +  ++DFG+++ F  ++ E       GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 223

Query: 388 YGYMAPEYAMEG----VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
             YMAP+    G      +V  D +S GVL+ E+++G   S F +     S
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA--SPFTVDGEKNS 270

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 9/95 (9%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEA 379
             I  I   + Y H      ++HR+LK  N+LL  +      K++DFG+A   + ++   
Sbjct: 109 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--- 162

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
             +  AGT GY++PE   +  +S   D+++ GV+L
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L YLHE     +I+RDLK  NVLLD E + K++D+GM +      +  +T    GT
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 173

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 7/100 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L YLH      V++RD+K  N++LD + + KI+DFG+ +   G  + A      GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 168

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
             Y+APE   +  +    D +  GV++ E++ G+    FY
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFY 206

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 24/103 (23%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVAGTY 388
           + L Y H  S   ++HRD+K  NV++DHE    ++ D+G+A  +   Q      RVA  Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRY 195

Query: 389 GYMAPE---------YAMEGVFSVKSDVFSFGVLLLEIISGKR 422
            +  PE         Y++        D++S G +L  +I  K 
Sbjct: 196 -FKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 30/106 (28%), Positives = 48/106 (45%), Gaps = 18/106 (16%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 382
           SI     + + + H   +   IHRD+K  N+L+      K+ DFG AR+     ++   +
Sbjct: 106 SITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDD 161

Query: 383 RVAGTYGYMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
            VA T  Y +PE       Y       V  DV++ G +  E++SG 
Sbjct: 162 EVA-TRWYRSPELLVGDTQYGP----PV--DVWAIGCVFAELLSGV 200

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 20/102 (19%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVAG 386
           + R L Y+H    + + HRD+K  N+LLD      K+ DFG A+I      E N + +  
Sbjct: 150 LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICS 204

Query: 387 TYGYMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
            Y Y APE       Y      +   D++S G ++ E++ G+
Sbjct: 205 RY-YRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 27/97 (27%), Positives = 44/97 (45%), Gaps = 10/97 (10%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP----KISDFGMARIFSGNQN 377
              +  I  G+ YLH     R+ H DLK  N++L  +  P    K+ DFG+A        
Sbjct: 111 TQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN- 166

Query: 378 EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                 + GT  ++APE        +++D++S GV+ 
Sbjct: 167 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   L++LH+     +I+RDLK  NVLLDHE + K++DFGM +    N     T    GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE   E ++    D ++ GVLL E++ G 
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I+  L YLHE     +I+RDLK  NVLLD E + K++D+GM +      +  +T    GT
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 9/95 (9%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEA 379
             I  I   + Y H      ++HR+LK  N+LL  +      K++DFG+A   + ++   
Sbjct: 132 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--- 185

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
             +  AGT GY++PE   +  +S   D+++ GV+L
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 37/97 (38%), Positives = 56/97 (57%), Gaps = 7/97 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN--TNRVA 385
           I RGL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR+   + +     T  VA
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 386 GTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
            T  Y APE  +    ++   D++S G +L E++S +
Sbjct: 194 -TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 21/104 (20%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           I++G+     Y H   R  V+HRDLK  NVLLD  MN KI+DFG++ + S       T+ 
Sbjct: 125 ILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS- 175

Query: 384 VAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLLLEIISGK 421
             G+  Y APE     V S       + D++S GV+L  ++ G 
Sbjct: 176 -CGSPNYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCGT 213

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 8/95 (8%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMARIFSGNQNEA 379
           I  +  I  G+ ++H+   + ++H DLK  N+L  +      KI DFG+AR +   +   
Sbjct: 190 ILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                 GT  ++APE       S  +D++S GV+ 
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 10/97 (10%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP----KISDFGMARIFSGNQN 377
            S I  I  G+ YLH     ++ H DLK  N++L  +  P    K+ DFG+A        
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV- 173

Query: 378 EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                 + GT  ++APE        +++D++S GV+ 
Sbjct: 174 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 7/100 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL +LH      +++RDLK  N+LLD + + KI+DFGM +       + NT    GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 181

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
             Y+APE  +   ++   D +SFGVLL E++ G+  S F+
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFH 219

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 23/95 (24%), Positives = 43/95 (45%), Gaps = 8/95 (8%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMARIFSGNQNEA 379
           I+ +     GL ++HE     ++H D+K  N++ + +     KI DFG+A   + ++   
Sbjct: 152 INYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 205

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                  T  + APE          +D+++ GVL 
Sbjct: 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 7/100 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA  L YLH    L +++RDLK  N+LLD + +  ++DFG+ +    + +  +T    GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGT 202

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
             Y+APE   +  +    D +  G +L E++ G     FY
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL--PPFY 240

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA GL +L       +I+RDLK  NV+LD E + KI+DFGM +    +     T    GT
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 184

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y+APE      +    D ++FGVLL E+++G+
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR      +   T  V  T
Sbjct: 136 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV-T 189

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +   +    D++S G ++ E+I G 
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 9/95 (9%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA 379
             +  I   + YLHE     ++HRDLK  N+L      +   KI+DFG+++I        
Sbjct: 152 DAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--- 205

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
               V GT GY APE      +  + D++S G++ 
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 12/93 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEANTNRV 384
           +   + YLHE     +IHRDLK  NVLL   + +   KI+DFG ++I  G  +   T  +
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--L 176

Query: 385 AGTYGYMAPE---YAMEGVFSVKSDVFSFGVLL 414
            GT  Y+APE         ++   D +S GV+L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.8 bits (173), Expect = 5e-13
 Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 7/100 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           IA GL +L       +I+RDLK  NV+LD E + KI+DFGM +      +   T    GT
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGT 505

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
             Y+APE      +    D ++FGVLL E+++G+  + F 
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFE 543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 31/93 (33%), Positives = 44/93 (47%), Gaps = 12/93 (12%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRV 384
           +   + YLHE     +IHRDLK  NVLL  +      KI+DFG ++I            +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTL 301

Query: 385 AGTYGYMAPE---YAMEGVFSVKSDVFSFGVLL 414
            GT  Y+APE         ++   D +S GV+L
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 24/95 (25%), Positives = 41/95 (43%), Gaps = 8/95 (8%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMARIFSGNQNEA 379
           +S ++ +   L +LH      + H D++  N++     +   KI +FG AR         
Sbjct: 105 VSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
           N   +     Y APE     V S  +D++S G L+
Sbjct: 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 68.8 bits (169), Expect = 7e-13
 Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 11/100 (11%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-----KISDFGMARIFSGNQNEANTN 382
           +  G+ + H     R +HRDLK  N+LL           KI DFG+AR F G      T+
Sbjct: 141 LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTH 196

Query: 383 RVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK 421
            +  T  Y  PE  +    +S   D++S   +  E++   
Sbjct: 197 EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 16/105 (15%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEA 379
            ++  +A  L +LH      + HRDLK  N+L +H       KI DF +      N + +
Sbjct: 115 VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 380 NTNR-----VAGTYGYMAPE-----YAMEGVFSVKSDVFSFGVLL 414
             +        G+  YMAPE          ++  + D++S GV+L
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 69.1 bits (169), Expect = 9e-13
 Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 21/104 (20%)

Query: 330 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP----KISDFGMARIFSG-NQNEANTNRV 384
            G+ YLH +    V+HRDLK +N+L+  E       KI+D G AR+F+   +  A+ + V
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 385 AGTYGYMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
             T+ Y APE       Y      +   D+++ G +  E+++ +
Sbjct: 196 VVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 10/95 (10%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA 379
            I+  I   + +LH      + HRD+K  N+L    + +   K++DFG A+  + N    
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--- 185

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                  T  Y+APE      +    D++S GV++
Sbjct: 186 -LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR      +   T  V  T
Sbjct: 173 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV-T 226

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +   +    D++S G ++ E++  K
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 8/95 (8%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMARIFSGNQNEA 379
           +  +  + +GL ++HE      +H DLK  N++   + +   K+ DFG+       Q   
Sbjct: 258 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 311

Query: 380 NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
           +     GT  + APE A        +D++S GVL 
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 9/96 (9%)

Query: 322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE 378
           I +I  I  G+ YLH+     ++H DLK  N+LL       + KI DFGM+R        
Sbjct: 134 IRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-- 188

Query: 379 ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
                + GT  Y+APE       +  +D+++ G++ 
Sbjct: 189 -ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 38/160 (23%), Positives = 63/160 (39%), Gaps = 22/160 (13%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   L  +H    +  IHRD+K  N+LLD   + K++DFG     +        +   GT
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGT 232

Query: 388 YGYMAPE----YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW 443
             Y++PE       +G +  + D +S GV L E++ G   + FY         TY+  + 
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFYADSLVG---TYSKIMN 287

Query: 444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHR 483
            K       D  + +   +  L+       L    D   R
Sbjct: 288 HKNSLTFPDDNDISKEAKN--LIC----AFLT---DREVR 318

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 29/98 (29%), Positives = 54/98 (55%), Gaps = 8/98 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEAN--TNRV 384
           + RGL Y+H  +   V+HRDLK +N+ ++ E +  KI DFG+ARI   + +     +  +
Sbjct: 129 LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185

Query: 385 AGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK 421
             T  Y +P   +    ++   D+++ G +  E+++GK
Sbjct: 186 V-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 23/99 (23%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH--EMNPKISDFGMARIFSGNQNEANT 381
           +++G++    Y H    +++ HRDLK  N LLD       KI DFG ++    + ++  +
Sbjct: 125 LLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 176

Query: 382 NRVAGTYGYMAPEYAMEGVFS------VKSDVFSFGVLL 414
               GT  Y+APE     V          +DV+S GV L
Sbjct: 177 --TVGTPAYIAPE-----VLLRQEYDGKIADVWSCGVTL 208

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 7/95 (7%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I  GL  LHE     V+HRDL   N+LL    +  I DF +AR  +   +   T+ V   
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDT--ADANKTHYVT-H 196

Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  M+   F+   D++S G ++ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 9/95 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I RGL Y+H      +IHRDLK SN+ ++ +   KI DFG+AR  +       T  VA T
Sbjct: 141 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVA-T 192

Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    ++   D++S G ++ E+++G+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 66.0 bits (162), Expect = 5e-12
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 20/99 (20%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   L YLH      +I+RDLK  N+LLD   + KI+DFG A+          T  + GT
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166

Query: 388 YGYMAPE------YAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y+APE      Y      S+  D +SFG+L+ E+++G
Sbjct: 167 PDYIAPEVVSTKPYNK----SI--DWWSFGILIYEMLAG 199

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL Y+H      V+HRDLK  N+ ++ +   KI DFG+AR          T  V  T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVV-T 186

Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    ++   D++S G ++ E+++GK
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 11/96 (11%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP----KISDFGMARIFSGNQNE 378
            I+  I   + YLH    + + HRD+K  N+L   +  P    K++DFG A+  + +   
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHN-- 218

Query: 379 ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLL 414
            +      T  Y+APE      +    D++S GV++
Sbjct: 219 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + +GL Y+H      +IHRDLK  N+ ++ +   KI DFG+AR          T  V  T
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVV-T 188

Query: 388 YGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK 421
             Y APE  +    ++   D++S G ++ E+I+GK
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 11/100 (11%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I   +  +H    L  +HRD+K  N+LLD   + +++DFG       +     +    GT
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGT 226

Query: 388 YGYMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE           G +  + D ++ GV   E+  G
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 8/93 (8%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201

Query: 388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
              +APE  +   ++   D ++ GVL+ E+ +G
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 24/98 (24%), Positives = 48/98 (48%), Gaps = 9/98 (9%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +   +  +H+   L  +HRD+K  N+L+D   + +++DFG       +     ++   GT
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGT 239

Query: 388 YGYMAPE-----YAMEGVFSVKSDVFSFGVLLLEIISG 420
             Y++PE        +G +  + D +S GV + E++ G
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 26/110 (23%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN------- 380
             R +  LH  +   VIHRDLK SN+L++   + K+ DFG+ARI   +  + +       
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 381 --TNRVAGTYGYMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
                VA T  Y APE       Y      S   DV+S G +L E+   +
Sbjct: 178 GMVEFVA-TRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 19/71 (26%), Positives = 35/71 (49%), Gaps = 3/71 (4%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G+ Y+H  S   ++HRDLK +N L++ + + K+ DFG+AR     +N  +   ++  
Sbjct: 165 LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 388 YGYMAPEYAME 398
              M       
Sbjct: 222 EDDMNLVTFPH 232

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 19/72 (26%), Positives = 35/72 (48%), Gaps = 3/72 (4%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           +  G  ++HE     +IHRDLK +N LL+ + + K+ DFG+AR  +  ++    N +   
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 388 YGYMAPEYAMEG 399
                    ++ 
Sbjct: 195 EEPGPHNKNLKK 206

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 33/120 (27%), Positives = 54/120 (45%), Gaps = 35/120 (29%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGT 387
           + + + YLH  S   ++HRD+K SN+LL+ E + K++DFG++R F   +   N   ++  
Sbjct: 118 LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 388 YG-------------------YMAPE-------YAMEGVFSVKSDVFSFGVLLLEIISGK 421
                                Y APE       Y      +   D++S G +L EI+ GK
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCGK 228

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 23/197 (11%), Positives = 50/197 (25%), Gaps = 43/197 (21%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
                 I  +  +A      H   R  V       S V +  + +  ++           
Sbjct: 126 PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP--------- 173

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
                          M          + + D+   G  L  ++  +           +S 
Sbjct: 174 -------------ATMPDA-------NPQDDIRGIGASLYALLVNRWP---LPEAGVRSG 210

Query: 436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
           L  A     +  A + ++P      +  ++          VQ D   R   S+++ ++  
Sbjct: 211 LAPAE----RDTAGQPIEPADIDRDIPFQISAVA---ARSVQGDGGIRSA-STLLNLMQQ 262

Query: 496 DTATLPPPTQPAFSVDR 512
            TA            + 
Sbjct: 263 ATAVADRTEVLGPIDEA 279

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 56.6 bits (137), Expect = 7e-09
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 17/110 (15%)

Query: 322 ISIINGIAR----GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP------KISDFGMARI 371
           +  +  I++    GL Y+H   R  +IH D+K  NVL++   +P      KI+D G A  
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           +  +           T  Y +PE  +   +   +D++S   L+ E+I+G 
Sbjct: 188 YDEHYTN-----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.2 bits (132), Expect = 4e-08
 Identities = 57/421 (13%), Positives = 115/421 (27%), Gaps = 129/421 (30%)

Query: 122 EYEECLLRYSNISFFSVLDTSFRLSLWNVENSPSRSFDQFV-----------WNSMNEAV 170
           E +  ++    +S       + RL  W + +       +FV            + +    
Sbjct: 50  EIDHIIMSKDAVS------GTLRL-FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102

Query: 171 NQALSTTKMFATVKKNYTASQTLYSLVQCTPDL--SRDDCSRCLRLAISPLD-------- 220
            Q    T+M+   +        LY+  Q       SR      LR A+  L         
Sbjct: 103 RQPSMMTRMYIEQRDR------LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156

Query: 221 ---GCCSIKIGGRVMYPS-CNFRYELYQFYNDTSNGTLPPVFFSPPSPGSVTSSKGGKGK 276
              G      G   +    C       +            +F                  
Sbjct: 157 GVLGS-----GKTWVALDVCLSYKVQCKMDF--------KIF------------------ 185

Query: 277 KATWIAIGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISI-INGIARGLLYL 335
              W+ +    +  T+  +L   +    +I+ + T  ++ D    I + I+ I   L  L
Sbjct: 186 ---WLNLKNCNSPETVLEMLQKLL---YQIDPNWT--SRSDHSSNIKLRIHSIQAELRRL 237

Query: 336 HEDSRLRVIHRDLKTSNVLLDHEMNPKISD-FGM-ARIFSGNQNEANTNRVAGTYGYMAP 393
                  +  +  +   ++L +  N K  + F +  +I    + +  T+ ++        
Sbjct: 238 -------LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT--- 287

Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMD 453
                                  I     +      E  +SLL     L C+ + L    
Sbjct: 288 ----------------------HISLDHHSMTLTPDE-VKSLL--LKYLDCRPQDL---- 318

Query: 454 PVLKQTCVDAELLKCIHIGLLCVQEDPAH-----RPNMSSVVVMLASDTATLPPP-TQPA 507
           P  ++          I I    +++  A        N   +  ++ S    L P   +  
Sbjct: 319 P--REVLTTNPRRLSI-IAES-IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374

Query: 508 F 508
           F
Sbjct: 375 F 375

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 16/100 (16%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMARIFSGNQNEANTNRVA 385
           +   LL+L     L +IH DLK  N+LL +      KI DFG +    G +         
Sbjct: 166 MCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQR--------I 215

Query: 386 GTY----GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
             Y     Y +PE  +   + +  D++S G +L+E+ +G+
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 50.7 bits (121), Expect = 7e-07
 Identities = 28/149 (18%), Positives = 49/149 (32%), Gaps = 56/149 (37%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--------------------------- 355
            II  + +GL YLH  ++ R+IH D+K  N+LL                           
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 356 ----------------------DHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP 393
                                   ++  KI+D G A     +  E        T  Y + 
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSL 262

Query: 394 EYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
           E  +   ++  +D++S   +  E+ +G  
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDY 291

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 18/100 (18%)

Query: 328 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMARIFSGNQNEANTNRVA 385
           I + L  LH   + R+IH DLK  N+LL  +     K+ DFG +            ++  
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---------EHQRV 256

Query: 386 GTY----GYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
            TY     Y APE  +   + +  D++S G +L E+++G 
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 46.4 bits (109), Expect = 1e-05
 Identities = 14/57 (24%), Positives = 19/57 (33%), Gaps = 2/57 (3%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 372
                  SI++ +   L        LR  HRDL   NVLL      K+      +  
Sbjct: 158 SSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 16/50 (32%), Positives = 25/50 (50%), Gaps = 6/50 (12%)

Query: 323 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKISDFGMA 369
            I+  I   + YLH    + + HRD+K  N+L   +      K++DFG A
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	541
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.98
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.98
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.95
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.95
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.95
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.95
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.95
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.95
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.95
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.95
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.94
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.94
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.94
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.94
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.94
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.94
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.94
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.94
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.94
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.94
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.94
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.94
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.94
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.94
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.94
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.94
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.94
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.94
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.94
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.94
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.94
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.94
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.93
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.93
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.93
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.93
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.93
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.93
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.93
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.93
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.93
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.93
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.93
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.93
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.93
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.93
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.93
3niz_A	311	Rhodanese family protein; structural genomics, str	99.93
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.93
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.93
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.93
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.93
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.93
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.93
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.93
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.93
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.93
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.93
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.93
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.93
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.93
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.93
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.93
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.93
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.93
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.93
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.93
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.93
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.93
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.93
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.93
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.93
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.93
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.93
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.93
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.93
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.93
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.93
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.93
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.93
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.93
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.93
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.93
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.93
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.93
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.93
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.93
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.93
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.93
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.93
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.93
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.93
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.93
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.93
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.93
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.93
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.93
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.93
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.92
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.92
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.92
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.92
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.92
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.92
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.92
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.92
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.92
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.92
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.92
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.92
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.92
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.92
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.92
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.92
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.92
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.92
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.92
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.92
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.92
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.92
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.92
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.92
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.92
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.92
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.92
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.92
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.92
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.92
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.92
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.92
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.92
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.92
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.92
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.92
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.92
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.92
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.92
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.92
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.92
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.92
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.92
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.92
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.92
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.92
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.92
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.92
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.92
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.92
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.92
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.92
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.92
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.92
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.92
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.92
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.92
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.92
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.92
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.92
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.92
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.92
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.92
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.92
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.92
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.92
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.92
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.91
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.91
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.91
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.91
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.91
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.91
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.91
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.91
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.91
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.91
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.91
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.91
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.91
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.91
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.91
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.91
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.91
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.91
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.91
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.91
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.91
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.91
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.91
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.91
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.91
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.91
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.91
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.91
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.91
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.91
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.91
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.91
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.91
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.91
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.9
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.9
3bhy_A	283	Death-associated protein kinase 3; death associate	99.9
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.9
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.9
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.9
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.9
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.9
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.9
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.9
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.9
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.9
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.9
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.9
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.9
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.9
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.9
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.89
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.89
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.89
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.89
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.88
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.87
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.86
3uqc_A	286	Probable conserved transmembrane protein; structur	99.82
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.82
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.72
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.43
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.05
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	98.71
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.11
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.33
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	96.56
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	96.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	96.35
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.35
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	93.67
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	93.58
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	91.58
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	90.83
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	88.37
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	86.7
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	86.18
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	85.56
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	84.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	84.42
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	82.38
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	81.68
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	81.34
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	80.24

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=303.78  Aligned_cols=195  Identities=25%  Similarity=0.358  Sum_probs=140.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++|+||+.+|.|...+++      .+..++|.++++|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||
T Consensus       107 ~iVmEy~~gGsL~~~l~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHV------QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             EEEEECCSSCBHHHHHHT------SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             EEEEEcCCCCCHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeecc
Confidence            456788888888766543      1346999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAME---GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      +++...............||+.|||||++.+   +.++.++|||||||++|||++|+.||.....      .........
T Consensus       178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~------~~~~~~~~~  251 (307)
T 3omv_A          178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN------RDQIIFMVG  251 (307)
T ss_dssp             SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHH
T ss_pred             CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh------HHHHHHHHh
Confidence            9987654443334445689999999999964   4589999999999999999999999853211      111111222


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCC
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPP  502 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~  502 (541)
                      .+..    .+.+. .........+.+|+.+||+.||++|||+.||++.|+.....+|.
T Consensus       252 ~~~~----~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          252 RGYA----SPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             TTCC----CCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             cCCC----CCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            2111    11111 11122234677888999999999999999999998876555543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-36  Score=302.24  Aligned_cols=191  Identities=27%  Similarity=0.346  Sum_probs=147.0

Q ss_pred             HHHHHHHHHHhhheeccccccc---------cCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC
Q 009186          287 ITTITLFILLGSFVWCRRRINK---------DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH  357 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~---------~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~  357 (541)
                      +++|+||+..|.|...+++...         +......|+|.++++|+.||++||+|||+++   ||||||||+||||++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECC
Confidence            4567788888888655533211         1233457999999999999999999999998   999999999999999


Q ss_pred             CCCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHH
Q 009186          358 EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLL  436 (541)
Q Consensus       358 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~  436 (541)
                      ++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||++ |+.||....      ..
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~------~~  254 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------NQ  254 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC------HH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC------HH
Confidence            99999999999987654443334445678999999999999999999999999999999998 899985321      11


Q ss_pred             HHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +. ......+....         .+......+.+|+.+||+.||++|||+.||++.|+..
T Consensus       255 ~~-~~~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          255 DV-VEMIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HH-HHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HH-HHHHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11 12222222211         1222334677899999999999999999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.3e-37  Score=304.08  Aligned_cols=192  Identities=25%  Similarity=0.336  Sum_probs=147.2

Q ss_pred             HHHHHHHHHHhhheecccccc------ccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC
Q 009186          287 ITTITLFILLGSFVWCRRRIN------KDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN  360 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~------~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~  360 (541)
                      +++|+||+..|.|...+++..      ........|+|.++++|+.||++||+|||+++   ||||||||+|||++.++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCc
Confidence            456788898898866654421      12334567999999999999999999999998   999999999999999999


Q ss_pred             cEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHH
Q 009186          361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYA  439 (541)
Q Consensus       361 ~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~  439 (541)
                      +||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |+.||....      ..+. 
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~------~~~~-  239 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------NNEV-  239 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHH-
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHH-
Confidence            99999999987654443333444578999999999999999999999999999999998 899985321      1111 


Q ss_pred             HHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          440 WKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       440 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ...+..+....     .    +......+.+|+.+||+.||++|||+++|+++|++..
T Consensus       240 ~~~i~~~~~~~-----~----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          240 IECITQGRVLQ-----R----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCC-----C----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            11222222211     1    1122345778999999999999999999999998743

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3e-36  Score=304.16  Aligned_cols=192  Identities=25%  Similarity=0.328  Sum_probs=137.8

Q ss_pred             HHHHHHHHHHhhheeccccccc--------cCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC
Q 009186          287 ITTITLFILLGSFVWCRRRINK--------DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE  358 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~--------~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~  358 (541)
                      +++|+||+..|.|...+++...        .......|+|.++++|+.||++||+|||+++   ||||||||+||||+.+
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCC
Confidence            4567888988888665544221        1223457999999999999999999999998   9999999999999999


Q ss_pred             CCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHH
Q 009186          359 MNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLT  437 (541)
Q Consensus       359 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~  437 (541)
                      +.+||+|||+++...............||+.|||||++.+..++.++|||||||++|||++ |+.||....      ..+
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~------~~~  268 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS------NTE  268 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC------HHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC------HHH
Confidence            9999999999987655444444445679999999999999999999999999999999999 899985321      111


Q ss_pred             HHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      . ......+....     ....    ....+.+|+.+||+.||++|||++||+++|+...
T Consensus       269 ~-~~~i~~g~~~~-----~p~~----~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          269 A-IDCITQGRELE-----RPRA----CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             H-HHHHHHTCCCC-----CCTT----CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             H-HHHHHcCCCCC-----Cccc----ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            1 11122222111     1112    2345778899999999999999999999998754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8e-36  Score=303.49  Aligned_cols=191  Identities=27%  Similarity=0.375  Sum_probs=147.1

Q ss_pred             HHHHHHHHHHhhheeccccccc---------cCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC
Q 009186          287 ITTITLFILLGSFVWCRRRINK---------DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH  357 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~---------~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~  357 (541)
                      +++|+||+..|.|...+++...         .......|+|.+++.|+.||++||+|||+++   ||||||||+|||++.
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~  220 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE  220 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCC
Confidence            3466788888888665544221         1123456999999999999999999999999   999999999999999


Q ss_pred             CCCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHH
Q 009186          358 EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLL  436 (541)
Q Consensus       358 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~  436 (541)
                      ++.+||+|||+++.+.............||+.|||||++.+..++.++|||||||++|||++ |+.||......      
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~------  294 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------  294 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------
T ss_pred             CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH------
Confidence            99999999999997765554444556678999999999999999999999999999999998 89998532211      


Q ss_pred             HHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.....+..+....     ...    .....+.+++.+||+.||++|||+.||+++|+.
T Consensus       295 ~~~~~~i~~g~~~~-----~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          295 EEFCRRLKEGTRMR-----APD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             HHHHHHHHHTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCC-----CCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            11222222222111     111    223457788899999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.5e-35  Score=294.77  Aligned_cols=187  Identities=20%  Similarity=0.241  Sum_probs=140.6

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEe
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKIS  364 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~  364 (541)
                      .+++||||+.+|.|...+++       .+.+++.++..++.||+.||+|||+++   ||||||||+||||+.++ .+||+
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~-------~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~  193 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQ-------MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALC  193 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEEC
T ss_pred             EEEEEEeccCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEe
Confidence            35677899999988766643       235999999999999999999999999   99999999999999998 59999


Q ss_pred             cccccccccCCCCc---ccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH
Q 009186          365 DFGMARIFSGNQNE---ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       365 Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      |||+++.+......   .......||+.|||||++.+..++.++|||||||++|||++|+.||......   .+....  
T Consensus       194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i--  268 (336)
T 4g3f_A          194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCLKI--  268 (336)
T ss_dssp             CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHHHH--
T ss_pred             eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHH--
Confidence            99999876543321   1223457999999999999999999999999999999999999998533221   122111  


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                       ........    .+    ++.....+.+++.+||+.||++|||+.||++.|...
T Consensus       269 -~~~~~~~~----~~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          269 -ASEPPPIR----EI----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             -HHSCCGGG----GS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HcCCCCch----hc----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             11111111    11    112234567788899999999999999999888653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.5e-34  Score=286.48  Aligned_cols=198  Identities=21%  Similarity=0.251  Sum_probs=142.0

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcC-----CCceEecccCCCcEEEcCCCCc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDS-----RLRVIHRDLKTSNVLLDHEMNP  361 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~-----~~~ivH~DLkp~NIll~~~~~~  361 (541)
                      +++|+||+..|.|...+++        ..++|+++++++.|+++||+|||++.     .++||||||||+||||+.++.+
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~--------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~  147 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             EEEEecCCCCCcHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence            4567889988888766643        24899999999999999999999871     1239999999999999999999


Q ss_pred             EEecccccccccCCCCcc--cccccccCCCCCChhhhccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcC--
Q 009186          362 KISDFGMARIFSGNQNEA--NTNRVAGTYGYMAPEYAMEG------VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH--  431 (541)
Q Consensus       362 kL~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll~elltg~~p~~~~~~~~--  431 (541)
                      ||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|+.|+.......  
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            999999998765443221  22345799999999999754      36789999999999999999988764322111  


Q ss_pred             ------cCcHHHHHHHhhhcCCccccccccccCCC-CHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          432 ------GQSLLTYAWKLWCKGEALELMDPVLKQTC-VDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       432 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                            .....+.........    .+++.+.... ..+....+.+|+.+||+.||++|||+.||++.|+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhcccccchHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                  111112222221111    1222222211 234566788999999999999999999999999763

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.1e-34  Score=287.37  Aligned_cols=179  Identities=22%  Similarity=0.288  Sum_probs=138.7

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      .+++||||+.+|.|...+++        ..+++.++..++.||+.||+|||+++   ||||||||+||||+.++.+||+|
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~--------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~D  213 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSD  213 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred             EEEEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEec
Confidence            45677899988888655532        24899999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+++.+.....  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...      ...+.... +..
T Consensus       214 FGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~-i~~  284 (346)
T 4fih_A          214 FGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMKM-IRD  284 (346)
T ss_dssp             CTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHH-HHH
T ss_pred             CcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHH-HHc
Confidence            999987654332  233468999999999999999999999999999999999999998432      12221111 111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ...     +.+.  ........+.+|+.+||+.||++|||++|+++
T Consensus       285 ~~~-----~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          285 NLP-----PRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SSC-----CCCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC-----CCCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111     1111  01112345677888999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-34  Score=287.00  Aligned_cols=177  Identities=24%  Similarity=0.295  Sum_probs=140.0

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++||||+.+|.|...+++       .+.+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       107 ~yivmEy~~gG~L~~~i~~-------~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DF  176 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRK-------IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF  176 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEc
Confidence            4567888888888766543       346999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...      +..+..... ..+
T Consensus       177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~i-~~~  249 (311)
T 4aw0_A          177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG------NEGLIFAKI-IKL  249 (311)
T ss_dssp             TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHH-HHT
T ss_pred             CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHH-HcC
Confidence            9999876554444455678999999999999999999999999999999999999998422      122211121 122


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV  490 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl  490 (541)
                      ..      .+....    ...+.+|+.+||+.||++|||++|++
T Consensus       250 ~~------~~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          250 EY------DFPEKF----FPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CC------CCCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CC------CCCccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence            11      111112    23567788899999999999999863

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8e-34  Score=280.74  Aligned_cols=178  Identities=23%  Similarity=0.338  Sum_probs=134.1

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-CCCcEEec
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISD  365 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-~~~~kL~D  365 (541)
                      +++||||+.+|.|...+++       ...+++.++..|+.||+.||+|||+++ .+||||||||+||||+. ++.+||+|
T Consensus       104 ~~lvmEy~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKR-------FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             EEEEEeCCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEe
Confidence            4567888888888666543       346999999999999999999999975 34999999999999984 78999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+++.....    ......||+.|||||++.+ .++.++|||||||++|||++|+.||....     .. .........
T Consensus       176 FGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-----~~-~~~~~~i~~  244 (290)
T 3fpq_A          176 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NA-AQIYRRVTS  244 (290)
T ss_dssp             TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SH-HHHHHHHTT
T ss_pred             CcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----cH-HHHHHHHHc
Confidence            9999864322    2334689999999998864 69999999999999999999999984221     11 112222222


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.....    +....    ...+.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~----~~~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          245 GVKPAS----FDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TCCCGG----GGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCC----CCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            221111    11111    224677888999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2e-34  Score=291.35  Aligned_cols=179  Identities=20%  Similarity=0.315  Sum_probs=138.9

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++||||+.+|.|..++++     .++..+++.+++.|+.||+.||+|||+++   ||||||||+||||+.++.+||+||
T Consensus        98 ~yiVmEy~~gg~L~~~i~~-----~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DF  169 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINA-----QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDF  169 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHH-----TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECST
T ss_pred             EEEEEeCCCCCcHHHHHHH-----cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccc
Confidence            4566888988888766543     23446899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.+....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...      ...+...... .+
T Consensus       170 Gla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~i~-~~  240 (350)
T 4b9d_A          170 GIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVLKII-SG  240 (350)
T ss_dssp             TEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHH-HT
T ss_pred             ccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHH-cC
Confidence            9998753221  1223467999999999999999999999999999999999999998432      2222222222 22


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ...     .+...    ....+.+|+.+||+.||++|||++|+++
T Consensus       241 ~~~-----~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          241 SFP-----PVSLH----YSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCC-----CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC-----CCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211     11111    2345677888999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.98  E-value=1.7e-33  Score=279.90  Aligned_cols=178  Identities=23%  Similarity=0.259  Sum_probs=136.2

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      ..+++||||+.+|.|..++++       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~-------~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~  168 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSK-------EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLT  168 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHH-------HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEec
Confidence            346778899999988766643       346999999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...      +..+...... 
T Consensus       169 DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~i~-  239 (304)
T 3ubd_A          169 DFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK------DRKETMTMIL-  239 (304)
T ss_dssp             SSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHH-
T ss_pred             ccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc------CHHHHHHHHH-
Confidence            9999986543322  223467999999999999999999999999999999999999998532      1222222211 


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~evl~  491 (541)
                      ++..      .+...    ....+.+|+.+||+.||++|||     ++|+++
T Consensus       240 ~~~~------~~p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          240 KAKL------GMPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HCCC------CCCTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             cCCC------CCCCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            1111      11111    2235677888999999999998     467764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.98  E-value=3.9e-33  Score=288.36  Aligned_cols=183  Identities=22%  Similarity=0.309  Sum_probs=140.4

Q ss_pred             HHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          286 IITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       286 ~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      .+++||||+.+|.|...+++        ..+++.++..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~--------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~D  290 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSD  290 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECC
T ss_pred             EEEEEEeCCCCCcHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEec
Confidence            45678899988888655532        24899999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+++.+.....  ......||+.|||||++.+..|+.++|||||||++|||++|+.||...      ...+..... ..
T Consensus       291 FGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~i-~~  361 (423)
T 4fie_A          291 FGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMKMI-RD  361 (423)
T ss_dssp             CTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHH-HH
T ss_pred             CccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHH-Hc
Confidence            999987654332  233468999999999999999999999999999999999999998422      122221111 11


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      ...     +.+..  .......+.+|+.+||+.||++|||+.|+++  +|++
T Consensus       362 ~~~-----~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          362 NLP-----PRLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             SCC-----CCCSC--TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             CCC-----CCCcc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence            111     11110  1112345677888999999999999999986  4543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.97  E-value=4.5e-33  Score=273.06  Aligned_cols=177  Identities=20%  Similarity=0.295  Sum_probs=125.5

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++||||+ .|.+...+++       +..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        89 ~ivmEy~-~g~L~~~l~~-------~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQ-------RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             EEEEECC-CEEHHHHHHH-------SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             EEEEeCC-CCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecC
Confidence            4566776 4555444432       346999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++......   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...      ...+. .+....+
T Consensus       158 la~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~------~~~~~-~~~i~~~  227 (275)
T 3hyh_A          158 LSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE------SIPVL-FKNISNG  227 (275)
T ss_dssp             CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHH-HHHHHHT
T ss_pred             CCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC------CHHHH-HHHHHcC
Confidence            998654322   2234679999999999988876 57999999999999999999998532      11111 1112222


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      ..      .+....    ...+.+|+.+||+.||++|||++|+++  +++.
T Consensus       228 ~~------~~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          228 VY------TLPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             CC------CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             CC------CCCCCC----CHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            11      111111    235667888999999999999999986  5553

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=1.6e-30  Score=262.17  Aligned_cols=201  Identities=31%  Similarity=0.509  Sum_probs=163.7

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++..+.|...+.+   .......+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       113 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYG---SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             EEECCTTCBTGGGSSS---SCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEcCCCCcHHHHHhc---cCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            3455556666544432   2223446999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcc
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEAL  449 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  449 (541)
                      +...............||..|+|||.+.+..++.++||||||+++|||++|+.||.............+.......+...
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            86543333333334568999999999999999999999999999999999999997665555556666665566666677


Q ss_pred             ccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          450 ELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       450 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..+++.+...........+.+++.+||+.||++|||+.+|++.|+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            77777777777788889999999999999999999999999999863

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=1.4e-31  Score=266.68  Aligned_cols=179  Identities=20%  Similarity=0.236  Sum_probs=122.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++|||+.+|.|...+++.    ......++..++.|+.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        91 ~ivmE~~~gg~L~~~l~~~----~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           91 YIQMQLCRKENLKDWMNGR----CTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             EEEEECCCSCCHHHHHHTC----CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEEecCCCCcHHHHHHhc----CCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCc
Confidence            4567778777775554331    11223567778999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcc----------cccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHH
Q 009186          368 MARIFSGNQNEA----------NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT  437 (541)
Q Consensus       368 ~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~  437 (541)
                      +++.+.......          ......||+.|||||++.+..++.++|||||||++|||++   ||...     .....
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~~~  235 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MERVR  235 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHHHH
Confidence            998765432211          1223579999999999999999999999999999999996   55311     01111


Q ss_pred             HHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       .............         .......+.+|+.+||+.||++|||+.|+++
T Consensus       236 -~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          236 -TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1111111111110         1122334567889999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=4.4e-30  Score=259.42  Aligned_cols=202  Identities=38%  Similarity=0.628  Sum_probs=161.8

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhc---CCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHED---SRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~---~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++..+.|...+++   .......+++..++.++.||+.||+|||++   +   |+||||||+||+++.++.+||+||
T Consensus       105 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Df  178 (326)
T 3uim_A          105 VYPYMANGSVASCLRE---RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDF  178 (326)
T ss_dssp             EEECCTTCBHHHHHHC---CSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEeccCCCHHHHHHh---ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccC
Confidence            3455555555444433   223345699999999999999999999999   7   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--CcCcCcHHHHHHHhhh
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL--SEHGQSLLTYAWKLWC  444 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~--~~~~~~~~~~~~~~~~  444 (541)
                      |+++........ ......||..|+|||.+.+..++.++||||||+++|||++|+.||....  .........+......
T Consensus       179 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          179 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             SSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             ccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            999876443322 2234568999999999999899999999999999999999999985322  2233445555555566


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCC
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTA  498 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~  498 (541)
                      ........+..+...........+.+++.+||+.||.+|||+.+|+++|++...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            666677777777777888899999999999999999999999999999997543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=2.5e-30  Score=267.45  Aligned_cols=194  Identities=20%  Similarity=0.236  Sum_probs=132.7

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++||||+. |.|...+++       .+.+++.++..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||
T Consensus       135 ~ivmE~~~-g~L~~~i~~-------~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIHS-------SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEECCS-EEHHHHHTS-------SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEeCCC-CCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecc
Confidence            44566664 444433322       346999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCC--cccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          368 MARIFSGNQN--EANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       368 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      +++.+.....  ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.....   ...+........
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g  280 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLG  280 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHC
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcC
Confidence            9987643321  2223456899999999998875 469999999999999999999999853211   111111111111


Q ss_pred             cCCcc--c------------cccccccCC---CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          445 KGEAL--E------------LMDPVLKQT---CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       445 ~~~~~--~------------~~~~~l~~~---~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      .....  .            .+.+.....   ..+.....+.+|+.+||+.||++|||+.|+++  ++++
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  350 (398)
T 4b99_A          281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK  350 (398)
T ss_dssp             CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred             CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence            00000  0            000000000   00011245778999999999999999999986  4554

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=3.3e-30  Score=263.59  Aligned_cols=126  Identities=25%  Similarity=0.357  Sum_probs=102.0

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-CCcEEec
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISD  365 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-~~~kL~D  365 (541)
                      +++||||+.++.|....+          .+++.++..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|
T Consensus        95 ~~lvmE~~~g~~L~~~~~----------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN----------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT----------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             EEEEEeCCCcccHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence            345667776666654442          3899999999999999999999999   9999999999999877 7899999


Q ss_pred             ccccccccCCCCc--------------------------ccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHH
Q 009186          366 FGMARIFSGNQNE--------------------------ANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEII  418 (541)
Q Consensus       366 fg~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~ell  418 (541)
                      ||+++........                          .......||+.|+|||++.+. .++.++||||+||++|||+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence            9999865432211                          111235799999999999875 4899999999999999999


Q ss_pred             hCCCCCC
Q 009186          419 SGKRNSG  425 (541)
Q Consensus       419 tg~~p~~  425 (541)
                      +|+.||.
T Consensus       242 ~G~~Pf~  248 (361)
T 4f9c_A          242 SGRYPFY  248 (361)
T ss_dssp             HTCSSSS
T ss_pred             HCCCCCC
Confidence            9999984

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=3.7e-30  Score=278.09  Aligned_cols=177  Identities=23%  Similarity=0.244  Sum_probs=134.9

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++||||+.+|.|...+++       ...+++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||+||
T Consensus       267 lylVmEy~~GGdL~~~l~~-------~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DF  336 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQ-------HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL  336 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHH-------HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccc
Confidence            4566788888887665543       346999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      |+++.+....    .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......   ...+...... .
T Consensus       337 GlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~---~~~~i~~~i~-~  408 (689)
T 3v5w_A          337 GLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHEIDRMTL-T  408 (689)
T ss_dssp             TTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC---CHHHHHHHHH-H
T ss_pred             ceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhc-C
Confidence            9998765432    234689999999999975 57999999999999999999999998532221   1111111111 1


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~evl~  491 (541)
                      ...      .+...    ....+.+|+.+||+.||.+|++     ++||++
T Consensus       409 ~~~------~~p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          409 MAV------ELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCC------CCCTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCC------CCCcc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            111      11111    2335677888999999999998     677764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.95  E-value=3.4e-29  Score=271.22  Aligned_cols=179  Identities=20%  Similarity=0.211  Sum_probs=133.0

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC--CCcEEec
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE--MNPKISD  365 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~--~~~kL~D  365 (541)
                      +++|||+.+|.|+.++.+      +...|++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|
T Consensus       230 ~iv~E~~~gg~L~~~i~~------~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~D  300 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVAD------EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLID  300 (573)
T ss_dssp             EEEEECCCCCBHHHHHTC------TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECC
T ss_pred             EEEEeecCCCcHHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEee
Confidence            344556666665444322      2346999999999999999999999999   9999999999999854  7899999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+++.+.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....      ..+.... +..
T Consensus       301 FG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~------~~~~~~~-i~~  370 (573)
T 3uto_A          301 FGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETLRN-VKS  370 (573)
T ss_dssp             CSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHH-HHT
T ss_pred             ccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHH-HHh
Confidence            999988654322   234579999999999999999999999999999999999999985321      1111111 111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ... . +.......    ....+.+|+.+||+.||.+|||+.|+++
T Consensus       371 ~~~-~-~~~~~~~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          371 CDW-N-MDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             TCC-C-CCSGGGTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCC-C-CCcccccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111 0 01111111    1235677888999999999999999987

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.95  E-value=3.9e-28  Score=202.43  Aligned_cols=107  Identities=19%  Similarity=0.477  Sum_probs=97.7

Q ss_pred             CCCcccccCCCCCCCCCCChHHHHHHHHHHHHhhcccCCCCCCcccCceeeccCC-CCCeEEEEEeccCCCChhhhHHHH
Q 009186           24 DKPTYIYHNCPRTNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTTGH-EPNKVYGLFLCRGDFGTETCQNCV  102 (541)
Q Consensus        24 ~~~~~~~~~C~~~~~~~~s~~~~nl~~l~~~l~~~~~~~~~~~~~~~f~~~~~g~-~~~~vy~~~~C~~D~~~~~C~~Cl  102 (541)
                      +++.++++.|++++++++|+|++||+.||++|+++++.++     .+|++...|. ++++|||++|||+|+++++|+.||
T Consensus         1 A~t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~-----~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl   75 (108)
T 3a2e_A            1 ANTAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSG-----YDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACL   75 (108)
T ss_dssp             CCCCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTT-----SEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHH
T ss_pred             CCcceeeeecCCCccCCCChHHHHHHHHHHHHHhhCcccc-----CCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHH
Confidence            3567899999887889999999999999999999998764     5677777664 458999999999999999999999


Q ss_pred             HHHHHHhhhcCCCCceEEEEccceEEEEcCCcc
Q 009186          103 SVATSYTAQLCPFGKENTIEYEECLLRYSNISF  135 (541)
Q Consensus       103 ~~a~~~~~~~C~~~~~a~~~~~~C~~ry~~~~f  135 (541)
                      +.|+.++.+.||++++|+||++.|+||||+++|
T Consensus        76 ~~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           76 SNLVNRIFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHHHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            999999999999999999999999999999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.95  E-value=6.3e-28  Score=240.05  Aligned_cols=185  Identities=14%  Similarity=0.126  Sum_probs=136.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC-----cEEecccccccccCCCCc-----ccccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-----PKISDFGMARIFSGNQNE-----ANTNR  383 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~-----~kL~Dfg~a~~~~~~~~~-----~~~~~  383 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.     +||+|||+++........     .....
T Consensus       101 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  177 (298)
T 1csn_A          101 RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN  177 (298)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccC
Confidence            35899999999999999999999999   999999999999987776     999999999876544322     12334


Q ss_pred             cccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHH
Q 009186          384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDA  463 (541)
Q Consensus       384 ~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  463 (541)
                      ..||..|+|||.+.+..++.++||||||+++|||++|+.||........................     +.+...    
T Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~----  248 (298)
T 1csn_A          178 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----RELCAG----  248 (298)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH-----HHHTTT----
T ss_pred             CCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH-----HHHHhh----
Confidence            56899999999999999999999999999999999999998654322222222111111111110     011111    


Q ss_pred             HHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcee
Q 009186          464 ELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSV  510 (541)
Q Consensus       464 ~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~P~~~~  510 (541)
                      ....+.+++.+||+.||++||++++|++.|+.....+.....-.+.|
T Consensus       249 ~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          249 FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            13457788899999999999999999999987654444444444444

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.95  E-value=3.8e-29  Score=257.49  Aligned_cols=165  Identities=30%  Similarity=0.391  Sum_probs=129.6

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...............+++.|+|
T Consensus       197 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~a  273 (370)
T 2psq_A          197 EEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA  273 (370)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCC
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceEC
Confidence            346899999999999999999999999   99999999999999999999999999987654443333334557788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||.....   .....    ....+...         ..+......+.++
T Consensus       274 PE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~~~~----~~~~~~~~---------~~~~~~~~~l~~l  337 (370)
T 2psq_A          274 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELFK----LLKEGHRM---------DKPANCTNELYMM  337 (370)
T ss_dssp             HHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHH----HHHTTCCC---------CCCTTSCHHHHHH
T ss_pred             HhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHhcCCCC---------CCCCCCCHHHHHH
Confidence            999999999999999999999999999 9999753221   11111    11111111         1111223457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||.+||++.||++.|+..
T Consensus       338 i~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          338 MRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHH
Confidence            8999999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.95  E-value=9.3e-29  Score=250.12  Aligned_cols=163  Identities=24%  Similarity=0.419  Sum_probs=126.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...............+|..|+||
T Consensus       112 ~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP  188 (327)
T 3poz_A          112 DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccCh
Confidence            45899999999999999999999999   999999999999999999999999999877655444444445568899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||......   ....    ....+...         ..+......+.+++
T Consensus       189 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~~~~~~~~~~~li  252 (327)
T 3poz_A          189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKGERL---------PQPPICTIDVYMIM  252 (327)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH----HHHTTCCC---------CCCTTBCHHHHHHH
T ss_pred             HHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHH----HHHcCCCC---------CCCccCCHHHHHHH
Confidence            99999999999999999999999999 99998532211   1111    11111110         11122234677899


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhc
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .+||+.||.+||++.+|++.|+.
T Consensus       253 ~~~l~~~p~~Rps~~ell~~l~~  275 (327)
T 3poz_A          253 VKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             HHHTCSCGGGSCCHHHHHHHHHH
T ss_pred             HHHcCCChhhCCCHHHHHHHHHH
Confidence            99999999999999999999865

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.95  E-value=3e-28  Score=245.80  Aligned_cols=194  Identities=25%  Similarity=0.332  Sum_probs=140.3

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhc----------CCCceEecccCCCcEEEcCC
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHED----------SRLRVIHRDLKTSNVLLDHE  358 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~----------~~~~ivH~DLkp~NIll~~~  358 (541)
                      ++++++..+.|...+++        ..+++.+++.++.||+.||+|||+.          +   |+||||||+|||++.+
T Consensus        99 lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             EEEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTT
T ss_pred             EEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCC
Confidence            44556656666444422        2489999999999999999999998          7   9999999999999999


Q ss_pred             CCcEEecccccccccCCCCcccccccccCCCCCChhhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcC
Q 009186          359 MNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-----VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQ  433 (541)
Q Consensus       359 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~  433 (541)
                      +.+||+|||+++.+.............||..|+|||.+.+.     .++.++||||||+++|||++|+.||.........
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            99999999999877655444444446789999999999863     4667899999999999999999998643322211


Q ss_pred             cHHH---------HHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          434 SLLT---------YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       434 ~~~~---------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ....         ..............+.....   .......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111         11111111111111111111   224456688999999999999999999999999853

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.95  E-value=1.3e-27  Score=245.37  Aligned_cols=209  Identities=14%  Similarity=0.138  Sum_probs=147.1

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc--CCCCcEEecc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD--HEMNPKISDF  366 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~--~~~~~kL~Df  366 (541)
                      ++++++ .+.|...+++      ....+++.+++.|+.||+.||+|||+++   |+||||||+|||++  .++.+||+||
T Consensus       129 lv~e~~-g~~L~~~~~~------~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DF  198 (364)
T 3op5_A          129 MIMDRF-GSDLQKIYEA------NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDY  198 (364)
T ss_dssp             EEEECE-EEEHHHHHHH------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCC
T ss_pred             EEEeCC-CCCHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEEC
Confidence            345555 5555433322      2346999999999999999999999999   99999999999999  8899999999


Q ss_pred             cccccccCCCCcc-----cccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH
Q 009186          367 GMARIFSGNQNEA-----NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       367 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      |+++.+.......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......  .........
T Consensus       199 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~--~~~~~~~~~  276 (364)
T 3op5_A          199 GLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD--PKYVRDSKI  276 (364)
T ss_dssp             TTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC--HHHHHHHHH
T ss_pred             CcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC--HHHHHHHHH
Confidence            9998754332211     112345899999999999999999999999999999999999998632211  111111111


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCceeccc
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSVDRI  513 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~P~~~~~~~  513 (541)
                      .. ...+.+.+++.+.....   ...+.+++..||+.||.+||++.+|++.|+........+....+.+...
T Consensus       277 ~~-~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~  344 (364)
T 3op5_A          277 RY-RENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVV  344 (364)
T ss_dssp             HH-HHCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC---
T ss_pred             Hh-hhhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEec
Confidence            11 11223333333321111   2456778889999999999999999999987665555555566665543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.94  E-value=2.6e-27  Score=235.34  Aligned_cols=186  Identities=16%  Similarity=0.164  Sum_probs=137.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE---cCCCCcEEecccccccccCCCCcc-----cccccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA-----NTNRVA  385 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~-----~~~~~~  385 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||++   +.++.+||+|||+++.........     ......
T Consensus       100 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  176 (296)
T 3uzp_A          100 RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT  176 (296)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccc
Confidence            35899999999999999999999999   9999999999999   478899999999998765443211     123457


Q ss_pred             cCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       386 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      |+..|+|||.+.+..++.++||||||+++|||++|+.||........................     +.+....    .
T Consensus       177 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~----~  247 (296)
T 3uzp_A          177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----EVLCKGY----P  247 (296)
T ss_dssp             SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----HHHTTTS----C
T ss_pred             cccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-----HHHHhhC----C
Confidence            899999999999999999999999999999999999998754433333333222211111000     0111111    2


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCceec
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSVD  511 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~P~~~~~  511 (541)
                      ..+.+++.+||+.||.+||++.+|++.|+........+..-.+.|.
T Consensus       248 ~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 3uzp_A          248 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred             HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence            4577888999999999999999999999875444433333334443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.94  E-value=5.6e-29  Score=255.89  Aligned_cols=189  Identities=27%  Similarity=0.325  Sum_probs=138.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC---CcEEec
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM---NPKISD  365 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~---~~kL~D  365 (541)
                      ++++++..+.|...+++..........+++.+++.++.||+.||+|||+++   |+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence            345666666665544443333344567999999999999999999999999   99999999999999655   499999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      ||+++.+.............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....      ..+.. ....
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~------~~~~~-~~i~  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------NQEVL-EFVT  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHH-HHHH
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHH-HHHH
Confidence            999976543333333334567889999999999999999999999999999998 999975321      11111 1111


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+....     .    +......+.+|+.+||+.||++||++.+|++.|+..
T Consensus       301 ~~~~~~-----~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          301 SGGRMD-----P----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCC-----C----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            111111     1    111233577889999999999999999999999753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.94  E-value=2.2e-27  Score=235.69  Aligned_cols=172  Identities=17%  Similarity=0.185  Sum_probs=132.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE---cCCCCcEEecccccccccCCCCc-----ccccccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNE-----ANTNRVA  385 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~-----~~~~~~~  385 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||++   +.++.+||+|||+++........     .......
T Consensus       100 ~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~  176 (296)
T 4hgt_A          100 RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT  176 (296)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccC
Confidence            35899999999999999999999999   9999999999999   78899999999999876544321     1223457


Q ss_pred             cCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       386 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      ||..|+|||.+.+..++.++||||||+++|||++|+.||........................     +.+....    .
T Consensus       177 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~----~  247 (296)
T 4hgt_A          177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----EVLCKGY----P  247 (296)
T ss_dssp             SCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----HHHTTTS----C
T ss_pred             CCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-----hhhhccC----C
Confidence            899999999999999999999999999999999999998754443333333222211111000     0011111    2


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ..+.+++.+||+.||++|||+.+|++.|++..
T Consensus       248 ~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          248 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence            45778889999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.94  E-value=3.8e-28  Score=243.49  Aligned_cols=185  Identities=30%  Similarity=0.456  Sum_probs=134.8

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++..+.|...+++      ....+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        85 v~e~~~~~~L~~~l~~------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKS------MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             EEECCTTCBHHHHHHH------CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCcHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccc
Confidence            4455555566444432      1345899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc------------cccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHH
Q 009186          370 RIFSGNQNEA------------NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT  437 (541)
Q Consensus       370 ~~~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~  437 (541)
                      +.........            ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~  235 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN  235 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence            8754332211            1113568999999999999999999999999999999999999876443322111000


Q ss_pred             HHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ..          ...+......    ....+.+++.+||+.||++|||+.++++.|+...
T Consensus       236 ~~----------~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          236 VR----------GFLDRYCPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             HH----------HHHHHTCCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hh----------ccccccCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            00          0001111111    1234677889999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.94  E-value=5.5e-27  Score=233.59  Aligned_cols=192  Identities=26%  Similarity=0.302  Sum_probs=137.2

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhh--------hcCCCceEecccCCCcEEEcCCCC
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLH--------EDSRLRVIHRDLKTSNVLLDHEMN  360 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH--------~~~~~~ivH~DLkp~NIll~~~~~  360 (541)
                      ++++++..+.|...++        ...+++..+++++.||+.||+|||        +.+   |+||||||+|||++.++.
T Consensus        83 lv~e~~~~g~L~~~l~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ--------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             EEECCCTTCBHHHHHT--------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSC
T ss_pred             EehhhccCCCHHHHHh--------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCC
Confidence            3445555555544442        235899999999999999999999        777   999999999999999999


Q ss_pred             cEEecccccccccCCCCcc--cccccccCCCCCChhhhccC------CCCcchhhHHHHHHHHHHHhC----------CC
Q 009186          361 PKISDFGMARIFSGNQNEA--NTNRVAGTYGYMAPEYAMEG------VFSVKSDVFSFGVLLLEIISG----------KR  422 (541)
Q Consensus       361 ~kL~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll~elltg----------~~  422 (541)
                      +||+|||+++.........  ......||+.|+|||.+.+.      .++.++||||||+++|||++|          +.
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            9999999997655433221  12234789999999999876      456799999999999999999          67


Q ss_pred             CCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          423 NSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       423 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ||........  .................+..   ..........+.+++.+||+.||++|||+.+|++.|++.
T Consensus       232 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          232 PFYDVVPNDP--SFEDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTTSCSSC--CHHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCCCCc--chhhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            7643322221  11111221111111111111   112234567888999999999999999999999999863

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.94  E-value=1.2e-27  Score=241.70  Aligned_cols=184  Identities=24%  Similarity=0.348  Sum_probs=135.5

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+...+++      .+..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        91 ~v~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQ------HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             EEEECCTTCBSHHHHHS------SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             EEEEeCCCCCHHHHHHH------ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCc
Confidence            34455555555443322      1346899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   .....    ....+.
T Consensus       162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~~~~  234 (325)
T 3kex_A          162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPD----LLEKGE  234 (325)
T ss_dssp             GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT---THHHH----HHHTTC
T ss_pred             ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH---HHHHH----HHHcCC
Confidence            988765544444445667889999999999999999999999999999999 9999853221   11111    111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ....         +......+.+++.+||+.||.+||++.++++.|+...
T Consensus       235 ~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          235 RLAQ---------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             BCCC---------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             CCCC---------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1110         0011223566888999999999999999999997643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.94  E-value=1.4e-26  Score=231.49  Aligned_cols=178  Identities=33%  Similarity=0.506  Sum_probs=137.1

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............|+..|+|
T Consensus       127 ~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a  203 (307)
T 2nru_A          127 TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA  203 (307)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCC
Confidence            346899999999999999999999999   99999999999999999999999999987654433333344578999999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh-cCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC-KGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+ .++.++||||||+++|+|++|+.||........  .......... ...+.+.+++.+ ..........+.++
T Consensus       204 PE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  279 (307)
T 2nru_A          204 PEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSV  279 (307)
T ss_dssp             HHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHH
T ss_pred             hHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHH
Confidence            998764 588999999999999999999999864332221  1111111111 122233333333 23456677889999


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +.+||+.||.+|||+.+|++.|+...
T Consensus       280 i~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          280 ASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            99999999999999999999998743

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.94  E-value=5.6e-27  Score=237.27  Aligned_cols=170  Identities=16%  Similarity=0.182  Sum_probs=128.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC-----cEEecccccccccCCCCcc-----cccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-----PKISDFGMARIFSGNQNEA-----NTNR  383 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~-----~kL~Dfg~a~~~~~~~~~~-----~~~~  383 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.     +||+|||+++.+.......     ....
T Consensus       100 ~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~  176 (330)
T 2izr_A          100 RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS  176 (330)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCC
Confidence            46999999999999999999999999   999999999999998887     9999999998765433221     1234


Q ss_pred             cccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHH
Q 009186          384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDA  463 (541)
Q Consensus       384 ~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  463 (541)
                      ..||..|+|||.+.+..++.++||||||+++|||++|+.||..................... ...    ..+....   
T Consensus       177 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~----~~~~~~~---  248 (330)
T 2izr_A          177 LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-TPI----EVLCENF---  248 (330)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-SCH----HHHTTTC---
T ss_pred             cCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-CCH----HHHhccC---
Confidence            67899999999999999999999999999999999999998644322211111111110000 000    0011111   


Q ss_pred             HHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          464 ELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       464 ~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                       . .+.+++..||+.||.+||++++|++.|+..
T Consensus       249 -p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          249 -P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             -H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             -h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence             1 677888999999999999999999999753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.94  E-value=7.5e-29  Score=255.93  Aligned_cols=184  Identities=29%  Similarity=0.383  Sum_probs=135.3

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..+.|...+++      .+..+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       188 ~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRT------EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             EEEEECCTTCBHHHHHHH------HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEEEcCCCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCC
Confidence            445566666666544432      1335899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||.....      .+ .......+
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------~~-~~~~~~~~  331 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------QQ-TREFVEKG  331 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------HH-HHHHHHTT
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcC
Confidence            9986443222111222335678999999999999999999999999999998 9998753221      11 11111121


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ....         .+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus       332 ~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          332 GRLP---------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            1111         1111234567788999999999999999999999763

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.94  E-value=6.4e-28  Score=243.64  Aligned_cols=180  Identities=24%  Similarity=0.335  Sum_probs=132.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.|...+++       ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        82 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             EEEECCTTEEGGGGSBT-------TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeec
Confidence            34566666666544432       345999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++.+.............||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......   ..   ...+....
T Consensus       152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~~~~~~~  225 (323)
T 3tki_A          152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QE---YSDWKEKK  225 (323)
T ss_dssp             CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HH---HHHHHTTC
T ss_pred             cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HH---HHHHhccc
Confidence            987644333333345678999999999988775 789999999999999999999985432211   11   11111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      ..  ..+      .......+.+|+.+||+.||++|||+.|+++.
T Consensus       226 ~~--~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          226 TY--LNP------WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TT--STT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cc--CCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            10  000      01123356678889999999999999999863

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.94  E-value=3.1e-29  Score=249.53  Aligned_cols=191  Identities=25%  Similarity=0.351  Sum_probs=132.3

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.|...+++      ....+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        90 lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQK------HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             EEEECCTTCBHHHHHHH------CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             EEEEeCCCCCHHHHHHh------cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcc
Confidence            34555555565444332      1235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCc-ccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc---------CcCcHHHH
Q 009186          369 ARIFSGNQNE-ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE---------HGQSLLTY  438 (541)
Q Consensus       369 a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~---------~~~~~~~~  438 (541)
                      ++........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+......         ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            9876543322 1222334667799999999999999999999999999999999987432110         00000011


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      .......+.         ....+......+.+++.+||+.||++|||+.||++.|+...
T Consensus       241 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          241 LIELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            111111111         11112223356778899999999999999999999998653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.94  E-value=5.8e-27  Score=235.07  Aligned_cols=189  Identities=28%  Similarity=0.418  Sum_probs=128.2

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++..+.|...+++    ......+++.+++.++.||+.||+|||+++ .+|+||||||+||+++.++.+||+|||++
T Consensus       112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHK----SGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEECCTTCBHHHHHHS----TTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEecCCCCcHHHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            3455555555443332    111234899999999999999999999986 34999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcc
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEAL  449 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  449 (541)
                      +......  .......||..|+|||.+.+..++.++||||||+++|||++|+.||.....      .+............
T Consensus       187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~~~  258 (309)
T 3p86_A          187 RLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP------AQVVAAVGFKCKRL  258 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHHSCCCC
T ss_pred             ccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCCCC
Confidence            7543322  122345689999999999999999999999999999999999999853221      11111111111111


Q ss_pred             ccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCC
Q 009186          450 ELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATL  500 (541)
Q Consensus       450 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l  500 (541)
                           .+..    .....+.+++.+||+.||.+|||+.+|++.|+......
T Consensus       259 -----~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          259 -----EIPR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             -----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             -----CCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                 1111    12335778889999999999999999999998865443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.94  E-value=1.1e-27  Score=242.75  Aligned_cols=195  Identities=22%  Similarity=0.248  Sum_probs=134.9

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhc---------CCCceEecccCCCcEEEcCCC
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHED---------SRLRVIHRDLKTSNVLLDHEM  359 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~---------~~~~ivH~DLkp~NIll~~~~  359 (541)
                      ++++|+..+.|...+++        ..+++..+++++.||+.||+|||+.         +   |+||||||+|||++.++
T Consensus        89 lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSL--------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             EEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTS
T ss_pred             EEEecCCCCcHHHHHhh--------cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCC
Confidence            45566666666544422        2358899999999999999999998         8   99999999999999999


Q ss_pred             CcEEecccccccccCCCC------cccccccccCCCCCChhhhcc-------CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          360 NPKISDFGMARIFSGNQN------EANTNRVAGTYGYMAPEYAME-------GVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       360 ~~kL~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      .+||+|||+++.+.....      ........||..|+|||.+.+       ..++.++||||||+++|||++|..|+..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            999999999987653321      111223468999999999976       3567789999999999999999776532


Q ss_pred             CCCcCc-CcHH----------HHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          427 YLSEHG-QSLL----------TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       427 ~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ...... ....          ...............+.....  ........+.+|+.+||+.||++|||+.|+++.|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            221111 1111          111111111111111111111  122355678899999999999999999999999987


Q ss_pred             C
Q 009186          496 D  496 (541)
Q Consensus       496 ~  496 (541)
                      .
T Consensus       316 l  316 (336)
T 3g2f_A          316 L  316 (336)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.94  E-value=1.1e-26  Score=230.64  Aligned_cols=171  Identities=25%  Similarity=0.424  Sum_probs=119.0

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++................|+..|+|
T Consensus       114 ~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  190 (289)
T 3og7_A          114 ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA  190 (289)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccC
Confidence            345899999999999999999999999   99999999999999999999999999986554333333344578999999


Q ss_pred             hhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          393 PEYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       393 PE~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      ||.+.   +..++.++||||||+++|||++|+.||......      +........+.....+.. +    .......+.
T Consensus       191 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~-~----~~~~~~~l~  259 (289)
T 3og7_A          191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSPDLSK-V----RSNCPKRMK  259 (289)
T ss_dssp             HHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCCCTTS-S----CTTSCHHHH
T ss_pred             chhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCcchhh-c----cccCCHHHH
Confidence            99986   567889999999999999999999998532211      111122222221111111 1    112234677


Q ss_pred             HHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +++.+||+.||.+||++.+|++.|+...
T Consensus       260 ~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          260 RLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            8889999999999999999999998764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.94  E-value=2.1e-26  Score=234.55  Aligned_cols=176  Identities=17%  Similarity=0.182  Sum_probs=129.9

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC--CcEEecccccccccCCCCc-----ccccccccC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM--NPKISDFGMARIFSGNQNE-----ANTNRVAGT  387 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~-----~~~~~~~gt  387 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+|||++.++  .+||+|||+++.+......     .......||
T Consensus       147 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt  223 (345)
T 2v62_A          147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT  223 (345)
T ss_dssp             BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCC
Confidence            6999999999999999999999999   99999999999999887  9999999999875432211     112345789


Q ss_pred             CCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          388 YGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       388 ~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||......  ............. .....+......   ......
T Consensus       224 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~  297 (345)
T 2v62_A          224 IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD--PVAVQTAKTNLLD-ELPQSVLKWAPS---GSSCCE  297 (345)
T ss_dssp             TTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC--HHHHHHHHHHHHH-TTTHHHHHHSCT---TSCCHH
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc--cHHHHHHHHhhcc-cccHHHHhhccc---cccHHH
Confidence            9999999999999999999999999999999999998532111  1111111111111 111111111110   012345


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHHHHhcCCCC
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVVMLASDTAT  499 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~  499 (541)
                      +.+++.+||+.||++||++.+|++.|+.....
T Consensus       298 l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          298 IAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             HHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            77788899999999999999999999986643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.94  E-value=2.5e-28  Score=246.76  Aligned_cols=184  Identities=28%  Similarity=0.394  Sum_probs=133.4

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.|...++.      ....+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       127 lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRT------HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             EEEECCTTCBHHHHHHT------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             EEeeCCCCCcHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCc
Confidence            34555555555444322      1345899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc-cccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          369 ARIFSGNQNEA-NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       369 a~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      ++......... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....      .+.. .....+
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~-~~~~~~  270 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------RDVI-SSVEEG  270 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHH-HHHHTT
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------HHHH-HHHHcC
Confidence            98765432221 2222345778999999998999999999999999999999 9999743211      1111 111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ...         ..+......+.+++.+||+.||.+||++.+|++.|+...
T Consensus       271 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          271 YRL---------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC---------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            110         111122345778889999999999999999999998753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.94  E-value=2.6e-27  Score=242.25  Aligned_cols=166  Identities=29%  Similarity=0.399  Sum_probs=129.6

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...............+|..|+|
T Consensus       187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a  263 (359)
T 3vhe_A          187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  263 (359)
T ss_dssp             TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence            445999999999999999999999999   99999999999999999999999999987655444444445678889999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||......   .   ........+....     .    +......+.++
T Consensus       264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~---~~~~~~~~~~~~~-----~----~~~~~~~l~~l  328 (359)
T 3vhe_A          264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---E---EFCRRLKEGTRMR-----A----PDYTTPEMYQT  328 (359)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---H---HHHHHHHHTCCCC-----C----CTTCCHHHHHH
T ss_pred             hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---H---HHHHHHHcCCCCC-----C----CCCCCHHHHHH
Confidence            999999999999999999999999998 99998532211   1   1111111211111     1    11122357778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||.+|||+.+|+++|+..
T Consensus       329 i~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          329 MLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHccCChhhCCCHHHHHHHHHHH
Confidence            8999999999999999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.94  E-value=5.1e-27  Score=236.30  Aligned_cols=196  Identities=16%  Similarity=0.203  Sum_probs=140.3

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE----cCCCCcEEec
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL----DHEMNPKISD  365 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll----~~~~~~kL~D  365 (541)
                      +++++..+.|...+++.    .....+++.+++.++.||+.||+|||+++   |+||||||+||++    +.++.+||+|
T Consensus        87 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEP----SNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             EEECCTTCBHHHHHHSG----GGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             EEeCCCCCCHHHHHHHh----ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEcc
Confidence            34555555554444321    12234999999999999999999999999   9999999999999    7778899999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHH
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAM--------EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT  437 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~  437 (541)
                      ||+++.......   .....||..|+|||.+.        +..++.++||||||+++|||++|+.||.........  .+
T Consensus       160 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~  234 (319)
T 4euu_A          160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE  234 (319)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HH
T ss_pred             CCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HH
Confidence            999987654332   22356899999999986        467899999999999999999999998543322211  11


Q ss_pred             HHHHhhhcCC--ccccc----------cc--cccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          438 YAWKLWCKGE--ALELM----------DP--VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       438 ~~~~~~~~~~--~~~~~----------~~--~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ..........  ....+          ..  .............+.+++.+||+.||++|||++|+++..+++.
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            1112111110  00000          00  1112334566777889999999999999999999999998755

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.94  E-value=1.7e-27  Score=240.97  Aligned_cols=165  Identities=24%  Similarity=0.394  Sum_probs=121.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus       112 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aP  188 (327)
T 3lzb_A          112 DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCH
Confidence            35899999999999999999999999   999999999999999999999999999876544433333344567889999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||......   .....    ...+...         ..+......+.+++
T Consensus       189 E~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~----~~~~~~~---------~~~~~~~~~l~~li  252 (327)
T 3lzb_A          189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEKGERL---------PQPPICTIDVYMIM  252 (327)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCC---------CCCTTBCHHHHHHH
T ss_pred             HHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCC---------CCCccCCHHHHHHH
Confidence            99999999999999999999999999 99998533221   11111    1111111         01112233577888


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      .+||+.||.+||++.|+++.|+...
T Consensus       253 ~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          253 RKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHHH
Confidence            9999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.94  E-value=2.2e-28  Score=258.52  Aligned_cols=195  Identities=25%  Similarity=0.412  Sum_probs=137.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++..|.|...+++     ..+..+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       254 ~iv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             EEEECCCTTCBHHHHHSH-----HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEEehhhcCCCHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCc
Confidence            345556555555444432     12345899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++........ ......++..|+|||.+.++.++.++||||||+++|||++ |+.||....      ..+.. .....+
T Consensus       326 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~------~~~~~-~~i~~~  397 (452)
T 1fmk_A          326 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVL-DQVERG  397 (452)
T ss_dssp             TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHH-HHHHTT
T ss_pred             cceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC------HHHHH-HHHHcC
Confidence            99876433211 1223346778999999999999999999999999999999 899974321      11111 111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPA  507 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~P~  507 (541)
                      ...         ..+......+.+++.+||+.||++|||+++|++.|+.......++..|.
T Consensus       398 ~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~  449 (452)
T 1fmk_A          398 YRM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG  449 (452)
T ss_dssp             CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred             CCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccc
Confidence            111         1112223467788999999999999999999999998776655554443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.94  E-value=2.7e-26  Score=228.88  Aligned_cols=176  Identities=22%  Similarity=0.322  Sum_probs=131.6

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.|...+++        ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        94 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~  162 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF  162 (297)
T ss_dssp             EEEECCTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEECCCCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCC
Confidence            44555555555443322        24899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      +.........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....      ..............
T Consensus       163 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~~~~  234 (297)
T 3fxz_A          163 CAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRALYLIATNGTP  234 (297)
T ss_dssp             CEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHHCSC
T ss_pred             ceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC
Confidence            8876543322  234578999999999999999999999999999999999999984321      11111111111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      . ..       .+......+.+++.+||+.||++|||+.|+++
T Consensus       235 ~-~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 E-LQ-------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             C-CS-------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C-CC-------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1 00       01122345678889999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.94  E-value=3.8e-27  Score=243.60  Aligned_cols=167  Identities=30%  Similarity=0.373  Sum_probs=131.6

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ....+++.+++.|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus       184 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~  260 (382)
T 3tt0_A          184 PEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM  260 (382)
T ss_dssp             CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGS
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCccee
Confidence            3456999999999999999999999999   9999999999999999999999999998765544333344456788999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||.+.+..++.++||||||+++|||++ |+.||....      .. .....+..+.....     ..    .....+.+
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~------~~-~~~~~~~~~~~~~~-----~~----~~~~~l~~  324 (382)
T 3tt0_A          261 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VE-ELFKLLKEGHRMDK-----PS----NCTNELYM  324 (382)
T ss_dssp             CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HH-HHHHHHHTTCCCCC-----CS----SCCHHHHH
T ss_pred             CHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------HH-HHHHHHHcCCCCCC-----Cc----cCCHHHHH
Confidence            9999999999999999999999999999 999974321      11 11222222211111     11    12345778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ++.+||+.||++|||+.+|++.|+...
T Consensus       325 li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          325 MMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            889999999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.94  E-value=1.6e-27  Score=241.19  Aligned_cols=173  Identities=24%  Similarity=0.339  Sum_probs=130.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+...+.+       ...+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~  160 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVA-------HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF  160 (328)
T ss_dssp             EEECCCTTCBHHHHHHH-------HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred             EEEECCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccC
Confidence            34555555555444322       235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFS-VKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +.......   ......||+.|+|||.+.+..+. .++||||||+++|||++|+.||...      ...+...... .+.
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~i~-~~~  230 (328)
T 3fe3_A          161 SNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ------NLKELRERVL-RGK  230 (328)
T ss_dssp             CGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHH-HCC
T ss_pred             ceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHH-hCC
Confidence            98654332   22345789999999999888765 7999999999999999999998532      1222211111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .      .+.    ......+.+++.+||+.||.+|||++|+++
T Consensus       231 ~------~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 Y------RIP----FYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             C------CCC----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             C------CCC----CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1      011    112335677888999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=4.3e-27  Score=239.25  Aligned_cols=169  Identities=29%  Similarity=0.393  Sum_probs=129.4

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++................+|+.|+|
T Consensus       166 ~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a  242 (344)
T 1rjb_A          166 LNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA  242 (344)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCC
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccC
Confidence            346899999999999999999999999   99999999999999999999999999987654443333444567889999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||......   ..   .......+...         ..+......+.++
T Consensus       243 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~---~~~~~~~~~~~---------~~~~~~~~~l~~l  307 (344)
T 1rjb_A          243 PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD---AN---FYKLIQNGFKM---------DQPFYATEEIYII  307 (344)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---HH---HHHHHHTTCCC---------CCCTTCCHHHHHH
T ss_pred             HHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH---HH---HHHHHhcCCCC---------CCCCCCCHHHHHH
Confidence            999999999999999999999999998 99998533211   11   11111111111         0111123457778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCCCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDTAT  499 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~~~  499 (541)
                      +.+||+.||.+||++.+|++.|+.....
T Consensus       308 i~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          308 MQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            8999999999999999999999875543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.93  E-value=2.4e-27  Score=246.49  Aligned_cols=183  Identities=18%  Similarity=0.219  Sum_probs=127.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC---CCCcEEe
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH---EMNPKIS  364 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~---~~~~kL~  364 (541)
                      ++|++|+.+|.|...+++     .....+++.++..|+.||+.||+|||+.+   |+||||||+|||++.   ++.+||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EEEEECCCSEEHHHHHHC-----C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEeCCCCcHHHHHHH-----hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEE
Confidence            445566666666544432     12345999999999999999999999999   999999999999998   7889999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcC-cHHHHHHHhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQ-SLLTYAWKLW  443 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~  443 (541)
                      |||+++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||......... ......    
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----  279 (400)
T 1nxk_A          207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----  279 (400)
T ss_dssp             CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----
T ss_pred             ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----
Confidence            999998654322   123456899999999999999999999999999999999999998543322111 111111    


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..+.. ....+.     .......+.+|+.+||+.||++|||+.+|++
T Consensus       280 ~~~~~-~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          280 RMGQY-EFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             HHTCC-CCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HcCcc-cCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111 000000     0112345778889999999999999999997

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=2.4e-27  Score=236.06  Aligned_cols=168  Identities=26%  Similarity=0.341  Sum_probs=124.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++....... .......||+.|+||
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aP  181 (294)
T 4eqm_A          106 GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSP  181 (294)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCH
Confidence            35899999999999999999999999   99999999999999999999999999987543322 222345689999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|||++|+.||...      .............. .. .......    .....+.+++.
T Consensus       182 E~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~------~~~~~~~~~~~~~~-~~-~~~~~~~----~~~~~l~~li~  249 (294)
T 4eqm_A          182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE------TAVSIAIKHIQDSV-PN-VTTDVRK----DIPQSLSNVIL  249 (294)
T ss_dssp             HHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS------CHHHHHHHHHSSCC-CC-HHHHSCT----TSCHHHHHHHH
T ss_pred             hHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHhhccC-CC-cchhccc----CCCHHHHHHHH
Confidence            9999999999999999999999999999998432      12222222221111 11 1111111    12345777888


Q ss_pred             hhcccCCCCCC-CHHHHHHHHhcCC
Q 009186          474 LCVQEDPAHRP-NMSSVVVMLASDT  497 (541)
Q Consensus       474 ~cl~~dP~~RP-t~~evl~~L~~~~  497 (541)
                      +||+.||++|| +++++.+.|+...
T Consensus       250 ~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          250 RATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             HHhcCCHhHccccHHHHHHHHHHHH
Confidence            99999999999 9999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.93  E-value=2.2e-27  Score=245.73  Aligned_cols=177  Identities=25%  Similarity=0.350  Sum_probs=129.6

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++|++|+.+|.|...+++       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       129 ~lV~E~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQR-------QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             EEEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecc
Confidence            345566666666544432       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcC--cCcHHHHHHHhhhc
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH--GQSLLTYAWKLWCK  445 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~  445 (541)
                      +++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..............
T Consensus       199 la~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          199 MCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             TCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             eeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence            997532222  22334679999999999999999999999999999999999999985432211  11111222222222


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM  486 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~  486 (541)
                      ...      .+..    .....+.+|+.+||+.||.+||++
T Consensus       277 ~~~------~~p~----~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          277 KQI------RIPR----SLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCC------CCCT----TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ccc------CCCC----cCCHHHHHHHHHHhcCCHhHcCCC
Confidence            111      1111    123456778889999999999995

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.93  E-value=3.9e-28  Score=250.11  Aligned_cols=183  Identities=27%  Similarity=0.416  Sum_probs=124.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.|...+++      .+..+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       123 lv~e~~~~~sL~~~l~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRK------HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             EEEECCTTCBHHHHHHT------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EEEeCCCCCcHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcc
Confidence            34455555665444432      2345899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc-cccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          369 ARIFSGNQNEA-NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       369 a~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      ++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ....    .....+
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~----~~i~~~  266 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVI----KAVDEG  266 (373)
T ss_dssp             --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHH----HHHHTT
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHcC
Confidence            98765432211 1122235678999999999999999999999999999998 9999743211   1111    111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                               .....+......+.+++.+||+.||++||++.+|+++|+..
T Consensus       267 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          267 ---------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             ---------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                     11111122335677899999999999999999999999763

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.93  E-value=1.6e-26  Score=245.38  Aligned_cols=170  Identities=16%  Similarity=0.223  Sum_probs=129.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE---cCCCCcEEecccccccccCCCCcc-----cccccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEA-----NTNRVA  385 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~-----~~~~~~  385 (541)
                      ..+++.+++.|+.||+.||+|||+++   |+||||||+||||   +.++.+||+|||+++.+.......     ......
T Consensus        98 ~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~  174 (483)
T 3sv0_A           98 RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT  174 (483)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccC
Confidence            35999999999999999999999999   9999999999999   688899999999998765443221     222467


Q ss_pred             cCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       386 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      ||..|+|||.+.+..++.++||||||+++|||++|+.||.....................    ..+. .+...+    .
T Consensus       175 gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~----~~~~-~l~~~~----p  245 (483)
T 3sv0_A          175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA----TSIE-ALCRGY----P  245 (483)
T ss_dssp             SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH----SCHH-HHHTTS----C
T ss_pred             CCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc----ccHH-HHhcCC----c
Confidence            899999999999999999999999999999999999998644332222222111111101    1111 111112    2


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..+.+|+..||+.||++||++.+|+++|+.
T Consensus       246 ~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          246 TEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             HHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            457788899999999999999999998875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.93  E-value=1.3e-26  Score=236.81  Aligned_cols=197  Identities=13%  Similarity=0.131  Sum_probs=138.8

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC--CcEEecc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM--NPKISDF  366 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~--~~kL~Df  366 (541)
                      ++++++ .+.|...+++.     .+..+++.+++.++.||+.||+|||+++   |+||||||+||+++.++  .+||+||
T Consensus       135 lv~e~~-~~~L~~~l~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Df  205 (352)
T 2jii_A          135 LVLPSL-GRSLQSALDVS-----PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGY  205 (352)
T ss_dssp             EEEECC-CEEHHHHHHHS-----GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCG
T ss_pred             EEecCC-CcCHHHHHHhC-----CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecC
Confidence            334555 55554443321     2356999999999999999999999999   99999999999999998  8999999


Q ss_pred             cccccccCCCCc-----ccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH
Q 009186          367 GMARIFSGNQNE-----ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       367 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      |+++.+......     .......||..|+|||.+.+..++.++||||||+++|||++|+.||....... ..... ...
T Consensus       206 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~-~~~  283 (352)
T 2jii_A          206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-EDIMK-QKQ  283 (352)
T ss_dssp             GGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHH-HHH
T ss_pred             cceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-HHHHH-HHH
Confidence            999865433211     11233478999999999999899999999999999999999999986432111 11111 111


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCC
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATL  500 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l  500 (541)
                      .+.. ......+......   .....+.+++.+||+.||++||++++|++.|+......
T Consensus       284 ~~~~-~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          284 KFVD-KPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             HHHH-SCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hccC-ChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            1111 1111111111100   11245777888999999999999999999998754333

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.93  E-value=3.3e-27  Score=239.69  Aligned_cols=174  Identities=21%  Similarity=0.251  Sum_probs=130.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+.+|.|...+++       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        82 lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~  151 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSR-------ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccc
Confidence            44566666666444332       235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....      ......... ....
T Consensus       152 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~-~~~~  222 (337)
T 1o6l_A          152 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELIL-MEEI  222 (337)
T ss_dssp             CBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HCCC
T ss_pred             hhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHHHHHHH-cCCC
Confidence            976432221  2334678999999999999999999999999999999999999984321      111111111 1111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                            .+...    ....+.+++.+||+.||++||     +++||++
T Consensus       223 ------~~p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 ------RFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                  11111    233567788899999999999     8999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.93  E-value=7e-27  Score=234.19  Aligned_cols=166  Identities=28%  Similarity=0.440  Sum_probs=129.1

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       139 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  215 (313)
T 1t46_A          139 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA  215 (313)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCC
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeC
Confidence            446999999999999999999999999   99999999999999999999999999987665544333344567788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||......   ..   ..........     ...    +......+.++
T Consensus       216 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~---~~~~~~~~~~-----~~~----~~~~~~~l~~l  280 (313)
T 1t46_A          216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---SK---FYKMIKEGFR-----MLS----PEHAPAEMYDI  280 (313)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---HH---HHHHHHHTCC-----CCC----CTTSCHHHHHH
T ss_pred             hHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch---hH---HHHHhccCCC-----CCC----cccCCHHHHHH
Confidence            999999999999999999999999999 99997533211   11   1111111110     001    11123457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||.+|||+.+|++.|++.
T Consensus       281 i~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          281 MKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCchhCcCHHHHHHHHHHH
Confidence            8999999999999999999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.93  E-value=3.3e-28  Score=257.33  Aligned_cols=186  Identities=26%  Similarity=0.412  Sum_probs=135.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..|.|...+++     ..+..+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       259 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             EEECCCTTCBHHHHHHS-----HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             EEEeecCCCcHHHHHHh-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCC
Confidence            44455545555433322     12235889999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||....      ..+.. .....+.
T Consensus       331 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~------~~~~~-~~i~~~~  402 (454)
T 1qcf_A          331 ARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEVI-RALERGY  402 (454)
T ss_dssp             GGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHH-HHHHHTC
T ss_pred             ceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC------HHHHH-HHHHcCC
Confidence            987543211 11122345778999999999999999999999999999999 999985321      11111 1111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCC
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTAT  499 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~  499 (541)
                      ..         ..+......+.+|+.+||+.||++|||+++|++.|+.....
T Consensus       403 ~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          403 RM---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CC---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            10         01112234577889999999999999999999999987544

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.93  E-value=9.1e-27  Score=233.19  Aligned_cols=169  Identities=22%  Similarity=0.281  Sum_probs=124.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.......   .....||..|+||
T Consensus       115 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aP  188 (308)
T 3g33_A          115 PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAP  188 (308)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCc
Confidence            34899999999999999999999999   99999999999999999999999999986543322   2345789999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc---CCccccc---cccccC-------CC
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK---GEALELM---DPVLKQ-------TC  460 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~l~~-------~~  460 (541)
                      |.+.+..++.++||||||+++|||++|+.||.....   .............   ..+....   ...+..       ..
T Consensus       189 E~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (308)
T 3g33_A          189 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSV  265 (308)
T ss_dssp             HHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHH
T ss_pred             hHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHh
Confidence            999999999999999999999999999999853221   1111111111110   0000000   000000       00


Q ss_pred             CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          461 VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       461 ~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+.....+.+++.+||+.||++|||+.|+++
T Consensus       266 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          266 VPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             SCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1112346778899999999999999999885

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.93  E-value=4.6e-27  Score=235.64  Aligned_cols=165  Identities=28%  Similarity=0.406  Sum_probs=129.0

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       144 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  220 (314)
T 2ivs_A          144 ERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMA  220 (314)
T ss_dssp             -CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCC
T ss_pred             ccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccC
Confidence            446899999999999999999999999   99999999999999999999999999987654443333334456788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||.....   .....    ....+....         .+......+.++
T Consensus       221 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~----~~~~~~~~~---------~~~~~~~~~~~l  284 (314)
T 2ivs_A          221 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP---ERLFN----LLKTGHRME---------RPDNCSEEMYRL  284 (314)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHH----HHHTTCCCC---------CCTTCCHHHHHH
T ss_pred             hhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HhhcCCcCC---------CCccCCHHHHHH
Confidence            999999889999999999999999999 9999753322   11111    111111111         111223457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||++||++.+|++.|+..
T Consensus       285 i~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          285 MLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            8999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.93  E-value=6.3e-27  Score=235.91  Aligned_cols=165  Identities=24%  Similarity=0.390  Sum_probs=120.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus       132 ~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  208 (323)
T 3qup_A          132 FNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL  208 (323)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCc
Confidence            35899999999999999999999999   999999999999999999999999999876544333333344567789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||.....   ......    ...+....         .+......+.+++
T Consensus       209 E~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~----~~~~~~~~---------~~~~~~~~l~~li  272 (323)
T 3qup_A          209 ESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIYNY----LIGGNRLK---------QPPECMEEVYDLM  272 (323)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHH----HHTTCCCC---------CCTTCCHHHHHHH
T ss_pred             hhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh---HHHHHH----HhcCCCCC---------CCCccCHHHHHHH
Confidence            99999999999999999999999999 8998753221   111111    11111111         1112234577889


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      .+||+.||++|||+.++++.|++..
T Consensus       273 ~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          273 YQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999998753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.93  E-value=5.6e-27  Score=238.67  Aligned_cols=161  Identities=22%  Similarity=0.318  Sum_probs=115.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+.............||+.|+||
T Consensus       103 ~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP  178 (343)
T 3dbq_A          103 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP  178 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCH
Confidence            35899999999999999999999999   99999999999997 578999999999876554433334456799999999


Q ss_pred             hhhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCH
Q 009186          394 EYAME-----------GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVD  462 (541)
Q Consensus       394 E~l~~-----------~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  462 (541)
                      |++.+           ..++.++||||||+++|||++|+.||.....     ...........         ......+.
T Consensus       179 E~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~---------~~~~~~~~  244 (343)
T 3dbq_A          179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDP---------NHEIEFPD  244 (343)
T ss_dssp             HHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCT---------TSCCCCCC
T ss_pred             HHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhcC---------CcccCCcc
Confidence            99865           6788999999999999999999999853211     11111111111         11111111


Q ss_pred             HHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          463 AELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       463 ~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                      .....+.+++.+||+.||.+|||+.|+++.
T Consensus       245 ~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          245 IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            112456778889999999999999999863

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.93  E-value=1.1e-27  Score=247.27  Aligned_cols=171  Identities=12%  Similarity=0.079  Sum_probs=125.4

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++ .|.|...+++..........+++..++.|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       178 v~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a  253 (377)
T 3byv_A          178 LYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL  253 (377)
T ss_dssp             EEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred             EEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhh
Confidence            34444 34454333332222333456888999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHH
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEG-----------VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTY  438 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~  438 (541)
                      +....     ......| ..|+|||.+.+.           .++.++|||||||++|||++|+.||........      
T Consensus       254 ~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~------  321 (377)
T 3byv_A          254 VRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG------  321 (377)
T ss_dssp             EETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC------
T ss_pred             eecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc------
Confidence            85322     2233456 899999999887           799999999999999999999999843221110      


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                                ...+.... ...    ...+.+++.+||+.||++|||+.++++
T Consensus       322 ----------~~~~~~~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          322 ----------SEWIFRSC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             ----------SGGGGSSC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             ----------hhhhhhhc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence                      01111100 111    245677888999999999999999985

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.93  E-value=1.2e-27  Score=244.59  Aligned_cols=174  Identities=26%  Similarity=0.328  Sum_probs=127.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++|+.++.|...+++       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       101 lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~  170 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK-------SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccc
Confidence            44566666666444432       235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....      ..+...... .+..
T Consensus       171 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~-~~~~  241 (353)
T 3txo_A          171 CKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN------EDDLFEAIL-NDEV  241 (353)
T ss_dssp             CBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HCCC
T ss_pred             eeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC------HHHHHHHHH-cCCC
Confidence            97533222  22334679999999999998889999999999999999999999985321      111111111 1111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH------HHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM------SSVVV  491 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~------~evl~  491 (541)
                            .+    +......+.+++.+||+.||.+||++      ++|++
T Consensus       242 ------~~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 ------VY----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------CC----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------CC----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                  01    11122346678889999999999998      77775

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.93  E-value=1.6e-27  Score=238.93  Aligned_cols=193  Identities=25%  Similarity=0.360  Sum_probs=133.8

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhh---cCCCceEecccCCCcEEEcCCCC-cEEe
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHE---DSRLRVIHRDLKTSNVLLDHEMN-PKIS  364 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~---~~~~~ivH~DLkp~NIll~~~~~-~kL~  364 (541)
                      ++++++..+.|...+++    ......+++.+++.++.||++||+|||+   ++   |+||||||+||+++.++. +||+
T Consensus        76 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~  148 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHG----AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKIC  148 (307)
T ss_dssp             EEEECCTTCBHHHHHHC----SSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEEcCCCCCHHHHHhc----cCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEc
Confidence            44556655666444432    1122347899999999999999999999   66   999999999999998887 7999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||++......     .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.....    ......+... 
T Consensus       149 Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~-  218 (307)
T 2eva_A          149 DFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----PAFRIMWAVH-  218 (307)
T ss_dssp             CCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS----SHHHHHHHHH-
T ss_pred             ccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc----cHHHHHHHHh-
Confidence            99998754322     1234589999999999998999999999999999999999999853221    1112222211 


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPA  507 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~P~  507 (541)
                      .+...     .+....    ...+.+++.+||+.||++|||+.+|++.|+......+.+..|.
T Consensus       219 ~~~~~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  272 (307)
T 2eva_A          219 NGTRP-----PLIKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL  272 (307)
T ss_dssp             TTCCC-----CCBTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred             cCCCC-----Cccccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence            11111     111112    2356778899999999999999999999987655554444433

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.93  E-value=2.8e-26  Score=230.25  Aligned_cols=170  Identities=21%  Similarity=0.278  Sum_probs=122.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++........  .....+|..|+||
T Consensus       114 ~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aP  188 (311)
T 3niz_A          114 TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAP  188 (311)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCccc--ccCCcccCCcCCH
Confidence            35899999999999999999999999   999999999999999999999999999875433222  2234679999999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcc---c-------------cccccc
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEAL---E-------------LMDPVL  456 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------------~~~~~l  456 (541)
                      |.+.+ ..++.++||||||+++|||++|+.||......   ................   .             ......
T Consensus       189 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (311)
T 3niz_A          189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD---DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKP  265 (311)
T ss_dssp             HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT---THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCC
T ss_pred             HHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCc
Confidence            99876 55899999999999999999999998643322   1222222211111000   0             000000


Q ss_pred             cCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          457 KQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       457 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .....+.....+.+++.+||+.||++|||++|+++
T Consensus       266 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          266 WSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00001112345778999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.93  E-value=1.1e-27  Score=255.95  Aligned_cols=165  Identities=24%  Similarity=0.333  Sum_probs=128.0

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... .......++..|+|
T Consensus       312 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~a  387 (495)
T 1opk_A          312 RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTA  387 (495)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce-eecCCCcCCcceeC
Confidence            356899999999999999999999999   99999999999999999999999999987643321 11223345678999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||.....   ....+.    ...+.         ....+......+.+|
T Consensus       388 PE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~---------~~~~~~~~~~~l~~l  451 (495)
T 1opk_A          388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYEL----LEKDY---------RMERPEGCPEKVYEL  451 (495)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHH----HHTTC---------CCCCCTTCCHHHHHH
T ss_pred             HhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCC---------CCCCCCCCCHHHHHH
Confidence            999999999999999999999999999 8888753221   111111    11111         111112223457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +.+||+.||++|||+.+|++.|+...
T Consensus       452 i~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          452 MRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            89999999999999999999999764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.93  E-value=2.3e-27  Score=238.04  Aligned_cols=185  Identities=22%  Similarity=0.319  Sum_probs=125.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++.++.|...+++       ...+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus        92 ~lv~e~~~g~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHT-------EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             EEEEECCCEEEHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             EEEEecCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeecc
Confidence            344555555555443322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCc-ccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNE-ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++.+...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||...      ......+......
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~------~~~~~~~~~~~~~  235 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD------SPVSVAYQHVRED  235 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHCC
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHhcCC
Confidence            99876543222 2223356899999999999999999999999999999999999998432      1222222222221


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHH-HHHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV-VMLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl-~~L~~  495 (541)
                      ....   .....    .....+.+++.+||+.||++||+..+++ ..|..
T Consensus       236 ~~~~---~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          236 PIPP---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             CCCH---HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCc---ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            1110   00011    1234567788899999999999766655 44443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.93  E-value=5.8e-27  Score=235.08  Aligned_cols=167  Identities=24%  Similarity=0.367  Sum_probs=122.3

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       141 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  217 (313)
T 3brb_A          141 PKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA  217 (313)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSC
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccC
Confidence            456999999999999999999999999   99999999999999999999999999987654433233334456788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||.....   ......    ...+...     ..    +......+.++
T Consensus       218 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~----~~~~~~~-----~~----~~~~~~~l~~l  281 (313)
T 3brb_A          218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDY----LLHGHRL-----KQ----PEDCLDELYEI  281 (313)
T ss_dssp             HHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHH----HHTTCCC-----CC----BTTCCHHHHHH
T ss_pred             chhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHH----HHcCCCC-----CC----CccccHHHHHH
Confidence            999999999999999999999999999 8888753221   111111    1111111     11    11123457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDTA  498 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~~  498 (541)
                      +.+||+.||.+||++.+|++.|+....
T Consensus       282 i~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          282 MYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            899999999999999999999987543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.93  E-value=3.1e-27  Score=237.41  Aligned_cols=174  Identities=22%  Similarity=0.290  Sum_probs=127.2

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-------cccccc
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-------NTNRVA  385 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-------~~~~~~  385 (541)
                      +..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++..........       ......
T Consensus       128 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  204 (317)
T 2buj_A          128 GNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR  204 (317)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccccccccccccccccccc
Confidence            456999999999999999999999999   9999999999999999999999999887543211110       011235


Q ss_pred             cCCCCCChhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCH
Q 009186          386 GTYGYMAPEYAMEGV---FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVD  462 (541)
Q Consensus       386 gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  462 (541)
                      |+..|+|||.+.+..   ++.++||||||+++|||++|+.||....... .......    ...         .......
T Consensus       205 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~----~~~---------~~~~~~~  270 (317)
T 2buj_A          205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALAV----QNQ---------LSIPQSP  270 (317)
T ss_dssp             SCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHHH----HCC-----------CCCCT
T ss_pred             CCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHHh----hcc---------CCCCccc
Confidence            689999999987554   6889999999999999999999974221111 1111111    010         0000011


Q ss_pred             HHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCC
Q 009186          463 AELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPP  503 (541)
Q Consensus       463 ~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p  503 (541)
                      .....+.+++.+||+.||.+||++.+|++.|+......|.+
T Consensus       271 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          271 RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence            12345778889999999999999999999999876544443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=9.8e-26  Score=228.25  Aligned_cols=193  Identities=26%  Similarity=0.324  Sum_probs=134.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhc--------CCCceEecccCCCcEEEcCCC
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHED--------SRLRVIHRDLKTSNVLLDHEM  359 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~--------~~~~ivH~DLkp~NIll~~~~  359 (541)
                      +++++++..+.|...+++        ..+++.+++.++.|++.||.|||++        +   |+||||||+|||++.++
T Consensus       111 ~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKS--------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             EEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred             EEEEeccCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence            344566656666444422        2489999999999999999999998        7   99999999999999999


Q ss_pred             CcEEecccccccccCCCCcc--cccccccCCCCCChhhhccCCCCcc------hhhHHHHHHHHHHHhC----------C
Q 009186          360 NPKISDFGMARIFSGNQNEA--NTNRVAGTYGYMAPEYAMEGVFSVK------SDVFSFGVLLLEIISG----------K  421 (541)
Q Consensus       360 ~~kL~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~------sDVwSlGvll~elltg----------~  421 (541)
                      .+||+|||+++.+.......  ......||..|+|||.+.+.....+      +||||||+++|||++|          +
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            99999999997654333221  1224568999999999987766554      9999999999999999          4


Q ss_pred             CCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCC-CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          422 RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQT-CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       422 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      .||........  ..............    .+.+... ........+.+++.+||+.||++|||+.+|++.|+...
T Consensus       260 ~p~~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          260 LPYHDLVPSDP--SYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CTTTTTSCSSC--CHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccHhhhcCCCC--chhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            55432222111  11111111111111    1111111 11255677889999999999999999999999998643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=2.3e-27  Score=244.26  Aligned_cols=183  Identities=25%  Similarity=0.356  Sum_probs=125.6

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++..+.|...+++      ....+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       169 v~e~~~~g~L~~~l~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRN------ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             EEECCTTCBHHHHHHC------TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EEECCCCCCHHHHHhh------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccc
Confidence            4555555666444432      2345899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc--cccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          370 RIFSGNQNEA--NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       370 ~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +.........  ......++..|+|||.+.+..++.++||||||+++|||++ |.+||.....   .......    ..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~~~~~~~----~~~  312 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL----LQG  312 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---SCHHHHH----HTT
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---HHHHHHH----HcC
Confidence            8654332211  1223456788999999999999999999999999999999 6666643221   1222211    111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ...  ..   ..    .....+.+++.+||+.||++||++.+|++.|+...
T Consensus       313 ~~~--~~---p~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          313 RRL--LQ---PE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             CCC--CC---CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC--CC---CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            110  00   11    12245778889999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.93  E-value=5.8e-27  Score=238.02  Aligned_cols=168  Identities=27%  Similarity=0.371  Sum_probs=128.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       168 ~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a  244 (343)
T 1luf_A          168 PPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP  244 (343)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecC
Confidence            457999999999999999999999999   99999999999999999999999999986543332233334567889999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||....      ..+. ......+....     .    +......+.++
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~------~~~~-~~~~~~~~~~~-----~----~~~~~~~l~~l  308 (343)
T 1luf_A          245 PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA------HEEV-IYYVRDGNILA-----C----PENCPLELYNL  308 (343)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHH-HHHHHTTCCCC-----C----CTTCCHHHHHH
T ss_pred             hhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC------hHHH-HHHHhCCCcCC-----C----CCCCCHHHHHH
Confidence            999999999999999999999999999 999974321      1111 11122222111     1    11123457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCCCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDTAT  499 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~~~  499 (541)
                      +.+||+.||.+||++.+|++.|+.....
T Consensus       309 i~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          309 MRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             HHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            8999999999999999999999986543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=2e-26  Score=229.14  Aligned_cols=167  Identities=28%  Similarity=0.335  Sum_probs=125.7

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC--cccccccccCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN--EANTNRVAGTYGY  390 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~~~gt~~y  390 (541)
                      ...+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.......  ........++..|
T Consensus       118 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y  194 (298)
T 3pls_A          118 QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW  194 (298)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccc
Confidence            345899999999999999999999999   99999999999999999999999999986543321  1222334578899


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +|||.+.+..++.++||||||+++|+|++|..|+....  ..........    .+...         ..+......+.+
T Consensus       195 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~----~~~~~---------~~~~~~~~~l~~  259 (298)
T 3pls_A          195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTHFLA----QGRRL---------PQPEYCPDSLYQ  259 (298)
T ss_dssp             SCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHHHHHH----TTCCC---------CCCTTCCHHHHH
T ss_pred             cChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHHHHhh----cCCCC---------CCCccchHHHHH
Confidence            99999999999999999999999999999666542111  1111111111    11100         001112345778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ++.+||+.||.+|||+.++++.|+...
T Consensus       260 li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          260 VMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            889999999999999999999998753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.93  E-value=1.3e-27  Score=241.51  Aligned_cols=185  Identities=21%  Similarity=0.231  Sum_probs=113.3

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC---CcEEec
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM---NPKISD  365 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~---~~kL~D  365 (541)
                      ++++++..+.|...+++       ...+++.++..++.||+.||+|||+++   |+||||||+||+++.++   .+||+|
T Consensus        83 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~D  152 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK-------KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIID  152 (325)
T ss_dssp             EEECCCCSCBHHHHHHH-------CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECC
T ss_pred             EEEEccCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEec
Confidence            34455555555443332       245899999999999999999999999   99999999999998765   799999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+++.......  ......||..|+|||.+.+..++.++||||||+++|||++|+.||..................+..
T Consensus       153 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~  230 (325)
T 3kn6_A          153 FGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK  230 (325)
T ss_dssp             CTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred             cccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence            999986543322  222356799999999999999999999999999999999999998643322111111122222222


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +... . ....    .......+.+++.+||+.||.+|||+.++++
T Consensus       231 ~~~~-~-~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          231 GDFS-F-EGEA----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TCCC-C-CSHH----HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCC-C-Cccc----ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            2111 0 0000    0112345778899999999999999999884

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.93  E-value=2.1e-27  Score=250.79  Aligned_cols=181  Identities=28%  Similarity=0.331  Sum_probs=135.0

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++++..|.|...+++.     ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df  333 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSR-----GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF  333 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-----CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEecCCCcHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeC
Confidence            44566666666665444321     1234799999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      |+++......     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......    ...
T Consensus       334 G~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~----i~~  401 (450)
T 1k9a_A          334 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEK  401 (450)
T ss_dssp             TTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT---TTHHHH----HHT
T ss_pred             CCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHc
Confidence            9998543221     12356789999999999999999999999999999998 9999854322   112211    111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +...         ..+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus       402 ~~~~---------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          402 GYKM---------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1111         11112234677888999999999999999999999764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.93  E-value=1.4e-26  Score=243.60  Aligned_cols=177  Identities=21%  Similarity=0.228  Sum_probs=129.9

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc---CCCCcEEecc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDF  366 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~---~~~~~kL~Df  366 (541)
                      +++++.++.|.....+       +..+++.++..++.||+.||+|||+++   |+||||||+|||++   .++.+||+||
T Consensus        88 v~E~~~gg~L~~~i~~-------~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA-------REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             EECCCBCCBHHHHHHH-------CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             EEEeCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccC
Confidence            3455555555443322       245899999999999999999999999   99999999999998   4578999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....      ..+. ...+..+
T Consensus       158 G~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~------~~~~-~~~i~~~  228 (444)
T 3soa_A          158 GLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED------QHRL-YQQIKAG  228 (444)
T ss_dssp             SSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHH-HHHHHHT
T ss_pred             ceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc------HHHH-HHHHHhC
Confidence            999876543222  223578999999999999899999999999999999999999984221      1111 1111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ... ...+..     ......+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~~-~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          229 AYD-FPSPEW-----DTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCC-CCTTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC-CCcccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111 101100     112345677888999999999999999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.93  E-value=1e-26  Score=233.36  Aligned_cols=153  Identities=22%  Similarity=0.315  Sum_probs=117.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++........   .....||+.|+||
T Consensus       152 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aP  225 (311)
T 3p1a_A          152 ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAP  225 (311)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCH
Confidence            35999999999999999999999999   99999999999999999999999999876543322   2234689999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |++.+ .++.++||||||+++|||++|..++...          ..+..+..+..    .+.+...    ....+.+++.
T Consensus       226 E~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~----~~~~~~~----~~~~l~~li~  286 (311)
T 3p1a_A          226 ELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYL----PPEFTAG----LSSELRSVLV  286 (311)
T ss_dssp             GGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCC----CHHHHTT----SCHHHHHHHH
T ss_pred             hHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCC----CcccccC----CCHHHHHHHH
Confidence            98875 7899999999999999999997764211          11122222111    1111111    2345778889


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+.||++|||+.|+++
T Consensus       287 ~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          287 MMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCChhhCcCHHHHHh
Confidence            999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.93  E-value=1.8e-27  Score=240.54  Aligned_cols=188  Identities=27%  Similarity=0.341  Sum_probs=134.1

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC---CCcEEecc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKISDF  366 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~---~~~kL~Df  366 (541)
                      +++++..+.|...+++..........+++.+++.++.||+.||.|||+++   |+||||||+||+++.+   ..+||+||
T Consensus       111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECcc
Confidence            34555455554444332223334456999999999999999999999999   9999999999999844   45999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      |++................++..|+|||.+.+..++.++||||||+++|||++ |+.||....      ..+ .......
T Consensus       188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~-~~~~~~~  260 (327)
T 2yfx_A          188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------NQE-VLEFVTS  260 (327)
T ss_dssp             HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHH-HHHHHHT
T ss_pred             ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC------HHH-HHHHHhc
Confidence            99976544433333334567889999999999999999999999999999998 888874321      111 1111111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +....     ...    .....+.+++.+||+.||.+||++.+|++.|...
T Consensus       261 ~~~~~-----~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          261 GGRMD-----PPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCC-----CCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11111     111    1234577888999999999999999999999753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.93  E-value=1.5e-26  Score=231.99  Aligned_cols=165  Identities=28%  Similarity=0.402  Sum_probs=129.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus       143 ~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (316)
T 2xir_A          143 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  219 (316)
T ss_dssp             TCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence            34899999999999999999999999   999999999999999999999999999876554443334445678899999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||......  .    ........+....     ...    .....+.+++
T Consensus       220 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~----~~~~~~~~~~~~~-----~~~----~~~~~l~~li  284 (316)
T 2xir_A          220 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E----EFCRRLKEGTRMR-----APD----YTTPEMYQTM  284 (316)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--H----HHHHHHHHTCCCC-----CCT----TCCHHHHHHH
T ss_pred             hhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh--H----HHHHHhccCccCC-----CCC----CCCHHHHHHH
Confidence            99999999999999999999999998 99997532211  1    1111111111111     111    1234577788


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.||.+|||+.+|++.|+..
T Consensus       285 ~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          285 LDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHH
Confidence            899999999999999999999763

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.93  E-value=1e-26  Score=235.07  Aligned_cols=179  Identities=19%  Similarity=0.254  Sum_probs=128.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC---CCCcEEec
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH---EMNPKISD  365 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~---~~~~kL~D  365 (541)
                      ++++++..+.|.....+     .....+++.+++.++.||+.||+|||+++   |+||||||+||+++.   ++.+||+|
T Consensus       106 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLP-----ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             EEEECCTTEEGGGGGSS-----CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             EEEEecCCCcHHHHHHH-----hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEee
Confidence            34556666666444322     22346999999999999999999999999   999999999999998   78999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+++.......   .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.....      .+...... .
T Consensus       178 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~-~  247 (327)
T 3lm5_A          178 FGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN------QETYLNIS-Q  247 (327)
T ss_dssp             GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-H
T ss_pred             CccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHHH-h
Confidence            999987643322   2235689999999999999999999999999999999999999843211      11111111 1


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ... .     ............+.+++.+||+.||.+|||++++++
T Consensus       248 ~~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          248 VNV-D-----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             TCC-C-----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccc-c-----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            000 0     000111122345677889999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.93  E-value=6.1e-27  Score=238.61  Aligned_cols=181  Identities=24%  Similarity=0.347  Sum_probs=130.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++.++.|...+++       ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        87 lv~e~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~  156 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQR-------QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM  156 (345)
T ss_dssp             EEECCCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred             EEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccc
Confidence            34555555555443332       235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCc--CcHHHHHHHhhhcC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG--QSLLTYAWKLWCKG  446 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~  446 (541)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..............
T Consensus       157 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~  234 (345)
T 3a8x_A          157 CKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  234 (345)
T ss_dssp             CBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred             cccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence            97533222  123346789999999999999999999999999999999999999854221111  11111122222221


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH------HHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM------SSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~------~evl~  491 (541)
                      ..      .+..    .....+.+++.+||+.||.+||++      .++++
T Consensus       235 ~~------~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          235 QI------RIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             CC------CCCT----TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             CC------CCCC----CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            11      1111    123456778889999999999995      56654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.93  E-value=6.2e-27  Score=239.18  Aligned_cols=175  Identities=23%  Similarity=0.294  Sum_probs=130.3

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.+|.|...+++       ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        97 ~lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQ-------VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             EEEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCC
Confidence            345566666666544432       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||....      ..+...... ...
T Consensus       167 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~-~~~  237 (353)
T 2i0e_A          167 MCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIM-EHN  237 (353)
T ss_dssp             TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HCC
T ss_pred             cccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC------HHHHHHHHH-hCC
Confidence            997543222  12334679999999999999999999999999999999999999985321      111111111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~evl~  491 (541)
                      .      .+..    .....+.+++.+||+.||.+||+     +++|++
T Consensus       238 ~------~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 V------AYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             C------CCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             C------CCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1      1111    12345677888999999999995     577764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=3.3e-27  Score=238.13  Aligned_cols=183  Identities=19%  Similarity=0.208  Sum_probs=133.2

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC--CCCcEEecc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH--EMNPKISDF  366 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~--~~~~kL~Df  366 (541)
                      ++++++.++.|..+..+      ....+++.+++.++.||+.||.|||+++   |+||||||+|||++.  ++.+||+||
T Consensus        78 lv~e~~~g~~L~~~l~~------~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Df  148 (321)
T 1tki_A           78 MIFEFISGLDIFERINT------SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             EEECCCCCCBHHHHHTS------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             EEEEeCCCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEEC
Confidence            34455555555444322      2345899999999999999999999999   999999999999987  789999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.+....   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....      ..+...... .+
T Consensus       149 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~-~~  218 (321)
T 1tki_A          149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET------NQQIIENIM-NA  218 (321)
T ss_dssp             TTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHH-HT
T ss_pred             CCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC------HHHHHHHHH-cC
Confidence            9998764332   2234568999999999998889999999999999999999999984321      111111111 11


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASD  496 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~  496 (541)
                      ...  .+......    ....+.+++.+||+.||.+|||+.|+++  .+.+.
T Consensus       219 ~~~--~~~~~~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          219 EYT--FDEEAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             CCC--CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CCC--CChhhhcc----CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            110  00000011    1345778899999999999999999997  55543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.93  E-value=1.3e-26  Score=240.13  Aligned_cols=159  Identities=22%  Similarity=0.332  Sum_probs=116.0

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+.............||+.|+|||
T Consensus       151 ~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE  226 (390)
T 2zmd_A          151 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE  226 (390)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChH
Confidence            5889999999999999999999999   99999999999996 5789999999998765443333334567999999999


Q ss_pred             hhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHH
Q 009186          395 YAME-----------GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDA  463 (541)
Q Consensus       395 ~l~~-----------~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  463 (541)
                      ++.+           ..++.++|||||||++|||++|+.||.....     .............         ....+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~~~---------~~~~~~~  292 (390)
T 2zmd_A          227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNH---------EIEFPDI  292 (390)
T ss_dssp             HHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCTTS---------CCCCCCC
T ss_pred             HhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCccc---------cCCCCcc
Confidence            9865           3688999999999999999999999853211     1111111111111         1011111


Q ss_pred             HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          464 ELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       464 ~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ....+.+|+.+||+.||.+||++.|+++
T Consensus       293 ~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          293 PEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1245677888999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.93  E-value=9.9e-27  Score=235.48  Aligned_cols=166  Identities=29%  Similarity=0.425  Sum_probs=127.9

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       158 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  234 (333)
T 2i1m_A          158 NSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA  234 (333)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccC
Confidence            346899999999999999999999999   99999999999999999999999999987654443333334567788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |..||......   ..   .......+...     ..    +......+.++
T Consensus       235 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~---~~~~~~~~~~~-----~~----~~~~~~~l~~l  299 (333)
T 2i1m_A          235 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---SK---FYKLVKDGYQM-----AQ----PAFAPKNIYSI  299 (333)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---HH---HHHHHHHTCCC-----CC----CTTCCHHHHHH
T ss_pred             HHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---HH---HHHHHhcCCCC-----CC----CCCCCHHHHHH
Confidence            999999999999999999999999998 88887532211   11   11111111110     00    11113457778


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||.+|||+.+|++.|+..
T Consensus       300 i~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          300 MQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhccChhhCcCHHHHHHHHHHH
Confidence            8999999999999999999999753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.93  E-value=1.6e-25  Score=225.83  Aligned_cols=158  Identities=22%  Similarity=0.349  Sum_probs=122.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++.........  .....||..|+|||
T Consensus       137 ~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE  211 (321)
T 2c30_A          137 RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPE  211 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHh
Confidence            5899999999999999999999999   999999999999999999999999998876543222  23457899999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++||||||+++|||++|+.||....      ..+.... ........     +..  .......+.+++.+
T Consensus       212 ~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------~~~~~~~-~~~~~~~~-----~~~--~~~~~~~l~~li~~  277 (321)
T 2c30_A          212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------PVQAMKR-LRDSPPPK-----LKN--SHKVSPVLRDFLER  277 (321)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHH-HHHSSCCC-----CTT--GGGSCHHHHHHHHH
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHH-HhcCCCCC-----cCc--cccCCHHHHHHHHH
Confidence            9999999999999999999999999999985321      1111111 11111111     100  01112356778889


Q ss_pred             hcccCCCCCCCHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~  491 (541)
                      ||+.||++|||+.++++
T Consensus       278 ~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          278 MLVRDPQERATAQELLD  294 (321)
T ss_dssp             HSCSSTTTSCCHHHHHT
T ss_pred             HccCChhhCcCHHHHhc
Confidence            99999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.93  E-value=6.7e-28  Score=260.04  Aligned_cols=173  Identities=26%  Similarity=0.434  Sum_probs=131.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... .......++..|+||
T Consensus       358 ~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aP  433 (535)
T 2h8h_A          358 KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP  433 (535)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccCCcCcccccCH
Confidence            45899999999999999999999999   99999999999999999999999999986543211 111223457789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||....      ..+. ......+...         ..+......+.+|+
T Consensus       434 E~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~------~~~~-~~~i~~~~~~---------~~~~~~~~~l~~li  497 (535)
T 2h8h_A          434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREV-LDQVERGYRM---------PCPPECPESLHDLM  497 (535)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC------HHHH-HHHHHTTCCC---------CCCTTCCHHHHHHH
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHH-HHHHHcCCCC---------CCCCCCCHHHHHHH
Confidence            99999999999999999999999999 898874321      1111 1111111111         11112234577889


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQP  506 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~P  506 (541)
                      .+||+.||++|||+++|+++|+.......+...|
T Consensus       498 ~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~  531 (535)
T 2h8h_A          498 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  531 (535)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHHhhccCcccCc
Confidence            9999999999999999999999876655444333

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.93  E-value=6.9e-27  Score=239.53  Aligned_cols=177  Identities=19%  Similarity=0.199  Sum_probs=130.5

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC----CcEEe
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM----NPKIS  364 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~----~~kL~  364 (541)
                      ++++++.++.|...+.+       ...+++.++..++.||+.||.|||+++   |+||||||+|||++.++    .+||+
T Consensus        92 lv~e~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           92 LILELVSGGELFDFLAQ-------KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             EEEECCCSCBHHHHHTT-------CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEEcCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence            34555555665444432       346999999999999999999999999   99999999999998877    79999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||+++.+.....   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....      ..+.. ..+.
T Consensus       162 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~------~~~~~-~~i~  231 (361)
T 2yab_A          162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETL-ANIT  231 (361)
T ss_dssp             CCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHH-HHHH
T ss_pred             ecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------HHHHH-HHHH
Confidence            9999987654321   234568999999999998899999999999999999999999984321      11111 1111


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .... . +++.....    ....+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~-~-~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          232 AVSY-D-FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TTCC-C-CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCC-C-CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111 0 01111111    1235677888999999999999999885

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.93  E-value=3.4e-27  Score=241.08  Aligned_cols=182  Identities=22%  Similarity=0.234  Sum_probs=130.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC---cEEe
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN---PKIS  364 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~---~kL~  364 (541)
                      ++++|++.++.|...+.+   ....+..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.   +||+
T Consensus       102 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVK---RADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             EEEEECCSSCBHHHHHHH---HHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             EEEEeCCCCCCHHHHHHH---hcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEe
Confidence            344555555555332222   1122345899999999999999999999999   999999999999987655   9999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||+++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....    ..    ......
T Consensus       176 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~----~~~~i~  245 (351)
T 3c0i_A          176 GFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ER----LFEGII  245 (351)
T ss_dssp             CCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HH----HHHHHH
T ss_pred             cCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HH----HHHHHH
Confidence            9999987654322  2234578999999999999999999999999999999999999985321    11    111111


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+...  ..+.....    ....+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          246 KGKYK--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HTCCC--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCCC--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11110  01111111    1245678889999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.93  E-value=4e-27  Score=239.66  Aligned_cols=182  Identities=21%  Similarity=0.246  Sum_probs=130.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-C---CcEE
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-M---NPKI  363 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-~---~~kL  363 (541)
                      ++++|++.++.+.....+       ...+++.++..++.||+.||+|||+++   |+||||||+|||+..+ +   .+||
T Consensus        92 ~lv~E~~~gg~L~~~i~~-------~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILR-------QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EEEECCCCSCBHHHHHHT-------CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEE
Confidence            345566656665444432       235899999999999999999999999   9999999999998543 3   4899


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      +|||+++........  .....||..|+|||++.+..++.++||||||+++|||++|+.||.......   ..+ ....+
T Consensus       162 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~-~~~~i  235 (342)
T 2qr7_A          162 CDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEE-ILARI  235 (342)
T ss_dssp             CCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHH-HHHHH
T ss_pred             EECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHH-HHHHH
Confidence            999999876443222  223568999999999988889999999999999999999999985322211   111 11222


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..+...      +...........+.+|+.+||+.||++||++.++++
T Consensus       236 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          236 GSGKFS------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHCCCC------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccCCcc------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            222211      011111122345677888999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.93  E-value=1e-26  Score=235.20  Aligned_cols=166  Identities=21%  Similarity=0.224  Sum_probs=110.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc----------cccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA----------NTNR  383 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~----------~~~~  383 (541)
                      ..+++.+++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||+++.........          ....
T Consensus       131 ~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (337)
T 3ll6_A          131 GPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT  209 (337)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-----------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhcc
Confidence            45999999999999999999999875 349999999999999999999999999998765432211          1113


Q ss_pred             cccCCCCCChhhh---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCC
Q 009186          384 VAGTYGYMAPEYA---MEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTC  460 (541)
Q Consensus       384 ~~gt~~y~aPE~l---~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  460 (541)
                      ..+++.|+|||.+   .+..++.++||||||+++|||++|+.||......      ...     .....    .....  
T Consensus       210 ~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~-----~~~~~----~~~~~--  272 (337)
T 3ll6_A          210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------RIV-----NGKYS----IPPHD--  272 (337)
T ss_dssp             --------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------CC----CCTTC--
T ss_pred             ccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH------Hhh-----cCccc----CCccc--
Confidence            4588999999998   5667899999999999999999999998432110      000     00000    00001  


Q ss_pred             CHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCC
Q 009186          461 VDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTAT  499 (541)
Q Consensus       461 ~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~  499 (541)
                        .....+.+|+.+||+.||.+||++.|+++.|+.....
T Consensus       273 --~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          273 --TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             --CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence              1112356788899999999999999999999876443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.93  E-value=8.4e-27  Score=235.69  Aligned_cols=176  Identities=20%  Similarity=0.215  Sum_probs=128.9

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC----CcEEec
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM----NPKISD  365 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~----~~kL~D  365 (541)
                      +++++..+.|...+++       ...+++.+++.++.||+.||.|||+++   |+||||||+||+++.++    .+||+|
T Consensus        92 v~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           92 ILELVAGGELFDFLAE-------KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             EEECCCSCBHHHHHTT-------SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             EEEcCCCCCHHHHHHh-------cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            3445545555433322       345999999999999999999999999   99999999999999887    799999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+++.......   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....      ..+..... ..
T Consensus       162 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~~-~~  231 (326)
T 2y0a_A          162 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLANV-SA  231 (326)
T ss_dssp             CTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHH-HH
T ss_pred             CCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHH-Hh
Confidence            999987643322   223568999999999998899999999999999999999999984321      11111111 11


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ... . ........    ....+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~-~-~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          232 VNY-E-FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             TCC-C-CCHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCC-C-cCcccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            100 0 00111111    1235677888999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.93  E-value=9.3e-27  Score=240.23  Aligned_cols=176  Identities=23%  Similarity=0.346  Sum_probs=130.1

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++.++.|...+++       ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        92 lv~e~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~  161 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQ-------NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNI  161 (384)
T ss_dssp             EEECCCTTEEHHHHHHT-------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEecCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccce
Confidence            44556666666444432       345899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAME---GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ++......   ......||+.|+|||++..   ..++.++|||||||++|||++|+.||.............    .+..
T Consensus       162 a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~~~~  234 (384)
T 4fr4_A          162 AAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH----TFET  234 (384)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH----HHHH
T ss_pred             eeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH----HHhh
Confidence            98764332   2234679999999999864   458999999999999999999999985433222111111    1111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-HHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-MSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~evl~  491 (541)
                      ...      .    .+......+.+|+.+||+.||.+||+ +++|++
T Consensus       235 ~~~------~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 TVV------T----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCC------C----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ccc------C----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            110      0    11122345778889999999999998 777764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.93  E-value=8.6e-26  Score=224.33  Aligned_cols=171  Identities=20%  Similarity=0.235  Sum_probs=122.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.......  ......+|..|+||
T Consensus        96 ~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aP  170 (292)
T 3o0g_A           96 GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPP  170 (292)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcCh
Confidence            45899999999999999999999999   99999999999999999999999999987643322  22335679999999


Q ss_pred             hhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC---ccccc---c---------cccc
Q 009186          394 EYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE---ALELM---D---------PVLK  457 (541)
Q Consensus       394 E~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~---------~~l~  457 (541)
                      |.+.+.. ++.++||||||+++|||++|..|+-..  ..................   +....   +         ....
T Consensus       171 E~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (292)
T 3o0g_A          171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL  248 (292)
T ss_dssp             HHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCC
T ss_pred             HHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC--CCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcch
Confidence            9998766 799999999999999999998885211  111122222222111100   00000   0         0000


Q ss_pred             CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          458 QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       458 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ....+.....+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          249 VNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0111123345678899999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.93  E-value=2.2e-27  Score=259.82  Aligned_cols=165  Identities=23%  Similarity=0.349  Sum_probs=124.5

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~  391 (541)
                      +..+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+....... ......++..|+
T Consensus       430 ~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~  506 (613)
T 2ozo_A          430 REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY  506 (613)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCcccee
Confidence            456999999999999999999999999   9999999999999999999999999998764432221 112234567899


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||++.+..++.++|||||||++|||++ |+.||.....   ....    ..+..+....         .+......+.+
T Consensus       507 APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~----~~i~~~~~~~---------~p~~~~~~l~~  570 (613)
T 2ozo_A          507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVM----AFIEQGKRME---------CPPECPPELYA  570 (613)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHH----HHHHTTCCCC---------CCTTCCHHHHH
T ss_pred             CHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHH----HHHHcCCCCC---------CCCcCCHHHHH
Confidence            9999999999999999999999999998 9999853321   1111    1122222111         11222346778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      |+.+||+.||++||++.+|++.|+..
T Consensus       571 li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            89999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.93  E-value=1.3e-26  Score=228.94  Aligned_cols=163  Identities=25%  Similarity=0.339  Sum_probs=116.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++........ ......+++.|+||
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  186 (281)
T 1mp8_A          111 YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAP  186 (281)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccCh
Confidence            35899999999999999999999999   999999999999999999999999999876443221 12234467789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||.....   .......    ..+....     +    +......+.+++
T Consensus       187 E~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---~~~~~~i----~~~~~~~-----~----~~~~~~~l~~li  250 (281)
T 1mp8_A          187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI----ENGERLP-----M----PPNCPPTLYSLM  250 (281)
T ss_dssp             HHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH----HTTCCCC-----C----CTTCCHHHHHHH
T ss_pred             hhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH---HHHHHHH----HcCCCCC-----C----CCCCCHHHHHHH
Confidence            99999999999999999999999997 8989853221   1111111    1111111     1    112234567788


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.||++||++.+|++.|+..
T Consensus       251 ~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          251 TKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999763

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.93  E-value=1.9e-26  Score=225.88  Aligned_cols=165  Identities=27%  Similarity=0.428  Sum_probs=126.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++......... ......++..|+||
T Consensus        99 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  174 (268)
T 3sxs_A           99 KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAP  174 (268)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccCCCcCcccCCH
Confidence            35899999999999999999999999   999999999999999999999999999865443322 22234456789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||.....      .+..... ..+...  ..+   .    .....+.+++
T Consensus       175 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~-~~~~~~--~~~---~----~~~~~l~~li  238 (268)
T 3sxs_A          175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------SEVVLKV-SQGHRL--YRP---H----LASDTIYQIM  238 (268)
T ss_dssp             HHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHH-HTTCCC--CCC---T----TSCHHHHHHH
T ss_pred             HHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh------HHHHHHH-HcCCCC--CCC---C----cChHHHHHHH
Confidence            99998899999999999999999999 9999753221      1111111 111110  001   1    1123577788


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcCCC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASDTA  498 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~~~  498 (541)
                      .+||+.||++|||+.++++.|+....
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          239 YSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            89999999999999999999987653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=3.8e-27  Score=239.99  Aligned_cols=174  Identities=24%  Similarity=0.316  Sum_probs=130.3

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.+|.|...+++       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        94 ~lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS-------CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeECh
Confidence            344566666666544432       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....      ..+.. ..+..+.
T Consensus       164 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~-~~i~~~~  234 (345)
T 1xjd_A          164 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD------EEELF-HSIRMDN  234 (345)
T ss_dssp             TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH-HHHHHCC
T ss_pred             hhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC------HHHHH-HHHHhCC
Confidence            9976432221  2334678999999999999999999999999999999999999985321      11111 1111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS-SVV  490 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-evl  490 (541)
                            +.+...    ....+.+++.+||+.||++||++. +|+
T Consensus       235 ------~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ------PFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ------CCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ------CCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                  111111    224567788899999999999997 665

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.93  E-value=1.5e-26  Score=233.08  Aligned_cols=171  Identities=25%  Similarity=0.278  Sum_probs=129.9

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++.++.|...+++       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        83 lv~e~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~  152 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRK-------SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF  152 (318)
T ss_dssp             EEECCCCSCBHHHHHHH-------TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EEEeCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCc
Confidence            34555555555444432       235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++.....     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...      ........... ...
T Consensus       153 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~i~~-~~~  220 (318)
T 1fot_A          153 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS------NTMKTYEKILN-AEL  220 (318)
T ss_dssp             CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHH-CCC
T ss_pred             ceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHh-CCC
Confidence            9865332     22457899999999999999999999999999999999999998432      11111122211 111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                            .+...    ....+.+++.+||+.||++||     ++++|++
T Consensus       221 ------~~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 ------RFPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ------CCCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCCC----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                  11111    223567788899999999999     8999884

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.93  E-value=2.1e-26  Score=225.93  Aligned_cols=163  Identities=31%  Similarity=0.448  Sum_probs=120.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC--------CCCcEEecccccccccCCCCcccccccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH--------EMNPKISDFGMARIFSGNQNEANTNRVA  385 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~--------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  385 (541)
                      ..+++.+++.++.||+.||.|||+++..+|+||||||+||+++.        ++.+||+|||++........    ....
T Consensus       100 ~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~  175 (271)
T 3dtc_A          100 KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAA  175 (271)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCCC
Confidence            35899999999999999999999987555889999999999986        67799999999976543322    2346


Q ss_pred             cCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       386 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      |+..|+|||.+.+..++.++||||||+++|+|++|+.||....      ..............     ...    +....
T Consensus       176 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-----~~~----~~~~~  240 (271)
T 3dtc_A          176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID------GLAVAYGVAMNKLA-----LPI----PSTCP  240 (271)
T ss_dssp             CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC------HHHHHHHHHTSCCC-----CCC----CTTCC
T ss_pred             CccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHhhhcCCCC-----CCC----CcccC
Confidence            8999999999999999999999999999999999999985321      11111111111111     011    11223


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus       241 ~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          241 EPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            457788899999999999999999999975

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.93  E-value=7.1e-27  Score=240.43  Aligned_cols=175  Identities=22%  Similarity=0.238  Sum_probs=130.4

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++++|+.+|.|...+++       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       114 ~~lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DF  183 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQR-------ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF  183 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeC
Confidence            3456667666666544432       235889999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...      ...+...... ..
T Consensus       184 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~-~~  254 (373)
T 2r5t_A          184 GLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------NTAEMYDNIL-NK  254 (373)
T ss_dssp             CBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS------BHHHHHHHHH-HS
T ss_pred             ccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHH-hc
Confidence            99986432221  233467999999999999999999999999999999999999998432      1111111111 11


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV  490 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl  490 (541)
                      ..      .+...    ....+.+++.+||+.||.+||++.+.+
T Consensus       255 ~~------~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          255 PL------QLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             CC------CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             cc------CCCCC----CCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            11      11111    123567788899999999999985433

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.93  E-value=2.3e-26  Score=236.71  Aligned_cols=154  Identities=10%  Similarity=0.025  Sum_probs=113.7

Q ss_pred             HHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhhhcc--C
Q 009186          322 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAME--G  399 (541)
Q Consensus       322 ~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~  399 (541)
                      +.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....     .....++..|+|||.+.+  .
T Consensus       197 ~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~  268 (371)
T 3q60_A          197 HILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTA  268 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEE
T ss_pred             HHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCC
Confidence            778899999999999999   999999999999999999999999999865321     113456799999999987  6


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccC
Q 009186          400 VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQED  479 (541)
Q Consensus       400 ~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~d  479 (541)
                      .++.++||||||+++|||++|+.||..........        +........................+.+|+.+||+.|
T Consensus       269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  340 (371)
T 3q60_A          269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD  340 (371)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSS
T ss_pred             CcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCC
Confidence            78999999999999999999999986443221110        0000000000111111111122346778888999999


Q ss_pred             CCCCCCHHHHHH
Q 009186          480 PAHRPNMSSVVV  491 (541)
Q Consensus       480 P~~RPt~~evl~  491 (541)
                      |++|||+.++++
T Consensus       341 P~~Rpt~~e~l~  352 (371)
T 3q60_A          341 RRRRLLPLEAME  352 (371)
T ss_dssp             TTTCCCHHHHTT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999974

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.93  E-value=8.1e-26  Score=223.74  Aligned_cols=164  Identities=24%  Similarity=0.481  Sum_probs=123.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC-----cEEecccccccccCCCCcccccccccC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-----PKISDFGMARIFSGNQNEANTNRVAGT  387 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~-----~kL~Dfg~a~~~~~~~~~~~~~~~~gt  387 (541)
                      ...+++..++.++.||+.||+|||+++ .+|+||||||+||+++.++.     +||+|||+++....     ......|+
T Consensus       116 ~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~  189 (287)
T 4f0f_A          116 AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGN  189 (287)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCC
T ss_pred             cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCC
Confidence            346899999999999999999999986 34999999999999988776     99999999975332     22335689


Q ss_pred             CCCCChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          388 YGYMAPEYAM--EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       388 ~~y~aPE~l~--~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      ..|+|||.+.  ...++.++||||||+++|||++|+.||......    ...........+.     .+.+..    ...
T Consensus       190 ~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~-----~~~~~~----~~~  256 (287)
T 4f0f_A          190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG----KIKFINMIREEGL-----RPTIPE----DCP  256 (287)
T ss_dssp             CTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC----HHHHHHHHHHSCC-----CCCCCT----TSC
T ss_pred             ccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc----HHHHHHHHhccCC-----CCCCCc----ccC
Confidence            9999999984  455789999999999999999999998533221    1111111111111     111111    223


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ..+.+++.+||+.||++|||+.+|++.|++
T Consensus       257 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          257 PRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            457788899999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.93  E-value=2e-26  Score=226.63  Aligned_cols=178  Identities=24%  Similarity=0.350  Sum_probs=129.6

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++..+.+...++       +...+++.+++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||.+
T Consensus        83 v~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  152 (276)
T 2yex_A           83 FLEYCSGGELFDRIE-------PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA  152 (276)
T ss_dssp             EEECCTTEEGGGGSB-------TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEecCCCcHHHHHh-------hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence            345555555544332       2346899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ..+.............|+..|+|||.+.+..+ +.++||||||+++|||++|+.||.......  ..    ...+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~~~~~~~~  226 (276)
T 2yex_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QE----YSDWKEKKT  226 (276)
T ss_dssp             EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HH----HHHHHTTCT
T ss_pred             cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HH----HHHhhhccc
Confidence            86543332222334568999999999987765 789999999999999999999985432211  11    111111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .  ..+      .......+.+++.+||+.||.+|||+.|+++
T Consensus       227 ~--~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 Y--LNP------WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             T--STT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c--cCc------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0  000      0112235667889999999999999999886

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.93  E-value=1.3e-26  Score=236.65  Aligned_cols=172  Identities=22%  Similarity=0.223  Sum_probs=131.0

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++.++.|...+++       ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       117 ~lv~e~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg  186 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRR-------IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             EEEEECCTTCBHHHHHHH-------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEcCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccc
Confidence            344566666666444432       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||....      ..+.... +..+.
T Consensus       187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~-i~~~~  254 (350)
T 1rdq_E          187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEK-IVSGK  254 (350)
T ss_dssp             TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH-HHHCC
T ss_pred             cceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHHHHH-HHcCC
Confidence            99875432     224578999999999999999999999999999999999999984321      1111111 11211


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~evl~  491 (541)
                      .      .+...    ....+.+++.+||+.||.+||+     +++|++
T Consensus       255 ~------~~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 V------RFPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C------CCCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C------CCCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            1      11111    2345677888999999999998     888875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.93  E-value=2.3e-27  Score=238.90  Aligned_cols=171  Identities=26%  Similarity=0.366  Sum_probs=127.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc-ccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aP  393 (541)
                      .+++.+++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++......... .......++..|+||
T Consensus       130 ~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aP  206 (318)
T 3lxp_A          130 SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP  206 (318)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeCh
Confidence            3899999999999999999999999   999999999999999999999999999876544322 122334577889999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc--------CcCcHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE--------HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      |.+.+..++.++||||||+++|||++|+.||......        ............         +........+....
T Consensus       207 E~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~  277 (318)
T 3lxp_A          207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL---------LERGERLPRPDKCP  277 (318)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH---------HHTTCCCCCCTTCC
T ss_pred             HHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH---------HhcccCCCCCcccc
Confidence            9999989999999999999999999999987432110        000000001111         11111111122234


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ..+.+++.+||+.||.+|||+.++++.|+...
T Consensus       278 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          278 AEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            56788999999999999999999999998754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.93  E-value=1.1e-25  Score=223.25  Aligned_cols=170  Identities=24%  Similarity=0.318  Sum_probs=119.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.......  ......+|..|+||
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aP  169 (288)
T 1ob3_A           95 GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAP  169 (288)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCc
Confidence            35899999999999999999999999   99999999999999999999999999986543221  12234679999999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC---cc-----cccccccc-------
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE---AL-----ELMDPVLK-------  457 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~~~~l~-------  457 (541)
                      |.+.+. .++.++||||||+++|||++|+.||.....   ...............   +.     ...++...       
T Consensus       170 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (288)
T 1ob3_A          170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW  246 (288)
T ss_dssp             HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCG
T ss_pred             hheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhhcccccccccccccCccH
Confidence            998764 589999999999999999999999853221   111111111111100   00     00011000       


Q ss_pred             CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          458 QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       458 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..........+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0001112345678899999999999999999985

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.93  E-value=3.3e-26  Score=242.52  Aligned_cols=190  Identities=27%  Similarity=0.369  Sum_probs=137.7

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++.++.|...+.+       ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        92 ~lv~E~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICK-------NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             EEEEECCSSEEHHHHTTS-------SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EEEEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence            344556655665444432       346999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++.......   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....      .... .....+
T Consensus       162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~-~~i~~~  231 (476)
T 2y94_A          162 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLF-KKICDG  231 (476)
T ss_dssp             SCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHH-HHHHTT
T ss_pred             chhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHH-HHHhcC
Confidence            9987644322   223568999999999988775 6899999999999999999999853211      1111 111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcCCCCCCCCCCCC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASDTATLPPPTQPA  507 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~l~~p~~P~  507 (541)
                      ...      ....    ....+.+++.+||+.||.+|||+.+|++  .++........|..|.
T Consensus       232 ~~~------~p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~  284 (476)
T 2y94_A          232 IFY------TPQY----LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPS  284 (476)
T ss_dssp             CCC------CCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSC
T ss_pred             CcC------CCcc----CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcc
Confidence            110      0111    1235677888999999999999999996  6665443333343343

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.93  E-value=1.3e-25  Score=225.92  Aligned_cols=170  Identities=24%  Similarity=0.308  Sum_probs=122.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++........  .....+|..|+||
T Consensus       103 ~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aP  177 (317)
T 2pmi_A          103 RGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAP  177 (317)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC--CCCCCSCCTTCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCccc--CCCCcccccccCc
Confidence            45899999999999999999999999   999999999999999999999999999876433221  2234689999999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC--Cccc------cccc----------
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG--EALE------LMDP----------  454 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~------~~~~----------  454 (541)
                      |.+.+. .++.++||||||+++|||++|+.||.....   ..............  ....      ...+          
T Consensus       178 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (317)
T 2pmi_A          178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDL  254 (317)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCS
T ss_pred             hHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhH
Confidence            999764 589999999999999999999999853321   11111111111000  0000      0000          


Q ss_pred             --cccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          455 --VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       455 --~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                        .+...........+.+++.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          255 RQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence              0000001112346778999999999999999999885

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=1.3e-26  Score=227.40  Aligned_cols=163  Identities=28%  Similarity=0.335  Sum_probs=125.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++....... .......++..|+||
T Consensus       101 ~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aP  176 (269)
T 4hcu_A          101 GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP  176 (269)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCH
Confidence            45899999999999999999999999   99999999999999999999999999986543221 122234467789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||....      ..+... ....+..     ...    +......+.+++
T Consensus       177 E~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~------~~~~~~-~~~~~~~-----~~~----~~~~~~~~~~li  240 (269)
T 4hcu_A          177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVE-DISTGFR-----LYK----PRLASTHVYQIM  240 (269)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHH-HHHTTCC-----CCC----CTTSCHHHHHHH
T ss_pred             HHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC------HHHHHH-HHhcCcc-----CCC----CCcCCHHHHHHH
Confidence            99999999999999999999999999 899975321      111111 1111110     001    111234577788


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.||++||++.++++.|++.
T Consensus       241 ~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          241 NHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCCcccCcCHHHHHHHHHHH
Confidence            899999999999999999999863

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.93  E-value=1.4e-25  Score=232.21  Aligned_cols=170  Identities=21%  Similarity=0.222  Sum_probs=126.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCC---------------------------------
Q 009186          314 AQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEM---------------------------------  359 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~---------------------------------  359 (541)
                      ..+++.+++.++.||+.||+|||++ +   |+||||||+|||++.++                                 
T Consensus       141 ~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (397)
T 1wak_A          141 QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA  217 (397)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------C
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccc
Confidence            4589999999999999999999998 8   99999999999999775                                 


Q ss_pred             ----------------CcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 009186          360 ----------------NPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRN  423 (541)
Q Consensus       360 ----------------~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p  423 (541)
                                      .+||+|||++......     .....||..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       218 ~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  292 (397)
T 1wak_A          218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL  292 (397)
T ss_dssp             CTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCC
Confidence                            7999999999865432     2234689999999999999999999999999999999999999


Q ss_pred             CCCCCCcCcCcHH---HHHHHhhh--------cCCcc-cccc---------cc----------ccCCCCHHHHHHHHHHH
Q 009186          424 SGFYLSEHGQSLL---TYAWKLWC--------KGEAL-ELMD---------PV----------LKQTCVDAELLKCIHIG  472 (541)
Q Consensus       424 ~~~~~~~~~~~~~---~~~~~~~~--------~~~~~-~~~~---------~~----------l~~~~~~~~~~~~~~l~  472 (541)
                      |............   ........        .+... +.+.         ..          -...........+.+|+
T Consensus       293 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  372 (397)
T 1wak_A          293 FEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFL  372 (397)
T ss_dssp             CCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHH
T ss_pred             CCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHH
Confidence            8654332221111   11111100        00000 0000         00          00123456677889999


Q ss_pred             hhhcccCCCCCCCHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~  491 (541)
                      .+||+.||++|||+.|+++
T Consensus       373 ~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          373 LPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GGGGCSSGGGSCCHHHHHT
T ss_pred             HHHhccChhhcCCHHHHhh
Confidence            9999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.93  E-value=4.3e-26  Score=227.03  Aligned_cols=166  Identities=27%  Similarity=0.341  Sum_probs=123.6

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc--ccccccccCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVAGTYGY  390 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~~y  390 (541)
                      ...+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++........  .......++..|
T Consensus       122 ~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y  198 (298)
T 3f66_A          122 THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW  198 (298)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccc
Confidence            345899999999999999999999999   999999999999999999999999999865433211  122234567889


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGK-RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      +|||.+.+..++.++||||||+++|||++|. +||....   .........    .+...     .....    ....+.
T Consensus       199 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~----~~~~~-----~~~~~----~~~~l~  262 (298)
T 3f66_A          199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLL----QGRRL-----LQPEY----CPDPLY  262 (298)
T ss_dssp             SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC---TTTHHHHHH----TTCCC-----CCCTT----CCHHHH
T ss_pred             cChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC---HHHHHHHHh----cCCCC-----CCCcc----CCHHHH
Confidence            9999999999999999999999999999954 4543221   111111111    11100     00111    123577


Q ss_pred             HHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +++.+||+.||++||++.++++.|+...
T Consensus       263 ~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          263 EVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            8889999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.93  E-value=6.4e-27  Score=236.43  Aligned_cols=173  Identities=27%  Similarity=0.370  Sum_probs=128.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aP  393 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++......... ......++..|+||
T Consensus       123 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (327)
T 3lxl_A          123 RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP  199 (327)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCH
Confidence            5899999999999999999999999   9999999999999999999999999998765433221 22334577889999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc--------CcCcHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE--------HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      |.+.+..++.++||||||+++|+|++|+.||......        ...............+         .....+....
T Consensus       200 E~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~  270 (327)
T 3lxl_A          200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG---------QRLPAPPACP  270 (327)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT---------CCCCCCTTCC
T ss_pred             HHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc---------cCCCCCCccc
Confidence            9999999999999999999999999999987432110        0000111111111111         1111122234


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCC
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTAT  499 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~  499 (541)
                      ..+.+++.+||+.||++|||+.+|++.|+.....
T Consensus       271 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          271 AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            5677889999999999999999999999876533

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.93  E-value=2.2e-26  Score=233.26  Aligned_cols=165  Identities=30%  Similarity=0.393  Sum_probs=127.7

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus       151 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  227 (334)
T 2pvf_A          151 EEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA  227 (334)
T ss_dssp             --CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCC
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeC
Confidence            345899999999999999999999999   99999999999999999999999999987654433333334456788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||....      ..+ .......+....     .    +......+.++
T Consensus       228 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~-~~~~~~~~~~~~-----~----~~~~~~~l~~l  291 (334)
T 2pvf_A          228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEE-LFKLLKEGHRMD-----K----PANCTNELYMM  291 (334)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHH-HHHHHHHTCCCC-----C----CTTCCHHHHHH
T ss_pred             hHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC------HHH-HHHHHhcCCCCC-----C----CccCCHHHHHH
Confidence            999998889999999999999999999 999974321      111 111111111111     1    11123457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||.+||++.+|++.|+..
T Consensus       292 i~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          292 MRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            8999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.93  E-value=2.5e-25  Score=223.55  Aligned_cols=199  Identities=24%  Similarity=0.282  Sum_probs=127.6

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.|...+++      .+..+++.+++.++.||+.||+|||+++   |+||||||+||+++ ++.+||+|||+
T Consensus       106 iv~e~~~~~~L~~~l~~------~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRD------AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             EECBCCCSEEHHHHTTS------SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             EEeecccCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence            34455545555433322      2346899999999999999999999999   99999999999998 67999999999


Q ss_pred             cccccCCCC---cccccccccCCCCCChhhhcc---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHH
Q 009186          369 ARIFSGNQN---EANTNRVAGTYGYMAPEYAME---------GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLL  436 (541)
Q Consensus       369 a~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~---------~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~  436 (541)
                      +........   ........|+..|+|||.+.+         ..++.++||||||+++|||++|+.||....      ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~  249 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP------AE  249 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC------HH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HH
Confidence            876432211   112223458899999999874         347889999999999999999999985321      11


Q ss_pred             HHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCceecc
Q 009186          437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSVDR  512 (541)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~P~~~~~~  512 (541)
                      ...+.. ..+........    .    ....+.+++.+||+.||++|||+.+|+++|+...........|...+..
T Consensus       250 ~~~~~~-~~~~~~~~~~~----~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~  316 (319)
T 2y4i_B          250 AIIWQM-GTGMKPNLSQI----G----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS  316 (319)
T ss_dssp             HHHHHH-HTTCCCCCCCS----S----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred             HHHHHh-ccCCCCCCCcC----C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence            111111 11111111111    1    1224667888999999999999999999999987776666666666543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.93  E-value=2.6e-26  Score=231.15  Aligned_cols=165  Identities=26%  Similarity=0.401  Sum_probs=128.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus       133 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (322)
T 1p4o_A          133 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  209 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccCh
Confidence            45799999999999999999999999   999999999999999999999999999865443333333344568889999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||....      ..+ .......+....     .    +......+.+++
T Consensus       210 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~-~~~~~~~~~~~~-----~----~~~~~~~l~~li  273 (322)
T 1p4o_A          210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQ-VLRFVMEGGLLD-----K----PDNCPDMLFELM  273 (322)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHH-HHHHHHTTCCCC-----C----CTTCCHHHHHHH
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------HHH-HHHHHHcCCcCC-----C----CCCCCHHHHHHH
Confidence            99999999999999999999999999 888874321      111 111111221111     1    112234577788


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      .+||+.||.+|||+.++++.|+...
T Consensus       274 ~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          274 RMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHcCCCcccCcCHHHHHHHHHHhh
Confidence            8999999999999999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.93  E-value=1.3e-26  Score=244.61  Aligned_cols=176  Identities=21%  Similarity=0.251  Sum_probs=131.5

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      +++|++|+..+.|...+++       ...+++..+..++.||+.||+|||+ ++   |+||||||+|||++.++.+||+|
T Consensus       223 ~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSR-------ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECC
T ss_pred             EEEEEeeCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEcc
Confidence            4556677766666444432       2358999999999999999999998 88   99999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....      ...........
T Consensus       293 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~  364 (446)
T 4ejn_A          293 FGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILME  364 (446)
T ss_dssp             CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC
T ss_pred             CCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC------HHHHHHHHHhC
Confidence            999975432222  2234678999999999999999999999999999999999999984321      11111111111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                       ..      .+...    ....+.+|+.+||+.||.+||     +++|+++
T Consensus       365 -~~------~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          365 -EI------RFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -CC------CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CC------CCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence             10      11111    224567788899999999999     9999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.93  E-value=2.1e-26  Score=236.28  Aligned_cols=176  Identities=20%  Similarity=0.230  Sum_probs=128.2

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC---CcEEecc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM---NPKISDF  366 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~---~~kL~Df  366 (541)
                      +++++.++.|...+.+       ...+++.++..++.||+.||.|||+++   |+||||||+|||++.++   .+||+||
T Consensus       106 v~e~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA-------REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             EECCCCSCBHHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEecCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeec
Confidence            3455555555433322       245899999999999999999999999   99999999999998654   5999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |++........   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....      ... ....+..+
T Consensus       176 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~------~~~-~~~~i~~~  245 (362)
T 2bdw_A          176 GLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHR-LYAQIKAG  245 (362)
T ss_dssp             TTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHH-HHHHHHHT
T ss_pred             CcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------HHH-HHHHHHhC
Confidence            99987653322   223578999999999999899999999999999999999999984321      111 11111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ... ...+..     ......+.+++.+||+.||++||++.++++
T Consensus       246 ~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          246 AYD-YPSPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CCC-CCTTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCC-CCcccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111 000000     111345677888999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.93  E-value=2.2e-26  Score=240.36  Aligned_cols=149  Identities=13%  Similarity=0.112  Sum_probs=116.7

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      .+..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....     .....| ..|+
T Consensus       204 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~  274 (413)
T 3dzo_A          204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFA  274 (413)
T ss_dssp             TSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTC
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-Ccee
Confidence            4567999999999999999999999999   999999999999999999999999998764322     233456 8999


Q ss_pred             Chhhh----------ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCC
Q 009186          392 APEYA----------MEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCV  461 (541)
Q Consensus       392 aPE~l----------~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  461 (541)
                      |||++          .+..++.++|||||||++|||++|+.||.........               ...+.. . ... 
T Consensus       275 aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~---------------~~~~~~-~-~~~-  336 (413)
T 3dzo_A          275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS---------------EWIFRS-C-KNI-  336 (413)
T ss_dssp             CHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS---------------GGGGSS-C-CCC-
T ss_pred             CchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH---------------HHHHhh-c-ccC-
Confidence            99999          4455888999999999999999999998533211110               000110 0 111 


Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 009186          462 DAELLKCIHIGLLCVQEDPAHRPNMSSVV  490 (541)
Q Consensus       462 ~~~~~~~~~l~~~cl~~dP~~RPt~~evl  490 (541)
                         ...+.+|+.+||+.||++||++.+++
T Consensus       337 ---~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          337 ---PQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             ---CHHHHHHHHHHccCChhhCcCHHHHH
Confidence               24577888899999999999977664

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.92  E-value=1.8e-26  Score=255.04  Aligned_cols=156  Identities=25%  Similarity=0.307  Sum_probs=122.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.......  ......||+.|+||
T Consensus       437 ~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~AP  511 (674)
T 3pfq_A          437 GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAP  511 (674)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCH
Confidence            46899999999999999999999999   99999999999999999999999999986432222  23346799999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |++.+..++.++||||||+++|||++|+.||....      ..+...... ....      .+    +......+.+|+.
T Consensus       512 E~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~------~~~~~~~i~-~~~~------~~----p~~~s~~~~~li~  574 (674)
T 3pfq_A          512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIM-EHNV------AY----PKSMSKEAVAICK  574 (674)
T ss_dssp             HHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-SSCC------CC----CTTSCHHHHHHHH
T ss_pred             hhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC------HHHHHHHHH-hCCC------CC----CccCCHHHHHHHH
Confidence            99999999999999999999999999999985321      112222221 1111      11    1122345677888


Q ss_pred             hhcccCCCCCCCH-----HHHHH
Q 009186          474 LCVQEDPAHRPNM-----SSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~-----~evl~  491 (541)
                      +||+.||++||++     +||++
T Consensus       575 ~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          575 GLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHccCCHHHCCCCCCCcHHHHhc
Confidence            9999999999997     77764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.92  E-value=2.5e-26  Score=238.57  Aligned_cols=195  Identities=16%  Similarity=0.206  Sum_probs=139.7

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE----cCCCCcEEe
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL----DHEMNPKIS  364 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll----~~~~~~kL~  364 (541)
                      ++++|+.++.|...+++.    .....+++.+++.++.||+.||+|||+++   |+||||||+|||+    +.++.+||+
T Consensus        86 lv~e~~~~g~L~~~l~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEP----SNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             EEECCCTTEEHHHHTTSG----GGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             EEEecCCCCCHHHHHHhh----hcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEe
Confidence            345666666665444331    12234999999999999999999999999   9999999999999    777789999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhcc--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHH
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAME--------GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLL  436 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~  436 (541)
                      |||+++......   ......||..|+|||.+.+        ..++.++||||||+++|||++|+.||.........  .
T Consensus       159 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~  233 (396)
T 4eut_A          159 DFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--K  233 (396)
T ss_dssp             CGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--H
T ss_pred             cCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--H
Confidence            999998754332   1223568999999999865        46788999999999999999999998543322211  1


Q ss_pred             HHHHHhhhcCCccccc---------------cccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          437 TYAWKLWCKGEALELM---------------DPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       437 ~~~~~~~~~~~~~~~~---------------~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +........ .....+               +..............+.+++.+||+.||++||++.++++.|+..
T Consensus       234 ~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          234 EVMYKIITG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHHHHHHHS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            122222211 111000               00111223456677788999999999999999999999988763

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.92  E-value=3.2e-25  Score=234.82  Aligned_cols=167  Identities=22%  Similarity=0.214  Sum_probs=118.5

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEY  395 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  395 (541)
                      +++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......   ......||+.|+|||+
T Consensus       161 l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~  234 (464)
T 3ttj_A          161 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEV  234 (464)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHH
Confidence            899999999999999999999999   9999999999999999999999999998754322   2234578999999999


Q ss_pred             hccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc------------------C-------Cccc
Q 009186          396 AMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK------------------G-------EALE  450 (541)
Q Consensus       396 l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------------~-------~~~~  450 (541)
                      +.+..++.++|||||||++|||++|+.||......   ............                  .       ....
T Consensus       235 ~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~---~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (464)
T 3ttj_A          235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK  311 (464)
T ss_dssp             HTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHH
T ss_pred             HcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHH
Confidence            99999999999999999999999999998532211   111111100000                  0       0000


Q ss_pred             cccccccCCC---CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          451 LMDPVLKQTC---VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       451 ~~~~~l~~~~---~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+...+....   .......+.+|+.+||+.||++|||++|+++
T Consensus       312 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          312 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000   1112456889999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.92  E-value=2.7e-27  Score=259.80  Aligned_cols=164  Identities=30%  Similarity=0.422  Sum_probs=124.2

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc-ccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~  391 (541)
                      +..+++.+++.|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...... .......++..|+
T Consensus       463 ~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~  539 (635)
T 4fl3_A          463 NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY  539 (635)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeee
Confidence            456899999999999999999999999   999999999999999999999999999876543322 1222334678899


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||++.+..++.++|||||||++|||++ |+.||.....      .+ .......+....         .+......+.+
T Consensus       540 APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~-~~~~i~~~~~~~---------~p~~~~~~l~~  603 (635)
T 4fl3_A          540 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SE-VTAMLEKGERMG---------CPAGCPREMYD  603 (635)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HH-HHHHHHTTCCCC---------CCTTCCHHHHH
T ss_pred             ChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCCCC---------CCCCCCHHHHH
Confidence            9999999999999999999999999998 9999853221      11 111222221111         11122356778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      |+.+||+.||++||++.+|+++|+.
T Consensus       604 li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          604 LMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            8999999999999999999999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.92  E-value=2.4e-25  Score=221.82  Aligned_cols=158  Identities=23%  Similarity=0.305  Sum_probs=120.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.+.....  ......||+.|+||
T Consensus       132 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  206 (298)
T 2zv2_A          132 KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAP  206 (298)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccCh
Confidence            46999999999999999999999999   99999999999999999999999999987643322  12335789999999


Q ss_pred             hhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          394 EYAMEGV---FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       394 E~l~~~~---~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |.+.+..   .+.++||||||+++|||++|+.||...      ........ ....... .  + ...    .....+.+
T Consensus       207 E~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------~~~~~~~~-~~~~~~~-~--~-~~~----~~~~~l~~  271 (298)
T 2zv2_A          207 ESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE------RIMCLHSK-IKSQALE-F--P-DQP----DIAEDLKD  271 (298)
T ss_dssp             GGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHH-HHHCCCC-C--C-SSS----CCCHHHHH
T ss_pred             hhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc------cHHHHHHH-HhcccCC-C--C-Ccc----ccCHHHHH
Confidence            9987655   478899999999999999999998432      11111111 1111110 0  0 001    12245677


Q ss_pred             HHhhhcccCCCCCCCHHHHHH
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ++.+||+.||++||++.|+++
T Consensus       272 li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          272 LITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHhhcChhhCCCHHHHhc
Confidence            889999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.92  E-value=2e-26  Score=227.60  Aligned_cols=163  Identities=24%  Similarity=0.345  Sum_probs=125.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++....... .......++..|+||
T Consensus       115 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aP  190 (283)
T 3gen_A          115 HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPP  190 (283)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCH
Confidence            35899999999999999999999999   99999999999999999999999999986543221 112233457789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||.....      .+.... ...+.     ....    +......+.+++
T Consensus       191 E~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------~~~~~~-~~~~~-----~~~~----~~~~~~~l~~li  254 (283)
T 3gen_A          191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEH-IAQGL-----RLYR----PHLASEKVYTIM  254 (283)
T ss_dssp             HHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHH-HHTTC-----CCCC----CTTCCHHHHHHH
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh------hHHHHH-Hhccc-----CCCC----CCcCCHHHHHHH
Confidence            99999999999999999999999998 9999853221      111111 11111     0001    111124577788


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.||.+|||+.++++.|+..
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          255 YSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999999753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.92  E-value=1.2e-25  Score=221.85  Aligned_cols=160  Identities=24%  Similarity=0.354  Sum_probs=125.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++........   .....++..|+||
T Consensus       117 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aP  190 (284)
T 2a19_B          117 EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSP  190 (284)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccCh
Confidence            46899999999999999999999999   99999999999999999999999999987654322   2234689999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|||++|..|+..         ....+.....+..        ....    ...+.+++.
T Consensus       191 E~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~~~~~~~~--------~~~~----~~~~~~li~  249 (284)
T 2a19_B          191 EQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFTDLRDGII--------SDIF----DKKEKTLLQ  249 (284)
T ss_dssp             HHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHHHHHTTCC--------CTTS----CHHHHHHHH
T ss_pred             hhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHHHhhcccc--------cccC----CHHHHHHHH
Confidence            999998999999999999999999999887521         0111111111111        1111    234667888


Q ss_pred             hhcccCCCCCCCHHHHHHHHhcCCCCC
Q 009186          474 LCVQEDPAHRPNMSSVVVMLASDTATL  500 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~~~~~~l  500 (541)
                      +||+.||.+||++.|+++.|.......
T Consensus       250 ~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          250 KLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             HHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            999999999999999999998765443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.92  E-value=1.2e-26  Score=243.33  Aligned_cols=188  Identities=15%  Similarity=0.195  Sum_probs=135.2

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++|++|+.+|.|...+++      ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~------~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSK------FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHT------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCcHHHHHHH------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            3456677777777555543      1345999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      |+++........ ......||+.|+|||++.     ...++.++|||||||++|||++|+.||....      ..+....
T Consensus       220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~------~~~~~~~  292 (437)
T 4aw2_A          220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGK  292 (437)
T ss_dssp             TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHH
T ss_pred             hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC------hhHHHHh
Confidence            999765443322 223457999999999987     4568999999999999999999999985321      1111111


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCC--CCCHHHHHH--HHhcC
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAH--RPNMSSVVV--MLASD  496 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~evl~--~L~~~  496 (541)
                      .........  -+....    .....+.+|+.+||..+|++  ||+++|+++  .+++.
T Consensus       293 i~~~~~~~~--~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          293 IMNHKERFQ--FPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             HHTHHHHCC--CCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             hhhcccccc--CCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            111000000  010001    12335667888999888888  999999986  45543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.92  E-value=2.9e-26  Score=226.32  Aligned_cols=162  Identities=23%  Similarity=0.334  Sum_probs=122.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++......... ......++..|+||
T Consensus       108 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  183 (281)
T 3cc6_A          108 NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSP  183 (281)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCc
Confidence            35899999999999999999999999   999999999999999999999999999875443221 12234567889999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||......   .......    .+....     ...    .....+.+++
T Consensus       184 E~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~----~~~~~~-----~~~----~~~~~l~~li  247 (281)
T 3cc6_A          184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLE----KGDRLP-----KPD----LCPPVLYTLM  247 (281)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHH----HTCCCC-----CCT----TCCHHHHHHH
T ss_pred             hhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHh----cCCCCC-----CCC----CCCHHHHHHH
Confidence            99998999999999999999999998 99998532221   1211111    111100     011    1224577788


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhc
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .+||+.||++||++.++++.|+.
T Consensus       248 ~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          248 TRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHccCCchhCcCHHHHHHHHHH
Confidence            89999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.92  E-value=2.2e-26  Score=237.94  Aligned_cols=178  Identities=19%  Similarity=0.208  Sum_probs=130.2

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC--CCCcEEecc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH--EMNPKISDF  366 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~--~~~~kL~Df  366 (541)
                      ++++++..+.|...+..      ....+++.+++.++.||+.||+|||+++   |+||||||+|||++.  ++.+||+||
T Consensus       125 lv~E~~~gg~L~~~l~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DF  195 (387)
T 1kob_A          125 LILEFLSGGELFDRIAA------EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDF  195 (387)
T ss_dssp             EEEECCCCCBHHHHTTC------TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             EEEEcCCCCcHHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEec
Confidence            34555555555443322      2345899999999999999999999999   999999999999974  467999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.......   .....||..|+|||++.+..++.++||||||+++|||++|+.||....      ..+..... ...
T Consensus       196 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------~~~~~~~i-~~~  265 (387)
T 1kob_A          196 GLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED------DLETLQNV-KRC  265 (387)
T ss_dssp             TTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHH-HHC
T ss_pred             ccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC------HHHHHHHH-HhC
Confidence            99987644322   223468999999999999999999999999999999999999985321      11111111 111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ...  .++..    .......+.+++.+||+.||.+|||+.++++
T Consensus       266 ~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          266 DWE--FDEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             CCC--CCSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCC--CCccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            110  01111    1112345678889999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.92  E-value=1.7e-26  Score=227.73  Aligned_cols=163  Identities=29%  Similarity=0.444  Sum_probs=126.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++........ .......++..|+|||
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE  180 (279)
T 1qpc_A          105 KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPE  180 (279)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChh
Confidence            5899999999999999999999999   99999999999999999999999999987643322 1222345677899999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+.+..++.++||||||+++|||++ |+.||.....      .+. ......+..     ...    +......+.+++.
T Consensus       181 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~-~~~~~~~~~-----~~~----~~~~~~~l~~li~  244 (279)
T 1qpc_A          181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEV-IQNLERGYR-----MVR----PDNCPEELYQLMR  244 (279)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHH-HHHHHTTCC-----CCC----CTTCCHHHHHHHH
T ss_pred             hhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHH-HHHHhcccC-----CCC----cccccHHHHHHHH
Confidence            9998889999999999999999999 8888743211      111 111111110     011    1112345778889


Q ss_pred             hhcccCCCCCCCHHHHHHHHhcCC
Q 009186          474 LCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +||+.||++|||+.++++.|+...
T Consensus       245 ~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          245 LCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccChhhCCCHHHHHHHHHHHH
Confidence            999999999999999999998754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.92  E-value=2.6e-25  Score=228.22  Aligned_cols=182  Identities=13%  Similarity=0.081  Sum_probs=133.2

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-----------
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-----------  357 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-----------  357 (541)
                      +|++|+..|.|...+++..  ......+++.+++.|+.||+.||+|||+++   |+||||||+|||++.           
T Consensus       144 lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          144 LVGELYSYGTLLNAINLYK--NTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             EEECCCCSCBHHHHHHHHH--TSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------
T ss_pred             EEEeccCCCcHHHHHHHhh--cccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccc
Confidence            3445555555544333211  123456999999999999999999999999   999999999999998           


Q ss_pred             CCCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHH
Q 009186          358 EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT  437 (541)
Q Consensus       358 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~  437 (541)
                      ++.+||+|||+++.+.............||..|+|||++.+..++.++|||||||++|||++|+.||.......      
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------  292 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------  292 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE------
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc------
Confidence            89999999999976543333333445679999999999999999999999999999999999999974221110      


Q ss_pred             HHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCC-CCHHHHHHHHhcC
Q 009186          438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHR-PNMSSVVVMLASD  496 (541)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~R-Pt~~evl~~L~~~  496 (541)
                                  ..+...+.....   ...+.+++..|++.+|.+| |+++++.+.|+..
T Consensus       293 ------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 ------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                        001111111122   2345567778999999999 5788888777653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.92  E-value=3.8e-26  Score=233.85  Aligned_cols=104  Identities=32%  Similarity=0.406  Sum_probs=93.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-------------------------CCCcEEeccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-------------------------EMNPKISDFGMA  369 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-------------------------~~~~kL~Dfg~a  369 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+|||++.                         ++.+||+|||++
T Consensus       133 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a  209 (360)
T 3llt_A          133 GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA  209 (360)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCc
Confidence            4899999999999999999999999   999999999999975                         788999999999


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      +.....     .....||..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       210 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          210 TFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             EETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             eecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence            864322     2235689999999999999999999999999999999999999854

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.92  E-value=2.3e-25  Score=226.12  Aligned_cols=173  Identities=22%  Similarity=0.266  Sum_probs=127.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhh--------hcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc--ccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLH--------EDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA--NTNRV  384 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH--------~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~~~~  384 (541)
                      .+++.+++.++.||+.||.|||        +.+   |+||||||+||+++.++.+||+|||++..........  .....
T Consensus       135 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~  211 (342)
T 1b6c_B          135 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR  211 (342)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSC
T ss_pred             CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccC
Confidence            4899999999999999999999        777   9999999999999999999999999998765443221  22345


Q ss_pred             ccCCCCCChhhhccC------CCCcchhhHHHHHHHHHHHhC----------CCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          385 AGTYGYMAPEYAMEG------VFSVKSDVFSFGVLLLEIISG----------KRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       385 ~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      .||..|+|||.+.+.      .++.++||||||+++|||++|          +.||........  ..............
T Consensus       212 ~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~  289 (342)
T 1b6c_B          212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP--SVEEMRKVVCEQKL  289 (342)
T ss_dssp             CCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCC
T ss_pred             CcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc--cHHHHHHHHHHHHh
Confidence            689999999999765      234789999999999999999          566543222111  11122222212111


Q ss_pred             cccccccccCC-CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          449 LELMDPVLKQT-CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       449 ~~~~~~~l~~~-~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                          .+.+... ........+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       290 ----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          290 ----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             ----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence                1111111 1235567788999999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.92  E-value=1.2e-25  Score=228.15  Aligned_cols=159  Identities=21%  Similarity=0.333  Sum_probs=122.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++........   .....||+.|+||
T Consensus       103 ~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aP  176 (336)
T 3h4j_B          103 KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAP  176 (336)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCH
Confidence            35899999999999999999999999   99999999999999999999999999986543322   2335689999999


Q ss_pred             hhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..+ +.++||||||+++|+|++|+.||........                .+.+.... ...+......+.+++
T Consensus       177 E~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~~-~~~p~~~s~~~~~li  239 (336)
T 3h4j_B          177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNSCV-YVMPDFLSPGAQSLI  239 (336)
T ss_dssp             GGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCSSC-CCCCTTSCHHHHHHH
T ss_pred             HHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHcCC-CCCcccCCHHHHHHH
Confidence            99987775 6899999999999999999999853221110                00010000 001111234567788


Q ss_pred             hhhcccCCCCCCCHHHHHH--HHhc
Q 009186          473 LLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      .+||+.||.+|||++|+++  +++.
T Consensus       240 ~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          240 RRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             HTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HHHcCCChhHCcCHHHHHhChhhcc
Confidence            9999999999999999985  4544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.92  E-value=2.4e-26  Score=236.76  Aligned_cols=182  Identities=20%  Similarity=0.180  Sum_probs=131.4

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE--cCCCCcEEecc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--DHEMNPKISDF  366 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll--~~~~~~kL~Df  366 (541)
                      +++||+..+.|...+.+      ....+++.+++.++.||+.||+|||+++   |+||||||+|||+  +.++.+||+||
T Consensus       163 lv~E~~~~~~L~~~l~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DF  233 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIID------ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDF  233 (373)
T ss_dssp             EEEECCTTCEEHHHHHH------TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCC
T ss_pred             EEEeCCCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeC
Confidence            34555555555333321      1345899999999999999999999999   9999999999999  56778999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.......   .....||+.|+|||++.+..++.++||||||+++|||++|+.||....      ..+........ 
T Consensus       234 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~-  303 (373)
T 2x4f_A          234 GLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN------DAETLNNILAC-  303 (373)
T ss_dssp             SSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHT-
T ss_pred             CCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhc-
Confidence            99987644322   223468999999999998889999999999999999999999984321      11111111111 


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      .. ..... ....    ....+.+++.+||+.||.+|||+.|+++  .+.+
T Consensus       304 ~~-~~~~~-~~~~----~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          304 RW-DLEDE-EFQD----ISEEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             CC-CSCSG-GGTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             cC-CCChh-hhcc----CCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            11 00011 0111    1345678889999999999999999997  5543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.92  E-value=2.2e-25  Score=230.75  Aligned_cols=109  Identities=29%  Similarity=0.460  Sum_probs=92.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC-----------------
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN-----------------  377 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-----------------  377 (541)
                      .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....                 
T Consensus       105 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~  181 (388)
T 3oz6_A          105 ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD  181 (388)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccc
Confidence            5899999999999999999999999   99999999999999999999999999986533111                 


Q ss_pred             --cccccccccCCCCCChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          378 --EANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       378 --~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                        ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             --------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence              111233578999999999986 6789999999999999999999999853

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.92  E-value=2.4e-26  Score=227.74  Aligned_cols=177  Identities=20%  Similarity=0.272  Sum_probs=128.0

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC--------c
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN--------P  361 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~--------~  361 (541)
                      +++++..+.|...+++      ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.        +
T Consensus        90 v~e~~~~~~L~~~l~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           90 VQEFVKFGSLDTYLKK------NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             EEECCTTCBHHHHHHH------TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEECCCCCCHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            3455555555444432      1234899999999999999999999999   999999999999998887        9


Q ss_pred             EEecccccccccCCCCcccccccccCCCCCChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHH
Q 009186          362 KISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAW  440 (541)
Q Consensus       362 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~  440 (541)
                      ||+|||++.....      .....++..|+|||.+.+ ..++.++||||||+++|||++|..|+....     .......
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~  229 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-----DSQRKLQ  229 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHH
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-----chHHHHH
Confidence            9999999865421      123457889999999987 678999999999999999999655432111     1111111


Q ss_pred             HhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCC
Q 009186          441 KLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTA  498 (541)
Q Consensus       441 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~  498 (541)
                      .........        ...    ...+.+++.+||+.||++|||+.++++.|+....
T Consensus       230 ~~~~~~~~~--------~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          230 FYEDRHQLP--------APK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHTTCCCC--------CCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             HhhccCCCC--------CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111111111        111    2246678889999999999999999999998654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.92  E-value=2.7e-26  Score=232.09  Aligned_cols=175  Identities=22%  Similarity=0.230  Sum_probs=125.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++.++.|...+++       ...+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        97 ~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           97 YLILEYLSGGELFMQLER-------EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             EEEEECCTTEEHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             EEEEeCCCCCcHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence            344555555555443322       235889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....      ..+....... ..
T Consensus       167 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~-~~  237 (327)
T 3a62_A          167 LCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN------RKKTIDKILK-CK  237 (327)
T ss_dssp             CC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHH-TC
T ss_pred             cccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHh-CC
Confidence            9875432221  2234568999999999999899999999999999999999999985321      1111111111 11


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                      .      .+..    .....+.+++.+||+.||++||     ++.++++
T Consensus       238 ~------~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 L------NLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             C------CCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             C------CCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            0      1111    1234567788899999999999     7778875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=3.3e-26  Score=226.72  Aligned_cols=166  Identities=23%  Similarity=0.337  Sum_probs=128.3

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~  391 (541)
                      ...+++.+++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......... ......++..|+
T Consensus       104 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  180 (287)
T 1u59_A          104 REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY  180 (287)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGC
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccccccccccc
Confidence            345899999999999999999999999   9999999999999999999999999998765433221 122234678899


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||.+.+..++.++||||||+++|||++ |+.||.....   ....    .....+...     .    .+......+.+
T Consensus       181 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~----~~i~~~~~~-----~----~~~~~~~~l~~  244 (287)
T 1u59_A          181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVM----AFIEQGKRM-----E----CPPECPPELYA  244 (287)
T ss_dssp             CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHH----HHHHTTCCC-----C----CCTTCCHHHHH
T ss_pred             CHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHH----HHHhcCCcC-----C----CCCCcCHHHHH
Confidence            9999998889999999999999999998 9999853221   1111    111111111     1    11122346778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ++.+||+.||++||++.+|++.|+...
T Consensus       245 li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          245 LMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            889999999999999999999998653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.92  E-value=8.9e-26  Score=227.88  Aligned_cols=176  Identities=18%  Similarity=0.243  Sum_probs=120.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.......  ......+|..|+||
T Consensus        95 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aP  169 (324)
T 3mtl_A           95 NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPP  169 (324)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccCh
Confidence            45899999999999999999999999   99999999999999999999999999976443221  22234679999999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC---Cccccccc---------cccC--
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG---EALELMDP---------VLKQ--  458 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---------~l~~--  458 (541)
                      |.+.+ ..++.++||||||+++|||++|+.||.....   ..............   .+......         ....  
T Consensus       170 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
T 3mtl_A          170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEA  246 (324)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCC
T ss_pred             hhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchh
Confidence            99876 5689999999999999999999999854321   11122222211110   00000000         0000  


Q ss_pred             --CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcCC
Q 009186          459 --TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASDT  497 (541)
Q Consensus       459 --~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~  497 (541)
                        ...+.....+.+|+.+||+.||.+|||++|+++  .+.+..
T Consensus       247 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          247 LLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence              000112345678999999999999999999987  555543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.92  E-value=1e-25  Score=224.56  Aligned_cols=170  Identities=24%  Similarity=0.394  Sum_probs=127.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc-ccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~a  392 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++......... .......+|..|+|
T Consensus       121 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  197 (302)
T 4e5w_A          121 NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA  197 (302)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCC
T ss_pred             ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccC
Confidence            35899999999999999999999999   999999999999999999999999999876544322 22233457888999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------CcCcCcHHHHHHHhhhcCCccccccccccCCCCHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL--------SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAE  464 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  464 (541)
                      ||.+.+..++.++||||||+++|||++|+.|+....        .................+..         ...+...
T Consensus       198 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~  268 (302)
T 4e5w_A          198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR---------LPCPPNC  268 (302)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCC---------CCCCTTC
T ss_pred             CeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCC---------CCCCCCC
Confidence            999999999999999999999999999998853211        00111111111111111111         1112223


Q ss_pred             HHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          465 LLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       465 ~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ...+.+++.+||+.||.+|||+.++++.|+.
T Consensus       269 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          269 PDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            3567789999999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.92  E-value=3.2e-26  Score=233.68  Aligned_cols=178  Identities=21%  Similarity=0.309  Sum_probs=121.6

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC---CCCcEEec
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH---EMNPKISD  365 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~---~~~~kL~D  365 (541)
                      ++++++..+.|...+.+       ...+++.+++.++.||+.||.|||+++   |+||||||+||+++.   ++.+||+|
T Consensus       125 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVE-------KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             EEECCCCSCBHHHHHTT-------CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEcc
Confidence            34455555555433322       235899999999999999999999999   999999999999975   88999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......      +.....+..
T Consensus       195 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~  265 (349)
T 2w4o_A          195 FGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILN  265 (349)
T ss_dssp             CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHT
T ss_pred             CccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHh
Confidence            99998654322   122356899999999999989999999999999999999999998432111      111111112


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .... ...+     ........+.+++.+||+.||++|||+.++++
T Consensus       266 ~~~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          266 CEYY-FISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TCCC-CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCc-cCCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111 1111     11122345778889999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.92  E-value=2.3e-26  Score=238.24  Aligned_cols=130  Identities=18%  Similarity=0.229  Sum_probs=102.1

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.+...++.     .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||.
T Consensus       103 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICT-----HFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             EEEECCTTCBHHHHHHH-----TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEEccCCCCHHHHHhh-----hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccc
Confidence            34455555555433322     11235899999999999999999999999   99999999999999999999999998


Q ss_pred             cccccCCC-----CcccccccccCCCCCChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          369 ARIFSGNQ-----NEANTNRVAGTYGYMAPEYAME--GVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       369 a~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      +.......     .........||..|+|||.+.+  ..++.++|||||||++|||++|+.||..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  239 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  239 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            76532211     1111223468889999999987  5789999999999999999999999854

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.92  E-value=1.3e-26  Score=241.29  Aligned_cols=186  Identities=17%  Similarity=0.205  Sum_probs=131.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++|++|+.+|.|...+++.      +..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       137 ~lVmE~~~gg~L~~~l~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKF------GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHH------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEcCCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence            4556666666665544321      235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHH
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAM-------EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAW  440 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~  440 (541)
                      +++........ ......||+.|+|||++.       ...++.++|||||||++|||++|+.||....      ..+...
T Consensus       208 la~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~  280 (412)
T 2vd5_A          208 SCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS------TAETYG  280 (412)
T ss_dssp             TCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHH
T ss_pred             hheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC------HHHHHH
Confidence            99876443221 223457999999999997       3568999999999999999999999984321      111111


Q ss_pred             HhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCC---CCHHHHHH--HHhcC
Q 009186          441 KLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHR---PNMSSVVV--MLASD  496 (541)
Q Consensus       441 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~R---Pt~~evl~--~L~~~  496 (541)
                      ..........  .+.+...    ....+.+++.+||+ +|.+|   |+++||++  .+++.
T Consensus       281 ~i~~~~~~~~--~p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          281 KIVHYKEHLS--LPLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             HHHTHHHHCC--CC----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             HHHhcccCcC--CCccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            1111000000  0111111    23456778889999 99998   58999885  45543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.92  E-value=1.6e-25  Score=228.51  Aligned_cols=171  Identities=22%  Similarity=0.292  Sum_probs=121.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc--ccccccccCCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVAGTYGYMA  392 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~a  392 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+......  .......||+.|+|
T Consensus       120 ~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  196 (351)
T 3mi9_A          120 KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP  196 (351)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccC
Confidence            4899999999999999999999999   999999999999999999999999999876533221  12234568999999


Q ss_pred             hhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC--Cc---------cccccccccCCC
Q 009186          393 PEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG--EA---------LELMDPVLKQTC  460 (541)
Q Consensus       393 PE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---------~~~~~~~l~~~~  460 (541)
                      ||.+.+ ..++.++||||||+++|||++|+.||......   .............  ..         .+.+........
T Consensus       197 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (351)
T 3mi9_A          197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKR  273 (351)
T ss_dssp             HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCC
T ss_pred             chhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhhccccccchhhccccccccccc
Confidence            999876 45799999999999999999999998532211   1111111111000  00         000000000000


Q ss_pred             -CHHH------HHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          461 -VDAE------LLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       461 -~~~~------~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       ....      ...+.+|+.+||+.||++|||++|+++
T Consensus       274 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          274 KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence             0111      234778999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.92  E-value=5.2e-26  Score=225.17  Aligned_cols=163  Identities=25%  Similarity=0.341  Sum_probs=126.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++........ .......++..|+||
T Consensus       106 ~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aP  181 (288)
T 3kfa_A          106 QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAP  181 (288)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCH
T ss_pred             CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCCh
Confidence            45899999999999999999999999   99999999999999999999999999987654332 222334567889999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|+|++ |..||......   ...+..    .....         ...+......+.+++
T Consensus       182 E~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~----~~~~~---------~~~~~~~~~~l~~li  245 (288)
T 3kfa_A          182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKDYR---------MERPEGCPEKVYELM  245 (288)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTTCC---------CCCCTTCCHHHHHHH
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hccCC---------CCCCCCCCHHHHHHH
Confidence            99999999999999999999999999 88887533211   111111    11100         011112234577888


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.||.+||++.++++.|+..
T Consensus       246 ~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          246 RACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhCCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.92  E-value=3.7e-26  Score=245.09  Aligned_cols=183  Identities=25%  Similarity=0.307  Sum_probs=133.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.+|.|...+.+   .......+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       261 ~lVmE~~~gg~L~~~l~~---~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYN---VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             EEEECCCTTCBHHHHHHT---SSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeccCCCHHHHHHH---hhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecc
Confidence            445666666666544432   1223456999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++.+......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ...+...... ...
T Consensus       335 la~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~-~~~  409 (543)
T 3c4z_A          335 LAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVL-EQA  409 (543)
T ss_dssp             TCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHH-HCC
T ss_pred             eeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHh-hcc
Confidence            99876443322  233579999999999999999999999999999999999999985432211  1111111111 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCH-----HHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM-----SSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~-----~evl~  491 (541)
                      .      .+    +......+.+++.+||+.||.+||++     ++|++
T Consensus       410 ~------~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 V------TY----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             C------CC----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             c------CC----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            0      01    11123456678889999999999975     66663

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.92  E-value=2.3e-25  Score=233.13  Aligned_cols=170  Identities=22%  Similarity=0.221  Sum_probs=121.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-CCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      +..+++..++.++.||++||+|||+++   |+||||||+|||++.+ +.+||+|||+++.+.....   .....+|..|+
T Consensus       150 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~  223 (420)
T 1j1b_A          150 KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYR  223 (420)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcC
Confidence            346999999999999999999999999   9999999999999965 5679999999987543322   22356899999


Q ss_pred             ChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh----------cCCccccccccccC--
Q 009186          392 APEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC----------KGEALELMDPVLKQ--  458 (541)
Q Consensus       392 aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~--  458 (541)
                      |||++.+. .++.++|||||||++|||++|+.||.....   ...+....+...          .....+...+.+..  
T Consensus       224 aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~  300 (420)
T 1j1b_A          224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP  300 (420)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCC
T ss_pred             CHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCC
Confidence            99998765 689999999999999999999999853221   111111111100          00001110111100  


Q ss_pred             ---CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          459 ---TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       459 ---~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                         .+.......+.+|+.+||+.||.+||++.|+++
T Consensus       301 ~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          301 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence               011112346788999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.6e-26  Score=236.58  Aligned_cols=182  Identities=23%  Similarity=0.294  Sum_probs=130.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+..+.|...+++       ...+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       135 ~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          135 HLILDYINGGELFTHLSQ-------RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEECCCCSCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             EEEeecCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence            344566555555433322       235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEG--VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      +++.+...... ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......  ............
T Consensus       205 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~  281 (355)
T 1vzo_A          205 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS  281 (355)
T ss_dssp             EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC
T ss_pred             CCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhcc
Confidence            99865432221 22345789999999999863  47899999999999999999999985432221  111111111111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVVML  493 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~~L  493 (541)
                       .      +..    +......+.+|+.+||+.||.+||     +++++++..
T Consensus       282 -~------~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 -E------PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -C------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -C------CCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence             0      111    112234567788999999999999     999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.92  E-value=3e-25  Score=225.14  Aligned_cols=150  Identities=21%  Similarity=0.296  Sum_probs=120.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......   .....||..|+||
T Consensus       125 ~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aP  198 (335)
T 3dls_A          125 PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAP  198 (335)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccCh
Confidence            35999999999999999999999999   99999999999999999999999999987644322   2235689999999


Q ss_pred             hhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..+ +.++||||||+++|||++|+.||......                     .......  +......+.+++
T Consensus       199 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------~~~~~~~--~~~~~~~l~~li  255 (335)
T 3dls_A          199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------------VEAAIHP--PYLVSKELMSLV  255 (335)
T ss_dssp             HHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------------TTTCCCC--SSCCCHHHHHHH
T ss_pred             hhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------------HhhccCC--CcccCHHHHHHH
Confidence            99988876 78999999999999999999998431110                     0000000  001123567788


Q ss_pred             hhhcccCCCCCCCHHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~  492 (541)
                      .+||+.||++|||+.++++.
T Consensus       256 ~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          256 SGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHccCChhhCcCHHHHhcC
Confidence            89999999999999999873

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.92  E-value=1.7e-25  Score=232.19  Aligned_cols=170  Identities=20%  Similarity=0.226  Sum_probs=122.6

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc-CCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ...+++..+..++.||+.||+|||+++   |+||||||+|||++ .++.+||+|||+++.......   .....+|..|+
T Consensus       135 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~  208 (394)
T 4e7w_A          135 KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYR  208 (394)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCcc
Confidence            346899999999999999999999999   99999999999999 789999999999987643322   22356799999


Q ss_pred             ChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC----------Cccccccccc----
Q 009186          392 APEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG----------EALELMDPVL----  456 (541)
Q Consensus       392 aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l----  456 (541)
                      |||.+.+. .++.++|||||||++|||++|+.||......   ..+....+.....          ...+..-+..    
T Consensus       209 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  285 (394)
T 4e7w_A          209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI---DQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHP  285 (394)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCC
T ss_pred             CHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCc
Confidence            99998765 5899999999999999999999998532211   1111111110000          0000000000    


Q ss_pred             -cCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          457 -KQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       457 -~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       ...........+.+|+.+||+.||.+|||+.|+++
T Consensus       286 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          286 FSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence             00011112346788999999999999999999996

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.92  E-value=5e-26  Score=225.92  Aligned_cols=163  Identities=30%  Similarity=0.416  Sum_probs=125.3

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aP  393 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++.......... ......++..|+||
T Consensus       113 ~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  189 (291)
T 1xbb_A          113 HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP  189 (291)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeCh
Confidence            5899999999999999999999999   9999999999999999999999999998765433221 12223456789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||.....      .+ .......+....         .+......+.+++
T Consensus       190 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~~~---------~~~~~~~~l~~li  253 (291)
T 1xbb_A          190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SE-VTAMLEKGERMG---------CPAGCPREMYDLM  253 (291)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HH-HHHHHHTTCCCC---------CCTTCCHHHHHHH
T ss_pred             HHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH------HH-HHHHHHcCCCCC---------CCCCCCHHHHHHH
Confidence            99998889999999999999999999 9999753221      11 111111221111         1112234577888


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.||.+||++.+|++.|+..
T Consensus       254 ~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          254 NLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.92  E-value=1.8e-25  Score=234.50  Aligned_cols=105  Identities=25%  Similarity=0.321  Sum_probs=93.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC--cEEecccccccccCCCCcccccccccCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN--PKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ..+++..++.|+.||+.||+|||+++   |+||||||+|||++.++.  +||+|||++......     .....||+.|+
T Consensus       195 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~  266 (429)
T 3kvw_A          195 QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYR  266 (429)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCcc
Confidence            34899999999999999999999999   999999999999999987  999999999764322     22356899999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      |||++.+..++.++|||||||++|||++|+.||..
T Consensus       267 aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          267 APEVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             CHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999999999999854

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=8.6e-26  Score=228.94  Aligned_cols=164  Identities=26%  Similarity=0.414  Sum_probs=119.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~a  392 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++......... ......++..|+|
T Consensus       142 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  218 (333)
T 1mqb_A          142 GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA  218 (333)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccC
Confidence            45899999999999999999999999   9999999999999999999999999998765432211 1222345778999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||.....      .+ .......+...         ..+......+.++
T Consensus       219 PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~-~~~~~~~~~~~---------~~~~~~~~~l~~l  282 (333)
T 1mqb_A          219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HE-VMKAINDGFRL---------PTPMDCPSAIYQL  282 (333)
T ss_dssp             HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH-HHHHHHTTCCC---------CCCTTCBHHHHHH
T ss_pred             chhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HH-HHHHHHCCCcC---------CCcccCCHHHHHH
Confidence            999999999999999999999999999 9999843211      11 11111111110         0111223457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +.+||+.||++||++.+|++.|+..
T Consensus       283 i~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          283 MMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHH
Confidence            8999999999999999999999764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.92  E-value=1.3e-24  Score=216.80  Aligned_cols=163  Identities=20%  Similarity=0.229  Sum_probs=124.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++................|+..|+||
T Consensus       104 ~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  180 (305)
T 2wtk_C          104 KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP  180 (305)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcCh
Confidence            45899999999999999999999999   999999999999999999999999999876543333333445689999999


Q ss_pred             hhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          394 EYAMEGV--FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       394 E~l~~~~--~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |.+.+..  .+.++||||||+++|||++|+.||....      ..+. ...+..+..      .+...    ....+.++
T Consensus       181 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~-~~~i~~~~~------~~~~~----~~~~l~~l  243 (305)
T 2wtk_C          181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKL-FENIGKGSY------AIPGD----CGPPLSDL  243 (305)
T ss_dssp             HHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHH-HHHHHHCCC------CCCSS----SCHHHHHH
T ss_pred             hhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHH-HHHHhcCCC------CCCCc----cCHHHHHH
Confidence            9987644  4779999999999999999999985321      1111 111111111      11111    22356678


Q ss_pred             HhhhcccCCCCCCCHHHHHH--HHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVV--MLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~--~L~~~  496 (541)
                      +.+||+.||.+|||+.++++  .+++.
T Consensus       244 i~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          244 LKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             HHHHccCChhhCCCHHHHhcCcccccC
Confidence            88999999999999999996  45543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=6.2e-25  Score=223.80  Aligned_cols=171  Identities=22%  Similarity=0.217  Sum_probs=122.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.+.....  ......+|+.|+||
T Consensus       107 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aP  181 (346)
T 1ua2_A          107 LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAP  181 (346)
T ss_dssp             SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCc
Confidence            45899999999999999999999999   99999999999999999999999999987643322  22235689999999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC---Ccccc------ccccccCCCC--
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG---EALEL------MDPVLKQTCV--  461 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------~~~~l~~~~~--  461 (541)
                      |.+.+. .++.++||||||+++|||++|.+||....   ....+..........   .+.+.      +........+  
T Consensus       182 E~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (346)
T 1ua2_A          182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH  258 (346)
T ss_dssp             HHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHH
T ss_pred             hHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChH
Confidence            998764 48899999999999999999999874321   111111111111110   00000      0000000001  


Q ss_pred             ---HHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 009186          462 ---DAELLKCIHIGLLCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       462 ---~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~  492 (541)
                         ......+.+++.+||+.||++|||+.|+++.
T Consensus       259 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          259 HIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence               1123567889999999999999999999974

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.92  E-value=2.9e-26  Score=238.62  Aligned_cols=184  Identities=19%  Similarity=0.239  Sum_probs=133.5

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++|++|+.+|.|...+++        ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       144 ~~lV~E~~~gg~L~~~l~~--------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence            3455677777777544432        24899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV----FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      |+++....... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||....      ........
T Consensus       213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i  285 (410)
T 3v8s_A          213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKI  285 (410)
T ss_dssp             TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHH
T ss_pred             ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhhHHHHH
Confidence            99987543322 1233467999999999998655    7899999999999999999999985221      11111111


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCC--CCCHHHHHH--HHhc
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAH--RPNMSSVVV--MLAS  495 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~evl~--~L~~  495 (541)
                      .........  +   .  .......+.+|+.+||+.+|.+  ||+++||++  .+++
T Consensus       286 ~~~~~~~~~--p---~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          286 MNHKNSLTF--P---D--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HTHHHHCCC--C---T--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             HhccccccC--C---C--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            111000000  0   0  0011245667888999999988  999999996  3444

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.92  E-value=5.2e-27  Score=235.67  Aligned_cols=187  Identities=20%  Similarity=0.239  Sum_probs=124.5

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC---cEEec
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN---PKISD  365 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~---~kL~D  365 (541)
                      ++++++..+.|...+++       ...+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.   +||+|
T Consensus        88 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHK-------RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             EEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             EEEEcCCCCcHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEE
Confidence            34455555555433322       235899999999999999999999999   999999999999998776   89999


Q ss_pred             ccccccccCCCC-----cccccccccCCCCCChhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCc-
Q 009186          366 FGMARIFSGNQN-----EANTNRVAGTYGYMAPEYAME-----GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS-  434 (541)
Q Consensus       366 fg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~-  434 (541)
                      ||++........     ........||..|+|||.+.+     ..++.++||||||+++|||++|+.||.......... 
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  237 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD  237 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence            999876542211     111223458999999999875     457899999999999999999999986433221000 


Q ss_pred             -------HHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          435 -------LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       435 -------~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                             ........+..+.. ...... ...    ....+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~i~~~~~-~~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          238 RGEACPACQNMLFESIQEGKY-EFPDKD-WAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             ---CCHHHHHHHHHHHHHCCC-CCCHHH-HTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccchhHHHHHHHHHhccCc-ccCchh-ccc----CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                   00111111111111 000000 001    1245778899999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.92  E-value=3.8e-26  Score=227.62  Aligned_cols=170  Identities=26%  Similarity=0.412  Sum_probs=119.2

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC---cccccccccCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN---EANTNRVAGTY  388 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~gt~  388 (541)
                      +...+++.+++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++........   ........|+.
T Consensus       114 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~  190 (303)
T 2vwi_A          114 KSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP  190 (303)
T ss_dssp             TTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCC
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCc
Confidence            3556999999999999999999999999   99999999999999999999999999876543221   11123356899


Q ss_pred             CCCChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          389 GYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       389 ~y~aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      .|+|||.+.+ ..++.++||||||+++|||++|+.||......   ...................++.....    ....
T Consensus       191 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  263 (303)
T 2vwi_A          191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM---KVLMLTLQNDPPSLETGVQDKEMLKK----YGKS  263 (303)
T ss_dssp             TTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHTSSCCCTTC-----CCCCC----CCHH
T ss_pred             cccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh---hHHHHHhccCCCccccccccchhhhh----hhHH
Confidence            9999999876 56899999999999999999999998543221   11111111000000000111111111    2245


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHH
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+++.+||+.||.+||++.++++
T Consensus       264 ~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          264 FRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCcCHHHHhh
Confidence            678889999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.92  E-value=8e-26  Score=221.36  Aligned_cols=180  Identities=22%  Similarity=0.310  Sum_probs=130.4

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++..+.|...+++     ..+..+++.+++.++.||+.||+|||+++ .+|+||||||+||+++.++.++|.|||+.
T Consensus        87 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHE-----GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             EEECCTTCBHHHHHHS-----CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             eecccCCCcHHHHHhh-----cccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccce
Confidence            3444555555444432     12335899999999999999999999875 34999999999999999999999999886


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCCCc---chhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSV---KSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~---~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      .....       ....+|+.|+|||.+.+...+.   ++||||||+++|||++|+.||....      ..+........+
T Consensus       161 ~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~  227 (271)
T 3kmu_A          161 FSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS------NMEIGMKVALEG  227 (271)
T ss_dssp             CTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC------HHHHHHHHHHSC
T ss_pred             eeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC------hHHHHHHHHhcC
Confidence            54221       2346789999999998765544   7999999999999999999985321      111112222121


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ..     +.+..    .....+.+++.+||+.||++|||++++++.|+...
T Consensus       228 ~~-----~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          228 LR-----PTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CC-----CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            11     11111    22345778888999999999999999999998643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.92  E-value=2.5e-25  Score=222.87  Aligned_cols=168  Identities=23%  Similarity=0.306  Sum_probs=118.4

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++.+++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++.........  .....++..|+|
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~a  204 (310)
T 2wqm_A          130 KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMS  204 (310)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc--ccccCCCeeEeC
Confidence            446899999999999999999999999   999999999999999999999999998765433221  223468899999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+.+..++.++||||||+++|+|++|+.||....    ........ ...........    ..    .....+.+++
T Consensus       205 PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~-~~~~~~~~~~~----~~----~~~~~l~~li  271 (310)
T 2wqm_A          205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCK-KIEQCDYPPLP----SD----HYSEELRQLV  271 (310)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHHH-HHHTTCSCCCC----TT----TSCHHHHHHH
T ss_pred             hHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hhHHHHHH-HhhcccCCCCc----cc----ccCHHHHHHH
Confidence            999999999999999999999999999999974321    11111111 11111111110    01    1223567788


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcCCC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASDTA  498 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~~~  498 (541)
                      .+||+.||.+||++.+|++.|+....
T Consensus       272 ~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          272 NMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            89999999999999999999987543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.92  E-value=5e-26  Score=233.37  Aligned_cols=179  Identities=22%  Similarity=0.248  Sum_probs=119.4

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC--cEEecc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN--PKISDF  366 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~--~kL~Df  366 (541)
                      ++++|+..+.|...+.+       ...+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.  +||+||
T Consensus        93 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Df  162 (361)
T 3uc3_A           93 IIMEYASGGELYERICN-------AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDF  162 (361)
T ss_dssp             EEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred             EEEEeCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeec
Confidence            33455545555433322       235899999999999999999999999   999999999999987765  999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVK-SDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~-sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      |+++......   ......||+.|+|||.+.+..++.+ +||||||+++|+|++|+.||......  .............
T Consensus       163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~~~~~~  237 (361)
T 3uc3_A          163 GYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRILSV  237 (361)
T ss_dssp             CCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--CCHHHHHHHHHTT
T ss_pred             CccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhcC
Confidence            9987432221   2233568999999999988887655 89999999999999999998543221  1122222211111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       ...      +..  .......+.+|+.+||+.||++|||+.|+++
T Consensus       238 -~~~------~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          238 -KYS------IPD--DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             -CCC------CCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -CCC------CCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence             100      000  0011245678889999999999999999996

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.92  E-value=9.7e-26  Score=223.28  Aligned_cols=158  Identities=26%  Similarity=0.380  Sum_probs=114.7

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE---cCCCCcEEecccccccccCCCCcccccccccCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVAGTYG  389 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~  389 (541)
                      +..+++..++.++.||+.||+|||+++   |+||||||+||++   +.++.+||+|||++..+.....   .....|+..
T Consensus       118 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~  191 (285)
T 3is5_A          118 GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTAL  191 (285)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccccC
Confidence            356999999999999999999999999   9999999999999   4567899999999976543322   234568999


Q ss_pred             CCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       390 y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      |+|||.+. +.++.++||||||+++|||++|+.||....      ..+.............. .   ...    ....+.
T Consensus       192 y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~-~---~~~----~~~~~~  256 (285)
T 3is5_A          192 YMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS------LEEVQQKATYKEPNYAV-E---CRP----LTPQAV  256 (285)
T ss_dssp             GCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCCCC------CC----CCHHHH
T ss_pred             cCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC------HHHHHhhhccCCccccc-c---cCc----CCHHHH
Confidence            99999875 568999999999999999999999985321      11111111111111000 0   001    123566


Q ss_pred             HHHhhhcccCCCCCCCHHHHHH
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +++.+||+.||++|||+.||++
T Consensus       257 ~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          257 DLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            7888999999999999999985

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.92  E-value=3.4e-26  Score=246.17  Aligned_cols=180  Identities=24%  Similarity=0.270  Sum_probs=132.7

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++|++|+.+|.|...+++     .....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       260 ~lVmEy~~gg~L~~~l~~-----~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFG  331 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYH-----MGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLG  331 (576)
T ss_dssp             EEEECCCCSCBHHHHHHS-----SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecc
Confidence            345566666666444332     12334899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  . ...........
T Consensus       332 la~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~-~~i~~~i~~~~  405 (576)
T 2acx_A          332 LAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--R-EEVERLVKEVP  405 (576)
T ss_dssp             TCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--H-HHHHHHHHHCC
T ss_pred             cceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--H-HHHHHHhhccc
Confidence            9987643322   2235799999999999998899999999999999999999999864322111  1 11111111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                            ..+    +......+.+|+.+||+.||.+||     +++||++
T Consensus       406 ------~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 ------EEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ------ccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                  011    111234567788899999999999     7888875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.92  E-value=7.4e-26  Score=224.14  Aligned_cols=159  Identities=26%  Similarity=0.356  Sum_probs=112.4

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      +..+++..++.++.||+.||+|||++ +   |+||||||+||+++.++.+||+|||++........   .....|+..|+
T Consensus       103 ~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~  176 (290)
T 3fme_A          103 GQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYM  176 (290)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCcccc
Confidence            45699999999999999999999998 8   99999999999999999999999999976543322   22346899999


Q ss_pred             Chhhh----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          392 APEYA----MEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       392 aPE~l----~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      |||.+    .+..++.++||||||+++|||++|+.||.....     .............. ..     ..   ......
T Consensus       177 aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-~~-----~~---~~~~~~  242 (290)
T 3fme_A          177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPSP-QL-----PA---DKFSAE  242 (290)
T ss_dssp             CHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCCC-CC-----CT---TTSCHH
T ss_pred             ChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCCC-Cc-----cc---ccCCHH
Confidence            99996    456689999999999999999999999853211     11111122111111 11     11   112345


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHH
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          243 FVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhhcChhhCcCHHHHHh
Confidence            778888999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.92  E-value=2.3e-25  Score=220.71  Aligned_cols=166  Identities=25%  Similarity=0.309  Sum_probs=125.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~a  392 (541)
                      ..+++.+++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++.......... ......++..|+|
T Consensus       116 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  192 (291)
T 1u46_A          116 GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA  192 (291)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCC
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeC
Confidence            35899999999999999999999999   9999999999999999999999999998765443221 2223456778999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||....      ..+.............     .    .......+.++
T Consensus       193 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~~~~~~-----~----~~~~~~~l~~l  257 (291)
T 1u46_A          193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGERLP-----R----PEDCPQDIYNV  257 (291)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCCCCC-----C----CTTCCHHHHHH
T ss_pred             chhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC------HHHHHHHHHccCCCCC-----C----CcCcCHHHHHH
Confidence            999998889999999999999999999 999984321      1111111111111110     1    11223457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +.+||+.||++||++.++++.|++..
T Consensus       258 i~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          258 MVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHccCCcccCcCHHHHHHHHHHhC
Confidence            89999999999999999999998754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.92  E-value=8.9e-26  Score=228.04  Aligned_cols=163  Identities=26%  Similarity=0.332  Sum_probs=124.0

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.....   .......++..|+|
T Consensus       136 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~a  209 (327)
T 1fvr_A          136 ASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMA  209 (327)
T ss_dssp             SCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCC
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccC
Confidence            456999999999999999999999999   999999999999999999999999998743211   11223356788999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||....      ..+. ......+..     ...    +......+.++
T Consensus       210 PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~------~~~~-~~~~~~~~~-----~~~----~~~~~~~l~~l  273 (327)
T 1fvr_A          210 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAEL-YEKLPQGYR-----LEK----PLNCDDEVYDL  273 (327)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHH-HHHGGGTCC-----CCC----CTTBCHHHHHH
T ss_pred             hhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc------HHHH-HHHhhcCCC-----CCC----CCCCCHHHHHH
Confidence            999998889999999999999999998 999984321      1111 111111111     011    11123457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +.+||+.||.+|||+.++++.|+...
T Consensus       274 i~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          274 MRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHH
Confidence            89999999999999999999998643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.92  E-value=1.5e-25  Score=220.95  Aligned_cols=158  Identities=28%  Similarity=0.325  Sum_probs=118.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++.......     ....++..|+|||
T Consensus       113 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE  184 (278)
T 1byg_A          113 VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPE  184 (278)
T ss_dssp             HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHH
Confidence            4889999999999999999999999   9999999999999999999999999987543221     1235678899999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+.+..++.++||||||+++|||++ |+.||.....   .....    ....+..     ...    +......+.+++.
T Consensus       185 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~----~~~~~~~-----~~~----~~~~~~~l~~li~  248 (278)
T 1byg_A          185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP----RVEKGYK-----MDA----PDGCPPAVYEVMK  248 (278)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHH----HHTTTCC-----CCC----CTTCCHHHHHHHH
T ss_pred             HhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHhcCCC-----CCC----cccCCHHHHHHHH
Confidence            9999999999999999999999998 9999853321   11111    1111111     111    1122345777888


Q ss_pred             hhcccCCCCCCCHHHHHHHHhcC
Q 009186          474 LCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      +||+.||++||++.++++.|+..
T Consensus       249 ~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          249 NCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcCChhhCCCHHHHHHHHHHH
Confidence            99999999999999999999763

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=9.1e-25  Score=224.47  Aligned_cols=171  Identities=23%  Similarity=0.268  Sum_probs=124.3

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.....     .....+|..|+|||
T Consensus       124 ~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE  195 (367)
T 1cm8_A          124 KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPE  195 (367)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHH
Confidence            4899999999999999999999999   999999999999999999999999999875432     22356899999999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC------------------cccccccc
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE------------------ALELMDPV  455 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~  455 (541)
                      .+.+ ..++.++|||||||++|||++|+.||......   ..+...........                  ........
T Consensus       196 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (367)
T 1cm8_A          196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD  272 (367)
T ss_dssp             HHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCC
T ss_pred             HHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCC
Confidence            9887 67999999999999999999999998532211   11111111000000                  00000000


Q ss_pred             ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcCC
Q 009186          456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASDT  497 (541)
Q Consensus       456 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~  497 (541)
                      +. .........+.+|+.+||+.||.+|||+.++++  .+++..
T Consensus       273 ~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          273 FA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             GG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            00 011122345778889999999999999999997  465543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.92  E-value=3.5e-25  Score=223.91  Aligned_cols=167  Identities=22%  Similarity=0.259  Sum_probs=123.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-------------------CCCcEEecccccccccC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-------------------EMNPKISDFGMARIFSG  374 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-------------------~~~~kL~Dfg~a~~~~~  374 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++.                   ++.+||+|||+++....
T Consensus       113 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  189 (339)
T 1z57_A          113 LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE  189 (339)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc
Confidence            35899999999999999999999999   999999999999987                   66899999999976432


Q ss_pred             CCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc--------C
Q 009186          375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK--------G  446 (541)
Q Consensus       375 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~  446 (541)
                      .     .....||..|+|||.+.+..++.++||||||+++|||++|+.||.......   ...........        .
T Consensus       190 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~p~~~~~~~  261 (339)
T 1z57_A          190 H-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE---HLAMMERILGPLPKHMIQKT  261 (339)
T ss_dssp             C-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH---HHHHHHHHHCSCCHHHHHHC
T ss_pred             c-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHhhc
Confidence            2     223568999999999999899999999999999999999999986432211   11111111000        0


Q ss_pred             Ccccc---------------------ccccc-cCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALEL---------------------MDPVL-KQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~---------------------~~~~l-~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .....                     ..+.. ...........+.+++.+||+.||.+|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          262 RKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             SCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            00000                     00000 01112345677889999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.92  E-value=4.5e-27  Score=231.72  Aligned_cols=165  Identities=25%  Similarity=0.286  Sum_probs=122.3

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcC--CCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDS--RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY  390 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~--~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  390 (541)
                      +..+++.+++.++.||+.||+|||+.+  ..+|+|+||||+||+++.++.+||+|||+++.......  ......|+..|
T Consensus       105 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y  182 (279)
T 2w5a_A          105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYY  182 (279)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccc
Confidence            345899999999999999999999976  12399999999999999999999999999976543221  12234689999


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +|||.+.+..++.++||||||+++|+|++|+.||....      ..+. ......+....     +..    .....+.+
T Consensus       183 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~-~~~i~~~~~~~-----~~~----~~~~~l~~  246 (279)
T 2w5a_A          183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKEL-AGKIREGKFRR-----IPY----RYSDELNE  246 (279)
T ss_dssp             CCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH-HHHHHHTCCCC-----CCT----TSCHHHHH
T ss_pred             cChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC------HHHH-HHHHhhccccc-----CCc----ccCHHHHH
Confidence            99999999899999999999999999999999985322      1111 11112222111     111    12345777


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ++.+||+.||++||++.||++.+..
T Consensus       247 li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          247 IITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHcCCCcccCCCHHHHHhChhh
Confidence            8889999999999999999986653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.92  E-value=1.7e-25  Score=224.15  Aligned_cols=173  Identities=18%  Similarity=0.243  Sum_probs=117.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++.........  .....++..|+||
T Consensus        97 ~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aP  171 (311)
T 4agu_A           97 RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSP  171 (311)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCccccCh
Confidence            35899999999999999999999999   999999999999999999999999999875433221  2234688999999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHH--------HHHhhhcCCccccccccccCCC----
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTY--------AWKLWCKGEALELMDPVLKQTC----  460 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~~----  460 (541)
                      |.+.+ ..++.++||||||+++|+|++|+.||..............        .+..+.................    
T Consensus       172 E~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (311)
T 4agu_A          172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLE  251 (311)
T ss_dssp             HHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHH
T ss_pred             HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhh
Confidence            99876 5689999999999999999999999854322111000000        0001111111000000000000    


Q ss_pred             --CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          461 --VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       461 --~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                        .+.....+.+++.+||+.||.+|||++|+++
T Consensus       252 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          252 LKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             hhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence              0112345778999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=6.3e-26  Score=221.86  Aligned_cols=163  Identities=28%  Similarity=0.346  Sum_probs=124.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++........ .......++..|+||
T Consensus        99 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aP  174 (267)
T 3t9t_A           99 GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP  174 (267)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccCh
Confidence            35899999999999999999999999   99999999999999999999999999986543211 112234467789999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |+.||....      ..+.. .....+..     ...    +......+.+++
T Consensus       175 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~-~~i~~~~~-----~~~----~~~~~~~l~~li  238 (267)
T 3t9t_A          175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVV-EDISTGFR-----LYK----PRLASTHVYQIM  238 (267)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHH-HHHHTTCC-----CCC----CTTSCHHHHHHH
T ss_pred             hhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC------HHHHH-HHHhcCCc-----CCC----CccCcHHHHHHH
Confidence            99998999999999999999999999 898875321      11111 11111111     001    111234567788


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.||++||++.++++.|+..
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.92  E-value=7.9e-25  Score=227.94  Aligned_cols=176  Identities=23%  Similarity=0.320  Sum_probs=115.5

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE----cCCCCcEEecccccccccCCCC-cccccccccC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL----DHEMNPKISDFGMARIFSGNQN-EANTNRVAGT  387 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll----~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt  387 (541)
                      ...+++..++.|+.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+++.+..... ........||
T Consensus       122 ~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  198 (405)
T 3rgf_A          122 PVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT  198 (405)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceec
Confidence            345999999999999999999999999   9999999999999    6778999999999987653321 1223346789


Q ss_pred             CCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcC------cCcHHHHHHHhhhcCC--cccccc-----
Q 009186          388 YGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH------GQSLLTYAWKLWCKGE--ALELMD-----  453 (541)
Q Consensus       388 ~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~--~~~~~~-----  453 (541)
                      +.|+|||++.+. .++.++|||||||++|||++|+.||.......      ....+...........  ....+.     
T Consensus       199 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  278 (405)
T 3rgf_A          199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEH  278 (405)
T ss_dssp             CTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTH
T ss_pred             CcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcch
Confidence            999999999874 48999999999999999999999985432210      0111111111111000  000000     


Q ss_pred             --------ccccCCCCH---------HHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          454 --------PVLKQTCVD---------AELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       454 --------~~l~~~~~~---------~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                              .........         .....+.+|+.+||+.||.+|||++|+++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          279 STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    000000000         01235678999999999999999999996

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.92  E-value=5.9e-26  Score=230.32  Aligned_cols=160  Identities=27%  Similarity=0.368  Sum_probs=124.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++........  ......|+..|+||
T Consensus       136 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  210 (335)
T 2owb_A          136 KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAP  210 (335)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCH
Confidence            35899999999999999999999999   99999999999999999999999999987543322  22335689999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|||++|+.||....      ..+.. ........      .+....    ...+.+++.
T Consensus       211 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~-~~~~~~~~------~~~~~~----~~~~~~li~  273 (335)
T 2owb_A          211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETY-LRIKKNEY------SIPKHI----NPVAASLIQ  273 (335)
T ss_dssp             HHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHH-HHHHHTCC------CCCTTS----CHHHHHHHH
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHHHH-HHHhcCCC------CCCccC----CHHHHHHHH
Confidence            99999889999999999999999999999985321      11111 11111111      111111    234667888


Q ss_pred             hhcccCCCCCCCHHHHHH--HHhc
Q 009186          474 LCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      +||+.||++||++.|+++  .+.+
T Consensus       274 ~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          274 KMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999996  4554

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.92  E-value=8.2e-25  Score=231.54  Aligned_cols=104  Identities=27%  Similarity=0.457  Sum_probs=86.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc---------------
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE---------------  378 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---------------  378 (541)
                      ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++........               
T Consensus       151 ~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~  227 (458)
T 3rp9_A          151 VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL  227 (458)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC----------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccc
Confidence            45999999999999999999999999   999999999999999999999999999876432211               


Q ss_pred             ----------ccccccccCCCCCChhhh-ccCCCCcchhhHHHHHHHHHHHhC
Q 009186          379 ----------ANTNRVAGTYGYMAPEYA-MEGVFSVKSDVFSFGVLLLEIISG  420 (541)
Q Consensus       379 ----------~~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwSlGvll~elltg  420 (541)
                                .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       228 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             -----------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence                      112335689999999976 456699999999999999999994

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.92  E-value=5.7e-25  Score=227.29  Aligned_cols=170  Identities=19%  Similarity=0.221  Sum_probs=122.4

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc-CCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      +..+++..+..++.||+.||+|||+++   |+||||||+||+++ .++.+||+|||+++.......   .....+|..|+
T Consensus       135 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~  208 (383)
T 3eb0_A          135 GRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYR  208 (383)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCcc
Confidence            456999999999999999999999999   99999999999998 678899999999987643332   22346789999


Q ss_pred             ChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC---------------Ccccccccc
Q 009186          392 APEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG---------------EALELMDPV  455 (541)
Q Consensus       392 aPE~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~  455 (541)
                      |||.+.+.. ++.++||||||+++|||++|+.||......   ..+..........               .........
T Consensus       209 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  285 (383)
T 3eb0_A          209 APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI---DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKD  285 (383)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCC
T ss_pred             CHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCccc
Confidence            999987754 899999999999999999999998532211   1111111110000               000000001


Q ss_pred             ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       456 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .....+......+.+|+.+||+.||.+|||+.|+++
T Consensus       286 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          286 WRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111111122345778999999999999999999984

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.92  E-value=1.1e-24  Score=218.41  Aligned_cols=167  Identities=19%  Similarity=0.210  Sum_probs=116.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++......... ......++..|+|||
T Consensus       130 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE  205 (309)
T 2h34_A          130 PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPE  205 (309)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHH
Confidence            5899999999999999999999999   999999999999999999999999998765433221 222356889999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC-ccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE-ALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+.+..++.++||||||+++|||++|+.||.....      . .......... ....    ...    .....+.+++.
T Consensus       206 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~-~~~~~~~~~~~~~~~----~~~----~~~~~l~~li~  270 (309)
T 2h34_A          206 RFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------S-VMGAHINQAIPRPST----VRP----GIPVAFDAVIA  270 (309)
T ss_dssp             GTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------H-HHHHHHHSCCCCGGG----TST----TCCTHHHHHHH
T ss_pred             HHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------H-HHHHHhccCCCCccc----cCC----CCCHHHHHHHH
Confidence            99988899999999999999999999999853211      1 1111111111 1111    111    12235667888


Q ss_pred             hhcccCCCCCC-CHHHHHHHHhcCCCCC
Q 009186          474 LCVQEDPAHRP-NMSSVVVMLASDTATL  500 (541)
Q Consensus       474 ~cl~~dP~~RP-t~~evl~~L~~~~~~l  500 (541)
                      +||+.||++|| +++++++.|+......
T Consensus       271 ~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          271 RGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             HHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             HhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            99999999999 9999999999765443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.92  E-value=4e-25  Score=225.17  Aligned_cols=167  Identities=20%  Similarity=0.263  Sum_probs=122.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE-------------------cCCCCcEEecccccccccC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-------------------DHEMNPKISDFGMARIFSG  374 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll-------------------~~~~~~kL~Dfg~a~~~~~  374 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+|||+                   +.++.+||+|||+++....
T Consensus       118 ~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  194 (355)
T 2eu9_A          118 QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE  194 (355)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc
Confidence            35899999999999999999999999   9999999999999                   5678899999999976432


Q ss_pred             CCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc--------C
Q 009186          375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK--------G  446 (541)
Q Consensus       375 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~  446 (541)
                      .     .....||..|+|||.+.+..++.++||||||+++|||++|+.||......   ............        .
T Consensus       195 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~  266 (355)
T 2eu9_A          195 H-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR---EHLVMMEKILGPIPSHMIHRT  266 (355)
T ss_dssp             C-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHHHHC
T ss_pred             c-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCcHHHhhhc
Confidence            2     22356899999999999999999999999999999999999998533211   111111111000        0


Q ss_pred             Ccccc-c--------------------cc-cccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALEL-M--------------------DP-VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~-~--------------------~~-~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..... .                    .+ .........+...+.+|+.+||+.||++|||+.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          267 RKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             SCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000 0                    00 0000112344567889999999999999999999984

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.92  E-value=2.5e-25  Score=224.49  Aligned_cols=178  Identities=20%  Similarity=0.254  Sum_probs=126.6

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..+.|....++    .......++..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus       138 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  210 (332)
T 3qd2_B          138 IQMQLCRKENLKDWMNR----RCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL  210 (332)
T ss_dssp             EEEECCCSSCHHHHHHT----CCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecCCCCHHHHHhc----ccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCc
Confidence            33455555555433322    112334577789999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCc----------ccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHH
Q 009186          369 ARIFSGNQNE----------ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTY  438 (541)
Q Consensus       369 a~~~~~~~~~----------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~  438 (541)
                      ++........          .......||+.|+|||.+.+..++.++||||||+++|||++|..|+.        ... .
T Consensus       211 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~-~  281 (332)
T 3qd2_B          211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERV-R  281 (332)
T ss_dssp             CEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHH-H
T ss_pred             ccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHH-H
Confidence            9876544221          11233568999999999999999999999999999999999876631        000 1


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ............         ........+.+++.+||+.||++|||+.|+++
T Consensus       282 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          282 IITDVRNLKFPL---------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHTTCCCH---------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHhhccCCCc---------ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            111111111110         01223345678999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.92  E-value=6.2e-25  Score=225.66  Aligned_cols=171  Identities=24%  Similarity=0.293  Sum_probs=114.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....     .....||..|+||
T Consensus       127 ~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aP  198 (367)
T 2fst_X          127 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP  198 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccCh
Confidence            45999999999999999999999999   999999999999999999999999999865322     2235789999999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcccccc-----------cccc--CC
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMD-----------PVLK--QT  459 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~l~--~~  459 (541)
                      |.+.+ ..++.++|||||||++|||++|+.||.....   ...+....+...... .+.+.           ..+.  ..
T Consensus       199 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (367)
T 2fst_X          199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPG-AELLKKISSESARNYIQSLTQMPK  274 (367)
T ss_dssp             HHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCC-HHHHTTCCCHHHHHHHHTSCCCCC
T ss_pred             HHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCC-HHHHHHhhhHHHHHHHhccCCCCC
Confidence            99887 6789999999999999999999999853221   111111111110000 00000           0000  00


Q ss_pred             CC-----HHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcC
Q 009186          460 CV-----DAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASD  496 (541)
Q Consensus       460 ~~-----~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~  496 (541)
                      ..     ......+.+|+.+||+.||.+|||+.++++  .++..
T Consensus       275 ~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             CCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence            00     011245778999999999999999999986  44543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.92  E-value=9.5e-25  Score=224.27  Aligned_cols=174  Identities=21%  Similarity=0.253  Sum_probs=123.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEc------CCCCcEEecccccccccCCCCccccccccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLD------HEMNPKISDFGMARIFSGNQNEANTNRVAG  386 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g  386 (541)
                      ..+++..++.++.||+.||+|||++ +   |+||||||+|||++      ..+.+||+|||++......     .....|
T Consensus       126 ~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~  197 (373)
T 1q8y_A          126 RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQ  197 (373)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCS
T ss_pred             cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCC
Confidence            3489999999999999999999998 8   99999999999994      3447999999999865432     223468


Q ss_pred             CCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCc---HHHHHHHhhhc------------------
Q 009186          387 TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS---LLTYAWKLWCK------------------  445 (541)
Q Consensus       387 t~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~------------------  445 (541)
                      |..|+|||.+.+..++.++||||||+++|||++|+.||..........   .+.........                  
T Consensus       198 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  277 (373)
T 1q8y_A          198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS  277 (373)
T ss_dssp             CGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC
T ss_pred             CccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCC
Confidence            999999999999999999999999999999999999986433221111   11111111000                  


Q ss_pred             CCccccccc----------cccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          446 GEALELMDP----------VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       446 ~~~~~~~~~----------~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      ......+..          .-....+......+.+|+.+||+.||++|||+.|+++  .+++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  339 (373)
T 1q8y_A          278 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD  339 (373)
T ss_dssp             --CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred             cchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhc
Confidence            000000000          0011234566778899999999999999999999987  4444

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.92  E-value=2.5e-26  Score=232.06  Aligned_cols=171  Identities=26%  Similarity=0.366  Sum_probs=126.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~a  392 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......... ......++..|+|
T Consensus       140 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  216 (326)
T 2w1i_A          140 ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA  216 (326)
T ss_dssp             TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEEC
Confidence            35899999999999999999999999   9999999999999999999999999998765433221 1222346778999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc---------CcCcHHHHHHHhhhcCCccccccccccCCCCHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE---------HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDA  463 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  463 (541)
                      ||.+.+..++.++||||||+++|||++|..|+......         ...............+..         ...+..
T Consensus       217 PE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  287 (326)
T 2w1i_A          217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR---------LPRPDG  287 (326)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC---------CCCCTT
T ss_pred             chhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCC---------CCCCCc
Confidence            99999888999999999999999999999886421100         000000011111111110         111122


Q ss_pred             HHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          464 ELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       464 ~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ....+.+++.+||+.||++||++.+|++.|+..
T Consensus       288 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          288 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            234677889999999999999999999999863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.92  E-value=2.5e-26  Score=226.82  Aligned_cols=171  Identities=20%  Similarity=0.250  Sum_probs=122.6

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-----------
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-----------  358 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-----------  358 (541)
                      +++++..+.|...+++.   ......+++.+++.++.||+.||+|||+++   |+||||||+||+++.+           
T Consensus        89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           89 QNEYCNGGSLADAISEN---YRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             EEECCTTCBHHHHHHHH---HHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------------
T ss_pred             EEEecCCCcHHHHHHhh---cccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccc
Confidence            34555455554333221   112345899999999999999999999999   9999999999999844           


Q ss_pred             --------CCcEEecccccccccCCCCcccccccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 009186          359 --------MNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLS  429 (541)
Q Consensus       359 --------~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~  429 (541)
                              ..+||+|||.+.......      ...|+..|+|||.+.+. .++.++||||||+++|||++|.+++...  
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--  234 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--  234 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS--
T ss_pred             cccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch--
Confidence                    478999999998754322      23488999999999866 5678999999999999999998765211  


Q ss_pred             cCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          430 EHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                          ..    +.....+...     .+...    ....+.+++.+||+.||++|||+.++++
T Consensus       235 ----~~----~~~~~~~~~~-----~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          235 ----DQ----WHEIRQGRLP-----RIPQV----LSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ----HH----HHHHHTTCCC-----CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----hH----HHHHHcCCCC-----CCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                11    1111122111     11111    2245677888999999999999999875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.91  E-value=7.4e-25  Score=223.45  Aligned_cols=154  Identities=29%  Similarity=0.400  Sum_probs=119.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....      ....||+.|+||
T Consensus       149 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aP  219 (348)
T 1u5q_A          149 KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAP  219 (348)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCH
Confidence            35899999999999999999999999   999999999999999999999999999765321      235689999999


Q ss_pred             hhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          394 EYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       394 E~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |.+.   ++.++.++||||||+++|||++|+.||....      .............      +.+...   .....+.+
T Consensus       220 E~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~------~~~~~~---~~~~~l~~  284 (348)
T 1u5q_A          220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNES------PALQSG---HWSEYFRN  284 (348)
T ss_dssp             HHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC------CCCCCT---TSCHHHHH
T ss_pred             hhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCC------CCCCCC---CCCHHHHH
Confidence            9985   5678999999999999999999999974221      1222222221111      111111   11234667


Q ss_pred             HHhhhcccCCCCCCCHHHHHH
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ++.+||+.||++|||++++++
T Consensus       285 li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          285 FVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHcccChhhCcCHHHHhh
Confidence            888999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.91  E-value=1.5e-24  Score=224.01  Aligned_cols=105  Identities=25%  Similarity=0.341  Sum_probs=92.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhh--cCCCceEecccCCCcEEEc--CCCCcEEecccccccccCCCCcccccccccCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHE--DSRLRVIHRDLKTSNVLLD--HEMNPKISDFGMARIFSGNQNEANTNRVAGTYG  389 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~--~~~~~ivH~DLkp~NIll~--~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~  389 (541)
                      ..+++..+..++.||+.||.|||.  .+   |+||||||+|||++  .++.+||+|||+++.....     .....||+.
T Consensus       152 ~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~  223 (382)
T 2vx3_A          152 RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRF  223 (382)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCcc
Confidence            348999999999999999999995  56   99999999999994  4778999999999876432     223568899


Q ss_pred             CCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       390 y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      |+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       224 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999999999999999853

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.91  E-value=2.8e-25  Score=224.70  Aligned_cols=170  Identities=19%  Similarity=0.207  Sum_probs=114.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc-----CCCCcEEecccccccccCCCCcccccccccCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-----HEMNPKISDFGMARIFSGNQNEANTNRVAGTY  388 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~-----~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~  388 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+|||++     .++.+||+|||+++.+......  .....+|.
T Consensus       127 ~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~  201 (329)
T 3gbz_A          127 PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITL  201 (329)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc--cCCCcCCc
Confidence            35899999999999999999999999   99999999999994     4455999999999876433221  22346799


Q ss_pred             CCCChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC---Cc---------cc----c
Q 009186          389 GYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG---EA---------LE----L  451 (541)
Q Consensus       389 ~y~aPE~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---------~~----~  451 (541)
                      .|+|||++.+.. ++.++||||||+++|||++|+.||......   .............   .+         ..    .
T Consensus       202 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
T 3gbz_A          202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKF  278 (329)
T ss_dssp             TTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred             cccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhh
Confidence            999999998754 899999999999999999999998532211   1111111110000   00         00    0


Q ss_pred             ccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          452 MDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       452 ~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ....+...........+.+|+.+||+.||++|||++|+++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          279 RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0000000000012345678999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.91  E-value=1.2e-24  Score=214.36  Aligned_cols=153  Identities=27%  Similarity=0.372  Sum_probs=117.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......    .....|+..|+|||
T Consensus       105 ~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE  177 (279)
T 3fdn_A          105 KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE  177 (279)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHh
Confidence            4899999999999999999999999   9999999999999999999999999986543222    22356899999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++||||||+++|+|++|+.||....      ..+.. .......      ..+    +......+.+++.+
T Consensus       178 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~-~~~~~~~------~~~----~~~~~~~~~~li~~  240 (279)
T 3fdn_A          178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETY-KRISRVE------FTF----PDFVTEGARDLISR  240 (279)
T ss_dssp             HHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHH-HHHHHTC------CCC----CTTSCHHHHHHHHH
T ss_pred             HhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc------HHHHH-HHHHhCC------CCC----CCcCCHHHHHHHHH
Confidence            9999899999999999999999999999985321      11111 1111111      011    11123356678889


Q ss_pred             hcccCCCCCCCHHHHHH
Q 009186          475 CVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~  491 (541)
                      ||+.||.+|||+.||++
T Consensus       241 ~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          241 LLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             HCCSSGGGSCCHHHHHH
T ss_pred             HhccChhhCCCHHHHhh
Confidence            99999999999999996

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.91  E-value=1.2e-25  Score=230.90  Aligned_cols=159  Identities=24%  Similarity=0.401  Sum_probs=120.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++..+.....   .....||+.|+||
T Consensus       195 ~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aP  268 (365)
T 2y7j_A          195 VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAP  268 (365)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccCh
Confidence            35899999999999999999999999   99999999999999999999999999887654322   2335789999999


Q ss_pred             hhhcc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          394 EYAME------GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       394 E~l~~------~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      |++.+      ..++.++||||||+++|||++|+.||....      .... ......+... ...+.. ..    ....
T Consensus       269 E~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------~~~~-~~~i~~~~~~-~~~~~~-~~----~~~~  335 (365)
T 2y7j_A          269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR------QILM-LRMIMEGQYQ-FSSPEW-DD----RSST  335 (365)
T ss_dssp             HHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHH-HHHHHHTCCC-CCHHHH-SS----SCHH
T ss_pred             hhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC------HHHH-HHHHHhCCCC-CCCccc-cc----CCHH
Confidence            99864      358889999999999999999999984321      1111 1111111110 000000 11    1235


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHH
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+++.+||+.||++|||+.++++
T Consensus       336 ~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          336 VKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhc
Confidence            778889999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.91  E-value=1.7e-24  Score=214.02  Aligned_cols=162  Identities=22%  Similarity=0.279  Sum_probs=125.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++.......    .....|+..|+|||
T Consensus       110 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE  182 (284)
T 2vgo_A          110 RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPE  182 (284)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHH
Confidence            5899999999999999999999999   9999999999999999999999999987643221    22356889999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++||||||+++|+|++|+.||....      ..+.... .....      ..+...    ....+.+++.+
T Consensus       183 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~-~~~~~------~~~~~~----~~~~~~~li~~  245 (284)
T 2vgo_A          183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS------HTETHRR-IVNVD------LKFPPF----LSDGSKDLISK  245 (284)
T ss_dssp             HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHH-HHTTC------CCCCTT----SCHHHHHHHHH
T ss_pred             HhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC------HhHHHHH-Hhccc------cCCCCc----CCHHHHHHHHH
Confidence            9999899999999999999999999999985321      1111111 11111      111111    22456778889


Q ss_pred             hcccCCCCCCCHHHHHH--HHhcCCCCC
Q 009186          475 CVQEDPAHRPNMSSVVV--MLASDTATL  500 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~--~L~~~~~~l  500 (541)
                      ||+.||.+||++.++++  .++......
T Consensus       246 ~l~~~p~~Rps~~~ll~h~~~~~~~~~~  273 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGVMEHPWVKANSRRV  273 (284)
T ss_dssp             HSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred             HhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence            99999999999999996  666544333

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.91  E-value=2e-25  Score=224.03  Aligned_cols=159  Identities=23%  Similarity=0.331  Sum_probs=113.4

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+++   |+||||||+||++++ +.+||+|||+++...............|+..|+|||
T Consensus       123 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  198 (313)
T 3cek_A          123 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE  198 (313)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHH
Confidence            5899999999999999999999999   999999999999974 789999999998765443333333456899999999


Q ss_pred             hhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHH
Q 009186          395 YAME-----------GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDA  463 (541)
Q Consensus       395 ~l~~-----------~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  463 (541)
                      .+.+           ..++.++||||||+++|||++|+.||.....     .............         ....+..
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~---------~~~~~~~  264 (313)
T 3cek_A          199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNH---------EIEFPDI  264 (313)
T ss_dssp             HHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTS---------CCCCCCC
T ss_pred             HHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHhccc---------ccCCccc
Confidence            9875           4688899999999999999999999853211     1111111111111         0011111


Q ss_pred             HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          464 ELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       464 ~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ....+.+++.+||+.||.+||++.|+++
T Consensus       265 ~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          265 PEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            1245677888999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.91  E-value=3.5e-26  Score=232.12  Aligned_cols=187  Identities=18%  Similarity=0.198  Sum_probs=114.1

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC---CCcEEe
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKIS  364 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~---~~~kL~  364 (541)
                      +++++++.++.|...+++     .....+++.+++.++.||+.||.|||+++   |+||||||+||+++.+   +.+||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~-----~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEECCTTEEHHHHHHT-----C-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEeccCCCCHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEe
Confidence            344566666666544432     12346999999999999999999999999   9999999999999864   459999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||+++......    .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||........   .........
T Consensus       174 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~  246 (336)
T 3fhr_A          174 DFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIR  246 (336)
T ss_dssp             CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred             ccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhh
Confidence            999998654322    2234678999999999888899999999999999999999999853322111   000000000


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      ...      ..............+.+++.+||+.||.+|||+.|+++  .++.
T Consensus       247 ~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          247 LGQ------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ccc------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            000      00000001122345778889999999999999999997  5554

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=1.1e-24  Score=221.32  Aligned_cols=169  Identities=22%  Similarity=0.216  Sum_probs=122.2

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC--CcEEecccccccccCCCCc--ccccccccCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM--NPKISDFGMARIFSGNQNE--ANTNRVAGTY  388 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~  388 (541)
                      ...+++..++.++.||+.||+|||+++   |+||||||+||+++.++  .+||+|||+++.+......  .......||+
T Consensus       162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~  238 (345)
T 3hko_A          162 DFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP  238 (345)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCG
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCc
Confidence            345788899999999999999999999   99999999999998776  8999999999865432211  1233456899


Q ss_pred             CCCChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHH
Q 009186          389 GYMAPEYAME--GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELL  466 (541)
Q Consensus       389 ~y~aPE~l~~--~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  466 (541)
                      .|+|||.+.+  ..++.++||||||+++|||++|+.||....      ..+.............  .+..     .....
T Consensus       239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~--~~~~-----~~~~~  305 (345)
T 3hko_A          239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN------DADTISQVLNKKLCFE--NPNY-----NVLSP  305 (345)
T ss_dssp             GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCTT--SGGG-----GGSCH
T ss_pred             cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------hHHHHHHHHhcccccC--Cccc-----ccCCH
Confidence            9999999975  678999999999999999999999984322      1122222222211111  1110     11234


Q ss_pred             HHHHHHhhhcccCCCCCCCHHHHHH--HHhcCC
Q 009186          467 KCIHIGLLCVQEDPAHRPNMSSVVV--MLASDT  497 (541)
Q Consensus       467 ~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~  497 (541)
                      .+.+++.+||+.||.+||++.++++  .+++..
T Consensus       306 ~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          306 LARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            5677888999999999999999986  455443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.91  E-value=1.8e-25  Score=226.22  Aligned_cols=171  Identities=23%  Similarity=0.337  Sum_probs=118.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.......  ......++..|+||
T Consensus       119 ~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aP  193 (331)
T 4aaa_A          119 NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAP  193 (331)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCc
Confidence            35899999999999999999999999   99999999999999999999999999976543322  12235689999999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHH----------HHHhhhcCCccc-cccccccCCCC
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTY----------AWKLWCKGEALE-LMDPVLKQTCV  461 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~~~-~~~~~l~~~~~  461 (541)
                      |.+.+. .++.++||||||+++|||++|+.||.......  .....          .+..+....... ...+.+.....
T Consensus       194 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
T 4aaa_A          194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREP  271 (331)
T ss_dssp             HHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCC
T ss_pred             ccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhhhccccccccCccccccch
Confidence            999875 68999999999999999999999985432111  01000          001111111000 00011110000


Q ss_pred             -----HHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          462 -----DAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       462 -----~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                           +.....+.+++.+||+.||++|||+.|+++
T Consensus       272 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          272 LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 112456788999999999999999999885

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.91  E-value=5e-25  Score=217.00  Aligned_cols=156  Identities=28%  Similarity=0.424  Sum_probs=100.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||+|||+++   |+|+||||+||+++.++.+||+|||++........  ......|+..|+||
T Consensus       107 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  181 (278)
T 3cok_A          107 KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISP  181 (278)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCc
Confidence            46899999999999999999999999   99999999999999999999999999986543221  12235688999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|||++|+.||........   .   .... .   .   +..+..    .....+.+++.
T Consensus       182 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~-~---~---~~~~~~----~~~~~~~~li~  244 (278)
T 3cok_A          182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L---NKVV-L---A---DYEMPS----FLSIEAKDLIH  244 (278)
T ss_dssp             ----------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-S---S---CCCCCT----TSCHHHHHHHH
T ss_pred             chhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H---HHHh-h---c---ccCCcc----ccCHHHHHHHH
Confidence            999988899999999999999999999999854321110   0   0000 0   0   001111    12345677889


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+.||++||+++++++
T Consensus       245 ~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          245 QLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHSCSSGGGSCCHHHHTT
T ss_pred             HHcccCHhhCCCHHHHhc
Confidence            999999999999999885

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.91  E-value=6e-25  Score=222.00  Aligned_cols=168  Identities=19%  Similarity=0.211  Sum_probs=120.5

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      +++.++..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.......   .....++..|+|||
T Consensus       127 ~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE  200 (330)
T 3nsz_A          127 LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE  200 (330)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChh
Confidence            889999999999999999999999   99999999999999777 799999999986543332   22346888999999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH---------hhhcCC--------------ccc
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK---------LWCKGE--------------ALE  450 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~--------------~~~  450 (541)
                      .+.+ ..++.++||||||+++|||++|+.||.......  ..+.....         .+....              ...
T Consensus       201 ~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (330)
T 3nsz_A          201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRK  278 (330)
T ss_dssp             HHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCC
T ss_pred             hhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhcccc
Confidence            9887 668999999999999999999999984322110  11110000         000000              000


Q ss_pred             cccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          451 LMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       451 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .................+.+++.+||+.||++|||++|+++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          279 RWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00011111111112456788999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.91  E-value=3.9e-25  Score=231.29  Aligned_cols=178  Identities=24%  Similarity=0.296  Sum_probs=123.6

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC---CcEEec
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM---NPKISD  365 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~---~~kL~D  365 (541)
                      ++++++..+.|...+.       +...+++.++..++.||+.||+|||+++   |+||||||+|||++.++   .+||+|
T Consensus       216 lv~e~~~~g~L~~~l~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          216 IVLELMEGGELFDKVV-------GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             EEEECCTTCBGGGGTS-------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             EEEEcCCCCcHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence            4556666666644432       2346999999999999999999999999   99999999999997554   599999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAME---GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      ||+++......   ......||+.|+|||++.+   ..++.++||||||+++|+|++|+.||......  .......   
T Consensus       286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i---  357 (419)
T 3i6u_A          286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQI---  357 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHH---
T ss_pred             cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHH---
Confidence            99998764322   2234578999999999853   56889999999999999999999998533211  1121111   


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       ..+.. ... +....    .....+.+++.+||+.||++||++.|+++
T Consensus       358 -~~~~~-~~~-~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          358 -TSGKY-NFI-PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -HTTCC-CCC-HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -hcCCC-CCC-chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             11111 000 11111    11345778899999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.91  E-value=1.4e-24  Score=214.40  Aligned_cols=162  Identities=21%  Similarity=0.261  Sum_probs=122.0

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC---cEEecccccccccCCCCcccccccccCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN---PKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~---~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      .+++.++..++.||+.||.|||+++   |+||||||+||+++.++.   +||+|||++........   .....|+..|+
T Consensus       101 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~  174 (284)
T 3kk8_A          101 FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYL  174 (284)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCc
Confidence            5899999999999999999999999   999999999999987665   99999999976543322   22356899999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |||.+.+..++.++||||||+++|+|++|+.||....      ..... .....+... ...+.     .......+.++
T Consensus       175 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~-~~~~~~~~~-~~~~~-----~~~~~~~~~~l  241 (284)
T 3kk8_A          175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHRLY-AQIKAGAYD-YPSPE-----WDTVTPEAKSL  241 (284)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH-HHHHHTCCC-CCTTT-----TTTSCHHHHHH
T ss_pred             CchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc------hhHHH-HHHHhcccc-CCchh-----hcccCHHHHHH
Confidence            9999999999999999999999999999999984321      11111 111111110 00000     01112356778


Q ss_pred             HhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      +.+||+.||++|||+.|+++  .+++
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~  267 (284)
T 3kk8_A          242 IDSMLTVNPKKRITADQALKVPWICN  267 (284)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred             HHHHcccChhhCCCHHHHhcCccccC
Confidence            88999999999999999986  4544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.91  E-value=1.7e-24  Score=222.79  Aligned_cols=172  Identities=22%  Similarity=0.209  Sum_probs=116.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......   ......||..|+|||
T Consensus       123 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE  196 (371)
T 2xrw_A          123 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE  196 (371)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHH
Confidence            3889999999999999999999999   9999999999999999999999999998654322   122356899999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh-------------------hhcCC------cc
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL-------------------WCKGE------AL  449 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~-------------------~~~~~------~~  449 (541)
                      .+.+..++.++||||||+++|||++|+.||......   .........                   .....      ..
T Consensus       197 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (371)
T 2xrw_A          197 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFE  273 (371)
T ss_dssp             HHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHH
T ss_pred             HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchh
Confidence            999999999999999999999999999998532211   000000000                   00000      00


Q ss_pred             ccccccccCCC---CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          450 ELMDPVLKQTC---VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       450 ~~~~~~l~~~~---~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      +.+........   .......+.+|+.+||+.||++|||++|+++  .++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          274 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             HHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence            00000000000   1123557889999999999999999999996  4553

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.91  E-value=1.4e-24  Score=218.77  Aligned_cols=159  Identities=20%  Similarity=0.214  Sum_probs=122.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC----CcEEecccccccccCCCCcccccccccCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM----NPKISDFGMARIFSGNQNEANTNRVAGTYG  389 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~----~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~  389 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++.++    .+||+|||++........   .....|+..
T Consensus       110 ~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~  183 (321)
T 2a2a_A          110 ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPE  183 (321)
T ss_dssp             SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCC
Confidence            45899999999999999999999999   99999999999999888    799999999987654322   223568999


Q ss_pred             CCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHH
Q 009186          390 YMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCI  469 (541)
Q Consensus       390 y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  469 (541)
                      |+|||.+.+..++.++||||||+++|+|++|+.||....      ..+.... +.....  ..++.....    ....+.
T Consensus       184 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~-i~~~~~--~~~~~~~~~----~~~~~~  250 (321)
T 2a2a_A          184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLAN-ITSVSY--DFDEEFFSH----TSELAK  250 (321)
T ss_dssp             GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHH-HHTTCC--CCCHHHHTT----CCHHHH
T ss_pred             ccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC------HHHHHHH-HHhccc--ccChhhhcc----cCHHHH
Confidence            999999999999999999999999999999999984321      1111111 111110  011111111    123567


Q ss_pred             HHHhhhcccCCCCCCCHHHHHH
Q 009186          470 HIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       470 ~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +++.+||+.||++|||+.|+++
T Consensus       251 ~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          251 DFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhc
Confidence            8889999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.91  E-value=7.3e-25  Score=224.86  Aligned_cols=175  Identities=23%  Similarity=0.306  Sum_probs=123.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aP  393 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++......... ......||+.|+||
T Consensus       124 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  200 (364)
T 3qyz_A          124 HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP  200 (364)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCC
Confidence            4899999999999999999999999   9999999999999999999999999998754332211 12345789999999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcc-----------cccccc-ccCCC
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEAL-----------ELMDPV-LKQTC  460 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~-l~~~~  460 (541)
                      |.+.+ ..++.++||||||+++|||++|+.||......   ................           ...... .....
T Consensus       201 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (364)
T 3qyz_A          201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV  277 (364)
T ss_dssp             HHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG---GHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCC
T ss_pred             HHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCC
Confidence            98765 45899999999999999999999998543221   1111111111000000           000000 00000


Q ss_pred             -----CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          461 -----VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       461 -----~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                           .......+.+|+.+||+.||++|||+.|+++  .++.
T Consensus       278 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  319 (364)
T 3qyz_A          278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  319 (364)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             CHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence                 0112345778999999999999999999996  4444

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.91  E-value=7.7e-25  Score=220.70  Aligned_cols=168  Identities=24%  Similarity=0.275  Sum_probs=122.5

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++......   ......++..|+|||
T Consensus       116 ~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE  189 (326)
T 1blx_A          116 GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPE  189 (326)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHH
Confidence            4899999999999999999999999   9999999999999999999999999997654221   223456899999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC---Cccc-------ccc---ccccCCCC
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG---EALE-------LMD---PVLKQTCV  461 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-------~~~---~~l~~~~~  461 (541)
                      .+.+..++.++||||||+++|||++|+.||.....   ..............   .+..       .+.   ........
T Consensus       190 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 1blx_A          190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV  266 (326)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTC
T ss_pred             HHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhcc
Confidence            99999999999999999999999999999853221   11111111111000   0000       000   00000011


Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          462 DAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       462 ~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ......+.+++.+||+.||++||++.++++
T Consensus       267 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          267 TDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            122345678889999999999999999984

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.91  E-value=3e-24  Score=225.46  Aligned_cols=108  Identities=27%  Similarity=0.464  Sum_probs=89.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc---------------
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE---------------  378 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---------------  378 (541)
                      ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++........               
T Consensus       124 ~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~  200 (432)
T 3n9x_A          124 IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH  200 (432)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC---------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccccccccccc
Confidence            45999999999999999999999999   999999999999999999999999999876433211               


Q ss_pred             -----ccccccccCCCCCChhhh-ccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 009186          379 -----ANTNRVAGTYGYMAPEYA-MEGVFSVKSDVFSFGVLLLEIISGKRNS  424 (541)
Q Consensus       379 -----~~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwSlGvll~elltg~~p~  424 (541)
                           .......||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus       201 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ----------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence                 112446789999999986 4566999999999999999999866554

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.91  E-value=4e-25  Score=220.63  Aligned_cols=158  Identities=28%  Similarity=0.455  Sum_probs=123.3

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.........  .....|+..|+||
T Consensus       114 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aP  188 (303)
T 3a7i_A          114 GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAP  188 (303)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--BCCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccc--cCccCCCcCccCH
Confidence            35899999999999999999999999   999999999999999999999999999876543322  2335688999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|+|++|+.||....      ....... ......     +.+....    ...+.+++.
T Consensus       189 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~-~~~~~~-----~~~~~~~----~~~l~~li~  252 (303)
T 3a7i_A          189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------PMKVLFL-IPKNNP-----PTLEGNY----SKPLKEFVE  252 (303)
T ss_dssp             HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHH-HHHSCC-----CCCCSSC----CHHHHHHHH
T ss_pred             HHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC------HHHHHHH-hhcCCC-----CCCcccc----CHHHHHHHH
Confidence            99999999999999999999999999999975321      1111111 111111     1111222    235777888


Q ss_pred             hhcccCCCCCCCHHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVVM  492 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~~  492 (541)
                      +||+.||.+|||+.++++.
T Consensus       253 ~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTC
T ss_pred             HHcCCChhhCcCHHHHhhC
Confidence            9999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.91  E-value=6.8e-25  Score=223.75  Aligned_cols=176  Identities=26%  Similarity=0.288  Sum_probs=121.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc--------ccccccc
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA--------NTNRVAG  386 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--------~~~~~~g  386 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.........        ......|
T Consensus       108 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~g  184 (353)
T 2b9h_A          108 MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA  184 (353)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccc
Confidence            5899999999999999999999999   9999999999999999999999999998764332111        1123468


Q ss_pred             CCCCCChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC---cccccc-c-------
Q 009186          387 TYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE---ALELMD-P-------  454 (541)
Q Consensus       387 t~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-~-------  454 (541)
                      |..|+|||.+.+ ..++.++||||||+++|||++|+.||......   ..............   ....+. .       
T Consensus       185 t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (353)
T 2b9h_A          185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFGIIGTPHSDNDLRCIESPRAREYIK  261 (353)
T ss_dssp             CGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHH
T ss_pred             cccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCchhccccccccchhhHHhh
Confidence            999999998765 67899999999999999999999998533211   11111111110000   000000 0       


Q ss_pred             cc---cC----CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcC
Q 009186          455 VL---KQ----TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASD  496 (541)
Q Consensus       455 ~l---~~----~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~  496 (541)
                      .+   ..    ...+.....+.+++.+||+.||++|||+.++++  .++..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          262 SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             cccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            00   00    000112345678899999999999999999986  45543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.91  E-value=5e-24  Score=213.67  Aligned_cols=159  Identities=25%  Similarity=0.350  Sum_probs=122.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++........  ......|+..|+||
T Consensus       120 ~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  194 (314)
T 3com_A          120 KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAP  194 (314)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccCh
Confidence            45899999999999999999999999   99999999999999999999999999976543322  12235688999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      |.+.+..++.++||||||+++|+|++|+.||....      ........... .......       +......+.+++.
T Consensus       195 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~~~~-------~~~~~~~l~~li~  260 (314)
T 3com_A          195 EVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH------PMRAIFMIPTN-PPPTFRK-------PELWSDNFTDFVK  260 (314)
T ss_dssp             HHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS-CCCCCSS-------GGGSCHHHHHHHH
T ss_pred             hhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcC-CCcccCC-------cccCCHHHHHHHH
Confidence            99999899999999999999999999999985321      11111111111 1111100       1112345778889


Q ss_pred             hhcccCCCCCCCHHHHHH
Q 009186          474 LCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~  491 (541)
                      +||+.||.+|||+.++++
T Consensus       261 ~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTT
T ss_pred             HHccCChhhCcCHHHHHh
Confidence            999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.91  E-value=6.2e-26  Score=232.32  Aligned_cols=124  Identities=27%  Similarity=0.419  Sum_probs=100.8

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++++..+.|...+++       ...+++..+..++.||+.||.|||++ +   |+||||||+||+++.++.+||+|||
T Consensus       108 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             EEECCCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEECCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECC
Confidence            34555555555443332       23589999999999999999999996 8   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      ++......    ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       178 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          178 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             CCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             CCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            98754321    12235689999999999999999999999999999999999999854

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.91  E-value=2e-24  Score=220.79  Aligned_cols=170  Identities=19%  Similarity=0.185  Sum_probs=122.9

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhh--hcCCCceEecccCCCcEEEcC-CCCcEEecccccccccCCCCcccccccccCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLH--EDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVAGTYG  389 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH--~~~~~~ivH~DLkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~  389 (541)
                      ...+++..+..++.||+.||.|||  +.+   |+||||||+|||++. ++.+||+|||+++.......   .....||..
T Consensus       123 ~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~  196 (360)
T 3e3p_A          123 QVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRY  196 (360)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcc
Confidence            446899999999999999999999  888   999999999999997 88999999999987654332   223467999


Q ss_pred             CCChhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc-----------C-Ccccccc---
Q 009186          390 YMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK-----------G-EALELMD---  453 (541)
Q Consensus       390 y~aPE~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~-~~~~~~~---  453 (541)
                      |+|||.+.+.. ++.++||||||+++|||++|+.||......   .......+....           . ......+   
T Consensus       197 y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (360)
T 3e3p_A          197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKG  273 (360)
T ss_dssp             GCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCC
T ss_pred             eeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHHHHcCCCCHHHHHhcccchhhcccccccc
Confidence            99999987654 899999999999999999999998542211   111111111000           0 0000000   


Q ss_pred             ---ccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          454 ---PVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       454 ---~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                         ..............+.+|+.+||+.||.+|||+.|+++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          274 IPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence               00001111123567888999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.91  E-value=2.2e-24  Score=214.22  Aligned_cols=159  Identities=27%  Similarity=0.380  Sum_probs=123.6

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++........  ......|+..|+|||
T Consensus       111 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  185 (294)
T 2rku_A          111 ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPE  185 (294)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcc
Confidence            5899999999999999999999999   99999999999999999999999999987543322  123356899999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhh
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL  474 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  474 (541)
                      .+.+..++.++||||||+++|+|++|+.||....      ..+. .........      .+...    ....+.+++.+
T Consensus       186 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~-~~~~~~~~~------~~~~~----~~~~~~~li~~  248 (294)
T 2rku_A          186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKET-YLRIKKNEY------SIPKH----INPVAASLIQK  248 (294)
T ss_dssp             HHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHH-HHHHHTTCC------CCCTT----SCHHHHHHHHH
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHH-HHHHhhccC------CCccc----cCHHHHHHHHH
Confidence            9998889999999999999999999999985322      1111 111111111      11111    12356678889


Q ss_pred             hcccCCCCCCCHHHHHH--HHhc
Q 009186          475 CVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       475 cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      ||+.||++|||+.++++  .+.+
T Consensus       249 ~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          249 MLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HcccChhhCcCHHHHhhChheec
Confidence            99999999999999996  4443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.91  E-value=4.3e-26  Score=251.20  Aligned_cols=163  Identities=25%  Similarity=0.318  Sum_probs=123.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........ ......++..|+||
T Consensus       486 ~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aP  561 (656)
T 2j0j_A          486 FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAP  561 (656)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCH
Confidence            45899999999999999999999999   999999999999999999999999999876443222 12234567889999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..++.++||||||+++|||++ |..||.....      .+.... ...+....     +    +......+.+++
T Consensus       562 E~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~~~~~~-i~~~~~~~-----~----~~~~~~~l~~li  625 (656)
T 2j0j_A          562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGR-IENGERLP-----M----PPNCPPTLYSLM  625 (656)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHH-HHHTCCCC-----C----CTTCCHHHHHHH
T ss_pred             HHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHH-HHcCCCCC-----C----CccccHHHHHHH
Confidence            99999999999999999999999997 8989753211      111111 11111111     1    112234577888


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.||++||++.+|++.|+..
T Consensus       626 ~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          626 TKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999999763

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.91  E-value=1.6e-24  Score=221.86  Aligned_cols=169  Identities=21%  Similarity=0.228  Sum_probs=114.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++......   ......++..|+||
T Consensus       129 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aP  202 (362)
T 3pg1_A          129 IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAP  202 (362)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCc
Confidence            46899999999999999999999999   9999999999999999999999999997543322   22335688899999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcc-----------cccccccc----
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEAL-----------ELMDPVLK----  457 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~l~----  457 (541)
                      |.+.+ ..++.++||||||+++|+|++|+.||......   ................           +.+...+.    
T Consensus       203 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (362)
T 3pg1_A          203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA  279 (362)
T ss_dssp             HHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC
T ss_pred             HHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh
Confidence            99877 67899999999999999999999998532211   1111111111000000           00000000    


Q ss_pred             ---CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          458 ---QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       458 ---~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                         ....+.....+.+++.+||+.||++|||+.|+++
T Consensus       280 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          280 RAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence               0001112345778999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.91  E-value=8.4e-25  Score=220.78  Aligned_cols=162  Identities=29%  Similarity=0.400  Sum_probs=103.6

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ...+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||+++.......   .....|+..|+
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~  192 (327)
T 3aln_A          119 DDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYM  192 (327)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------
T ss_pred             cccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCcccc
Confidence            34689999999999999999999998 8   99999999999999999999999999976543321   22346899999


Q ss_pred             Chhhh----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          392 APEYA----MEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       392 aPE~l----~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      |||.+    .+..++.++||||||+++|||++|+.||......     .+.. .....+.     .+.+...........
T Consensus       193 aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~-~~~~~~~-----~~~~~~~~~~~~~~~  261 (327)
T 3aln_A          193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQL-TQVVKGD-----PPQLSNSEEREFSPS  261 (327)
T ss_dssp             -------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSC-----CCCCCCCSSCCCCHH
T ss_pred             CceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHH-HHHhcCC-----CCCCCCcccccCCHH
Confidence            99998    4566899999999999999999999998532111     0000 0000111     111111111122346


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHH
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+++.+||+.||.+||++.+|++
T Consensus       262 l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          262 FINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhhCChhhCcCHHHHHh
Confidence            778889999999999999999975

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.91  E-value=2.7e-24  Score=211.66  Aligned_cols=157  Identities=19%  Similarity=0.209  Sum_probs=118.8

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE---cCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+||++   +.++.+||+|||++........   .....+|..|+
T Consensus       102 ~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~  175 (277)
T 3f3z_A          102 VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYV  175 (277)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCcc
Confidence            4899999999999999999999999   9999999999999   7888999999999987543322   22356899999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |||.+.+ .++.++||||||+++|||++|+.||.....      .+.... ...+....  ......    .....+.++
T Consensus       176 aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~--~~~~~~----~~~~~~~~l  241 (277)
T 3f3z_A          176 SPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD------SEVMLK-IREGTFTF--PEKDWL----NVSPQAESL  241 (277)
T ss_dssp             CHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHHCCCCC--CHHHHT----TSCHHHHHH
T ss_pred             ChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH------HHHHHH-HHhCCCCC--Cchhhh----cCCHHHHHH
Confidence            9998865 489999999999999999999999853211      111111 11111100  000000    113456788


Q ss_pred             HhhhcccCCCCCCCHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+||+.||++||++.++++
T Consensus       242 i~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          242 IRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            89999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.91  E-value=6.8e-24  Score=210.28  Aligned_cols=158  Identities=23%  Similarity=0.347  Sum_probs=119.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc-CCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..++.++.||+.||.|||+.+ .+|+|+||||+||+++ .++.+||+|||++......    ......|+..|+|
T Consensus       124 ~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~a  198 (290)
T 1t4h_A          124 KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMA  198 (290)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCC
Confidence            35899999999999999999999975 2499999999999998 7889999999999754322    1223568999999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+. +.++.++||||||+++|+|++|+.||....     .... .......+......    ...    ....+.+++
T Consensus       199 PE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~-~~~~~~~~~~~~~~----~~~----~~~~l~~li  263 (290)
T 1t4h_A          199 PEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQ-IYRRVTSGVKPASF----DKV----AIPEVKEII  263 (290)
T ss_dssp             GGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHH-HHHHHTTTCCCGGG----GGC----CCHHHHHHH
T ss_pred             HHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-----cHHH-HHHHHhccCCcccc----CCC----CCHHHHHHH
Confidence            99876 568999999999999999999999985321     1111 11112121111111    111    123577888


Q ss_pred             hhhcccCCCCCCCHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~  491 (541)
                      .+||+.||.+|||+.++++
T Consensus       264 ~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          264 EGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHSCSSGGGSCCHHHHHT
T ss_pred             HHHccCChhhCCCHHHHhh
Confidence            9999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.91  E-value=5.9e-25  Score=223.74  Aligned_cols=191  Identities=20%  Similarity=0.279  Sum_probs=133.2

Q ss_pred             HHHHHHHHHhhheecccccc-ccCCCCccccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCCcEEec
Q 009186          288 TTITLFILLGSFVWCRRRIN-KDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISD  365 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~-~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~~kL~D  365 (541)
                      +++++++..+.|....+... -.......+++..++.++.||+.||.|||+ .+   |+|+||||+||+++.++.+||+|
T Consensus       119 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~d  195 (348)
T 2pml_X          119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSD  195 (348)
T ss_dssp             EEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEec
Confidence            34556666667654422110 112225679999999999999999999999 88   99999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEG-VFSV-KSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      ||.+......    ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||......  ...    ...+
T Consensus       196 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~----~~~i  265 (348)
T 2pml_X          196 FGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VEL----FNNI  265 (348)
T ss_dssp             CTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHH----HHHH
T ss_pred             cccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH----HHHH
Confidence            9999875433    22345689999999999877 6666 999999999999999999998533221  111    1111


Q ss_pred             hcCCcccc------cccccc---CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          444 CKGEALEL------MDPVLK---QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       444 ~~~~~~~~------~~~~l~---~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..+.....      ..+...   ..........+.+++.+||+.||.+||++.|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111000      000000   0000122346778899999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.91  E-value=2.3e-25  Score=237.51  Aligned_cols=162  Identities=25%  Similarity=0.325  Sum_probs=122.2

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE---cCCCCcEEecccccccccCCCCcccccccccCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY  390 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  390 (541)
                      ..+++.+++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.+.....   .....||+.|
T Consensus       121 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y  194 (484)
T 3nyv_A          121 KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYY  194 (484)
T ss_dssp             SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccc
Confidence            45899999999999999999999999   9999999999999   5678899999999987644322   2335689999


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +|||.+.+ .++.++||||||+++|+|++|+.||....      ..+.... +..+...-.. +..     ......+.+
T Consensus       195 ~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~-i~~~~~~~~~-~~~-----~~~s~~~~~  260 (484)
T 3nyv_A          195 IAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN------EYDILKK-VEKGKYTFEL-PQW-----KKVSESAKD  260 (484)
T ss_dssp             CCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH-HHHCCCCCCS-GGG-----GGSCHHHHH
T ss_pred             cCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC------HHHHHHH-HHcCCCCCCC-ccc-----ccCCHHHHH
Confidence            99999865 68999999999999999999999985321      1111111 1121111000 100     112345678


Q ss_pred             HHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      ++.+||+.||.+|||+.++++  +++.
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            889999999999999999995  4554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.91  E-value=3.7e-24  Score=220.21  Aligned_cols=165  Identities=21%  Similarity=0.280  Sum_probs=117.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.....     .....+|..|+|||
T Consensus       140 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE  211 (371)
T 4exu_A          140 EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPE  211 (371)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHH
Confidence            3899999999999999999999999   999999999999999999999999999865322     22356799999999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcccc---------------ccccccC
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALEL---------------MDPVLKQ  458 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~l~~  458 (541)
                      .+.+ ..++.++||||||+++|+|++|+.||.....   ............. ...+.               +......
T Consensus       212 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (371)
T 4exu_A          212 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGV-PGTEFVQKLNDKAAKSYIQSLPQTPRK  287 (371)
T ss_dssp             HHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC-CCHHHHTTCSCHHHHHHHHHSCCCCCC
T ss_pred             HhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC-CcHHHHHHhhhhhhhhhhhccCCCcch
Confidence            9987 6789999999999999999999999853221   1111111110000 00000               0000000


Q ss_pred             ---CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          459 ---TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       459 ---~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                         ...+.....+.+|+.+||+.||++|||+.|+++
T Consensus       288 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          288 DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence               000112356778999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.91  E-value=4.7e-25  Score=235.20  Aligned_cols=164  Identities=24%  Similarity=0.313  Sum_probs=121.0

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc---CCCCcEEecccccccccCCCCcccccccccCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGY  390 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~---~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  390 (541)
                      ..+++.++..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++.+.....   .....||+.|
T Consensus       116 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y  189 (486)
T 3mwu_A          116 KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY  189 (486)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCCC
Confidence            35899999999999999999999999   99999999999995   456799999999987644322   2235689999


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +|||++.+ .++.++|||||||++|+|++|+.||....      ..+.... +..+...... +..     ......+.+
T Consensus       190 ~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~-i~~~~~~~~~-~~~-----~~~s~~~~~  255 (486)
T 3mwu_A          190 IAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN------EYDILKR-VETGKYAFDL-PQW-----RTISDDAKD  255 (486)
T ss_dssp             CCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH-HHHTCCCSCS-GGG-----GGSCHHHHH
T ss_pred             CCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHH-HHhCCCCCCC-ccc-----CCCCHHHHH
Confidence            99999865 58999999999999999999999984321      1111111 1111111000 100     112345678


Q ss_pred             HHhhhcccCCCCCCCHHHHHH--HHhcCC
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV--MLASDT  497 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~--~L~~~~  497 (541)
                      ++.+||+.||.+|||+.++++  .++...
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            889999999999999999997  455543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.90  E-value=5.6e-25  Score=235.10  Aligned_cols=176  Identities=24%  Similarity=0.295  Sum_probs=126.8

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC---CCcEEec
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKISD  365 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~---~~~kL~D  365 (541)
                      ++++++..+.|...+.+       ...+++.++..++.||+.||.|||+++   |+||||||+|||++..   +.+||+|
T Consensus       113 lv~e~~~~g~L~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          113 LVMECYKGGELFDEIIH-------RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             EEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEecCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence            34555555555433322       235899999999999999999999999   9999999999999764   4599999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||++..+.....   .....||+.|+|||++. +.++.++|||||||++|+|++|+.||....      ..+.. ..+..
T Consensus       183 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~-~~i~~  251 (494)
T 3lij_A          183 FGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT------DQEIL-RKVEK  251 (494)
T ss_dssp             CTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH-HHHHH
T ss_pred             CCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHH-HHHHh
Confidence            999987654322   23356899999999876 568999999999999999999999985322      11111 11111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +... ...+.. .    .....+.+++.+||+.||.+|||+.++++
T Consensus       252 ~~~~-~~~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          252 GKYT-FDSPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             TCCC-CCSGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCC-CCchhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            1111 001111 1    11235677888999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.90  E-value=2.8e-24  Score=213.34  Aligned_cols=159  Identities=27%  Similarity=0.403  Sum_probs=117.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-CCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..+..++.||+.||.|||+++   |+|+||||+||+++. ++.+||+|||++........  ......|+..|+|
T Consensus       117 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~a  191 (295)
T 2clq_A          117 LKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMA  191 (295)
T ss_dssp             CTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCC
T ss_pred             CCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccC
Confidence            34678999999999999999999999   999999999999987 88999999999986543221  1223568899999


Q ss_pred             hhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          393 PEYAMEGV--FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       393 PE~l~~~~--~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      ||.+.+..  ++.++||||||+++|+|++|+.||......    .. .........     ..+.+..    .....+.+
T Consensus       192 PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~-~~~~~~~~~-----~~~~~~~----~~~~~~~~  257 (295)
T 2clq_A          192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP----QA-AMFKVGMFK-----VHPEIPE----SMSAEAKA  257 (295)
T ss_dssp             HHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH----HH-HHHHHHHHC-----CCCCCCT----TSCHHHHH
T ss_pred             hhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch----hH-HHHhhcccc-----ccccccc----cCCHHHHH
Confidence            99997654  789999999999999999999998432111    11 111110000     1111111    22345677


Q ss_pred             HHhhhcccCCCCCCCHHHHHH
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ++.+||+.||++||++.++++
T Consensus       258 li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          258 FILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHccCChhhCCCHHHHhc
Confidence            888999999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.90  E-value=3.7e-24  Score=211.24  Aligned_cols=158  Identities=20%  Similarity=0.233  Sum_probs=118.5

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC----CcEEecccccccccCCCCcccccccccCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM----NPKISDFGMARIFSGNQNEANTNRVAGTYGY  390 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~----~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  390 (541)
                      .+++.+++.++.||+.||.|||+++   |+|+||||+||+++.++    .+||+|||++........   .....++..|
T Consensus       104 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y  177 (283)
T 3bhy_A          104 SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEF  177 (283)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCc
Confidence            5899999999999999999999999   99999999999998877    799999999986543321   2234688999


Q ss_pred             CChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          391 MAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       391 ~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      +|||.+.+..++.++||||||+++|+|++|+.||....      ..+. ...+......  ........    ....+.+
T Consensus       178 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~-~~~~~~~~~~--~~~~~~~~----~~~~~~~  244 (283)
T 3bhy_A          178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET------KQET-LTNISAVNYD--FDEEYFSN----TSELAKD  244 (283)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHH-HHHHHTTCCC--CCHHHHTT----CCHHHHH
T ss_pred             cCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc------hHHH-HHHhHhcccC--Ccchhccc----CCHHHHH
Confidence            99999998899999999999999999999999985321      1111 1111111100  01111111    1245678


Q ss_pred             HHhhhcccCCCCCCCHHHHHH
Q 009186          471 IGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ++.+||+.||++||++.++++
T Consensus       245 li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          245 FIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHh
Confidence            889999999999999999996

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.90  E-value=4e-24  Score=178.17  Aligned_cols=92  Identities=21%  Similarity=0.425  Sum_probs=86.0

Q ss_pred             CCchhHHHHHHHHHHHHHHhhccccceeeeeeccCCCccEEEEEEeccCCChhhhHHHHHHHHhcccccCCCccceEEEC
Q 009186          154 PSRSFDQFVWNSMNEAVNQALSTTKMFATVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVMY  233 (541)
Q Consensus       154 ~~~~f~~~~~~l~~~l~~~a~~~~~~~a~~~~~~~~~~~vyglaQC~~Dls~~~C~~CL~~a~~~~~~~c~~~~g~~v~~  233 (541)
                      +++.|++++..||..|..+++.++.+|+++.....+.++||||+||||||++++|+.||+.++.++.++|++++||+||+
T Consensus        17 ~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~   96 (108)
T 3a2e_A           17 SGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQL   96 (108)
T ss_dssp             TTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSBSSEEEEE
T ss_pred             CCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCCceEEEEC
Confidence            34789999999999999999888788888877666778999999999999999999999999999999999999999999


Q ss_pred             CCcceeeccccc
Q 009186          234 PSCNFRYELYQF  245 (541)
Q Consensus       234 ~~C~lRye~~~F  245 (541)
                      ++|+||||.|+|
T Consensus        97 ~~C~lRY~~~~F  108 (108)
T 3a2e_A           97 VDCFIQYEQRSF  108 (108)
T ss_dssp             TTEEEEEESSCC
T ss_pred             CCEEEEEeCCcC
Confidence            999999999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.90  E-value=1.5e-24  Score=227.81  Aligned_cols=160  Identities=29%  Similarity=0.393  Sum_probs=112.8

Q ss_pred             cHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-------------CCcEEecccccccccCCCCcc--cc
Q 009186          317 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-------------MNPKISDFGMARIFSGNQNEA--NT  381 (541)
Q Consensus       317 ~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-------------~~~kL~Dfg~a~~~~~~~~~~--~~  381 (541)
                      ++..++.++.||+.||+|||+++   |+||||||+|||++.+             +.+||+|||+++.........  ..
T Consensus       113 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~  189 (434)
T 2rio_A          113 KEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL  189 (434)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC---------
T ss_pred             cchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeee
Confidence            45567889999999999999999   9999999999999754             479999999998765433221  12


Q ss_pred             cccccCCCCCChhhhcc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCcccccc
Q 009186          382 NRVAGTYGYMAPEYAME-------GVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMD  453 (541)
Q Consensus       382 ~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (541)
                      ....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......    ...    .........   
T Consensus       190 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~~----i~~~~~~~~---  258 (434)
T 2rio_A          190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----ESN----IIRGIFSLD---  258 (434)
T ss_dssp             -----CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----HHH----HHHTCCCCC---
T ss_pred             cCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----HHH----HhcCCCCcc---
Confidence            34578999999999975       568999999999999999999 99998532211    111    111100000   


Q ss_pred             ccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          454 PVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       454 ~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       .+...........+.+++.+||+.||.+|||+.+|++
T Consensus       259 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          259 -EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence             1111123345567889999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.90  E-value=7.6e-24  Score=212.51  Aligned_cols=159  Identities=26%  Similarity=0.370  Sum_probs=111.5

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..++.++.||+.||.|||++ +   |+|+||||+||+++.++.+||+|||++........   .....++..|+|
T Consensus       119 ~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~a  192 (318)
T 2dyl_A          119 GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMA  192 (318)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccC
Confidence            3589999999999999999999995 8   99999999999999999999999999876543321   223468999999


Q ss_pred             hhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          393 PEYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       393 PE~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      ||.+.     ...++.++||||||+++|||++|+.||.....     ..+........ ....     +...  ......
T Consensus       193 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~-~~~~-----~~~~--~~~~~~  259 (318)
T 2dyl_A          193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQE-EPPL-----LPGH--MGFSGD  259 (318)
T ss_dssp             HHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHS-CCCC-----CCSS--SCCCHH
T ss_pred             hhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhcc-CCCC-----CCcc--CCCCHH
Confidence            99984     45688999999999999999999999853211     11111111111 1110     1100  011235


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHH
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+++.+||+.||.+||++.+|++
T Consensus       260 l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          260 FQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhh
Confidence            677888999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.90  E-value=6.6e-24  Score=213.96  Aligned_cols=162  Identities=26%  Similarity=0.358  Sum_probs=115.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++..++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++........  ......|+..|+||
T Consensus       124 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP  198 (326)
T 2x7f_A          124 NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAP  198 (326)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccCh
Confidence            46899999999999999999999999   99999999999999999999999999876543221  12235689999999


Q ss_pred             hhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHH
Q 009186          394 EYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKC  468 (541)
Q Consensus       394 E~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  468 (541)
                      |.+.     +..++.++||||||+++|+|++|+.||....      ......... ........    ...    ....+
T Consensus       199 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~~~----~~~----~~~~l  263 (326)
T 2x7f_A          199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------PMRALFLIP-RNPAPRLK----SKK----WSKKF  263 (326)
T ss_dssp             HHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHH-HSCCCCCS----CSC----SCHHH
T ss_pred             hhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhh-cCccccCC----ccc----cCHHH
Confidence            9987     5668899999999999999999999984321      111111111 11111111    111    12356


Q ss_pred             HHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          469 IHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       469 ~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      .+++.+||+.||.+||++.++++  .+++
T Consensus       264 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          264 QSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             HHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence            77888999999999999999987  4543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.90  E-value=5.3e-24  Score=213.59  Aligned_cols=177  Identities=18%  Similarity=0.239  Sum_probs=120.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc-CCCCcEEecccccccccCCCC-cccccccccCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQN-EANTNRVAGTYGYM  391 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~  391 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++ .++.+||+|||+++....... ........++..|+
T Consensus       115 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  191 (320)
T 2i6l_A          115 GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR  191 (320)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTC
T ss_pred             CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccccccccccccccc
Confidence            35899999999999999999999999   99999999999997 567899999999987543221 11223345788999


Q ss_pred             Chhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc----------CCcccccccccc-CC
Q 009186          392 APEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK----------GEALELMDPVLK-QT  459 (541)
Q Consensus       392 aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~-~~  459 (541)
                      |||.+.+ ..++.++||||||+++|||++|+.||......   ............          ......+..... ..
T Consensus       192 aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (320)
T 2i6l_A          192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPH  268 (320)
T ss_dssp             CHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCC
T ss_pred             CcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCC
Confidence            9998875 67899999999999999999999998533211   111111000000          000000000000 00


Q ss_pred             -----CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcC
Q 009186          460 -----CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASD  496 (541)
Q Consensus       460 -----~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~  496 (541)
                           ........+.+++.+||+.||++|||+.++++  .++..
T Consensus       269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          269 KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence                 00112346778999999999999999999986  56543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.90  E-value=1.5e-24  Score=232.31  Aligned_cols=183  Identities=25%  Similarity=0.271  Sum_probs=131.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC---CcEEe
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM---NPKIS  364 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~---~~kL~  364 (541)
                      +++++++.++.|.....+       ...+++.+++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+
T Consensus       122 ~lv~e~~~gg~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          122 YLVTEFYEGGELFEQIIN-------RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEEECCTTCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEEecCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence            344555555555443322       235899999999999999999999999   99999999999998876   58999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||++..+.....   .....||+.|+|||.+. +.++.++||||||+++|+|++|+.||....      ..+.. ....
T Consensus       192 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~-~~i~  260 (504)
T 3q5i_A          192 DFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN------DQDII-KKVE  260 (504)
T ss_dssp             CCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH-HHHH
T ss_pred             ECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC------HHHHH-HHHH
Confidence            9999987654322   23356899999999886 568999999999999999999999985321      11111 1111


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcCC
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASDT  497 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~  497 (541)
                      .+....  +......    ....+.+++.+||+.||.+|||+.|+++  ++++..
T Consensus       261 ~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          261 KGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             cCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            111110  0000011    1245778889999999999999999985  555544

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.90  E-value=1.9e-24  Score=217.75  Aligned_cols=148  Identities=23%  Similarity=0.405  Sum_probs=117.9

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc-CCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++..++.++.||+.||+|||+.+   |+||||||+||+++ .++.+||+|||+++......    .....||..|+|
T Consensus       144 ~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~a  216 (320)
T 3a99_A          144 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP  216 (320)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCC
Confidence            35899999999999999999999999   99999999999999 77899999999998764322    223468999999


Q ss_pred             hhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..+ +.++||||||+++|||++|+.||....        .    .. ....      ......    ...+.++
T Consensus       217 PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~----~~-~~~~------~~~~~~----~~~~~~l  273 (320)
T 3a99_A          217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E----II-RGQV------FFRQRV----SSECQHL  273 (320)
T ss_dssp             HHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----HH-HCCC------CCSSCC----CHHHHHH
T ss_pred             hHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h----hh-cccc------cccccC----CHHHHHH
Confidence            999987775 688999999999999999999984211        0    00 1110      011111    2356778


Q ss_pred             HhhhcccCCCCCCCHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+||+.||++|||+++|++
T Consensus       274 i~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          274 IRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            88999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.90  E-value=2.7e-24  Score=219.60  Aligned_cols=165  Identities=21%  Similarity=0.243  Sum_probs=118.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.....     .....++..|+|||
T Consensus       122 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE  193 (353)
T 3coi_A          122 KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPE  193 (353)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHH
Confidence            4899999999999999999999999   999999999999999999999999999764322     22356799999999


Q ss_pred             hhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC------------------Ccccccccc
Q 009186          395 YAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG------------------EALELMDPV  455 (541)
Q Consensus       395 ~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~  455 (541)
                      .+.+ ..++.++||||||+++|||++|+.||......   ..+..........                  .......+.
T Consensus       194 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (353)
T 3coi_A          194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKD  270 (353)
T ss_dssp             HHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCC
T ss_pred             HHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCcc
Confidence            9877 67899999999999999999999998532211   1111111100000                  000000000


Q ss_pred             ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       456 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +. .........+.+++.+||+.||++|||+.++++
T Consensus       271 ~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          271 FT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00 111123456778889999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.90  E-value=6.8e-24  Score=211.84  Aligned_cols=162  Identities=23%  Similarity=0.335  Sum_probs=123.1

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEE---cCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      .+++.+++.++.||+.||.|||+++   |+|+||||+||++   +.++.+||+|||++......    ......|+..|+
T Consensus       102 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~  174 (304)
T 2jam_A          102 VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYV  174 (304)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCcc
Confidence            5899999999999999999999999   9999999999999   78889999999998754321    122346899999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |||.+.+..++.++||||||+++|||++|+.||.....   ....    ..+..+.. .. ....    .......+.++
T Consensus       175 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~----~~i~~~~~-~~-~~~~----~~~~~~~~~~l  241 (304)
T 2jam_A          175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLF----EKIKEGYY-EF-ESPF----WDDISESAKDF  241 (304)
T ss_dssp             CTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH----HHHHHCCC-CC-CTTT----TTTSCHHHHHH
T ss_pred             ChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH----HHHHcCCC-CC-Cccc----cccCCHHHHHH
Confidence            99999998999999999999999999999999843211   1111    11111111 00 0111    11123457788


Q ss_pred             HhhhcccCCCCCCCHHHHHH--HHhcC
Q 009186          472 GLLCVQEDPAHRPNMSSVVV--MLASD  496 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~--~L~~~  496 (541)
                      +.+||+.||++||++.++++  .+++.
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          242 ICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHHcCCChhHCcCHHHHhcCccccCC
Confidence            89999999999999999996  55553

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.90  E-value=4.2e-24  Score=212.86  Aligned_cols=159  Identities=22%  Similarity=0.331  Sum_probs=116.8

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.+++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++.......  .......|+..|+||
T Consensus       112 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aP  186 (302)
T 2j7t_A          112 RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAP  186 (302)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCC
Confidence            35899999999999999999999999   9999999999999999999999999875422111  112234688999999


Q ss_pred             hhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHH
Q 009186          394 EYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKC  468 (541)
Q Consensus       394 E~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  468 (541)
                      |.+.     +..++.++||||||+++|+|++|+.||....      ........... .......       +......+
T Consensus       187 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~~~~-------~~~~~~~l  252 (302)
T 2j7t_A          187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKS-DPPTLLT-------PSKWSVEF  252 (302)
T ss_dssp             HHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS-CCCCCSS-------GGGSCHHH
T ss_pred             eeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC------HHHHHHHHhcc-CCcccCC-------ccccCHHH
Confidence            9984     5678899999999999999999999985322      11111111111 1111110       11123457


Q ss_pred             HHHHhhhcccCCCCCCCHHHHHH
Q 009186          469 IHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       469 ~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+++.+||+.||.+|||+.++++
T Consensus       253 ~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          253 RDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHcccChhhCCCHHHHhc
Confidence            78889999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.90  E-value=8.3e-24  Score=207.90  Aligned_cols=158  Identities=25%  Similarity=0.371  Sum_probs=114.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++........   .....++..|+|||
T Consensus       107 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE  180 (276)
T 2h6d_A          107 RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPE  180 (276)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHH
Confidence            4899999999999999999999999   99999999999999999999999999987543321   22346789999999


Q ss_pred             hhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHh
Q 009186          395 YAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGL  473 (541)
Q Consensus       395 ~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  473 (541)
                      .+.+..+ +.++||||||+++|+|++|+.||....      ... .......+..      .+...    ....+.+++.
T Consensus       181 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~-~~~~~~~~~~------~~~~~----~~~~l~~li~  243 (276)
T 2h6d_A          181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPT-LFKKIRGGVF------YIPEY----LNRSVATLLM  243 (276)
T ss_dssp             GGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHH-HHHHHHHCCC------CCCTT----SCHHHHHHHH
T ss_pred             HHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHH-HHHHhhcCcc------cCchh----cCHHHHHHHH
Confidence            9987765 689999999999999999999984321      111 1111111111      01111    1235677888


Q ss_pred             hhcccCCCCCCCHHHHHH--HHhc
Q 009186          474 LCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       474 ~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      +||+.||.+|||+.++++  .+++
T Consensus       244 ~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHccCChhhCCCHHHHHhChhhcc
Confidence            999999999999999997  3554

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.90  E-value=1.5e-23  Score=208.53  Aligned_cols=158  Identities=23%  Similarity=0.345  Sum_probs=120.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.+++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++........   .....++..|+|||
T Consensus       120 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE  193 (298)
T 1phk_A          120 TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPE  193 (298)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHH
Confidence            5899999999999999999999999   99999999999999999999999999987543322   22356889999999


Q ss_pred             hhc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHH
Q 009186          395 YAM------EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKC  468 (541)
Q Consensus       395 ~l~------~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  468 (541)
                      .+.      ...++.++||||||+++|||++|+.||....      ..... .....+... ...+.     .......+
T Consensus       194 ~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~-~~~~~~~~~-~~~~~-----~~~~~~~l  260 (298)
T 1phk_A          194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------QMLML-RMIMSGNYQ-FGSPE-----WDDYSDTV  260 (298)
T ss_dssp             HHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH-HHHHHTCCC-CCTTT-----GGGSCHHH
T ss_pred             HhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc------HHHHH-HHHhcCCcc-cCccc-----ccccCHHH
Confidence            985      4568899999999999999999999974321      11111 111111111 00010     11223457


Q ss_pred             HHHHhhhcccCCCCCCCHHHHHH
Q 009186          469 IHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       469 ~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+++.+||+.||++|||+.++++
T Consensus       261 ~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          261 KDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHccCCcccCCCHHHHHh
Confidence            78889999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.90  E-value=4.2e-24  Score=215.28  Aligned_cols=160  Identities=26%  Similarity=0.326  Sum_probs=119.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC---cEEecccccccccCCCCcccccccccCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN---PKISDFGMARIFSGNQNEANTNRVAGTYGY  390 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~---~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  390 (541)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.   +||+|||+++......   ......|+..|
T Consensus       109 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y  182 (322)
T 2ycf_A          109 KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTY  182 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCc
Confidence            46899999999999999999999999   999999999999987665   9999999998754321   12235689999


Q ss_pred             CChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHH
Q 009186          391 MAPEYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLK  467 (541)
Q Consensus       391 ~aPE~l~---~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  467 (541)
                      +|||.+.   ...++.++||||||+++|+|++|+.||......  ..+.....    .+... . .+.....    ....
T Consensus       183 ~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~----~~~~~-~-~~~~~~~----~~~~  250 (322)
T 2ycf_A          183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQIT----SGKYN-F-IPEVWAE----VSEK  250 (322)
T ss_dssp             CCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHH----HTCCC-C-CHHHHTT----SCHH
T ss_pred             cCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHH----hCccc-c-Cchhhhh----cCHH
Confidence            9999974   456889999999999999999999998533221  11221111    11110 0 0111111    1345


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHH
Q 009186          468 CIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       468 ~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+++.+||+.||++||++.++++
T Consensus       251 ~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          251 ALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHcccCHhhCCCHHHHhh
Confidence            778899999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.90  E-value=7.8e-24  Score=212.13  Aligned_cols=147  Identities=21%  Similarity=0.391  Sum_probs=117.5

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc-CCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      .+++.+++.++.||+.||+|||+++   |+||||||+||+++ .++.+||+|||++.......    .....|+..|+||
T Consensus       135 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aP  207 (312)
T 2iwi_A          135 PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPP  207 (312)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCc
Confidence            5899999999999999999999999   99999999999999 78899999999998764332    2235689999999


Q ss_pred             hhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFS-VKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s-~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.+..+. .++||||||+++|||++|+.||....        + ..    ....      .+..    .....+.+++
T Consensus       208 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~-~~----~~~~------~~~~----~~~~~~~~li  264 (312)
T 2iwi_A          208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E-IL----EAEL------HFPA----HVSPDCCALI  264 (312)
T ss_dssp             HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H-HH----HTCC------CCCT----TSCHHHHHHH
T ss_pred             eeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H-Hh----hhcc------CCcc----cCCHHHHHHH
Confidence            999877764 58999999999999999999984210        0 00    0000      0111    1233567788


Q ss_pred             hhhcccCCCCCCCHHHHHH
Q 009186          473 LLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~  491 (541)
                      .+||+.||++||++.|+++
T Consensus       265 ~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          265 RRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999997

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.89  E-value=9.8e-24  Score=209.82  Aligned_cols=160  Identities=24%  Similarity=0.343  Sum_probs=112.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCC------------cccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN------------EANT  381 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~------------~~~~  381 (541)
                      ..+++.+++.++.||+.||+|||+++   |+|+||||+||+++.++.+||+|||++........            ....
T Consensus       111 ~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (303)
T 1zy4_A          111 LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL  187 (303)
T ss_dssp             GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccccccccc
Confidence            45788999999999999999999999   99999999999999999999999999976543211            1122


Q ss_pred             cccccCCCCCChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCC
Q 009186          382 NRVAGTYGYMAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTC  460 (541)
Q Consensus       382 ~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  460 (541)
                      ....|+..|+|||.+.+. .++.++||||||+++|||++   ||...     ....+. ...+....      ..+....
T Consensus       188 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~~~~~~-~~~~~~~~------~~~~~~~  252 (303)
T 1zy4_A          188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----MERVNI-LKKLRSVS------IEFPPDF  252 (303)
T ss_dssp             ------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHHHH-HHHHHSTT------CCCCTTC
T ss_pred             ccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----hhHHHH-HHhccccc------cccCccc
Confidence            335688999999999764 68999999999999999998   33210     011111 11111111      1111222


Q ss_pred             CHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          461 VDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       461 ~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .......+.+++.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          253 DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            2333445678899999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.89  E-value=1.9e-23  Score=219.21  Aligned_cols=159  Identities=26%  Similarity=0.374  Sum_probs=110.6

Q ss_pred             ccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-----CCCcEEecccccccccCCCCc-ccccccccCCC
Q 009186          316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-----EMNPKISDFGMARIFSGNQNE-ANTNRVAGTYG  389 (541)
Q Consensus       316 L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-----~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~  389 (541)
                      +.+.+++.++.||+.||+|||+++   |+||||||+|||++.     ...+||+|||+++........ .......||+.
T Consensus       115 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~  191 (432)
T 3p23_A          115 HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG  191 (432)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTT
T ss_pred             ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcC
Confidence            445566799999999999999999   999999999999953     335789999999876533221 22334578999


Q ss_pred             CCChhhhc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          390 YMAPEYAM---EGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       390 y~aPE~l~---~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      |+|||++.   ...++.++|||||||++|||++ |..||......       ...... .........      ......
T Consensus       192 y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~-~~~~~~~~~------~~~~~~  257 (432)
T 3p23_A          192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILL-GACSLDCLH------PEKHED  257 (432)
T ss_dssp             SCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHT-TCCCCTTSC------TTCHHH
T ss_pred             ccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHh-ccCCccccC------cccccc
Confidence            99999997   4567889999999999999999 89887422110       111111 111111111      112334


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..+.+|+.+||+.||.+|||+.+|++
T Consensus       258 ~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          258 VIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            45778999999999999999999984

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.89  E-value=7.5e-23  Score=202.54  Aligned_cols=157  Identities=26%  Similarity=0.329  Sum_probs=117.5

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC---CCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      .+++.+++.++.||+.||.|||+++   |+|+||||+||+++.+   +.+||+|||++........   .....++..|+
T Consensus       117 ~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~  190 (287)
T 2wei_A          117 RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYI  190 (287)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCccccc
Confidence            5899999999999999999999999   9999999999999764   4699999999987644322   12345788999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |||.+.+ .++.++||||||+++|+|++|+.||....      ..+. ...+..+...... +. ...    ....+.++
T Consensus       191 aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~-~~~~~~~~~~~~~-~~-~~~----~~~~~~~l  256 (287)
T 2wei_A          191 APEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN------EYDI-LKRVETGKYAFDL-PQ-WRT----ISDDAKDL  256 (287)
T ss_dssp             CHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH-HHHHHHCCCCCCS-GG-GTT----SCHHHHHH
T ss_pred             ChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC------HHHH-HHHHHcCCCCCCc-hh-hhh----cCHHHHHH
Confidence            9998865 58999999999999999999999974321      1111 1111122111000 00 011    12456778


Q ss_pred             HhhhcccCCCCCCCHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+||+.||++|||+.++++
T Consensus       257 i~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          257 IRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcccChhhCcCHHHHhc
Confidence            89999999999999999997

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.88  E-value=9e-24  Score=229.84  Aligned_cols=189  Identities=21%  Similarity=0.204  Sum_probs=126.2

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC---cEEecc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN---PKISDF  366 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~---~kL~Df  366 (541)
                      +++++.++.|...+++    ......+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.   +||+||
T Consensus        96 VmEy~~ggsL~~~L~~----~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           96 AMEYCEGGDLRKYLNQ----FENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             EEECCSSCBHHHHHHS----SSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEeCCCCCHHHHHHh----cccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence            3445555555443332    122345899999999999999999999999   999999999999997765   899999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCc--CcHHHHHHH-hh
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG--QSLLTYAWK-LW  443 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~--~~~~~~~~~-~~  443 (541)
                      |++........   .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........  ......... ..
T Consensus       169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            99987644332   2335789999999999999999999999999999999999999853211000  000000000 00


Q ss_pred             hcCCcccc--ccc--cccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHH
Q 009186          444 CKGEALEL--MDP--VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS  488 (541)
Q Consensus       444 ~~~~~~~~--~~~--~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~e  488 (541)
                      ........  ...  .............+.+++.+||+.||++|||+.+
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            00000000  000  0112233345677888999999999999999966

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.87  E-value=2.9e-23  Score=230.27  Aligned_cols=163  Identities=20%  Similarity=0.258  Sum_probs=120.9

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      +|++|+.++.|....+         ..+++.+++.|+.||+.||.|||+++   |+||||||+|||++.+ .+||+|||+
T Consensus       161 lv~E~~~g~~L~~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          161 IVMEYVGGQSLKRSKG---------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEECCCCEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             EEEEeCCCCcHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence            4455555555543221         15999999999999999999999999   9999999999999986 899999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++.....      ....||+.|+|||++.++. +.++||||||+++|+|++|..||.......                 
T Consensus       228 a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------  283 (681)
T 2pzi_A          228 VSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------  283 (681)
T ss_dssp             CEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------
T ss_pred             chhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------
Confidence            9875432      3356899999999987664 889999999999999999988764211100                 


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-HHHHHHHHh
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-MSSVVVMLA  494 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~evl~~L~  494 (541)
                         +.   ...........+.+++.+||+.||.+||+ ++++...|.
T Consensus       284 ---~~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          284 ---LP---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             ---CC---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ---cc---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence               00   00001112345778999999999999995 555555554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.86  E-value=9.3e-23  Score=203.22  Aligned_cols=162  Identities=15%  Similarity=0.167  Sum_probs=112.9

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC---CCCcEEec
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH---EMNPKISD  365 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~---~~~~kL~D  365 (541)
                      ++++++..+.|...+++     .....+++.+++.++.||+.||.|||+++   |+||||||+||+++.   ++.+||+|
T Consensus        92 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEECCCCSCBHHHHHHH-----CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEeecCCCcHHHHHHh-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEec
Confidence            34455555555443332     12346999999999999999999999999   999999999999998   78899999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||++....                        +..++.++||||||+++|||++|+.||........       .    .
T Consensus       164 fg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------~----~  208 (299)
T 3m2w_A          164 FGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------S----P  208 (299)
T ss_dssp             CTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------C
T ss_pred             cccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------h----H
Confidence            99986432                        13467899999999999999999999843221100       0    0


Q ss_pred             CCccccccccccCCCC----HHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          446 GEALELMDPVLKQTCV----DAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~----~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                       .....+.... ...+    ......+.+++.+||+.||.+|||+.|+++  .+.+
T Consensus       209 -~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          209 -GMKTRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             -CSCCSSCTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             -HHHHHHhhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence             0000000000 0001    112345778889999999999999999996  4544

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.82  E-value=1.5e-21  Score=193.30  Aligned_cols=157  Identities=13%  Similarity=0.062  Sum_probs=107.6

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++|+.++.|...+++        . ....++.+|+.||+.||+|||+++   |+||||||+|||++.++.+||++++
T Consensus       107 ~lv~e~~~g~~L~~~l~~--------~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT--------S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT--------C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EEEEEecCCCCHHHHHhc--------C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc
Confidence            344566555555444321        1 344578899999999999999999   9999999999999999999997433


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                                            |++       .++.++||||||+++|||++|+.||............   .... .+.
T Consensus       175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~~  221 (286)
T 3uqc_A          175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AGQ  221 (286)
T ss_dssp             ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TSC
T ss_pred             ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-ccC
Confidence                                  333       2588999999999999999999998643322110000   0000 000


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ...  ...+...    ....+.+++.+||+.||++| |+.|+++.|+..
T Consensus       222 ~~~--~~~~~~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          222 PIE--PADIDRD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             BCC--HHHHCTT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             CCC--hhhcccC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            000  0001111    22357788899999999999 999999999863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.82  E-value=1.2e-20  Score=191.02  Aligned_cols=152  Identities=14%  Similarity=0.046  Sum_probs=110.5

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhh-hcCCCceEecccCCCcEEEcCCC--------------------CcEEecccccccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLH-EDSRLRVIHRDLKTSNVLLDHEM--------------------NPKISDFGMARIF  372 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH-~~~~~~ivH~DLkp~NIll~~~~--------------------~~kL~Dfg~a~~~  372 (541)
                      ..+++.++..++.||+.||+||| +++   |+||||||+|||++.++                    .+||+|||+++..
T Consensus       156 ~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~  232 (336)
T 2vuw_A          156 KLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE  232 (336)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEE
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEec
Confidence            35899999999999999999999 899   99999999999999887                    8999999999875


Q ss_pred             cCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHH-HHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcccc
Q 009186          373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVL-LLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALEL  451 (541)
Q Consensus       373 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvl-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  451 (541)
                      ...       ...||..|+|||++.+.. +.++|||||+++ .++++.|..||...      ................  
T Consensus       233 ~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~--  296 (336)
T 2vuw_A          233 RDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTF--  296 (336)
T ss_dssp             ETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCC--
T ss_pred             CCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhcc--
Confidence            422       347899999999998666 899999998776 77788898886210      0000011111100000  


Q ss_pred             ccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 009186          452 MDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV  490 (541)
Q Consensus       452 ~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl  490 (541)
                       ...............+.+|+.+||+.|     |++|++
T Consensus       297 -~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          297 -KTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             -SSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             -CcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence             000011112345667889999999976     899887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.72  E-value=5.3e-20  Score=199.13  Aligned_cols=123  Identities=16%  Similarity=0.101  Sum_probs=82.4

Q ss_pred             hHHHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEe
Q 009186          285 TIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       285 ~~v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      ..+++||||+.++.|...+++       ++.++..   +|+.||+.||+|||++|   ||||||||+|||++.++.+||+
T Consensus       315 ~~~yLVMEyv~G~~L~d~i~~-------~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~  381 (569)
T 4azs_A          315 QSGWLVMEKLPGRLLSDMLAA-------GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLI  381 (569)
T ss_dssp             SEEEEEEECCCSEEHHHHHHT-------TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEEC
T ss_pred             CEEEEEEecCCCCcHHHHHHh-------CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEe
Confidence            346677888888877666543       3346554   58899999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRN  423 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p  423 (541)
                      |||+++.......  ......||+.|+|||++.+ .+..++|+|++|++++++.++..+
T Consensus       382 DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          382 DFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            9999987654332  2334679999999998865 467789999999998877665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.43  E-value=2.3e-15  Score=161.86  Aligned_cols=99  Identities=24%  Similarity=0.276  Sum_probs=83.2

Q ss_pred             HHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-----cccccccCCCCCChhh
Q 009186          321 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-----NTNRVAGTYGYMAPEY  395 (541)
Q Consensus       321 ~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~  395 (541)
                      ++.++.||++||+|||+++   |+||||||+|||++.  .+||+|||+++.........     ......||+.|+|||+
T Consensus       433 ~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv  507 (540)
T 3en9_A          433 NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEI  507 (540)
T ss_dssp             CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHH
T ss_pred             HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHH
Confidence            5689999999999999999   999999999999998  99999999998764432211     1234679999999999


Q ss_pred             hcc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 009186          396 AME--GVFSVKSDVFSFGVLLLEIISGKRNS  424 (541)
Q Consensus       396 l~~--~~~s~~sDVwSlGvll~elltg~~p~  424 (541)
                      +..  ..|+...|+|+..+-.++.+.++.++
T Consensus       508 ~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          508 WERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            986  56788899999999999888877664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.05  E-value=5.4e-11  Score=116.97  Aligned_cols=59  Identities=20%  Similarity=0.121  Sum_probs=51.8

Q ss_pred             HHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhhhc
Q 009186          320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM  397 (541)
Q Consensus       320 ~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~  397 (541)
                      +...++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.               +..+.|||++.
T Consensus       194 ~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          194 NPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            34579999999999999999   99999999999999 99999999999863               23478899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=98.71  E-value=8.5e-09  Score=99.80  Aligned_cols=51  Identities=22%  Similarity=0.255  Sum_probs=46.4

Q ss_pred             cHHHHHHHHHhHHHHHHHhh-hcCCCceEecccCCCcEEEcCCCCcEEecccccccc
Q 009186          317 DWKRRISIINGIARGLLYLH-EDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF  372 (541)
Q Consensus       317 ~~~~~~~i~~qi~~gL~~LH-~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~  372 (541)
                      ++.++..++.||+.+|.||| +.+   |+||||||+|||++.  .++|+|||++...
T Consensus       168 ~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          168 KELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             ChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            35677899999999999999 888   999999999999998  8999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.11  E-value=1.2e-06  Score=89.07  Aligned_cols=49  Identities=24%  Similarity=0.348  Sum_probs=43.1

Q ss_pred             HHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCC----------cEEeccccccc
Q 009186          320 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN----------PKISDFGMARI  371 (541)
Q Consensus       320 ~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~----------~kL~Dfg~a~~  371 (541)
                      ....++.||+.+|.+||+.|   ||||||||.|||+++++.          +.|+||+.+..
T Consensus       206 ~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          206 DPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            44678899999999999999   999999999999988763          78999997754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.33  E-value=8.9e-05  Score=72.99  Aligned_cols=83  Identities=20%  Similarity=0.299  Sum_probs=49.7

Q ss_pred             CCceEecccCCCcEEEcC--CCCcEEecccccccccCCCCcccc------------cccccCCCCCC-hhhhccCCCCcc
Q 009186          340 RLRVIHRDLKTSNVLLDH--EMNPKISDFGMARIFSGNQNEANT------------NRVAGTYGYMA-PEYAMEGVFSVK  404 (541)
Q Consensus       340 ~~~ivH~DLkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~~------------~~~~gt~~y~a-PE~l~~~~~s~~  404 (541)
                      ...++|+|+++.||+++.  ...+.|+||+.+..-.........            ......++... |+....  ....
T Consensus       190 ~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~  267 (304)
T 3sg8_A          190 YPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMK  267 (304)
T ss_dssp             CCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHH
T ss_pred             CceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHH
Confidence            346999999999999998  455789999987652211000000            00011112222 332211  1223


Q ss_pred             hhhHHHHHHHHHHHhCCCCC
Q 009186          405 SDVFSFGVLLLEIISGKRNS  424 (541)
Q Consensus       405 sDVwSlGvll~elltg~~p~  424 (541)
                      .+.|+++.++|.+.+|..+|
T Consensus       268 ~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          268 EKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHcCCHHH
Confidence            68999999999999998763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=96.56  E-value=0.0019  Score=64.91  Aligned_cols=31  Identities=13%  Similarity=0.381  Sum_probs=26.3

Q ss_pred             CceEecccCCCcEEEcCCCC--cEEeccccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMN--PKISDFGMARI  371 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~--~kL~Dfg~a~~  371 (541)
                      ..++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            46999999999999997753  58999998764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=96.36  E-value=0.0016  Score=62.13  Aligned_cols=30  Identities=27%  Similarity=0.362  Sum_probs=24.9

Q ss_pred             CceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+++.||+++.+..+.|+||+.+.
T Consensus       183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence            459999999999999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=96.35  E-value=0.0018  Score=61.35  Aligned_cols=29  Identities=21%  Similarity=0.238  Sum_probs=25.1

Q ss_pred             ceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          342 RVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       342 ~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      .++|+|++|.||+++.++.+.|+||+.+.
T Consensus       185 ~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          185 VVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence            49999999999999877656799999864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.35  E-value=0.012  Score=54.21  Aligned_cols=93  Identities=9%  Similarity=0.053  Sum_probs=58.8

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +.+|+++++|.++.|.+.+|.-+-.+..  -..+=+.|..|+|..+|.+.+.+ ..+.              .....+.+
T Consensus        43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~  105 (229)
T 2yle_A           43 NQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPVA  105 (229)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------------------
T ss_pred             CCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc--------------ccccCCCC
Confidence            5689999999999999999877622110  11223356889999999887653 1110              11224668


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRN  423 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p  423 (541)
                      ||... ...+.+.=|||||++||.-+--..|
T Consensus       106 pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          106 GKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             hhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            88653 3446788899999999999875443

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=93.67  E-value=0.066  Score=52.72  Aligned_cols=30  Identities=23%  Similarity=0.289  Sum_probs=26.6

Q ss_pred             CceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            359999999999999888889999999764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=91.58  E-value=0.19  Score=48.93  Aligned_cols=32  Identities=38%  Similarity=0.488  Sum_probs=26.2

Q ss_pred             CCceEecccCCCcEEEcC---CCCc-EEeccccccc
Q 009186          340 RLRVIHRDLKTSNVLLDH---EMNP-KISDFGMARI  371 (541)
Q Consensus       340 ~~~ivH~DLkp~NIll~~---~~~~-kL~Dfg~a~~  371 (541)
                      ...++|+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            345999999999999987   4554 7999998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=90.83  E-value=0.17  Score=51.68  Aligned_cols=30  Identities=23%  Similarity=0.379  Sum_probs=26.4

Q ss_pred             CceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ..++|+|+++.|||++.++ ++|+||+.+..
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            3599999999999998776 99999988764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=88.37  E-value=0.44  Score=46.74  Aligned_cols=31  Identities=29%  Similarity=0.472  Sum_probs=26.5

Q ss_pred             CceEecccCCCcEEEcCC----CCcEEeccccccc
Q 009186          341 LRVIHRDLKTSNVLLDHE----MNPKISDFGMARI  371 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~----~~~kL~Dfg~a~~  371 (541)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            459999999999999874    6789999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=86.70  E-value=0.58  Score=45.66  Aligned_cols=29  Identities=28%  Similarity=0.432  Sum_probs=24.8

Q ss_pred             CceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ..++|+|+++.||+++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4589999999999999 4 789999987654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=86.18  E-value=0.26  Score=46.66  Aligned_cols=30  Identities=23%  Similarity=0.248  Sum_probs=25.6

Q ss_pred             CceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       193 ~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          193 SVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             EEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence            458999999999999987666799998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=85.56  E-value=0.31  Score=47.46  Aligned_cols=30  Identities=33%  Similarity=0.332  Sum_probs=25.2

Q ss_pred             CceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+++.||+++.+..+.|+||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            359999999999999977555799998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=84.42  E-value=0.32  Score=48.26  Aligned_cols=30  Identities=20%  Similarity=0.232  Sum_probs=25.0

Q ss_pred             CceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+++.||+++++..+.|+||+.+.
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            459999999999999964446899998775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=82.38  E-value=1.1  Score=46.16  Aligned_cols=17  Identities=29%  Similarity=0.421  Sum_probs=15.1

Q ss_pred             CCceEecccCCCcEEEc
Q 009186          340 RLRVIHRDLKTSNVLLD  356 (541)
Q Consensus       340 ~~~ivH~DLkp~NIll~  356 (541)
                      ...++|+|+.+.|||++
T Consensus       289 ~~v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          289 PIVLCHCDLLSSNIINT  305 (458)
T ss_dssp             CEEEECSCCCGGGEEEC
T ss_pred             CeeEEecCCCCCcEEee
Confidence            34699999999999998

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=81.68  E-value=1.1  Score=44.46  Aligned_cols=29  Identities=21%  Similarity=0.432  Sum_probs=24.1

Q ss_pred             CceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+++.|||++.+. +.|+||..+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            4599999999999998654 8999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=81.34  E-value=0.97  Score=44.57  Aligned_cols=31  Identities=26%  Similarity=0.385  Sum_probs=27.2

Q ss_pred             CceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	541
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-40
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-39
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-36
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-36
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-35
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-35
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-34
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-34
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-34
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-33
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-32
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-32
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-32
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-31
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-25
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-25
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-24
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-24
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-24
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-23
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-23
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-23
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-22
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-22
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-22
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-21
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-21
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-20
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-20
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-19
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-19
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-19
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-18
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-18
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-18
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-18
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-16
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-15
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-14
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-14
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-13
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-09

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 9e-45
 Identities = 44/193 (22%), Positives = 87/193 (45%), Gaps = 17/193 (8%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
              + +  + I I    A+G+ YLH  S   +IHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 97  IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
            S         +++G+  +MAPE      +  +S +SDV++FG++L E+++G+       
Sbjct: 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----- 208

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
                +       +  +G     +  V         + + +     C+++    RP    
Sbjct: 209 -YSNINNRDQIIFMVGRGYLSPDLSKVRSN--CPKAMKRLM---AECLKKKRDERPLFPQ 262

Query: 489 VVVMLASDTATLP 501
           ++  +     +LP
Sbjct: 263 ILASIELLARSLP 275

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 1e-40
 Identities = 39/200 (19%), Positives = 73/200 (36%), Gaps = 18/200 (9%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHED-----SRLRVIHRDLKTSNVLLDHEMNPKISDF 366
               +  +  I +    A GL +LH +      +  + HRDLK+ N+L+       I+D 
Sbjct: 93  NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152

Query: 367 GMARIFSGNQN--EANTNRVAGTYGYMAPEYAMEGV------FSVKSDVFSFGVLLLEII 418
           G+A       +  +   N   GT  YMAPE   + +         ++D+++ G++  EI 
Sbjct: 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

Query: 419 SGKRNSGFYLSE----HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH-IGL 473
                 G +       +       + +   K    + + P +       E L+ +  I  
Sbjct: 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272

Query: 474 LCVQEDPAHRPNMSSVVVML 493
            C   + A R     +   L
Sbjct: 273 ECWYANGAARLTALRIKKTL 292

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (365), Expect = 6e-40
 Identities = 50/196 (25%), Positives = 79/196 (40%), Gaps = 18/196 (9%)

Query: 298 SFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 357
           S      R    S     L    ++ I   +A G+ YL E    + +HRDL T N L+  
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGE 175

Query: 358 EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
            M  KI+DFG++R              A    +M PE      ++ +SDV+++GV+L EI
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235

Query: 418 ISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQ 477
            S       Y     + ++         G  L          C +   L+  ++  LC  
Sbjct: 236 FSYGLQ--PYYGMAHEEVI----YYVRDGNILA---------CPENCPLELYNLMRLCWS 280

Query: 478 EDPAHRPNMSSVVVML 493
           + PA RP+  S+  +L
Sbjct: 281 KLPADRPSFCSIHRIL 296

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 3e-39
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 19/182 (10%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
            G +L   + + +   IA G+ ++ E +    IHRDL+ +N+L+   ++ KI+DFG+AR+
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
              N+  A          + APE    G F++KSDV+SFG+LL EI++  R    Y    
Sbjct: 159 IEDNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI--PYPGMT 215

Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
              ++    +   +G  +   D   ++            +  LC +E P  RP    +  
Sbjct: 216 NPEVI----QNLERGYRMVRPDNCPEE---------LYQLMRLCWKERPEDRPTFDYLRS 262

Query: 492 ML 493
           +L
Sbjct: 263 VL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 6e-39
 Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 19/190 (10%)

Query: 318 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 377
             + + +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K++DFG+AR+   N+ 
Sbjct: 112 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168

Query: 378 EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLT 437
            A          + APE A+ G F++KSDV+SFG+LL E+ +  R               
Sbjct: 169 TARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-------------- 213

Query: 438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT 497
             +      E L+ ++   +  C          +   C +++P  RP    +   L    
Sbjct: 214 -PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

Query: 498 ATLPPPTQPA 507
            +  P  QP 
Sbjct: 273 TSTEPQYQPG 282

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 7e-38
 Identities = 42/196 (21%), Positives = 84/196 (42%), Gaps = 19/196 (9%)

Query: 299 FVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 358
           ++           K  +    + + ++ GIA G+ YL     +  +HRDL   N+L++  
Sbjct: 90  YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSN 146

Query: 359 MNPKISDFGMARIFSGNQNEANT-NRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEI 417
           +  K+SDFG++R+   +     T +       + APE      F+  SDV+SFG+++ E+
Sbjct: 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206

Query: 418 ISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQ 477
           ++      + LS H               E ++ ++   +             + + C Q
Sbjct: 207 MTYGERPYWELSNH---------------EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQ 251

Query: 478 EDPAHRPNMSSVVVML 493
           ++ A RP  + +V +L
Sbjct: 252 QERARRPKFADIVSIL 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 6e-37
 Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 17/195 (8%)

Query: 301 WCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 360
           +  ++  ++      L ++  +     +A+G+ +L        +HRDL   NVL+ H   
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKV 202

Query: 361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            KI DFG+AR    + N            +MAPE   EG++++KSDV+S+G+LL EI S 
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262

Query: 421 KRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDP 480
                      G  +    +KL   G  ++      ++            I   C   D 
Sbjct: 263 GV-----NPYPGIPVDANFYKLIQNGFKMDQPFYATEE---------IYIIMQSCWAFDS 308

Query: 481 AHRPNMSSVVVMLAS 495
             RP+  ++   L  
Sbjct: 309 RKRPSFPNLTSFLGC 323

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-36
 Identities = 48/189 (25%), Positives = 77/189 (40%), Gaps = 17/189 (8%)

Query: 305 RINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 364
           ++  +      L  +  I     +A+G+ +L      + IHRDL   N+LL  +   KI 
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKIC 176

Query: 365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNS 424
           DFG+AR    + +            +MAPE   + V++++SDV+SFGVLL EI      S
Sbjct: 177 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----S 231

Query: 425 GFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP 484
                  G  +     +   +G  +   D    +              L C   +P+ RP
Sbjct: 232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRP 282

Query: 485 NMSSVVVML 493
             S +V  L
Sbjct: 283 TFSELVEHL 291

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-36
 Identities = 45/212 (21%), Positives = 80/212 (37%), Gaps = 32/212 (15%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
               +  +  ++    IA+G+ YL      R++HRDL   NVL+    + KI+DFG+A++
Sbjct: 104 HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
               + E +         +MA E  +  +++ +SDV+S+GV + E+++       Y    
Sbjct: 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIP 218

Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
              +      +  KGE L                     I + C   D   RP    +++
Sbjct: 219 ASEIS----SILEKGERLPQPPICTID---------VYMIMVKCWMIDADSRPKFRELII 265

Query: 492 ML--------------ASDTATLPPPTQPAFS 509
                             +   LP PT   F 
Sbjct: 266 EFSKMARDPQRYLVIQGDERMHLPSPTDSNFY 297

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 8e-36
 Identities = 46/202 (22%), Positives = 77/202 (38%), Gaps = 17/202 (8%)

Query: 292 LFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 351
           L     SF+  +            LD +  +S    +A+G+ +L        IHRDL   
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR 174

Query: 352 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFG 411
           N+LL H    KI DFG+AR    + N            +MAPE     V++ +SDV+S+G
Sbjct: 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 234

Query: 412 VLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI 471
           + L E+ S   +    +    +                +++    +    +    +   I
Sbjct: 235 IFLWELFSLGSSPYPGMPVDSK--------------FYKMIKEGFRMLSPEHAPAEMYDI 280

Query: 472 GLLCVQEDPAHRPNMSSVVVML 493
              C   DP  RP    +V ++
Sbjct: 281 MKTCWDADPLKRPTFKQIVQLI 302

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 9e-36
 Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 19/183 (10%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           +   +  K  I +++ ++ G+ YL        +HRDL   NVLL  +   KISDFG+++ 
Sbjct: 100 QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 156

Query: 372 FSGNQNEANTN-RVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE 430
              ++N             + APE      FS KSDV+SFGVL+ E  S  +    Y   
Sbjct: 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGM 214

Query: 431 HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
            G  +      +  KGE +       ++            +  LC   D  +RP  ++V 
Sbjct: 215 KGSEVT----AMLEKGERMGCPAGCPRE---------MYDLMNLCWTYDVENRPGFAAVE 261

Query: 491 VML 493
           + L
Sbjct: 262 LRL 264

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-35
 Identities = 45/208 (21%), Positives = 84/208 (40%), Gaps = 39/208 (18%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           K  ++  +    +   + +GL YL    + +++HRD+K SN+L++     K+ DFG++  
Sbjct: 97  KAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR--------- 422
              +      N   GT  YM+PE      +SV+SD++S G+ L+E+  G+          
Sbjct: 155 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

Query: 423 --------------NSGFYLSEHGQSLLTYAWKLWCKGEALELMD-------PVLKQTCV 461
                          +       G+ L +Y           EL+D       P L     
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270

Query: 462 DAELLKCIHIGLLCVQEDPAHRPNMSSV 489
             E    ++    C+ ++PA R ++  +
Sbjct: 271 SLEFQDFVN---KCLIKNPAERADLKQL 295

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 41/179 (22%), Positives = 75/179 (41%), Gaps = 19/179 (10%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
           ++     + +   I+  + YL    +   IHRDL   N L+      K++DFG++R+ +G
Sbjct: 111 EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
           +   A+         + APE      FS+KSDV++FGVLL EI +   +           
Sbjct: 168 DTYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----------- 215

Query: 435 LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
                +      +  EL++   +    +    K   +   C Q +P+ RP+ + +    
Sbjct: 216 ----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 5e-35
 Identities = 47/177 (26%), Positives = 68/177 (38%), Gaps = 19/177 (10%)

Query: 317 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ 376
             +  + +   +  G+ YL E     VIHRDL   N L+      K+SDFGM R    +Q
Sbjct: 99  AAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155

Query: 377 NEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLL 436
              ++        + +PE      +S KSDV+SFGVL+ E+ S  +      S       
Sbjct: 156 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----- 209

Query: 437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
                +        L  P L  T           I   C +E P  RP  S ++  L
Sbjct: 210 ---EVVEDISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (330), Expect = 5e-35
 Identities = 39/180 (21%), Positives = 74/180 (41%), Gaps = 21/180 (11%)

Query: 317 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ 376
              + + ++ GIA G+ YL     +  +HRDL   N+L++  +  K+SDFG++R    + 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 377 NEANTNRVAG---TYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQ 433
           ++       G      + APE      F+  SDV+S+G+++ E++S              
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE----------- 231

Query: 434 SLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVML 493
                 +      + +  ++   +             + L C Q+D  HRP    +V  L
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 7e-35
 Identities = 47/184 (25%), Positives = 69/184 (37%), Gaps = 23/184 (12%)

Query: 310 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 369
           S   + L     +     +   + YL        +HRDL   NVL+  +   K+SDFG+ 
Sbjct: 94  SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT 150

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
           +  S  Q+            + APE   E  FS KSDV+SFG+LL EI S  R    Y  
Sbjct: 151 KEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV--PYPR 203

Query: 430 EHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
              + ++        KG  ++  D                 +   C   D A RP+   +
Sbjct: 204 IPLKDVV----PRVEKGYKMDAPDGCPPA---------VYEVMKNCWHLDAAMRPSFLQL 250

Query: 490 VVML 493
              L
Sbjct: 251 REQL 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 9e-35
 Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 21/201 (10%)

Query: 293 FILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 352
           F+     +         ++  + L  ++ +     +ARG+ YL +    + IHRDL   N
Sbjct: 101 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARN 157

Query: 353 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGV 412
           +L+      KI+DFG++R   G +             +MA E     V++  SDV+S+GV
Sbjct: 158 ILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 214

Query: 413 LLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG 472
           LL EI+S       Y       L    ++   +G  LE       +            + 
Sbjct: 215 LLWEIVSLGGT--PYCGMTCAEL----YEKLPQGYRLEKPLNCDDE---------VYDLM 259

Query: 473 LLCVQEDPAHRPNMSSVVVML 493
             C +E P  RP+ + ++V L
Sbjct: 260 RQCWREKPYERPSFAQILVSL 280

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-34
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 20/190 (10%)

Query: 303 RRRINKDSTKGAQLDWKRRISIINGIARGLLYLHE--DSRLRVIHRDLKTSNVLLDHEMN 360
              I K + +   LD +  + ++  +   L   H   D    V+HRDLK +NV LD + N
Sbjct: 93  ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 152

Query: 361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            K+ DFG+ARI + + + A      GT  YM+PE      ++ KSD++S G LL E+ + 
Sbjct: 153 VKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 210

Query: 421 KRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDP 480
                 + +   + L         +G+   +            EL + I      +    
Sbjct: 211 MP---PFTAFSQKELA----GKIREGKFRRIPYR------YSDELNEII---TRMLNLKD 254

Query: 481 AHRPNMSSVV 490
            HRP++  ++
Sbjct: 255 YHRPSVEEIL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 20/184 (10%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           +      K  I     +A+G+      +  + +HRDL   N +LD +   K++DFG+AR 
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179

Query: 372 FSGNQNEANTNR--VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
               + ++  N+        +MA E      F+ KSDV+SFGVLL E+++       Y  
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPD 237

Query: 430 EHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
            +   +  Y  +         L+ P   + C D        + L C       RP+ S +
Sbjct: 238 VNTFDITVYLLQ------GRRLLQP---EYCPD----PLYEVMLKCWHPKAEMRPSFSEL 284

Query: 490 VVML 493
           V  +
Sbjct: 285 VSRI 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 3e-34
 Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 18/201 (8%)

Query: 293 FILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 352
           ++            N       QL  K  +S    +ARG+ YL      + IHRDL   N
Sbjct: 109 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 165

Query: 353 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGV 412
           VL+  +   KI+DFG+AR          T        +MAPE   + +++ +SDV+SFGV
Sbjct: 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225

Query: 413 LLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG 472
           LL EI +   +   Y     + L    +KL  +G  ++       +            + 
Sbjct: 226 LLWEIFTLGGS--PYPGVPVEEL----FKLLKEGHRMDKPSNCTNE---------LYMMM 270

Query: 473 LLCVQEDPAHRPNMSSVVVML 493
             C    P+ RP    +V  L
Sbjct: 271 RDCWHAVPSQRPTFKQLVEDL 291

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 3e-34
 Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 20/216 (9%)

Query: 296 LGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 355
           L S++   R    ++   A     + I +   IA G+ YL+ +   + +HRDL   N ++
Sbjct: 110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166

Query: 356 DHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLL 415
             +   KI DFGM R            +      +M+PE   +GVF+  SDV+SFGV+L 
Sbjct: 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226

Query: 416 EIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLC 475
           EI +       Y     + +L    +   +G  L+  D                 +  +C
Sbjct: 227 EIATLAEQ--PYQGLSNEQVL----RFVMEGGLLDKPDNCPDM---------LFELMRMC 271

Query: 476 VQEDPAHRPNMSSVVVMLASDTATLPPPTQPAFSVD 511
            Q +P  RP+   ++  +  +    P   + +F   
Sbjct: 272 WQYNPKMRPSFLEIISSIKEEME--PGFREVSFYYS 305

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 4e-34
 Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 18/179 (10%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
               +         + +  G++YLH    + + HRD+K  N+LLD   N KISDFG+A +
Sbjct: 96  PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV 152

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSE 430
           F  N  E   N++ GT  Y+APE      F +   DV+S G++L  +++G+         
Sbjct: 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW------ 206

Query: 431 HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
              S     +  W + +        +    +   LL         + E+P+ R  +  +
Sbjct: 207 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--LLHK------ILVENPSARITIPDI 257

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 5e-34
 Identities = 40/198 (20%), Positives = 76/198 (38%), Gaps = 19/198 (9%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           K  ++       +++ ++ G+ YL        +HRDL   NVLL +    KISDFG+++ 
Sbjct: 102 KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158

Query: 372 FSGNQNEAN-TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE 430
              + +     +       + APE      FS +SDV+S+GV + E +S  +    Y   
Sbjct: 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKM 216

Query: 431 HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
            G  ++        +G+ +E       +            +   C       RP+  +V 
Sbjct: 217 KGPEVM----AFIEQGKRMECPPECPPE---------LYALMSDCWIYKWEDRPDFLTVE 263

Query: 491 VMLASDTATLPPPTQPAF 508
             + +   +L    +   
Sbjct: 264 QRMRACYYSLASKVEGHH 281

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 6e-34
 Identities = 39/180 (21%), Positives = 77/180 (42%), Gaps = 21/180 (11%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMAR 370
           +   +  K   S    I +GL +LH  +   +IHRDLK  N+ +     + KI D G+A 
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163

Query: 371 IFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE 430
           +   +        V GT  +MAPE   E  +    DV++FG+ +LE+ + +    +   +
Sbjct: 164 LKRASF----AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQ 216

Query: 431 HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           +   +    ++    G     + P         E+ + I     C++++   R ++  ++
Sbjct: 217 NAAQI----YRRVTSG-----VKPASFDKVAIPEVKEII---EGCIRQNKDERYSIKDLL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 38/182 (20%), Positives = 71/182 (39%), Gaps = 19/182 (10%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
              +   ++ + +   +   + YL      + +HRDL   N L++ +   K+SDFG++R 
Sbjct: 93  MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
              ++  ++         +  PE  M   FS KSD+++FGVL+ EI S  +         
Sbjct: 150 VLDDEYTSSVGSK-FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK--------- 199

Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV 491
                   ++ +   E  E +   L+         K   I   C  E    RP    ++ 
Sbjct: 200 ------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 253

Query: 492 ML 493
            +
Sbjct: 254 NI 255

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-32
 Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 24/175 (13%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
            D +R  + I  +A  L Y H     RVIHRD+K  N+LL      KI+DFG +     +
Sbjct: 103 FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
           +       + GT  Y+ PE     +   K D++S GVL  E + GK        E     
Sbjct: 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEANTYQ 210

Query: 436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
            TY      +    + +    +      +L+         ++ +P+ RP +  V+
Sbjct: 211 ETYKRISRVEFTFPDFVTEGAR------DLISR------LLKHNPSQRPMLREVL 253

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 5e-32
 Identities = 39/183 (21%), Positives = 74/183 (40%), Gaps = 24/183 (13%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
               L   +   +       L YLH+    ++IHRDLK  N+L   + + K++DFG++  
Sbjct: 103 LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGF 426
            +      ++    GT  +MAPE  M     +  +  K+DV+S G+ L+E+   +     
Sbjct: 160 NTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP---P 214

Query: 427 YLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM 486
           +   +   +L        K E   L  P    +   +     +     C++++   R   
Sbjct: 215 HHELNPMRVL----LKIAKSEPPTLAQP----SRWSSNFKDFL---KKCLEKNVDARWTT 263

Query: 487 SSV 489
           S +
Sbjct: 264 SQL 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 5e-32
 Identities = 43/183 (23%), Positives = 67/183 (36%), Gaps = 18/183 (9%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
                           +A G+ YL      R IHRDL   N+LL      KI DFG+ R 
Sbjct: 104 HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160

Query: 372 FSGNQNE-ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSE 430
              N +           + + APE      FS  SD + FGV L E+ +  +    ++  
Sbjct: 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGL 218

Query: 431 HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
           +G  +L    K+  +GE L   +   +            ++ + C    P  RP   ++ 
Sbjct: 219 NGSQIL---HKIDKEGERLPRPEDCPQ---------DIYNVMVQCWAHKPEDRPTFVALR 266

Query: 491 VML 493
             L
Sbjct: 267 DFL 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (307), Expect = 9e-32
 Identities = 46/178 (25%), Positives = 71/178 (39%), Gaps = 27/178 (15%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           L      ++ +G  +GL YLH      +IHRD+K  N+LL      K+ DFG A I +  
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-- 166

Query: 376 QNEANTNRVAGTYGYMAPEYAM---EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG 432
                 N   GT  +MAPE  +   EG +  K DV+S G+  +E+   K       + + 
Sbjct: 167 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNA 219

Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV 490
            S L             +   P L+           +     C+Q+ P  RP    ++
Sbjct: 220 MSALY---------HIAQNESPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 2e-31
 Identities = 41/180 (22%), Positives = 66/180 (36%), Gaps = 19/180 (10%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           LD    I     ++  L YL      R +HRD+   NVL+      K+ DFG++R    +
Sbjct: 105 LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-D 160

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
                 ++      +MAPE      F+  SDV+ FGV + EI+         +  +    
Sbjct: 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--- 217

Query: 436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS 495
                     GE L +             L   +     C   DP+ RP  + +   L++
Sbjct: 218 ---VIGRIENGERLPMPP------NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-29
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 23/195 (11%)

Query: 317 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ 376
           D  +  ++     + L +LH     +VIHRD+K+ N+LL  + + K++DFG     +  Q
Sbjct: 114 DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 377 NEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLL 436
           ++ +T  + GT  +MAPE      +  K D++S G++ +E+I G+     YL+E+    L
Sbjct: 171 SKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL 225

Query: 437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV----VM 492
                L       EL +P      + A     +     C+  D   R +   ++    + 
Sbjct: 226 ----YLIATNGTPELQNP----EKLSAIFRDFL---NRCLDMDVEKRGSAKELLQHQFLK 274

Query: 493 LASDTATLPPPTQPA 507
           +A   ++L P    A
Sbjct: 275 IAKPLSSLTPLIAAA 289

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 4e-26
 Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 16/209 (7%)

Query: 291 TLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 350
           T   L+   V        D      +  +    ++  + RGL +LH     RV+HRDLK 
Sbjct: 88  TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKP 144

Query: 351 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSF 410
            N+L+      K++DFG+ARI+S          V  T  Y APE  ++  ++   D++S 
Sbjct: 145 QNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSV 201

Query: 411 GVLLLEIISGKR-----NSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL 465
           G +  E+   K      +    L +    +     + W +  AL       K      + 
Sbjct: 202 GCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF 261

Query: 466 LKCIHIGLL-----CVQEDPAHRPNMSSV 489
           +  I          C+  +PA R +  S 
Sbjct: 262 VTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  104 bits (260), Expect = 1e-25
 Identities = 30/192 (15%), Positives = 60/192 (31%), Gaps = 22/192 (11%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-----KISDF 366
            G +   K        +   +  +HE     +++RD+K  N L+    +       + DF
Sbjct: 94  CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150

Query: 367 GMARIFSGNQNEAN-----TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
           GM + +     + +        ++GT  YM+    +    S + D+ + G + +  + G 
Sbjct: 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210

Query: 422 RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPA 481
                     G    T   K    GE  +             E  K +H           
Sbjct: 211 LPW------QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH---YARNLAFD 261

Query: 482 HRPNMSSVVVML 493
             P+   +  + 
Sbjct: 262 ATPDYDYLQGLF 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 3e-25
 Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 20/173 (11%)

Query: 315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 374
             D          I   L YLH      +IHRDLK  N+LL+ +M+ +I+DFG A++ S 
Sbjct: 104 SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160

Query: 375 NQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
              +A  N   GT  Y++PE   E      SD+++ G ++ ++++G      + + +   
Sbjct: 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP---PFRAGNEYL 217

Query: 435 LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS 487
           +     K   + +  E   P  +      +L++        +  D   R    
Sbjct: 218 IFQKIIK--LEYDFPEKFFPKAR------DLVEK------LLVLDATKRLGCE 256

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  103 bits (258), Expect = 7e-25
 Identities = 34/180 (18%), Positives = 66/180 (36%), Gaps = 21/180 (11%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGMA 369
           +  ++     +  +  + +GL ++HE      +H DLK  N++   + +   K+ DFG+ 
Sbjct: 117 EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLS 429
                 Q+        GT  + APE A        +D++S GVL   ++SG      +  
Sbjct: 174 AHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS---PFGG 227

Query: 430 EHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
           E+    L       C     +     + +   D   ++        +  DP  R  +   
Sbjct: 228 ENDDETLRNVKS--CDWNMDDSAFSGISEDGKD--FIRK------LLLADPNTRMTIHQA 277

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (253), Expect = 1e-24
 Identities = 30/190 (15%), Positives = 61/190 (32%), Gaps = 20/190 (10%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL---LDHEMNPKISDFGM 368
              +   K  + + + +   + Y+H       IHRD+K  N L           I DFG+
Sbjct: 96  CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152

Query: 369 ARIFSGNQNEAN-----TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRN 423
           A+ +   +   +        + GT  Y +    +    S + D+ S G +L+    G   
Sbjct: 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 212

Query: 424 SGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHR 483
                +                 + +     VL +    +E    ++    C       +
Sbjct: 213 WQGLKAAT-----KRQKYERISEKKMSTPIEVLCKGY-PSEFATYLN---FCRSLRFDDK 263

Query: 484 PNMSSVVVML 493
           P+ S +  + 
Sbjct: 264 PDYSYLRQLF 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  100 bits (250), Expect = 3e-24
 Identities = 40/184 (21%), Positives = 70/184 (38%), Gaps = 25/184 (13%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           +   L  K    I+  +   +  LH+   L ++HRDLK  N+LLD +MN K++DFG +  
Sbjct: 103 EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGV------FSVKSDVFSFGVLLLEIISGKRNSG 425
               +       V GT  Y+APE     +      +  + D++S GV++  +++G     
Sbjct: 160 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---- 212

Query: 426 FYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN 485
                H + +L     +    +           T  D  L+         +   P  R  
Sbjct: 213 -PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD--LVSR------FLVVQPQKRYT 263

Query: 486 MSSV 489
               
Sbjct: 264 AEEA 267

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  100 bits (250), Expect = 9e-24
 Identities = 35/181 (19%), Positives = 68/181 (37%), Gaps = 21/181 (11%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGM 368
            +  ++     I+ +     GL ++HE     ++H D+K  N++ + +     KI DFG+
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGL 175

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           A   + ++          T  + APE          +D+++ GVL   ++SG      + 
Sbjct: 176 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS---PFA 229

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
            E     L    +  C  E  E     +     D   +K        +Q++P  R  +  
Sbjct: 230 GEDDLETLQNVKR--CDWEFDEDAFSSVSPEAKD--FIKN------LLQKEPRKRLTVHD 279

Query: 489 V 489
            
Sbjct: 280 A 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 97.5 bits (242), Expect = 3e-23
 Identities = 44/180 (24%), Positives = 83/180 (46%), Gaps = 19/180 (10%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           +  KR I +I    + L + H+     +IHRD+K +N+++      K+ DFG+AR  + +
Sbjct: 108 MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164

Query: 376 QNE-ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQS 434
            N    T  V GT  Y++PE A       +SDV+S G +L E+++G+     +  +   S
Sbjct: 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVS 221

Query: 435 LLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA 494
           +     +        + + P  +   + A+L   +   L  + ++P +R    +   M A
Sbjct: 222 VAYQHVR-------EDPIPPSARHEGLSADLDAVV---LKALAKNPENRY--QTAAEMRA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.2 bits (244), Expect = 4e-23
 Identities = 36/181 (19%), Positives = 71/181 (39%), Gaps = 21/181 (11%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP--KISDFGM 368
           T   +L+ +  +S ++ +   L +LH      + H D++  N++     +   KI +FG 
Sbjct: 94  TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150

Query: 369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
           AR      N      +     Y APE     V S  +D++S G L+  ++SG      +L
Sbjct: 151 ARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN---PFL 204

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
           +E  Q ++    +     E     +   K+  +  E +  +      + ++   R   S 
Sbjct: 205 AETNQQII----ENIMNAE-YTFDEEAFKE--ISIEAMDFVD---RLLVKERKSRMTASE 254

Query: 489 V 489
            
Sbjct: 255 A 255

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 98.7 bits (245), Expect = 4e-23
 Identities = 46/170 (27%), Positives = 70/170 (41%), Gaps = 22/170 (12%)

Query: 318 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 377
                     I  GL ++H      V++RDLK +N+LLD   + +ISD G+A  FS  + 
Sbjct: 106 EADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161

Query: 378 EANTNRVAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLL 436
               +   GT+GYMAPE   +GV +   +D FS G +L +++ G     F   +      
Sbjct: 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHE 216

Query: 437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM 486
                L    E  +   P L+       LL+        +Q D   R   
Sbjct: 217 IDRMTLTMAVELPDSFSPELR------SLLEG------LLQRDVNRRLGC 254

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.7 bits (240), Expect = 1e-22
 Identities = 37/177 (20%), Positives = 71/177 (40%), Gaps = 18/177 (10%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---KISDFGMARIF 372
              +    I+  I   + YLH    + + HRD+K  N+L   +      K++DFG A+  
Sbjct: 108 FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164

Query: 373 SGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG 432
           + + +         T  Y+APE      +    D++S GV++  ++ G      + S HG
Sbjct: 165 TSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHG 218

Query: 433 QSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
            ++          G+  E  +P   +  V  E+   I      ++ +P  R  ++  
Sbjct: 219 LAISPGMKTRIRMGQ-YEFPNPEWSE--VSEEVKMLIR---NLLKTEPTQRMTITEF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.8 bits (235), Expect = 4e-22
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 22/177 (12%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
              + D  R       I  GL +LH      +++RDLK  N+LLD + + KI+DFGM + 
Sbjct: 96  SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
                 +A TN   GT  Y+APE  +   ++   D +SFGVLL E++ G+    F+  + 
Sbjct: 153 NM--LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS--PFHGQDE 208

Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
            +    +             ++   K      +LL            +P  R  +  
Sbjct: 209 EE---LFHSIRMDNPFYPRWLEKEAK------DLLVK------LFVREPEKRLGVRG 250

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 4e-22
 Identities = 45/194 (23%), Positives = 77/194 (39%), Gaps = 19/194 (9%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           K   L        +  I RGL Y+H      V+HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 102 KTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158

Query: 372 FSGNQNEANT-NRVAGTYGYMAPEYAMEGVFSVKS-DVFSFGVLLLEIISGK-----RNS 424
              + +          T  Y APE  +      KS D++S G +L E++S +     ++ 
Sbjct: 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218

Query: 425 GFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELL---------KCIHIGLLC 475
              L+     L + + +       L+  + +L     +             K + +    
Sbjct: 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 278

Query: 476 VQEDPAHRPNMSSV 489
           +  +P  R  +   
Sbjct: 279 LTFNPHKRIEVEQA 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 92.1 bits (228), Expect = 3e-21
 Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 8/106 (7%)

Query: 317 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ 376
                      +   L YLH      +I+RDLK  N+LLD   + KI+DFG A+      
Sbjct: 102 PNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158

Query: 377 NEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR 422
                  + GT  Y+APE      ++   D +SFG+L+ E+++G  
Sbjct: 159 -----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.1 bits (223), Expect = 9e-21
 Identities = 35/181 (19%), Positives = 60/181 (33%), Gaps = 32/181 (17%)

Query: 311 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMA 369
           T+   L  +   S    +   + + H      V+HRD+K  N+L+D      K+ DFG  
Sbjct: 102 TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158

Query: 370 RIFSGNQNEANTNRVAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGKRNSGFYL 428
            +              GT  Y  PE+          + V+S G+LL +++ G        
Sbjct: 159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------ 208

Query: 429 SEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSS 488
                         +   E +       +Q         C H+   C+   P+ RP    
Sbjct: 209 -------------PFEHDEEIIRGQVFFRQRVSSE----CQHLIRWCLALRPSDRPTFEE 251

Query: 489 V 489
           +
Sbjct: 252 I 252

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 2e-20
 Identities = 41/187 (21%), Positives = 72/187 (38%), Gaps = 18/187 (9%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
           +      S +  + +GL + H     RV+HRDLK  N+L++ E   K++DFG+AR F   
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

Query: 376 QNEANTNRVAGTYGYMAPE-YAMEGVFSVKSDVFSFGVLLLEIISGK-----RNSGFYLS 429
                      T  Y APE       +S   D++S G +  E+++ +      +    L 
Sbjct: 156 VRTYTH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213

Query: 430 EHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG-----LL--CVQEDPAH 482
              ++L T    +W    ++    P   +            +      LL   +  DP  
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273

Query: 483 RPNMSSV 489
           R +  + 
Sbjct: 274 RISAKAA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 4e-20
 Identities = 37/196 (18%), Positives = 75/196 (38%), Gaps = 21/196 (10%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
              +        ++  +  GL Y+H +   +++HRD+K +NVL+  +   K++DFG+AR 
Sbjct: 110 VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166

Query: 372 FSGNQNEANTNR--VAGTYGYMAPEYAM-EGVFSVKSDVFSFGVLLLEIISGK-----RN 423
           FS  +N           T  Y  PE  + E  +    D++  G ++ E+ +         
Sbjct: 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226

Query: 424 SGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLL--------- 474
               L+   Q   +   ++W   +  EL + +        ++   +   +          
Sbjct: 227 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286

Query: 475 -CVQEDPAHRPNMSSV 489
             +  DPA R +    
Sbjct: 287 KLLVLDPAQRIDSDDA 302

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 5e-20
 Identities = 41/209 (19%), Positives = 76/209 (36%), Gaps = 19/209 (9%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
               L      + +    +GL YLH+     ++HRDLK +N+LLD     K++DFG+A+ 
Sbjct: 93  NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 149

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGK-----RNSG 425
           F              T  Y APE      ++ V  D+++ G +L E++         +  
Sbjct: 150 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207

Query: 426 FYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELL------KCIHIGLLCVQED 479
             L+   ++L T   + W    +L           +    +        + +       +
Sbjct: 208 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267

Query: 480 PAHRPNMSSVVVM--LASDTATLPPPTQP 506
           P  R   +  + M   ++     P    P
Sbjct: 268 PCARITATQALKMKYFSNRPGPTPGCQLP 296

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.5 bits (213), Expect = 2e-19
 Identities = 34/220 (15%), Positives = 71/220 (32%), Gaps = 19/220 (8%)

Query: 283 IGTIITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 342
              + +   L ++        ++           +  +       + + L  L       
Sbjct: 67  HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRN 121

Query: 343 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFS 402
           V+HRDLK  N+L++     K+++FG+AR F        +  V   +           ++S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 403 VKSDVFSFGVLLLEIISGKR------NSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVL 456
              D++S G +  E+ +  R      +    L    + L T   + W     L    P  
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 457 KQTCVDAELLKCIHIG-----LL--CVQEDPAHRPNMSSV 489
                 + +     +      LL   ++ +P  R +    
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 85.7 bits (211), Expect = 3e-19
 Identities = 50/210 (23%), Positives = 83/210 (39%), Gaps = 19/210 (9%)

Query: 293 FILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 352
            +L+   +    +   D  +G  L+     S +  +  G+ Y H+    RV+HRDLK  N
Sbjct: 75  LVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQN 130

Query: 353 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAM-EGVFSVKSDVFSFG 411
           +L++ E   KI+DFG+AR F     +        T  Y AP+  M    +S   D++S G
Sbjct: 131 LLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188

Query: 412 VLLLEIISGK-----RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDP--VLKQTCVDAE 464
            +  E+++G       +    L    + L T   K W     L   DP   + +      
Sbjct: 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248

Query: 465 LLKCIHIGLL-----CVQEDPAHRPNMSSV 489
            LK +    +      ++ DP  R      
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.4 bits (213), Expect = 4e-19
 Identities = 39/202 (19%), Positives = 66/202 (32%), Gaps = 18/202 (8%)

Query: 301 WCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-M 359
              R     S     L        +  + R L Y+H      + HRD+K  N+LLD +  
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTA 160

Query: 360 NPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
             K+ DFG A+     + E N + +   Y            ++   DV+S G +L E++ 
Sbjct: 161 VLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218

Query: 420 GKR-----NSGFYLSEHGQSLLTYAWKLWCKG--EALELMDPVLKQTCVDAELLKCIHIG 472
           G+      +    L E  + L T   +   +      E   P +K               
Sbjct: 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE 278

Query: 473 LL-----CVQEDPAHRPNMSSV 489
            +      ++  P  R      
Sbjct: 279 AIALCSRLLEYTPTARLTPLEA 300

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 32/174 (18%), Positives = 62/174 (35%), Gaps = 16/174 (9%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 375
              +    +I  +   + YLH+   +    +        LD +    ISDFG++++    
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163

Query: 376 QNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSL 435
                 +   GT GY+APE   +  +S   D +S GV+   ++ G      +  E+   L
Sbjct: 164 SV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKL 217

Query: 436 LTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSV 489
                K   + E        +  +  D   ++        +++DP  R      
Sbjct: 218 FEQILK--AEYEFDSPYWDDISDSAKD--FIRH------LMEKDPEKRFTCEQA 261

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.8 bits (209), Expect = 1e-18
 Identities = 39/175 (22%), Positives = 70/175 (40%), Gaps = 22/175 (12%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           +      +R       I   L YLH      V++RD+K  N++LD + + KI+DFG+ + 
Sbjct: 98  RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK- 153

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEH 431
             G  + A      GT  Y+APE   +  +    D +  GV++ E++ G+     + ++ 
Sbjct: 154 -EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL---PFYNQD 209

Query: 432 GQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNM 486
            + L         +      + P  K       LL         +++DP  R   
Sbjct: 210 HERLFELILM--EEIRFPRTLSPEAK------SLLAG------LLKKDPKQRLGG 250

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 84.1 bits (207), Expect = 2e-18
 Identities = 39/185 (21%), Positives = 65/185 (35%), Gaps = 25/185 (13%)

Query: 301 WCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 360
                +     +  +            I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179

Query: 361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISG 420
            +++DFG A+   G         + GT   +APE  +   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

Query: 421 KRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDP 480
                       Q +  Y   +  K          LK       LL+        +Q D 
Sbjct: 235 Y-----PPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD------LLRN------LLQVDL 277

Query: 481 AHRPN 485
             R  
Sbjct: 278 TKRFG 282

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.5 bits (203), Expect = 5e-18
 Identities = 41/183 (22%), Positives = 70/183 (38%), Gaps = 25/183 (13%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP----KISDFG 367
           +   L  +     +  I  G+ YLH    L++ H DLK  N++L     P    KI DFG
Sbjct: 106 EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162

Query: 368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFY 427
           +A              + GT  ++APE        +++D++S GV+   ++SG      +
Sbjct: 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PF 216

Query: 428 LSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDA-ELLKCIHIGLLCVQEDPAHRPNM 486
           L +  Q  L     +       E  D     T   A + ++        + +DP  R  +
Sbjct: 217 LGDTKQETLANVSAV-----NYEFEDEYFSNTSALAKDFIRR------LLVKDPKKRMTI 265

Query: 487 SSV 489
              
Sbjct: 266 QDS 268

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.9 bits (191), Expect = 3e-16
 Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 23/193 (11%)

Query: 312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 371
           K  +L   R   ++  + +GL Y+H      +IHRDLK  N+ ++ +   KI DFG+AR 
Sbjct: 114 KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR- 169

Query: 372 FSGNQNEANTNRVAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIISGK-----RNSG 425
               Q ++       T  Y APE  +  + ++   D++S G ++ E+I+GK      +  
Sbjct: 170 ----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225

Query: 426 FYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH-------IGLL--CV 476
             L E  +   T   +   + ++ E  + +     ++ +    I        + LL   +
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285

Query: 477 QEDPAHRPNMSSV 489
             D   R      
Sbjct: 286 VLDAEQRVTAGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.7 bits (180), Expect = 5e-15
 Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 18/164 (10%)

Query: 324 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 383
           +   +   +L L    +L +I+RD+K  N+LLD   +  ++DFG+++ F  ++ E     
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYD 189

Query: 384 VAGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISGKRNSGFY-LSEHGQSLLTYAW 440
             GT  YMAP+    G        D +S GVL+ E+++G     F    E          
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRR 247

Query: 441 KLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP 484
            L  +    + M  + K      +L++        + +DP  R 
Sbjct: 248 ILKSEPPYPQEMSALAK------DLIQR------LLMKDPKKRL 279

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 73.1 bits (178), Expect = 1e-14
 Identities = 28/122 (22%), Positives = 53/122 (43%), Gaps = 5/122 (4%)

Query: 301 WCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-M 359
                I K   +G  L + ++I     +  GL Y+H   R  +IH D+K  NVL++    
Sbjct: 109 NLLALIKKYEHRGIPLIYVKQI--SKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDS 164

Query: 360 NPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS 419
              +    +A + +    + +      T  Y +PE  +   +   +D++S   L+ E+I+
Sbjct: 165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224

Query: 420 GK 421
           G 
Sbjct: 225 GD 226

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.9 bits (175), Expect = 3e-14
 Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 6/105 (5%)

Query: 317 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ 376
           D +R   ++  +  G+ +LH      +IHRDLK SN+++  +   KI DFG+AR    + 
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

Query: 377 NEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK 421
                     T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 174 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 69.9 bits (170), Expect = 1e-13
 Identities = 27/109 (24%), Positives = 50/109 (45%), Gaps = 8/109 (7%)

Query: 316 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSG 374
           L        +  I + L Y H    + ++HRD+K  NV++DHE    ++ D+G+A  +  
Sbjct: 126 LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182

Query: 375 NQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKR 422
            Q     N    +  +  PE  ++  ++    D++S G +L  +I  K 
Sbjct: 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.2 bits (163), Expect = 1e-12
 Identities = 45/202 (22%), Positives = 78/202 (38%), Gaps = 23/202 (11%)

Query: 301 WCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 360
                   +  K  +L       +I  I RGL Y+H      +IHRDLK SN+ ++ +  
Sbjct: 103 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 159

Query: 361 PKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV-FSVKSDVFSFGVLLLEIIS 419
            KI DFG+AR            R      Y APE  +  + ++   D++S G ++ E+++
Sbjct: 160 LKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

Query: 420 GK-----RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG-- 472
           G+      +    L    + + T   +L  K  +    + +   T +       + IG  
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN 274

Query: 473 -----LL--CVQEDPAHRPNMS 487
                LL   +  D   R   +
Sbjct: 275 PLAVDLLEKMLVLDSDKRITAA 296

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 55.6 bits (133), Expect = 1e-09
 Identities = 18/100 (18%), Positives = 33/100 (33%), Gaps = 11/100 (11%)

Query: 318 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 377
            +    +++ I   +   +      ++H DL   NVL+  E    I DF  +        
Sbjct: 102 VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGW 157

Query: 378 EANTNR-VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLE 416
                R V     Y +  Y        + D+ S    +L+
Sbjct: 158 REILERDVRNIITYFSRTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	541
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.98
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.98
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.97
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.97
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.96
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.96
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.96
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.96
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.96
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.96
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.96
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.96
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.96
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.96
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.96
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.96
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.96
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.96
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.96
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.96
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.96
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.95
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.95
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.95
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.95
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.94
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.94
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.94
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.94
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.94
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.94
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.93
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.93
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.93
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.92
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.92
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.92
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.16
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	87.13
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	85.9
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	85.72
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	81.16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-35  Score=287.26  Aligned_cols=194  Identities=23%  Similarity=0.360  Sum_probs=138.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+.+|.|...+++      .+..+++.+++.|+.||++||+|||+++   ||||||||+|||++.++.+||+|||
T Consensus        79 ~lv~Ey~~~g~L~~~l~~------~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHI------IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             EEEEECCCEEEHHHHHHT------SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             EEEEecCCCCCHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccc
Confidence            456677777777655532      1245999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAME---GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      +++...............||+.|+|||++.+   +.++.++|||||||++|||++|+.||.....      .........
T Consensus       150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~------~~~~~~~~~  223 (276)
T d1uwha_         150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIFMVG  223 (276)
T ss_dssp             CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHH
T ss_pred             ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh------HHHHHHHHh
Confidence            9987655444444455679999999999864   3589999999999999999999999853211      111111122


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCC
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLP  501 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~  501 (541)
                      .+.....+ ..+..    .....+.+|+.+||+.||++|||++||++.|+.....+|
T Consensus       224 ~~~~~p~~-~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         224 RGYLSPDL-SKVRS----NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             HTSCCCCG-GGSCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             cCCCCCcc-hhccc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            21111100 01111    223457788899999999999999999999987554443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.7e-34  Score=289.44  Aligned_cols=189  Identities=27%  Similarity=0.366  Sum_probs=140.1

Q ss_pred             HHHHHHHHHhhheeccccccc----------------cCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCC
Q 009186          288 TTITLFILLGSFVWCRRRINK----------------DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS  351 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~----------------~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~  351 (541)
                      ++++||+..|.|...+++...                .......|++.+++.++.||++||+|||+++   ||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence            345677777777544433211                1123456999999999999999999999999   999999999


Q ss_pred             cEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCc
Q 009186          352 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSE  430 (541)
Q Consensus       352 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~  430 (541)
                      |||++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |+.||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987665544444445678999999999999999999999999999999997 89998532211


Q ss_pred             CcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 009186          431 HGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLA  494 (541)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~  494 (541)
                         ..   .......+...         ..+......+.+|+.+||+.||++|||++||+++|.
T Consensus       274 ---~~---~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 ---AN---FYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             ---HH---HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---HH---HHHHHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence               11   11222222111         111122346778899999999999999999999996

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.6e-34  Score=279.13  Aligned_cols=181  Identities=23%  Similarity=0.287  Sum_probs=136.7

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++|||+.+|.|...+++       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        78 ~~ivmEy~~gg~L~~~l~~-------~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DF  147 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDF  147 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBT-------TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEeccCCCcHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccc
Confidence            3456788888888665533       346999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      |+++.+.............||+.|+|||++.+..+ +.++|||||||++|||++|+.||......  ....    ..+..
T Consensus       148 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~----~~~~~  221 (271)
T d1nvra_         148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEY----SDWKE  221 (271)
T ss_dssp             TTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT--SHHH----HHHHT
T ss_pred             hhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH--HHHH----HHHhc
Confidence            99987654443333445689999999999988876 67899999999999999999998532211  1111    11111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .......        .......+.+|+.+||+.||++|||++|+++
T Consensus       222 ~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         222 KKTYLNP--------WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TCTTSTT--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCc--------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111000        0111235667888999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.6e-34  Score=280.72  Aligned_cols=184  Identities=28%  Similarity=0.421  Sum_probs=137.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+..|.|......     .....+++.++++|+.||++||+|||+++   |+||||||+||||+.++.+||+|||
T Consensus        83 ~iv~Ey~~~g~L~~~~~~-----~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKT-----PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             EEEEECCTTCBHHHHTTS-----HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecccc
Confidence            345677777777543322     12335999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++........ ......||+.|+|||.+.++.++.++|||||||++|||++|..|+....     ...+ .......+.
T Consensus       155 la~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~-~~~~i~~~~  227 (272)
T d1qpca_         155 LARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPE-VIQNLERGY  227 (272)
T ss_dssp             TCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHH-HHHHHHTTC
T ss_pred             ceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHH-HHHHHHhcC
Confidence            99876543322 2234568899999999999999999999999999999999766542111     1111 111122211


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      .     +.....    ....+.+|+.+||+.||++|||+++|+++|++
T Consensus       228 ~-----~~~p~~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         228 R-----MVRPDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             C-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C-----CCCccc----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            1     111111    23457788899999999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.2e-34  Score=281.53  Aligned_cols=195  Identities=25%  Similarity=0.396  Sum_probs=139.0

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      +|+||+..|.+......     .....++|.+++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        88 lv~Ey~~~g~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             EEECCCTTCBHHHHHSH-----HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             EEEEecCCCchhhhhhh-----cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccch
Confidence            45666666665433322     12335999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCc
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEA  448 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  448 (541)
                      ++........ ......||+.|+|||.+.++.++.++||||||+++|||++|..|+.....  ....+    .....+..
T Consensus       160 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~----~~i~~~~~  232 (285)
T d1fmka3         160 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVL----DQVERGYR  232 (285)
T ss_dssp             TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHH----HHHHTTCC
T ss_pred             hhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHH----HHHHhcCC
Confidence            9876443322 22345689999999999999999999999999999999997766532211  11111    11111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 009186          449 LELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDTATLPPPTQPA  507 (541)
Q Consensus       449 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~P~  507 (541)
                           .....    .....+.+++.+||+.||++||++++|+++|++.....+++.+|.
T Consensus       233 -----~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~  282 (285)
T d1fmka3         233 -----MPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG  282 (285)
T ss_dssp             -----CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred             -----CCCCc----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCC
Confidence                 11111    223457788999999999999999999999998777766666664

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.3e-34  Score=282.15  Aligned_cols=190  Identities=26%  Similarity=0.340  Sum_probs=133.2

Q ss_pred             HHHHHHHHhhheecccccc---------ccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC
Q 009186          289 TITLFILLGSFVWCRRRIN---------KDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM  359 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~---------~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~  359 (541)
                      +++||+..|.|...++...         ........+++.+++.++.||++||+|||+++   |+||||||+|||++.++
T Consensus        95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKN  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCC
Confidence            4456666666644333211         11223456999999999999999999999999   99999999999999999


Q ss_pred             CcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCcCcCcHHHH
Q 009186          360 NPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGK-RNSGFYLSEHGQSLLTY  438 (541)
Q Consensus       360 ~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~-~p~~~~~~~~~~~~~~~  438 (541)
                      .+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. .||.....   .   +.
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~---~---~~  245 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---D---EE  245 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC---S---HH
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH---H---HH
Confidence            99999999998766555444455567999999999999999999999999999999999975 45532211   1   11


Q ss_pred             HHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          439 AWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       439 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .......+....     ...    .....+.+++.+||+.||++|||++||+++|++.
T Consensus       246 ~~~~~~~~~~~~-----~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         246 FCRRLKEGTRMR-----APD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HHHHHHHTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCC-----CCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            122222222111     111    1233577889999999999999999999999753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=5.6e-34  Score=282.09  Aligned_cols=184  Identities=26%  Similarity=0.340  Sum_probs=128.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+..|.|....++      ....++|.+++.|+.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       103 ~iv~Ey~~~g~L~~~~~~------~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQ------NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             EEEEECCTTEEHHHHHHT------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEEEEecCCCcceeeecc------ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcc
Confidence            455677777777544432      2345999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCccc---ccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          368 MARIFSGNQNEAN---TNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       368 ~a~~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      +++.+........   .....||+.|+|||.+.++.++.++|||||||++|||++ |+.||....      ..+.... .
T Consensus       174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~------~~~~~~~-i  246 (299)
T d1jpaa_         174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT------NQDVINA-I  246 (299)
T ss_dssp             ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHH-H
T ss_pred             cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC------HHHHHHH-H
Confidence            9987654432221   122357889999999999999999999999999999998 899974321      1111111 1


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..+..         ...+......+.+|+.+||+.||++|||+.||++.|+..
T Consensus       247 ~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         247 EQDYR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             HTTCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HcCCC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11111         111122334577889999999999999999999998753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.9e-34  Score=278.19  Aligned_cols=184  Identities=26%  Similarity=0.338  Sum_probs=127.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+..|.|...+++      ....++++.++.|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        76 ~lv~E~~~~g~L~~~l~~------~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFG  146 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFG  146 (263)
T ss_dssp             EEEEECCTTCBHHHHHHT------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC
T ss_pred             EEEEEecCCCcHHHHhhc------cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccc
Confidence            456677777777554432      2346899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......... .....||..|+|||++.+..++.++|||||||++|||+++..|+...  ........    ....+.
T Consensus       147 la~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--~~~~~~~~----~i~~~~  219 (263)
T d1sm2a_         147 MTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVE----DISTGF  219 (263)
T ss_dssp             -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--CCHHHHHH----HHHHTC
T ss_pred             hheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--CCHHHHHH----HHHhcC
Confidence            998765433222 23356899999999999999999999999999999999965443211  11111111    111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .  ...       +.....++.+|+.+||+.||++|||++||+++|++.
T Consensus       220 ~--~~~-------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         220 R--LYK-------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             C--CCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C--CCC-------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1  111       111234577889999999999999999999999863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3e-33  Score=271.45  Aligned_cols=173  Identities=25%  Similarity=0.353  Sum_probs=134.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+.+|.|...+++       ...+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 ~ivmEy~~~g~L~~~l~~-------~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQK-------LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             EEEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EEEEeecCCCcHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccc
Confidence            455778888877655433       235999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...      ...+. ........
T Consensus       152 ~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~-~~~i~~~~  220 (263)
T d2j4za1         152 WSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------TYQET-YKRISRVE  220 (263)
T ss_dssp             SCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHH-HHHHHTTC
T ss_pred             eeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC------CHHHH-HHHHHcCC
Confidence            998654322    23457999999999999999999999999999999999999998432      11111 11112211


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .      .+...    ....+.+++.+||+.||++|||++|+++
T Consensus       221 ~------~~p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 F------TFPDF----VTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             C------CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C------CCCcc----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            1      11111    2235667888999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=6.4e-34  Score=280.00  Aligned_cols=186  Identities=25%  Similarity=0.341  Sum_probs=139.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+..|.+...+.+     .....+++..++.|+.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        89 ~iv~E~~~~g~l~~~l~~-----~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             EEEEECCTTCBHHHHHHH-----SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEEeecccCcchHHHhhh-----ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccc
Confidence            345567777776554432     12346999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++........ ......|+..|+|||.+.++.++.++|||||||++|||++|..|+....     ... ........+.
T Consensus       161 ~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~-~~~~~i~~~~  233 (287)
T d1opja_         161 LSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLS-QVYELLEKDY  233 (287)
T ss_dssp             CTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHH-HHHHHHHTTC
T ss_pred             ceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-----hHH-HHHHHHhcCC
Confidence            99876544322 2233467889999999999999999999999999999999777652111     111 1122222221


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ..         ..+......+.+|+.+||+.||++|||++||++.|+...
T Consensus       234 ~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         234 RM---------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CC---------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            11         111122346778999999999999999999999998754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.1e-33  Score=272.06  Aligned_cols=178  Identities=22%  Similarity=0.324  Sum_probs=136.4

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++||||+.+|.|....++        ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        92 ~~ivmEy~~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DF  160 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF  160 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEecCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccc
Confidence            4567788887777543322        25899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.+.....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...      ...+........+
T Consensus       161 G~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~~~~~~  232 (293)
T d1yhwa1         161 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE------NPLRALYLIATNG  232 (293)
T ss_dssp             TTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHHC
T ss_pred             hhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC------CHHHHHHHHHhCC
Confidence            99987654332  223457999999999999999999999999999999999999998422      1222222222221


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ... .       ..+......+.+++.+||+.||.+|||++|+++
T Consensus       233 ~~~-~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         233 TPE-L-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SCC-C-------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCC-C-------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111 0       001112345677889999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.1e-34  Score=277.95  Aligned_cols=184  Identities=23%  Similarity=0.276  Sum_probs=128.4

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCC--CceEecccCCCcEEEcCCCCcEEe
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSR--LRVIHRDLKTSNVLLDHEMNPKIS  364 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~--~~ivH~DLkp~NIll~~~~~~kL~  364 (541)
                      +++++||+.+|.|....++.   ...+..+++.+++.++.||+.||+|||+++.  .+|+||||||+|||++.++.+||+
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~---~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~  156 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKG---TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  156 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred             EEEEEecCCCCcHHHHHHhc---cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence            34567888888876554331   1234569999999999999999999998652  249999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||+++.+......  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....      ..+. ...+.
T Consensus       157 DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~------~~~~-~~~i~  227 (269)
T d2java1         157 DFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKEL-AGKIR  227 (269)
T ss_dssp             CHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHH-HHHHH
T ss_pred             eccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC------HHHH-HHHHH
Confidence            99999876543322  234678999999999999999999999999999999999999985321      1111 11222


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .+....     +...+    ...+.+|+.+||+.||++|||++|+++
T Consensus       228 ~~~~~~-----~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         228 EGKFRR-----IPYRY----SDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HTCCCC-----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCC-----CCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            222211     11112    235677888999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-33  Score=276.70  Aligned_cols=181  Identities=28%  Similarity=0.357  Sum_probs=137.8

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      +|+||+..|.|...+++       ...+++.++++|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        84 lvmE~~~~g~L~~~l~~-------~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGl  153 (277)
T d1xbba_          84 LVMEMAELGPLNKYLQQ-------NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL  153 (277)
T ss_dssp             EEEECCTTEEHHHHHHH-------CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHhh-------ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhh
Confidence            34677777777554432       345999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc-cccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          369 ARIFSGNQNEA-NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       369 a~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      ++.+....... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||....      ..+ .......+
T Consensus       154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~------~~~-~~~~i~~~  226 (277)
T d1xbba_         154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSE-VTAMLEKG  226 (277)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHH-HHHHHHTT
T ss_pred             hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC------HHH-HHHHHHcC
Confidence            98765443322 2334568899999999999999999999999999999998 899985321      111 11222222


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ....     ...    .....+.+|+.+||+.||++|||+++|+++|+.
T Consensus       227 ~~~~-----~p~----~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 ERMG-----CPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCC-----CCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCC-----CCc----ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            2111     111    223457788999999999999999999998875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-33  Score=277.06  Aligned_cols=183  Identities=22%  Similarity=0.286  Sum_probs=140.8

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++|+||+.+|.|...++.      .+..+++.++++++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        84 ~lvmE~~~~g~L~~~l~~------~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFG  154 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVG------KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFG  154 (285)
T ss_dssp             EEEEECCTTEEHHHHHTT------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEeCCCCcHHHHhhc------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccch
Confidence            356788888877554322      2346999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCc-ccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          368 MARIFSGNQNE-ANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       368 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      +++.+...... .......||+.|+|||.+.++.++.++|||||||++|||++ |+.||.....   ...    ......
T Consensus       155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~----~~~i~~  227 (285)
T d1u59a_         155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEV----MAFIEQ  227 (285)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHH----HHHHHT
T ss_pred             hhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHH----HHHHHc
Confidence            99877554332 22233468899999999999999999999999999999998 8999853221   111    122222


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +...+     ....    ....+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       228 ~~~~~-----~p~~----~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         228 GKRME-----CPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             TCCCC-----CCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCC-----CCCc----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            22211     1112    23457788999999999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-32  Score=268.51  Aligned_cols=165  Identities=25%  Similarity=0.403  Sum_probs=120.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc-ccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~a  392 (541)
                      ..+++.++++++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++........ .......||..|+|
T Consensus       105 ~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~A  181 (283)
T d1mqba_         105 GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA  181 (283)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSC
T ss_pred             ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccC
Confidence            46999999999999999999999999   999999999999999999999999999876543322 22233467899999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      ||.+.++.++.++|||||||++|||++|..|+.....  ....    ......+..         ...+......+.+|+
T Consensus       182 PE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~----~~~i~~~~~---------~~~~~~~~~~l~~li  246 (283)
T d1mqba_         182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEV----MKAINDGFR---------LPTPMDCPSAIYQLM  246 (283)
T ss_dssp             HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHH----HHHHHTTCC---------CCCCTTCBHHHHHHH
T ss_pred             HHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHH----HHHHhccCC---------CCCchhhHHHHHHHH
Confidence            9999999999999999999999999997666432211  1111    122222211         111122234677899


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      .+||+.||++|||+.||+++|+..
T Consensus       247 ~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         247 MQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHCcCCHhHCcCHHHHHHHHHHH
Confidence            999999999999999999999764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.9e-32  Score=265.50  Aligned_cols=177  Identities=23%  Similarity=0.333  Sum_probs=131.0

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc-CCCCcEEecc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDF  366 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~-~~~~~kL~Df  366 (541)
                      +++|||+..|.|...+++       ...+++.++..++.||++||+|||+++ .+|+||||||+|||++ .++.+||+||
T Consensus        88 ~ivmE~~~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKR-------FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             EEEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEeCCCCCcHHHHHhc-------cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeec
Confidence            345677777777555433       235899999999999999999999975 3499999999999996 5789999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.....    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....     .. ....+....+
T Consensus       160 Gla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~-~~~~~~i~~~  228 (270)
T d1t4ha_         160 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NA-AQIYRRVTSG  228 (270)
T ss_dssp             TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SH-HHHHHHHTTT
T ss_pred             CcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-----cH-HHHHHHHHcC
Confidence            999864322    2234679999999998865 69999999999999999999999985221     11 1112222222


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .....    +....    ...+.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~----~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 VKPAS----FDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCCGG----GGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCcc----cCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            11111    11111    234667888999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.2e-33  Score=272.23  Aligned_cols=177  Identities=24%  Similarity=0.291  Sum_probs=132.3

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++++|||+.+|.|....++       .+.+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        83 ~~ivmEy~~gg~L~~~~~~-------~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DF  152 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRK-------IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF  152 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEccCCCCHHHhhhc-------cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccc
Confidence            3456777777777544432       345999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...      +..+.... +...
T Consensus       153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~-i~~~  225 (288)
T d1uu3a_         153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG------NEYLIFQK-IIKL  225 (288)
T ss_dssp             TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHH-HHTT
T ss_pred             ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc------CHHHHHHH-HHcC
Confidence            9998876544444444567999999999999999999999999999999999999998532      11111111 1121


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVV  490 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl  490 (541)
                      ..      .+...    ....+.+|+.+||+.||.+|||++|++
T Consensus       226 ~~------~~p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         226 EY------DFPEK----FFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CC------CCCTT----CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CC------CCCcc----CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            11      11111    223567888999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-32  Score=271.93  Aligned_cols=190  Identities=28%  Similarity=0.358  Sum_probs=143.0

Q ss_pred             HHHHHHHHHhhheecccccc---------ccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC
Q 009186          288 TTITLFILLGSFVWCRRRIN---------KDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE  358 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~---------~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~  358 (541)
                      +++++|+..|.+...++...         ........|++.++++++.||+.||+|||+++   ||||||||+|||++.+
T Consensus        95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTED  171 (299)
T ss_dssp             EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred             EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCC
Confidence            34566666666644433211         11234567999999999999999999999999   9999999999999999


Q ss_pred             CCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHH
Q 009186          359 MNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLT  437 (541)
Q Consensus       359 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~  437 (541)
                      +.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |+.||....      . .
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~------~-~  244 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V-E  244 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------H-H
T ss_pred             CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC------H-H
Confidence            9999999999987765555444555678999999999999999999999999999999998 677764221      1 1


Q ss_pred             HHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          438 YAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..+..+..+....     .....    ...+.+|+.+||+.||++|||+.||++.|+..
T Consensus       245 ~~~~~i~~~~~~~-----~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         245 ELFKLLKEGHRMD-----KPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHHHHHTTCCCC-----CCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCC-----CCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            2223333332221     11122    24577899999999999999999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.7e-32  Score=268.29  Aligned_cols=180  Identities=23%  Similarity=0.279  Sum_probs=133.4

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++||||+..|.|.....+      .+..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        84 ~~lvmEy~~~g~L~~~~~~------~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DF  154 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLE------LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADF  154 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHH------HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEec
Confidence            4566788888877554332      1235999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAM-----EGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK  441 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~  441 (541)
                      |+++......  .......||+.|+|||++.     +..++.++|||||||++|||++|+.||.....   ...+.   .
T Consensus       155 G~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~~~---~  226 (288)
T d2jfla1         155 GVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRVLL---K  226 (288)
T ss_dssp             TTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHH---H
T ss_pred             hhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHH---H
Confidence            9987643221  1223467999999999984     45588999999999999999999999853221   11111   1


Q ss_pred             hhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          442 LWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       442 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .. .+.......       +......+.+|+.+||+.||++|||++|+++
T Consensus       227 i~-~~~~~~~~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         227 IA-KSEPPTLAQ-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HH-HSCCCCCSS-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HH-cCCCCCCCc-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11 111111111       1112345678889999999999999999976

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-32  Score=265.81  Aligned_cols=182  Identities=24%  Similarity=0.338  Sum_probs=137.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+..|.+......      ....+++..+++++.||++||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus        75 ~iv~Ey~~~g~l~~~~~~------~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG  145 (258)
T d1k2pa_          75 FIITEYMANGCLLNYLRE------MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFG  145 (258)
T ss_dssp             EEEEECCTTEEHHHHHHS------GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCS
T ss_pred             EEEEEccCCCcHHHhhhc------cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcch
Confidence            344566666665433222      2335899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++.+...... ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||....      ..+... .+..+
T Consensus       146 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~------~~~~~~-~i~~~  217 (258)
T d1k2pa_         146 LSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETAE-HIAQG  217 (258)
T ss_dssp             SCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC------HHHHHH-HHHTT
T ss_pred             hheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC------HHHHHH-HHHhC
Confidence            99876544332 2334568899999999999999999999999999999998 788875322      111111 12222


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ...  ..       +......+.+++.+||+.||++|||+++|++.|.+
T Consensus       218 ~~~--~~-------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         218 LRL--YR-------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCC--CC-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCC--CC-------cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            111  11       11223467788999999999999999999999865

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-32  Score=274.57  Aligned_cols=125  Identities=27%  Similarity=0.420  Sum_probs=105.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhc-CCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      ++|+||+.+|.|...+++       ...+++.++..++.||+.||.|||++ +   |+||||||+|||++.++.+||+||
T Consensus        80 ~iVmEy~~gg~L~~~l~~-------~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             EEEEECCTTEEHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeC
Confidence            456788877777655533       23589999999999999999999974 7   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGF  426 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~  426 (541)
                      |+++.+...    ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       150 Gla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         150 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             CCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             CCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999865422    22346899999999999999999999999999999999999999854

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.7e-32  Score=268.36  Aligned_cols=164  Identities=24%  Similarity=0.407  Sum_probs=126.2

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.++++++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...............||+.|+|
T Consensus       105 ~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A  181 (317)
T d1xkka_         105 KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA  181 (317)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccC
Confidence            346899999999999999999999998   99999999999999999999999999998765554444445678999999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.++.++.++|||||||++|||++ |+.||.....   ..+...    ...+...         ..+......+.+|
T Consensus       182 PE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~----i~~~~~~---------~~p~~~~~~~~~l  245 (317)
T d1xkka_         182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSI----LEKGERL---------PQPPICTIDVYMI  245 (317)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHH----HHHTCCC---------CCCTTBCHHHHHH
T ss_pred             hHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---HHHHHH----HHcCCCC---------CCCcccCHHHHHH
Confidence            999999999999999999999999998 7888753221   112211    1121111         1111223457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.||.+|||+.||++.|+.
T Consensus       246 i~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         246 MVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhCCCChhhCcCHHHHHHHHHH
Confidence            999999999999999999998865

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-32  Score=267.92  Aligned_cols=181  Identities=24%  Similarity=0.325  Sum_probs=126.5

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      ++++++..|.+.....+      ....+++.+++.++.||++||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        84 iv~E~~~~g~l~~~~~~------~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQV------RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             EEEECCTTEEHHHHHHH------TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEEEeccCCcHHhhhhc------cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence            44566666666433322      2346899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          369 ARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       369 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      ++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++ |.+||.....   ..+...    ...+.
T Consensus       155 a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~----i~~~~  226 (273)
T d1mp8a_         155 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGR----IENGE  226 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHH----HHTTC
T ss_pred             heeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCC
Confidence            9876543322 2334568899999999999999999999999999999998 8888753321   222221    11222


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhc
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      ...     +...    ....+.+|+.+||+.||++|||+.||++.|+.
T Consensus       227 ~~~-----~~~~----~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         227 RLP-----MPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             CCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCC-----CCCC----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            111     1112    23457788899999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.3e-31  Score=265.46  Aligned_cols=167  Identities=27%  Similarity=0.373  Sum_probs=128.5

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ....|++.+++.|+.||+.||+|||+++   ||||||||+|||++.++.+||+|||+++...............+++.|+
T Consensus       133 ~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~  209 (301)
T d1lufa_         133 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM  209 (301)
T ss_dssp             --CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGC
T ss_pred             CCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcC
Confidence            3456999999999999999999999999   9999999999999999999999999998765444344444567889999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGK-RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIH  470 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  470 (541)
                      |||.+.+..++.++|||||||++|||++|. +||...      ...+... ...++....     ....    ....+.+
T Consensus       210 aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~------~~~e~~~-~v~~~~~~~-----~p~~----~~~~~~~  273 (301)
T d1lufa_         210 PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM------AHEEVIY-YVRDGNILA-----CPEN----CPLELYN  273 (301)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHHH-HHHTTCCCC-----CCTT----CCHHHHH
T ss_pred             CHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC------CHHHHHH-HHHcCCCCC-----CCcc----chHHHHH
Confidence            999999999999999999999999999986 455322      1112111 122222211     1112    2245778


Q ss_pred             HHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          471 IGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       471 l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      |+.+||+.||++|||+.||+++|+...
T Consensus       274 li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         274 LMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            999999999999999999999998753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.3e-31  Score=265.75  Aligned_cols=183  Identities=21%  Similarity=0.220  Sum_probs=126.4

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc---CCCCcEE
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD---HEMNPKI  363 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~---~~~~~kL  363 (541)
                      ++++|||+.+|.|...+.+       ...+++.++..++.||+.||+|||+++   |+||||||+|||+.   .++.+||
T Consensus        82 ~~lvmE~~~gg~L~~~l~~-------~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl  151 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVE-------KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMI  151 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHT-------CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEeccCCCcHHHhhhc-------ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEE
Confidence            4566788877777655532       346999999999999999999999999   99999999999994   5788999


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      +|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....      ..+.... +
T Consensus       152 ~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~-i  221 (307)
T d1a06a_         152 SDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN------DAKLFEQ-I  221 (307)
T ss_dssp             CCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHH-H
T ss_pred             eccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC------HHHHHHH-H
Confidence            99999986543322   234579999999999999999999999999999999999999984321      1111111 1


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      ..+...  .....    .......+.+|+.+||+.||++|||++|+++  .+++
T Consensus       222 ~~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         222 LKAEYE--FDSPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HTTCCC--CCTTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             hccCCC--CCCcc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            111111  01111    1112345778889999999999999999987  3554

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.96  E-value=3e-31  Score=267.76  Aligned_cols=184  Identities=20%  Similarity=0.228  Sum_probs=136.6

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc--CCCCcEEe
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD--HEMNPKIS  364 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~--~~~~~kL~  364 (541)
                      ++++|||+.+|.|...+.+      +...+++.++..|+.||+.||+|||+++   |+||||||+|||++  .++.+||+
T Consensus        98 ~~ivmE~~~gg~L~~~l~~------~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~  168 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVAD------EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI  168 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTC------TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEEC
T ss_pred             EEEEEEcCCCCCHHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEe
Confidence            3456777777777554432      2346999999999999999999999999   99999999999995  46789999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||+++.+.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...      ...+..... .
T Consensus       169 DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i-~  238 (350)
T d1koaa2         169 DFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE------NDDETLRNV-K  238 (350)
T ss_dssp             CCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHH-H
T ss_pred             ecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC------CHHHHHHHH-H
Confidence            9999987654332   23467899999999999999999999999999999999999998422      111111111 1


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH--Hhc
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM--LAS  495 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~--L~~  495 (541)
                      .....  +......    .....+.+|+.+||+.||++|||++|+++.  +..
T Consensus       239 ~~~~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~  285 (350)
T d1koaa2         239 SCDWN--MDDSAFS----GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  285 (350)
T ss_dssp             HTCCC--SCCGGGG----GCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred             hCCCC--CCccccc----CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            11110  0111111    112356778889999999999999999974  544

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.3e-31  Score=265.84  Aligned_cols=177  Identities=25%  Similarity=0.327  Sum_probs=131.4

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++++||+..|.+.....+       +..+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        91 ~iv~E~~~~g~l~~~~~~-------~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG  160 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG  160 (309)
T ss_dssp             EEEEECCSEEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EEEEEecCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecc
Confidence            455666666655322211       246999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAME---GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      +++....      .....||+.|+|||++.+   +.++.++|||||||++|||++|+.||...      ...+.......
T Consensus       161 ~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~------~~~~~~~~i~~  228 (309)
T d1u5ra_         161 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQ  228 (309)
T ss_dssp             TCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHH
T ss_pred             cccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHh
Confidence            9986432      223579999999999864   45899999999999999999999998422      12222222222


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      . .....     ...   .....+.+|+.+||+.||++|||++|+++  .+..
T Consensus       229 ~-~~~~~-----~~~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         229 N-ESPAL-----QSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             S-CCCCC-----SCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             C-CCCCC-----CCC---CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            1 11111     111   11235677888999999999999999986  4543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.96  E-value=3.2e-31  Score=267.69  Aligned_cols=187  Identities=19%  Similarity=0.220  Sum_probs=138.9

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEc--CCCCcEEec
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD--HEMNPKISD  365 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~--~~~~~kL~D  365 (541)
                      ++||||+.+|.|.....+      ++..|++.+++.|+.||+.||+|||+++   |+||||||+|||++  .++.+||+|
T Consensus       102 ~ivmE~~~gg~L~~~~~~------~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~D  172 (352)
T d1koba_         102 VLILEFLSGGELFDRIAA------EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIID  172 (352)
T ss_dssp             EEEEECCCCCBHHHHTTC------TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECC
T ss_pred             EEEEEcCCCChHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEee
Confidence            456777777777543322      2346999999999999999999999999   99999999999998  578999999


Q ss_pred             ccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          366 FGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       366 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      ||+++.+.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....      ..+...... .
T Consensus       173 FGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~i~-~  242 (352)
T d1koba_         173 FGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED------DLETLQNVK-R  242 (352)
T ss_dssp             CTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHH-H
T ss_pred             cccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHH-h
Confidence            999987654332   234578999999999999999999999999999999999999984221      111111111 1


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcCCCC
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASDTAT  499 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~  499 (541)
                      ....      ............+.+|+.+||+.||.+|||+.|+++  ++++....
T Consensus       243 ~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~  292 (352)
T d1koba_         243 CDWE------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN  292 (352)
T ss_dssp             CCCC------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred             CCCC------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence            1110      011111112345678889999999999999999987  36654433

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1e-31  Score=267.47  Aligned_cols=167  Identities=28%  Similarity=0.412  Sum_probs=130.0

Q ss_pred             CCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCC
Q 009186          312 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       312 ~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ....+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||.++...............||+.|+
T Consensus       138 ~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~  214 (311)
T d1t46a_         138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM  214 (311)
T ss_dssp             --CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHc
Confidence            4456999999999999999999999999   9999999999999999999999999999876655555555678899999


Q ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          392 APEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       392 aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      |||.+.++.++.++||||||+++|||+++..|+.....  ...   ..+.....+..     +    ..+......+.+|
T Consensus       215 aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~--~~~---~~~~~i~~~~~-----~----~~~~~~~~~l~~L  280 (311)
T d1t46a_         215 APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--VDS---KFYKMIKEGFR-----M----LSPEHAPAEMYDI  280 (311)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--SSH---HHHHHHHHTCC-----C----CCCTTSCHHHHHH
T ss_pred             CHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC--HHH---HHHHHHhcCCC-----C----CCcccccHHHHHH
Confidence            99999999999999999999999999995555321111  111   11122222111     1    1111223467788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.||.+|||+++|+++|++
T Consensus       281 i~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         281 MKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHH
Confidence            999999999999999999999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.5e-31  Score=263.31  Aligned_cols=176  Identities=20%  Similarity=0.207  Sum_probs=126.1

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      +..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++........  .....||+.|+|
T Consensus        94 ~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~a  168 (299)
T d1ua2a_          94 SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRA  168 (299)
T ss_dssp             CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhcc
Confidence            346899999999999999999999999   999999999999999999999999999876543322  223578999999


Q ss_pred             hhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC---Cccccc------cccccCCCC-
Q 009186          393 PEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG---EALELM------DPVLKQTCV-  461 (541)
Q Consensus       393 PE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------~~~l~~~~~-  461 (541)
                      ||.+... .++.++|||||||++|||++|+.||.....   ...+....+.....   .+....      ........+ 
T Consensus       169 PE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (299)
T d1ua2a_         169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL  245 (299)
T ss_dssp             HHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCH
T ss_pred             HHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCCh
Confidence            9998755 579999999999999999999999853221   11111111111100   000000      000000001 


Q ss_pred             ----HHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcC
Q 009186          462 ----DAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASD  496 (541)
Q Consensus       462 ----~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~  496 (541)
                          ......+.+|+.+||+.||++|||++|+++  .|++.
T Consensus       246 ~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             HHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                112346788999999999999999999986  56643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.5e-31  Score=260.51  Aligned_cols=197  Identities=21%  Similarity=0.247  Sum_probs=139.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcC-----CCceEecccCCCcEEEcCCCCcE
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDS-----RLRVIHRDLKTSNVLLDHEMNPK  362 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~-----~~~ivH~DLkp~NIll~~~~~~k  362 (541)
                      ++++||+..|.|...+++        ..++|.++++++.|++.||.|||+..     ..+|+||||||+|||++.++.+|
T Consensus        77 ~lv~Ey~~~g~L~~~l~~--------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             EEEEecccCCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence            455777777777655543        24899999999999999999999741     12399999999999999999999


Q ss_pred             EecccccccccCCCCc--ccccccccCCCCCChhhhccCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCc--
Q 009186          363 ISDFGMARIFSGNQNE--ANTNRVAGTYGYMAPEYAMEGV------FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHG--  432 (541)
Q Consensus       363 L~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~------~s~~sDVwSlGvll~elltg~~p~~~~~~~~~--  432 (541)
                      |+|||+++........  .......||+.|+|||++.+..      ++.++|||||||++|||++|..|+........  
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            9999999876544322  2233467999999999987543      57789999999999999999887643221110  


Q ss_pred             ------CcHHHHHHHhhhcCCccccccccccCCC-CHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          433 ------QSLLTYAWKLWCKGEALELMDPVLKQTC-VDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       433 ------~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                            .............+    .+++.+.... ..+....+.+|+.+||+.||++|||+.||+++|+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                  11111122211111    1122221111 224456688999999999999999999999999753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.6e-31  Score=262.36  Aligned_cols=185  Identities=24%  Similarity=0.332  Sum_probs=136.4

Q ss_pred             HHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccc
Q 009186          289 TITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM  368 (541)
Q Consensus       289 ~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~  368 (541)
                      +|++|+..+.+....+.      +...+++..+++++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus       106 lv~E~~~~g~l~~~~~~------~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~  176 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRN------ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL  176 (311)
T ss_dssp             EEEECCTTCBHHHHHHC------TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred             EEEEEeecCchhhhhcc------ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccc
Confidence            34466666666443322      2345788999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--cccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          369 ARIFSGNQNEA--NTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       369 a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      ++.........  ......||..|+|||.+.++.++.++||||||+++|||++|+.||.....  ........    ..+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i----~~g  250 (311)
T d1r0pa_         177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYL----LQG  250 (311)
T ss_dssp             GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTT
T ss_pred             hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHH----HcC
Confidence            98765443222  22335688999999999999999999999999999999998888643221  11111111    112


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      ....  .   ..    .....+.+|+.+||+.||++||++.||++.|++..
T Consensus       251 ~~~~--~---p~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         251 RRLL--Q---PE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             CCCC--C---CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC--C---cc----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1111  1   11    12245778899999999999999999999998753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.96  E-value=4.4e-31  Score=258.56  Aligned_cols=185  Identities=22%  Similarity=0.306  Sum_probs=131.2

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++||||+.++.|.....+       .+.+++.+++.++.||+.||+|||+++   |+||||||+|||++.++..+|+|||
T Consensus        87 ~lvmE~~~g~~L~~~~~~-------~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHT-------EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEECCCEEEHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCT
T ss_pred             EEEEECCCCCEehhhhcc-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhh
Confidence            455777777766543322       345999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCC-cccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQN-EANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      .+........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||...      ...+.........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~~~~~~  230 (277)
T d1o6ya_         157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD------SPVSVAYQHVRED  230 (277)
T ss_dssp             TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHCC
T ss_pred             hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc------CHHHHHHHHHhcC
Confidence            9876543322 22333467999999999999999999999999999999999999998422      2222233333222


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-CHHHHHHHHhc
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-NMSSVVVMLAS  495 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-t~~evl~~L~~  495 (541)
                      .....   .....    ....+.+++.+||+.||.+|| |++++++.|..
T Consensus       231 ~~~~~---~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         231 PIPPS---ARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCCGG---GTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCCc---hhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            21110   11111    224567788899999999999 89999887753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.2e-30  Score=252.68  Aligned_cols=164  Identities=26%  Similarity=0.352  Sum_probs=126.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcc-cccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~a  392 (541)
                      ..+++..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.+....... ......++..|+|
T Consensus       106 ~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~a  182 (273)
T d1u46a_         106 GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA  182 (273)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCC
Confidence            45999999999999999999999999   9999999999999999999999999999875544332 2233457889999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||.+.+..++.++||||||+++|||++ |+.||...      ...+........+....     .....    ...+.+|
T Consensus       183 PE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~------~~~~~~~~i~~~~~~~~-----~~~~~----~~~l~~l  247 (273)
T d1u46a_         183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEGERLP-----RPEDC----PQDIYNV  247 (273)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTSCCCCC-----CCTTC----CHHHHHH
T ss_pred             HHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc------CHHHHHHHHHhCCCCCC-----Ccccc----cHHHHHH
Confidence            999999999999999999999999998 89997422      22222222222221111     11112    2457788


Q ss_pred             HhhhcccCCCCCCCHHHHHHHHhc
Q 009186          472 GLLCVQEDPAHRPNMSSVVVMLAS  495 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~~L~~  495 (541)
                      +.+||+.||++|||+.+|++.|++
T Consensus       248 i~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         248 MVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHh
Confidence            999999999999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.7e-32  Score=260.57  Aligned_cols=180  Identities=27%  Similarity=0.304  Sum_probs=131.5

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++|++|+..|.+...+++.     ....+++..+++|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~ey~~~g~L~~~l~~~-----~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg  148 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSR-----GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFG  148 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHH-----HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             EEEEeccCCCCHHHHHHhc-----CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccc
Confidence            4566777777776555331     1235899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIIS-GKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++.....     .....++..|+|||.+.++.++.++||||||+++|||++ |+.||....   ...+....    ..+
T Consensus       149 ~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i----~~~  216 (262)
T d1byga_         149 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV----EKG  216 (262)
T ss_dssp             C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHH----TTT
T ss_pred             cceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC---HHHHHHHH----HcC
Confidence            99864332     223457889999999999999999999999999999998 677764321   11222211    111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..     +.+    +......+.+|+.+||+.||++|||+.+|+++|+..
T Consensus       217 ~~-----~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         217 YK-----MDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-----CCC----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            11     111    112234567888999999999999999999999753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.8e-31  Score=262.44  Aligned_cols=176  Identities=22%  Similarity=0.275  Sum_probs=134.3

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++|++|+.+|.|....++       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.+|.+||+||
T Consensus        80 ~~iv~ey~~gg~L~~~~~~-------~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSR-------ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             cccceeccCCCchhhhhhc-------ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeec
Confidence            3456677777777554433       345899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....      ..+. ...+..+
T Consensus       150 G~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~------~~~~-~~~i~~~  220 (337)
T d1o6la_         150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERL-FELILME  220 (337)
T ss_dssp             TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHH-HHHHHHC
T ss_pred             ccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC------HHHH-HHHHhcC
Confidence            99986543322  2334679999999999999999999999999999999999999985322      1111 1111121


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~evl~  491 (541)
                      ..      .+....    ...+.+|+.+||+.||.+||+     ++|+++
T Consensus       221 ~~------~~p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         221 EI------RFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CC------CCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC------CCCccC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            11      111122    234677888999999999995     788875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.7e-31  Score=264.93  Aligned_cols=185  Identities=16%  Similarity=0.182  Sum_probs=136.1

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC---CCCcEE
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH---EMNPKI  363 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~---~~~~kL  363 (541)
                      +++++||+.+|.|...+++     .....+++.++..|+.||+.||+|||+++   |+||||||+|||++.   ++.+||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~-----~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHS-----CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEEECCCCCcHHHHHHh-----cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccc
Confidence            4667888888888665543     12346999999999999999999999999   999999999999986   456999


Q ss_pred             ecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhh
Q 009186          364 SDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLW  443 (541)
Q Consensus       364 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  443 (541)
                      +|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   .........
T Consensus       156 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~---~~~~~~~~i  229 (335)
T d2ozaa1         156 TDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKTRI  229 (335)
T ss_dssp             CCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC
T ss_pred             cccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH---HHHHHHHHH
Confidence            99999987654332   234579999999999999999999999999999999999999985322111   111111111


Q ss_pred             hcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          444 CKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       444 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..+..      .+...........+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         230 RMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSCSS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11000      0000001122346788999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.5e-31  Score=264.33  Aligned_cols=189  Identities=24%  Similarity=0.263  Sum_probs=137.3

Q ss_pred             HHHHHHHHHHhhheecccccc---------ccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC
Q 009186          287 ITTITLFILLGSFVWCRRRIN---------KDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH  357 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~---------~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~  357 (541)
                      +++|++|+..|.|...+++..         ........|++.++++++.||+.||.|||+++   |+||||||+|||++.
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE  162 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcC
Confidence            345566666666654443311         11234567999999999999999999999999   999999999999999


Q ss_pred             CCCcEEecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCCcCcCcHH
Q 009186          358 EMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKR-NSGFYLSEHGQSLL  436 (541)
Q Consensus       358 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~-p~~~~~~~~~~~~~  436 (541)
                      ++.+||+|||+++......   ......||..|+|||.+.++.++.++|||||||++|||++|.. ||..      ....
T Consensus       163 ~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~------~~~~  233 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG------MTCA  233 (309)
T ss_dssp             GGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT------CCHH
T ss_pred             CCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC------CCHH
Confidence            9999999999997643222   2223468999999999999999999999999999999999765 4422      1122


Q ss_pred             HHHHHhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          437 TYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      +.... ..++..     +..    +......+.+|+.+||+.||++|||++||++.|+...
T Consensus       234 ~~~~~-i~~~~~-----~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         234 ELYEK-LPQGYR-----LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             HHHHH-GGGTCC-----CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHH-HHhcCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            21111 222211     111    1122346778889999999999999999999987643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1e-30  Score=265.33  Aligned_cols=176  Identities=23%  Similarity=0.242  Sum_probs=132.7

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++||||+.+|.|...+++       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        83 ~ivmE~~~gg~L~~~l~~-------~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ-------HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEEEecCCCcHHHHHHh-------cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeec
Confidence            456777777777655433       345889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      +++.+....    .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......   .......... ..
T Consensus       153 la~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~~~~~-~~  224 (364)
T d1omwa3         153 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHEIDRMTL-TM  224 (364)
T ss_dssp             TCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS---CHHHHHHHSS-SC
T ss_pred             eeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcc-cC
Confidence            998765432    234579999999999975 46899999999999999999999998543221   1111111111 10


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPN-----MSSVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~evl~  491 (541)
                            ...+....    ...+.+|+.+||+.||++|||     ++|+++
T Consensus       225 ------~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 ------AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ------CCCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ------CCCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                  01111112    234677888999999999999     688875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=2.4e-30  Score=257.65  Aligned_cols=172  Identities=24%  Similarity=0.284  Sum_probs=131.3

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      ++|+||+.+|.+....++       +..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        80 ~ivmE~~~gg~l~~~~~~-------~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRK-------SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             EEEECCCCSCBHHHHHHH-------TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eeEeeecCCccccccccc-------cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCc
Confidence            445666666665443332       345788999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE  447 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  447 (541)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...      ...+...... .+.
T Consensus       150 ~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~i~-~~~  217 (316)
T d1fota_         150 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS------NTMKTYEKIL-NAE  217 (316)
T ss_dssp             SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHH-HCC
T ss_pred             cceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc------CHHHHHHHHH-cCC
Confidence            99875432     22467999999999999999999999999999999999999998532      1222222211 111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          448 ALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       448 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                      .      .+....    ...+.+++.+||+.||.+|+     |++++++
T Consensus       218 ~------~~p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 L------RFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             C------CCCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             C------CCCCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            1      111111    23466788899999999996     8999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=4.3e-30  Score=259.36  Aligned_cols=170  Identities=22%  Similarity=0.238  Sum_probs=129.9

Q ss_pred             HHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccccc
Q 009186          290 ITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA  369 (541)
Q Consensus       290 v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a  369 (541)
                      +++++.+|.+...+.+       .+.+++.++..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||++
T Consensus       119 v~e~~~~g~l~~~l~~-------~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a  188 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRR-------IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             EEECCTTCBHHHHHHH-------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccccccccchhhhHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceee
Confidence            3455555655444332       235899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCcc
Q 009186          370 RIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEAL  449 (541)
Q Consensus       370 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  449 (541)
                      +.+...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...      .......... .+.. 
T Consensus       189 ~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~i~-~~~~-  255 (350)
T d1rdqe_         189 KRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD------QPIQIYEKIV-SGKV-  255 (350)
T ss_dssp             EECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHH-HCCC-
T ss_pred             eecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc------CHHHHHHHHh-cCCC-
Confidence            876432     22457999999999999999999999999999999999999998422      2222222221 1111 


Q ss_pred             ccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          450 ELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       450 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                           .....    ....+.+++.+||+.||.+|+     |++++++
T Consensus       256 -----~~p~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 -----RFPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CCCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCcc----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 11111    223567788899999999994     8999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-30  Score=257.11  Aligned_cols=179  Identities=19%  Similarity=0.199  Sum_probs=133.9

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC----CcE
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM----NPK  362 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~----~~k  362 (541)
                      +++++||+.+|.|...+++       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++    .+|
T Consensus        88 ~~iv~E~~~gg~L~~~i~~-------~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          88 VILILELVAGGELFDFLAE-------KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EEEEEEcCCCccccchhcc-------ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceE
Confidence            3456777777777555433       235999999999999999999999999   99999999999998876    489


Q ss_pred             EecccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHh
Q 009186          363 ISDFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKL  442 (541)
Q Consensus       363 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~  442 (541)
                      |+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...      ...+.... 
T Consensus       158 l~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~-  227 (293)
T d1jksa_         158 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLAN-  227 (293)
T ss_dssp             ECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHH-
T ss_pred             ecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC------CHHHHHHH-
Confidence            999999987643322   22356899999999999999999999999999999999999998532      11111111 


Q ss_pred             hhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          443 WCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       443 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      +......  ..+.....    ....+.+|+.+||+.||++|||++|+++
T Consensus       228 i~~~~~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         228 VSAVNYE--FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHTTCCC--CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHhcCCC--CCchhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111110  00111111    1235678889999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-30  Score=260.67  Aligned_cols=176  Identities=23%  Similarity=0.323  Sum_probs=135.1

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++|+||+.+|.|...+++       ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        78 ~yivmEy~~~g~L~~~i~~-------~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          78 LFFVMEYLNGGDLMYHIQS-------CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             EEEEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             eeEEEeecCCCcHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceecccc
Confidence            4566788877877655543       335899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG  446 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  446 (541)
                      |+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...      ...+. +.....+
T Consensus       148 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~------~~~~~-~~~i~~~  218 (320)
T d1xjda_         148 GMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ------DEEEL-FHSIRMD  218 (320)
T ss_dssp             TTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHH-HHHHHHC
T ss_pred             chhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC------CHHHH-HHHHHcC
Confidence            99986543332  233457999999999999999999999999999999999999998532      11111 1111121


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHH-HHHH
Q 009186          447 EALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMS-SVVV  491 (541)
Q Consensus       447 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-evl~  491 (541)
                      ..      .+....    ...+.+|+.+||+.||++||++. ++++
T Consensus       219 ~~------~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 NP------FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CC------CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CC------CCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            11      111112    23467788899999999999995 6764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.96  E-value=3.1e-30  Score=251.94  Aligned_cols=179  Identities=21%  Similarity=0.288  Sum_probs=134.8

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecc
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF  366 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Df  366 (541)
                      +++++||+.+|.|...+++       +..+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        85 ~~ivmE~~~~g~L~~~l~~-------~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          85 FFLVFDLMKKGELFDYLTE-------KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             EEEEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             eEEEEEcCCCchHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence            4566788877777655543       336999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCCCCCChhhhcc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHH
Q 009186          367 GMARIFSGNQNEANTNRVAGTYGYMAPEYAME------GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAW  440 (541)
Q Consensus       367 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~  440 (541)
                      |+++.+.....   .....||..|+|||.+.+      ..++.++||||+||++|||++|+.||....      .... .
T Consensus       155 G~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~------~~~~-~  224 (277)
T d1phka_         155 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------QMLM-L  224 (277)
T ss_dssp             TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH-H
T ss_pred             hheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC------HHHH-H
Confidence            99987654332   233578999999999863      346889999999999999999999985321      1111 1


Q ss_pred             HhhhcCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          441 KLWCKGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       441 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .....+... ...+     ........+.+++.+||+.||++|||++||++
T Consensus       225 ~~i~~~~~~-~~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         225 RMIMSGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHhCCCC-CCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111222111 1011     11112345778889999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.1e-30  Score=254.08  Aligned_cols=165  Identities=27%  Similarity=0.381  Sum_probs=130.7

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..+++.++.+++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++...............+|+.|+||
T Consensus       128 ~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP  204 (308)
T d1p4oa_         128 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  204 (308)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCH
Confidence            45899999999999999999999998   999999999999999999999999999876555444444555789999999


Q ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHHH
Q 009186          394 EYAMEGVFSVKSDVFSFGVLLLEIISGK-RNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHIG  472 (541)
Q Consensus       394 E~l~~~~~s~~sDVwSlGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  472 (541)
                      |.+.++.++.++||||||+++|||++|. .||..      ....+... ...++.....         +......+.+++
T Consensus       205 e~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~------~~~~~~~~-~i~~~~~~~~---------p~~~~~~l~~li  268 (308)
T d1p4oa_         205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG------LSNEQVLR-FVMEGGLLDK---------PDNCPDMLFELM  268 (308)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT------SCHHHHHH-HHHTTCCCCC---------CTTCCHHHHHHH
T ss_pred             HHHccCCCCcccccccHHHHHHHHHhCCCCCCCC------CCHHHHHH-HHHhCCCCCC---------cccchHHHHHHH
Confidence            9999999999999999999999999985 55532      12222221 2222222111         111234678899


Q ss_pred             hhhcccCCCCCCCHHHHHHHHhcCC
Q 009186          473 LLCVQEDPAHRPNMSSVVVMLASDT  497 (541)
Q Consensus       473 ~~cl~~dP~~RPt~~evl~~L~~~~  497 (541)
                      .+||+.||.+|||+.+|+++|++..
T Consensus       269 ~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         269 RMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHhc
Confidence            9999999999999999999998764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.1e-29  Score=247.19  Aligned_cols=170  Identities=24%  Similarity=0.268  Sum_probs=124.1

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   .......||+.|+|
T Consensus       110 ~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~A  183 (305)
T d1blxa_         110 EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRA  183 (305)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcC
Confidence            446899999999999999999999999   999999999999999999999999998764322   22345679999999


Q ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC---c------c-cccc---ccccCC
Q 009186          393 PEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE---A------L-ELMD---PVLKQT  459 (541)
Q Consensus       393 PE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~------~-~~~~---~~l~~~  459 (541)
                      ||++.+..++.++|||||||++|||++|+.||.....   ...+...........   +      . ....   ......
T Consensus       184 PE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (305)
T d1blxa_         184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK  260 (305)
T ss_dssp             HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGG
T ss_pred             cchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCchhcccccccchhhhhccccccchhh
Confidence            9999999999999999999999999999999853221   111111111100000   0      0 0000   000000


Q ss_pred             CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          460 CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       460 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ........+.+|+.+||+.||++|||++|+++
T Consensus       261 ~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11112345677889999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=1.4e-28  Score=243.28  Aligned_cols=171  Identities=17%  Similarity=0.179  Sum_probs=126.1

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC---CCCcEEecccccccccCCCCc-----ccccccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH---EMNPKISDFGMARIFSGNQNE-----ANTNRVA  385 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~---~~~~kL~Dfg~a~~~~~~~~~-----~~~~~~~  385 (541)
                      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+++.+......     .......
T Consensus        98 ~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~  174 (299)
T d1ckia_          98 RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT  174 (299)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCC
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcC
Confidence            46899999999999999999999999   999999999999864   456999999999876544322     1233467


Q ss_pred             cCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHH
Q 009186          386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAEL  465 (541)
Q Consensus       386 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  465 (541)
                      ||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................     .+.+...+    .
T Consensus       175 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~----p  245 (299)
T d1ckia_         175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-----IEVLCKGY----P  245 (299)
T ss_dssp             CCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-----HHHHTTTS----C
T ss_pred             CCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-----hhHhccCC----C
Confidence            99999999999999999999999999999999999999865433322211111111000000     01111122    2


Q ss_pred             HHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          466 LKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       466 ~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                      ..+.+++..||+.||++||+++++.+.|+..
T Consensus       246 ~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            3567788899999999999999998888753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.9e-29  Score=244.24  Aligned_cols=177  Identities=21%  Similarity=0.244  Sum_probs=126.3

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ...+++.++..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||.++.......  ......||+.|+|
T Consensus        96 ~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~a  170 (298)
T d1gz8a_          96 LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRA  170 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeee
Confidence            346999999999999999999999999   99999999999999999999999999987643332  2334578999999


Q ss_pred             hhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC--ccccc------ccc---ccCC-
Q 009186          393 PEYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE--ALELM------DPV---LKQT-  459 (541)
Q Consensus       393 PE~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~------~~~---l~~~-  459 (541)
                      ||.+.... ++.++|||||||++|+|++|+.||....   ................  .....      ...   .... 
T Consensus       171 pE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (298)
T d1gz8a_         171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS---EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD  247 (298)
T ss_dssp             HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCC
T ss_pred             hhhhccccCCCccccccccchhhhHHhhCCCCCCCCC---HHHHHHHHHHhcCCCchhhccccccccccccccccccccc
Confidence            99887665 5789999999999999999999985321   1111111111110000  00000      000   0000 


Q ss_pred             ---CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH--HhcCC
Q 009186          460 ---CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM--LASDT  497 (541)
Q Consensus       460 ---~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~--L~~~~  497 (541)
                         ........+.+|+.+||+.||++|||++|+++.  +++..
T Consensus       248 ~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             HHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             hhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence               001123467788999999999999999999974  66543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.6e-29  Score=252.23  Aligned_cols=184  Identities=19%  Similarity=0.214  Sum_probs=136.0

Q ss_pred             HHHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC--CCcEEe
Q 009186          287 ITTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE--MNPKIS  364 (541)
Q Consensus       287 v~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~--~~~kL~  364 (541)
                      +++||||+.++.|...+++      .+..+++.++..|+.||+.||+|||+++   |+||||||+|||++.+  ..+||+
T Consensus        76 ~~lvmE~~~gg~L~~~i~~------~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~  146 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINT------SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKII  146 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTS------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEEC
T ss_pred             EEEEEecCCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEc
Confidence            4566777777777655532      2346999999999999999999999999   9999999999999854  478999


Q ss_pred             cccccccccCCCCcccccccccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhh
Q 009186          365 DFGMARIFSGNQNEANTNRVAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWC  444 (541)
Q Consensus       365 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  444 (541)
                      |||+++......   ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....      ..+...... 
T Consensus       147 DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~------~~~~~~~i~-  216 (321)
T d1tkia_         147 EFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET------NQQIIENIM-  216 (321)
T ss_dssp             CCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHH-
T ss_pred             ccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC------HHHHHHHHH-
Confidence            999998754332   2233568999999999999999999999999999999999999985321      111111111 


Q ss_pred             cCCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhc
Q 009186          445 KGEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLAS  495 (541)
Q Consensus       445 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~  495 (541)
                      .+...  ++.......    ...+.+|+.+||+.||++|||++|+++  +++.
T Consensus       217 ~~~~~--~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         217 NAEYT--FDEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HTCCC--CCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             hCCCC--CChhhccCC----CHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            11110  011111111    234678899999999999999999997  4544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.5e-29  Score=241.17  Aligned_cols=148  Identities=23%  Similarity=0.386  Sum_probs=117.6

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCC-CCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      ..+++.++..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+++......    .....||+.|+|
T Consensus       105 ~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~a  177 (273)
T d1xwsa_         105 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP  177 (273)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCC
Confidence            46999999999999999999999999   9999999999999854 789999999998653322    234679999999


Q ss_pred             hhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHHHHHHHHHH
Q 009186          393 PEYAMEGVF-SVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDAELLKCIHI  471 (541)
Q Consensus       393 PE~l~~~~~-s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  471 (541)
                      ||++.+..+ +.++|||||||++|||++|+.||....         ..   . .+..      .+....    ...+.++
T Consensus       178 PE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i---~-~~~~------~~~~~~----s~~~~~l  234 (273)
T d1xwsa_         178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EI---I-RGQV------FFRQRV----SSECQHL  234 (273)
T ss_dssp             HHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HH---H-HCCC------CCSSCC----CHHHHHH
T ss_pred             HHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HH---h-hccc------CCCCCC----CHHHHHH
Confidence            999987775 677999999999999999999985311         00   0 1110      111122    2356778


Q ss_pred             HhhhcccCCCCCCCHHHHHH
Q 009186          472 GLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       472 ~~~cl~~dP~~RPt~~evl~  491 (541)
                      +.+||+.||++|||++|+++
T Consensus       235 i~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         235 IRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHccCCHhHCcCHHHHhc
Confidence            88999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.94  E-value=9.6e-28  Score=235.70  Aligned_cols=171  Identities=24%  Similarity=0.323  Sum_probs=119.7

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMA  392 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  392 (541)
                      .+.+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||.+........  ......+++.|+|
T Consensus        94 ~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~  168 (286)
T d1ob3a_          94 EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRA  168 (286)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCC
T ss_pred             cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhh
Confidence            346999999999999999999999999   99999999999999999999999999987644322  2233468899999


Q ss_pred             hhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCC---cc---cc---------ccccc
Q 009186          393 PEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGE---AL---EL---------MDPVL  456 (541)
Q Consensus       393 PE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~---------~~~~l  456 (541)
                      ||.+.+. .++.++|||||||++|||++|+.||.....   ...............   ..   ..         ..+..
T Consensus       169 pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (286)
T d1ob3a_         169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP  245 (286)
T ss_dssp             HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCC
T ss_pred             HHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcc
Confidence            9998764 468999999999999999999999853211   111111111111000   00   00         00000


Q ss_pred             cCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          457 KQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       457 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ...........+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00111112346778899999999999999999984

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=242.12  Aligned_cols=170  Identities=19%  Similarity=0.186  Sum_probs=122.1

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEecccccccccCCCCcccccccccCCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVAGTYGYM  391 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  391 (541)
                      ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.+......   ....|+..|+
T Consensus       116 ~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~  189 (350)
T d1q5ka_         116 KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYR  189 (350)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCccc---cccccccccc
Confidence            446999999999999999999999999   99999999999999875 8999999999876543322   2357899999


Q ss_pred             Chhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHH-----------HHhhhcC----Ccccccccc
Q 009186          392 APEYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYA-----------WKLWCKG----EALELMDPV  455 (541)
Q Consensus       392 aPE~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~-----------~~~~~~~----~~~~~~~~~  455 (541)
                      |||.+.+ ..++.++|||||||++|||++|+.||......   ..+...           +......    .........
T Consensus       190 aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~---~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (350)
T d1q5ka_         190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP  266 (350)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCC
T ss_pred             ChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH---HHHHHHHHHhCCChHHhhhhhccchhhccccccccCc
Confidence            9998875 46899999999999999999999998533211   111111           1111000    000000000


Q ss_pred             ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       456 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ............+.+|+.+||+.||++|||+.|+++
T Consensus       267 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             GGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000111122345778889999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.94  E-value=1.1e-27  Score=235.99  Aligned_cols=171  Identities=13%  Similarity=0.126  Sum_probs=127.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcC-----CCCcEEecccccccccCCCCc-----ccccc
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-----EMNPKISDFGMARIFSGNQNE-----ANTNR  383 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~-----~~~~kL~Dfg~a~~~~~~~~~-----~~~~~  383 (541)
                      ..+++.++..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.+......     .....
T Consensus        96 ~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~  172 (293)
T d1csna_          96 RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN  172 (293)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCc
Confidence            35899999999999999999999999   999999999999974     567999999999876543221     12334


Q ss_pred             cccCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccccccccccCCCCHH
Q 009186          384 VAGTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALELMDPVLKQTCVDA  463 (541)
Q Consensus       384 ~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  463 (541)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||..................-.....     +.+....+  
T Consensus       173 ~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-----~~l~~~~p--  245 (293)
T d1csna_         173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----RELCAGFP--  245 (293)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH-----HHHTTTSC--
T ss_pred             eEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh-----HHhcCCCC--
Confidence            67999999999999999999999999999999999999998643332222111111111000011     11112222  


Q ss_pred             HHHHHHHHHhhhcccCCCCCCCHHHHHHHHhcC
Q 009186          464 ELLKCIHIGLLCVQEDPAHRPNMSSVVVMLASD  496 (541)
Q Consensus       464 ~~~~~~~l~~~cl~~dP~~RPt~~evl~~L~~~  496 (541)
                        ..+.+++..||..+|++||+.+.+.+.|++.
T Consensus       246 --~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         246 --EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             --HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             --HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence              3466788899999999999999988887653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=238.84  Aligned_cols=173  Identities=21%  Similarity=0.259  Sum_probs=121.5

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc--ccccccccCCCC
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVAGTYGY  390 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~~y  390 (541)
                      ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+......  .......||+.|
T Consensus       111 ~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y  187 (318)
T d3blha1         111 LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY  187 (318)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGG
T ss_pred             ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHH
Confidence            345889999999999999999999999   999999999999999999999999999876543322  122335689999


Q ss_pred             CChhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc--CCcccc---------ccccccC
Q 009186          391 MAPEYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK--GEALEL---------MDPVLKQ  458 (541)
Q Consensus       391 ~aPE~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---------~~~~l~~  458 (541)
                      +|||.+.+. .++.++|||||||++|||++|+.||....   .........+....  ......         +......
T Consensus       188 ~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T d3blha1         188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQ  264 (318)
T ss_dssp             CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSC
T ss_pred             hhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC---HHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccc
Confidence            999998765 58999999999999999999999985321   11111111111100  000000         0000000


Q ss_pred             CCCHH-------HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          459 TCVDA-------ELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       459 ~~~~~-------~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      .....       ....+++|+.+||+.||++|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         265 KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00111       1234567899999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.5e-27  Score=235.90  Aligned_cols=175  Identities=23%  Similarity=0.306  Sum_probs=122.9

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCc-ccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aP  393 (541)
                      .+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus       105 ~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aP  181 (345)
T d1pmea_         105 HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP  181 (345)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechH
Confidence            4899999999999999999999999   999999999999999999999999999865433222 223446789999999


Q ss_pred             hhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcCCccc-----------cc--cccccC-
Q 009186          394 EYAME-GVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKGEALE-----------LM--DPVLKQ-  458 (541)
Q Consensus       394 E~l~~-~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~--~~~l~~-  458 (541)
                      |.+.. ..++.++||||+||++|||++|+.||.......   ................           ..  .+.... 
T Consensus       182 E~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (345)
T d1pmea_         182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV  258 (345)
T ss_dssp             GGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCC
T ss_pred             HHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCC
Confidence            99854 457899999999999999999999985322110   1111100000000000           00  000000 


Q ss_pred             ---CCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH--Hhc
Q 009186          459 ---TCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM--LAS  495 (541)
Q Consensus       459 ---~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~--L~~  495 (541)
                         ...+....++.+|+.+||+.||++|||++|+++.  |+.
T Consensus       259 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~  300 (345)
T d1pmea_         259 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  300 (345)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             CHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence               0000112357789999999999999999999974  543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.1e-27  Score=236.32  Aligned_cols=179  Identities=23%  Similarity=0.263  Sum_probs=124.4

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      ..|++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......     ....||+.|+||
T Consensus       116 ~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aP  187 (346)
T d1cm8a_         116 EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAP  187 (346)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCT
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCcc-----ccccccccccCH
Confidence            35999999999999999999999999   9999999999999999999999999998754322     245689999999


Q ss_pred             hhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc--------CC----------ccccccc
Q 009186          394 EYAMEG-VFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK--------GE----------ALELMDP  454 (541)
Q Consensus       394 E~l~~~-~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~----------~~~~~~~  454 (541)
                      |.+.+. .++.++|||||||++|||++|+.||......   ..+.........        ..          ..+....
T Consensus       188 E~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (346)
T d1cm8a_         188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK  264 (346)
T ss_dssp             HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC
T ss_pred             HHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH---HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCccccc
Confidence            998764 5689999999999999999999998533211   111110000000        00          0000000


Q ss_pred             cccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH--HhcCCCCCCCCC
Q 009186          455 VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVVM--LASDTATLPPPT  504 (541)
Q Consensus       455 ~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~l~~p~  504 (541)
                      .+. .........+.+|+.+||+.||.+|||+.|+++.  |+........|.
T Consensus       265 ~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~  315 (346)
T d1cm8a_         265 DFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ  315 (346)
T ss_dssp             CGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C
T ss_pred             chH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccccc
Confidence            000 0111122356788899999999999999999973  665443333333

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.93  E-value=1.1e-27  Score=239.89  Aligned_cols=171  Identities=18%  Similarity=0.213  Sum_probs=120.3

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCC-CcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      .+++.++..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.......   .....+|..|+||
T Consensus       125 ~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aP  198 (328)
T d3bqca1         125 TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGP  198 (328)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCc
Confidence            4899999999999999999999999   99999999999998765 589999999987654332   2345689999999


Q ss_pred             hhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHH--H-----HHHHhhhcCCc------cccc-------
Q 009186          394 EYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLL--T-----YAWKLWCKGEA------LELM-------  452 (541)
Q Consensus       394 E~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~--~-----~~~~~~~~~~~------~~~~-------  452 (541)
                      |.+.+.. ++.++|||||||++|||++|+.||............  .     .....+.....      ....       
T Consensus       199 E~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (328)
T d3bqca1         199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR  278 (328)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCC
T ss_pred             ccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccc
Confidence            9987654 799999999999999999999998543221110000  0     00000000000      0000       


Q ss_pred             -cccccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          453 -DPVLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       453 -~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                       ...............+.+|+.+||+.||++|||++|+++
T Consensus       279 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000011111112345778899999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.7e-27  Score=236.15  Aligned_cols=180  Identities=22%  Similarity=0.275  Sum_probs=130.3

Q ss_pred             HHHHHHHHHhhheeccccccccCCCCccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEeccc
Q 009186          288 TTITLFILLGSFVWCRRRINKDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG  367 (541)
Q Consensus       288 ~~v~~~~~~g~l~~~~~~~~~~~~~~~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg  367 (541)
                      +++++++.++.|...++.       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       105 ~~v~e~~~~~~L~~~i~~-------~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQ-------RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEECCCCSCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eeeeecccccHHHHHHHh-------cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeecc
Confidence            344566666666544432       234788899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCCCCCChhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhc
Q 009186          368 MARIFSGNQNEANTNRVAGTYGYMAPEYAMEGV--FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCK  445 (541)
Q Consensus       368 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  445 (541)
                      +++.+...... ......|++.|++||.+.+..  ++.++|||||||++|||++|+.||.......   ...........
T Consensus       175 ~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~~i~~~~~~  250 (322)
T d1vzoa_         175 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILK  250 (322)
T ss_dssp             EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHH
T ss_pred             chhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhccc
Confidence            99876433322 233457899999999997653  6789999999999999999999985432222   11111111111


Q ss_pred             CCccccccccccCCCCHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 009186          446 GEALELMDPVLKQTCVDAELLKCIHIGLLCVQEDPAHRP-----NMSSVVV  491 (541)
Q Consensus       446 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~evl~  491 (541)
                      ..      +.+    +......+.+++.+||+.||++||     |++|+++
T Consensus       251 ~~------~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         251 SE------PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CC------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CC------CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            11      111    112244677788899999999999     4788885

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=4.8e-26  Score=224.01  Aligned_cols=171  Identities=20%  Similarity=0.239  Sum_probs=121.5

Q ss_pred             ccccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCCh
Q 009186          314 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAP  393 (541)
Q Consensus       314 ~~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  393 (541)
                      +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++........  .....++..|+||
T Consensus        96 ~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~p  170 (292)
T d1unla_          96 GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPP  170 (292)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCH
T ss_pred             cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhh
Confidence            45889999999999999999999999   999999999999999999999999999876543322  2234567889999


Q ss_pred             hhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC---Ccc---cc--------ccc-ccc
Q 009186          394 EYAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG---EAL---EL--------MDP-VLK  457 (541)
Q Consensus       394 E~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~--------~~~-~l~  457 (541)
                      |.+.... ++.++|||||||++|||++|+.||..  ..................   ...   ..        ... .-.
T Consensus       171 e~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (292)
T d1unla_         171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL  248 (292)
T ss_dssp             HHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCC
T ss_pred             hHhccCCCCCchhhccccchHHHHHhhCCCCCCC--CCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchh
Confidence            9987665 68999999999999999999999632  111111222111111110   000   00        000 000


Q ss_pred             CCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          458 QTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       458 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..........+.+|+.+||+.||.+|||++|+++
T Consensus       249 ~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         249 VNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0111122345778889999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1e-25  Score=227.36  Aligned_cols=182  Identities=21%  Similarity=0.271  Sum_probs=123.7

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.....     ......|+..|+|||
T Consensus       117 ~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE  188 (348)
T d2gfsa1         117 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPE  188 (348)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHH
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc-----ccccccccccccCch
Confidence            5999999999999999999999999   99999999999999999999999999875422     223456888999999


Q ss_pred             hhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHHhhhcC------------------Ccccccccc
Q 009186          395 YAMEGV-FSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWKLWCKG------------------EALELMDPV  455 (541)
Q Consensus       395 ~l~~~~-~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~  455 (541)
                      .+.+.. ++.++|||||||++|+|++|+.||......   .............                  .........
T Consensus       189 ~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (348)
T d2gfsa1         189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN  265 (348)
T ss_dssp             HHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCC
T ss_pred             hhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcc
Confidence            877654 688999999999999999999998532211   1111111000000                  000000000


Q ss_pred             ccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcCCCCCCCCCCCCc
Q 009186          456 LKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASDTATLPPPTQPAF  508 (541)
Q Consensus       456 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~l~~p~~P~~  508 (541)
                      +.. ........+.+|+.+||+.||++|||++|+++  .+++.......|..+++
T Consensus       266 ~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~  319 (348)
T d2gfsa1         266 FAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY  319 (348)
T ss_dssp             HHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC
T ss_pred             hhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC
Confidence            000 00011245678899999999999999999997  56655444444444444

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3e-25  Score=224.49  Aligned_cols=168  Identities=22%  Similarity=0.215  Sum_probs=116.2

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.++..++.||+.||+|||+.|   |+||||||+|||++.++.+|++|||+++......   ......+|+.|+|||
T Consensus       115 ~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE  188 (355)
T d2b1pa1         115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE  188 (355)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChh
Confidence            4899999999999999999999999   9999999999999999999999999987654332   223456899999999


Q ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHH-------------------HhhhcC------Ccc
Q 009186          395 YAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAW-------------------KLWCKG------EAL  449 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~-------------------~~~~~~------~~~  449 (541)
                      .+.+..+++++||||+||+++||++|+.||......   .......                   ......      ...
T Consensus       189 ~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (355)
T d2b1pa1         189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP  265 (355)
T ss_dssp             HHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHH
T ss_pred             hhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH---HHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccc
Confidence            999999999999999999999999999998532110   0000000                   000000      000


Q ss_pred             ccccccccCC---CCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 009186          450 ELMDPVLKQT---CVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV  491 (541)
Q Consensus       450 ~~~~~~l~~~---~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~  491 (541)
                      ..+.......   ........+.+|+.+||+.||++|||++|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0111111111   11234567889999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.92  E-value=7.3e-25  Score=222.18  Aligned_cols=188  Identities=20%  Similarity=0.212  Sum_probs=130.7

Q ss_pred             CccccHHHHHHHHHhHHHHHHHhhh-cCCCceEecccCCCcEEEcCCCC------cEEecccccccccCCCCcccccccc
Q 009186          313 GAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMN------PKISDFGMARIFSGNQNEANTNRVA  385 (541)
Q Consensus       313 ~~~L~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~DLkp~NIll~~~~~------~kL~Dfg~a~~~~~~~~~~~~~~~~  385 (541)
                      ...+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.      ++++|||.+......     .....
T Consensus       119 ~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~  190 (362)
T d1q8ya_         119 HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSI  190 (362)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCC
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeecccccccccc-----ccccc
Confidence            4568899999999999999999998 77   999999999999987654      899999998764322     23456


Q ss_pred             cCCCCCChhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcCcCcHHHHHHH---hh--------hc---------
Q 009186          386 GTYGYMAPEYAMEGVFSVKSDVFSFGVLLLEIISGKRNSGFYLSEHGQSLLTYAWK---LW--------CK---------  445 (541)
Q Consensus       386 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~---~~--------~~---------  445 (541)
                      ||+.|+|||.+....++.++||||+||+++||++|+.||.................   ..        ..         
T Consensus       191 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  270 (362)
T d1q8ya_         191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFN  270 (362)
T ss_dssp             SCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBC
T ss_pred             ccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccc
Confidence            89999999999999999999999999999999999999854332211111111110   00        00         


Q ss_pred             -CCccccccc----------cccCCCCHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhcC--CCCCCCCCCCCc
Q 009186          446 -GEALELMDP----------VLKQTCVDAELLKCIHIGLLCVQEDPAHRPNMSSVVV--MLASD--TATLPPPTQPAF  508 (541)
Q Consensus       446 -~~~~~~~~~----------~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~evl~--~L~~~--~~~l~~p~~P~~  508 (541)
                       ......+..          .............+.+|+.+||+.||.+|||++|+++  .+++.  ..+...|.+|..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~  348 (362)
T d1q8ya_         271 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY  348 (362)
T ss_dssp             C--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred             cchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccC
Confidence             000000000          0112234566778999999999999999999999987  36532  334455555555

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.16  E-value=1.9e-12  Score=117.58  Aligned_cols=91  Identities=16%  Similarity=0.165  Sum_probs=62.9

Q ss_pred             cccHHHHHHHHHhHHHHHHHhhhcCCCceEecccCCCcEEEcCCCCcEEecccccccccCCCCcccccccccCCCCCChh
Q 009186          315 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVAGTYGYMAPE  394 (541)
Q Consensus       315 ~L~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  394 (541)
                      .+++.....++.|++++|.|||+++   |+||||||+|||++++ .++|+|||.+....+........+....    -.|
T Consensus        99 ~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~  170 (191)
T d1zara2          99 RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IIT  170 (191)
T ss_dssp             GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH
T ss_pred             chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH
Confidence            3666777889999999999999999   9999999999999965 5899999998764322211100000000    011


Q ss_pred             hhccCCCCcchhhHHHHHHH
Q 009186          395 YAMEGVFSVKSDVFSFGVLL  414 (541)
Q Consensus       395 ~l~~~~~s~~sDVwSlGvll  414 (541)
                      . ....|+.++|+||+.--+
T Consensus       171 ~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         171 Y-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             H-HHHHHCCCCCHHHHHHHH
T ss_pred             H-HcCCCCCcccHHHHHHHH
Confidence            1 235678889999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=87.13  E-value=0.16  Score=45.54  Aligned_cols=30  Identities=27%  Similarity=0.362  Sum_probs=25.2

Q ss_pred             CceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+.+.||++++++..-|+||+.+.
T Consensus       183 ~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cEEEEeeccCcceeecCCceEEEeechhcc
Confidence            348999999999999977666799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=85.90  E-value=0.16  Score=45.28  Aligned_cols=30  Identities=23%  Similarity=0.274  Sum_probs=25.4

Q ss_pred             CceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      ..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         175 LVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            358999999999999987667799998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=85.72  E-value=0.096  Score=48.80  Aligned_cols=29  Identities=34%  Similarity=0.358  Sum_probs=25.6

Q ss_pred             ceEecccCCCcEEEcCCCCcEEecccccc
Q 009186          342 RVIHRDLKTSNVLLDHEMNPKISDFGMAR  370 (541)
Q Consensus       342 ~ivH~DLkp~NIll~~~~~~kL~Dfg~a~  370 (541)
                      .+||+|+.++||+++.+...-|.||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            49999999999999988767899999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=81.16  E-value=0.52  Score=45.18  Aligned_cols=30  Identities=27%  Similarity=0.355  Sum_probs=25.6

Q ss_pred             CceEecccCCCcEEEcCCCCcEEeccccccc
Q 009186          341 LRVIHRDLKTSNVLLDHEMNPKISDFGMARI  371 (541)
Q Consensus       341 ~~ivH~DLkp~NIll~~~~~~kL~Dfg~a~~  371 (541)
                      ..++|+|+.+.|||++++ .++|+||..+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            359999999999999876 489999987754